>SEQF2502_00001 hypothetical protein
MNKERLAAFMDAVLAIIMTILILELKKPETATLKALWNLRVNFFAYTISFFWLGTMWINM
HNEWHKIKYITPAVVWANVVLLFFSSFFPYVTSFVTSYYNSSVAQGFYGIIVLAVTFCNI
ISGHLIGKANRNDEKLQESLKIRMRWLSIDTIIKIIGLIISCTFYPPAMMTSVYITLLGI
VLPAQYKAAKRRREK
>SEQF2502_00002 HTH-type transcriptional regulator VirS
MKFFQLIPSGQFGLENVAEEFGISGRTLQRNLSAENTSFNQLVKDIQKIMTFNYLEAEEL
SIDEIAYLVGYTEISSFYRAFKNWTGKTVSQYQKEK
>SEQF2502_00003 hypothetical protein
MKENRELELKLTITNTFLKTVSAFANYGSGRIIFGIDDNGKIVGIDDLDETCLSLENKIN
DNIVPKPNFSFIKNNRDKTITLVVKEGLDKPYLYKGKAYKRNDTSTVEVDRLELNRLTLE
GMNRYFEELRSNDQELKFEVLKKELKEKLAIENFSIDLLKTLNLYDDKEGYNNAAALVAD
KNSFSGIDIARFGKDINEILDRNTFVNMSIFSQFHKTIEVFERYYKYEEIQGFERIEKEL
IPEKAFREVIANAIIHRTWDINSNIRISMFENRIEVVSPGGLPSGITEKEYLNGQISQLR
NPILGNVFFRLKYIEMFGTGIRRINEIYRNYSTKPIYEINENSIKITLFTIFNKIFLSKD
EKIVFEILKDGNILSNKEISEITGFKKDKNLKLLKSLVEKKYIVTIGNGRGTKYYKN
>SEQF2502_00004 hypothetical protein
MKRIVILLSLVLGSLSFSFGLGYPQITVEKGYCEGGKVIRRYTMGEEVHGGGGTRTVMNF
KLCRINGLRYRNIGVTILGYYKNSTLSMNEGINIAIDYDKRIIFYDPAGL
>SEQF2502_00005 HTH-type transcriptional activator HxlR
MRKIYTECPVEYTASMIANKWKILILRDLLTGTKRYNELTKSIVGISAKVLTENLRQLES
DGIVVRKVYPVVPPKVEYSLTKKGSELKPIFDLMNEYGNKYKKK
>SEQF2502_00006 hypothetical protein
MKNYSIGIADGARTEFHQTLGLTGAEVSFNSLPAGVSVPFVHSHKENEEIYIITEGKGTL
TIDGEVVKIKKGNVIKISPNGKRQFAAADDEGISYVCVQVKENSLTSYTENDAIIY
>SEQF2502_00007 hypothetical protein
MTHTEHIIKVMPTGESVWKENPKVLGISEKRYYFDSNGEIVRYIDEK
>SEQF2502_00008 Putative HTH-type transcriptional regulator YwnA
MQISSRFTIALHIFACVEVFKDEYKITSDFLAGSINTNPVIIRKILTQLKNAGLITVARG
IGGIEVTKPLKEITFYDVYVAIEPLENNELFNFHKNPNPECPVGKNIHKLLDRKMETIQK
AMEDEMKKYTLESLKNEIQEILGKED
>SEQF2502_00009 Protein-ADP-ribose hydrolase
MEKNKEQEKRLDYLLEEFKADSVEYKDIEIPEDINGKRCILRSLMNVRMPKKMSDSVLKV
QDEYLSVCAEEKGIVQLSDIPVTKGNISIWQGDITRLEVDAIVNAANSQMLGCFIPMHMC
IDNQIHTYAGVQLREECSHKMKELRKKYGSYYEQPTAIPMITNAYNLPAKNVIHIVGPIV
RNRLTAELEQELADCYTNVLNMCLENNLKSVAFCCISTGVFCFPNKRAAEIAVDTVQKWL
VENPNAMERVIFNVFKEEDKKYYEEILQ
>SEQF2502_00010 hypothetical protein
MKKSYSRRNGYLETIQKGLVVLGTFENKFSLGKGSREERIELLKNEIQNADAIVVGAGSG
LSTSAGFTYSGERFEKYFFDFIKEYGIADMYSGGFYPFPNDEIRWAWWARHIYFNRYVKA
PKPVYNELFSLLKDKDYFVITTNVDHQFQKAGFDKKRLFYTQGDYGLFQSVNPQIQKTYD
NEEWVMKAMEAQGFVKDENEVFSIPMNGEILMRIPAELIPKCPDDGSDMTTNLRADSSFV
EDEGWHKAS
>SEQF2502_00011 hypothetical protein
MHILFLELGVGRNTPVIVKYSFWYMTMENKKAVYACINYREAFCPIKLEDRSICLDGDIG
EVLGEIYKKIEEDI
>SEQF2502_00012 hypothetical protein
MKKERLVAFFDAIIAIVMTVLVLELPKIHGTTLSAIWENRVHYFAYITTFTLFAVFWDTH
HTIFDKVEKVTPKIARIQIFLLFLNTLFPYITSWVSENPHSYLVECVYTFFLLGANIVYS
WLCDELMKADSKNIKLKNTITTLRRHKIATILQSSSLIIGLFNPMFMLIIGFISLSIWYI
PMPKIRKNK
>SEQF2502_00013 NADP-dependent 7-alpha-hydroxysteroid dehydrogenase
MKKVILLTGASSGIGYQTAESLAKEGHVVYGAARRTEKMETLKQFGVKPMYLDVTDEESI
KSAIDTIIGNEGRIDVLINNAGYGSYGAIEDVEISEAKMQFEVNLFGLARLVQLVLPHMR
KQKSGRIINVSSMGGRMTSYFGGWYHATKYALEAFSDALRMEVADFGIDVSLIEPGLIKT
DWGIIAANKLVDSSKDGAYEKEALRTSEGMKKQYSGNMGSNPIVITKAISKAVNSRRPKA
RYLIGFMAKPLVFLHTVLPARIFDKIMKNASK
>SEQF2502_00014 HTH-type transcriptional regulator VirS
MKITMPKQFQDFLKSIGLSIENILEETGIPNILWKEEIQLSTEEYYLFLKKIDEVITDEQ
ISAISNIDNLNVFIPSFFAALSSKNGREGLKRLAKYKKLIGPVFLEIKEFEEIVQVQYFF
EQREKELPRFAVLNEQLMLINLLNKGIGEKISPVSVTSPFEYGELLTKEINTAINKAKQN
EVIFSMKDLKKPFLTANNIMVEYLEPQLKQKLAEMESETFETFASRVQKKLFQLIPSGRF
GLENVAEEFGISGRTLQRNLSAENTSFNQLVKDIQKIMTFNYLETKELSIDEIAYLVGYT
ELSSFYRAFKKWTGKTVLQYQKGKK
>SEQF2502_00015 NADP-dependent isopropanol dehydrogenase
MGEKMKAFVMKRIGEVGWITKDRPKCGPTDAIIKPLALAPCTSDIHTVYEGGVGERHDMV
LGHEACGEVVEVGELVKDFKVGDKILVAAITPDWNSVEAQAGYPMHCGGMLAGWKFSNVK
DGVFGEYFHVNDADGNLALIPKGMDYGTACMLSDMVPTGFHSAELADIQFGDVVAVFGLG
PVGLMGVAAAALKGAGRIIAVDSREQVVPIAKAYGATDIVDFKKAPADEQIMELTDGKGV
DRVLIAGGDQKVFATAVKVLKPGGRIGNVNYLGSGEFIEIPRVEWGAGMGHKQIFGGLMP
GGRLRLEKLARLIEFGKLDPSLLITHRFEGFENVEKALELMRTKADGVIKPVVYMTSQRI
NE
>SEQF2502_00016 Zinc-binding GTPase YeiR
MKKLRILVISGFLGAGKTTFIKEMVKSTKREYVIFENEFGDVNIDGEILRNNTEEMKENN
QKNGNVELNVWELTSGCACCSTKADFISSLLVIDNTLNPDFLIVEPSGIAILSNILKNVT
NTGYDRIKMFPPITIIDAGTYFKYKNKYDEIFIDQIKMAAHIQLSKVENMADEELQLIYE
DIKSFNPNADIFTNDYHNQNTDYWNALFSGELVKTENSDLIDVKNKMQNMTYKNSYSDNP
AILVSFLEKLISGFYGDINRAKGVFKGNDYNMHFDVVDTNYNITILEDSSENNAVFIGNP
IDKELLIKELDEMKNLK
>SEQF2502_00017 hypothetical protein
MKQKNIFLRGIDSFTLHILAILFMTLDHSWNVFFVNQNQIRMNLLGRLAFPIFAFMLVEG
FYKTKNRSKYLKRIFIFAVISEIPFNLLLSTSIFESPSIFFPYNNVLWTFGIALYMLVLI
EKIKNKDNLPVTVKIFGKIIISILAMFITRLIGSDYLEYGIMTVLVFYFFRSRKWWNFVA
QVILLAWINIFLIPRYDFSFYLFGNKIYAPVQSFAIFSLVFIWLYNGKQGIHNKITKYMF
YSFYPLHLLLIVMIYIFLKKYIIY
>SEQF2502_00018 Lipopolysaccharide assembly protein B
MKKIILILVSVLFLVSCSGGIPFSEEEKGALKKAKTEIAEMKKNPTMAEKEKILQKGLEV
QEKYLRIGVVYFKSVEKDIPIADYYLARNYSARGEKEKALKWARKGSDRGVKEASAFAGQ
IYANQRDEMNARKYYIKAMDQGDYREDTLFRVWVYGERKEINSEVVEAFKRNLNKNIEVK
NALAFYYQRHDYFDEAEKLYKELVNEKYPNAERLLGELYMWKKDYDKAEEWLLKESEKLF
SHSEDNVKRIEEKRARLLRLLAEVYEMKGDYGKAENSLLKAKELAHKELALTSLAKLYEK
QGKYNQALKINEELEELEKIEKQKKLNHKRNKKWRVL
>SEQF2502_00019 hypothetical protein
MRIEKLEFVKNIDKFENNSDEYVEINLNRKVTELSSVSYEKKLYSFYLLIGEDGRINSLE
ILNILKMAKFTHKIEIPENIIEGDIYFKREEYNEAGIKVKELDFLEIDIPKNIIGCYFTD
NKLNIYFGVKICENIVILINRDNYAEGILIYGKFEIEDDRFYWKK
>SEQF2502_00020 hypothetical protein
MENLKLKMIDFTGKSENVVSERDMIFSFNNGEIKIYLSYETGELKKIEIVSENEKIEKEI
GMEAVLKFKGNSVILDYEYGLYEYVEIEIEDKLEKYWADGKTVYLKEGKKIFLEVEIWEG
YLLFFDDECRMAGFGTEFKNRKE
>SEQF2502_00021 hypothetical protein
MNKYILLMLLCLLIGCRNQGNDVVIKDIDDVYFYLENKKNPEKAQLMARIAYELNKENYK
EAEKYFLKVAKYDKTAYVSIADMYYEHIDENEGKKRYKIAFEKGNKKAGTILGMIAEDNN
DYKKAEEWYKKSLDKENVLGYKSFATFLYKTNRKNEAEKYFIEAGNRKDADSMLYLIKIY
YMKKDNEKLKYWQDKILNTKEIFRFDDEANDLLEYSLSKDRMDKEFFELYIKGEESILKK
DYDTAEKYFLQMEKLKKEGILYTADFYYRFKDEKEKGMEKYKKAYENGLKKAAVFIGIIE
HRNRNIDEAKKWYRIAANAEYTDSQIYLAQILEEEGYKLESFDLYLKAAELKDYRAIDYL
LKYYYRGKKLKEIKEWVDVVKNSTKLKNYNEGQSGRIKQYEKFLKEKE
>SEQF2502_00022 hypothetical protein
MKNEDFMFDEYDVVKAKRKLSDKVLKNSIGTVVMIFPEFLNDYMVEFMEDEKTLDILVIK
GD
>SEQF2502_00023 putative pyridine nucleotide-disulfide oxidoreductase RclA
MKKYDAVIIGFGKGGKTLAGFLAGKGQNVALIEKSDKMYGGTCINIGCIPTKKLVDSTKV
LKNKGLSGIEEKERFYTKSINNKNTLIGALRGKNYEMLATKENIDIYDGFGSFVSKNVVN
IESNGENVQIEGEKIFINTGSTTIIPGIKGLKESNYVYTSTSIMELKELPKKLTILGAGY
IGLEFASMYADFGSEVTVIDLAQRLMPREDEEIADRAKAIFEAKGIKFLLESKIEEIIDK
NGKGYVQISQGSSKSEIESDAILVAIGRKPNTEGLNLEAAGVKTDEKGAVIVDETLKTAA
DNIWAMGDVKGGLQFTYISLDDFRIIRDNLYNGGNRTVKDRNVIPYSVFVNPPLSRVGMT
ESEAIAKGYEVKTGRLEAMAIPKAKIEGVTDGLLKAVVDAKTDKILGCTLLCNTSHEMIN
IVAAAMKAEQKYTFLKDMIFTHPTMSEALNDLFGSVK
>SEQF2502_00024 hypothetical protein
MEDIIKKVNEFSKLARERELTEEEKKEREKYRKMYIEKFKESMRGHLDSIKVVRVDDDGN
PIDDDGNVIEPEA
>SEQF2502_00025 Phosphoglycolate phosphatase
MKYDLVIFDLDGTLMDTSKSITKTVNSAMEELGKKQYSANECVKFVGGGVSGLARNILGK
EKYDDIMNEEMEKVIRKYYDIYFDYGVEPYEGIPELLDFLTEKNIKKGIVTNKDHETALS
AVEKKLSKWKFDGIFGSNEKEYPNKPNPYNVDRMAQDLNVSKDKILFIGDMLVDVNTAKN
AGVDIVYCKWGFGEVKGETGISEDVKVSNVQEIIKKIK
>SEQF2502_00026 tRNA-specific 2-thiouridylase MnmA
MEKRKRVVLGMSGGVDSSVAAILLKEQGYDVIGVFMKNWEEKDENGVCMAEEDYKDVIAV
AEQLEIPYYSVNFVKEYWDKVFTYFLDEYKRGRTPNPDVMCNKEIKFRVFLDYAMKLGAD
YVATGHYARINHEEVEDENGKRIKSTMLRGVDDNKDQTYFLCQLSQEQLEKVLFPLGKYT
KPQIREIAEKYNLATAKKKDSTGICFIGERDFNKFLSQYLPAKGGDIVNTHGKVLGHHNG
LMYYTIGQRKGIGIGNTKEGTGEPWFVVDKDLEKNELIVTQGDNSVLYSKGLIATDFNFI
NEVQFPLECTVKFRYRQKDTKAVINKLDENKYEVMFDEPQKAVTLGQIVVAYDGEVCLGG
GVIDKIIK
>SEQF2502_00027 hypothetical protein
MKELVFCLNATMPVFLLMILGYVFRRVGVIDLEFADKMNRFVFLALLPVLLFKELSLSDF
SAIWDLKYLLFCFFTTFLSILIMCISSIFLKDRSIRGEFIQASFRSSAALLAYAFVQNVY
GEAKIVALMVIGAVPLYNVASVVILMLLRPKQGKLNRVVLKNTLKGVIKNPLILGILAGM
IWAMLKIPQPVIMKKSISTFAAAATPLGLLALGASFDVKEVFSKIKVVLVSSSFKLIILT
AIFLPIAVKMGFKDEKLVAVLGMLGSPTTPTSFTMARGMGHNGSVTSGTVMVTTIMSIFT
LTSWLYILKIAGLV
>SEQF2502_00028 hypothetical protein
MKLKKYFLIGMTALLVVVSCNNKKDNKNKEKVKVVGVKKDISKEEIKKYSEYLKISEEPN
SEEWNDFFTEIKKDEFFEKNGNIKDISGEIISIVNLDDSINLIGEYIKEITDEMQKSPKM
ESIDKNAENLVDSLIQEQKVLTEINDYFEKGDYKTDKLGKVDELNEKYKVVLRNRIENSK
ILSNSLHEFAEAINKKMEAQLQMDGKTAKLSILKFVNSADRFAEAAFSKNNLNFDEEEIK
GLEKANNELQKAYKNIAKMTVESAKKENISESDFKKIKESSETLSENTQKMLTGVKNQNI
QDVVISASNILSAKTDLENVFNVLLMQNNK
>SEQF2502_00029 L-cystine-binding protein FliY
MKKILLLMALALSVFMCSVQKEEKKEEDNASGIPKKMVVGLDDSFVPMGFKNEKGEIVGF
DIDLARAVAQKLGSEVEFKPINWDSKILDLNGGNIDLIWNGLTITDERKKETEMTKPYLT
SHQLIIVKAGSSIKTKADLKGKIVGSQTESSGEEAVKKSGEDKTFKEFKTYAQYDQAFMD
LDAGRIDAIIADEVLAKYTKKTKETQAKKELYSILGDNYGEEEYGIAAKKGNTKLVEAIN
KAIEELKADGTYQKIYSKWFKD
>SEQF2502_00030 Glutamine transport system permease protein GlnP
MRQALPIFIELVKTLPNIIVLYILTILFSIPLGILGALAYAGKNKIIKFFISVYTWIFRG
TPLMLQLMVVYYGIPLMKIGGYKIVLEPYTAATITFIINYAAYLVEIMRSGIESIEKGQH
EAAKVLGYSYWQKIIYVILPQAIRRVLPTLGNEAITLIKDTSLIYVLAVTEVMKRTKELA
NIYYNITPYICAIIIYLVLSFAIDRLFKNIEKRNKVRI
>SEQF2502_00031 Glutamine transport ATP-binding protein GlnQ
MKSEKIAKDRKNMEEKKIVEVKKLKKQYGDNVILKNINLHINKGEVVSLIGPSGSGKSTI
LRCIVDLESITSGEILIEGNNLTDKNVDKKIKKEMLLKTGMVFQTFNLFPHMLVRNNIVR
TLKLVKKMDTEKAENIAKEMLNLVGLSDKINSYPNELSGGQKQRVAIARALALHPDIMLF
DEPTSALDPELVKEVLDIIRKLKSQKITMLIVSHEMNFVREISDRVIVMEKGEILETGTA
QQIFENPVSRRVREFIEYK
>SEQF2502_00032 Methionine import ATP-binding protein MetN
MEGFIKIKNLVKKYQNNNSKELLAVNNVNLDIGQGDIYGIMGLSGAGKSTLIRLLNRLEE
PTSGEILVKQEIVDKKNNTVTGYEYKNILKFNMKMLRQYRKKTGMIFQHFNLLNSRSVAE
NVAFPLEISKWKKKDIEKRVDELLEIVGLSDKKQNYPEQLSGGQKQRVAIARALANNPKI
LLSDEATSALDPRTTNSILELLKDINKKFGITIILITHQMEVIKKICNKTAIMSDGQIIE
KGETKEIFLNPKTDLAKEFVGNISHEEFRTEEEKKQREENNGKLRLRLKYNEDQVNESYI
TKIIRKYDVEVNILSGFIDKVGDIIVGNLLIEISASEEKAKDIIEWLKENKIDSEVL
>SEQF2502_00033 Methionine import system permease protein MetP
MGFDWIKFFQFQNMVVPLWETVYMVFISTIAALIIGLPIGILLVTSDEKGVKPNKTIHKL
LDMIIVNITRSIPFIILMVLLIPLSRLLVHKSYGSIAFIIPLSLGSAPFVARIIEGALKE
VDEGLIEASKSMGATTPEIIFKVMIPEAMPALVHGMTLTLISLIGYSAMAGTIGGGGLGN
AAVIDGYQRSKPEVMWQATIVIILLVQIIQFIGNSIVKILTNKRKRV
>SEQF2502_00034 D-methionine-binding lipoprotein MetQ
MKKILLVLVVALFFVACGNSDKSAKDAENKKVQKLKVAATPVPAGEILNVVKDDLKKQGI
ELEVVEFNDYVQPNKVLQSKEVDANLFQHIPYMENFSKKNGFEMVAVGKVYLPTLALYSK
KIKSINELKNGDTILLPNDPTNLARALILLDKGGIIKLNDNKNTEATLKDIVSNPKNIKF
EELSAEQLPPRLPEVAASIVNSSFALNAGLSYKDDGLLKEDKDSPYANVLATLKGNENDP
KIQKLLKALQSEKVKKYIEEKYKDVIIPVF
>SEQF2502_00035 Membrane lipoprotein TpN32
MRKILSLLLAIALFLVACGNKNENKESTSSQSGAAKTEKLIVGATPIPHAELLNLVKDDL
KKEGIELEVVEFNDYVQPNKALADKSIDANFFQHVPYMEDFGKKNHIDMVAVGNIHLEPM
ALYSKKIKNVNELKNGDTLIIPNDPTNGGRALILLDKAGIIKLKDNTKLDSTPADIIKNP
KNIKIETLSNEQIAPRLSEVAGAIINSNFAIDAKVTKNEIILIEGKDSPYVNVVTVLKEN
QNDERVKKLVKALQSEKVKKYIEEKYDGRVIPAF
>SEQF2502_00036 Neutral endopeptidase
MKKLLIVSLFLASINLIYAENENVDNSKLSLEKVNQNNGNLTTKPVQQRSGFWDFYEKQQ
AKLLKEKDKELFDDLSTKSKAQDDFYKYVNENWDKKTQIPSTKPAWGSFYELNEKNQDFL
RNLIKELKSKKASLTADEKKVLTLYDSYSDMKKRNEEGLSPIQKDLEKINGIQNIEDLKK
YNVEVTKYGSSEFYGWGVGTDLNNSKNNAVYLGSAGIGLSRDYYQKDTKENRAILEEYTK
YVSDMLKYLGEDNTLERAKKIVAFEKKIANTLMTNEERHDVKKYNNPVKVSDLGTLSKNV
DLAQYLKQLNVKTDKVIITELNYYKNLDNFVNDENIDIIKDYMRYNLISSAAGVLNDELG
ARSFEFFGKYLNGQKERETLEKRALNFTDGSLGEIIGKIYIQRNFSPEAKKNAKEMVDYI
KKAMKNRIEKLDWMSAATKKKALEKLAKVNVKIGYPDKWKDYSKMTISSNDSLYDQLKGI
SEWGYNEELKKVGKPVDKTEWYMSPHTINAYYSPTSNEIVFPAGILQYPFYDYSKLEVAS
NFGAIGSVIGHELTHAFDVSGAEYDGDGNVKNWWTAEDKAKFDMATKKLENQFSKYTVGD
GVYVNGKYTLTENIADLGGLNVAYDALQLYLKDHPNSSKAYPDTINKLFFLSFARMWRQK
STPEYLKNLAKTDSHSPNIFRVNGTLENIDAFHKVFETKPGDKMYKAPEDRIKIW
>SEQF2502_00037 UDP-3-O-acyl-N-acetylglucosamine deacetylase
MKRKTIKNIIEIFGIGLHKGKEIKMKLKPVNQETGIVFKRMDVTDKNNIIKVAYKNLFDL
ERGTNIQNEDGVKLHTIEHFMSALSVCGITDIFVEIEGNEMPILDGSSIQFVEKIESAGT
SELDEEIEPVVIKEPVIFSDEKAGKYVMALPYDGFKISYTIDFNHSFLKSQYYELEVNFE
NYVENIAKCRTFAFDYEIDFLKKNNLALGGSLENAVVVGADGPLNPEGLRYPDEFVRHKI
LDIIGDLYVLGTPIKSHIIAIKAGHFVNSQLTGMIAKKYL
>SEQF2502_00038 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ
MATNETIMNVEDIMKILPHRYPFLLVDRVIEKNGTDSLVAIKNLTMNEEFFQGHFPGKPV
MPGVLQMEALAQAVGLLMLEPGKIPLFMSIDKCKFRKPVVPGDQLRLEVEKLSVRRNIIV
AKGKCLVDGAVVSEGELKFAVTDM
>SEQF2502_00039 Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase
MSLNNIHPTAIVDPNAKLGENVKIGAYSIIGPEVTIGNGTIVESHVVIEGETIIGENNYI
FSFASIGKEPQDLKFAGEKTRVVIGNNNKIREFVTIHRGTIDKYETRIGNNTLVMAYVHI
AHDCIIGDNCVLANAATFAGHVEVEDYAVVGGLTAVHQFTRVGRHAMIGGCSAVNQDVVP
YMLSEGNKARAVYINIVGLQRRGFSEEQIKRLRELYKIIFKKKLKLEKALQTVERDYGQY
EEAQNLINFIRKSKRGITR
>SEQF2502_00040 hypothetical protein
MTMKKVGLIAGNGKLPELFLNQCTLKGIEPFSVYLFESVEDDVKKHKNSVKYSVAQVGKI
ISYFKKNGITQLIMLGKVEKNLIFSNLKFDLTATKILLSTKNKKDKNILKAIINYIESEN
IEVLPQNYLLDEYIARNEVYTKISPNKNEEKTIEIGIEAARMLTDIDAGQTVVVKDESVI
ALEGVEGTDKTILRGGELAGKNCIVVKMARRNQDYRIDVPTIGLETIKKVAEINACGIVI
EADKMLFIDKEEVINFANKNKIFIKGIKI
>SEQF2502_00041 Lipid-A-disaccharide synthase
MKNNNDSLNLKKKKKIFISCGEMSGDLHASYIVEEMRKKDENIEFFGVVGDKSIKAGVKA
VNHIKNNDVMGFVEALKKYRYFTKKAREYLQFIRENEVETVIFVDFGGFNLKFFELLKKK
ILKKELQNLRMIYYIPPKVWAWGKGRIKKLRKFDDVIVIFPFEKEYYDESLRKDKSKGLK
VEYFGNPFVDKYDFSDKLGKKILLLPGSRRQEIEKFLPIIVKLIRNEKVKNEKFLMKLAN
EEHKKYIRDFKEKYKIDVLKIPNLEITFDEIKNIRKDCKYAIATSGTVTFEISLTGLPVI
VVYKTSAINAFIARHIVKIKYITLTNLNADKEIFKELLQEDFSEEKLLKEMGIIEKNKKN
IVLELKKEREKLGNFGVLKKIANYLLKK
>SEQF2502_00042 Multidrug export protein MepA
MEKKREELLKGSILKLFVKYFIPTLIGSAAVVLYNIVDRFFVGKISEKALAGAGIAFYIV
MLIIAFSMFIGVGAGTIISIRLGQGKKGEAKKILGNAITLFAILGLLLYAFLILNIDTVL
RYSGANNETLPYARAYLEIILLAILPLFYSFGLSNILNAAGAPRVAMFSMLIGAVVNIIL
DYVAVMIIHTGIEGTAYATLIGNVLSAVFVLWFLIVGKLPFKIDMFGFKLEEESVIAIRF
SKLKLDPKIVKDIFSIGMSPFLLQAASSGVGLVTNKIVDIYGGTYGVAVMTIINSYLPIM
TMSVYAVSQAVQPIIGFNYGAKNFTRVKKSLMTAIGAGAILSFAFWVIVMLLPKQLILFF
NEKSTPEALREGIKAIRIYFSLVIISSFGITVPNYFQATGRSKYSVTMNLMRQVVIFLAV
VIVFSNIWKLDGVWLAQPFTDFLFFLILLVFLYREKKFFDKMIENQSHLLESKKIESTEY
EKTDKNNK
>SEQF2502_00043 Glycerol-3-phosphate acyltransferase
MITILLMALSYILGSVPNALWIGKVFKGIDVRQHGSKNTGSTNAARVLGAKLGILTLILD
ISKGLVPTLIAILLKVDFFENLTKIENFDYVLVGICAILGHVFSIFMNFKGGKAVATTLG
VFLVLVPKAILFAAIVFFVVFAIFRYVSLSSIFAAISLPIFTYFLYQQIIYVILGILIAI
LIVAKHKSNIERLRNGTESKFNLKSKK
>SEQF2502_00044 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MKNILVIGGGSWGTCLSKLLVENGHKVYLWEHNEEVRKVIRDTKENPKFLPNIKLPDSLN
VVDDYGEILKNPKKYGKIDILLLATPTQFLRNILKRLKNFLNYNIILVNVAKGLEITTKK
RISEIVAEELENKEYSYVLLAGPTHAEEVAQKLPSAILSVSKDEEAAKIVQTTFSNLYFR
VYTGTDLMGAELAGALKNCLAIAAGIADGMGYGDNTKAALITRGINEMFEIAKFYNANPK
TFMGLSGLGDIIVTCTSKHSRNRYVGEKLGQGQKIEDIVSHMNMVSEGAETIKALYKIIK
ENDLKAPIFTALYEVIYGGKPVSELESTFMSRDLKSEFLN
>SEQF2502_00045 RNA polymerase sigma factor SigA
MEDNNLNLMSLYLSDIQKFDLLSKEEEYELLKRIREDNDEQARQLLILSNLRLVISTAKK
SLGNGLPLIDLISEGNIGLIKAINKFDYEKGHRFSTYAVWWIKQSIKKAIINIGRDIRIP
SYKYEQLSKVNKVIKNYTAIHGEAPSTEYIAKKVDLKESKVILLLGEFQDIMSLNETIGD
NIYLEDVIGKNDDVEDKIIKEDQLVEMKELLEKVLNERERLILEYRYGLYDNKIHTLKEI
GEQMGITRERVRQIEKKAITKLKEHLEEYKDIL
>SEQF2502_00046 DNA polymerase III subunit beta
MLHIIVDRKSLLRAMTIVENAVTENKIREVLSGIYIETQGEKAILRGTDLELSINTEIEA
QVKEDGKIVIKHKLIEEFLKQISDDKITLIEENGKLIIQAGSTNTEFSLYNVENFPVQSK
LENGVEYVFEKGKLLSNIENVKISASPNPENLAVNCIRVEIEENKLKLISSDTYRLTYIE
EDLEDSQKNKENLSLSIPLKTIDGLVKIMRLIDEEKITLKSDGSKVFFKFSSVEILTRTI
DLQFPDYKSILNNSQHNKKILLNTKDFLSVLKRTAIFVRDNKESKNGGIFLFSNNKLLLT
GTSENAQIKEEIVTIQEGEDLRISLNVKFLLDYISTIEGKVTVLELLNDKSSVIVKDEDN
DKSLYFTMPLAIRGN
>SEQF2502_00047 Homoserine O-succinyltransferase
MPIKIPNNLPAVDILAKENIFVMDERRALSQDIRPLKFIIINLMPTKIETETQLLRLLSN
TPLQIEVTFLKMASYVSKNISKEHMSNFYKTFNDIKNDYFDGLIITGAPVENMPFEEVIY
WKELTEVMEWSRTHVYSTMCICWGAQAALYYHYGIKKYPLKEKLFGIYPLKIDICHTMLL
RGFDEVFNMPQSRHTKVHAKDIEKIPELEIIANSKEAGVSIVRSRDKRNIFIMGHLEYDR
MTLAKEYERDVKLGKAIKVPYNYYPNDDTSKAPLFVWRAHANLLFSNWINHHVYQGTPYD
LTTLGKAPNFQI
>SEQF2502_00048 hypothetical protein
MNIYLKENIKRLMLFLILTLALVCKTKPEDKYFWYTPHEVISNVDKLQPGDILILSKKPT
LRSMWGHAAVLNEHKKIIEFPTYSAGYSESPIYAWENIDRKIAIFRLKGIDDKFKSALFK
EIDETVTKPYGLTFTKDFDKRLYCSQFVYLVFKKAGKRVGRKVDLDSNGGGWVMPFDIMD
SPLLENISIYTQ
>SEQF2502_00049 Iron-sulfur cluster carrier protein
MQTNPALAERKQRIDSNMSKIKHKIVVMSGKGGVGKTTTSVNLAFGLSLRGYKVGILDAD
LHGPNIPIMFGKEGVKLSKISKPLEITENLHISSLSFFVPDNSPVVWKGPQKITAIMEML
EGIKWGEIDYLIVDLPPGTGDETLGIAQNIGTDSKAIIVTTPQKVSLLDSTRSINFARLI
NLDVLGVIENMSGFICPDCQKEVNIFKKGGAEKMAQEKKTDFLGSIPLDGNIVESSDNGL
PFISNDSLAARRMNDIITKVIEKTEKENEK
>SEQF2502_00050 Response regulator MprA
MKVLVFNKNEKTRMVVGQLLKELSFNVILAENEEQMLDALKTETLDISFLDINSIEDFPL
AIERITRYKKQSYILMAIEQDDRYAKTEALLKGIDDYVYNDFRLEELSAKFRAIVRILNK
RLTEDEMGILTAYDLTLNPANREVKRDGKEIELTNKEFLLLEYFLRNKNRVLTRTMISEK
IWDIDFVSESNIVDVYVNFLRSKIDKGHDQKIIKTVRSVGYIIKE
>SEQF2502_00051 Superoxide dismutase [Mn]
MFKQIELPYGFDALEPSIDTKTMEIHYGKHHAAYTNNLNSTLKDNAPQFLEKSIEEILTN
LDALPENIRGAVRNNGGGFYNHNLYFEVMGPNAGGEPKGELAEKINEAFGSFDKFKEEFS
KAAATRFGSGWAWLVVNKDGKLKVTSTANQDNPLMPGVTACGCSEGTPILGIDVWEHAYY
LNYQNRRPDYITAFFNVINWDAVSKKYEAAK
>SEQF2502_00052 hypothetical protein
MEKVTKDMNIMEAVEKYPIIAQVLMRYGLGCVGCIISSAETLGEGIAVHGLNPDMIIEEV
NMILEKQEG
>SEQF2502_00053 hypothetical protein
MINTFTFLTLLLLFVRIYSLVSLLFLSEKRVQFAERITVFILLFEVLTIFLYTFFNSFRY
LLPPVLMLLKTQKFFILKNFSVTLLIYSILNLALAFTFGSQNIFKFINRFLVGIILLTNI
IYGFMLII
>SEQF2502_00054 Protease HtpX 
MFINTMKTGFLMFGLVFLFVAIGGALGNQQGALIGLIIAGGMSFYSYWFSDKMVIRAYNG
QEVNSQNNPRLYHLIQRLTKNADLPMPKIYIIPERQPNAFATGRNPQNAAVACTAGLLEL
MDDNELAGVIAHELGHIKHRDILISTIAATFAGAIANIARFLPYVSSGDNRNGERRRNNV
ATAMLVSLLAPIAASIIQMSISRKREYMADRAGAEFSGNPLYLRNALQKLENYSHSIPMN
REDPATAHMFIVNPFSNLGNLKNLFSTHPSTDDRIRELEKMAREKNLL
>SEQF2502_00055 hypothetical protein
MGKESTDMENMYEGKNIKIILDRKNLDNFVIREFVLNENINEHQKLEVQLEMDDEQRKSL
EKIIEKENVEIEIELSGINQNVKKKIFCGIVDYFEILDYGSYGCRILIRAFSKSIIFDRK
NEKKYRVFQDVNLMFSDIINEINKDYTEKRLEIKYSDIAKKQIGTLVVQFDETDWEFLVR
LASQLKTGLFVVEQGIILFGMVEMGEIKKENRYFSDYSLVRDYKNLYYKVQSNKVINLGN
TISISENIGKNKNNSENSDENKRSFSVLKTKIFLKNFVLKSEFLASDMGTYHVFKKYNKK
IRGCRIEANVERVFEDGGIAKMEVKFSEGLKRIVQERSDSESNDRAYDDYGIKKFPLSYQ
TFYSQTNTGFFCTPEVNDTVEVYFPNEDERFAKVSWAINNKGNGRFSDYTKRNFQVNQSD
FNFNLNLNNFEVKTAEKYSVESPNIVENADNFVNKSNQNMVIASNNYLGIESIGDADFYA
SRINIIGKEKEITMESLSSDVRIKGKKVHSN
>SEQF2502_00056 pH-gated potassium channel KcsA
MKKKIEDLHKNKRFRISYQVIFIFLAVYSFTTTILDLHGDIHIFGNRLLEFIDMSIYLIF
AIDYFIRFTFSKDKLDFIENNIPDLISIIPYYSIFRLFRIFKIRRFAKTFRQLKLTRTYL
IIKRFRKKIKNFLKLNGLIYLLIFAALGIVVSALIVSYVEKLSYFNGLWWAFVTATTVGY
GDVYPHTFIGRIIAIFLILIGMGTFGMITGAITSYFLNRQADLIPDDNLDEYILNSQNYT
DTEKQEIITFIQFIRNKRKK
>SEQF2502_00057 Coenzyme A disulfide reductase
MYDNKKIIIQLNIMKIIVIGGGAAGMMFSTQYKKANPEDEIILFEKSSYVAWAGCPTPYF
IADELKKSDVLHGTPEDFINRGINVKIHHEVTKIDFENKTLTVKGNEINGTISYDKLVIA
VGAKSFVPNIAGYSQNLENVFTLSHAEHAFKIKDFLNENKSRLKNAVVVGAGFIGLEMAE
SFRKNGLNVTLIEKADQIFPNVSENLKKRIYKEIEKNNVTLKLNSGVSEIISENNVAKSV
KLDNGETVDFDIALFSIGITPNIDFLPKELKTDSGKITVNDKFETNIKDVYAIGDCIFNK
YYKTDRNLYAPFGDVANKHGMFLAKHLSGKNVSWKGLIRSFATSFYDVKLAQTGLSLKEA
LELGYNADVVSMKAMYKNSGFEDSVPASAEIIYDKDKKIVLGGAMAGKEAVAQFVDQIAI
VITLETPIEKFIEIDFAYSPTNASVWNPLLVTYRKVIK
>SEQF2502_00058 Uridine kinase
MSYQTIIVGIAGGTGSGKTSVTQAIIENLERTGIHSILLEQDSYYKRNDHLTYEQRTKLN
YDHPDAIDFDLLEKHILALKDGKSIEKPIYDFQVHNRINETQHIEPANLIIVEGILVLAI
AKIRDLFDAKLFVDTDDDERLLRRIERDLNERARSFESIKNQYINTVKPMHLEFVEPSKR
YADVIIPRGKDNKVGIKMVASRLRYLFNKLNKK
>SEQF2502_00059 hypothetical protein
MNRENEIFEKEMLGKSLREMFFEMNVEMQERFQEIKDKFLEVKIAENSENENIFVETVLV
KSEDVFKMDGVFFPVTDKVDIFSEDYGNIYLENVYLNLDLRKINEVSEREFNGWVNVDGN
NYEIKVRFVRNENYFDEIKKLHNSFELNGKSWKTLNMAHFMRCYKIELVEYDFEIERDIL
EKIQNEDYEITYDFEEIQDKVLRNRELLWNIEKKKIISTIFVHPTKIDLSFEYTINFEDN
EQILVSNHENDDILCCYYSGKNKLNIVSKKNTGDVWDIFSIKPIEKCRKILEIFEKNSEN
QENYFHFTNFKNESFIDKIQKKNKNTRSRAFLEKYFLEYEFTKDEIILRDINFKENIEQN
LDIYDCNENLRNEFQREYFNKKPKLNLFVEIKTFNEYSEDKVSFLISEIQNNYSEFECRG
YLYGE
>SEQF2502_00060 hypothetical protein
MANKNKKGYPYIWAVPINTQFELENNVSAYIEVNDDFFYDKFEKKKVVKVNPYVRFNKIF
TDFVNYYDNLFEIESKLQKDNKIKNLTMENVIKKESKISSFRRRKNAADESREDKNEHIL
KNFKRNIENNAISYLRELDFVSGTTVIDIVCEKISEDIRKGILGKYLKKYFLLLNREEQE
YVALLIYNEKINNVNSMKNFKFGIKYFFLDSLIYREKHQKNKIIIYINKEKNKENIAKIK
TLELLFLEFGLELKIFWKNHFGVVSVGETVKIDEIAVF
>SEQF2502_00061 hypothetical protein
MKYRLRITDEESKKEINVSEDEIIEVKYKIGLAEDTNLANSRSTVEMEITGKIISNLENA
GNNLNSENKSVNDDLYERNKKNIIDLVEWAESYLQKSDYRNLEMFVDLGSNKKMDLKFTN
MFVYNFLQEMSIEKGIGIFKLKLRQKFHQKNKLDIK
>SEQF2502_00062 hypothetical protein
MIIDIELNEKKQKQLKEVLKYDNNFINNLISKELDKIEENEQISKSEIKRIMKLSEKAKK
SPMISLENFGKKMGF
>SEQF2502_00063 hypothetical protein
MSHNLKGYWKYKPLKDYRIIVEIQDDKLIVLVVEIEHRSKVYLILNKLKKAFLK
>SEQF2502_00064 NADP-dependent 3-hydroxy acid dehydrogenase YdfG
MNRNIFITGATSGIGKETAYAFAKNGDNVILCARNLDKLKEIKADIDRKYGTNAYIFVLD
VTKYNDVVKFTKKILEDVKKVDILINNAGLALGLDKFQDYDIADIEQMINTNVKGLLYVT
RQILPSMVANNAGHIINIGSTAGIYAYAGAAVYCATKSAVKVLSDGIRIDTIDKNIKVTT
VQPGIVETNFSNVRFHGNMEQAKKVYEGVEALKPEDIANTILYIANQPKHVQISDITIMA
TNQATGFNIYRKK
>SEQF2502_00065 50S ribosomal protein L21
MFAVIKTGGKQYKVEVGTVLKVEKLAADVDSDIEINEVLLVGEGDNVKVGTPVVEGAKVV
ATVKSHGKADKKINFKYNKKTYYRKKGHRQLFTAIEIKSINA
>SEQF2502_00066 hypothetical protein
MIKIEIQRQNNRITYFKIKGHADFSGFGEDVICAAVSSVGQMTINGLIETLKLQEKLEYV
EKDGLITCDLKESELTDEELEKADILIESMYSYLKAVARSYSEFVRLEEKIEKK
>SEQF2502_00067 50S ribosomal protein L27
MLLKLNLQLFASKKGQGSTRNGRDSNPKYLGIKKYDGEAVKAGNIIVRQRGSKFYAGTNA
KLGKDYTLFALTDGYVKFEKFGNGKKRVSIYPERAEA
>SEQF2502_00068 DNA polymerase I
MKRAVILDTSAIMYRSHFALMGMRNSSGMSTGATFGFINTLESVIREFRPDYLVACLDVK
RDELERTEELETYKAHRESMPEELVMQIDTIMKVLDGYRIPKYKKAGQEADDVIATFATK
FSNDADEEIEVFVITGDKDLAQLVDEKINIALLGKGDKNSAFKQIKTDEDVVEYLGVTPD
KIPDLFGLMGDKSDGIPGVAGIGPKNGAKLITAYGNLEGIYENIDEIKGKQKEKLLTDRE
NAFISRELATVKKELNVEYDKNKLKFEEKDFDSLLKLYEELDFKRFSKAIQEEREKLQSE
GQEGLTEGEKGILEKNKRLNEDKLEKERLEQEKEEIKRQELEYDRENPIFDGISHFYEQV
EYEHNSEMDKKMDEIQELKGKLIAEYEDQKKKAEENVMESQKSEKNRKVKGGKIYFERNY
GKVMSWNEAYSVIEKMDKKVAIFENMLGISICDEKTNIVLLDSELQDILQNDNQENVESG
AQINLFALSNSADEKKNNKKNIENIYKLLSEKEIIAYNVKEYMKNGESEYFGYSVGGKTY
GINNNRFGIKCTEYFDILLARYVLGTESLQEIEEIILDEFEVEIATFEEKFKKERRKKNF
SNVSDNVISEFLSKRTFFIYKLETILKNRLQNEQFLNIFDKLESRLIPVLAQMEETGIKI
DKKYFGEFQNELEEKINMLQNEIYELAGEEFNIDSPQQLGEVLFEKLQIPSGKKTKTGYS
TNVEVLEMIANNGELAEDKRMIGKKLLEYRAYKKLLSTYIEPIPKLADKEDRIHTTFNQN
GTSTGRLSSANPNLQNIPVRTDDGIRIRTGFVAKEGHSLISFDYSQIELRVLAELSKDKH
LVQAYQDDQDLHSLTARKIFFKTEEDEISRNERSIAKVINFSILYGKTPFGLSKELGITV
QEASQYIRTYFEEYPRVRKFLEIVTETAKLHGFVETFYGTRRYISGINAKNKNIQAQAVR
MAVNTVVQGTAANIIKKVMIELHEEFKNDKNIKMLLQVHDELIFEVCDEFSKEYMEKIEK
IMENTVKFKKVPLKANGSVAKNWGLLK
>SEQF2502_00069 Ammonium transporter NrgA
MDTASVVFILFSSALVLFMTPGLAFFYGGLGRRKNVINTMMMVILPIAIAVVMWFLVGYS
LAFSGNGKFIGNFGNVLLRGVSETASTKGYKIPDAAFALFQMMFSIITVSIATGAVTGRI
KFAPFLVFAPIWLIFVYYPLAHMVWGGGLLAKMGALDFAGGDVVHISSGVSGLVLATIIG
KRREFTRTEYRPHNVPFVLLGTGILAFGWLGFNAGSALEANSTAIHAFITTMLSLAAATC
SWVIIEKLSNGTPTLVGTSTGLVAGLVAITPGAGYVSYGSAILMGFLVSPICYFAISSLK
HKLQYDDALDAFGCHGVGEIFGGIATAIFTTPSLTPEKGNFGLLYGGTHLFGATVAAILI
TAIWAGTFTFVIIKVIGVFLPLRATDREEAVGMDDSEHKETAYPTFMGLDS
>SEQF2502_00070 Nitrogen regulatory protein P-II
MKKIEVIIRSDKLEDLKDALTKAKVKGMTVSQVLGHGNQKGYTESFRGQKITPTLLAKLK
IEIITQDDNVEKLVDIIINAVYTGEVGDGKIFILPIDDVIRIRTKERGKDAL
>SEQF2502_00071 Inner membrane protein YgaZ
MINTEKYLKGLKAGIGMGIAYIPFGLTVGLIAKNNGMYTIVTAAMSFGIYAGGSEAMLLK
MVYVQHSTAIEVIISVLMINLRYLLLNLLIFRQLKNGTKLFEKILVGVGLTDETITYAII
KGENSPWYIIGLNTVPYFCYAGSSVLGSLFGNMIPEVFRASLSFILYSIYFSLLVMSLQK
LPKFFEVVIYVISAKLVFMYLPILNKVSSGWAMILIMIGSSLIYAVRHRKDEVKENE
>SEQF2502_00072 hypothetical protein
MNNLEVFKVVVISALVTVALRLLPLFVKIPKNPIMNKFFEALPYSVLALMVFPDIFTSGG
TSPYDIVKILIGMGVVAFLSLKRFGLGIIVSVSLVMIFLFDLAKIYL
>SEQF2502_00073 Arginine transport system permease protein ArtQ
MEDLEKTRKIIKTTFFMAVVVITVLLVFPHDMQPHEWEIYASSYFVTTLGLTVIGAAIGI
LFGMLLAFFKFQKTGNEVFNMIKDAVIDEYVDIMRGTPMMLQLLTLSFVIVVFNNYWVAA
IALGLNSAAYVEETIRSGIESIDRGQMEAARATGMPYRMAMNEIIMPQAVKNILPALVNE
FINLFKETSIVGYISVMDVTMNSKSLQAAYYSIKPILFTGVVYYISVKLFSFIGKRLEMK
LKEND
>SEQF2502_00074 Arginine transport ATP-binding protein ArtM
MISFNKKCRESEGIEGIGNDVRDKEMIRIKNLKKKYGNLEVLKGISTEVKEGEVISIIGP
SGSGKSTFLRCINRLEEPTSGEIRIDGKNILKRRVDINKIREEVGMVFQHFNLYPHKTVL
ENITLGPIRLKKISKPEAEKLAMELLEKVGLADKRNVYPNKLSGGQKQRVAIARALAMNP
KIILFDEPTSALDPEMIGEVLEVMRELAHAGMTMIVVTHEMGFAKNVANRVFFMDGGYIL
EDAKPADLFENPKTERAKEFLDKVLNH
>SEQF2502_00075 putative histidine-binding protein
MKKVLVVITMIVFGILSCGNKNNADNKGVKKLVVGTDGVFPPFGYIEKGELVGFDIDLIK
QIGKDLGYEIEMKVQPFDALIPSLKAGKLDAIISGMSATEERKRSVDFTDEYYKSTQMFL
KKKGNNQLTSKESLAGKKIGVQLGTIQELEARKIKNANVVTNDATINLILDLKNGKTDAV
ILENIVAKEFIKKNPDIEVFYEEKLPYGMAIAFNKGKNTEIIKKINEDLKKLKKNGKYDE
LVKKYGLETGKN
>SEQF2502_00076 putative histidine-binding protein
MKKIFLVLTLLIFGVMSCGKKDNGEKKLRVGLNAIFAPFEYVENGKITGFDVDMINEIGK
NLGYKIEIIDQSFDGLIPSLKAGKIDIIVSGMSSTEQRKKSVDFTDDYFISKETYLRRKG
NNSVTPNSLSGKKIGVQLGTIQEIEARTIKGATVVPNESTVNIILDLKAGKIDAIILEKA
VATEYMKKNPEMEIFDEKPASIGMAMAIDKGKNPELIKQINAELKKMRENGKYDELIKKY
DLENSQK
>SEQF2502_00077 Peptidoglycan-binding protein ArfA
MKKPTLVAVSSMVAMTVPLASEKITTSEMRKDIIRPNMADIQQDIKDVPTLDTPNPERTS
SKINSSEDNPDLITVILKEDGSGTKIVNNDKASSSQNSETIQSQSEKEDSSIISQPEVFE
IQKKPINNPEKVQMSKSEIISLSSDELNFHKNSTDLKKEAYPVLNDVKDYIEKNDFLVSI
IGYTDTSGMASYNKRLSLRRAEIVSSKLIELGLSKDRIVGIIGRGENNPAKSNETSEGRG
SNRRVEFRFVKKGQV
>SEQF2502_00078 hypothetical protein
MASYKNFDFKKLYFIVYIALILIVVFLAFKLGIFLFPFTIALFFSILTRPFTRFLQNKLK
LSKKLSTIISIVSFLLIFFGIIGWGSLKLISEIYKLSQNLNSYSEMMQKLWTDGMEKVYA
YLGNFPSGFTKQVNDTINAFISTGSAKLGIFIKGLINFITSIPTVILYICITILATFFIS
LDKDEIVVFLEHQFPKSWLDKVFNIKTDMFTVLGSYIKAQIILMTICFFELLICLNLLSF
LGLNVPYPLLMSIIICLIDALPILGAGTILIPWAVISFALSDIKLGIALIIIYLFVLSVR
QMMEPKLVSQNLGVHPLITLISMYSGFKIFGVIGFLIGPIVMIILKNVFSKELEVGFFRD
IFGDGDTSSNKKSNNKKLLKK
>SEQF2502_00079 D-3-phosphoglycerate dehydrogenase
MYKVLVGEYIDDEAVARLQNARDVKVDVKVGISREEILEIIHEYDALIVRSVIKVDKELL
DKAKNLKIVGRAGNGTDNINIPEATAHGVIVANTPDSNTVSACEIAIGLMIASARNIVAA
NNFIKSGKWEREIFVGNELFEKTLGIIGLGRIGGLVATRMKAFGMKLVAYDPYISDERFK
RYGCEKAKTLDELMEKADVITIHTPKTKETLDMINAENIHKLKDGVRLVNAARGGLFNEE
AVAEGLRSGKIASFGYDVHAVEPRSECVLYEFDNVVTTPHIGATTYEAQRNVGTQVVKQV
LNGLRGEIVETAVNLPAIGREEFLIVKPYINLAEKLGKIYFQIEKTPITNVAINYYGEIA
EQETALVDSTAIKGILEPVLKEEVNYINSKPLAEKRGINISINKKDHKYKNYSSAIEFVI
TNEDGKKIYVVGTIGMNNEERIVSIKNHDVDMAISDNMIYLGNEDVPGVIGAVGATLGRG
NINIATMNVGRRENSAIMLLTVDNEVGRRTLKALRELSQIKWAHYLDLTI
>SEQF2502_00080 hypothetical protein
MDASKYFKELKKLIKKVDFLNYLKIIFLTVSIVLSKNNLFFITNAGLIFSILNSFVKKEN
DKFGNKFVFDFEIFIFQSITLFYLNRQTLLMGIKLFDIEYFSKIILNAKYLNGELLFFIL
FGLPYIFIRKKSKAYKYYICIIVLYFCLFEDIFHTGFSLLGINYWIGLLFIFVNIIFLPT
FIDFVIISLAVLYFMKDNKNYKVMYLLLIFCCIFRLSLAARLFL
>SEQF2502_00081 Homoserine kinase
MGLKFKVKVPGTSANIGVGYDCLGVALDYFLELEVEESNKIEFLENGKPFSIPIEDNLIF
EAIKYTEKHLVKNIPSYKVNIVRNDIPISRGLGSSSSAIVAGILIANKFAGDVLDINEVA
KLAVEMEGHPDNVVPAIFGGMVLTAHDKENLVYSSLISSDDLCFYVMIPNFKLSTEKARS
VLPKMYLVSDAINNISKLGLLVNAFNKGEYDNLRFLLGDKIHQPYRFALINNSEKIFEAS
KKHGALGEYISGAGPTLISLNYDNDEFLENMKKELAELSDNWTIEKKKINLKGAEVY
>SEQF2502_00082 hypothetical protein
MKKQLKKILPCIMAGITGISYGNTNSKDDTDNLIKISENENKIAENLEAKNSSEKLISDN
SISEKRNFKQNSNFNTKKEIIDDPDRIQINLEYMGGFSKKHKDSDNEIIKSQQVVMPAFR
WTGKSGVNASFWKGITDVGGGLIPYVAFGSYKAAPSGDPHQQYLVKRDEDMEQIARNKAA
GIKNIGYTYTHGSTRNLDLVYADIDNFVNFYGRENIAGYFIDEIEGGATQAQIDYMAKIY
NYIKSKYPEMTVIANNGWGIRDGIAPYADIWMTQEVSATEYLNNYRARTSEFEKDPANSN
HILHVIYNATPEQYEEIIKLSRERNAGNLFITSDTNAYPNGYDDLPTYFEDLMMTINNFT
PKTGSLFSPENQAAEKVTVEMPRSKVDLDLTKAARSAIYKNLENSKDGQYKIDIAYMGNY
GGKYKDKESNVQYDSDTDGVLADVSKDFGKFSLGTVFGSQKSKVNYKGKFSNVKEKITSS
QFGLNGKYDFNDNIDLTGNMIYSSNKHAFDTNTGLGAIANAEYKSKILDFSVKAGYKFLF
DNGYVKPYAGLGITKVKEGSIDKLHISNTSKTISEGIVGVYGEKSFGKLDLFGNLEYEQR
FNKKSYHSEREYSRRYTIAPLNYASGTINVEAGLKYNISDNFKIKTSYELRDSKNSLLKL
GFGAEF
>SEQF2502_00083 Ribosome maturation factor RimP
MEQILNEFEKKIESHLKEMNLELADLEYVRDGGYNYLRVYVEKMDGTTTLDDCIDFSREI
DGIADELIEEKFFLEVSTPGVERRLKKPKDFVRFLGEKVNVQAKSNIEGAKRFVGKLEKF
EDDTIFLLDDKLGKIVEIPLSKLKKATLIYELPNGILNSEEE
>SEQF2502_00084 Transcription termination/antitermination protein NusA
MKGRDQKIFLEALDELEKEKGILKEELLETIETALLAAYKKNYGEKDNVKVTINRNSGDV
KVYSQRLIVENVENPEEEISLEDAISVKKRAKLGDILDLEINAESFKRNAIQNAKQIVVQ
KVRECEKRNIFNKFKEIENSIVSANVRKTDEKGNLYVDINGLEAIVPQKELSPTDKFVQG
DRIKIFIGEVEEATKFTKTFVSRKSEELLRGLLELEVPEIYEGIIEIKNIAREAGSRSKV
AVYSNDKNLDVKGACIGRNGMRIQTIIDELQGEKIDVVLWNEDVREFVKNALNPAQVLSV
EIVEEGEDNLKVAKVVVAENQLSLAIGKKGQNSRLAARLCGVKIDIHTGSDEMAGSEEDE
FKEKSAFQDSLDETENIEKTSDSQNDIEVEESAFAGLSEDNE
>SEQF2502_00085 Putative ribosomal protein L7Ae-like protein
MDTVDGKNLENKKNDKMDKEKSKPERMCICCRRKGKKSEFFRISEQNGKYIFDREMKVQA
RGFYVCKTNECIEKLSKNRKYKIEIEQLVKMLEQIKGEKKSIIDILKPMKNSEYFVFGID
ETIEGVQKEKVKLLIIPKDIKTKYIEEFEKLKENFNFEIIFVERKEELIRLFSRNVNVVG
IFNKKVIKGILSKVEVMNG
>SEQF2502_00086 Translation initiation factor IF-2
MKVHELAKESGFTASKFMEEIRKFGIDKRHHMNVLSGEEVNLIRKKLQKDVQNQNQSDGS
KTENLNKNEGKPKETAAKTVNNHSDNQKNNSIEQNKSNEQNINKNYDTPKRTLEKKKDNN
KNKFDKNENKKKMEMKVNLSSQNNNKQNEINKDKQNYQNRDNRDNRENGTRNFQSRDNRN
KDGFKRDGRDNNFRKDNRSFNREGNNQPRDNRDNRGFQNRDNRDSRDSRENGTRNFQSRD
NRSKDGFKRDGRDNNFKKENRSFNRDGNNQLRDNRDNRSFQNRDNRDNRDNKGNGTRNFK
DRQNNRGFSDRGGFNKDKEDFRRDNRNFSGGKKESQAEIPAATVAEKGKAGGKGKGKFEK
KKYEKNRRDREQHEKELRSDFRKDDKKKKKNKKHEKAVKDEIVRIEGESIGMITIGDEIV
IKDLAEKLGINVSDIIKKFFMEGKLLTANAILSFEEAEEVALDYEVIVEKEEIEEVSYGE
KYHLEQEDKEDELVTRAPVITIMGHVDHGKTSLLDALRHTNVMSDEAGGITQKIGAYQVN
WKGQRITFIDTPGHEAFTEMRARGANITDISILIVAADDGVKPQTVEAISHAKEAGVPII
VAINKIDKPGADPMKVRTELTEYGLMSPDWGGNTEFVEISAKQKINLEELLETILITAEL
EELKANPNKRPKAVVVESRLDPKMGAVADVLVQEGTLKIGDVFVAGEAHGRVRSMLDDRG
KKINKAIISQPVEITGFNVVPNAGDILYGVESDKQAKKIVEDFIRERKVNDQNKKKHISL
ESLSQELEEQELKELKCIIRADSKGSVEALKESLEKLNTEKVVVNVIQGSAGAVTEGDVK
LAEASNAIIIAFNVRPTTPARIIAEKTGVEIRNYNVIYHATEEIEKAMKGMLDPEFKEVY
FGRIEVKQVFKVSNVGNIAGAVVVDGKVTKDSKIRVIRDGIIIFDGELGSLKRFKDDVKE
VVMGQECGIGIQDFNDIKAGDIIESYIMEEIPR
>SEQF2502_00087 Ribosome-binding factor A
MNDRRKKGLEKEISRIIGMTLLTEIKNEKIKNLVTIHKVELTKDGRYLDLTFSILDLKNN
VNREKIAEDLNKLKGFFRKKIGSQLTVRFVPEVRIHLDDSVEYGVKIASILSEIKKENSD
TE
>SEQF2502_00088 Single-stranded-DNA-specific exonuclease RecJ
MKWELKSYDKNYLVSKSSEFGESRLISRLLLNRGINTKEKVQKFLNSDKEDIHNPFLFED
MENAVKRIQKAGKNKEKIIVYGDYDVDGISGVAYLVMMLRKLGLNVDYYIPNRVHKGAGI
NKHVLTFLKKRDAKLFITVDTSINNLEEILMLKSEGIDIIITDHHRQTGIFENEFENEGK
KLGVLVINPKSSKNYPNKFLSGSGVAFKLTDAVYEIFGANKKILYDCLDIIMIGTVADVV
PMTDENRFIIKKGLSNLKKTKIKGLKYIINYLKINPKNITTSDIGFFVAPIFNALGRIDN
SKIVVNFFIQEDDFKLFSIIEEMKRANKIRRYLENEIYNELEEKIQHLERPKYIFMKSRK
WHSGVIGVVCSRISIKYNIPVILVSIKNGYGKASCRSIEGINIFDILKSVSDKLERFGGH
DLAAGFLVSEKYLGEIEKYLRYKLARKNRENVQKILYVDAWLNIENLNKRKLNDINRLSP
FGLDNQEPNFMDADVSFLNLTKFGINNRHFKGFVKKNNRIISVIGYNLGHKLKTNNFYKK
KFKIVYTPIFKSVHSDLFIELKIKDFK
>SEQF2502_00089 Trigger factor
MAVKKLNETTYEVSAVREGEELKHLKDHVLVHFKDAKVDGFRPGHVPAKVIESKFKKEIE
GEILNHIISDEYRKAVAENELKPIADIKLEKYENNDDKVEVVFTIPVLPTFELGQYRGVE
VEKENVEVTDETVNEEIERLRESAAKLKEIAEDEEAKNDDVVNINFEGFIDGEAFDGGKA
EGYDLTLGSHSFIDTFEDQIAGHKKGDEFDVNVTFPENYGAANLSGKPALFKVKVNSIKR
KEEAELNDDLAKELGFDSVEDMNAKTRENITKREETRAENEFKNKVVDAVVSATEVEIPE
ALVQREIDYQINRFAQQLQMQGINLNQYFQMTGQTMDSMRENAKENAEKAVKTELVLAEI
AKDEEIKATDEEVAKEIETLAAMYGLEKDALIADVRKNGNYERFIDETNYRLVNQKTIDL
LVNEAKVK
>SEQF2502_00090 ATP-dependent Clp protease proteolytic subunit
MSVYSPVVIENDGRGERSYDIYSRLLKDRIIFVSGEVEDGMANAIVAQLLFLDAQDNEKD
IVMYINSPGGVITAGLAIYDTMRHIKSDVSTVCVGQAASMGAVLLSAGAKGKRYSLPNSR
IMIHQPLGGARGQATDIQIQAKEIERMKEITSKILSEATGKSVEEIYADTERDNFMSPEE
AVNYGLIDKIL
>SEQF2502_00091 ATP-dependent Clp protease ATP-binding subunit ClpX
MAKKKNYCSFCGREEDEVERLVQSPEEDDVFICNECIEDSAELLDSFREYDKNEQNREIT
LLKPKEIKAKLDEYIIGQEQPKKVLSVAVYNHFKRITHKQQKKTDDDVELQKSNVLLVGP
TGSGKTLLAQTLAKTLNVPLAIADATTLTEAGYVGDDVENVLLKLIKAADYDIEAAEHGI
IYIDEIDKIARKSENMSITRDVSGEGVQQALLKIIEGTVASVPPQGGRKHPNQEMIEINT
KDILFIVGGAFEGLEAKVKDRVNEKRVGFGLETNKTKLDDLTLFENVLPEDLIKFGLIPE
LIGRLPVITALHGLDEEAMIKILTEPKNSLVKQYKKYFEMENVDLEFDKDAIVEIAQLAL
KRKIGARGLRSIIESVMTDLMYEIPSKDNVKKVIITKEAVTDKNKVIVE
>SEQF2502_00092 Lon protease 1
MQNKPFIATRELVVFPGVVTPIFIGRQSSLKSLEEAVARFDNKLVLTSQKDANIEEPKFP
EDVYETGVLVHIIQTVKMPNGNVKVLVEAKHRVLINQFSKDKNGVDYAEYEEIFSKPIDE
SKAEALKRKVIDEFSKYAKKTNKVLPDIIYNLKEISSIDKVFDLICTNLMIATDVKQGLL
ETLDVEERAYKILSILEREIEIFMLEREIENRVKEQMAEVQKNYYLREKIKVMREEMGEG
TDSDEELEELDQRVKDAKIPQDLKDKLVKELSRMKKMPDFSAESSVIRTYIETVLELPWE
VSTSDEIDIKKAEKILNEDHYGLEEVKERILEFLAIKKLNKTLKGSIICLVGPPGVGKTS
LAHSVARSMNRKFTRISLGGVRDEAEIRGHRRTYVGAMPGRIINSLKQVGVNNPVMLFDE
IDKMASDFRGDPASAMLEVLDPAQNNSFEDHYIDHTFDLSNVFFICTANDLGGIPGPLRD
RMEIISIESYTEFEKLNIAKKYLIPQTQEENGLKDFKISFSDKAVMKIINEYTREAGVRN
LRREIGKLFRKIAKEILLSKSDSKKISVSEAKVKKYLGNAKFRIDKVKEKEGKIGVVNGL
AWTAVGGTTLEVQAVKMEGKGVLQLTGKLGDVMKESARVAYSYVRHIKNELGIKEKFNET
TDVHLHFPEGAVPKDGPSAGITITTAIISVLTNKEVRQDVAMTGEITITGEVLAVGGIKE
KVIGAHRVGIRDVVLPFDNKVDTEELPKEIADQMKFYFAKTYDDVKKIVFVNKEVKKVIK
KK
>SEQF2502_00093 Carboxynorspermidine synthase
MGKKALVIGAGGVSNVVCHKCAQNSEVFSSIMIASRTKAKCDEIKERIEKSKYAGRIEIQ
TAQVDANNVPELVALINEYKPDIVINVALPYQDLTIMDACLETKTDYLDTANYEPLDTAK
FEYKWQWAYKEKFEKAGITAILGSGFDPGVTGVFSAYAQKHYFDEINYIDILDANAGDHG
YPFATNFNPEINIREVTANGSYWEDGKWVETEPMEIKRVYNFPQIGEKDMYLLHHEELES
LAVNIKGIKRIRFFMTFGQSYLTHLKVLENVGMTSIEPIEFEGKQIVPLQFLTAVLPDPA
SLGPRTKGKTNIGNIFRGKKDGVEKTYYVYNVCDHQECYKEVSSQAISYTTGVPAMIGAA
MVLTGEWKKPGVFNVEEMNPDPFMDALNKFGLPWIEDFNPVLVD
>SEQF2502_00094 PTS system glucose-specific EIIA component
MGLFDLFKKGNKGEEVKKEFDGKVIAPISGNLLPLSEVPDEVFAQKMIGDGVAIEPTASG
VMVAPASGRIEKIFDTNHAFSIVTPAGIEIFVHLGMDTVKLEGKGFERIAEEGAVVKAGD
PIVKYDYDFLKANAKSIITPVIISNSDDYSSLNPVESGKAVAGETLVLNVVK
>SEQF2502_00095 Multidrug export protein MepA
MKTIFKTQSNEERREMILNGKVINTLLFLSIPTLLVGIIQALIPLSDSLFLNRLTNVEVA
SSVTFSQPVLNIMIALSQGLGVATLVMLGRLYGKGRMLAVKETMLQIFVFSFVIGLFIIP
VCVFSAFIISKYTTAEIRDNVYIYIALYSLVMPFVFLAAIYNSSKNAIGRPEVTFIRIFL
LLILKIIFNSIFLYVLKMGIVGAVMASLFSYIAITIWMFYDLFLKNGDVKLDLRNYSMKL
PIIKRLLNIGFPSMLNYAFLYLGFFLINKEMEKFGAIALNAQGIASNINAICFILPSSIG
TTVSSMISINMGTGNVKKSKDVFKIGWRTGAILSILTIILILPISMPLVLTFTKVPKVIE
IADKALHIYTYSVIGFSIFMISQGVFIALGRTKVPLVMSILRIWLLRYIFILVTQKYLGL
YSIFWGNLFSNTLAGLIFFISVKSIDWKKGFKNKESNYIKLQKKSLDK
>SEQF2502_00097 Diaminopimelate decarboxylase
MKLFGTAKINEKGNLSIGGVDTIELAKEFKTPLYVMDQELIETTIDKMKEAFQSTRFKTR
IAYAGKAFLTTGMIKLVESKGLDLDVVSGGELYTAHKAGFPMKRVHLHGNNKLVNEIEMA
VEYGIDTIVVDNEDEIAKIEKVCKEKGKKQAVLVRIDPGIEAHTHHYIKTSGLTSKFGIS
LFQENLIDIVKRLNDSPYIEFKGFHTHIGSQIFQSAFFIFALDEIFKYLDRLKKELGIVV
HTVNMGGGFGVYYKNGDDPKPIEEVLSEIITYTEAMEIKYQIGFKELCIEPGRSIVGNAG
TTLYEVGGIKETVGGKTYVFIDGGMSDNIRTALYQAEYEAGVVNKMEDTDTRDVTLAGKL
CESGDIIIQNGKLPKLTKVGDIVAVGTTGAYCYTMSSHYNRMVTPGVVFVKDGKAKVAVR
RESYEDLLRNDEIFEL
>SEQF2502_00098 Aspartokinase
MIIVHKYGGTSVATTEKIMNIAKYLGSVKDSGNDVVVVVSAMGKTTDALIKLAHEITENP
DSREMDRLMSTGEQQTISLLSIALQTLGYEAISLTGAQAGIKTSGHYMKNKIDDINGDVI
KGHLNEGKIVVVAGFQGVNKDGDVTTLGRGGSDTSAVALAAALGGKCEIYTDVDGIYSID
PRVYSDAKKLPYISYDEMMELAYLGAGVMEPRAVELGGKYGVEIYVGKSLGEKNGTIITS
IQKIKEIKEMEERVITGVSINENVLMVNVEEIPTNAQNVYEIFEKAEANGINIDMISQND
VTSHHGSFAFTCPKTDIAALEKIGKEIEAEFPKTSFIINQYVTKVSIVGIGLISNVGVAA
KMFKILSENDISFHQISTSEISISLVVDEVMGKKVAELFAREFDI
>SEQF2502_00099 Sulfoacetaldehyde reductase
METVLITGASSGIGYELAKIYAKNGHNLVVVARNKDKLEILKKEIFEEISKNIKITVIEN
DLSLENAAERLYNQVKSEKLKINVLVNNAGVGIYGKFSESDEETMKRNDAMINLNIKAVV
ELTRLFLNDMLKDGNGGILNVSSIAAFMPGPLMSTYYASKAFVQSFTEAVREEVKNDVRG
KNIRISALCPGPTDTGFEKSSNLEESSLFERLKVMTAKKVAEIGYKEFQKEKAVIIPGIF
NRIAVFGIRFLSRKFVVKMARKLQEKKNKN
>SEQF2502_00100 Diaminopimelate epimerase
MLKFEKYQGAGNDFVIVSEKELIEKGIPEYGEFASQVCDRHFGIGADGLIILKYVASMPF
MFFFNADGSQAPMCGNGIRCFSHYLVNNHLIDGNEFVVKTVPGDLTIRVNYDEEKDDFSA
RVNMGKPIFNIKELINTEKEQFLREKINIDGKEIEISYIFMGTDHSVIFVNDFSDYDIDE
IGEKIENYTDLFPKKVNVNFVKVYDRKRMEVITWERGAGRTLACGTGATASAVLAKTFGF
VDDKVNVKVPGGQLVIEYEGEENDAFMTGPSEKIAEGLYKFQR
>SEQF2502_00101 4-hydroxy-tetrahydrodipicolinate synthase
MKFEGSYVALITPFKNNGTELDEDKLRELVNYHIENGTAGIVPCGTTGEAPTLTFAEHEK
VIKIVVEEVKGRIQVVAGAGSNNTARAVELTKYAKELGADAALSTCPYYNKPSQRGLYEH
YKTIAKEAKFPVMLYNVPGRTGTNIEAETIAKLAELPEIVAVKEATGSLEQMIKIQDLCG
DKIEILSGEDHLILPMLSIGAKGVVSVVANIMPQEMSDLISSFLNKNFDKAFELHTKLYD
VSRNMFVEGNPVTVKAAMKILGKLDNDVVRLPLVAAEADTYGKLTKVFKEKGIF
>SEQF2502_00102 putative M18 family aminopeptidase 2
MIHTTRELEEIQKNFIEMEVKSFAREVIEFIDESPSTYHVVKNCSDILDENGFERIMPRE
KWEIKKGGKYFLKKSSSTIIAFTVGEDFDVKNGFKIFGAHTDSPCFRIKPNPEIITENVV
RLNTEVYGGPILSTWFDRPLSIAGRVIVKGENSFFPRTVKIKIDEPLLTIPNLAIHQNRE
VNNGVKIDKQNDVLPVISLINKNFEREGYLERIILEKTGIKKEDIIDFDLYLYATEKGCL
LGANEEFMSSPKIDNLASVYTGLIGLLEAEENQDRINIFVAFDNEEIGSATKQGADSNYL
LNTLERVSLALGLSRGDFLQMLESSYILSADAAHAAHPAHLGKTDPTNRGKINEGISIKI
SAKQKYTSDGYSIAVIKQLIEGTEIQIQPFVNESNELGGSTIGPISSTHLDIDGVDLGVP
MLAMHSVRELCGIFDVFYLKELAKEFFSKR
>SEQF2502_00103 Chromate transport protein
MKVYLELFWIFFKIGAFTLGGGYAMVPLIQAEIVVKKKWIEEEEFIKLLALAQSSPGALA
VNISVFVGYKMKKMLGVAVTVIASTLPSFIVILLIASLFSNIQDNIYVIKAFKAIRPMVV
ALIAASVYTIGKSAKINRKTLWIVILVAAMVVFLKFPPIAMIILGAVLGNVWMIWRGNK
>SEQF2502_00104 putative chromate transport protein
MILLILFFIFFKIGLFSFGGGYAILPLIQADVVDFHKWVNIQQFTDIVAISQVTPGPISL
NSATYVGYLVGNKAGVWNGILTGTVATIGLILPSVIVMSFFSKFYLKFQDNKYIDNAFAG
LKIVVVGLILAAAMLLIDKNNFIDWKSVVIFIVSMALVLKWKMSPILLTVIAAIVGIIIY
>SEQF2502_00105 Secretory immunoglobulin A-binding protein EsiB
MKKKYIIATLILILVFSCGKKNKRARNSQNNVTLENKMNDKIKELTEKAKKGDTEAQAEL
GEIYLQGDGIKADYKKSMEWSKKAAENKNYRAMRNIGILYLEGLGVKKDYKKAFSSFSSS
VDGGDAQGPRYLGIMSENGLGVKKSLDDAEFYYEIGDSSGDLVSSYKLGKLYEKVGDYAK
SIEFYKKAEDRIDKTAAPMYEALGDLYANGKGVEKSTKEAREYYEKAIKSGSQEAKNKLV
KLK
>SEQF2502_00106 Lipopolysaccharide assembly protein B
MLETLIFREIRYNENNKQLLKENLEKIKNNPDNVEVLKTLASIYHALKENNKAIEIYEKL
VNLQPNEIEIRAFLGYLYYENEELDKAEENFNRALDVSTKDEPFILFLLGNIYSRKGKIS
EAVDCYDLAIFLDFDMYIAHIDFARKYEHMGRHKKALEEYKAAFRIDSRDEGLIEKIHYI
EDKYGNVINKENKKINFKATNAEVI
>SEQF2502_00107 tRNA 2-thiocytidine biosynthesis protein TtcA
MVNLVCEAILPDCPMKDVEEIEKSIVTTYKKSIWSKFLKAISDFDMIQNGDKIAIGVSGG
KDSLLLVKLFQELKKDRRKNFEFKAVSLNPGFRNSDLDNFKNNLNKLNIDCDIIDTNIWE
IANEKAKDYPCFLCAKMRRGILYTQVEELGFNKLTLGHHFDDVIETTLINMLYAGTMKTM
TPKVPSTSGKLELIRPLIYVKEADIIDYTKTNGIRAMNCGCTIEAGKTSSKRREVKNLLA
ELEEKNPGVKQSVFNSMRNINLDYVFGYTGGDIDKNK
>SEQF2502_00108 tRNA (guanine-N(1)-)-methyltransferase
MAQRVIDKFGDEEISIGDYVLSRGDLLTLIIMDFVIRIKEGVIKKESFETDSFYNGLLGF
PQYTRPVEIDGYTVPEVLQSGNHAKISEYRQFHSIEKTMKNRMDLFEKKLENIDEDLEFK
KVYKKYLKNK
>SEQF2502_00109 hypothetical protein
MKMGSQLKKGLIILAGIAMLSMSLAAKEMVTYPKDNKATQALGFVKLENSFGISSSPEGN
TVYINSGGKPLERVFGAVEDNDNKFSKIKNNKVIINGGVLATNGFWEKDGVKAVRGGSVY
GGAGQNSVVSDNEIIIKGDSKIGGNVYGGYSHRGSVINNKIVIESNSVLFGKESILFGGR
GSRNINVKDNKPEPVDVITGNTLDLKAKNIKVKDIKNFEKIVFEISNKTRQNDKILILTN
SEGAAPEKPEIVKISSKVTDLSETEKEKILAEKNKAINLDINVIFQNKPSKNIRNLKITL
INAENGLEFNKLPENIEKTEKGYKYSVKFEKDAKNLYAIINASLIKN
>SEQF2502_00110 hypothetical protein
MKKLIILSILLTTLSCGLNNKGNNDKKSEKNSVEKVRTSEQEVKEMVELWNKASSNGDFT
VLENMLADKVEYYQQTVTRDYYIKDQKKFFEKNPVYGQVIKGDINIQQISDTQYKAEFVK
EVTTKKGTKDYPSYLVFKKIGDEWKLILESDTVSDANIEKKKKQKTESPNKSTYYYGDNQ
TLIGTFDIKKIFVEDGAANENGKTIYPYFLFLSSPIKVVPSVANDSENVVETGVTELHLV
LDENLINYLKSNQAYGKKVKMTGELFHSQTIHHQSAVLMNVKNIEILN
>SEQF2502_00111 Tryptophan--tRNA ligase
MRSLSGIQPSGILHIGNYFGAIKQFVKLQDKYEGFYFLANYHALTSSPKGEDLKSNTINV
ILDYLALGLDPKKSTLFLQSDVPEHTELSWILSNISPMGLLERAHSYKDKVAKGIKPNVG
LFTYPILMAADILMYSPDIVPVGKDQKQHVEITRDIAIKFNETYGKEIFKLPKEKIVENV
ATVPGTDGDKMSKSYGNVINMFGSKKSLKKQIMNIVTDSTPLEEPKDPDNNITKLYALFA
TEAEVEALKEKFRAGNFGYGHAKNELFDKFMDYFTPFQKKREELENNMDYVYEILHEGAV
KARSIATAKMDEVRDVVGLLKKNY
>SEQF2502_00112 Ribonuclease
MNRNRLTKILLLIIVVLFGLGKMYFGRNSNKIKNDFSKGFVAQDEKSSKFAKWENNKKNK
NKKNIAEKQYKSDKKLENKKYKIDYEHVIGGDENSQGKVTGGHSLLRGDVRIVKKIGSPA
KNGVYRASIEVRKKDGTWQSKTSNGGVNTIFPENWDEARIIDEINSAWENRKDLKGRDSN
MWQGISKSGVLIRGYKSPRITAYPVYENH
>SEQF2502_00113 hypothetical protein
MIIKFGYYDDEDFGLTAFPEIKFSELEIEKNKKKNRYLEKKKKEYTKYLITGIMEDFPDT
KIIDILLPKLKQIESGELRETTWDGQAFQHKIDKNKVEFEHTIFGICEEYPLWSCKFEEY
KKVLESWKKFLRMEFDLKSEIMVEI
>SEQF2502_00114 Trans-2-enoyl-CoA reductase [NADH]
MVIKPRLKGGLALTNHPIGAKEFVKRQIDYVKSQDKYKGPKKVLIIGSSSGYGLATRISL
AFGAGAETIGVAFEKGIEGKRTGSAGWWNTIAFDEAAEKEGLKYKNFIGDAFSFEMKDDV
IKFIKEEFGGKIDLLIYSLASGVRTDPIDGITYRSALKSTTKEITGPTINFEKETMEETT
MGVATPEEIKSTIKVMGGEDWKLWIEALDKGGVLSEGFKTVAYSYLGPKVTYGIYKEGTI
GAAKRDLEHTSDVLNDFLKEKYNGEAYVSLSKALMTKASAVIPIFPLYAALLYKVMKEKG
IHEGTIQQKHRLLTQMVYGNHPVIDDERRLRPDNWEMREDVQAEVEALWDKITPENFKEI
SDYAGAREEFMQLNGFDFDNVDYDADLDLEELAKLRP
>SEQF2502_00115 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MGMTIDFTGKTVLVTGAAKGLGKDMALLFASCGANVHIGDFNTEEAEKTVAELKNFGVKA
DFTKCDVSNEEEVQKMVEEAKALGNGELDAVVNAAGVISIQDLLYTNAKEMQRVLNINVV
GSALVLKHSLETMMKQKFGNIILVSSIAGREGMDMLQIYCASKAGVTSLVQSGARRGAPY
NVRVNGILPGIIRTSMWEEILDGMSHNWDPNNKEEVSPEVREELWKKSVESLIPLGHAQS
GKDIAYATAFLASDFAKEITSECLSIDGGTTVGR
>SEQF2502_00116 hypothetical protein
MDDKKLMILEEKLKNELSEDKINYINKYKLKLNDKRQWMTTKNNVPERVYFSHNFILKNT
ILEVIFRKYQLCYAKLKYFRKNLDKFSYFKYDPKLGFIETEFWDIEFFCHEKSGKYIDLR
YLQQITEIEVFLEFVNWLESL
>SEQF2502_00117 hypothetical protein
MIKRIDTKSGKTISYVYNLKDEDYRIVSERLEMDEEKIKNVIDEEIFTPRISKSDWEIYK
LYYPTVKKPVIDKEVTSYEINPIVICMREDKVVILDDDYFEDFYDFVEEYAELRDDILEE
NRFFLNMLHKISQSLYKYVRILIGEHDKIETVLREQQSNEKLISLSEVEQGFYVYNIAMR
NLDYVVENLKEDEQFQQFEEYMTRILQEINFTLDLSFSYCEICKTTRETYSSYIGNNMNI
TMKVLAAATILITVPNMIFGFYGMNVKLPLQDTGFWALIIIFIIMTVLMIVLWKYLKKKV
L
>SEQF2502_00118 putative oxidoreductase
MAVKNKVVIVTGASSGIGKATAKLLGESGAKVVLAARNEDKLQQAVAEIKEKGGEAAYKV
TDVSKREEVKALVDFAISEYGKIDVIFNNAGLMPNAPLSELKNSEWDEMIDVNLKGVLNG
IEAVLPHFIKQKSGHVISTSSVAGLNTYLGAGVYCATKHGVKALMEVLRKESANEKMNVR
TTTLYLGAFRTELATRITNKAIKERIEFLYDTIGADPIIVAEAVKFAIDLPEEVSMNEIT
LYPTAQL
>SEQF2502_00119 HTH-type transcriptional regulator TreR
MSKYKEVYENIKKQIKDGKLKSKDYLKSEADLAIDYSCSVLTVRKALALLESEGYIQKIK
GKKSIVLEKGDLKNISLTSIQTFQELNKIKNIDVKANLVSLYIVQGVEELMEKFNVSKTA
DFYKVVRTYSLDGEVVQYAISYFDRKIVTYLNDEIASKSIYEYLENELNLKISYSRREIK
FRSATDEERRYINLENIDRVVVIETYAYLSNGNLFQYETITYHPDKFTFTAIAKR
>SEQF2502_00120 Pectate lyase
MKKIVLVISLMISLILCSAEKTDFIREVLAKNDGFASEGKGTTGGTQAVQKNIFKVTNKK
EFVAALGNRKNTEPKILMIYGTIDFDTDDNGKSLKMEDYMAKGYDFQKYLETHASKSSAP
KSLKEDQEAKREQSQKNQSKSITVHVPANTSIIGIKNAKLKGVDLVLDSNNIIIRNIMFE
PPYDYFPSWDPKDGKEGNWNSEYDSISIKGGTHIWIDHCHFQDGPETIEKYFNRKYEHRD
GLIDISNQSDYITLSYNIFENHNKAILIGNSDSKMTDEGKLNVTLHHNYFHNLVQRAPRV
RFGKVHVYNNYYQSDNKNSEYSYSYSLGVGKNSKIYAENNVAEVKDKDYKDFVKVFGGKE
LTTINNIFNGQKIDKFDESLSKVNWVPTLYQKIDATNEVKDKVLNNAGIFKK
>SEQF2502_00121 hypothetical protein
MTNTNATNLRKNLFSYLESAIDYNDVINVNTKKGNAIIISEAEYNGLLETLYLLSDPNMK
EKIETAKNATSDDYEVFEW
>SEQF2502_00122 Toxin RelK
MVEEYKIYILKKANKDKEKIKQFPALKNNVDKLINLIKKNPFQTPPFYEILTKDLKGYYS
RRINKQHRLVYEVIEEEKRINIISMWTHYEF
>SEQF2502_00123 hypothetical protein
MLKRDEYIKKIVPFIDKDVIKVLTGIRRSGKSVMLKLLMEELKNRGINENQFIYINFENL
KYRNLKNYERLYDFILNKVDDKYKSYYVFLDEIQEVEGWEKCVNSLRVDEELRFDIYITG
SNAKLLSGELSTYLAGRYVEFVVYPFSFKEFFEIIQEKNQEIKVKEAFQKYVKFGGMPFL
HNLDYNFEASMQYLQDLYASIILKDITQRNNIRDTDLLERIINYVIMNIGNTFSATSISK
FFKSENRKVATETILNYIKACEEAFLVYRVARNDLLGKKILNVNEKYYIADHGIREAIME
NNQKNIN
>SEQF2502_00124 hypothetical protein
MYFEMLRRGYNVKIGKVDNLEVDFVCKKNDETIYIQVSYLLASEDTKEREFSVLENIKDN
YPKYVLSMDEFDMSRNGIKHVNLIEFLVK
>SEQF2502_00125 Deoxyribose-phosphate aldolase
MMKISKFIDHTILKANATREDIKKLCDEAKEYGFYSVCVNGANVEYAFSQVKDSDVKVAA
VVGFPLGAMATDVKVFEAKKAIEDGASEIDMVINVGALKDKDYELVENEIRRIKEAIGKN
VLKVIIETCYLTDEEKVKACELAVNANADFVKTSTGFGTGGATFEDVELMKKAVGNKAKV
KASGGVRDFETAKKYIELGAERLGTSSGIAIVTGAESEGSGY
>SEQF2502_00126 hypothetical protein
MKFKNYLFFVFLLLISVISFGKNTNAQEILLTDNGVILNLRGIFKMDWDKSDPEVPCSGT
GYGEMLFYPENKDIVNGKPLVLRLRDFDYNNPDVNADYEKETAKEEKIITETLKKNFPEE
YQKMQKIRKGKFEVPATVKIKKVLPYTECDFTTVYVYATELKRVAGAKSKITEVKTKKSK
DFEEEFVDPNEPFDLKKYEVSSKDGYANLREKPTTNSKIVSKMDNETVVKYITKYGDWYY
IFDVEYPNESNKLSKTKEYRGFIHKSQLKKYTD
>SEQF2502_00127 Putative 3-methyladenine DNA glycosylase
MTFEEIEKFYKKDTIMVAKELLGKILISKNENEIFAGYIVETEAYLGEFDRAAHGYGKKR
TPKVEALFEKAGTVYIHSIHSHKMLNIVTCEKGNPQSVLIRAIEPILNVEKMEENRGKSG
ILVSNGPGKFTKAFGIDDRFYKTEIQITEKNMFEIENFSEKLGNKNFEIKYDISKINEKY
LYLDFENAKIPKKIGISERIGVPNKGVWTEKNLRFFVEGNRFVSGMKKADMKDDVWK
>SEQF2502_00128 hypothetical protein
MKKNILKVLLFLVLANVGFGDVAQIIGDYYSIDKGKVYYRNKILEGVNPKTAELIGFSLL
KDDKNVYYMGKKIKDVKIKNFEKLGQNYWKNENKIYYRDKKIENADIMSFKVLNEDYAKD
KNHVYSGNEVIDPSPLLGKIKNPETFEFLPNGIIYATLYGKDKYNVYYINNTMLNCFDSY
YFIYEVKGINRDKVEVLNKWFIKDDKNIYFKGKILEGVDYNTFEVLPNGDGKDKNRSYEY
LTKDELKWF
>SEQF2502_00129 hypothetical protein
MEFRLITYNIFGARLTNGRELARSLKKYKPDFIGLQEVDRNTRRSKFRDVVQEMAQELGY
NYYYFQKAMDFDSGEYGIAFISKYDVKNIYIHQLPGSSKEKRQILAARLNTQKFKNKILI
VNTHLDNSLDNKNEELADLFAAIEGFKGDVKFLCGDFNLLPTTEYYAKIRKDWNDSYFEG
RDLENKNNSENRELETARIDYVMAKKGTDYKVKKSFYINDDSRDWTKLSDHLPYMAVFEV
E
>SEQF2502_00130 hypothetical protein
MIIDSHQHLILPTELQIEQMNKAGVDKAILFTTTPHPEKAKTLTEFKNEMSILFKILGGE
NSLENNKKRFKKDISDLMKVINNYPDKFYGFGTVPLGLSLEETQIWIKQYIIDNGLKGIG
EFTPGNDEQVSQLETIFKALKQYENFPIWVHTFNPVTLNGIKILENLTRKYFKTPVIFGH
MGGYNWMEVTEIHQMPTLIYPLLFLHSH
>SEQF2502_00131 HTH-type transcriptional activator HxlR
MSKTEAVSNACPMELGINILSGKWKLRILWNLYIKKVVRFNELQRNLGNITTKTLTEQLR
ELEDKKMIKRTIYPEIPPKVEYSLTEIGNSIEPVLKTLCDWGNEYLELIDNNTDKV
>SEQF2502_00132 hypothetical protein
MEEKYYLEITSMNDYKKEEMVVKFTVVTEEIGNIVKKEKNDLKMTDILTDKMTDKELQRL
KILRRIF
>SEQF2502_00133 hypothetical protein
MDVSIITWDENYYDSCYEDYLQIMKNNEIVYYGYCYELISYNEEARYKFVFEFNYGDIKN
KCDMGIVKFENNFLMVPYREKIYQYDYKYLPLKFTEQQLLRLMSKEEISLINKISCSDIL
LQWLGLSNFKGYFDTFKEYKKQLFYDIYFVDIDKLDDNIENFFKEISKLRNREIVKILKN
DFEIVTAYLNTGKIWEAFLKKDDKIYLNTELDVSIDVTDIVEKYYKKEREKVLKEIVKYG
DKLYGNKIFKI
>SEQF2502_00134 hypothetical protein
MEIKYSKFEINMWDIFFLVIYLSHLLGGIDILFNKKEKGGIFFLAIGISYFVYRFLLVMI
IKNKMKFDFSDYEVKIKGLFFEKMIAYNDIKTLTVRKNILGSYDILLNFDSSMNIYKYFC
NLIMDVSIESNHKKSYIFCDIKNKDEILEYLLEKIGYPKKEIREKKEEEKLYVKYSIFEK
HYMMCFAVFSLMIIFSVGIAWGYLNLMIKLFTIIILLLVVTVIRFFKKDYIMKRYSNYSI
SISEKKKEIYIMDDFFEKDRKIIIEYGNTNFNSIKFNFYYFQNNVMPKNYKKCDD
>SEQF2502_00135 hypothetical protein
MKYVAIDEQDEKGFEEYIESLKKSGMELSEEEIQEIKDDINDQVSFCLMNNDKKFDEIFE
KVSEINEEAYLNGYGWAALIESYLENNYPELYEDYDSDPEAGGYVGRYFGNTKENWEKIR
KVAEIVEDLIENEEKIYKYIEENGDDIFWDSF
>SEQF2502_00136 hypothetical protein
MVFNINDNGDIEDFEVDWLGKKVYVSMEEAEIYNKELEKQMSLILDNVEEWDVKIKNSIV
KKYLGMANNCLRENKLSVPLENVIQKLGNSLTKYDVENARNGIITENFFFQNLTIDEIMP
YSISQFSVWVYDEVFFDEYVFITDAEIYEKVVFDDLTNIYKK
>SEQF2502_00137 hypothetical protein
MKNRDYIEGFIEGVSMCWNDGMKVCPEYTAIYIDTFFIDNDKNNDLNEIIKKKLLQYYES
SSSEKKDDNIRKKLEKLNIVFKKNRKYEKLIKQNETKTGYDRISEFIKLQTEFTVEEIIE
NLENKADKKEQYWNVRRFFYQITHWFGEPVNFYVAIKKYEAILSEFYAYNVFSAGIIRYK
EYLLMIVYGSDE
>SEQF2502_00138 Phosphopentomutase
MKKIERITIIVLDSVGAGELPDANLFDDCGSNTLGNMAKAHGGMNLPNMGKLGLGNITEI
EGTPAVENAEGAYGRAIEVSQGKDSTTGHWEIAGVPLERPFPNYKNGFSNEVIKEFEEKT
GRKVMLNKPISGTVAIDQYGEEQIRTGNWIVYGSADPVFQIAANEEIIPLEELYKACEIA
LEICNEKSPVARVIARPYVGKKVGEFKRTANRHDFSIDPPKESMLERLKKAGLDVVGIGK
TSDLFNGKGITDNRKANQDNLDGIKKTIAALKEDTKGLIFTNLVDFDAVYGHRRNVEGYV
KALIEFDNWLPEIEKNLKDDEILIITADHGNDPTYKGTDHTREYIPIMIYGKNVKKNVNI
GTRKTFADIAATVEEILLGTEKEGSFAKEIIKYGV
>SEQF2502_00139 hypothetical protein
MEFKIEQITFEDLKKSLNKKQVEIDKFLNKMKKEMIKEFKKERKGCCYNCLKEENKKEEK
SMICNSHTVPQSILKNIVINEKVYYYSNNILEMPYEKKDKGLNEAGTFHLICRKCDNDIF
TQYENEISIYGIKLSNKALRQIEMKNVLKMIYENKLEYIGYKKRMEYLNSCMNFGNTPFF
VDLIEDIKDTYVKKEEYRKQIDKFEKRYDYLKKGEVRYRVLYEEELPYIIPIAFQTTIGL
ITDFEGNYINNPLEDYEKSEFFYFCCFPFKEKDNMKQSGSKIIVFEDINNKRYKTFFDKL
KKFEKNEQLAILNYILFAYSEEYFISKGISKEVLQRLKTLANITPDLKIYNEVPEEKIRQ
EYAKIYDYSKYNEYPNLFLKKYEIKL
>SEQF2502_00140 hypothetical protein
MKCEEKYEKSEEKWLNWAIELQSLAQAGLAYGKDKFDIERFERIREISAEMVAYKTDISV
EKVKNLFCNEVGYQTPKIDVRGVIFENDKILLIQESNGKWALPGGWADVYLSVKENVLKE
VKEEAGIEASAEMIIALLDVTKNQGKKIPYGITKVFVLCEYLSGKFEKNIETIDSRYFGI
DELPELEEKKITVDQIKMCFEANKNKDKWKVIFD
>SEQF2502_00141 Ribosome hibernation promotion factor
MKIIISGKQLKVTDAIKAYTEEKISRISKYSDAITEVDVVLTVEDTKSEGPVHKADGLVF
ASGTKIKIEAENKDLYAAIDDLSDRLERQVRKYKEKQKDHNKKGTR
>SEQF2502_00142 Phosphoribosylformylglycinamidine synthase
MNYRIFVEKKKDFRVEAQNLFSDLKENVGISGLSDVRVLNIYDVFNLGENDLEKLERTVF
SEINADNVFRSLDEVFEEKNSENVYFSVEFLPGQYDQRADSAIQCVNLLIDKDNNINVKS
GKLIILYGKISPEELAKIKKYYINEVEAREKDLNVLSENVETENKDDVIVYDGFTEKAKE
EIASLKDKLELAMTVNDLLFIQEYFKNEEKRNPTETEIRVLDTYWSDHCRHTTFETIIDD
IKIENETYKNIIEKAINEYFESREYVHADRISKKPMTLMDLATIFGKEQRKNGNLPDLEV
SDEINACSIYIDVPIERIDEDGEKSTTTEKWILQFKNETHNHPTEIEPFGGASTCIGGAI
RDPLSGRTYVYQAVRISGSADPTEKIADTMAGKLPQKVITQVAAHGFSSYGNQIGLATTH
VNEIYDEGYKAKRMELGLVVGAAPAENIIREKPKNGDIIILLGGRTGRDGIGGATGSSKE
HTTESSEKSSAEVQKGNAIVERKIQRLFRNRNVTKLIKKCNDFGAGGVSVAIGELADGLE
IDLNKVRVKYIGLNGTELAISESQERMAVVIEKQNLDKFIEFANEENLEAYQVAEINDSN
RLVMKYNGKAIVDISRDFLNTNGAASNINITIENTPKLNLNREIEGNDFRSKFINNLKDL
NVASQRGLVETFDSTIGATTVLMPFGGKYQLTPAEVSVQKVSVINAETDVASMVGYGYNP
YVAKQSTFHGGAYAVIESMAKVVAGGGNYKNIRFTFQEYFERLGQDSKKWGRPLSALLGA
LHIQKAFGLPSIGGKDSMSGTFNDISVPPTLVSFAVSVTDAENVISSEFKKSGNNVYLIT
TPNDENDLPKLDELKINFDFVTENIRNKKIVSAMAVKNGGIAESIAKMAFGNKLGVDITA
DLPENEWFKVNYGSFVVETAGNIENKNAVLLGKVTDNAKITINNITFDLDELIGAWEIKL
ERIFPTKKEVEEEHKIAHCKGVKYEKLEKIETQNVISNISNTYAKPRVFIPVFPGTNSEY
DLEKAFNREGGLAKIGVFNNLSHSNILSSIDNFVKEINNSQILMLPGGFSAGDEPDGSAK
FMVAVLKNKKVKEAVENLLKRDGLILGICNGFQALIKSGLLPYGEIRELNETSPTLTFNT
IDKHMSKIVQTKIITNNSPWLADMKEGDIHSIAISHGEGRIVITEEEYKKLFKNNQIATK
YVDLDGNSTMDSQFNPNGSYYAIEGMLAYNGRIFGKMGHSERKGKNVYKNIYGNKEQNIF
RNGIKFFK
>SEQF2502_00143 hypothetical protein
MKKINKFLFLAILLSLVLSNCQRKEEKSENAQNKKVENVSNQDVLREISLDEMLDFEHIP
KNWKEEFREIAENMPRYGNNVVKISMYFYEKDFFYDYKKIFLDDNNNFVKPDEKQINDFL
KMASEKNFSDFDSIIQAMEKENKKDKLFSKLTGNWIESLKIWKLKADNLKNYYQSGDYKK
DNFSKGKTLNSEYLESIKQRKEKYKELNKIFIFKLKYLLKKTAVFYADQQYGNNTPISDL
FKESLLIDIFCYKLYDWNEIYNAEETFEVPVEEKDSEKYLQDLKKIQSEIKKLSDTMENK
EYEFINSKTIINKEIYLLAKKENKANLELINQIMSDMENKTYTDINAIGILLMKRNNEIE
QVIRKQLARSR
>SEQF2502_00144 hypothetical protein
MRKIMFITIVISILASCPIMFLFVDWKLEKPRDLEKEAKI
>SEQF2502_00145 hypothetical protein
MKDKRDGKENNKILFLKKENGNWNGNYTEEIENKIKEIPILYKNRKFYNAENDKVINNLK
NFNFYFQIQSFKLDKFENIKILKSENTSVLGFKNEFDLVLQAEYSDNKNFYSYFSKNFND
IRNNKEKIIFYGKYVKNTDRNIVNIVMETSDLKINEKCGYDILNRELK
>SEQF2502_00146 N5-carboxyaminoimidazole ribonucleotide mutase
MKVAIFFGSQSDTDKMRGAANCLREFGIEFEAYVLSAHRVPEKLEEVLADVEKRGAEVII
AGAGLAAHLPGVIASKTILPVVGVPLNGALEGLDALYSIVQMPKSIPVATVGINNSYNSG
MLAVQILAVKYPEIREKLINFRKEMKAKFIADNEKKVEL
>SEQF2502_00147 Phosphoribosylaminoimidazole-succinocarboxamide synthase
MEKREKIYEGKAKSVFATDKADEIIMYFKDDATAFNGVKKDQLEDKGILNNKISTLLYGY
LIKHGVKTHWIKTLNEREQLCKKVEIVPLEVIIRNRATGSFVKRYAAEEGKIFKRPTFEL
SYKNDDLGDPLLNDDHALALELVTEEELAKIKEQTFLINDLLSKLFDKMNLILVDYKVEF
GRDKDGNILLADEISPDSMRLWDKDTLKKLDKDRFRQDLGDVMGAYREVLRRLEKALAE
>SEQF2502_00148 Amidophosphoribosyltransferase
MIKSLNEECGVFGVFGHPNAARLTYYGLHSLQHRGQEAAGIVVSDGVRVNGHRGPGLVSE
VFNDDRIFNRLEGNSAIGHVRYATSGSSSGRNIQPFLFQFFDGSIALAHNGNLINAKTLK
RELEEHGAIFHSTSDTEVLVHLIRRSKEKDFLSQLKDALRQVKGGFSFLVQTQTELYGAV
DPFEFRPLILGKTKNGAYILASETCALEIVGAEFVRNIRSGEVVIIDKDGYRIEKYTDDT
STAIAAMEYVYFARPDSDISGINVHSARKRCGRRLAQEAPVENADIIIGVPNSSLSAASG
YAEESGKPYEMGLIKNQYVARTFIQPTQELREQGVRMKLSAVKGVVKDKVVVMIDDSIVR
GTTSSRIVQLLKEAGAKEVHVRIASPEFKFPIFYGIDVSNSSELISANKTVEEVREYIGA
DSLAFLSIDGLIDSIGLNFDAPYTGLCMECFNGDYPAGLGDYEEEFYALLTPIQKEALKE
LKK
>SEQF2502_00149 hypothetical protein
MYIVSLNYVKAVGEVEKYLEEHIKFLEKYYGMGKFICSGRKNPRTGGVILLNAENLEEVK
KIISEDPFNINRIAEYEITEFFPTKYVEDFANFVK
>SEQF2502_00150 Phosphoribosylformylglycinamidine cyclo-ligase
MSISYKDSGVDKEEGYRSVAKIKERVKATYNKNVMNELGSFGALYKLGEYKKPILVSGTD
GVGTKLKVAFETNKYDTVGIDCVAMCVNDILCHGAQPLFFLDYLACGKLDSNVSSEIIKG
VVEGCLQGDSALVGGETAEMPGFYADGEYDIAGFAVGVVEEEKMVNGSKVQEGDVIVAIP
SSGAHSNGFSLLRKLFTDFSEEYNGKTIGEHLLTPTKIYVKPIQKVMEKVQVNGMAHITG
GGLIENVPRTIPDGLCANIEKAKVKVHPLFKHEAFSRVPEEEMWGTFNMGVGFVVIVNKN
DVKTVIDILAENGEEAYELGAIVKGDEKINLY
>SEQF2502_00151 Phosphoribosylglycinamide formyltransferase
MSNKNKKRIAVLVSGGGSNLQSIIDNIEQGNLNCEISYVIADRKCHGLERAAKHGIKNVL
LDRKVLKEKLSDKISNVLENDDKKTDYIVLAGYLSILSPEFIKKWSRKIINIHPSLLPKF
GGKGMYGMNVHRAVIEAKETESGCTIHFVDTGVDTGEIILQIKVPVLSDDTPEVLQKRVL
EKEHVLMIEGIKKLLEK
>SEQF2502_00152 hypothetical protein
MSKIIVHDKFKFRLFPKTIWIDNEKKKLKPNSEIIFETNEDYVILSEKKSKKRKLGLDLE
NKEEVVVEIKYNFFILSMIFLVPVLFVIIILIFNLDEIDAKQLGTVIGILIYIMFLKIEK
FEIVSVLEPVQN
>SEQF2502_00153 4-alpha-glucanotransferase
MFERSSGILLHPTSLPGKYGIGTLGKEAFAFVDFLKKSNQKLWQIFPLGPTGYGDSPYQS
FSTFAGNPYLIDFDLLVEENLLSQSDLEGISFGENPENVDYGAIYNQKYPLLRKVYENYK
NTKENKEREELKHLFEEFKVHNQSWLNDFAMYISLKNHFNGLPWNEWPEDIKSRQPEAME
KYYEIIKEEVEYQKFIQFLFFKQWNAVKKYANENGVKIIGDIPIFVAADSSDAWANPEIF
LFDEERKPVKVAGVPPDYFSATGQLWGNPLYNWDKLKELNYKWWIDRVRANLSTCDIIRI
DHFRGFDEYWAVPYGDKTAENGTWCPGPRIDLFNAIKNELGTLPIIAEDLGTMTQGVIDL
REATGFPGMKILGFAFDSKEENDYLPHTYTKNCVVYTGTHDNDTLIGWFTKANEDDKQFA
RDYLNSRSDDEIHWDAIRGAWSSVASMAIAPIQDFLGLGSEARINTPGLASGNWQWRLKE
GVLTDELAERIAKLTKVYSR
>SEQF2502_00154 Maltose 6'-phosphate phosphatase
MKILTINVHAWLEKNQMEKIDILAKAIAEKQYDVIAMQEVNQLMNNPVIFDDIRQENYGW
VLLEKLQEYTDTDYYYHWSNSHIGYGKYNEGVAIITRHKIKEEDEFYCTFAQSVRTISSR
RIVSITIDYNGQEIEFYSCHMNLPNCETEDMGKSIQNILTRTKNDNLKILMGDFNTDAIG
NPEHYKNIVSQGLFDTYTLAEKKDNGITVDKGIDGWTNDKSQKRIDYIFSNKEIKVKESK
VIFNNENKRIVSDHFGVEVEIEL
>SEQF2502_00155 PTS system maltose-specific EIICB component
MMKKIQRFGGAMMAPVLLFAFTGIVVGLSSVFTNTEIMGNIAKEGTAWYNFWYVISEGGW
TVFRQMPILFAIGLPISLANKTNARACMETFALYTTFNYFVSAILKVFYGIDAAKQVADK
VTGYSAIGGVPTLDTNLFGGILIAALVVYLHNKYFDKKLPDFLGVFQGSVFVYIIGFVVM
IPCAFLTVLIWPKFQMGISALQGFMKASGIFGVWIYTFLERILIPTGLHHFVYTPFVFGP
AAVPDGIQVFWVQHIKEFAQSTQSLKSLFPQGGFALHGNSKIFGAPGIALAMYATAKSDK
KKAVAALLIPIIFTAVISGITEPLEFTFLFIAPVLFAVHACLAATMAATMYAFGVVGNMG
GGLLDFLFLNWIPMFKNHSGTVIIQIVIGLIFTVIYFFVFRFLILKMDLKTPGREDDDEE
MKLYTKADYRAKHGEGDGKGGASSAEDEYARKGAIILEALGGRENIEELNNCATRLRVSV
KDADKLLPDAAFKAAGAHGVVRKGTAIQVIIGLSVPQVRERIEDMMKKG
>SEQF2502_00156 Undecaprenyl-diphosphatase BcrC
MQLKLANYIFSVDKFFFKHLSYNSNFSIFKHSESIEKFFRLITKLGEGYLELMLTVVLLS
FFLINKQKYNFLKKYILAVIFTLLSTQIILNIMKVLFARARPSITINPDKFYGIMTLIKN
SSFWKGNYVSFPSGHTITIWGTIWILSFIIKSKAIKIPLFILGILVGMSRIYLVRHWTTD
VVASVILSYFIAKFVHKKMFENKERIRKTRSFSYGRKTNIGILKKDIMANTLNYKNKKIE
I
>SEQF2502_00157 hypothetical protein
MKILIVIIFYLRIFILIKLLFLSNLNIPKENEIYTYLKFVNFEYTLLIFSNDKKNILNLF
INICFLFWLLKIM
>SEQF2502_00158 hypothetical protein
MFGIVFKFIKNNEYVYYSLYSVLSLAIIFIFYKYIKLFEKFNDLKKIFLWYLVFFGIYGP
YKKLKVKNYLIRFLISTSILVIISIGDKL
>SEQF2502_00159 hypothetical protein
MANSNFFGQLRETRFSETVENIAGERLKVASTQNEIKSAFEEAYSDLGYKAEIKFSTPEE
TPELKDKAGTAYVSSTGVHTMIININAKENNTKSGLIGTISEEGSHIINGAKGRQIETGT
EEKGLESTGRATNSYFQDKYKDDKTTISMKSDGAIDTSKLGVNVGDSPEYEDIFTIKNSL
YKGLSDNQIVEKVGKDYNWKGVNYRNLVEEIMQKDHDNSLLSYIKDHVGEKITIAVISTL
ARKYLIGKGFSDAAATKAGGWIAFGLFTVNEVSKLKEFRNFGSNGRAALILALGKERERF
NSAVKAASWEMDYIL
>SEQF2502_00160 hypothetical protein
MLKKIMLIVLITIIALSFKLLVINNIFVPEAFYWDIFSNDWKNRDYRIEWEAGCKIIEIG
KKGKYYYGRVVSGGVTLYKPGKYDYSKCEDEYFLIDSSESLSSNLAFNGGIYYKKKEKIL
NITKEYKVKKPYNFFMFSILR
>SEQF2502_00161 hypothetical protein
MPDEMYRLFNDKATTSLMNKIINKWTNFIKGKNSNERKYENRFREHKIVDFTLEFTALGH
TNLFTSSYGKIKKLMESIM
>SEQF2502_00162 hypothetical protein
MKNQKNFFKTGILSFLLLGGLLAYGATSNNRNIATKISREEAVKIAKKNTPNGQLKKVKL
ENTKRGPVYDIELWEGNTNTKKEYKIDANTGQIFRAKTDIDDDELNPAIANTKISVEQAK
SIAKKQAPNATFKSIELERKKGKLVYKVDLIEGNTKKEYKIDAETGEILDFEID
>SEQF2502_00163 UDP-glucose 6-dehydrogenase
MNIAIIGTGYIGLVQGVVMSDLGFNVVCIDNDEVKIETLKQGKSPIYEPELEETLKKSLK
NGKIKFTLDYNSGIKNADVIFLAVGTPPLDDGSSNLNYITAAIKNLAQFLSKDSLIITKS
TVPMGTNKKIKKIILDELKKRNMGNLNVSVISNPEFLREGKAVYDFLNPDRIVVGIDEND
NKEKIKKEIYKIYEYFLKKQIPIIFTNLETAELSKYSSNAFLSVKISFINEMAMLSEKTG
ANIEDVSKIMGFDHRIGNEFLNAGLGFRGSCFPKDTLAILNIGKNNDCEMSIVNSAVKFN
DDLKDILIKKIKNKLGSTKDKTISILGLSFKPETDDIRESPAIKIIKKLMNLRAKIKVYC
PQGMEKTKKELENYSDCIKYCKNEYECAKNSDCLILTTEWEQFKNMDLERIKNVMKSNYF
FDFRNMFSDNENIRNYFHYYPIGRN
>SEQF2502_00164 Undecaprenyl-phosphate 4-deoxy-4-formamido-L-arabinose transferase
MEISFVVPIFNEEENIPLLVEKLELAVKGKYSEYEFILVDDGSTDKSKEILEKLSKDKKY
LKPIFFKKNCGQSAALSAGFKYCSGDIVVSMDGDLQTNPKDISLLIPYLKEYDMVNGMRA
TRQDGFYRKLVSLVGNSFRNFITKDNIRDTGCPLKVFKREVVKSFYLYKGMHRFLPTLAK
INGFSVIEIAVPHYDRIYGKSKYTTFNRLFVGFEDVFAVRWMKKRRINYEITDKKNY
>SEQF2502_00165 Undecaprenyl phosphate-alpha-4-amino-4-deoxy-L-arabinose arabinosyl transferase
MKLPTKKITKFNFYKDFKLKRIKIKFKFEYFIPIVLILVTLPLFNRMFTQRNELKYLYIA
QDIIKNKNPFVYYLSGKLYTDKPPLFFWIIIFSKFIFRNYYTYGIVIFNIFIESFLLIKL
YRFLKIKFDENIAIMSIFITFTGILQYVSVIVVRMDIYLSCFIALSLLNFFECYEKNDYQ
KNWITFVYIGFAFLFKGIVGLLTPLLVIILFKFTASKKYSLKEAGFYKGLAIILAFVLFW
IIPAYISLGNIFINELFFKQLFGRAVKAFTHKRPFYYYLYTLPMTVFPWTVYSVYVMYKS
IISWIKEKNTNDFEKFLLIWIFSTLFYLSVSSSKLVIYLLPIVTPIGILTAINYRKIPFE
TKNILFFITISIFIVASIVMIFSNSRDFVPFKVISIFSLFNIGIVSLLLFLKAGKKAGFI
FLGLLFPIVTFVAGFNISKINKMTDARNYDSNYLYIEKK
>SEQF2502_00166 hypothetical protein
MEKIFIILGLAGQLMFSARFLVQWIASEKRKKSVVPISFWFLSLFGSFLLLIYAIYRKDI
VFTLGQLFGFIVYIRNLLIIKNTEKIEKNIKKGKLK
>SEQF2502_00167 UDP-N-acetylglucosamine 4-epimerase
METYLITGGAGFIGSHLVKKLLSEHFKIIVVDNFDDFYNYKIKISNLCEATNTFFEIKYD
KKEKNLKEFVNFINNADKNMILLNKDIRNFDDLKETFKNYKFDGIVHLAVKAGVRPSFER
PLDYEETNIKGTLNLLELCKKFKINNFVCASSSSVYGDTPKLPFSESDNIKKTLSPYALT
KKTCEEMAYLYYKNYGIKVIMLRFFTVYGPGQRPDLAIHKFAKKLKYNEKISIYGDGKTG
RDYTYIDDIIAGITASIKFINKKNECYEIFNLGNNRVITLMEMVKIMEKISGYKADLEFC
VFQKGDMPMTYADISKAKKLLGYNPKTDFEDGIEKFFAWFEKKESKI
>SEQF2502_00168 2,3-dimethylmalate dehydratase large subunit
MGMNLTYKILKKNLLKGELKAGNEIAVRVNQTLTQDSTGTMAYLQLNAMNIDKVATEISV
AYVDHNMLQSSFENADDHEFIKTSAEKHNIVFSKPGNGICHRLHLERFGKPGKILIGSDS
HTPTGGGLGMLAIGAGGLDVAIGMARGLYYLKVPKVYNIELRGKLQPWVSAKDVILYVLK
ELTVKGGVGFVMEYTGEGIKSLSVEDRATITNMGAELGATTSIFPSDENTKIFLEKQSRG
EDFVELLPDEDAVYDEKLVVNLDELVPLAAFPHSPDNVHEIPKDKKLKVDQIAIGSCTNS
SYSDFMKLAAILDGKKVHPDVSLVLSPGSSNIMKMISENGALAKFIAAGARLLEAACGPC
IGMGQAPKTNGISLRTFNRNFKGRCGTMSAGVYLVSTETAAASAITGYLTDPRELGAEII
IDEPEKFEVSDNYFIFPNPNEDEAKKERETVKIVMGPNIKPFPIGEELKDSFTKKVILKT
GDNITTDDICPSNAALLPFRSNIPKLSEHCFETIIPDFKERAEKNDGGIVVGGENYGQGS
SREHAALLPLYLGIKAVIAKSFARIHKANLINSGIIPLEFENVEDYNNIDEYDELQLSDI
PNSLINGRFIVKNLTKNIEFPAKFNGSERELKILKFGGYLKFATSDEFLS
>SEQF2502_00169 Isocitrate dehydrogenase [NADP]
MKKITLIPGDGIGYEISESLVKIFDAAKVPIEFETENAGSDVYEKTGELIPESLYESVKR
NKIAIKGPITTPIGKGFRSINVYLRKKYDLYTNFRPSRNLPGIETRYNNIDLAIFRENTE
GIYIGEEKYENEEKTSAIAIKRITRKGSKRIIQSAFEYAKNNGISKVTVVHKANILKFTD
GMFLDIAREISKEYENIQLEKLIIDNMCMQLVTNPERFKVIVTMNLYGDILSDLVAGLVG
GLGVAPGANIGDDIAIFEAVHGSAPDIAGQNKANPLALLLSSIEMLKYLKLDNFAKNIEN
AILKTLTDGCKTADLGGSATTTEFTDRIIENLK
>SEQF2502_00170 Citrate synthase
MKSDFINELGVMFTENNYISDDIYNKLNVKRGLRNKNGTGVLVGLTKIGSVLGYSIDKDG
KKVPSEGKLYYRGIPIEKLVAQFRKEKTFCFEKTMFLLLFGKVPSNFELKMFISTLKEYQ
HLPDEFIEDFILRKPGTDIMNQLQRSVLCLYTLDENPDDISLSNLIDQSLNLIAKFPSLL
VYCYQACNYKHFNKSLIIHNPVEEYSIAQNILHMLRSDNNFTELEAEVLDLILVIHAEHG
GGNNSTFTSHVVSSTRTDTYSSISASIGSLKGPMHGGANSMVTKMVEDIKKNTNPYDEVK
LKEYLKKIFQKEVFDKKGRIYGMGHAVYTISDPRAVILKKKAYELAKEKKALEEFELFSS
IEKLTREIGKELKGKNFEICANVDLYSGFVYKLLNIPQNIFTPLFALSRIASWNAHRMEQ
ILVDKKLIRPAYKAIDENGNVFL
>SEQF2502_00171 HTH-type transcriptional regulator TreR
MSKYKEVYNDIKEKITNGTFKAREFLESESELARKYSYSKDTIRKALSMLELDGYIQKIK
GKNSMVLENGRFKNSLSNLRTSKELNKIENIDIATNLVELSVVSGIKEIMDIFEVSEEVS
FYKVSRIRILEGEALEYETTYFDMRIVPFLDKKIAESSTYDYLEKKLHLKISHSRREIKF
RYATEDEKKYMDLKDFNAVIVVESHTYLSNGTLFQYGINSYRPDKFVFSTVAKR
>SEQF2502_00172 Transcriptional activator protein CzcR
MRILVIEDEKNLNDIIVKRLILEKYGVDTCFNGNDALEYIFSTEYDVIVSDIMLPGIDGF
EILKRIRKKEIKTPVLLLTALDGIEDRVKGLDYGADDYLVKPFAFDELMARIRVLLRRNS
TNGNFNASNVFSIANLRVNCNSHDVFRDDVPIKLSTREFTILEYMIRNKERVLSREQIEQ
HIWNYDYEGGTNVIDVYIRYLRRKIDKDFDPKLIHTVRGIGYVLKVE
>SEQF2502_00173 Sensor histidine kinase ResE
MKRFVNSNWIQLKIGLWYMGIMILLVLSSLYIVFYISENIIHSSVRTYLKDVVIHRLDYL
TIKNGEIIIDSNFDTMIQNVEISIYDKDFKFLYGNSPNGFEMDNKKSKDDKIIIVRSHNQ
KWYVYNKMINLGSYGKVWIRGVMPNIGQSNAIETVIHISFIILPFFLILSAIGGYIITKN
AFTPIKKIRKIAEEINEGNDLSQRIDLGKGDDELHTLANTFDVMFDRLQTSFENEVQFTS
DVSHELRTPITVILTQSEYGKNHIKSVEEAKNSFKIIEKEGQKMSKLVSQLLTLARMERG
KQKLNLENINLSELLEMTVETQICAAEAKNIKFITKIVPEIYAKIDEMMIMRVFTNLISN
AISYGKPNGTIIIELFLEENKIISKISDDGIGIPKDELDKIWLRFYQVDPSKSGDSSGLG
LSMVKKIIELHNGEIFVESKLGAGTTFIVIL
>SEQF2502_00174 hypothetical protein
MKIRFLKMTLLGMLLASLLVFSGGKERKKLNVIKAKQIALAKVPGATFANVLEFDVEDNR
FYKGKINYRNVAYNFEIDVYTGKVINWSEEKSSNK
>SEQF2502_00175 hypothetical protein
MINRIIKKESFNYTITLVIFLLSISFLTKGSIIGQRNKMELVPKINIKTSDTQITPNKAK
EIALAHAGVAEAAANFKKIKLDNKNGKSIYEIEFIANKSRYEFIVDAKNGSIIKFEKR
>SEQF2502_00176 Glucokinase
MKYYVGIDLGGTNTKIGLVDEKGNIIFKTIVKTDSMEGFSETIQRLSKILLTQVEGSNIS
FDDVLSVGVGVPGPVLNSRIVKFWANFPWKNGVDLALEFEKNLGKPVKVDNDVNVITLGE
MWKGAAQGYKNVLGLAIGTGIGGGIIVDGKLVSGENGAGGEVGHIKIEPNGKLCGCGQKG
CWEAYASATGIIREANSRLAVNKQNLLYEMTKGRELEAKDVFDAAKENDKFSLELVDYEA
EKLAFGIGNLLSTLDPEIVVIGGGVALSGDILFDRVKEKLKDVAFPSTLENLKLATATLG
NDAGILGAAYLGMM
>SEQF2502_00177 Pyrroline-5-carboxylate reductase
MELGIIGAGNMGSSILKGVITSNFLVSDDITVFDLNQEKVENLVKKYGIKAAESENELVE
KSNILILSVKPNIVPIVLKKIKDKLDKNTIILSIAAGVSIDFIEKNIGNDKKVVRTMPNT
PAQVMQGMTAVSFNSNIEENEKNVIFKLLNSFGKSVEIEEKLMHVYTGISGSLPAYVYVF
IEALADGGVLEGMPRNKAYEIIAQAVLGSAKMMLETKKHPGILKDEVTSPGGTTIAALKV
LEDGKFRGTVMEAVKACTEKSKDMAQK
>SEQF2502_00178 Cob(I)yrinic acid a,c-diamide adenosyltransferase
MKIYTKYGDEGFTRLYGGQRVSKTHVRVEAYGTMDEVCSLLGVIIAEIREDEKLNDVLGK
IREECENIQQQLFDCGSDLATPDGLREYKQTIDDVKWLEERMDEYIPQLPKLECFVIPGG
SRMSSMFHLMRTSTRSLERKMIAVIEAGENVNKIGLQYINRLSDYFFVIACLVNLKLGIN
ETIYKKSKKIFKVKNEK
>SEQF2502_00179 hypothetical protein
MMEYFELDKRKNFDERKYLSTELLDKLGLNKYRNLIEENDAIYCSGKYGYKLKNETYEKI
KEILYEMYKDAYDLEDEEEKEMFNEEIEAFFCDKKLLSVWRLFFEDRVLEECVENWKHSP
HIGLDNEEKLRDDLIPLDLIENKEDEIFLLHKVNGGIYFYYAFTFVIKIADNFDEFIDNL
YEI
>SEQF2502_00180 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MNKIKNNYEVGQKLEIEIEKIVFGGEGLGRVDGFTVFVPMSVPGDKLEVEIISVKKSYAR
GLITRIIEPSKDRIEDLSKISFEDFDGCDFGMLKYEKQLEYKDKMLEEVLTKIAEIDLRK
VKISKIIGSDKKINYRNKTAEPFFKKNGIIQTGFYSRKSHNVFSAKKSLLKSEIAKIIID
KFLEKVNSFAGTKKEFKVFNEVNNTGFLKQIMIRNNEKDEVMIVVVVNKNSQYNQLSKVL
EDMYDENDYIKSIYISVKTEQNNVILGKNVHLFGSQYLEEEMEGLKFKIYPNSFFQINKK
QVLKLYDVAIKFLNEENKNIDKIYEKTVIDAFSGTGTIAMMLSKNIKKVIGIESVESSTL
AAKLTSYENSIQNVEFVNGKVEKELPKILKRENVGAIVFDPPRRGIEESALKSVVQNRIE
KIVYISCNPATFARDVKILTENGYVLKKVTPVDMFPQTGHIEVVGLLEK
>SEQF2502_00181 putative hydrolase YxeP
MDSQEINKFIKENVDKIYDEMVKVRRTIHENPELGDEEFETSKLIKRFLTENGIEFFEII
NTGVVATIYNDKENMKNKTVATRADIDALPILEENEVEYKSKNIGKMHACGHDAHTTIQL
GVAKILAENKDKWNGTVRFFFQPAEETSGGSDRMIKAGALEFEKEKDKKIDAFFALHMAP
EIELGKIGIKYGKAHASSARIHLTINGTSAHAALPHKGVDAILIGAKVMEYLQSIVSRRI
DPREESVITIGAFNGGFADNVVCDKVEMKGTARTMSEETRTFIIETLERDLPKFVEALGG
TVNVDIVRGYAPVINNDEMTERVENNIVDLYGKSALELIKQPRMDVEDVSYFLNEIPGCF
FRLGTRVEEKGLIYDLHHPKFNIDEESLKIGMGLQLKNILEYLK
>SEQF2502_00182 hypothetical protein
MGIYEIIIGTMFIPFLFILSIFFSLSLRKRNMQKIISAEISDALKDLKPREFFYNLLKME
RTAKPVYCAEIFLLAIDTIYILFGGYAEYLKELKFAQEFSDFPINPMSSVFIKFGIPIFL
WFIVLFLLLFALFMKKKENKRLAEMLDNLEKYRFLNYAKEDFINSEKIVKTGMVAQSDLK
IGSRYLFSIYPAYIIPYSWISDIKIDRVYNRGGSYSSLTFIFTKSFKYEKIFFAKKEVAE
KVRDFILENEDFH
>SEQF2502_00183 hypothetical protein
MFIFMLILQLVILIISITTIIYLITRKNTMECFYIENEILCLNSMPTKKIPLSDIDYIEF
YCSRFRNSCRGLIKIHTINSKVVKRFFQTSKFTFFVTEQMVLDEINKLTPILKEYSIPYT
INYN
>SEQF2502_00184 hypothetical protein
MDKNRKRWGYIFDEKLDMLIPNIPRQKKFVKIFLILSLIFFIIALMQLYFLDKTSPKQII
FLIYSGGSVFFLLFLAIVIKVNISFIERKLKQLEETTLPYEFEIHPLKDNSYIFLCIILF
IMFITILYFKLNELLKNFTSKDIFFVIFMIITIAVNFSFFLENLKKRKYSLIISGRIIKL
LYENNEIEFIEIDNIRYAKFYAANAGKGRKERNPTFQIFDKEEKKFVEMSIKPTDYCLLK
KYFTKYNVMIDDLYEYF
>SEQF2502_00185 hypothetical protein
MSISFYVKNKKKFLGYEPILNVETALSLLDKELYTYNTGNIDINDLLLSPVSNYQCLLIG
DGKESARGFELYYDNKNKNYSIRVFTPSSREDWLLALEYIKALAKKFDSKIISETGEEYT
VDNIDKFDYEGDILYGIEGISSRVKGEDSTLYSIFGINRIVSFNQEMIDRIENSDSPIDT
FSNMVKEIQYLDAFSANQRFFRNKEDGKIIGTYTLTQNLRMILPYKPSVEFENSDMVKNE
DIAFWNIGLVIIDGDENDPNSYQVVGQLDYNDFIKKLPKDKYHFIDASYILVEPLSKEKI
LGLLEISVN
>SEQF2502_00186 hypothetical protein
MKFFQNILIIVVVVTIIFLIKKLMITKKLEKKENKKLENKNLSIYELIKSSIQECGKLPE
DFALPQEEENGIPWADGAMDGVFLYHTAINEENIETLKNIVFQISEGKFKEAQNNLDHLD
FLMVSSRTSLLNWIIQESEKINANNMYEFTISQLKTSKNKENIKFSLAVLLLMGVEKDVK
AMEIIKTLALSDEFTLFCLDIITRLENSNEEIFEIAKKVKGWGRVHSIAYLEPANDEIIK
EWILEEGCHNEIDPAYTALTCVKKINLLELLDEENISNKKFNAISYLITALLNEGPASGI
SSLENKEMLIERYLKKAKYLSSTENDYRAVMMIKEYIKDDKKINNNFIKICNEILNSERT
VNNIKELMKKGYSYDIAKYIKIDIEPYALEYLQSNLLKNPYIMYDISKKENIEKLVLLVE
KRLPLEKMKGSPTDKINFRNEEFTVLDVAVRTLENFEGIGKNLMICALNSPYENVRYGAA
NTLEKWKGKGYIFPDEIIQNIKNLEKIEVDDELKEKLNKLVK
>SEQF2502_00187 hypothetical protein
MNMEIIQICDITLTVKFALKTKTNIEYFPFEYEKSIEFLFSKNKIDFLEKNYKARNIEEW
FDYCLKLSLEDIKILLPVSSKNLNISNDLNTGKIKLICYFKNNLILYFTPKWKKTSGGRN
VIYTAHKYENSINGKLKFYDNTEDFKNILSKIATLADKINFSNFGNIFRKAFNILNGESF
ENIRNTLYGQTLFKIPKINARLFYSAKISNVFGGMSSWNDSPPYYAHKKGLESEYDSLTE
ELLTQIRLALLYSVNEW
>SEQF2502_00188 hypothetical protein
MFRKKNEIFYVGKVEIIINESTLDVFRNTIYYVDMQDALCIKSVPFITCDIYEDEFPDHL
IAQVGLEDDEENDILPSVEELKNKKIVCFIQLDEHIMR
>SEQF2502_00189 hypothetical protein
MKKLNFKIEEKECILYTNENKKIEYILIQPVDEHDMQLLDNEVKYISENTDKNFSLAAFK
IEDWNSELTPWEMPLLRGKGNFGDGAGKTLEFIKEKLIPSLAEFMNIQEKNVKYILGGYS
LAGLFSLWSGYETNTFYGVAGVSPSVWYEGWIDFVRNAELKANNVYLSLGKLEETSKHKI
LAKIGDNIREYSEILKNSGIEKSILEWNEGNHFNDSDIRTGKGFVWILENC
>SEQF2502_00190 Mono(2-hydroxyethyl) terephthalate hydrolase
MKKFKLMMVSSLLMVAGITTFAAKTNNKKLEKKSVVFTGATKEKCMSLKNSKIYQTEITS
TEWKEEGPLEEDANASFSGSSTAKASAPAHCVVKEKIENRKGADGKDYSIGFELRLPAKW
NNKFLFQGGGGLDGSVSPATGTARPSGSTAEPALTRGYAVVSTDSGHFGSNTSFAKDQQA
ILNYAF
>SEQF2502_00191 Mono(2-hydroxyethyl) terephthalate hydrolase
MQAAMYYPNEFDGIIAGNPGFRLSKAAIGEIWDNNQFLKYVPTDKNGNKIVADALTQEDL
DAVAQGVLDRCDAKDGLKDGIVNNWEKCDFKPEMVEKKIGKKKVALLNAVFNGAKNSKGE
NVYAS
>SEQF2502_00192 Mono(2-hydroxyethyl) terephthalate hydrolase
MGWRMWKHGTSKTGTPNSMNFMMGTASLSDYYMKPARPGMKPTEFDFDKDVAKTNEIGGL
NDADKTDLSTFKARGRKVIIYEGVSDPVFSAHDIRDWYKKLVENMGNIDNFTRLFMVPGM
NHCGGGPVMENFDALTALEKWTEENIAPDYIVGKAGKEYPDPNKEQPLCPYPKVATYIGG
DKNKASSFKCK
>SEQF2502_00193 Putative sugar phosphate isomerase YwlF
MKIAMAGDHAGFNLKKEIKELLESQGHEVIDFGPFNEESCDLPDFIYPASLAVSKLEVDR
GIFIDGVGYGSALIANKIYGVYAAVCQDPFCASLARSHSNTNVLCLGGKIIGSAIAQEIV
KTWMTTDYLINEKKYTNRVNKVVEIAEKHIRKDI
>SEQF2502_00194 Malolactic enzyme
MKSGYEILNDPFLNKGTAFTKEEREKYGLLGLLPAQFQTIEIQAKQVYKQFQAKDKLIEK
RHFLMEIFNTNRTLFYYLFNEHVVEFMPIVYDPVIAESIENYSELFVNPQNAAYLSVKEP
ENIETILKNAASDRNIRLIVVTDAEGILGIGDWGTNGVDISVGKLMVYTAAAGIDPSTVL
PVVIDAGTNRKELLENEFYLGNKFERVRGDEYYNLIDKFVKTAEKIFPDLYLHWEDFGRL
NAANILKKYENEIATFNDDIQGTGIITLAGILGALKISGEKLTDQVYMCFGAGTAGAGIA
KRILDEMIEQGLSETEAKKRFYLVDKQGLLFEDTEGLTPEQIPFARKRDEFENSDELINL
EAAVKAIKPTILVGTSTVPKTFTKEIIQEMAKHTKRPIIFPLSNPTKLAEASAKDLIEWT
DGRALIATGIPSDPIEYKGTVYEIGQANNALIYPGLGLGIIATKSRLLNDKIISAAAHSL
GGIVDTNKPCAAVLPPVSKLTEFSETVALAVGESVLEQKLNREPVDNLKEVIENTKWIPE
YKKL
>SEQF2502_00195 tRNA pseudouridine synthase A
MNKLIRDFENTKYFGYMFFIEYDGQKFESFDENPNKKSVKAEFRKILESSKIKIFKGIQQ
AGRTDTNVSAKGNILYINSKNIIDFSKLKLLGTEGLEINKIVRTLPFLEFPQMIEKRYYI
YEYPENLVKNNEERISQICEKVSGKRDFYEFTSEKGKKLKNHIREVFVKYENGRLYFVGD
GFLPQQVRIMSNFILNNTKLDIEKLNNKNFENRKLGIKDKALDGKYLILEKVEFSEELEK
ISFFDVENIEELMVLKNEDYGKDFVKLNEKSLEAGNSASKINGLNEELKNIGGIAKIKKI
EKNGYFTVFFVEKKDKGEFIGKNGKNIRKLKKIFGDIVVKEM
>SEQF2502_00196 hypothetical protein
MYIIRKAIEYFKPKINRAYMNEALKRLTENEKKIFLEMSDYDKFHSLEVYKKLRKTELRN
DDKYLKLALLHDCGKGNVSIVTRILHKLGFKTELQNHAQRSFEKLEKVDEEVAILAKNHH
NREYSEEMGIFQKCDDES
>SEQF2502_00197 hypothetical protein
MEDKYKMTLEENIFVAKRNIVDSIWKSANLEGIAVTYPQTETIFQGLGIQNMKVKDINAI
VNLKHSWEFILENIEYPVDLNYICKINQLIGEANVNPFPGQLRFSDVSMGGTDWKPEIPD
KEKVNDSLNKILESGNSATEKAINLMLYLMRSQLFYDGNKRTSMMAANQVMIQNGAGIIS
VPIKYQEKFLELLVKFYETNNMDEIRELIYNHCIDGINFKRE
>SEQF2502_00198 Ribosomal large subunit pseudouridine synthase D
MNEKKEKYEIENEFEGEIDSENEKNIFVLNEEAGSRIDKFLSERMELTRTRIQQLIKDEN
ILVNGKKTKPAYKIEENDVVKVVIPELETVEIKPENIDIEIIYEDNDLAVINKRAGIVVH
PANGHYSGTLVNAILYHIKDLSGINGEIRPGIVHRLDKYTSGLLIIAKNDKAHLKLSQMF
HDKAVKKTYLAILKGKLNQKSGRIVTQIGRDKNDRKKMAVINDLNSGKTAITNYEVISQA
EKFTLVKIHIETGRTHQIRVHMKHLGYPILGDSVYGRPDSEKRQMLHAYKLEFQHPITEE
NMEFIAELPEDFKKALKKCGLELENY
>SEQF2502_00199 Ribonuclease HII
MDEKKLGNKKNELLEFDKKYNKIVVGVDEAGRGPLAGPVVAGAVIVNQDFPELQEINDSK
KLAEKKRERLFEAIEKNCIVGIGIASEKEIDEMNILNATFLAMRRAINQVAEKSAFDIVL
VDGNHLIREYEGKQECIVKGDGKSLAIATASIVAKVTRDRMLCEIAKEFPEYEFEKHKGY
GTKKHREILLEKGACKYHRKTFLKKILGVKN
>SEQF2502_00200 hypothetical protein
MDSKEFAFALNSEENFEDSFDFDELEEKLQSQLKLELSELEILKENQKQIGDPDNLGKVV
EDVIWEQVNNQIAIVAGEDFVKENGDLKLDLRSEAHIQTPENFEKGKIAKHNYISKKKLE
QNYDRYKNMSHKDFRKKYVNPGMDDEDKGLKRAGDLKKKGINTVVDIYNGRQIPTNTKLE
NGKNNPKAAEREHVRPSAELYENSSLQMANNNEELTDIINNPQNLQGYTTSERNKRKSNK
LPDEIDNRDKTKHWKEADEKAEKFIEKKEREGEERLRKEGIQTQKEEAFRIGGTALRAVV
MGLLVDLIREIITKLVKWFKTTKGKFEMLWDSLKEAIYSFIGKMKTHVINAGNVLFTTIA
TAIVGPVFRTLKQVWMLLKQGWQAIKNAIDYIKSPENKNKPIGRLILETGKIVIAGLTGA
GAIVLSEVIEKGLSSIPILLVEIPLLGSLANIIGIFMGAVVSGIIGAIAIHFIQKIIEKQ
MKNEVLSKQIDKGNQVLITQYKIQKLNGEKLIYQKGQVASNIINRHEKLSKYNAEIERET
EEKNKVYKEELEEYKKNAEKNLEKYIAENIIISSEEEIKNQEKIEKNFDEINSLLNSLID
>SEQF2502_00201 hypothetical protein
MGKYEMLETNSRIIAEKFDEYKNNLKVFSEQNVKDIKLSKVESEEWWNFIHGGNHVVTGE
ELNKLSSQIQNHLIGINDVKNKIIKEFGVIYNTFNALDNEYIKNITQSMMKSNEAINKAN
KGLIEAEKRIEDIKEVNGKIQIAQKNIKFIQEKLQVAQQDIGRNMEIIKKVVEGLSLFKA
KIDSYRHLKDIDNMWNDLKKLESKVLTISEDIKEVKIYIQRNVDELNSTKISKDKSENYI
IDEDTELKLKKLKRTVLISNISFGIITILLFSLFFMGSK
>SEQF2502_00202 Stage V sporulation protein K
MSKYKENFLNYASKLDAVTNSNGKITKYGMSIVEENSRESTVLLLKKIAEIVDSKEFSKD
IKEIANFLKKSLVEYYGYLEIKRICNLDEVVEDARSLTDLLEELNNLIGLKNVKSKVNDL
IIYQKVQKMREKEGLNAVKSTLHLSFTGNPGTGKTTVARIIGRIYKQLGLLSRGHFIEVS
RTDLIAGYQGQTALKVKNVIEKAKGGVLFIDEAYSITENEQSDSYGRECITELTKALEDY
RNDLVVIVAGYSEPMKNFFSSNPGLKSRFNTFIEFEDYNTKELLEILISMCKNNDYDLTE
KAKVKLNDFFETELQNKKENFSNGRMVRNIYDDLVMNHARRIVSIKNITKEDLLLITDLD
FKL
>SEQF2502_00203 hypothetical protein
MNKREVGFKYENIAKDYLILQGLVFVESNFYTRFGEIDLIFFEKSSQTLVFVEVKYRRND
FFGSAIEMVTEEKQNRIFASSQVYLLKKNWDRNVRYDIIGVSKDSGNIEWLKNAF
>SEQF2502_00204 hypothetical protein
MRNDEKCCKCGMDIFEIKKVAIPTKRAVGAKIAIDTFYLKICKNCGYTEMYSTKIIQKVE
DPV
>SEQF2502_00205 hypothetical protein
MFRNRDIISGEELVECDIVSKDTRNILNSLKKLRKLNNIYYVWDYNREFKRLIYSYKYNH
RKVMAKLIAELVKEEFYYVLKREKIDVVVSVPVSRKRKNERGYNQVDEILNFLKVNYVQL
ERIKNTKKMAGILNEEDRNKNIKGAFKISGNIDFKNKNILILDDIITTGATLREIKSSIL
EQFEGDVNKKNIKIIVFCLAAAREIKMNRGEI
>SEQF2502_00206 Neopullulanase 2
MSFKLKMKLLLFLVSSVISFSTSVQNENFHKNINDTVNIQENYLISASKRNNKKNSENFE
KNKKVNDKADVTDENADVSKKNELKYSQRNDGIIDLDSLVHKEDTEFRVLNGNNVKIMLK
TKNNDIYSAEIVYDGGKKLMRGIGNYGGNEIFMAEIPSSVSSYYFVLTDDKTKYYMGRNI
SKNLKDIERFEFSRSKKLTTIPEWARGSVGYQIYIDSFRNGDVDNDAIFNEFGTDDFAEP
TGEIRSGRSKKDLVLAYWGGNEKPQFSLNEWNSNYEEKNEWEENTLNDVQNYTRYYGGDL
EGIIEKLDYIKDLGIEYIILSSPFYSLSNHKYDTIYFNHVDPYFGYIEQTGTSKGLDIKS
KVHNNNGDMELNLLIFNPETDKNLLDEDLLDPKTWVWTDSDLKLASLVKKAHQKGLKVVL
EVAADTTSNRFFAINNKEFSNWYLKDTVLDLKNPEVRNYIENAMKKWILGPDGTFKKEIY
DDGIDGIRYVYYDNANKEYIANITENLKKYKPDLLITGEVSNSITKDIEDGIYDSGADYN
IINNIIKYTVNTNPNFRIGGVEFATKLNEIYNRYSSNRFNMTQVFIGSLDTDRIFSGMIN
PNRVYDRNNQSDQGYLNIRPDLYDGTAVNKLKRVVAMQMMLPATPIIYYGDEKGMWGADS
PRNRKPMLWEDYEPYDNETDNIIKYKDRLRSLPSVVEVNEVQKWISYPVKSNPDIENHYR
ALLKIRKEHKNLFKNGKLRILEVYSDPKTKGRIDSEITAYLDDQKRRAKLYQGRDINPAR
PNTDFISYEISDGNESMIMVVNNGSDEYPLSLQVPKLFGFYRNQLNLKENYAISDKKIQI
NVKPYEVKVLYSNAKNMFDSFRENKNKK
>SEQF2502_00207 Thymidine kinase
MIQNSKIGTLEVVTGSMYSGKSEELIRRLRRAEYAKQKIVAFKHAIDNRYGENGVFSHEN
NSFRAYPVSDVSQMEEIMEKNVDAEVIGIDEVQFFGKKVVDFCKKYVEYGKRVIVAGLDM
SFRAEPYEPVPELMSIADQVDKLHAICMVCGKPAYASQRLINGEPAYYDDPLVMVGANEN
YEARCRRHHIVRYRSDKKGKIYFIVGTEINVGKKFVEKMYEEQLVDNKKIETIVIKGQMD
ENEKSNLIKLRKKINTALIENDYIFVRITGGLLLKLEGSYSILDFMCEFRKNSEVIIVSK
NKKGVLNQILLTVDLLKKSDLNLKEIVYKNGNSHAGEEKEENGVIEKISKITEVKYREL
>SEQF2502_00208 ATP-dependent DNA helicase PcrA
MSSILDELNEEQRKAAEKIEGPVLILAGAGSGKTRTVTYRIAHMVKEIGISPLNILALTF
TNKAAREMKERAVALIEHEANNLVVSTFHSFSVRLLKTYSERIGYGRNFNIYDVDDQKSI
ITKIKKEMGIKDSDGIQPGKLANKISKLKEQGIGIKELEREIDMRIPANRLFGEIYQKYN
EVLKANNAMDFSDLLLNARKLLDDAFVLEKIQERYRYIVVDEYQDTNDIQYEMINLIAAK
YRNICVVGDEDQSIYAFRGANINNILNFERDYKEAFTVKLERNYRSTKKILDTANELIKN
NKSSKGKTLWTDGSDGEKIKIYNAATVFDEANFIITEMKKKKKDGAEYKDMTILYRTNAH
SRVLEEKLLAANIPYKIYGGMQFFQRKEIKDILAYLSLLNNKNDNHNFYRIINVPKRSVG
EKTLEKIQEVANEKNISMLEALHYIDSIPVRTATKLALQEFYNMMQSIYSNLDEMSIKEI
FDEILIKTHYIDSIEDNKEDRVRNIEELLNSIAEIEKQNPNMSLNEYLDMISLSSATDEM
EEDENYVKLMTIHSSKGLEFDYVFLAGMEDGLFPSISFDAPEEELEEERRLCYVAITRAK
KELFISYSSSRKIWGKDDNARRPSRFIYEMKQENLEYVSGEYGNKLQNPRSFTPKVENFN
PFSKNKIGTFGKKLNSSQAAVPNMNSKYKVGDVVKHKKFGRGKIKKVDMKSMIVEFMVGE
KKIALVLADKILEK
>SEQF2502_00209 Sugar phosphatase YidA
MIKLIAIDMDGTLLNGKKHIDKAQKEAIHEAIDAGIKIVLCTGRPLYGILPFYEELGLSE
LDSEGYVILNNGCSIHKTKNWELIDQVNFTSDDIDYLYKFSEGYDINFTLVNDYYYFNID
DRKPTDELITDAGFVFSDITNISLKEAKNGKHKIIKIMFLGNPNIMANFQKENESILKDK
YSSVLSQPYIYEILPKGNNKGTGLKKLAKKLGIKQEEIMAIGDGNNDIEMFEYANYSVAM
ENGTKSARKAAKYQTDSNENNGVAKAIRKYALNYSE
>SEQF2502_00210 30S ribosomal protein S9
MAEKIQYLGTGRRKTSVARVRLVPGETGVIINGKDMREYFGGREILAKIVEQPLELTDTL
NKYGVKVNVTGGGNTGQAGAIRHGVSRALLVADAELRGALKEAGFLTRDSRMVERKKYGK
KKARRSPQFSKR
>SEQF2502_00211 50S ribosomal protein L13
MSKYTVMQKKEEVVRNWYEIDAEGKVLGKLATEIAVRLMGKHKPSYTPHVDGGDFVIVLN
ADKIAVTGNKLLDKKYYRHSGYPGGLKVRSLEEMLQKQPTEVIRKAVERMLPKNKLGSQM
INRLRLFTGTEHTHTAQKPERIEL
>SEQF2502_00212 1-deoxy-D-xylulose-5-phosphate synthase
MALEKVNSPKDLKNLKREEMVELAADIRKALLNRLTNYPKGGHVGPNFGVVEMTIALHYV
FNSPIDKIVFDVSHQAYPHKILTGRKDGFLYEDKFKTVNGYTDQDESEHDFFRVGHTSTS
VSLATGLAKARDLKGAKENIIALIGDGSLSGGLAYEGLSNAAEQGGNLIIIANDNDQSIA
ENHGGLYKNLRELRESNGEAPNNFFKSLGLDYKYVADGHDINKLIEVFKEVKDIDHPIVL
HIHTIKGKGLPYAEKDREPWHYNANFDPKTGEPKTKPEPKEEFGTITFDFLTDKMEKDPT
VTFINAGVPMGFGFTKDRREKLDKLRKQYVDVGIAEEHATTFSSGMATNGAKPVFGVIST
FVQRTYDQISHDIAINKAPTVTLVFGGTLKGMNDVTHLGYFDIPMISNIPNIVYLAPTTK
EEYLAMLDWAIDQNENPVFIKVPGGAVQHSETDVDKDYSNLNSYKVVEKGNDVAIIGLGE
FFALGKEVKKLLKEKAGIDATLINPRFISGVDGSLLNELKENHKLVVTLESGQKEGGFGT
KISSFYGTSDMKVLNVGAKKEFTDEVPYDVFFEENRLTKEQIVKDILMAIK
>SEQF2502_00213 Homoserine dehydrogenase
MKIGIIGLGTVGEGVLKVLTKEKESIFEKSRADIEVKYACDLNIDREFSFDFDKSILTND
YKKVLNDPEIKIVVELIGGETIAKKIIIEAFQAKKSVVTANKALIAKFGVELFQIAKENG
VSFLFEAAVGGGIPIVTPLMESLVANTITEIRGIMNGTSNYILTKMKEDNLSFDEALKIA
SEKGYAEADPTFDVDGIDAGHKINILASLAYGGSIKFKDMQLSGIRDISTVDIFSANKLN
LTIKLIASSKLLSEKSAQISVEPTLIPNSEILAKVDDVYNAIETTGSYTDKTLFYGKGAG
MDPTASAVVADIVKIVTRNHIESDYFFNSTKVFEIVDSNTVKDSYYVRVSDDFDIENSPF
ELINQIENYYIILADNLSKNEINEILKDAKEKLVLRIMK
>SEQF2502_00214 Aspartate kinase Ask_LysC
MALIIQKYGGTSVANAERVKEVAKRVVKYKKAGHDVIVVVSAPAGRTDALVKRAYELSDT
PNKREFDMLLTSGEQISIASLAIAIEELGEKAVSLNAFQVNFKTTSVHTKAKIIDIDTQI
IQEKLDKGNVVVFAGFQGITENNEITTLGRGGSDTTAVALGAALDADEVEIYTDVDGVYT
ADPRIVKNATKLKTISYQEMLELAASGAKVLHPRSVEIAAKYGIKIHLRSSFDDSTGTIV
QKDEEFEKFENQNIYTEGEAMEKVKIAGITSSKNEGKITLFGVPDKPGIAAKVFSRLAKE
KISTDIILQSSSINKELNNISFTVKIDDLKEAVAISEQIKEKIGAEGVLYKEKIAKVSVV
GIGLKSHYETTAEIFDTLAENGINIDMISCSEINVSCIIYEDDVNKAVNALHKRFIENED
>SEQF2502_00215 hypothetical protein
MEDKKKLIIITSIIAVGIPLFAISTQTILKKARDDYYKIQKQQIEDEKAKERAEKEQRLA
QEKAEREKQIQQEKEEKEKRITEERNERRQKAAEQKLQREQTAQDRQNKREKVKITNAAP
VFTPEPEVTTTEKHELTPEEVRKAKNALKEARASYFSGNKAAKPSKTSKNTDKIIIKSDS
KGNVEAIRHTKEENAKAQRILKEIRDSYYKNSTR
>SEQF2502_00216 D-lactate dehydrogenase
MKIVVFDAKPYDIEFFDKWNETFGADITYFEEKLSLKNVMLTKYQDVVCTFVNDDLNAKV
LNILSKNGVRVIAARCAGYNNIDLKAARENRITVLRVPAYSPYAVAEHALALLMSVNRKT
HKAYNRTREGNFSLAGLTGMDLNGKTAGIIGTGRIARIFIRILNGLGMKVIGYDKYPNEQ
AAKEENFTYVTQDEVFAKSDVISLHCPLFPETRHTINKETIAKMKDGVIIINAARGGLID
TEALVEGLKDKKIGGAGLDVYENESSYFFEDESASVLEDDLLARLLSFNNVVLTSHQAFL
TTEALDNIAEATFNNILSYVKDEPLKNEVWYNEETGKVVEGLRK
>SEQF2502_00217 Peptide chain release factor 2
MKLILKKSGGIFDIGNLKNEISELEKKTFEADFWNTDNCQEILKNISAKKKLLEEYDKLN
GIFEDVSTIIEFIEMGDNSFENELEQKSQDLKNEIDNFKTKLLLDEEYDMNNAILTINSG
AGGTEACDWAEMLYRMYDRWANRHNFKVEVLDSLAGEEAGIKSITLNIKGNYAYGYLKGE
KGVHRLVRISPFDSNARRHTSFAAVNVTPEIEDDVEIDIRPEDLKIDTYRASGAGGQHVN
TTDSAVRITHIPTNTVVTCQNERSQLKNRETAMKILKSKLFELELEKQEKEMAELKGTES
KIEWGSQIRSYVFQPYKMVKDHRTKAEEGNVEKVMDGDIDLFINEYLKYVKS
>SEQF2502_00218 Ribonuclease M5
MKKESNTQNKKIKIKEIIVVEGRDDITAIKRVVDAHIIALNGFSALSKKTINKIVELSRN
NDLILFTDPDFAGKKIRDTLKRYIPNIKHAFVSQKDATRDDNIGVENANDEAILDALKNV
ITAHQNVEDRFNISDLIDNGFVSGNNSKEHRIMLGDLLKIGYYNAKQLLKALNSFNISRE
QFEEAVKKINESNI
>SEQF2502_00219 Cytosol non-specific dipeptidase
MKIENLYPEKVFHYFSEISKIPRGSNKEKKISDWIVEFAKERNLEVVQDKAFNVFIRKPA
TAGYEEYSPLILQGHMDMVWEKNKNTHFDFETQGIELVVEDGFLKAKGTTLGADNGIAVA
YALAILDSDDLKHPELEIILTTDEEDGMSGVNNLDFGIFSGKTLINLDTEEYGQVYVSSA
GGARIFNEFNFDAEKLEDDDTVISVDVKGLLGGHSGAEIHLGLGNSNKILADVLNHLNKK
YTLSIMDIDGGEKTNAIPREAVALLAVKLEDEKVSDFEKLAKLAFENVTKDFKIIDKNPV
IEVKEIKKEELKNQGKMSISNTNAVISFFHEFPNGVIAMSEDIKGLVETSINLGVIKTEN
KDGKINIKVQSLPRSSINKSLEKLLNDVKELSEKYEVAVKINSPYPSWEYRKDSKIRDIV
VNSFKKITGKKPEIKAIHAGLECGVFDNNMENVDIVSIGPNIYGAHTPEERMEIDSVGKT
WELLLKAMEDYNIKK
>SEQF2502_00220 hypothetical protein
MEFYKRLIIKILERSSVGSDNRILKKLKSGYDLTQREMAELEELLEHIL
>SEQF2502_00221 Purine nucleoside phosphorylase DeoD-type
MGTPHIGANKGDIAETILLPGDPLRAKYIAETFLEDAVQYNNVRGMLGFTGTYKGKKVSV
QGTGMGVPSIGIYAHELIAEFGVKNLIRIGTAGSYQEDIKVRDVVLAMSASTDSAINKLR
FNGADYAPTANAEMLFKAYEIAKQKGLNIKAGNVFTSDTFYGDDPNAWKKWAKFGVLCVE
METAQLYTTAAKLGANALTLLTISDSFITHEVTSAEERQTTFNEMIEVALETAISL
>SEQF2502_00222 Polyribonucleotide nucleotidyltransferase
MFDEKIYSFNLGNQEIKISTGKIARQAGGSVIVQCGGTVLLVTATRSKDVKEGQDFFPLT
VDYIEKFYASGKFPGGFIKRESKPGTDEILISRLIDRPIRPLFPEGFLNAVHIVITVFSY
DEVNYPENLATIGVSAALGLSDIPFAGTVAGVTVGYINGEYILNPTGEQLLESEIQLSVA
GTKDAVTMVEAGAKEVSEEVMLEAIMFGHEKIKEICAEQDKFLAQFDVQKYEFEKKEVEP
EIKEFIDGFENEVENAIMTPGKLEKYEAIDNLEIELFERYVEKLESEEREIDENLEKELK
KYYRDVEKRLVRDAILYKQYRADGRKTTEIRPIDVEIDTLPVPHGSALFTRGETQALVVA
TLGSKEDEQIIDGMEDETRKKFFLHYNFPPYSVGEAGFMRAPGRRELGHGNLAERALKHV
MPDQDKFPYTVRLVSEITESNGSSSQATICGGSLALMAAGVPIKSTVAGIAMGLIKEGDT
FTVLTDIQGLEDHLGDMDFKVAGTKDGITAIQMDIKIEGITREIMEIALKQALEGRMFII
DKMEAVISEPRAEVSENAPKIEVIKINPDKIAGLIGPGGKVIRAIIDETGVSIDIDDDGT
VSIFGKESENMKKALELVKNQTQSVELNGIYEGKVTKLMKFGAFVEVLPGKEGLLHISEI
SNKRIEKTEDALKEGQIVRVKVISMENEDKFNLSMKALL
>SEQF2502_00223 CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase
MKMNLPNKLAILRIILVIPFVIFLSLALEFSEIIGISIMLRIFAAIIFVGAAITDYYDGK
IARKYNMITNLGKLLDPLADKILVISALITFAKFNQISLWFVIIIIFRELLITGLRSIVA
AEGVVIAADKLGKWKTATQMVALTLIILIPFSFIVNNILLIIPLILTVVSGVEYVVKCKN
ILNK
>SEQF2502_00224 hypothetical protein
MDIIITLILKIFDTYAILILVNILGSWIDPYNQIIFFQWVRKVTEPYLRMFRIIIPIGTM
NFDISAILGLMVIEMMKKMFVRAVLLGMF
>SEQF2502_00225 Periplasmic serine endoprotease DegP
MKLKKIITTSFMAAALTATAAVNKTDFLQNKQIVQNTNVTGDMYSAQDAFASVYDKAKDS
VVNIRTKKTIVVETYNPLEAFLFGTSGVRQQRRESGSLGSGFIISSDGYMMTNNHVIEGA
DEIYVKLADGHEYLAKLVGTSPEVDIAILKVNANRTFKPLKFANSDNIKIGHWAIAFGNP
LGLNSSMTVGVIGASGRSSLGIEQVENFIQTDASINQGNSGGPLLNINGDVIGVNTAIYS
PNGGSVGLSFAIPSNLAENVRDSIIKNGKYERPYIGISVLDLSSELKKERRISYSTGILV
QQVYPNSPAAKYGLKANDIILEINGKPVTSAGSFIGELAAKKIGETVNLKVASNGKEKNI
SMKLESFSYQQQTRQQRR
>SEQF2502_00226 Biotin synthase
MLKNNNQIELVKFISHLKNKIINEKYDITHEEAIFLSKIPNDDIETLNLLFEAANQIREK
FCGENFDLCTIINAKSGKCSENCKYCAQSIHFKTAVDVYGLISKETALCEAKRNENEGAH
RFSLVTSGRGFNGNEKELNDLAEIYESIREHTKKLSLCASHGICTKEALQKLANAGISMY
HHNLETSRRFYPNVCTSHTYDDRVNTIKNAKAIGLNVCSGGIFGLGETIEDRIDMAFDLK
ELKVNSVPINILTPIPGTPFENNKAVEPLEILKTISIYRFIMPKTHLRYAGGRIKLGNYV
KTGLKCGINSALTGNFLTTTGTTIEKDKNMVTELGYKI
>SEQF2502_00227 Biotin transporter BioY
MKQNILSNSIKIKTKEKEFLKSIFLVLSGVIFLSIMSQLIIPLYFTPVPISLGSFGVILI
ALVYGRKLGIATVLSYVAAGSLGAPIFAGFKAGSLFSPTGGYILGYIAATVILGFLSDKG
VAKSYVKTFLSLLLASAVILILGALVLMLFVPIKNVFMAGVLPFIPGDMLKAVAATLLFP
RLWKFIKKNKN
>SEQF2502_00228 Signal transduction histidine-protein kinase ArlS
MKKIKLKKIKDKIIFANTVSLVFISFIIILGMTIFLIHKAVEAETKEMDKLVLSAIEKLN
NVPTDKLKETYKNYDYADKQYISLAVEKNGNFIYLTDDENHSDFKKIEENKLEIKWDRFV
YKRIYTVNNIKYYAIRNFEFMEAHEILYVMLLMFVLITISIIVISKIVAEYVLNPLSNII
FQSKEINNHNIDAQLTKTRDDEIGELIDVLNETFKKKEEIIKSQKTFSSDVSHELKTPLA
IMKGYLDILEWGKNDKDLLNEAIENLNLEVKNIERIINTLFLSSNLEKITIKKEVIDVKQ
LFEKIKKDYELLNIKRKILVKSDGNVNIFVDKNLISEVLRGLIDNSIKYSVGNIELIAKE
NIMAEVIVRNYGEGIPEEEKKKLFNRNFQGKNAKKGAGLGLSIIKDIILLNDGEIYLENR
KDGVDVRMEFKKVEIEE
>SEQF2502_00229 Response regulator ArlR
MLIVEDDKKISRILKLQLEHKNHEITIIENGIDALNEIDKKRDFYDLMLLDLGLPSMEGN
EVCKNVRKISEVPIIVVSAKNNTEEKVELLKSGASDYVTKPFDFLELDARIDINIRKEKN
SEIVYKTLKLNTENYSVYLEETPVLLTKTEFELVKLLTENKEEIVSRDKIVEKIWGWDAS
DNLLDSTIKKIRQKLGKEKIKTVRGIGYILKI
>SEQF2502_00230 Phosphoserine phosphatase SerB1
MKESKNKNVAAFFDIDGTIYRDSLLIEHFKMLVQYEYIDMMTWEGKVKEKFSKWENRTGD
YDDYLDELVQTYMEALKNFSKEDMDFIAKRVMKLKGDKVYRYTRERLKFHKEKKHKVIII
SGSPDFLVSKMAERYGVEDYRASIYEVNENGIFTGNVIPMWDAKSKQKAITDFCKKYDID
LKKSYAYGDTTGDLTMFKNVGNAIAINPAKKLLQKIKRDKELKEKVMIVVERKDVIYKLK
ADVSII
>SEQF2502_00231 Putative 2-hydroxyacid dehydrogenase
MEKNLKIVYLDRVTAGPIDLREKFDKYGEYTEYEDTEVGEIDERIEDVDVVITTRIRLGK
KQFEKAKKLKLILITATGFNHIDVKSANEFGIKVANVSGYSTNSVAQLAITFLLNELTPV
NKYFEEVKNGKWIDIHVPDYQKYPIDDVEGKILGIVGFGNIGKKVAQMAEALGMEVMVAG
KDYKKVEEDGVLRYDLDEVLEKCDVLTLHVPLTNSTRNLINLEKMKKMKRSARILNLARG
PVINQDDLYFALKNKIIKSAAIDVTSVEPIEKNSKLFELENIVITPHIAWKSEKSMITLM
NDVEKNLKLFLEGKLEGLK
>SEQF2502_00232 hypothetical protein
MLVSNFNGIKLEFDGLYYGGNYEIEVFGDGRFYYSYIENTSVELKKGSFQINQKEIMIFE
EMMEYFELLKNQRNYMINEFNFGNGVLVIQKDNGREEKIRLGKEMMFEYAKTLIDKYAKK
SRRLFLLDTYLEGAKYIRNFAIKIKDEVQLDLFREFNGISLNAVAVYNSRKEKVGYLPKS
QSEIIARMIDAGKKFVAVPIPFDEETALKVYLVD
>SEQF2502_00233 hypothetical protein
MGFRLSVKGQENEILLDKESILDVKYISETPDDSNARATDLGVILEIRGKILAAASGDTE
DDTRKVAQWSLVPSEASDAYRQASLEIISAGQMVRKIDMTNVFVVDYIEEYGNQAGTGTF
SLKIKQKKEKVKEVAIEGGYAAQEA
>SEQF2502_00234 hypothetical protein
MKDHVSVLVSIPPKISVLSFMGYLNRKSALMMFDFI
>SEQF2502_00235 hypothetical protein
MEKNKVYLSLGGNIGDRKGYIQKAIKMIGKINGIKILGKSGLYDMKLL
>SEQF2502_00236 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase
MFLNVVIKIETKFSEREILKIINKIEAELDRKREIRWGPRTIDIDILLFSNKKIDEIDLI
IPHKEMLNRLFVLIPLIEIYDGDYFEKEVIVKRIDELFKIEDQKIQKIND
>SEQF2502_00237 hypothetical protein
MLKINEIKNRNPKNIVIEFDGEKNELNKFGNFLEDKNVFSFNQDKKIVGIFKYSELK
>SEQF2502_00238 Dihydropteroate synthase
MKKENNFEFENGINKLKDILQRDRLIWKGNNFEFDLTTESVIYSILNITPDSFYDGGRNS
SVDKVLKRIEADIKNGAKIFEFGGKSSKPNFDDISAQEEWNRIEKYIEAVKKEFPDVVLA
LDSDTEEVIEKGLDAGIDIINDFNGFASEGKLKLVEKYKPALVVMNNGRFDEIPNLKNYL
ESYFDERVKAILGTGIEREKISIDPGVGYSSNNSMNTPEDMERIKSVKYLRDMKLPIMVA
ISRKSFNEKIFQLTLEERLMGTLIFESLMVQDGGRILRVHDVKETRDILNMLEVYNKF
>SEQF2502_00239 Metalloprotease LoiP
MKQYSKILFLITAVTMISSCTVAPLTGRRQLKLVSDESVAEKSVSTYREFIQQANAKGLL
ANNTADGQRLRRIGGRISVAVEKYLNENGMSKKISGLQWEFNLIKTKEINAFAMPGGKIA
FYTGIMPILNSDSGIAFVMGHEIGHVIGGHHAEASSNNALAGIAAGVTDALTGGNIISSL
VSSGLSITLLKFNRTQEYEADKYGMIFMAMAGYNPSEAITALERMDSIGARQGAEILSTH
PSGKNRIEAARKFLPEAMKYYNAK
>SEQF2502_00240 tRNA-dihydrouridine(20/20a) synthase
MGNKVSIAPMVDRTDRNFRNFVRMINKDVLLYTEMITALAILNGDLEYILGFDEVEHPIV
LQIAATNPKEAYQAVKIAEKYAYDEINLNVGCPSDRISGNMMGAYLMAFPEEVVNIVKAM
KDATNKPISIKHRIGIDGKNILPNTFDRTLFDKYEDMINFIHITEKAGVNKYIIHARIAI
LAGLDPKQNRSIPPLRYDEIYRAKKENPNLHIEINGGIKTVKEIDEHLKHVDSVMLGREI
YDNPMILTEFGKYYGSEKKINITRKEIIEKMIHYVENMEKQNLRPHLFLMHTHGLFHNVR
GSKAWKRAINDPKADSGTLRKLLKEMENLR
>SEQF2502_00241 Nitrite transporter NirC
MRNNQTLEQVSNVAESKVQLLKNSKGKYFLSSFMAGMFIELGILLTFTVGGVSSGLPTNK
ILMGVSFGIALSLVVVFGTELFTGNNMIGVTGMLNKAITFKDMIFMWIAAYIGNIVGSVV
LAIIYVFSNSASKSVVDFIVKVSKAKVAALPQELFFKGILCNILVCLAVLAGIKLKEETA
RLIMVFWCLFAFITAGFEHSVANMTLLMMGIMYKGITLNGYFYNLLFVTLGNIVGGGFIG
YACYYLGKKEIKK
>SEQF2502_00242 Anaerobic sulfite reductase subunit A
MKISLNRENFNSALEKLKREYKIYAPIEIPFRGTFSDTSVIRYSEIDKIEEICFDKKSHF
SAKEVMLPITQTMFYFTEDGCTMPKEQNEKYLIFLRSCDLHSVKRVDEVYLNNKFLDIYY
KRVRDKVKFVVFGCPNSFENCFCVDMKTNKTDEYNIGIKVTDDKVFADIRDDELKAYFDE
VISENKENSKVNENVEFEMEFVEDNEIHVDIPDNIELSDIINLDLWREYDSRCIACGKCN
FVCPTCTCTTTQDVFYSENDNNGERRRVWASCHVNGFTDMAGGHSFRQRHGDRMRFKVMH
KISDFKKRFGYQMCTGCGRCDDACPEYISFSNCINKLSAELKRISAEKRGEKSE
>SEQF2502_00243 Anaerobic sulfite reductase subunit B
MNTNTLNTINIDEQDIIDMNVYLPTVHKLLFIEKVTELEWLFRVEYKNGKVNAGQFMQVS
LPGVGEAPISVANFNLEEGYLDFLIRKVGKVTDKIFELKAGDRIFLRGPYGNGFPIEEYK
NKHIVMVVGGSGIAPVRPIIEYFTKHPEEMKSFKIIVGYKNYESVIFEKEFLRWRKNIEI
LVTLDNAESARNLGKTENEFHEGMVTKYIPDLKIENMNETEFIVVGPPIMMHFACLEILK
LDVPVEKIWVSFERKMSCAVGKCGHCKIDETYICLEGPVFKYDKAQKLLD
>SEQF2502_00244 Anaerobic sulfite reductase subunit C
MSMDLNRKVVTKNAYRVTKDRSKTALRVRVPGGAVTAEIMGLVADIANTYGDGNVHITTR
QGFEVLGINWKDIEKVNKMVQPIMEKLDINYKDKDKGYAAAGTRNVAACIGNKVCPKGAY
NTTELAKKIEKAIFPNDFHFKVALTGCPNDCQKVRMHDFGIIGMAKPELDESRCVSCGMC
ERKCKKLSTGAISYKNYKPVRDHQKCIGCGECVLNCPTGAWTRSPKKYYKLAIMGRTGKQ
NPRLAEDWLFWADEESIIKIMKNTYEYVDKYIDRSLPKEHIGYIVDRTGFEEFKKWALKG
VNLPEETVMVNNIYWGNGIKYQGIL
>SEQF2502_00245 hypothetical protein
MDKYKKLKNDFNKKDYHGEDPSEVNEYDEYDEYEEHQDKDNDDCDKD
>SEQF2502_00246 hypothetical protein
MENFWKKEENNIEIQNIEILNNGKVEKSKLFLLEIEDEINLKIEIENMVYFSKSDNIFDS
IVELRKKLELNNIYLLCNASAINVYPSTMQKEFGGTKAYKLQMGKQATLNDVVDIFDYDS
ELKIGSVKEQEEFYESWIESF
>SEQF2502_00247 hypothetical protein
MRIIKRDKNGEEIAEIFGIYWDEERNQTLFLGMTDKYSGMYVYSESEVEIIDPNINFRTI
YLSGHLPGIFHWALIEKDLLDEVIDGNLELRKKFLDVLRSENIIDW
>SEQF2502_00248 hypothetical protein
MEKINDFNEAKNLLEKYLDKKISINKLKKNYFIDDIKFIKEELEKAYLFKDKTKLDILFW
LIFTFDFYSEEFINILCKISKEEWHWRHEDIAIYFMKMKLPSTLECLYELAISDFEKYRD
DEYCQLVEKCCYALGAIGTEEAKEKLKLLAKSSKDIIREHVEDTFEMYKLS
>SEQF2502_00249 hypothetical protein
MKISAKYEKELKKFFELSKKFYIVNFQLRNEELISNFSGVTDEEKIDMIKEGIKQACYKK
NSDEIAYLMYSIGIFGLFPKYSLNFVKSFSELSREEFHEEHEDIASYFQSLHLPQTIDTV
YELAISNFEKYRWDDNFALVRKCCFALGDINTPKAKEKLELLLQSDEEMIRKHVMEQLNR
CDFTNKDVE
>SEQF2502_00250 hypothetical protein
MKKEEERNIYAVFDDKTIRVYQAYSNEIADEALKLGKFGSKFSLNRMTWIKPSFLWMMYR
SGWATKQGQERILAIDLKREGFDEIVKNAVLSSFREVSDLSKEEWKEKLENSEVRCQWDP
DRDIYGNPIGRRAIQLGIKGEMVKKYINDWIVNITDITDKVVEIRNSIQNGTFSESMLPQ
EKKYILND
>SEQF2502_00251 NADH oxidase
MKVVVIGCTHAGTAAILNLRKMNPEAEVTVFERNDNISFLSCGIALYVGGVVKDPKGLFY
SSPEKLKELNVDTKMKHEVKNVDIEGKKIHVVNLENGNEFDETFDKLIITSGSWPIIPSI
EGINLNNILLCKNYNHSNEIIERAKNSQKIVVVGAGYIGVELVEAFTDNGKEVVLVDAEE
RILSKYFDKEFTDVAEESIKQRGIVLATGEKVLKFEGSNENVAKVITDKNEYEADMVIMC
VGFLPSTSLFKGQLEMLPNGAIKVDEYMRTSNKDVMAAGDCCSVFYNPLQKEVYIPLATN
AVKMGTLAGINLFENKIRHIGTQGTSGIKIYENNMAATGLTEESAKEEGIEVESVIAVDN
YRPEFMPTYEKVTLKVVFEKNSRRILGAQLTSKIDLTQSINTLSVCIQNKMTIEELAFVD
FFFQPHYNKPWNFLNLAGLNALK
>SEQF2502_00252 hypothetical protein
MDKIIVKYDKNFRMKIENNRNSEIILTDRNGEMLSPSELLAASVASCAMTVLSIKLESNN
QNFQNCYAEVGKKVDLTTFKVTEINIAFHLKKEYSQKVREKAEKSVEEMCVVGRSLSKDV
RQNYSFIYDVEN
>SEQF2502_00253 hypothetical protein
MIYDILDFLEELFWKVRAYYRKRKSTVISIFIFIISIYAGSLIYFLKDERIRLIKENRKY
NFWFVHNFDFKRKLYAMNYGFSLNETVRLYNFNFKRYLVGLKWKIGSKDVFYVFILPYNR
KYFYVPERQILYLKKADYSKEFEKEAIDYKNIGEFLEVKLVEDEKDRKIRKFLKFLEENN
>SEQF2502_00254 hypothetical protein
MKKFLVILMFLLNILGFSALKNGIYSVEKRYDGNWNSFVKLTVRDGKIIGAQYDRKNKNG
ELFSMSQNSFRDIALEISRSLINSQSVSSVTGKDAKAVSEFKEMSNFLMDKANNGETGDF
QM
>SEQF2502_00255 hypothetical protein
MLKKSIIVLFSCLSISNLSAAAVPKVSAKRSSEYSAQSSHALTSYYSTVDNVAIAGNFAT
VKETGQPFTGVYVEFDKVGNAQVVRNYQNGTLNGPMFLYYQNGNLQKVANYINGIREGED
VDFYGNGNSKTIRNYKNGMLNGASYDFDEFGRLTSSLEYINNMKNGKELKISNGIVTNEN
NYTNGQLNGEAKSYYSNGIVRSNGNYSRNYRNGQWTWNYENGAKKLIENYQNGIITDILG
YSRNGSKEREMKLVNGNGNFTQYYDNGKVKVQGALRNYKAYGNWTFYNKDGYVTDTQAFY
>SEQF2502_00256 hypothetical protein
MDLYNLRNNMRSRYFSMWEYLNNGFEIFKMFVKNHPLIVFLYFIFSTIMVLFITFPFTEQ
AIKMYEFTKKINNEKMQENINEYASLLSRLFSMLLLYALISLIIQFVAVIIRKKAGLEIE
MEEEKREKMRKSNFKLGEIILKFVTMIAVYLIIGIVLMMFIVVLSLFLGSSSGLFIVSVI
YLVLFLNILYLQQIYYLRNVNLVEAFKYNLYLSKGKRLRILLPIIMITLIAFFINYALNH
FAGMAIGNLQMLGIVTSVTSGIVKTFSTLYTIITENLIYFNVEYMDLKELK
>SEQF2502_00257 hypothetical protein
MNFENLQKDLFERKFKLGEYFSKTFELLKIFLKENKLWFILLTIGNTWLLFSNILIQHIG
ISLKIAESTGDNRGILGALFSNILVLFGIVIVSLGLGLLRVIIYMKSGYKIEGREKEYRF
ENAFIKYLKYIGLSLLFIVAIMIVVMLLLLITTILAIATKEIHSNFVGYILIAIPLIAYV
AIILAFILNILYFFQIFYVRNMKIWDSFKYNLELSKKNRFRIIVPAIIIVLINLIFIVPF
SISIFTFLPTYIGFIASVICGFFSGILGVAGIVMNIVVFLNVEYDYLKKQDEKRNENNSK
ENNSDDLNLE
>SEQF2502_00258 hypothetical protein
MGIFDFFKSSEKKDKEKEKAGNGNNSNTAKNVQIRRQIYDITNNESEMMENGNYTEDFTD
ISYYDDFGKEFKMPKKDWLDKKLYPSIRKNWNNMDGLYPIIQDAFSKGIYTEVKEAVLRF
YATDENFERKLILLGTYHTKIGAYQNALELYEKNLNIDNVTEGLCIAYAEVLELCGKAPE
AERKYYDALEINPNSATAFKKYFDIVKKRNVKEYESKLEKLSEINGNWRAKMMRAMVFFK
KGDKESGNFFLINALKESGYNSEVMYITSSIYILNELYDEFKQYVLAYYNPEKHNAYTAL
NVLKYYKVRNLYKEGLELCKFTSKFPWIEHYKKFMHYEDYFWKMKVNSESISNNEGISNH
FFSTNKPIWYYGFNHPEFMLNQSRRVKPNVLILTFTSIGEKSELAENLAVSLPLYLNENL
HYKTNLNYQLAIAYNKESLFVSKKRYSTDYMKLIRQQNNNLNFVLAGNILKMPNVEKYEI
EIYLYDTFNEQKSILVNKIYDENNIYSVQNDLLKAVSTFFERDFSIKYERNLNNLILFSP
KLKFLIQSKIHKEHQSWRYKKLLSDQIDVVLEDRNNDLKKINLLALLYEIKETNSQLLKF
QKPLIYSMNIHGIFETQTLKILAPIIFKIFDDDVNFQANIEALNITDSNYLSWINKFSGE
>SEQF2502_00259 hypothetical protein
MLFYKKIVAVVISIFYIFANCSFYNSIFHEYTNNRLFHITTWLGIVEALFWITLFLSVFQ
LEDKSIQKGDRTREEKEKEIKKDTRDLIICFFIFIASLICINISRVILTSSPYINDIAST
VSSYTMFIGGTRVLFIFSAIMFIFIAVSRKNIFLIIISAINTIISIMIWLDFDGNITAIM
RITIAILAIIYYLKNDIIKFNKKNGTK
>SEQF2502_00260 N-acetylmuramoyl-L-alanine amidase AmiD
MKKNVANILFLISILSVGNILNANNQDVSKDVKKPIEIRIDDNGQVRKDQSGPNKNKKND
NSGQNSYVNTNTQRGGTETISNSAGTVKVDASSYNSQGQDYRQKFIILHYTAGNRDSSLK
TLTENEVSAHYLVSDDKSEPVYSLVDENKRAWHAGVSDWKGRNNLNDTSIGIEIVNGGDV
SGTFVPYKDFQIKEVAVLVKYLADKYEIPATNILGHSDIAPQRKSDPGPLFPWRELYTQY
NIGMWYDNETKNNYEREYETKLSMTPVSDVQRELNKFGYGISITGSWDKQTKNVIKAFQH
HFRPSNYSGEMDVETFAILKALNEKYNKK
>SEQF2502_00261 Aspartate aminotransferase
MKKFSNRALNMHYSPIRKLVPYIDEAKRNGVKVYQLHIGQPDVETPDTFFEGLNNYKEKI
VKYTNSAGIIELRESFSKSYKKVEINLLPEEILITQGGSEAIQITLQTLCNPGDEVLVPE
PYYTNYDSFLRIADAKLVPIETSIENHYHLPAREEIEKLITPKTKAIMFSNPSNPTGIVF
RPEETELIKEIAIKYDLYIITDEVYRQFIYDEEIAKSYQSFMSIPEIEDRVILVDSISKH
YSATGARIGVIASKNKDFMAQALKFCQARLSVSTIEQYASTNLINTLDTYIDNTKLEYKV
RRDMIYNNITKIPGVVTYKPSSSLYLIAELPVDDIEKFAIWLLTEFRYENQTLSFAPGPG
FYTTPGKGIKEARFSFCTHNLIEIENGMKVLKKALEEYNKINK
>SEQF2502_00262 hypothetical protein
MENKENFIEKDIKNAKEILERMNPNQKVNYHTILTKLISDWKSKNIRPKIMIHSCCAPCS
TYTLEFLTQYADVTVLFANNNIHPKAEYEKRALVQQEFINKFNERTGNNVGFIEDEYKPA
DFYRAVKGLENEKEGGERCTVCFQMRLDIVAKKAQELGFDYFGSALTLSPHKNSQLINTL
GLEIQEIFDVNYLPSDFKKNNGYKRSVDMCAEYDVYRQCYCGCIFAALDQGIDLNEYK
>SEQF2502_00263 Serine/threonine-protein phosphatase 1
MELNIRRIKEDDYQKIFVLTDIHGRFDLFEKIMEKIDLKKEDLLLILGDSCDRGKFSFEL
YNWYEKMIQKGYNIIHLMGNHENMLFESISDENTRLNWLYNGGNVTIKSFFEHQTEEKTI
DEYWKNNKFYEEKWLFNFIEKMPHIIESENHLFVHAGIDFSKNLEDQEIKYLLWTRDDWY
KKNNTGKIVYYGHTPQKDISIKNNCINLDSGCFSTDVLRCVELKEKKLFVLKNNNVKIEK
FDIKQIKKKLTEERKEERKKEYEKLIEDYKEYIIDLENKTDKTKKDEQNLLEVKENLKKL
IRLKRILEK
>SEQF2502_00264 hypothetical protein
MFNAELKERAKKDLEEVYEDYKRTLANTVNHSESLYEKKVYAVEILKNFSSYIQKLSNKP
IEFETILGKIEMNIKKFDNKIEEVAKEVNQAKVVPTAVAGAGALAGAGVAAFAPTAAMAI
ATTFGTASTGTAIASLSGAAATNAALAWLGGEALAAGGGGIVGGEALLALAGPIGWAIGG
SALLGAGLILNGKNKEAADKIEEQILEIKKEMMKIMKLDIKVLMSEKEIKEISDNMENGF
ELIKYNNDYNQFSIENKERLATLMNISESLSTKIGEFVSNE
>SEQF2502_00265 hypothetical protein
MNKYELKEKEWKLSTCDRYDFMIAGFSGAIAGIIDVFFVGNPSLSKLGSLTDDGADELVK
KFAKVSGWKPKIDNENNVASAIGFLEGKFRVNYDQRNTTDVNKLFKMGAKNHHIKSLSHS
PDIIGLFFSILNQFTSTATFVSEGKIFNIDTSDGKFELKGNNFIEKLFCGFCNWIGHIMS
DLSGSSGGRGKINAGRGSGIPIPFMELFLMCDFGKFQNGNDRQTLAVTMTRVFQEGYDAR
FGVTMSIPVLIQELMIRSLWIIKKRYFEKKDWKECIPTEKHGDLRLMLLIGYTTFCLIDG
IDAGLRSGGNMVQFILHLNYVAWVRLIMLVFKELIIRYGPFIKEYLDKFLYSIFNTIKNL
NEQKLIEEFYERIQKTDREITRTLYEFIQQVQEEYKQRQKLLIESFSKKNNATQQMIYSV
EYAKIMGVSKEKIIYSIEELDELLKK
>SEQF2502_00266 hypothetical protein
MSENYYDNEFEKLKEELNNLKKEAGKNEEIDQENERIEKKRKQEEEIEEVEYQEKKAREI
VDMSSVAAGGVGVIPIPFADAIPISGIQLNMIYQINEKFNVETEAKMIVSGLGTVIGASM
IGRTVASNLLKFIPIVGSVASIGTAAAITKAMGEAYIITLKNLCIRYIKEGRSTNYLDID
DIIEEFKNNFKPPKK
>SEQF2502_00267 N5-carboxyaminoimidazole ribonucleotide synthase
MNFVYISPQFPKTNWEFCDRLKKNGVNILGIADIEYNQLDQKLKDSLTEYYKVSSLENYD
EVLKAVAFFTHKYGKIDWLESNNEYWLTQDAQLRSDFNITTGIKADKIANIKEKSKMKKA
YKKAEVPSADFSLVTTPAKAKKFIEKVGYPVVTKPDNGVGASDTHKIKNEEELKAFFENR
NKDIKYIMEEYVDGDLVSYDAIIDSNGNPLFETGIFEPAIMDVVNDGLDVFYYVQKKMPE
KLLDAGRKAIKGFGIKSRFVHLEFFKLNKDKDGLGKKGDYVGLEANMRPAGGYTPDMYNY
ANNTDVYQIWADMVAFDKIEKANLNEDLEKNYCVYASRRDNNNYVHSHDEIKQKYGNAIV
MDERMPDIFSEAMGNYMYTAKFATKEEMEEFINFIHEKA
>SEQF2502_00268 hypothetical protein
MQVEYRKEYSHNLGREMEFKRYGHAGKPVLVFPSQDGDCNQYEEFGMIDVLSDYIEQGRL
QLFCVGSVDKESWSDINGNPRYRIEMQEKWFNYIANEFVPRMQDISWRSDIIVTGCSMGG
AHAGILFFRRPDLFDTLISLSGMFDASMFFGDYKDDLVYNNSVVDFLRNMPWDHYYLDLY
RQKNIIICIGQGAWEGELLPSNRELAHILYEKQVPAWTDFWGYDVAHDWDWWRLQIRYFM
EHLDI
>SEQF2502_00269 putative ABC transporter ATP-binding protein
MLKKLFSSLREYKKSALISPIFIGIEVIFEMLIPTLMAMIIDNGLNGNNGKGDMNFIIVM
GLITLGVAMLSLLSGIQASKYASYASAGFAKNLRKDLFSKIQSFSFTNIDKFSTAGLITR
FTTDVNNIQNSFQLLIRGFVRAPLMMCVAIFMSFMINPGLSMIFVVAVLFLGTFLAFIIF
KVHPIFTAAIRKYDDINASLQENINGIRVVKAYIREKYETGKFKKATENLKNMLLKGENI
IIFVSPVMQLTVFSCILLLSWFGAKMIVVHELTTGELTSLFAYTTNILMSLLMLAMMLVN
IVFSRASGDRIAMVLNEEPSIKNPENGITEVKDGSILFKNVDFSYSNNPEVLNLTKINLE
IKSGETIGIIGGTGSAKSALVQLIPRLYDVLDGELLVGGVNVKDYDIKTLRDNVAMVLQK
NVLFSGSIKDNLRWGNENATDEEMEHACKLAQADEFIQKFPKKYDTRIERGGANVSGGQR
QRLCIARALLKSPKILILDDSTSAVDTKTDKLIREAFKNELPHITKIIIGQRISSIKDSD
KILVLEDGVITAAGTHDELIKMSNVYREVYESQTERSDE
>SEQF2502_00270 putative ABC transporter ATP-binding protein
MAKDNKKSQKSESKNQIKGLIRLLGYMFKHYKIRTLFVIAFICLGSFGMVIGTMYSKELI
DGVIIPNIGKNNPEFLKSLISIIFKMITVYAGAVACTYIYEVFMIYIAQGTLKKLRDDVF
IHMESLPIKYFDTNAHGDIMSVYSSDIDALRNMMVESLSQVISSIITIISVLISMFILNV
PLTFFVVVMIIIMIVTTKTISAKSSKNYTAQQRNIGIVNGYVEEMIEGLKVVKVFSYEKK
ADERFNKLNTALFNRANNAMKFANILGPAVGNLGNINFVLTSVLGSIIVFNNIAGFTIGG
LVSFLQFIKVINQPVSQIAQQLTSVILASAGAQRVFNLLDQTPEQDNGYVTLVNANIDEN
GNITETEKHTGAWAWKYPHSDGIISYERLMGDVVFEDVTFGYNDEKTILHNINLYAKPGE
KIAFVGATGAGKTTITNLINRFYDINSGKIRYDGINIEKIKKHDLRESLGIVLQDTHLFS
GTVADNIRYGKLDATDEEVYAAAKLANADHFIKHLPQGYDTYLSGDGSSLSQGQRQLLSI
ARAAIADPPVLILDEATSSIDTRTEKIVQEGMDKLMVGRTVFVIAHRLSTIKNSDVIMVL
DQGKIIERGNHNELIAQKGTYYQLYTGGFENQ
>SEQF2502_00271 Antitoxin YefM
MLAVSFSTMRNNLKNYCDKAVKENEDVIVTRKNEENVVLINLEKYNQFLKAVQNAEYLAK
IDRGFSQMKSGKGQVHDLIEVDDE
>SEQF2502_00272 Endoribonuclease VapD
MYAIAFDLKIDDLKKNYGDPYNRAYDEIRQELEILGFEWTQGSLYVNSTEKNTLAEVYKA
ITKLKSIEWFKNSVRDIRAFKVEDWSDFTAIVKE
>SEQF2502_00273 hypothetical protein
MIITVIKISIILFVFLFCFVQYFIIKEYITDRKAVNENKKVDYVIILGARVKGEKPTKSL
MERIKAATEYLRKNPEVKVIATGGQGKNEGVAEGLAIKRDLLKNRISEDRIILEDKSKNT
VENFRFSLEKIENIENSKNILNNNKKNQKIKVLIVTNDYHIFRSKNIARKVGFDNENYEI
YGLPAKTPLISIPKSYFREFLSNVNYFIFQSRNQLKVK
>SEQF2502_00274 Elongation factor 4
MLDQKNKRNFSIIAHIDHGKSTIADRLLEQTGTVTQREMVDQLLDSMDLEREKGITIKAQ
AVTLKYKARNGETYELNLIDTPGHVDFIYEVSRSLAACDGALLVVDAAQGIEAQTLANVY
LALENDLEILPVINKIDLPSADPDKVKLEIEEVIGLPADDAVLVSGKTGFGIEDLLESII
KHIPAPKGEINNPLKALIFDSHYDDFRGVITYIRIIEGKIAKGDRIKIMSTEKEFDVLEV
GIFSPKMKEVDELTVGSVGYIITGIKSIKDTQVGDTITHVQNPTSTALEGYRPALSMVFA
GIYPVSTDDYEDLREALEKLQLNDASLSYAPETSLALGFGFRCGFLGLLHMEIVVERLRR
EFNIDLISTAPSVKYHVTPEQGEMVVIDNPAEFPEGKKYIEEPYVKGTIIVPKDYVGNVM
ELCQEKRGTFINMNYLDETRTMISYDLPLAEIVIDFYDKLKSRTKGYASFEYEMIGYKES
DLVKVDILVSGNPVDAFSFIAHKDNAYYRGRAIVEKLKDVIPRQQFEIPLQAALGTKIIA
RETIKALRKNVLAKCYGGDITRKKKLLEKQKEGKKRMKAIGNVEIPQEAFLSVLKLND
>SEQF2502_00275 DNA polymerase III PolC-type
MNKEIKLNKNIIFFDVETNGFQGSSVLSMSAIKVNYNSENSGEERNKWKKVSEFNRFYFR
NEGEELNEGAINVNGLTDDVILSERKNIIQNTGIEYPLTFKEDMDNFFLFCQDTSHFVAH
NIKFDRSFVDFPLQNQFDTMLTNIDIVKVTGSSCGNYKWPKLMECANYYNVPFEESQLHG
SYYDVLIMFRIFFKMMKHKTGNKRILEFLEKE
>SEQF2502_00276 Putative DNA repair helicase RadD
MSILAKKSESSNLINTEEKNDNFLEITEYKENLEFEVLETFSDKISDFIGKNDYQKVIEF
TEKQLYLLNQAFTDESEKIKIQNTDFHFELPLKRKNKDIIGNINELIINEKAKFRNFFIY
LKQELLNCKKFYFIVSFIRYSGIQLLISTLDELEKQGIQGEIITSVYLNITDSKALRKLL
SYENIKVKVYNNSSESFHTKAYLFEKEKYHSVVIGSSNISQSALYSAEEWNVKLTDSSFF
NIYGKSLNQFEKLWHSNEAIELTQDFIDEYEKYKKSINAQNTFDYRKTKIEQENKFVPNS
MQKRVLQKLKETRINGNKKGLVISATGTGKTYLAAMDIKQFFEIKSNAKNKLFEINDKKS
KTSNIKFLFIAHREELLENAINVFSKILKIDKNEFGRIYGGLKEIDKNIIFASIQSLRNC
YNEFKPSFFDYVIVDEFHHSMSDSYLKTLSYFNSKFLLGLTATPKRMDGKDILSLCDYNV
VDEIGIKEALEEDLIVPFHYFGVNDYMINYDNIPYKNGKYNEKILLENLLLNTRTDYIVE
KINKFGFDGDELSAVAFCQNIEHAFFMKEEFSKKGYKSAVITANTSSNERSEILEKFKNK
KIEILCVVDILNEGIDIPTINLLLFLRPTMSSTIFIQQIGRGLRKAKNKDFVTIIDFIGN
HKKDYLLINYFSNEVDNKDTLFTKKEKIINEVKNQFSNIPKSCYVELDRICQNRIIEKIE
KINFSSKNILKEMYLDYKAEIGKSEDEFLQVRDFDTNIELFQELCLKMHSFYNAQLQFED
SKIFKKENEKNPLNKTEIEFLEYLEKKLTLVEPFTFLIIDYLVTGKEYINNNDLLNKYKE
FFDIKGNFEKYYLLNRIFEELMEDEILEKTLYGYKFSKKYKKLFSNEKLNKKNTMKSNQK
VNKSNFINRLKQLIYLGLNEFKRNDLDEFNENILISYKEYKRVELQILLDSKVPKGSWRA
GYANTEKDICLFATIDKTHIFQENLKYDNSLFADDIIQWISQPKTSHNSSVGQMFIHHKE
KGFKVHIFIRKYAFMNGNKTNPFIYLGNAKYYSSQGDKPMKILWKLDKKIPQKLIYELYK
F
>SEQF2502_00277 hypothetical protein
MKIRYKNIDYLVMGICYFKNNKESHYLIEEEKKIKWISETFIEVEKSKMPFNWSLSLVNN
SKYDFLCGYYELCNLPEHFEGIMLGNKKDLEIFLKKERKN
>SEQF2502_00278 hypothetical protein
MKVKLKENGTIHEVFGIVILDNRKKLFLLYSNFEVLDTELEIVDGRIPFDWHWKIINKEW
CKIIIGPQKLTKNLIYAAYHWEGEEALEYKKLQSDEMKKNWQKNLEYYDEVLNYSNIFDN
MLYKFER
>SEQF2502_00279 Tyrosine recombinase XerC
MPVYYNADKKTWYAMFYAKDYKGVNKKYKKTGFKKKKEAQEYEYEFKKKIAKSVNMSFQS
LYELYFEDYSKRHKPTAINTVENFFRLHILPFFGDVEISKINSYMIREWQNEMLEKKNEN
GKPFSENSKANIYAALKSLFNWAAKYQGLNENPCKNLGAFGSKKNRSEMKIWSVDDFNKF
INFLESKNKEKNGKYSDAITIFKVLFWTGLRIGEVLALTFDDINLEEKFIDVNKTISRIN
KKEYVTTPKTLGSIRKVLLPENLISDLKSYFSKFELELTKKNLKSQRIFNLKKSQLRYIL
EKYSIQADVEKIRLHDFRHSHASYLLFIQADITAISKRLGHDNLQTTINTYSHLYKDANK
QLMKKLNNNS
>SEQF2502_00280 hypothetical protein
MIKEKIRYTKTGKRLEVYEFKAKLHQKVVMSKNQFEEHIFPKHPEITLEIIKEVLENPDF
VTKQSKSRKEHFYQKKIGKLNYFVVISQHKNVKNLRFVLTAFMAKDSNFLKEKNIHYRYK
K
>SEQF2502_00281 putative lipid II flippase MurJ
MFKSSFIVMIINMLSRILGLIREMIIGSVFGATGMTDAYVSATKIPNFFTTLFGEGSLGT
VFIPIYNRGIEEEGKERTDDFVFSLLNLIVAFTSTLSVIMIFFSKQILKVTTGFNDPKRF
DAANNLLKIVAFYFLFIALSGVVSSLLNNYKKFAVSASMGIVFNLTIIVGTLLLKNKMGI
YGLGVAYLLSGVFQLVIMLPQFFQIMKKYKFILNLKDEYVKEMFILMVPTLVGIFGYQIN
EIVDNRFATSLPAGTASALNYASRLYLLPIGVFAISLAVVIFPTLSKAVVKNDSRTVKRV
VHQGLYMLSFLIVPSSVILFGYAKEIVRLVYERGKFNAIAVKVTSETLQFYALGLLFFST
IHLLTRSHYVYKDRKTPVISSFTAIFTNIVLDALLYKQYRHVGLTFATSFSAMVNFIILY
ISLNKKYVKLRNLKYIAILGVTFASSMISYWASSMIKFNSKYGIVVNLIIFAIIYLVIWF
ILIFIFRKDLIKKILRRKRKW
>SEQF2502_00282 Segregation and condensation protein A
MENIIQIKIENFEGPLDLLIHLIEKKKMDINSINISQIIDDYLSYIHTQKGLNLKIKVEF
LIMATDLIEIKAYSILNRDKKIEKIENLEKKIIEYQLFKEISELFSKYENEYNVPHTRTG
TESIGNEIIEYDISSLNLDNLFKSLNNLINSKMMKKDNLGERMILNLEDDNYSTEEAHNE
ISEIIKEDRKVEFNHLLKNKFSKSRIVTLFLCILDMFKNGEIDIIVEENIFFIKSIK
>SEQF2502_00283 Riboflavin biosynthesis protein RibF
MIKFITKNLAEIKEIIEYCINTGIPDYHKNIEEIKKSKNTVILGNFDGVHKGHQIILEKA
VKQAKEKNLKTIVYTFSEYPKNKQTKITTCSEKAYLLSKSKIDYLYLEQFEKVKNYSPKE
FVEKVLIDTLNANEVYCGFNFTFGKDKSGNVNILKKLLKKKNIKLNIQDAVLDEDGEVIS
STRVRNLIKKGDFDKVRELLGHNFIILGEVVYGKQLGRVIGFPTANLKFENKIYPEFGVY
GVKIHIQDNDIIYNGVMNIGKNPTVDVGVLSVEANIFDFNEDIYGKIILIEVLENIRREK
KFGSVEELKEQIGKDVYYWKNKILDKDKCQKENR
>SEQF2502_00284 hypothetical protein
MALFSSEKKSKEKRENEGLNRQFSANNDENTNGISTISMETTITGTIETNSVFNMEGVLN
GDIKGNKLIHVGKTGQVKGNITAETVVVDGEVSGEIIADKVEIGNTGKVYATITSAVFVI
QEGGLFEGRKKIKIALIKEEDGKGKKENKKVEEKPKVETAEKKNSKEL
>SEQF2502_00285 hypothetical protein
MRSSIYNIVDFENSRKRECESDYFNSKFFEMFPTKYEKLLREYEVILFKDNVKISFLSMD
FSDDFLYDGEYSFFEKIFLTLFGIIHLKDSEKSFDNFIDFEKIKKFKEIFDKIYIEIFNE
KIDKGDKKVIDFMNELKLEISKVLKRFSLEEVKEYREIIKEYAGTTWEKMKKLKKKSESL
FHKKILLYKLVSLENLLNVQYERHFLQNYVCVWNDLYLDNDYDDNGAFSNLFFLNKIDKG
VYFADDMVLFSFELAKVANSFDEFMDNIENFNLGSYSRFFKK
>SEQF2502_00286 Bifunctional NAD(P)H-hydrate repair enzyme Nnr
MKMLLGGNETTRKIDSYAINELRIPSIMLMENAAISFTKHISKNEDNFLIICGKGNNGGD
GYAIARQLFSKDKNVKIFCISDENMSNDCFVNYEICKNSGIEIFYKLEELDKLLLECDIV
IEGIFGTGLNSEIKGTYKDIILKINEYSKNKKVYAIDIPSGINGDTGEIMGVSVKADVTI
SFVTYKKGFLKSDIKEYLGTVIIENIGLNKNNIDHIVSEYYLTSEIIKGFHIKRDENSHK
GDFGKVLIFAGSSGFYGAGNIVAKSCVRSGAGLTTVITDKNNFSLNVFVPEAMSFPINFE
NIEKNFEKLENEILNSDVIAIGPGIGKSQKALKIFEKLISIERNNKGNLIKLVLDADALN
LLSENKGLFEKIKNRSVLTPHLVEFSRLSGFSPEEINKNKLEIAKDFAQKYEITLLLKGK
NTVITDRKTLFVNSTGNSRMANGGMGDCLTGIICSLAGQKYGLAESACIGAYLHGKIADK
LVEQQYIVNASHIIENISKCMKEIFEV
>SEQF2502_00287 Histidinol-phosphatase
MKTKIIIFPSNLHAHTFYCDGKNNAEDYILTAIEKGFTSVGLSGHSFTKFDTEYCMSEKG
TLEYLKELKNLKEKYKDRIQVYVGIEADFYSGFNSKLDKNLGLDFRIGSVHYIKDKEKDE
YYCVDNTPEILEYGIKNYANEDKKAFIEAYFDNIVKMVHTQKPDIIGHLDLVKKFNKDFK
YFDESADWYKNKVEYVLDEIAKSGAIVEINTGGMSRGWTQTPYPSSFILERILAKNIPVT
ISSDAHEVQNIDFYFDESLEIIRKIGFKSVKILKDGKFQDFDI
>SEQF2502_00288 Phosphoribosyl-AMP cyclohydrolase
MNIEQIKFDEKGLVPVIIQDYYTKEVLTLAYMNKESLEITLRDKKTCFFSRSRQELWLKG
ETSGNYQHVVSVKYDCDADALLVEVKKDGPACHTGAESCFFNSLFEAEDYSSFTPEKLYE
LIKDRKVNPNEKSYTTYLFEKGLDKILKKVGEECTEVIIGAKNNDNDELRYEIADLYYHT
LVLMIEQGLTIQDVKDELAKRHVVDHKVKQEKMGGEK
>SEQF2502_00289 hypothetical protein
MKKVDLVDESMFEYKFKNPKVQKYKDEIKEEILRSVIYM
>SEQF2502_00290 Imidazole glycerol phosphate synthase subunit HisF
MLAKRIIPCLDVRNGKVVKGVNFTGIKEVDSPVELAKFYNKSGADELVFYDITASVEERG
LFTDILKEVASQIFIPLTVGGGINTLDDFDRVLKAGADKVSVNSGAIRNPKLIEEAAKKY
GDQCVVLSVDVKRVDGKFKVFAKGGRESTGIDAIEWFVNGQENGAGEVVVNSIDTDGVKN
GFDLELLEILSQKLSIPIVASGGAGNMEHFRELFKIPGIDAGLAASIFHFKEVEIMKLKK
YLKSNGVEMRI
>SEQF2502_00291 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase
MIEIFPAIDLHNGQAVRLKQGDYNQVEVFFKNPVEVLDFFNKNNSKNLHIVDLDGAKDGN
TKNYEVIKELVEKSDFFVQVGGGIRDEERIKKYIELGVNRVILGTIAVENEEFLKEMVKK
YGDKIAVSVDAKDEKVAVKGWTETVELNSVEFCKKLSDIGVKTIIYTDISKDGMLSGTNL
EIYKKLSKVVNSDIIASGGITFLDEIKELNKNHIYGAIVGKAIYSGNLDLKEVLEISK
>SEQF2502_00292 hypothetical protein
MKKIILLMSIFAIVNLNAKSRSEMISQDLSKLGVSQEIILKTIELDKEMPNVVSEPDREK
VKKLALKIEELLKKNEKNFVLSENLINIYNALGKSDAEKLNNLKRYEKYNPYEVSKLFFS
NMYYSNKGDFDSYNKNYEILKEKYPDYLITRIAVTYTIGEDAIWNVMQIDEKTALASLNS
IMKMCDDKKKTEESHISDEQAWAYKLTMGWFAISFYLNENRTQDAIDFYYKNFEGKNKPD
KEILDYSKYQNWFIKSELARANKNDFYNNKKLFEENLKKINMFD
>SEQF2502_00293 Imidazole glycerol phosphate synthase subunit HisH
MIAVIDYGVGNLFSLLSSLNYVGLDTKLTNDVEEIKNAKGIILPGVGAFRDAISNLEKYG
LKDILINEAKNGKPFLGICLGMQMLFEKSYEYGEFEGLGLINGTVEEIKKHIPENSDLKI
PHMGWNNLKINDEFRNDKILKNVNVENEEYVYYVHSYFAKTDMKNIVAYSEYGTKIPGIV
KNKNVYGMQFHPEKSGDTGLKLLKNWGELVK
>SEQF2502_00294 hypothetical protein
MKKKKKGLAIGNSDFKEIIQENGYYVDKTKFIEDLLEDLSKVKLFTRPRRFGKTLNLSML
KYFFDVKNAEENRKLFDNLYISKSEYMENQGQNPVILISLRNAEAENWENSFFNTKNLVK
SLYKQFQYIKEKLDEFDLEDFFNIVKDKYNADWENSLKNLSRYLYEYYGKKVIILIDEYD
TPMTSAWNEGYYEKSRRFFKSFYSNTLKDNEYLQFAVVTGILRVAKEGIFSGLNNLKTYT
VLNNKYAKSFGLIETEVKNALEYYGLEQNIEKVRKWYNGYKFGNIQIYNPWSIINYLDEK
EIDVYWINTSDNRLIHAAIDNADKDLFDELKDLFNNGTTEQMVMASSNMDRLKDPQEVWQ
LLLFGGYLTVEEKIAMNEYALKLPNYEVKTFFKDMFVQNLGGFSRFREMIKAFKNFEFDR
FEKLLNEIFLVSMSYHDTSKTEKPYHTFILGMMLYLDNEYTVLSNNETGYGRNDLALNPI
NKRDVGYIFEFKVAKTEEELEERAEEALSQIENKKYPVLLKECGVKEIVHIGMAFFGKRV
KVKYKVVKN
>SEQF2502_00295 hypothetical protein
METRNRLGKKEEIKSSIESIVKLIENYRKYVIDYNDNYGSRIVEIILYAFTSPFLQDIRF
KLESDSEKLDVPQFLFIGGTAGSGKSNLLQILQKMLGLSKSKPILYNNIIPTGRTKKADT
ITQIQLWMNENNVAPILIDEIDEEFFSNKDRGNNLIVNVSNLSTSNFDFTPCFIGTTNAL
EYSLPQRAQRRSYYVKNDKVFDTELKKKSVKAYTEVFEIINDTLFQDFVIRFAEKLADDN
LSWKNYSLHSSTGLIDFLYWSREIFKEYFEIAQIEMPAWFPETRYDDTVENNQSLWRKLY
EYNHQDFKVQKEKGVYLFKLKSLDSEEGQSNRFGTKILPSTKYLNALSQKCKNDNNSSDI
IEIKIKEFHDWIGVPLPKELEHKKTILDFFKKKKSEK
>SEQF2502_00296 hypothetical protein
MEEKWKLRVPISSTIHSKFYLLKNDTETRLIFGSANLSFQAFSNKRNQFENIVIFDNSPL
FNQFEEYFNEITLTCTDFITKAIRKKAKSKIKVLDENNDEKQEEKFSVRFTQDENSKLQI
DISKDIVKEFNEVIVKEEDSVALPIIEEIKTIDEKQKIIENEKKEELEVEKFAYELSINT
ISRQAKKKESMVVMPETFAKKIKPKLEIKIAPKLNQATPERELLFSKDTDRGFGRSGLYI
EENGNTKPFGQKGRNKKFY
>SEQF2502_00297 hypothetical protein
MEKELESETLTLFENENIEKTEAIKVKNTLFTILNGERVDLEIEEIFDSNRFYEIKAVTF
SADESFLNKYLTPFKSVDLVIGIKDIDVQVRGRKALENETKNLIESQKAIIKKKQIRFF
>SEQF2502_00298 hypothetical protein
MEIQKELFSLQDKEYMKFLSKLTPNVSENTIIGVRIPEIRKLAKKLVKNNEYEDFLKKLP
HKYYDENLLHGAIISESKDFEKCIKLLDNFLPFVDNWAVCDTISPKIFKKHKKELIEKIK
EWSQSDKTYTCRFGVEMLMTHFLDEDFKKEYLEMVANIYSEEYYVKMVVAWFFATALAKQ
WDYAVIYLEDNRLDVWVHNKTIQKARESLRISLEKKEYLKKLKRGKEN
>SEQF2502_00299 hypothetical protein
MKKILLGLFILGTLGMAQGNYKINVKNGVKFSQSEIDQESKEIENIVNRDLFEKVNDAFQ
KKILVKVREFNKKYMDNLINESMKEVPQNQRQSFKEFMRNISNIINNTLITKDIFETDIK
SISFSGENDAKVKILIKTKNIDSTFNFGKFFDNSIRKSEISEEESNDLRKIDKNKLDAFY
KYLEDDIKEFVKKSSYEEENIDVKVNKVNGKWQLELKNANINEVFDNLGKEVFDTK
>SEQF2502_00300 Histidine biosynthesis bifunctional protein HisB
MRKSKIERNTFETKIKVELNIDGTGKYENNTGVGFLDHMLDLFAKHGRFDLKIYCDGDTQ
VDDHHSAEDIGIALGKCFYEALGDLKGVRRYGNFLLPMDEALTLVAVDLSGRYFLNFDVN
IPTEKVGTFDTELVEEFFIGFTRHLNATLHIKNIAGTNSHHIIESIFKGVARALAEAVSI
DEKYKDEIPSTKGVLV
>SEQF2502_00301 hypothetical protein
MLYDEAKNVLYASERAEFFIRKLGFDFDKIDKNEIIFLLNKEFERAITERESKFYDSSEC
LRVLCGYLYCLGDISDVPLLEKVKYGIDMDVGTMIDSEWIDSLKNNGIEMEEYDIQSKQE
IIEGFVDYYKFFYTL
>SEQF2502_00302 Histidinol-phosphate aminotransferase
MGKFWNNKIKEIEPYTPGEQPKDKKYIKLNTNENPYPPSAKVIEKIKSMNLEDLKLYPDP
DVMELGKVIAEYFSNKINDKITRKQVFIGNGSDEVLAFIFMTFFNARDKVYYPDITYSFY
PVYADLFNLKEVKIPLNDSFEIEIQKYFGLDGHIIIANPNAPTSIALKLDEIEEIVKNNP
NQLVIVDEAYVDFGAESAVKLINKYDNVLVVQTFSKSRSMAGIRLGYALGSENIIEGLNR
LKFSFNSYTIDRISIEAGIESFKDDEYFEKTNAKIIQTREKTVEKLKKLGFKVLNSSANF
IFISHKDVYAGDLYKQLKENGVLARYFAKDRINNYLRVTIGTDEEMGIFIEKLEEIIFQR
KKF
>SEQF2502_00303 hypothetical protein
MENVPKKQKQAAKEYFNKIHEVMGKNFLGEIDNLKIFVNEISFSEKNKAKVKIVSKFKDI
DNIDTDKIIDEAIEKANISYKELENIEKINKIKFDKFYKYLDEEIKEKLNNFDYDENYSE
IEVKKINGKWKLEHDFNTFMNEMTSGFNDIDN
>SEQF2502_00304 hypothetical protein
MKKILLGLFILGTLGMAQSNYEVYVKSGVKISQSEVDRDSKEIENLVNKEIIERYNTEGK
KTIKGLYREYMNKSIDGKCS
>SEQF2502_00305 hypothetical protein
MVKRTKYLEKLKKIKDMQIIKVITGVRRCGKSTLLSQFKNSLIESGILEKQIISINFEDL
KFEDLKDYKLLYQYINERLVPNKKNYIFIDEIQEVENFQRAVDSLFIKDNTDIYITGSNA
MMLSGELATLLSGRYIEISILPLSFSEYLELDETQDVRQTWNKYFENGGFPYAIQIKDDD
IRKDYLMGIYNTVLLKDIVARNKVQDITLLESVVKFLFENIGNIVSPKKIADTLVSYGRK
TTSSTVENYIEALKSSFILYKAGRYDIKGKQHLKSLEKYYIVDIGLRKLLINKKHSDIGH
ILENIVYLELIRRGYTVYIGKIGDLEIDFIAERNNEREYYQVSATILDENTFKREITPLK
KVKDNFQKFIISMDEINLSEDGIKHINILDFLQNRDN
>SEQF2502_00306 Histidinol dehydrogenase
MIKTIKYSKDVDLEKELARSQFSYVDVNETVESILKDVKARGDKALIEYTEKFDGVKLEN
LEVTEEEIQKAFDTIDKDLMEVIQYSHDNIKKFHEKQVRNDFLIRQENGVILGQVVNPIE
KVGLYVPGGTAAYPSTVLMNAVPAKIAGCKEIVMVTPPTKDGTILPSLLVAAKISGVDRI
FKVGGAQSIAALSYGTETVPKVYKIGGPGNIYVAMAKKMVYGKVSIDMIAGPSEVLIIAD
ESADSVHTAADLLSQAEHDKLAACILVTTSQRLADEVAVEVEKQLKELPREEIARTSIET
QGRIIVVENMDEAVFVSNFVAPEHLELAVDNPFELLPKIKNAGSIFMGHNTPEPLGDYLA
GPNHTLPTSGTAKFSSPLSVDDFVKKSSFIYYSKQGLEEVKDKVIKFAENEGLTAHARSV
SKRFDK
>SEQF2502_00307 ATP phosphoribosyltransferase
MINIALPKGRLGNKVYDLFEKIGYESSEIKEDNRKLIFENREKNVRFLLVKPSDVGVYVE
KGSADIGVVGRDVLLEENPDIYELMDLGFGKCKFAIAGPVNFKENFDRPLVVATKYLNVS
KRYFDSINRDVELIKLNGSIEIAPILGLSDVIMDIVETGTTLKENNLKVLKTIEDISARF
IANKSSYRFKNEEIEKIVKSIKEIL
>SEQF2502_00308 ATP phosphoribosyltransferase regulatory subunit
MKNYIKNLSKKDLILLNIRKMYDSYGYKRISLPSFEEYDLYNENKDFIDRNVLTVMSPNG
KLLALRPDITLSVAKKISKDQSLKYSKIYYQENTYNLTKYVGYDENEQLGIELIGKESTF
LDFEIVDLAIKSLDIINEKSMITLSHARFISSIFDNLNLEYEVKEEIFDCINKKNSHDIK
KILENNKFISENVKQLIYKIPELSGNLDDIEKELLKYEVNDDIKKILLELKQLNNLLFKF
HKKSKIVFDFSIVKNLNYYNGIILQGYIEGFPNVILTGGRYDKLFEKFGVDTGAIGFAIL
TDSLKGYYKDEDKNDFEILIAYDNSDFEKLVKFVNDFQEKGLRVRTENIENFKENDSEIF
NYNEKYLFKNGNLIKK
>SEQF2502_00309 putative DHNTP pyrophosphohydrolase
MKMENINFLKNHVMSLIEYEPELSKKIESILEILLKADVKNLINRKSKVHLSASAVVFKN
EKCYFIRHPYLKTILLPAGHVENDEMPLDTAIREFFEETGFSAVVDKKMKNFGLIDVNVI
EIPENSLKNEEEHVHIDFRYKLLLDEERERQEAELECFLLAEDEASGEFKRYYKYL
>SEQF2502_00310 hypothetical protein
MKDVTPKSNLEILIKCLGIAIGIVAVIALLKLALRIFLSVAIWIIPITLILFIYQKFNDR
Y
>SEQF2502_00311 hypothetical protein
MKKENFLKQFPKEQEYLASKLYNYYEIAQDYEIISFTEEFYTPNFWKKLGKKFGGVNIVC
DGVFEDSDRRQIAFVPDSFIDGIDGHNNFGLNRNELQFPNKLLRISINSRFHEYLHKDFL
GSLMGLNIKRELLGDLILKSDSKSKQIFGYIPVSEKIADYIVSELKQIGKATCKIEIVDI
KSKNELPKYRYDDKLITIPSKRLDSIVSTITNLSRTKVIDPIEKGKVFVDYVEEKDKSKL
LEIGSLITIRGFGKYKLFLDKGETRKGKERILIKKYI
>SEQF2502_00312 hypothetical protein
MLKNAKKLYEKYKKIKIAAEDLKKAGKLKNNLGAVTTKFELLVRMVKSDRRGEFKIPTMD
KVKIAGAIIYVISTIDAVPDILPIIGFGDDIGVVAYVISKLGNLISEYEKFEMQKKEEKS
ENTDWDNLRVVSED
>SEQF2502_00313 hypothetical protein
MKKIDKKKILGIALLTSLSIFAGTTANNTIKTTTAASNTANDECRPPHRLQKDSNGNLVD
ENGNIVKKPDPARIEELKTKLNNGKITKAEGAEIAKMLDKRGPHKPNDKCKPKDAPKRLT
DTEIQSLTNSLNSGKVSKDEAAKLIEMLNHRFKGSKPNDMPLN
>SEQF2502_00314 Glycine betaine/carnitine/choline transport system permease protein OpuCB
MNKLILTFLEKKDELFSGIVEHIQISFIALIIALIIAIPLGIYLSYHKKLANIVIAINGV
IQTIPSLAILALLIPIVGIGRKPAIIALILYALLPILHNTYTGITGVDPMYMVTSRALGM
NKFQQLTKVQLPLAMPVIMTGVRTAAVLIIGTATLASLVGAGGLGKLILLGLDRNNNYLI
LLGAIPAALLAILFDFIFKQLEKLSIKKILVFLILITFACLFGSISSFNNTKKDKLIISG
KLGSEPEILINIYKILIEENSKLGVELKPGLGKTSFVFNALKNGDIDIYPEFSGTAVFTF
LNETPVNNNAEDVFNQAQKGMETKFKMVMLKPMKYNNTYAIAVSKKFADENNLKTISDLA
RVKDKIKAGFTREFNDREDGYLGLKKLYQFEIPNIKEFEPKLRYVAVQSGDINLVDAYST
DPELAQYNMVILKDDKHLFPPYQGSPMMREETLKKYPKLKKILEKLSGKISDEEMSTMNY
RVSVKGEKAEDVAREYLRNAGIIKK
>SEQF2502_00315 Choline transport ATP-binding protein OpuBA
MIEFINVGMTYPNGNVGLKNINLTINESEITVFIGPSGSGKTTLLKMINRLEDNTTGEVK
INGKNVKDYNIHKMRWDIGYALQQVALFPHMNVEENIAIVPELKKWKKEKIDARIDELLN
MVGLEPEKYRKRNPSELSGGEAQRVGIARALAADPKIILMDEPFSALDPITRANLQEDVK
KLQKQIHKTIVFVTHDIEEAFLLGDKICIIQDGELVQAGTKHEIISNPKNDFVKKFIAIK
KKEGEIYE
>SEQF2502_00316 HTH-type transcriptional regulator MgrA
MKSNSGFYIGRIKQVNTRLLNKFLAQKNITAFNGEQGRILHVLWENDGISNRELSKKSGL
AMSSLTTMLERMEEKNLLIRKFCPSDKRKSLIFLTDYAKSLKSEYDEISDKMTEISFEGI
SNEERLAFEVTLEKVLHNFERAEQKFNKK
>SEQF2502_00317 Alcohol dehydrogenase
MERKFMKAMVLEKPCTAEEMKIKNVPIPEVKENWILVKIRAFGINRAEIFTRQGDSPSVK
LPRVIGIECVGIVEEPSNSDFKKGDKVFSMMNGMGREFDGSYAEYILIPKNQVYRLPDEK
DFFKNIELKSKELLKERFSKNLEITEENIFWSEIAAYPELYYTAYGSLFKSLKLKEGETL
LVRGGTGSVALAAIQLAKAINVRVIATSRSASKKQFLKEKGADEVIVGNENFDENLKKLF
PDGVDKVLELIGRPTLKSSLKSVKQGGIVCMTGCLGGWIIEDFEPLVDIISESYLTSFDS
TNVNKDTVNEMFDFLEKHNIKPCISKIFTLDEISLAHKYLESNNANGKVIIIVR
>SEQF2502_00318 Ferric uptake regulation protein
MKLTKKRQQILNLVKSSDTPVNAKFLKSKVDFDLSTVYRALEFLEKNNYIFSFDFENEKY
YFKEENANFFICDSCKHIETMPEFSNEETEKEKSELKKRGFSLLSHLSIFKGKCNDCD
>SEQF2502_00319 High-affinity zinc uptake system binding-protein ZnuA
MKKLLSLLLLSALFIFSCGNKSETKKEQGTTTGTREKIVTSVPPLRWLTQKIAGDDFEVI
SIVQPNMNHELFEPKPSDLKILENSKVFFTYNMLGFEETISDSLNDKNKIVNVLDGVDKN
LFIKGDHDHDHEHGKKEEHEHHEHEGIDPHVWFSLDMMPKIAENIKNELSKLYPDKKETF
EKNYNAFITELNQVKTELSQKMASKTKKSFMIYHPALNYFLKNYAIEEISIEQEGKEPSA
QQIKEIIDEAKEHNVTTILVQPQFPKQSAEAISKEIPNSKVAEFNVDKENVFENLKQFVD
YLN
>SEQF2502_00320 High-affinity zinc uptake system ATP-binding protein ZnuC
MTNGQNKKLVSVKNLNFKYSNDYILNDINLDIFKGKNVAILGRNGGGKSTLVKVMLGFLR
KNSGSIEFFTSENKIGYLPQIREFDTSFPINIFDLVISGLTNKNNLFRRFNNEEKKRAEI
LLKEFDIFHLKNKLINEVSGGQLQRALIARALISSPELIFLDEPESFLDKEFEFKLFEKI
KELSDSTIVVISHELEKIYDYIDSIFVVEGSIRVYEKKEDYVCSNPYLHSHK
>SEQF2502_00321 Manganese transport system membrane protein MntB
MEFIKIFEYAFMRNALIVGLLSSICCGIIGTYIVNKKMVFISSSISHASYGGIGIGIYLI
YFFNLPIKDPLFFGLIFSILSGVLILVLKDTLHVDGDLGIGIVMSMGMAIGIIFAFLTPG
YQSDMSTYLFGNILLSNTLNIILLLILDIITITFFIIFYKSIVYTSFDENFYKIHSVPVT
FINYFMIILISSVIIINIKTIGIILIISILTIPQAIAASLARKYSAIIILSIIFSFIGIL
SGLYFSYTLNIPSGPSIIVLLTILLALVKVGGFVKGKFLN
>SEQF2502_00322 hypothetical protein
MFPIYMWVKGYKGLKNFEITFDNNYEIKYNRDKDTLSINKKCESANNTIENFYSIDKTIG
NIDSVNLLIGKNGSGKTSILEVLNSNLILDIENRNNDSIILYKSSRNDEDFIIEGNGNRF
LEIKELPIVDELIKENYQDNKNYIGKIGVIKFSFREKTINATQREILSEIYAQSETIIYK
WNVGLGNVSKEEIYNYLIKVNQEKNNNNFENAYFTLLIPDLYEELKKSKNGEIKEKIKKI
ENLDFSEIDSFFKLYNNKNENNFNFDEIENFDNKNEDNLKDIIFNNYFNYIYLHIILEIL
NKNSKKIYELKEIKGELLELLNDKSLFEKCEILFKKYDKLTGMGFDWYIPKRYGIIERIA
SLIEKISEKEIDIQNPEGTIKKIRINCKKKNEKLVELLKEYDSFLIPKSENSLDISLKNI
EDIIKIEEEGLSDGERIKLQYFSTLHGVLRGELKNKEYITLLFDEIESFLHPEWSRRFLY
ELIEELGRYEDKKFKLIFATHSPFLIADVLAKDCIYLSKNKKGKIKAEIKEDVKTFGANI
IDLFKNTMFLESTFGKFATEKIKGIVHKIEKAEKYSDIKHEVDFIIGEIGEKLISNKLKS
MIESKFENKYEEEKDEEYYRKKIEEYQAKLEKLGNKENNKNS
>SEQF2502_00323 hypothetical protein
MSNKSEKDSIKKYLDILEKIKEGEKDFIVEKKSVKEFEKLDINKEYLPQNLLFYKEYLPN
ELFKYANLYGEGQKIDEKETWSRHKLLSLIGIEICPYCQRNYISSYEENNDEKTTADLDH
FYPKSLYPFLALSLYNFIPSCQICNSRFKGNKDTRNSVYLYKEGFDKLGVKFRTSKEVIS
EILGERYSDFYVKIDYENLKNKEDVEKVKNSIENLGLDRLYKKSHNQYIQNLLYNIEKYP
ENYLENCVEMFESDVDKKKQLEEYFKDIVKEPYRKRIENGEPLAKLTKDILEEFNIKI
>SEQF2502_00324 hypothetical protein
MIKIDVEKINNWDIIKEKHSKWYEINILPNIRRVYNKLYKKDLNAFVEKKLKEKLGNNLK
KNSKNCKNKLLFEEYKKHKKSEKDFIKKYLNILEKIIKKGKNFVIEEKEKFDEDLFDKSF
LENLKND
>SEQF2502_00325 hypothetical protein
MKIIISPSKTKKISNLPIKDSGSLTEKEPFYLEITNEIIEKIKTFSVEEIEKKFKLKSEK
AQKLSEFYQNYENEKSGNALASYTGVAYKAIKIETFDKSDFEYLESHLIILSALYGVLTP
YTNVKEYRLDMTNSIFESKSLYEVWKTSVNEYFEKEDVILNLASKEYSKLIIPDKLIDFE
FWEDSKGKLRQVSTNSKKMRGFTLNYIVKNKISDVKKLRNITLDGYVFDEDMSDERKFVY
VKK
>SEQF2502_00326 Ribonucleoside-diphosphate reductase subunit beta
MEKKIYEAVNWNTPENDYVEMFWEQNLKQFWIDTEYIPSKDIDSWNSLEPAMKLAYLHVL
GGLTLLDTLQSHTGMPKIIDHIESLQNRSVLSYMCMMETIHAKSYSTIFTTVASTREINE
TFRWVQENPHLQYKANKIDGYYQKMNNPEASKREIAMALAASVYLETYLFYSGFFLPLWL
AGQGEMVASCDIIKKIIADESIHGVFVGLLFQELYNSFNEEEKADMRAELKKLMYDLYEN
ETRYTDEIYGDLGLTGDVKEYIRYNANKALMNLGFEEEFEVKNVNPIVLNGLNVETTQHD
FFSKKSTNYEKALEVVHLHDDDFKFNNDELDLEI
>SEQF2502_00327 mRNA interferase YafQ
MRGKKEEYKYSIILTGKFKKHLKNLKKQKKDLKLLESIISILAKGEKLPPKNKDHKLVNN
YDGARECHITPDWLLIYEIAEDKLILILLASGSHSELF
>SEQF2502_00328 hypothetical protein
MATVNTSIKIDEETKKEAQKLFKDLGLSLSTAINIFLKQAIREKGIPFYINSLPENSELA
QAFEEAKQIKKNPSNYKSYSSPEDMFKDVLGEDYEG
>SEQF2502_00329 hypothetical protein
MDKPFKTFKEQVEILNGENGGKLRVKTDDETIYYLMRYNYYSIINFYKEPFLKGKDLNGN
DIYKSGVHFNHLKALYDFDKSLRMLFFDVLTQLERAFKTAIAYYYSECYTNKESYLELNN
YYVGVRNENIYIISHLVKKLNFLRNNKSNSIIKHYSTTKDNIPFWIVINFFTFGEMSRFY
LILENRVQNKIISHFRNLYKNEYTNLPKLNNNFIKTFLRASSLFRNIAAHNERMYDFSSK
NIVNINNIIGITNNKKQKLFTIYEGLKLFLSKEEYESLTKKLRELLSLLEFKLKDIIDIN
INDILYKMDFPKDWHK
>SEQF2502_00330 hypothetical protein
MENKEYYAQVGCAVGPLLEIKKQDFIEIKKMYSECRKFLWIEEKFNILKENYLEFKKEIK
HFYTIIDQNQTNESNLKKLISKKIIQYNRLVFNFLSSVRLYIDQVQKDLNSINPEYKQKF
KKKTNILYDDNIEYQIMELLRNHMQHQGLIIEEILIIKTDIKDSFSYVGINVRYEELKKV
EGFNKKIKKINDIPTNTKSINIISLLDKYYDNIVTLHDYYRNIISENLKKNFNIISIKIF
EIFFNIYIDKIKIEEKDKDILKKECQKYINTIDNEVVRIAFLVNDVDKNNININKENFLF
EKMYLDKLKKYMEFKSTCSEKEYPYKSLLYYNHNENLGGRTSIIVINYIQSI
>SEQF2502_00331 hypothetical protein
MKKSLVILGNGFDKNLGLKTGYWDYFEYTSGTKIKKYIEIIINNEINSKFYLKSKILETL
KTFIIGDIEKIINDNSIIDVNDIKTGIEKMINYNKQIINGIDNNIEDHTKDHSLEYLRGH
ILVNLKFSNSFLISFGLFIPFLLFLEPEYENWYSIEEQIVNYVEDIIDIINYLYNNNKSI
FFEKKYEIKNMIKNFIEKSKLKNYNYSYDILKRYDLIYYLIIKRTKEYNQGKLERKLWES
YCNGIITKIEYINFILENIFSIDLYFKTKEDKKKLRLTSKNDEKSNIDKKYTINLMEYLN
YFENDFLKYVENLNIPKISDKEIKKIMGDNELYIINFNYTTYLKEYLETNKHFNYKDMLN
INGEIKTDLVIFGIDEIQIQNNHRKKELEKFLKLKKGQKDWKLLIKNCEITDFEEIIFFG
HSLADADYSTLKEIFDYFNIKDNENIKLIFKTKDKFYNNHKKEIEHFMARYLGKNHKNVM
DKIFCIEIV
>SEQF2502_00332 Ribonucleoside-diphosphate reductase subunit alpha 1
MVDNRAKKWIYLNNEIMVKKGEDFQLEKDKEAVYSYFVDYVNKNTVFFHNLEEKMRYLIK
NDYYIDFYKMYSHDEIKELFKMVYDKKFRFASFMSASKFYQSYALMDDTGEKFLERYEDR
VSAVSLYLAQGNFEKAKEYALMLINQEYQPATPTFLNSGKKRSGELVSCFLDEMGDNLSG
IGYIFDSSMKLSSIGGGVAINLSKIRARGEAIKGVEGRASGVLPIMKILEDIFSYANQLG
QRAGAGAVYLNVFHSDINEFLDSKKINVDEKIRIKSLSIGVIVPDKFMQLAMEDEVCYTF
NPHTVFLEYGQYLDEMDMNEMYEKLVDNPNVKKKKINARELLVKISQTQKESGYPYLFFK
DNANKEHALKEIGAVKFSNLCVAPCTKILTKEYGYTEIGQHENEKVHVWNGEEWSKTTVI
KTGTDQKLLKVSTDNFQTVDVTPYHKFYIKDENEKVVEKRAHELKVGDRLIKFDLPKYEN
KNREILENAYANGFYSGDGCEYDVKDRKNLTNKMIYLYGEKKELLDKFDNLEYSKSENED
RIILNYCKGLKDKFFVPFNYEISSIVKWLSGLADADGTVSKNNGNNSLQIASTNLEFLSN
TRLLLQEIGILSKINKMRDTEIRELPLNNGTDECGKFECKPLYRLLITHRNLQKLVELGF
ETFRLKFDLEHTPNRDACAFEKITAVEEIDGVYDTYCFTEEKRHMGMFNGMLLGNCTEIM
QLSEVSDINAYYEEDTIRRGISCNLGSLNIAILMENKRIKEATKAAIDSLTMVSDLTNID
IVPSIKKANDELHSVGLGAMNLHGYLAKNFIMYESKEALDFCNVFFMMVNFYSLERSMEI
AKEKGQTFKDFEKSEYANGNYFDKYITKEYMPQTEKIKQLFEGIYIPTKEDWANLKEQVM
KHGIYNAYRMAIAPNQSTSYIMNSTASVMPVVDTIEVREYGDSTTFYPMPYLTNDNYFFY
KSAYDMDQKNILKLISVIQRHVDQGISTILYTKSTDSTRDLARLYIYAHRLGLKSLYYTR
TRKATIEECISCSV
>SEQF2502_00333 Protein NrdI
MYIYYDSKTGNVERFIKKMQSQRPDWHFIKINPTMIIKNEGHFLTFTTKIGEIPTTTDEF
LQNENNSKLLKSVSSSGNRNWGQFFAVAADKIQEKYGIPVLMKFELSGTNTEVENYINYL
ENNYK
>SEQF2502_00334 Thioredoxin
MKKLVKFEKNDCNPCAMVSDLLDKKGVEYERINPFDNPELAVKYRVRSVPTVILFEENEE
VKRTIGFKPEEINEIISMM
>SEQF2502_00335 Methionine synthase
MENKYKNSYNLLQNDLKNKILMLDGAMGTMIQRENLTADDFGGEKYEGCNDYLVLKRPDI
IKNIHKKYLEAGSDIIETNSFGALEIVLKDYDLEDKVFEINKRAAELVNEAIAEYRSEHP
EVTRNLYIAGALGPSNKSISVTGGVTFEELIHNYYTAVSGLLAGGVDLILFETIQDTRNL
KAAYLGLKKAMEENYTVPLMLSFTIESTGTTLAGQTADAFYYAVNHMNPFSVGLNCATGP
EFMTQFLKTLNNISNTYISVYPNAGLPNEDGEYEETPDTLSAKIEPFFQNHYLNIVGGCC
GTTPEHIQRIKEKSINYEPRVIDKNKDFNDVSGLIALETPKDRPVYVGERTNVIGSRIFK
NLIANEKFDEATEVARLQIKGRADVIDICLANPDRDEIADMKSFLDKVAKFAKIPLMIDS
TDINVVKEGLTYLQGKGIINSINLEDGEKKFADMAKVIKDFGASVVVGLIDEEGMAVSVE
KKLKVARRSYELLTKKYGIDERDIIFDTLVFPVATGDQKYIGSATATIEAIRQIKAEMPN
VKTILGVSNVSFGLPIAGREVLNTYYMQKAYEAGLDYAIINTEKVIPMNEISDEEKELSE
NILFHTNDENVSKFANFYREKKAAKKVADTSNLTTEEKVANLVVEGSKKDLTILLDELLK
KYSPIEIINGPLMTGMDEVGRLFNNNDLIVAEVLQSAEVMKASVSHLEQFMKKDESSVKG
KVIMATVKGDVHDIGKNLVGIIIGNNGYEVIDLGINTPAEKIREAIIEHKADFLGLSGLL
VKSATEMVNTMEVLREAGIDIPIFVGGAALTEKFTVNKIEPAYKNNIVIYSRDAMTALSD
LNKMIDEKKFEEFKKHLQKRRELVTIKDAKKLEQLKVKPTVSDIKDADGTFDFSKVELPK
YNFEKIYKSQTLNKQILTNIKAKDVFPFVNLQMLIGKHLGMKWIVNNLIEKQDPRTIKLY
NEILDIVENGDEYFDIKAIYKFFPARRKAGKRKDDFKIEILSDDLSTVLETFDFPRQKYG
QYLSLNDYVSPEGIDYIGFFVATAGEKSRLVSNELKEKGEFYRGHIVNSIGLELAEATSE
YIHKMMRQDVGIIDKNISLNEILNAQYQGNRYSFGYPACPDLSDQRKLFNLLKPERYGIT
LTEEFMMYPEATVSAIVFSQPFCKYFNM
>SEQF2502_00336 hypothetical protein
MRDKKVTVGGQAVVEGVMMRGPKAIATAVRKQDGSIVYKKIALTEKSNKWLKVPFVRGVI
ALYDAMVVGTKELIFASNQAGHEEEKLTDKQVGFTVMTSVLLGIAVFMWLPSAIGGFFFK
DSVLKANIVEAVIKLVLFLGYIYGISFLKDIQRVFEYHGAEHKSIMNYEMEKELSPKNAK
VCTRFHPRCGTSFLLLVMFISILVFSTVDLFFKVPTGHFSMIIYKLVTRILFVPFVAGLS
YEIQRWTSYHLDNVFAKIIAVPGMWLQKITTREPDESQLEVAIVALNVALGNEVPNATEV
FE
>SEQF2502_00337 DNA integrity scanning protein DisA
MVKKVVNKKKILEHIFDRVAPGTALREAIDKIQEAKLGALIVLGNPNNLKDVMGGGFELN
TVYSPQKVYELSKMDGGIILSEDIKTIYGANIQLQPNYSIETDESGTRHQAAHRIAQQKG
NLVVAVSERRNKITIYYGKFRYLLNEIGDLLTKSSQAITALEKYSLAIEKNHVNLSILEF
DNMVTLYDIVECVRMYGLLFRMSEELIEYMAELGSEGRLIKIQYEEIMLNKNESFDALIK
DYKISNETAEKIGLRVKSLTKEELLDDEKIVCLLGFDTNIINLDEKIEPRGYGLLSNITK
ISKKDREILVKEFSNVQSILMSTASDIAKIKGVSKYKAEHINKSLKRIKNRAVIDRE
>SEQF2502_00338 DNA repair protein RadA
MAAKKGKTRYICSECGYSSLKWLGKCPNCDSWGTFEEEIDIKRTFKDVESQDVSISKITE
IEIEKEFRMVTPFEEFDRVLGGGLIKGEVVLITGSPGIGKSTFLLQLSQEYAKIGNVFYV
SGEESPRQIKQRAERVNVKSENLYILNDTNIEKIESVILRDKPKVVVVDSIQTLYSENVN
SIPGSVTQIRETTLKIIEIAKKNEIAFYIVGHVTKDGKLAGPKLLEHMVDAVLQIEGEEN
SYYRIIRSIKNRYGSTNEISIFDMKENGISEVKNPSEFFISDRDEKNIGSIIVPIFEGSR
VFLFEVQSLLGTPNFGMPRRTVEGYDKNRVEILSAVLSRSLKVDVNSKDIYINIPGGIDL
NDRSSDLAVIFSLLSSVKGVPISQKIAAIGELGLRGEVRKVSFIKNRVNELEKMGFTGVY
LPKSHQADFEKEKIKIKLNYISNISELVERIR
>SEQF2502_00339 Phosphopantetheine adenylyltransferase
MEKIALYPGSFDPITKGHIDIIKRSSNLFDKLIIGIFKNSTKSKAWFSDEEKVEMIQEIL
KKEGIKAEIKIFNGLLVDFMYKENVNILIRGLRALSDYEYELQFTLTNKTLAKSEFETVF
LTASREYLYLSSSLVKEVALNRGDLSFFVTENVERRLIDKVEK
>SEQF2502_00340 Ribonuclease 3
MENNGNRNVNELIKKIGYEFKNEEYLHEALTHRSYANEIEKDRRFNNEKLEFLGDAILNL
ITTEYIYDLYEKKTEGELAKLKSQIISEPVFSTIASELELGEYLYLSNGEIMSGGRHRRS
ILGDAFEALIGAIFKDSDYYTAKSIALKFLLGKINKLEEIEGTGDYKTVLQEFVQGKYRK
MPEYNLIKTSGPDHDKIFEMSVSWNNTVHGIGIGKSKKEAEKHAAKEALSKLKK
>SEQF2502_00341 3-oxoacyl-[acyl-carrier-protein] synthase 2
MRRVVITGIGLVTPLGTGKEKAWTNLLNGECGIDTITQFDSSQHPVHIAAEVKDFVPENY
IEKKELKKIARFSQFAIAASKEALADAKLEITNENADRIGVIIGSGIGGLDVIEQEVEKL
VTKGPRRVSPFYIPAAILNMASGNTSIYTGAKGPNKTVVTACASGTNSIGDAFQAILLGK
ADAMIAGGTEATVTPSGIAGFANLKALSTNPDPKKASRPFTADRDGFVLGEGAGVLILEE
LEHAKKRGARIYAEVVGYGETGDAYHMTAPADGGEGAARAFRMALEQGNIKPEEVGYINA
HGTSTPANDKNETQAIKSAFGEHAYKLAVSSTKGATGHLLGGAGGIEAGFLALAISEGIM
PPTINYENPDPLCDLDYVPNKPVKRDIEVGMSSSLGFGGHNAVLAFRKYK
>SEQF2502_00342 Acyl carrier protein
MLDKIKSIVVDQLGVDEDQVTEDASFVDDLGADSLDTVELIMAFEEEFDIEIPDEDAQKI
KTVKDVMEYIEAKQ
>SEQF2502_00343 RNA polymerase-associated protein RapA
MGHKSISLELKKQITPSIFVIGQEYYNESLGNITALFADGNFMTVEGEYKENSLCKTSIT
VEQKKGEFIEANCDCMFFKNNKKNCCKHIVTLGMMADHSEKISKVIGTDEIEMMFEDDFE
EDNKKMAQIKEKRKKEKEKAAKSVKRKETEDDGKNKSRQRVKLREEKLNAASFAKSEGTS
VEADNLLNNGNLENINLKNKSEKVRFEVFGEGGENAENTGFLEKNGTADFQEMENNEEIL
ENVENISEKINEIYNLHLESENIDDEEKQEMRLEVEIDEGSYSDYKYGYDYNQENNVPDY
ILRIKAGFKKIYYVKDILKFIEAIVKEKEYEVTSKITYSPKNCFFNETNQKIINAIYEYS
KEIQSVINSGIKDKKGLKVYEMLLNKLLTAMEKGKNLVLLGETKQIMNSYEPLFVVENDR
IAMRNIEKISENSPFYTFANDTTKVFKMDENEERFFGKFDFLDTELFNQLSNEDNRKLCA
VLGYENVNIAEYVEEDGCIDIFVSETDEKEIVKVNLSNTVCAIEKNGKYFIPRKNAKIFE
ELKKLVEGYSITNVELIEGTYNVNYEGLGKISEYIDKKYADKVKIHLENKIKNARNIDVH
IGIKKVENNFLNVSFDIEGIKTEDVEIVMEAIKNEQKYITLSSGELVKIANKSIEELVGI
VDSISNLKVGENKISKIKALQLAQISKNIQEDLVKMDEFKDLFHKIKNREEIEPNNIKVN
LFPYQKLGFNWLKNMYDIGFGGILADDMGLGKTLQTISLLNEIYQENRNFTALIIVPSSL
LYNWKEEIIKFTGITPTLIEGTAAQRKEIISKGSKGFLITTYQALRNDIEEYKNREFDVV
VLDEAQNIKTTTSQIKKAVMKINSKVNFALTGTPVENNILELWSIFDFVIPGYLDNLTKF
KKTYKEAIVNPNSSKINNLREIIAPFLLRRTKKEVLTELPDKIESNMVVTLSTEQKQLYM
SYIKQAKSEMKKFNENDNNRMKILAILTKLRQICNSPTLFKEDYKGEVAKLEVLRDILPD
ITENGHRLLIFSQFVGTLKEIEKELADMGIEYFYIDGNVKSKERVDICNKFNAGERQVVL
ISLKAGGTGLNLVGADVVIHYDPWWNIAVENQASDRAYRIGQKKSVQVIKLVTEGTIEEK
IIKIQESKRQLSENLLESKDGEKVLFEMSDKELMELLS
>SEQF2502_00344 Ribosomal-protein-alanine acetyltransferase
MENIVSELVKIHNENFKNKVEDKYFSEMILGEQYEIYCLFNFLGKNIFVKKLENESGKEN
KNLGENQKGEINFDKNRENEKNVLGYIVFYGTIESTDIFEVAIKKEYQGRGFGKKLLIES
MKDLIEDKKNIEIKNKFLLEVNEKNKKALKLYKKIGFEEISIRKNYYGKDENAVIMIKYY
>SEQF2502_00345 Signal peptidase I S
MNILLWGAFYIIATLFLLYFFIREKQVIQWIRIKEDETLQKVSLEKSDKNFMVGNVLTIV
ALIITAVFLVVVDKSKDPNIWIKVWGIYGVFALNIIVYVLRKQHEWIFLLNLIMLFLGKL
MFNILDTNFYIYLIINVVISLILIYLFKELSTEKITEQSILKEATQGNEKLEKIVTESKI
RNEGVSEIFKKIFPNDNLSVEERIAKEKRKRSTFGKALTRIDNALLAVILVAVIQMFYIG
NYVIPTGSMEPTILVKDRVFTNMVKYHFSNPKVGQIIAFKEPMTDKVMYTKRIVGEPGTT
LQIAKGKMTTNEFEIANINNDPKYPTTANSRKEFNEEMKKYNEAMDKFNSEKVKAVGGAI
MLNDKKSEVLERLTPQKFYLPEGLLMNNKIYIPKKGDKVKLDKVIVINKVFGQTTDGTLI
GQVDWESYYDGKGFKNITGKEFLELIKTDKNFKDIIGNDDEFTADPRNTLTNKYYTFTLK
VEGRNEMVMPIMDFKYNDELFKKLLNGETITLDKNYYMAMGDNTSNSKDTRYFGLVAEPR
IKGELLVRWWPLTRIGLL
>SEQF2502_00346 50S ribosomal protein L19
MKEKLIELVEKNYLKADVPQFKAGDTVAVHYKVKEGNKERIQVFEGVVIRVSGGSVAKNF
TVRKVSQGIGVERIIPLNSPLVEKIEVKRIGKVRRSKLYYLRNLSGKAARIKEIRK
>SEQF2502_00347 hypothetical protein
MVFKLIKLVILLIFFSVNIGYSSTEEIKDIDENDPNVLKFLNKRNIDFKKPPYDENPWYN
TGILEFSLHSPERTKYRFLMYFKTFEKVDYEVIDNRGQNFSIFKDITLDSLLDANFLDTF
YSNSPLKLKNKKRFLFGKVSSVGYVKESLINVLKLELYFINPNNTLETKVFFKTGWLTGL
LDKHGHEKEKLEDGFDISSNNPKDVVTIITGNEVVHKVSEDLEGTDKELYDFVMKLFKDE
IPKEYFEYRDKGYIKYH
>SEQF2502_00348 hypothetical protein
MIKKLPLTGEHYELGYRNIVKKYTWLFMNEKGNLKEAPFEGLGKLGSVEEYRTVGIGKTT
PDEAKRSTGPSLDGKGKYNLDGDITENMLRIEHKLRLRGAYQNGF
>SEQF2502_00349 Regulatory protein MgsR
MNKLYCYPRCTTCKKAVKWLEENGIDYEYKHIVEETPSKEDIKKYYKKSGLPLKRFFNTS
GNVYKELNLKEKLAEMSEDEQFELLASNGMVLKRPLLVGKDFVLVGFKEAEWIEKLK
>SEQF2502_00350 hypothetical protein
MKNRTSSFLLKGLVTIILILGYVLIQEFLNPLMLTRIALIFAIVIHPSGYIIFALILILA
LMLIFYLGFLIQRILKYPKINIVVMIMIFTYFVIKYIFADNNSTFFAPTEKERYIFIIVS
HIFFSVGLLWKKK
>SEQF2502_00351 Protease 4
MMFILKMLLEIVIMLILCVILNLIFIKKILRVKNKKKLPLKKVKTVVFDVKKLKEDVAMS
ALKGKEKLSYYQILQGLNNLLEDKNIKKVIIDVDKLNLTLSQLEEVSKVFDKIRKNKEVV
AIGTLFEESRYREAMLADKIFMFDTRQSTMIFRGYLHKEFYLKSFLEKFGIRMNVLHIGD
YKVAGEKFSHNQMSEEKKESIKNIKDKVFEDFLELVKSKRGVDIENEILSGNLIFAGAKK
ALEYKLIDGVADYDEIGINYKEDTVSIEEYIGMLKEKKEKAKDTIAVVNLEGVIDVKNPN
KNITYENVCEKLEELKEIKNLKGLVLRINSPGGSALVSEKIYKKLKKLTVPIYVSMGDVC
ASGGYYIATTGKKLFANNFTLTGSIGVVMMYPEVAGTMKKLDVNLEGFGKGVGFDMLNPF
EELGNDSREKLIYNMNEVYSEFKEHVMAARGMNENELEKIAQGRVWLGSEAKNINLVDEI
GTLEDCIKAMANDLRLDKYKVKIVELTQTLKETLADIKMPFVSEEIREKIEFLQGNMNQI
LYYENDFEL
>SEQF2502_00352 UvrABC system protein B
MDFKIHSKFQPTGDQPQAIQKIVENLENGITDQILLGVTGSGKTFTVANVIEKINRPALI
MAPNKTLAAQLYNEYKQFFPENAVEYFVSYYDYYQPEAYIMQTDTYIEKDSSINDEIDKL
RHAATAALLNRRDVIIVASVSAIYGLGSPEAYKKRSIPIDVETGFERNELIKRLISLRYE
RNDIAFERGKFRVKGDILDLHPSYQDTGYRFEFFGDDLESISEINTLTGQKIRNIKRITI
MPATHYLTNEDTKVMFEAIKKEMEERVHFFQKEGKLLEAQRIEQRTKYDLEMIEEIGYCK
GVENYSRYLTGKSEGEAPDTLIDYFPEDLVVFLDESHISVPQINGMYKGDRARKQSLIDN
GFRLPSAYDNRPLKFEEFFEKVPQAVYISATPSDYELEHSNGEVVEQLVRPTGIVEPSID
IRETKNQIDDLIDEIKTRTARKERILVTTLTKKMAEELTDYYLEYGIKVKYMHSDIDTLE
RTEIIRGLRKGEFDVLVGINLLREGLDIPEVSLVAILEADKEGYLRSRRSLIQTMGRAAR
NVEGHVILYADRITGSMQEAIDEVNRRREVQEKYNLENNINPKSIVREIAESIVDYEIEK
ENEANKAIKQYKSEKEVEKEIKKLDKQIKKLAEELNFEEAIKLRDKMNELKKLLIEL
>SEQF2502_00353 hypothetical protein
MEKEEYLFRILISQVLDSLNPELKFKNLKKDINNGFIPFELEGLEKDLQLIMKDLEIISF
EDNQIEDSKIFKLPNNQGKIIVSKLADYEKRKFFNKLRDIDYVVEMDTNIVSYLDRFYKN
QLTKEDEKLKLDIVRIIEDLDKKRENFLLGSCNLYIIESIMRDKEIDEEIILDSVNSVEY
LINFGYKKKLKDITLKQVVNNIKNRIIYIIKRKQRVKNIKNRISHIREIKNQYVDRNLLI
YCLILKSFYIKITIPNINKRIEELINFINNELYYYMENETLLCITYLLDAENQKFFGKIN
KNLRNTKEKIEIEKIKGYIKGMVWDLSHLRILQEINIKEHKNGKIQLPVILSADEGLNEI
INFNKIKKFCFFEKYRIPVYEKNIKTYTKNYKHKNKKISKNIPLMIEKLESEEMLTRERK
RTRNSKFYYNKLADKIYTEIVNFISNK
>SEQF2502_00354 GTPase Era
MKSGFITIVGRPNVGKSTLMNKLVKEKVAIVSDKAGTTRDQIKGIVNIGENQFIFVDTPG
IHKPKHLLGEHMTNVALEALENVDLIMFMLDGTQEISTGDIFVNENVRSVKTPIVLVINK
IDKMSDEEIEEKKKEIREKLGEFDEIITLTAEYAIGIHKIFEVAEKYLSNDVWFYPEDYY
TDLPVNKIVVETVREKILHHTKDEIPHSVAVEIINVETKPTIRKYDINIYVERDSQKGII
IGKDGAMLKKIGIEARREIEHLIDLKVNLKLWVKVKKKWRKNKKFLDEMGYGK
>SEQF2502_00355 hypothetical protein
MSLPKCPKCGSEYVYEDGNMLVCPECFYEWAETEEESSDEAVVKDANGNILQNGDNVTII
KDLKVKGASSDLKRGTKVKNIRLIDDGIHNIDCKIDGFGAMKLKSEFVKKI
>SEQF2502_00356 ComE operon protein 3
MKKGENIGDNGIVEKSNKKRDFKNVSFRRIVKKSNKNEDSKRNENFRNVENIKVNKNNEA
NENLKNKENIKNNEHSNKFENSEFDKYILEMKKQREKVARKRYIKSELLRRRKNLKKFFC
MEIGIEEVKRAWQFGMLILAGIVLFLFYLNFVTFKGELAGEKVLYVKIDGNRGSVLKVNN
KYLKNQAGIENKKGLEYGFYLMRYKIRKVISKNGNVKIDGKILGYKESRLNGVRKYILNI
FDELFITDENLYAFSRAAVLGEKAEVSKDMKEKFKYTGLAHLIVISGTHISLVVIGIVKI
LDGLSLGYRFKYLMALAALTFYCALIGFSPGILRAYIMGAMMILARILFEQEESKKSLLV
SFIVIIVLNPYSVFDISMQLSYAAVVAIIFVNPEFKKLYQEKVLDKIKNEVLRNTVDLIF
LSLTIQITSIPLFLYYFEKLPLFSFLLNIVGIPIGTVVIQCLFFAVLLNIFKLSLFNGIV
VFVTEIIFKAFEGFIYAGSKIPLLQININGKAPLWTVFLYYGVLFFITLFIMPLFTAKIN
INEN
>SEQF2502_00357 hypothetical protein
MKIKGDSNGFTLIEVLLYISIMAILFMVISVNLQKQRQNQEFAIQKRNISQFIRKIQQYA
QHNRKEYVLDFKISEKMAYFLDEKNGQKDIIDKMEISKNLSYMTNNSNKNADFRRRTTNE
GNFERGFSVYLLDKKGEKIYYRISTNTINAAKYPIISIYRAKKPINLSDDYLKANLWEEE
I
>SEQF2502_00358 hypothetical protein
MELFRKNGQNARKVFTEIAKALEEKTDGFHLQKVSSWMNQAQIARPYLWVFLRQDGDSDT
ESGIALRVFKNERTRKVGISLEVSFVERKIGENTLENQNKVLEVPIDEPLYYFVQFAKSK
ENCALDRFEGNESNRKRFLKEWKNGEIRKVLVKFDVEEIERFESLDELVEEFLKGFKLLM
PFYAATH
>SEQF2502_00359 Curved DNA-binding protein
MNFDEAFKILEIDPTDDKKKIKIAYSEMLKKYHPEEFPEIFMKTNEAYRVALEFEKADFD
EVKSENKMTEKNNENEEFFERVKKNFEENKEKSFFENFEDIFSDEKNESEFENIFSNKNN
YVNKKTFEESEEFSNIFDEKKNLKKSISEWIEGLKSLILSEKRPLTEYRKILREFHFNFD
NLEKKQIREIFQKSELYNYAWRNLTRIEIELLIYNLNSSDEIVDILGETWADSGKNENTS
LNKIAKKISSENFLENEEGYEQFIQDYFNINVFKLFKKNVALYSYRDIEQVGNTFKFVFY
KIKNEYIEINNYMKILGMGYKDGLEAKITVFIMFMFLSTIIALFFLDTNVAWNITVFGGI
FFTIIDWLNIIYEKDFGWSMRCGFSNYLFILMTIIFLGRLIVIGNAEYDSSFSKFLLYFL
LISQYLFINIILFIKMVTTTYVRYEKIKEFSKKILNVFVLKR
>SEQF2502_00360 Curved DNA-binding protein
MNFDKAFKILEIEPTDDKKKIKIAYSKMLKEYHPEEFPEMFMKIREAYQTALAFEEYNFD
EVKYNKTNFKNRNFFEIEKNFENDDYEEIFFENDIQNTGIEDEEFSDVFSGKYEWMEENL
KSWLKEIRRILNREKVSFIYLKVFLKRFDKFSDDEKSRIRDILGLENNDFEDNLILKSEN
LFEFEKEYIISCLSNNKNEFGEIKGLYNSKEEKDNDKALENFVERYFNVKKLNIFGFFIF
WNIYRGNYRYLDIKINKKIHNLFFNLTNNLLLKRIVYSYKKIKNIFYHLEITCEDDIGED
DAFIHTLIFLLSCIALIFICIFSLPAIINTKEIDYRNVVKSFELVKIYWIVLTVTRTYLD
FSLAKRGNNLNMASMLNIQIILLGSYLISIYFNYKIKNFWLFGILIWMIIKLIIVNRIKY
LRLKNYAKQILDKIYN
>SEQF2502_00361 Chaperone protein HscC
MGRMIGIDLGTTNSLATYIDDNGEIQFIKNEYGNILIPSVVGIDENDAIIVGELAKERRM
MNAGETASNFKRRMGTDAKIKVKNRTFDAQMLSSFVLKHLKENAEKQLSEKIDRAIISVP
AYFNDKQRRDTKMAAELAGLTVERLINEPTAAAMSLGSHILDQNLKFIVLDLGGGTFDVT
LLETFENIMEVLSISGDTMLGGEDFTTKICEIFLKNIKLSIADLSRDERTKLYTKADRAK
KLISLKNVEIEMEIKGKKYKSEITQENFRETVKPLLVKMKVAIDKALQDGNTDAREIEKV
ILVGGAVKLGIIEEFVEKYFHKMRGEKIYFNNDDFIENNKLVSIAADPDTVVAYGVGIAV
GMKERNKVFKERILTDVCPFTLGTEIVGRRFAPIIPRNTTVPTSRSEYFYTIEDYQSQVT
VGIYQGESLNIDDNLFLGEFLLDVPQNLAGKEAINVRFTYDINGILEVEAKVVSTGVKKS
KLIINGDLSEEEKNEKIKMLEEIKIQSENKNKDKLLLERANRIYAEIVNTEIRNHISEYL
ENYQKIVVTGDRIRIQKTKKSFSEFLDKIDPEINDMSVEDILKDFEDETEEEDMKEEDEL
EFWN
>SEQF2502_00362 hypothetical protein
MKRKNLLKILGLLILSGNVASAKYLGKLEKTYSKTSDYKMKITSVKSGKSKRNVSKMLSN
QEIDLKLIEKIGDSNYFRNKNGIYYKSGEKVLKLDGVDKDSFEVMKFGNYGKDKNSVFYH
NRKLDGVKPIGFEELDERFATYEGVLFHNGEKVEGVRRIESGDMDMNGLERIRVSDHWDL
GYSNYFKNKDGIYYAGESKFLKLNGADKDSFSVTFKGKYGKDKNSVYYQDKKMDGVKPSE
FIELNDIFAKDRNNIYIDGKKLENFEARDFLILDEKRFEYKNKKYYYDKKSKTVKEDK
>SEQF2502_00363 hypothetical protein
MKRKSLLKILVLFILAGTIANAEYLKKDGEVYYEMPYLEIKLKVKDADAKTFENLGEDKM
KIIGYFGKDSKNVYFLGKKLKDVSTKKFEILDEKYVKDYKNLYNLKTDSLSFFSIDEIKP
KKVSIDGLDVKSFKVLENKKASLTDYYTDKNSVYFHKDDLRKITGADKNSFEILEEYIAR
DKNNVYSKGEKLGNIDIKSFKYFEDGLAKDKNRVFYIEDNKDVTGVDAKTFERMGESYYF
RDKNNIFALKDYNPYDLEMLKNIDRNSFNTLSKEIGKDKNGVYYFGEKIDGISSDNAKIV
EALGNSDYILQSGNDHYLMTVNEKDSDNNERFEIKKIDSLNIDFDTFKYFEMSNLYKDKN
SFYYHSDNDLKKIKSNIDVKSAEKVLKLNDFIKDKNNLYYYSNGKIEKINLKIDVNNLEY
LDDGNSTFSNYLRDGKNIYFVDNEYGKVKIMKNVDRNTFKVVNGNYGVDSKNVYCFGEKL
DFVGLDGLKIFNETYLKDNKNVYEISANDNDKVKVEPIKNLNIDVASFEDIFGGLNYKDK
NSVYYVDENNGEVSLKILKGADPATFEFGIISKDKNSVFIGNQKLKGVSSKGFEVLNDSL
DFVKDYKNVYYLDRESDGITYKVEVLDTKGVDIPSFEFFGNSYNKYYKDKNNIYLLNDRD
DKMKLEKLAGANPKTFEIMDGNFARDDKNLYIFEYKVDGIDPKTFEALNYEMIKDKNGVY
FLENISEENENSEIKTKKLNLKGLDLRSFKKVDDSDYYFKDKNSIYYEDSGNLHKIESAD
LKTFKDLDYNFAKDKNNIYYKNKKLDGIDAASFEKIEFNFIKDKNRLYKIDEDEEKNEIK
LIPINEKVNLENFEEIGGNYYKDDKNLYYFGENEFKKIEEADPDSFKYDNENYTFIAKDK
NNVYFEGEKVKGIDVKSAEGIDGLWMKDKNSVFYRGKKLEKISSNKFQYFDGGISYDKIL
IDKNGAYKLLESENQKDKIIPLDSKNIDLKTLERFDTPIDGSNYFKDKNGVYFLNGEKFV
KINGADRNSFEVTMSGKYGKDKNNVYFEGKKMEGENPKEFEEIDIND
>SEQF2502_00364 hypothetical protein
MKNNKKTKLPIGVSNFKDIIEKNYYYFDKTKFIENILEDGSQVKLFTRPRRFGKTLNMSM
LKYFFDVKNKDENRRLFEGLNISKSEYFDMQGNFPVISISFRNYDEENWENGFKAIKGIV
KRLYSDYKFLIEKMDEIEIEEFNSVRRGLDSVEWEASLLNLSKYLYEYYGKKVIVLIDEY
DQPIINSYIKGNYEKAISFFKSFYGLVLKDNEYLEMGVMTGILRVAKENIFSGLNNLEVH
TILDDEFTEYFGIMEDEVEKALEDFGLEYELKDVQKWYNGYLFGNRKVYNPWSIVNFLKN
GNLKPYWVNTSGNALIKLYLKKLRDSIFDDFTKLLNKKSILKIINDNMTFGNLKANFEKN
IWNLFFHSGYLTLAEKYNENDVYLKIPNEEILKMFSEMFIEVYFDDYEKFLYMSDALRKG
EISNFKKYLKEILLENTGIFDVSGTYKEQFYHGLMLGLILTLKNEYEITSNNFAGKGRYD
LLLKPKNILEGKEGIIIELKIINEVKNLNDNKIHEKLEKECEVALKQIDEKEYSSVLKNA
GVEKLLKIGIAFLGKEFEIKFERE
>SEQF2502_00365 hypothetical protein
MNKILVAYFSATGTTKKVAEKLAKATGENLFEIKPQVEYTSEDLNWNDKKSRSSVEMNDE
FSRPEIENVVENIDDYDTVFIGFPVWWYIPPRIIQTFIEKHNLSGKKIITFATSGGSGIK
GSTDFLKKNYSDLNIIEGKRFGWNESLESIGAWVEKIKKF
>SEQF2502_00366 hypothetical protein
MRKKITAGRDLLGNIAPKFAQLNDDVLFGEVWAREDKLSARDRSLITVTGLMASGILDSS
LKFHLKSALENGVTREELAEAVTHLGFYVGWPKAWAVFRLLKEIYSEDGTADPVSSLFGK
GDYNEAYAKYFNGRTYLKTLVEPNDTSKVGIHNVVFEPGVINNWHSHSNGQVLLVTDGYG
WYQEDGKEAIELHPGDVVNIPKNVKHWHGAAKDSWFTHIALSDSGSTEWFGILSEDEYEK
LPKAVNAR
>SEQF2502_00367 hypothetical protein
MELRILKYFLMVAKEENIIENKEFINIEGVKLLNKGNLNYVK
>SEQF2502_00368 putative oxidoreductase
MKTTKIQEIDVPKVALGTWSWGFGGIAGGDSIFGNKLGKDELKPVFDRAMDLGLKLWDTA
TVYASGQSETILGEFVKDRSDAIISTKFTPELAEERGDNAIFEFLDKSLERLNKKVIDIY
WIHNTKDMEKWAPKLVDVLKSGKVKKVGVSNHNLEQIKYVNNLLKEAGFQLHAIQNHFSL
LYRTIETTGILDYCKENNIAVFSYMVLEQGALSGKYTKENPLPAGTRRGEAFPPETLAKL
EPLFYEMKILGGKYSATIPEIATAWAIAKGTIPIIGVTKPNQVDDAKRAASVELSDEDVE
LMDRVAISTGVTVKGEWESSM
>SEQF2502_00369 UTP--glucose-1-phosphate uridylyltransferase
MSIKKIRKAVIPAAGLGTRVLPATKAQPKEMLVIVDKPALQYLVEELLEAGIEEILIITG
RNKGSIENHFDYSYELERTLEENGKKDLLKVVNHISEMSNIYYVRQKKPLGLGHAISCAE
SFVGDEPFVVLLGDDIIYTDREKGQFPVTKQLIEKYNELQGGTILGVQEVPHKNVSKYGI
IKPLKQFDEKTVIVEDFVEKPLVNEAPSNLAALGRYVLEPEIFSYLKNTKPGKGGEIQLT
DAILAMKNNGEKLYAYNFDGLRYDTGDKFGMFVANVEFGLRHEELKDRVKEYLKNLIKEL
>SEQF2502_00370 hypothetical protein
MKKIISSLLFLAGIQGFSNTCNFANNPDIFLDRVIKKIQTEKRSNDIFCDSDNVKMAYYT
IEDENYNANIGITIKATPTTTNDEFKKEFYKKFDEYKNFFTKIDTKNLGKNPLPDKEIVR
FYVQFPDEKSIIIIGKYEYDLKTKEYHMIANSRAKEYFEKLKLFEPLAIKVSYSDEGHIF
>SEQF2502_00371 Large-conductance mechanosensitive channel
MFKEFKEFISRGNVMDLAVGVIIGAAFGKIVTSLVDDIIMPIIGIILGKIDFSNLKLVIT
PANGSTPEAAVKYGLFIQNVVNFFIMAFVIFLMVKFVNKLRKPATTEKPAEPEPTKEEVL
LSEIRDILKNK
>SEQF2502_00372 hypothetical protein
MDFENNKNEQHHSNHNIEELDRIRNEVTNNSSNSNFNENINGSITLTLDDLTVKNMRFMA
TVIKILSVLGVIVGAFQILILFLGIFTIIISIKFFKSANALEDTLIMKDGEQLKTYFNEQ
SKALKLYIIFIIVGIIIGILFYGFLMVCVIAALANDTIL
>SEQF2502_00373 Cell division protein FtsZ
MEGRFAYNLYLQDWDNGMKDKMNMKVIGIGGMGINFVNFMIASGVKKVEYITIDTNSESS
DSSHAEKKIFLDTGVKECSREKAERVAFQCENQFQKLLLGTNILFLISGIGGATGSGIMP
VILEVAKKLKIFTISIVARPFYLEGFETLKIANTGIKKIEKLTDSLIIIPNEKLYNYIDR
KEPLESVYNTVNLIIKEGIEGIVNILTEVGFMNIDFLDVKAVLHNAKNTIIRVGEGKGDN
AVDKIIEQLMENNLFEGKLENAKRVLVNFTTGTSVSLMDIGKITEKISDIVKDKNVNLIW
GVVIDPSYDEIKKIKTVVISSV
>SEQF2502_00374 hypothetical protein
MAEKNEAVLTAENEKKLEKNRKNNFPKWDSEKKNLLVKILIVVGLVLCIFGIMDKIFEHT
VFNFFKNLTMPYLEKTYEESKKMFLTLSLLKGTTDIIEGSTVNVSMIVGMEIEIGDIIQP
IYDMINILWKVSLASVVILKLETIYYEIFKVKLATILTFISLITIFPYTIYKNKVTKIFR
KISKYSFFILLYIYIVLPSAIFINSTISRYFEKEYKEPAIVELNQDLGRLNKVKDEMLSL
DQSKSIFNIPGQIDSAKGKIDNFTKEINTISKDLVEDAPVIIGILLLTSIVLPLLIAILL
YVITKSVIFEKLSGVGKK
>SEQF2502_00375 tRNA threonylcarbamoyladenosine dehydratase
MNNKNQTFARFSMMVGEDGIEKLNNSRVIIFGVGGVGSYTVEALARAGVGHITMVDFDEI
SESNINRQLHSLRSTIGKSKVDVMKDRILDINPECEVELVKKLVADDIDEILGDFEKVEN
FEESKDLNNGKKNCKYKYDFVVDAIDVIGSKVNLIEYCVENKINIISSMGFGNKMHPEMV
EIAKIKNTSVCPMARTIRSILKKKKIINIPVVYSREIPVKPDKSELFKEELPTEFRENNE
IPRKTTPGSNSFVPGTAGLVLASYVVRKILEWD
>SEQF2502_00376 hypothetical protein
MDYKEDIKRWRLILGKDTEEEFSSMDSEAIPSFTEEDWLMDKALDAIYNPTGQFMGGDSA
GRGPSNPQISRWLGDVRTLFDKELVKIIQTDAMERCGLKQLLFEPEILDQVELNINLAST
IMLLKEQIPQKSKESVRNFIKKIVEEINKLLESNIRRAVRAALNKKQHSPIPSASSLDFK
TTIRRGIKNYNRELKKIVPEHYYFFERASVNPTSKFTVILDIDQSGSMGESVIYSSVMAC
ILASIASLKTRVVAFDTEIVDLTEKSDDPVDLLYGFQLGGGTNINKSIKYCTKYVENPKK
TIFFLISDLIEGGNRGEMLRRLQEMKDSGVIVVCLLAISGDGKPYYDSQMSGKIASLGIP
CFACNPEKLPLLLERVLKNMDLSSFEKEFGKKK
>SEQF2502_00377 hypothetical protein
MGERNLELENQGIEQWIKKIKENFEIVTAILGFIIIGIDYIIKLYLSKDKEKLYDIPSKY
FFSFDYNRILYMLIIIIIPILLFLLLIYNKEKSSDSSQIKDEKKIQNFLCHIVISYQLLV
FNVYQLRLDNKLSYYYFILLFLFFIFDFGVLVYYNFFKSRNQRSEIEKKIAWVWIAEFII
GIGILINSSINSHNYELTTVEGKKMIVLSEYGDNYLVVPYSEKSKECKKKFCFFVGTYEL
IEKTGHSLESIIINNDEIEIKKEKFVANPK
>SEQF2502_00378 hypothetical protein
MKKQNEVKPNIFGVRHFSPAGAHYLRDYLDEIQPKIVLIEGPSDFNDLISEITGKNIVPP
IAVMAYTLEAPIQTIVYPFAEFSPEYQAILWTKENGVECRFCDLPSSIFLGVESVKKNLD
ENPEENLNDYIYRKINEYLEDSDDEVFWERVVEQASDYKAYRSGARDYGKHLRELTLSNT
VSDAKNIIRESYMCKVVSDVCKEGYEMDEIAMVVGAFHVEGIESGKLILTEKEIKKLPKL
ESKKTLMPYSYYKLSTYSNYGAGNKAPGYYEFLWNGLEKEDPFFATYMYLSKIAEYQREN
GNMVSSAQIIEAVHLATSLANLHDGKIPTLKDIKDAAITCMAHGSYSELVLAMANVEVGK
KIGSIPKEAIQTSIQSDFYNLLKELKLEKYRSLTATEIKLDLREKLRVQSEKLAFMDLER
SFFFHKLRVLNISFAKLIGNRQENTTWAEEWILQWKPETEIEIVETILKGDTIEFATAFE
LMQRIEGAKTLSEMAEIVKDAFYCGMPKALEKAFQALQNFITGDVPIDEIAKTMSTLSVM
LRYGDIRKLDTKVLIPILEQLFLRVCLILPSESFCDNNAAVELAKSIIIMHTVVENHDFL
DRERWYSLLLEISKRDDLNTKISGLAMAILLEAGKIDNEVLGKEVEKRLSKGVPADLGAT
WFEGLSMKNHYTLIARLGLWEKLQNYISNLDEEEFKRALLFLRRAFADFTSNEKHDIAEN
IAEIWGLNKNDVSAVINDDLGENEKEIIAGLEEFDFDDI
>SEQF2502_00379 hypothetical protein
MAKKEELQRLTAEQMFQDEIDALIKAEKNPIPTGWKMSPKSVLTYICGGKAGRKVITPKY
IGNKRLVEIAISTLVTDRALLLIGEPGTAKSWLSEHLTAAINGDSTRVIQGTAGTTEEQI
RYSWNYAMLIAEGPTKDALIPSPIYKAMEDGAIARVEEISRCASEVQDALISLLSEKRMS
VPELNVEIPAKKGFSIIATANTRDKGVNEMSAALKRRFNIVVLPSPKTLEAEIDIVRSRV
TQLAGNLDLNAKLPEEEVIEKVCTVFRELRQGVTLDGRQKIKPTANVLSTAEAISLLANS
MALAGSFGDGEISDYDLAAGLQGAVVKEDSKDGQIWEEYLENIMKKRGSEWLDLYKECKA
LNKATK
>SEQF2502_00380 hypothetical protein
MNLEPLYELKNRLENVSIVGINLVKDDFRLQRAVDQMKGYASAAKVFKQIYEMGQKLIEG
DEEDKCDLFLDLLALLDAVLCTQATTYTGGNLQKIETTIGKENFYQELHYSELSELIAAF
KGTGGGRFRVIDSTLRWDNPEIVNDFRVKKFMINGLNDSYSGIIDLMIKMLKKQGKEIIP
LLKEGFDPQGKKEMIARLEIIKDICKGEENEFYKYCVENGGKEVKEVAIGALAYDQDNVD
YLLDLMKKERGKLKNKVFESLAYMDDERVKKEWDKFFRKKPFENMEYMAGTEQQWVSDYI
NNYIKEYTEDLKNKTLKTKEERRKVQEEVAELCSVSSNKRTEKTLSLYKELYPYNKAAVK
RILSHYIVTEINKEITNLIKKLSKIYEGEFLEQEFLISLIKDKPETTYKNFSKFAGVGKD
EKGIKKLFHTFFANNKLSKNKEEAKAQEDFSTLFNVIFHIHYDEENKEYILYWQNINDYS
VMKIKLNGFDKKWYNIIFNIEDDFYENWNYYSSYHRDLKNLYNPDIKGMKEKYGAFYYNI
ILSRIPYSEDIEFLNKLEWTNYKNFLKGKIDIEKNAPKLHNRVRSIGYILNEVPISESEL
IKQIEELFEMDKKTKRMSINLCEKWLEKLNNGMKVKEL
>SEQF2502_00381 hypothetical protein
MKRLEESRIIAMAPNASAISNAKKLCDKGAFLKLWRSVDDTLYMGECKGSGKSNYTVSVD
FIDEENPVTRCTCPSRQFPCKHGLALLFEILRGKKFEECEIPEDILAKREKKEKLKAKRA
NEEKEVKKKTSSKASKSARTKKIKKQLEGLDLIKKISSQLLKVGLSAMGSVSITEYRDIV
KQLGDYYLPGPQVLFQRLLLEIQAYKEDQDKGHYQTALECLKKLRAIEKKGREFLNEQLE
KNDPELTDNTLYEDLGGVWKLTQLNDLGLKKENARLVQLSFEVNYDEASKIFTDCGYWID
LESGEVSYTANYRPRSAMKYIKQENSNFSLLTVPTLTFYPGGVNKRIRWDAASFDKIESS
CYKEIKKHAQSVDHAVKIAKNELKNILTNNEVALLLEFEKIMFVEEEGKKKYILIDKNQK
MIELRDKKNKEFSENFYELLPNECLENQVMFVKLFYEGRNIYAQAQSIITDDKIIRFGF
>SEQF2502_00382 hypothetical protein
MKYNLAFKYRIYPNKEQELLINKTFGCVRFVYNTILYIANKIYEETGKNKIITPASLKSE
N
>SEQF2502_00383 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha
MSIKDEIKELEEAISELKAFSAEKNIDFSAQITELEKKLEDKYKDFEENEMDAWNRIQIS
RNPQRPYTLDYINELTQDFVELHGDRLSKDDHAIVGGLAMIDGYKIMVIGHQKGRDIDSN
LYRNFGMASPEGYRKALRLMRMAERFKLPILTLIDTAGAYPGIEAEEKGQGEAIAKNLAE
MFGLRVPIVSVVIGEGGSGGALGIGVADSILMLENSVYSVISPEGCASILFNDSTKAPEA
ARSLKMDAISLKSLGIIDGIIKEPLGGAHRNFEEMAQNLKAAVVEEFKRIDKYSLRELLK
KRYEKYRRIGDFFEE
>SEQF2502_00384 Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
MGLFSSRKSKKKYVTLTSKSKLTVDIVDDNKWKKCNRCNEIIYNEDLKNNLNVCPKCGNY
FRLTAFERIELLIDEGTFMEEDMTLNSKNVLNFPGYEEKLEVSRERSRMLDGVISGTGKI
NGIEVSIAAMEFSFMGGSMGSVVGERITRALERGLKKKIPVVVVSSSGGARMQEGILSLM
QMAKTSGAVKKLNDAGIPFISVPVDPTTGGVTASFAMLGDVIITEPNAFIAFAGPRVIEQ
TVNQKLPKGFQRAEFLLEHGMVDIISERKDLKTTIYRVLEKLV
>SEQF2502_00385 Ribosomal large subunit pseudouridine synthase C
MEKNEINVNSEMEGMRLDRYLRKSLKNEPLSRIFGAIRSGDVKVNGEKTKENYRLLLNDK
IIIKNLSMENIKKTKKTENKIRKFQISQNELEKYKKMIIFENEDFFIVNKAEKIPMHKGT
GHKYGLAEVFKKIYKKENINFANRLDFETSGLVIGCKTLKFLRYISQKIRDNEVHKKYFA
IVHNRKFKKKNKFLENNFEENKKDFKIENYLTTAENRVIVSENPVSRESKKSITYFKYTN
IDKLKNQKKILDLLGKNKNISLLDIELITGRKHQIRAQLADKELFIVGDKKYGIKDRSDR
FFLCCYFLSFDEYKFSILDRVFF
>SEQF2502_00386 Peptidoglycan glycosyltransferase MrdB
MFQSQRIIEDLKNNIFRMDKMILSIVYALVTISTIFVYSATRQNGMVVKNILWIVIGTIL
MFIIASFDYKRIKLYIWHIYGIGAVLLLLVRFAGKKTLGAQRWIALGPFQLQPSEFVKVI
IILIIAYWIVEKYKNGINNLKDIIGSILPALPLILLILIQPDLGTTLITISAFLFMIFLY
DANMKPIWIIGIVVMLSVYPVYRFVLSSYQRDRVETFLHPEKDKKGSGWHVIQSKISVGA
GGVLGKGVLQGSQSRLEFLPEAQTDFIFSVLSEEMGFFGSTLVLLLYFGLIYDIMRIARI
IQDSFGRLILYGLAGVIFMHVIVNVGMTIGLVPVTGKPLLFMSYGGSSFLASFIIIGIVE
SIKIHNNK
>SEQF2502_00387 putative zinc protease
MIEKIRTNTGIEVIFDKLENISTCSVGVFVKTGSRDESDTEEGISHVLEHMIFKGTPTRN
YFEISDEIDYLGANVNAHTTKEETVFYINALTQFLGKSVDILFDIVTNSTIDEKELEKEK
DVIVEEIKMYKDSPDDLVFEINYADCINGQYGKPIIGTEASVKGFTAEEIRKYYMERYTK
DNISIVVSGNFDKDEIIQKVNEYFGKLADKKVDRCEKIDFSFNAGKKVISKDINQVNICI
SHQSEDYNSKNKIYTDILSNIIGGSMSSRLFQEIREKKGLAYSVYTFNQYYLSGGLTSTY
IGTNIENYEKAIEITLAEFKKLCESGVTKDELQKAKNKYMSRLAFSMENPRSRMGILGNY
YIRKNEILDTERIKREVSVVDLTDVNNFAKTAYLTENITVLGNIEKISKE
>SEQF2502_00388 hypothetical protein
MNKLDKYIISNYIKSFILGMMMFYLIFLLAESISLTGWLMDGKLKGHDAIKYLRYGTPEI
ITNTAPLGVLLGSLLCISKMAKQLEIAAMKTSGISFARIALFPMIFSFLVSMGVFWINYD
MLGKSNTKKENLKSLKIDNKEPVRAQKKFVFVKIDKRTVLYSENVNKNTGTMEYIEIFKF
EKGFSKIGKIYTSPFAKINLKTNVWTFKNLKEYDSRTNLTKPADTKKFKFIASMEDVLAS
PVKAKNLTMPELREKTVYFTRVGADSLNLRIEFYYRISFALSSFVMCLIGLSLGSRYVRG
GAALNIGLSVIIGYAYYGISTILRSMAVSGTVPIYAACFIPLIVFLVVGIKLFRDSEY
>SEQF2502_00389 hypothetical protein
MKIIDRYIYNSLILPSLFGISIFTFIMMLNVVMEVMERLFASDLPFISIIDYLFYAMPGV
LVQTIPMGAFLGVMLVYGGLSETNEIVAMEGSGIGLFRILRPAFIFGIVLTLIGLGLEIY
VNPRALENINAQTKQVLASKPSSLTEEKVFLVNEEKGFGFYIDEVNNEAATAKNFLIINK
RGDNHYPIVFLAENAKFDPGIINLSKVKGYAFEKDGSNQVSAEYMEQEIPITTFFRENKK
EVKKSRKEMNIKELNKFYKENINKPGEKETALKAQVEIYQRLIGPLASTFLCWLGVLLSV
GHRRSGRGISFGISLIVIFGYIGMASYAKIMVLKNNVPANIAMWIPNFVLFMLCIYFSIK
KYRRN
>SEQF2502_00390 hypothetical protein
MILDIGFVALLIIFILLGYRRGFSLEFFNMFKYIFIIFITNYIYKFFLDSERIKPQNQLK
IFIIIVVVQCIVYSAILIINKKFLRSIRIERFDKFSGMIFGMIKLFFVAIIVYIVVIAGS
IKSKSIKNARNKSFCIKIMTKYALRFTDSFPGFIENDVKRYVISQREKEVINDVLHDYEN
PEPDKFEKSKEIN
>SEQF2502_00391 Alanine racemase
MRCWAEININNLYSNIDEIEKIVPKEKIIAVIKADAYGHGMLKICDALIKKGIKNFAVAT
SDEALKIKELHNDIMVLILGPVENEYMDLIADKKIYFMVTDFEEIEFLEKTGTENSKTVD
VFIKIDTGMGRVGFQESEVEQLNKILKNVKHINPIGIFSHFSSSDSDKGYTKLQERKFKA
MCEKISSGIPSIRYRHLHNSFGMLKFQESIQDFVRAGIIIYGGVTNKETAPYKFKPVMSL
FAKISYIKTLKEDSFISYGNTYLGKAGKTYATVSIGYADGVRRDLSNKGHVFYKGHKCEI
VGRVCMDQLMILLPDELKDMAKKGDVVEFFGENISVVEVAELCGTISYEILCGISQRVPR
IYVEK
>SEQF2502_00392 hypothetical protein
MKINLKVIKNRKLYLGISTVMVLISLISLFTIKLNLGVDFKGGELIQLKYSKKIDQNAVN
STLNSLIGKIPQMKAKRVQFSDTDNTVIIRTEQMSSTQKAKVMSELKQNTGKFEAVKNET
VGAVIGKELTANAFQALLIGSILIVIYITVRFEFIYAIAGIAALIHDVIIAFGVITMLRY
EIDTPFIAAILTILGYSINDTIVVFDRIRENIKKNRAGRNKVSMSFGEIIEKSINQVFTR
SIYTSLTTLFSVIVLLILGGDTLKTFSMTLFVGMLVGTYSSVFVASPLVYIMKKGKDEPK
AKDTVKDSGKTVNGYDEKDKVLV
>SEQF2502_00393 hypothetical protein
MQNKKSHYIWLLVVIIVPIVILSLNKIKLGLDLRGGTSVVLQAQGKIEPDTMSKVKSIIE
RRVNSIGVAEPVIQLSGNDKLIVELAGIKDPQKAVELIGTTAKLEFRIKNRDGSYGPVLL
EGSALKSAGVTRDQMGMPSVSFELSSQGANTFAKITRENIGKQLAIMLDNKEQSAPTINS
EISGGSGVITGRFSMEEANNLANLLKSGALPVEIKIVENRTVGATLGVDSIKQTGVAGLI
ALCVISVFMIAIYKIPGIVADIALLINGVLVLGLLSGVGAALTLPGIAGFILTLGMAVDS
NVITYERIKDELRFGESLHDAVEKGYENAFPAIIDGNITTLLVAAVLFFFGTGPIKGFAV
TLSLGVVATVITGVFVSKIFLRLFIQVFKIKREQLFWKGALNNED
>SEQF2502_00394 Putative pre-16S rRNA nuclease
MRKFIGLDVGDVRIGVAKCDPLGILATALEVIDRTKIDPIARIKEILDDEGTKKIVVGMP
KSLDGSKKRQVEKVEEFVEELKKEIIGIQIIFVDERYTTTEAEHYLKNYSKKNGKERRKV
VDMVAASIILQKYLDTLA
>SEQF2502_00395 Alanine--tRNA ligase
MTGNEIRKSFVDFFKSKEHKHFESASLIPDDKSLLLTVAGMVPFKPFFLGEKEAPFPRIT
TYQKCIRTNDLENVGRTPRHHTFFEMLGNFSFGDYFKKEAIEWSWEYITKVLKLDPERLY
VSVYKTDDEAYEIWNKEIGVPEDRIVRLGEEDNWWAAGPVGSCGPCSEIYYDTQNMGKNN
EEINCKPGDEGDRFLEIWNLVFTEWNRLEDGSLVPLPEKNIDTGAGLERIASVVQKKDNN
FETDIFMPIIKGIEKVLDIKKEEFEITVKVIADHIRASVFLIADGVLPSNEGRGYILRKI
IRRAFGAGIVAKQKLEITKDDLFLYKLVPYVVENMKEAYPELVEKQEYIEKVLRLEQERF
ALTLKNGIEMLTEEIEKMDKEGTKKLSADASFKLYDTFGLPFELTELILENQGYEVSEEE
FNQRLEEQVKRSKNSRVTVSDMIKDDFIDKFFEEHGKTEFTGYEKFEDEGKILHIAKSEG
ISGYEVIFDRTPFYAESGGQVADTGIITSGEFEGKVVNVVKKHDVFIHQVEIVKGIAPAV
GAEVKMEIDADRRKDIQRNHTATHILHKVLRENLGTHVEQSGSLVDDEKLRFDFSHYEAI
EPEMIEKIEKAVNDIILSNLKVKIDFENIEDAKKRGAMALFSDKYGDVVRVVEIDGYSIE
LCGGAHVKSTGEIGLFNIESESGIASGTRRITATTGHASLKYVNKLEEKLSKVAGMLKTD
GKNVVDVVEKYIAEAKNIVKEYEQLQTKLVKYEINELLENVDEINGVKVLKAAFENKDVN
ELKEIVDRGKEKLQSGIIILGTNNDGKAIFVVGVTKDLISKVKAGEIVKVAAQVAGGNGG
GRPDFAQAGGKDGNAVKEAVDKVFEFVNGKL
>SEQF2502_00396 hypothetical protein
MNNKNRKLKKKYIYFFMEGSKNCSEDKYIKEYYGQFQDKAVDIGFRFISCGDGSWKNIEK
EINKEKRNIIDENIEIWCVLDKDKNDLDKINKECVKNNYKLIFSNCSFEVWLLYHYENIK
IGECSQKNYENILTRKLNKKYKKSEGIKFTLDDKERAIRQSKKIHEKYQRLEEKINNSFN
CTNFYMILEKFKEVFYNFDLE
>SEQF2502_00397 hypothetical protein
MLLDIEIKNLKSFKNQTIFSMEAENKIEDRNSFEVEVGKEKFELLKTAVLFGGNASGKSN
FTSVLSIFRYYLFNKGIEKYNKEGFRFGEEDKNSTIKVRNVVDNKIYEYILEINFNTKKI
IKEKLYITALERKLVFERENNKIVKYDKEIFSEYEITIGFINETLTDSDSVISRIIEWRV
PEEIEKYIFYIDKIKINNYSDDLGKYIYENKNNKKLVIEFLKKIGIIVNDIEVYREKNEF
FLKNIRESKEFQILSEKEQEKLLSQIAYIYRIHFVYEDNQKQKYKLDYYEQSAGTQKILS
MFFPIYNLLNNGGVMIIDELDITLHYSLIKEIIKMFNSVEYNRKNAQLIFTTHNLLLLDF
NLFREDQIWFLENNNVSTGTELYSLSDIEGYEKNKYLLRDYLNGNFGGIPKLEDFGVDLW
LEKKE
>SEQF2502_00398 putative peptidase
MKNMILTSSLYESIGFVKEFLDKNTKSKKILFIPTAANVEEYKNYMYLTEKAFEDIGYEV
DNLDISIFSEKTVKEKLSKAEIIFISGGNTFYLLQELKRKNLISYLKERIEKGLLYIGES
AGSVITGPNIEYASLADDKTLAKELSDYTGMNLIDFYIVPHFGEEPFAESSEKIVELYKD
KLDLKLINNKEVILIENDDFRIIKEKNKNR
>SEQF2502_00399 Lipopolysaccharide export system ATP-binding protein LptB
MARKISIEADSLKKIYKNREVVKNVSLAMEKGEVVGLLGPNGAGKTTTFYMITGIVRPNH
GRVMYNGQEITNLPMFKRARLGLGYLPQEASVFRNLTVEENIVSVLEMRGVRKKERIATM
QSLIEEFKLSHVAKSLGYALSGGERRRVEIARTISTNPDFILLDEPFAGVDPIAVEDIQN
IIMQLKERGLGILITDHNVRETLRITERAYIMAEGTILISGTGEQIANDETARRVYLGDN
FKLD
>SEQF2502_00400 hypothetical protein
MIFLDKAILYLTQNIEKPREVIEEELEFVIKQCILNYLVNEKKININELSDLNITLVIDF
EDDDVNNKKKMVVEEYMFEVNHKNTPLVRTFRLGTDNEHYIRTDLKELENEIDMFENGIG
ISKKD
>SEQF2502_00401 hypothetical protein
MERYSVIKEKNPREIVLLKGFSCAYGKCAFCNYILDNTNNEEEMKKVNFEALSRVTGEYG
VLEVINSGSVFELNGMTLEKIREVCKEKNIKILYFEAYFGYLNRLNEIREYFSEQEVRFA
FGLETFDNDYRTKVLKKNFILNERVLEKLKSEYQMCLLMICTKGQTKEQILSDIEKGLKN
FKELVVSVFVNNDTEIERDEELVAWFLSEIYPKYKDMPNIEILVDNKDFGVYVQ
>SEQF2502_00402 hypothetical protein
MLNFLNHLQFGVNELLWLGYLILNFSAVALAYRFWGKGGLLSVVPLSIVLANIQVGKMMT
LFGFDGITMGNIAYGGIYLASDILTENEGKHYSRKVVSLGFAAMLFTTFIMQIVLKVKVS
PDDTMQGALSAVFGFMPRLAISSVCGFAVSQSFDIWSYQFIRKFRPSFKDIWIRNNASTM
ISQILDNIVFSFLAFTGVYPFKTVIGIIFSTYLLKIVISLLDTPFVYIATLWKKQGKISD
>SEQF2502_00403 tRNA1(Val) (adenine(37)-N6)-methyltransferase
MKKTGEETITPIKNMKIIQRNDFQNFTLDSVLLSDFVKINRKTKKILDIGTGCGIIALLL
AQCSKAQITGIELQKTMAEIAERNVENNKFENQVKIINEDIKNYKNIFNRDEFDTIVTNP
PYFEFTGDISQTNDLEQLANARHNIDLTLEEIIKISSYLLKNMGSFSIVFRSERLVEVLA
LLQKYKLEPKRMKNCYTKWNENSKICLLEAIKDAKKGFSIEMPIFVYDENRQKNEYIENL
YKSSDLKIKKE
>SEQF2502_00404 Transcriptional regulatory protein PmpR
MGRHGTIAGRKEAQDKKRAASFTKLVRLITVAARGGENPEFNVALKHAIEKAKAINMPND
NINRAIKKGAGTDGSTAFETLNYEGYGPAGVAIIVEALTDNKNRTASSVKMAFDRNGGNL
GVSGSVSYMFGRKGEIIIEKTDDIDEEALMEVALEAGMEDMETLEDSFYITTEPANFDAV
ADALRNAGYKLLEADIQYLPSIEVETLEENDLQKLRKLIDVLENDDDVQKVHHNYAGEL
>SEQF2502_00405 Fructose-bisphosphate aldolase class 1
MKERLERMRNGKGFIAALDQSGGSTPKALKLYGIDESEYSNDTEMFDLIHKMRTRIIKSP
AFSDKEIVGAILFEQTMDRKIDDKYTADFLWEEKGVLPFLKVDKGLEELKDGVQVMKPIP
GLDELLKRANERHIFGTKMRSVIKKASQTGIAKVVDQQFEVADKIIAAGLVPIIEPEVDI
HNVDKAECETILKNEIKKHLDKLPETSNVMLKVTLPTVENFYEDLTKHPRVVRVVALSGG
YPRKEANEILAKNKGVIASFSRALTEGLSAQQSDDEFNKDLAKAIKEIYDASVK
>SEQF2502_00406 Bifunctional NMN adenylyltransferase/Nudix hydrolase
MKKYKTGLVLGRFQTFHKGHEYIINKALEICDKVLVFIGSSDKFGTIENPFSYELRKKLI
KKVYENEIVENKLVIFPLADLGAGNVTKWGDYLFCEAEKILGKVDYIVYGEESKCKSWFS
EKIKKSVNFIVISRDDIKINASTLRNYMKENDFEKWRKFVNEKNWGEFEKMREILIKI
>SEQF2502_00407 Nicotinate phosphoribosyltransferase
MKLKPIITSLLDTDLYKFNMNQVIFHKHTDLVGEYHFKCRTPNIFFTKEMVTEINEQIDH
LCGLRFKNEELNYLRSIRFIKPDYVEFLRLWHPIKDYVTTVLENGELRVIVSGPLFSAMQ
FEIYLLEIINEVYFRMKFNYDELIISAKEKLEKKILDFKNKKYNFKFAEFGCRRRLSREW
QEEVVKKLSRETQNMVGTSNVFLAMKYNLVPIGTYAHEYVQMYQGIDSIPLSYTNHYALK
DWYDEYKGDNGTALTDTITTDLFLRDFDRSMVNNYTGVRHDSGDPYIWAEKILNHYQKYG
IDPKTKTLLFSDSLNFDEAEKIYQTFKDKVKISFGIGTFVTNDTKEKPLNIVIKLQYVNG
RPVAKLSDVEGKVMCDDEKYLKYLKASVKFRLEREKEY
>SEQF2502_00408 NH(3)-dependent NAD(+) synthetase
MKNEKEKVIEWIKKYFEENGKNCKAVVGISGGTDSSVVTALCVAALGRENVIGVLMPKGM
QHDIDYSKKLVEFLKIKHYEINVEKPVNDLKELILQQMGVNPDEFDAYKTNQPARIRMAV
LYGISAIVGGRVANTCNLSEDFVGYSTKFGDAAGDFSPISDFTKTEVRKLGAELGLPEMF
LKKVPEDGMSGKSDEEKLGFSYEVLDEYIRTGNISDLRIKEKIDYLHKINLHKILPMSSY
KKGEK
>SEQF2502_00409 DNA polymerase III PolC-type
MNTKYLKIKPSNDFFRKYGIKNFEIEYVNLFSKKKEMEIFVRVHNFAAHSEIQDLRWSLY
KSFEDGVKLKIKLDVNPELIREDVTGFVKFMIENYKDESKRYQYIFATYEVKSIENSIFI
KLPSHHLIEEAQKTDAKEELKNKICECSDNSVNIEFINGEFKEIKEILNAKDKLNSVKAS
ELPKYENTGANNGNGYSNGGNFNGNNNGYRRKKIPDIDAMPFSMLDILNIGDNVALEGKV
FNLDIKETKNGKLMCDFMITDYTDSISCRIFFNMDENIQVKVGEWVKVTGSFESDMYTGE
MYVRTQKVKAIDSKDVKKEDNAPKKRIELHAHTNMSEMSGVMSIKDYAKRAKEFGHSGIA
VTDYGVVHSFPFAFKEANEDFKVILGLEAYMVDDEQDLITNPKDKMIEDEIYVVFDIETT
GFDPFNDKIIEIGAVKMRGREIIGEFSEFVNPEIPIPPKITELTTITDEMVANAEKIETI
LPRFLKFCADTTVVAHNAKFDVGFIKQKTIEQRLEYSPSVIDTLPLARTLLPELNKYGLA
SLVDYFKITLETHHRAVDDAKATAEVFQKFLNMILSKGLMKLTEINTELQPNIQNAETLN
TMILVKNQAGLRDLYELVSRSNIEFFGMRRPRIPKTLLNSMRKNLLIASSASASERNKGE
LVNLFLRGAEKDDIEEKAKFYDYIEIQPHTNYADMVERADKEIDNYDKIKEMNKYFYELG
KNQNKIVVATGDAQYLEEREAINRNVLLLGSGTMWKTKVSEGVREYEFFDRKLYFKTTEE
MLKTFDYLGEDIAMEVVVENTHKISNMIEQVRPVPTGFYPPKIDGAEEEVREMTYKRLKE
LYGENIDESLKERVEKELNSIIQNGFAVLYLIAQKLVHKSVNAGYLVGSRGSVGSSIVAY
LMGITEVNGLYPHYRCPNCKYTEFMNEEGSGVDYPDKNCPKCGTKYIKDGHAIPFEVFMG
FNGDKVPDIDLNFSGEYQGEIHKYTEELFGSDNVFRAGTISTLAERNAFGYVKKYLEEVE
GTPEIKERKAEIMRIAKGCEGARKTTGQHPGGMIVVPKDKSIYDFCPIQRPANDMKSTSK
TTHFDYHVMDEQLVKLDILGHDDPTTLRILQDLTGVDIYTIPLDDKEVMSLFSGTEALGV
TSEEIESPTGTSGIPEFGTSFVKQMLVDTKPKTFAELVRISGLSHGTDVWLNNAQDYVRS
GIATLSQIITVRDDIMNKLIDDGLDKSLAFSIMEFVRKGQPTKNPEKWKEFSKKMKEHGV
EQWYIDSCEKIKYMFPKGHAVAYVMMAVRIAYFKVHYPIEFYTAFLNRKVGDFKMTTMFR
PIDDLKKAKMEMDRKGNLNAKEKQELFLYEILIEMHYRKIELDQIDIYKSEAKLFTIQDG
KIRMPLIAMDGLGDAVAENIVSERKENSFLSIEDLVKRTKLNKTIVELMKEYGCFQELSD
TNQQTLF
>SEQF2502_00410 Formate--tetrahydrofolate ligase
MTDIEIAQNAKLKKIGEIAQSIGLMEDDYEPYGKYKAKVSLDVLKRNAGKKDGKLILMTA
VTPTPPGEGKSTVTVGLTQALNKLGYKSIAALREPSLGPVFGMKGGAAGGGMSQVVPMEE
INLHFTGDIHAISAAHNLISACIDNHIHFGNELDIDVNNITFKRVLDMNDRNLRSIVVGL
GPKVNGVPRENSFQITVASEIMAIFCLADSITDLKERIGEIVFAYNRKGEMLKVKQLNIQ
GAVAALLKDAIKPNLVQTLENTPVFIHGGPFANIAHGCNSLLATKMALKLSDYVVTEAGF
AADLGAEKFLDIKARLGNLEPNVIVIVATVRALKHHGGDKDLKSENIETLTKGLVNLEKH
IESMQKYNLPVVVAINKFITDTDAEIQVIKDFCAKMDVEVANCEIWEKGGEGGKELVEKV
MNAIEKNEKSDKKYTPLYDLNLSIQEKIEKIAKEIYGADGVNFAPKALNNIKKYVENGYD
KLPICISKTQKSLSDNPNLLGRPTGFTITINEVRLSAGAGFLVAMAGEIIDMPGLPRKPA
AELIDIDENGVISGLF
>SEQF2502_00411 hypothetical protein
MENTKVKMRRRDREITDNEKIKEIIKACDCCRLGLNDNGKVYIVPLNFGFTEENGNYTFY
FHGARTGRKLDIIKQNNYVGFELDTNHKIYTKGDKACNYTARFQSVIGNGKVEIIEDSQE
KMKALLELMKHNTGKAEWEFDEKMLKAVCVFKLAVEEMSCKEHE
>SEQF2502_00412 Secretory immunoglobulin A-binding protein EsiB
MGIFGKIINKFRNKNNEEEKYLKIAREHINKAGENLTKEQIDEMMKLGMDTRELYPEVSK
LYFERIEDYFPPASTMLATFYMDKDDEMYEKYCLKAANQGENIAKKSLAIFYAKNNNEEK
MLEWYNKLDDKEDYDVLAYMSNYYMFQDNYDKVKEINFTILKNKKDDKYAPNCLGDAYFA
ENDFENSEKYYKMALENGSPDSKDKLFNLYQTTENIEKFRELIERDEAKRGEDFLSLGNL
YFHKKDYKMAEKWYLKSEKLGFLEAKYNLGYVYYEIGNFDKAEKYFQEVIEKIPHLKESA
VKKLINVYNSQANVYLTSGDFDKAEKYLKILVEKYGIKECYYNLAVINRQKGNIEKYKEY
ILKGIEFGDNECMFSYALSVYSETGKYTEEVDMWLKKAAEKDHVDAMYELGLFASEQNRI
EDSKKWYKKAAEKGETTAMNNLANIYSEEGNKEEAMKLYLKSAEKGNPLAFFNLGNYYEE
NNNIELAKEYYGKVLDSLKGYPTCKIEQEALAKLKKLQNNSELKNN
>SEQF2502_00413 Cystathionine beta-lyase PatB
MSENYDFETLLSRKGQGSFKWEAMYREVPNLSDDIVPFSVADMELKIAPEIREGLKKYID
EVILGYTGATNKYYEAVISWMKRRHNFKVEKDWIVCTSGVVAALYTGVKAYLQEDEGVII
FTPVYYPFYNAIKSSNRKIVDCGLIEIDGYYEIDFEKFEEFAKDENNKMLILCSPHNPVG
RVWKRKELEKIGKIALENDLIIISDEIHCDILMPGFKHTVLQTLSDELAEITVTCTAPTK
SFNLAGIGVSNIIIKNKKLRKQFEAQMTKDGSHVFAALGFKACELAYNEAEEWFNQFLKL
VDKNQKLVKQFFEEKFIGFKAPLIEGTYLQWLDFRALGLKDEELKAFMTKKANAFFNEGY
IFGKAGSGFERINLAVPTRYIEAVLERIYNAIKKEYPKFCK
>SEQF2502_00414 hypothetical protein
MRKKINNIINSGKEKIKRKKIEIGMLALINTVIGFNINADPLNLPKEYSENIAVKGYEND
VFDYDFNNDGIDEKIVISYNIVDNLIGAVVSIYTNQSGKDILTYQITFDKKFNIMELQAM
QKMLDKVKEYYPEYSKNIQPNETRYITIYGDNKTNDIVFDKVKFNNHSPENTNNFLFIKK
SSSMLDAPNGSVIANLGFSEKPEILFDMVSDAPNAQTKWYYTEFTKRFTTNVSKKVKKDK
NGKVIAENPTTVKGFITGGDDNVSKRGFYWDKMINKIEIVNDFITKAINDNEQLYIITEY
APLSRDKPSKKDKFGNKNNQSIIGYTNSKKEGEIINIPDQTIFRIIGEENNMLKIETPFY
GGPYFIEKVQGTYQKVENIKEEVNKFIAIDPSSQTEVLFQRIPETQKYEVITYSYVTTGK
DGYGSYETPHGAFLIAFTRPYMTFTRHARPGDKTIPGRSDLAVAGSAKYAVRFSGGGYMH
GIPTNFEFKGSTLDTSTAQKIGTYKESHKCVRHFDDQIGFIVKWINADSKIKDRDNTIPE
EPVIAVVL
>SEQF2502_00415 hypothetical protein
MIKKINLTKMKFLIAAIAILSVISINAFSAPKVKETKKIEVKKAEQKKIEWKQISLEPDL
DGDGIKDKIDVDYAVDGNNVHLKFTPYIFSEKAKFVKGKSVEKVISKSEFEAKFDTFIKG
FIAEYPKKSGVSPKPKQNTQTPISEKQEITKPSTTPGTKINNENKKPTLQNDTQKNNKTI
KNNTESQETIDMKKEDNPKGNTKIETPKNSNSQNGSHSYIKEFSAQRPKNLTFNFQYDKN
SPKDMDEFVFIKTATSIKKEPNSSSKTIKSASYSQKYKTTGIVGNKSDEWYEIFFDNQLG
YIPKSAAEKREFDWNDMMNKVEKTNKFINEALSANKKLYVLDDYTPLGGGENGKRDKFGN
RANQSEFGYLDKTFKDYINIPDRTIMVIDEQNDKYIKVKIDAYDNGIYYLKPSTGKYLKD
AGITGEITRFIYVDRASQNEMVIEKSGNNWNVVTSSFVTTGKDSGNSFATPYGTFLIAYS
KPVMQYTGSDNKTVVGDAKNAVRFSGGGYMHSIPSLFEPKNTREQRKAATAKKIGTYPES
HKCIRHYDDQIKFIYDWLGNSTPGHKEGYRVPSVPTVMLVK
>SEQF2502_00416 Ketol-acid reductoisomerase (NADP(+))
MAGNILGTTVYYDADCDLSKLEGKKITILGYGSQGHAHALNLKEGGFDVTVGLRKGSKSW
DAATEAGFTVKETADAVKGADIVMILIPDELQAEVYAKDIAPNLKEGAYIAFGHGFNIHF
KKIVPREDISVFMVAPKGPGHLVRRTFQEGSGVPCLVAVEKDPAGDAMEVAKAWASAIGG
GRSGILETTFRQETETDLFGEQVVLCGGVVELMKVGFEVLTEAGYDPVNAYFECIHEMKL
IVDLIYEGGLATMRNSISNTAEYGDYLTGPKIITKETKEAMRGILKDIQSGKFANDFLAD
YKAGQPFLKEKRQEFANHGVEKVGAELRKLMPWIKK
>SEQF2502_00417 hypothetical protein
MNIIITEIILVILIGIYSILTWYFFGRDPKRKSIIPEFSEPKNISSMFVAYINGERDSKE
ILKIGILSLMLKGYISQVDENGTGNKKHILNKKNRDNLKLRKETLFQEENNLLDVLSEND
LFGNKLGIIGFKNRIVHFLEKKYKRIIYKNNYLFFVPVISGIAVSIVFILLKLLQGNLES
AIIGTMFIFIWLEYVHRMSAGILKFLYVAVMLGIIVAVMMYMEVYLGLSLFILGIIFLVY
EKAIGKYTVSGQRKMEYIKGLKMYFETAEKNKIDKFETEEEKLNYFNRIFPYIIALKVED
EKIGIFKDSLGFLNIMGSYAEAQYYVNEYVDRKFPIFRKKYIFW
>SEQF2502_00418 Cysteine desulfurase IscS
MKIVYLDNAATTKMSDKVIEEMTKSFSENYGNPSSVHSLGQRAKSAVERARHIIAQNLKV
EITEIVFTSGGAEGNNLAIRGFLKANKDKGKHIITSKIEHSTILKTFEQLENEGYEVSYI
GVDENGVVDIEELKQELREDTALVSIMFVNNETGVVQPIKEIGKILEERNIFFHTDAVQA
IGKFEIFPKDLKIGALTATAHKFYGPKGAGFVFIDKKYSVEKEIWGGSQERNRRAGTENV
HGVLGLGVALEEVYENLEEMSEKERELQNYLEKRLKSEIGKLEKKIKINGEKVNRIKTTT
NVYIEGVDIQMLLVALDLRGICISGGSACMSGSLENSHVLKAMGLNDEELKGSFRISIGK
DTTIEEIDYFVENLIEVI
>SEQF2502_00419 Putative phosphatase
MNNIKAIFMDLDGTVLTSEHKVSENLIRKLRELEKKGVKIFIATGRTFSSSKPFVEMLGI
KNPVINYNGGRVTNPLNNEVIFEKPVEAQDVEELIKVSREKGIHLNLYMDDKLYIENETD
EGKKYSESVEIPYYVKNFDEFIGKASTKALFIAENSILLELKKELEEKLPHINFVFSKPH
YLECLNKEVNKGLAIKELLKKYDISPEETMAFGDQWNDLEMLKFVKYGYLMGNATEELKQ
EFSKDKITLSNDEDGIYEVIKAL
>SEQF2502_00420 DNA polymerase III subunit alpha
MGNKFVHLKLHTEYSLLEGVGKIDEYVGRAKEIGAKALAITDTSMFGVIEFFKKCKNAGI
KPIIGLEVFLDGLEKVGEFSLTLLAKNQNGYKNLSKLSSISYSRFTRNRNKIKYDELKKY
SDDLYILSGGINSEVVKGILDLENTQVRRVIEKLGKDFGDNFFIEVPAVERLEKARKMLF
DIVRKNKFDNFVITNDVYYPNREDAVLQKIVESIKEGSKIDTEKSGNSEILYDDLYLKSE
NEIEKSFENKEYSEFYGTGINNVEKIVENCNVDFEFHNFKFPKYSLPQNISEKEFLRNLV
FEGLFHKYLKKSVSDSEKLQLDKNFEIIEKEIAKDEIAGQKLKEVKIWEELLKNNLENVL
ERAEYELEIIDKMGYNGYFIIVWDFIKFSRENGVYVGPGRGSAAGSIVSYALNITEIDPL
EYNLIFERFLNPERISMPDIDIDFDQEQREIVINYVVNKYGAEYVAHIITFGTLKARLAI
RDVGRVLNVSLVKVDKIAKMIPFNTELKDALNNIPEIRKMYETDREIKRVIDYSLKLEGK
VRHASVHAAGVVISKDVLSDEIPTYSDGKTKIVSTQYQMKELEELGILKMDFLGLKNLTI
LRKTVENIEKRRKTKIVLNDIPLNDEKTYELLTKADTMGVFQCESAGIRSLMKKMKIEKF
EDIIALLALYRPGPLRSGMVDDFINVKNNRTEIKYIDDSLKYILEETYGIILYQEQVMKI
VSEMANYSLGEADELRRAIGKKNPELMKKNREKFVTNAENKGVLSKKANEIYDLVEKFGG
YGFNKSHSAAYALIVYWTAYFKANYPLEFFAAIMTTEVHNLDRFVVFVNEAKEKGINIFL
PDVNLSDYDFEIEENQADKENFGKVGIRFGLFAIKGVGAALINEIKKERKNGKFVSYKDF
GYRMKQNGITKKQLESLILSGALDGLDGNRFEKYKSIDKVLEYSQKKYESEEDLQMILFG
GKKEISVDFQMEKSDEFPQKVLLQNEKEYLGIYVSSHPLNEKKNLINIIFHNKISEISQK
ELKKVRIIGIVKNVKKFATRTGKEPMVKFEMEDFQKSIEVVCFPREYVTFGYKITEGQIM
VLEGIVNSEQNKNTVILNNICNIENLEENKNLKLYILIDEEVKEKNQELKQIILKNKGDN
QVFLAFKTNEKKEVVKLSEKYNVNLSLKFIRKVAKLVGVERIKLK
>SEQF2502_00421 hypothetical protein
MFFLNNKKLKKSFEVLLIIIIFFTINIVTFSEKSEFLAIGNLKIVRQEPLVIKREDLNIT
IEKNKTIKVESVYTFENIGNYNVKSTFMFWLDTNIEKSLKEDFSNKNTNNQGKFVKNIKF
LTDYKKAQNLRAVIKFDENIYESQVTDSIQREWFAISKVIPSMEEGKIAVYYDLVNTKFS
RNKDFVYSFELVDNFFNKNKAEILYINVYNKSDLKIDSINFKDYEFKNISKNSTKEHYEL
LESGVNLDGKISIKFK
>SEQF2502_00422 Ribosomal RNA small subunit methyltransferase D
MRIVAGTLKNRRIKSREGRETRPTLERIKEAIFSIIGEKVADAKFLDLYSGTGNVSFEAL
SRGAKRAIMIEEDKEALRVIIENVNHLGVEEKCRAYKNDVFRAIEILSRKNETFDIIFLD
PPYKENISTKTIEKISEENLLERDGIIISEHSTYEKMADKIGNFVKYDERDYNKKVVSFY
RFED
>SEQF2502_00423 hypothetical protein
MKIEETNEIEEEIENEETENEETEKNKLITNPFNTKDIKITPKTTSLDNIIKRLENEEID
LNPDFQRNGGLWDNSKMSRLIESIILRLPLPIFYFDISNNDKWIVIDGLQRLTTIKRFIV
DKNLKLTNLEFLKEFQGKKFDDLERNIRRTIEETEIVTYQMEPQTPKEVRYSVFNRINTG
GITLNPQEIRQALNQKNNGVKLLEEITKEKDFKNIVNVTSKRMVDRELVLRYIAFKKYNY
RKLNQEKKSLPKLLDETMEIVDTIEFENNEYVVMKTSLLKTLSNLIEIFEKKYLFNKKLI
DNSKIKVLNKSLFEIWTVLVSDLDNKEILRLKNKKEILKKNI
>SEQF2502_00424 hypothetical protein
MINKLKLINFKCFKENEFFFKELNLLTGINSGGKSSVIQSLLLIKQNFEKRQEIKELIKL
LSFNDKNTVFKDIFLNDKYVKLGLINDILNEKAIDDEIFIELEIDNKKLDTKIKLDDEKK
IVAQYKKIENWEFLISEDNFFYLSANRIFPKENYEYSREKILKGQIGNNGEYSIHYLAEY
YNDEIKIKNLKSNDTNNYQFRENVSRWLGKISKGIDITAVVNDAKEEVRLNYNYGSRNFL
PQNVGFGITYTLPIIILLLKAQKGDIIIIENPETHLHPAAQSELAKLCCKVAAEGVQLII
ETHSDHFLNAIRVSVKENIISSNEVQVYYFNKNYEENEIEMEEIKIDSNGRIENWPKGFF
DEWDIQLEKLLW
>SEQF2502_00425 hypothetical protein
MGYSVGETFMVEFVILNSSSLPFKDKYEFEKNIIEFLKVTNYLSQKLKNYIKIKTFIEIK
DMIIYSNKTLKETIYSIKDEVLRRKLFSLISNKVIKIENPILNKTNENKTYGLKEYKYED
KENKEFGYVDIFGTVLVSFLSNEKWNKIEIELLKISFLENEEIKEEKIKILNISLEKHFE
EIRIKEFLEDRKIEIINELIKNYENKKDFLKKVHINKVVEETFTKIKNTRMFEEFVTIVC
NLEMGAKKIKDYEVSDESDSVKGKFKLKEKRCFKFDDGSYRYIFKHMKNFSNGYRMYFEE
KKDKIIICYFGKHLSTKKHKN
>SEQF2502_00426 Exodeoxyribonuclease 7 small subunit
MAVKKQSYEENIAQIDEILEKLESEELSLDDSISEYEKAIKLIKDSEKLLEAGEGKVMKV
LEKNGKMEMEEFE
>SEQF2502_00427 Farnesyl diphosphate synthase
MLQKYLKEKKKAVEDNLIELLGNYRGKYPEKLAEAMEYAVMNGGKRIRPILMYMICDLFE
KNNCKSYDKIKEIAAALEFIHCYSLVHDDLPAMDNDDYRRGKLTVHKKYNEAIGVLVGDA
LLTEAFGIIANSKSLGDKNKIEIISRLSEYAGFFGMVGGQFADIESEHKKVEIDTLKYIH
AHKTGKLLTAAIELPMIALDIEGEKREKMVEYSKLLGIAFQIKDDILDIEGDFEEIGKKS
NDVKNEKTTYPSIFGLDESKRLLQEYLEKARKIIVDDFNGNQLFLELTDYFGNRKK
>SEQF2502_00428 Laccase domain protein YfiH
MFIEKKNYFYIEEFEKYGITAVYTKKNAGNMSDYCPIKNQEEGIQKKNREKLLKELGLSN
KQEVMTFQTHSNNVKIIDENTEKYYYEKQDDIDGFLTKRKDIAIFTFYADCLPIFVYDKE
NQVIGAWHSGWPGTFKEMMKSGLLEMQKKYGTQVENVVMALGIGIGQKDYEVGNEFYDKF
VEKFGKSNREIVEKSFWFNDKTGKYHFDNTKFNELMALKLGIKQENLIVADESTFDEKFH
SYRRERKNAGRATAMISFK
>SEQF2502_00429 hypothetical protein
MKKILFLVFLMIEAIGFSVNCNWYTGNTESASKMVELVKNTKLTDKIYCDVEKNKMVYET
EDKNNDSFMEVGLIYNKGSKKGLTYIEIANYLDEFEKDVIKLYPWKNLTELEYSNSPEYY
KYRMYIYSPENKDEFMIYMILYDTINGEWKRLYSKDFWNKNDENAVEMIEIMEKVGARAT
DDIVY
>SEQF2502_00430 Cobalamin biosynthesis protein CobD
MNFLIKIWTAFILDLIFGDPEKITHPVQIIGKMITFLEKKLYGKKGSFAGGAVLGILVVA
STFFVMYGFVELTKIVKVLEILEIYLMYTVFSVKSLAREGKRVYKILKLGNLKVAREKLS
YLVSRDTEKMDKVMIIRSTMETISENMVDGVIAPMFYMFVGGLPLAMAYKAINTLDSMVG
YKNEKYAKFGTFSAKLDDMVNFIPARISGIFITAASYILRYNYKNAWKIFKRDRKNHASP
NSGHSESAVAGALGVQFGGKVSYFGKEVKKPTIGDKLKEFRLDDIKKNILLMYMTSFVSM
CCFSTIYLVYLML
>SEQF2502_00431 Agmatinase
MRNKNIHTFIGCDNEYNESKIAIFGAPFDSTTSFRPGTRFASAVMRNESFGIETYSPYQD
KDLEDIKVFDGGDLELSFGNSESTLQDIQDETAKILKDGKIPFMIGGEHSVTLGAVKAVA
EKYPDLHIIQFDAHTDLRDEYLGQYYSHASVIRRCWDIVGDGKIFQFGIRSGERDEWKFA
KEHLHTTKFNFDGLDEVVEKLKGKPVYFTLDLDVLDPSEFPGTGTPEAGGVTFVELHKAI
EKISQLNIVGLDMNELSPVYDQSGQSTALACKLLREILLFIYR
>SEQF2502_00432 Polyamine aminopropyltransferase
MELWYTEEHTKNVRFSIKVDKQLVSVKSDFQRIDIFESQEFGRFLTLDGFMMLTEKDEFI
YHEMITHVPIAVNPKAKKILVIGAGDGGTVRELVKYKHIERIDMVEIDKMVVDLCREYLP
KTANKLDDERVCIYYEDGLKFVRSKTDEYDIVIVDSTDPFGPGEDLFTREFYGNCFNALK
DDGILVNQHESPYYEADAKATARANKQLRAVFPFATVYQLHIPTYPSGHWLFGFASKKYN
PVEDLKADEWNKFGIETRYYNTELHKGSFALPNYVKDLIK
>SEQF2502_00433 hypothetical protein
MADSRFLKFFNYILLVEGSYSNDKNDKGGETKYGITKERARECGYKGNMKDLTKAMAQKI
YEEKYYKARKLDQVKNDKVALSIFDFSVNAGKYGIKKAQEAVNKVYGKNVVSMDGAIGTQ
TLKYLNEVNPDKFLVVYHSLQREYYKYLAKRDATQNDFLTGWLNRIKVKENYLRNV
>SEQF2502_00434 Arginine decarboxylase
MGKNIDKDRQNKTVLFDALKNHLSNRVVRFDVPGHKGGRGNKEFRDFIGLDAMQMDVNSM
KPLDNLCHPTSVIKEAQDIAAEAFGAKEAYFMVSGTTGAVQAMIMATCKAGDKIIIPRNV
HRSAINAMVICGAIPVYINPGLNKKLGISLGMSINDVKKAIQENPDAKAILVNNPTYYGI
CSDLKSIVKLAHENDMFVLVDEAHGAHFSFDDNLPISGMAAGADMAAISMHKTGGSLTQS
SILLSGERINADYVRQIINLTQTTSSSYLLMTSLDVARKNLAINGKELFEKTVKFAEYAR
NEINKLGGYYAYGKELIDGDSVYDFDMTKLSVYTKDIGLAGIEVYDILRDDYEIQIEFGD
LGNILAIISAGDRGLEIERLISSLAEIKRLYSKDSTGMFDHEYINPDVVLPPQKAFYSEK
EMIPIKDSAGKISGEFVMAYPPGIPILAPGERITEEIISYIEYAKEKGCLLTGTEDMHVE
KINVVLE
>SEQF2502_00435 S-adenosylmethionine decarboxylase proenzyme
MNELENNKIKLYGFNNLTKTLSFNIYDICYAETEREQKDYIAYIDEQYNSERLTKILIRV
AEMIGAQVLNISKQDYEPQGASVNVLIAEERISPENIDKSCNRGKSFFEEIGMDENSIKK
GGASQDTDTVHAHLDKSHITVHTFPEYHPDNSISTFRVDIDIATCGEISPLNTLNYLIDS
FDSDIITIDYRIRGFTRDISGKKFFTDHNITSIQDYIEPEKLKIYDAIDVNVYQSNIFHT
KMLIKEIRLQNYLFNQDVYEIAPKKRLEITDRLRKEMIEIYSGMNIY
>SEQF2502_00436 hypothetical protein
MKLILEEDINYKTRINDFGVEPINKRIITTGEKLIYFNKGKFEKESGGKVKNCEIIKYIK
EKNQLFVSSIFFVSTPNGKVYKCDGNKKRIVELVFDMGDIIQVMNFITSGRIVYIKESAL
FSYDVDTKELISTKLSKCKKNGSYKIFTSGENVIIKFREDHEQINTISIFENRLKKIFEI
KTENNHAYSKIVGLQYFAGTEDGEVEIWNILDQELYNSIKISDRKVTYIEEFEGKYFIGL
ENGELIITDMKFNILKQEKILKERIIKICVIENEIYVMGCENKIVKYRMIL
>SEQF2502_00437 hypothetical protein
MKKSILILALLVSGISFSNTNVSATKNKSMCKWIKNPNIYVSKEIELINHSQLKGSIYCD
VENDYMTYYVGIGNIEIGLLYNLNEKKELTYKNIFNILSDFQSDILKLLPTNIPEKNEKN
KPRYYTYRLYVYDAKRGDTFMLFKYIFDTTKPDGDWKIYYNNEIFSRTSENMQRVLKNAG
YLPTEDIVY
>SEQF2502_00438 hypothetical protein
MIFLKSLGSIFPIIVMIAIGYVLKKRHWFHHTFSENVSKLITNVALPCSIFYSVLKYLNM
DALKEVSNRLIFTFASVIIGYVAAFVVIKIVKMRNGRRGVFYNAVVNANTIFIGLPLNMA
LFGEAASKYYLMYYITNTVSIWTLGYMLLANDPMEGGSGDGKGGFNLKKLLSPPLIAFVI
AFVVLLSGIKIMTPIVETTKYLGSIVTPLALLYIGIVLADAGLHSIRFDLDTNLALLGRF
VFSSIVMIVLLKIAEHYVHLNDLEIKTFVIQSAAPVFAALPILVNETDGDIGYSTNVVTT
STILFILVVPILMSILNVIHI
>SEQF2502_00439 hypothetical protein
MKSFRENIFRDNNLKKRVSEEVFKEFKTLQLGKIELSKEKLATGLEVLRVLYDNLVRNIG
IFQLIQIYYLNYKVN
>SEQF2502_00440 putative FMN/FAD exporter YeeO
MKDLTKGNELKTIIYFSLPILIGNLFQQIYNISDTIIVGNFLGKESLAAVGSSYQINVLI
IAVSIGISLGTSILISQYFGAKDMGNLKITANTGFIFSIVLSLIVTTLGFLLSNNILILI
NVPQKLLLEANIYLKIIFIGVVPTFGYNSLTNTLKGVGDSKTPTYILITSVILNIILDIF
FVAVLNSGVAGAAIATVISQFVSFFLCLLYIKFKYPNLIFKKYYFNLNFNILKEILIIGM
PAMLQQVLISLGFIVIQILVNGFGTDCIAAFISASRIDSFAELPSINLGQALMTFTAQNY
GAKKMDRIIKGGKDSLILGISFSIIISIIIFIFPSFFISIFNRNPEVIFIGNQYLRIISA
FYVIFCTMQILNGLLLGYGKSLVPLIASITSFCMFQVPLAILLSKTSLGYNGIWIAAPIG
WTGGLLIRVWYFIKISKKI
>SEQF2502_00441 HTH-type transcriptional activator HxlR
MEEKIYTCPLELTQKILSKKWTVIILWLLRHGKVRTKDFKNQIKGSNEKMIIEHLNYLIE
EKLIEKREYDVYPKKTEYVLTEKGKDLLPILELMQSYGEKYYV
>SEQF2502_00442 Sorbitol dehydrogenase
MATMKAARWHNRKDVRVEEVEIPEIRRENQIKIKVEYAGICGSDLHEYLGGPIFIPVNEP
HPYTGEKAPITMGHEFCGEIIEIGSKVTKFKVGDRVTVEPILAKNGLIGKYNLDPNLNFV
GLAGGGGGFSEFVVVNEDQAHKLPDEIDYEQGALTEPAAVAVYAVRQSKFNTGDTAAVFG
CGPIGLLIIDALRASGATEIYAVEVSSERQEIAKKLGAIIVDPTKVDSVKFIKEKTNGGV
NVSYEVTGVPAVLQQSLEAAEKDGELMVVSIWETEAPIQPNEVVIQERTIKGVIAYRDVF
PKTLELMKQGYFSKDLLVTKRIKLKDIVNEGFEALVKEKSQVKILVSPK
>SEQF2502_00443 hypothetical protein
MTLFTRPRRFGKTLNMSMLKYFFDVKDKEENKKLFENLKIYNSEYMSEQGKYPVIFISLK
DLKGNTWEECLNRLKLFIFDLYAEFEYIREKMNEWDKRKFEKVLYEKEDADYIMSLKFLA
DSLYKYYGEKVIILIDEYDAPIINAFDKGYYNEAINFFQTFYSPALKTNNSLKYGVLTGI
TRIIKEGIFSGLNNLKVDTILDKKYSEYFGLLEGEVIEMLDYFGMKYKIEEVKEWYNGYL
FGESEVYNPWSIVNYIDNGEIKAYWANVSGNTLLENMLDHAGESVYDDLKRFTDGESIEK
YISDGTTIKSLLSNDDEIWQLLLYSGYLTKAKNQEKESDSNIYNLKIPNKEIRKYFGNMF
LNRFFGTEVKTNILIKALENGDIKKFEKTLGEIMINMLSHFDLDKEMEKIYQVFMIGLVG
FLMGKYEIISNNESGYGRYDLAMIPIKSNEKAYLMEFKISKTKKGMEEKAQKALKQIDEK
KYDTKLKARGIKNILKIGVAFHGKEVKVVFK
>SEQF2502_00444 hypothetical protein
MGLKKIKDNYFENLKMNKYELFVKVVDYIGNFPNILDGFYINGSGQGYGDYDSVLINSGF
NEIDGETSILYRNFLWRLRGKGLLYI
>SEQF2502_00445 hypothetical protein
MFHYFLTYYLENIHCYSNLISFIEQEFVNYTKFIDEAKNYKINLDIKNIFTRDNLRNFLL
NYNFEENRYNLGTINFLKKEITYWDINIKKKFFSYLLGKKILKNFLSKRVFEFKEKRKDF
FGESVAYDMKFEISKNKEKIKIKYYNWDLIIALKNSTGISFLNGLLEKNINDFITKEEAE
ILISKKYKNEREKENVEIISKEDFLKELEIIVDAYKNIYNDNEVRKMFENFKENF
>SEQF2502_00446 hypothetical protein
MCKKKILLCILIIIFIVFFIKFKFFPFFIAIFIIYIISDSFYLKNLDFKIINLKEIFLLK
NLEKIIILIFYLFIGIYFLYYTSVVLSYYKEVSIFRNKIKNSKIYYSENGKKIVYSKDLK
NIFLKELNFSNIFKKTYPYDISFDEKYYFYNDKNEKIVFYNNNCESWDTIFKFRGYQDHV
NIKVRDHNICQKIIKEISDSK
>SEQF2502_00447 Glutamate--tRNA ligase
MSNSDNKKVRVRIAPSPTGDPHVGTAYIGLFNYVFAKHNGGDFLLRIEDTDRTRFSEDSE
QQIFDAMKWLGLNYDEGPDVGGDRGPYRQSERFEIYKEYAKKLVEKGEAYYCFCTPDRLQ
KLRERQVAMKQAPGYDGHCRNLSKEEVEAKLAAGEPYVIRLKMPYEGETIVNDGLRGEIR
FENSKIDDQVLLKSDGFPTYHLANIVDDHLMGITHVIRAEEWISSTPKHIQLYKAFGWDE
PKWYHMPLLRNADKTKISKRKNPVSLNYYREEGYLKEGLLNFLALMGWSFGENKEIFTIE
EMIENFSFDKISLGGPVFDLVKLGWVNNHHMRLKNLDELTKLAIPYFVKAGYYADENLSD
EDYKKLRRIVEITREGSHTLKELPMNSSIYFEDEFELPVIEEGMNSKARKSVKKLRDSLE
TETGKKAINLFIEKIDALNEEISEDEAKQVLHELQDEIGEGPGAVLMPLRAVVTGKARGA
DLYTVIAAIGKERTLKRVQNTLEKIK
>SEQF2502_00448 hypothetical protein
MKKFLLFMMMLFSTTVFAESVNAKVTNKINFGISPKELKNIIKSEPLSDSHDDGNYAVYY
YKNIEDPLGIKRQLNSFAFSENKLFSAVFDSVTTDEEHTKIIEDYKKNASKVLKEKLNVK
EYKGALILYNSKKIIEIYRMLDHTFISVYLYAPENLKDILKNYE
>SEQF2502_00449 hypothetical protein
MEDIIIEDEIIVRESSDVEKFDKNNDGVLKKLQLDVPFLKNNVKEYFEDDEKYMDLLYSM
ADRSGVERVLKMRFLLGKGVSIRDILWRSGKNKEELKEYIVKFRKYGIGENEKTTQDNVV
RELSMAAIFLGTFGVWSGERYVGNGTWRSPDNFNLKLDKSWELYFDMTCGDSSEYFFQID
IDDTLNFMNFLIDIIYEKNVKENKLKCYFGDIF
>SEQF2502_00450 hypothetical protein
MSDKEIIEAETVKENGNNPLKVIQLDMEYLKENAEEYLTDDEKFMDLLYSISDRSGVEKL
LKMRFLSGGAVPLRDILWRSGKTKEELANYKVKFRKYGDKPEEKKTEDNIVRELLMSDVL
EGSFRGWENERCTMDLSKYQWIGIGNSIKGSFGNCRWVSNDGHYNLKIKKTGEIYLKMRW
FFVSNGSGNGYYTFKIDADDTENFMNFLIDIIYEKNVKADNLKNYFEDIY
>SEQF2502_00451 hypothetical protein
MSDDIIVIEDVQEVETMNDESTKALKWCS
>SEQF2502_00452 hypothetical protein
MVQLNVDYLRENAEEYLTDDEKFMELLYSISDRSGIEKLLKMRFISGGAVPLRDILKETW
KTKEELANYKFKFRKYGDKPNEKETEDNIVRELPMSYVYEGSFLGWENERCSYDYNDYQY
TNYHGNNSDAKWYSIDGHYNLKIEKTGEIYLKMRWYYQYSDNNNDKGNGYYTFKIDLNDT
LNFMNFLIDLIYEKNAKSAEVKNYFGDIY
>SEQF2502_00453 hypothetical protein
MKKETLLESLKEIDSKLVNEVKKQDLFTDIYEVTDFDLLGENFGDIALYKINEITYEEEE
KAPRREAFENVLGALRDSFNNFLYIILGTKEKVSIYFGVAKNSYIDSSNSILELQDVGDM
ILKPSIEGNFRGSKIKEIISDEKEEVLKVIRNQGNKYAYFEGNPGINESEDRSDFQGIDR
LIDIMSVGNQGTFGLVIYANPIQKEEIVEIEKDIYKQYNYYNTVHKRSYQLGENQSNNTG
ESATVGSGTSESTAKGKSSNETSGSSETKTEGSSASDTKGSNESETKGTNYNKATGNTWG
NSEGSNKTENTGKSTTTGTSNGSSTSSKSSSTGESAGTSWGTNKNKSEGGSKTITEGSNL
SQAKGTSTSRTSGTSLSKATGTSTSKTSGTSENKTIGTTKNNSTTKNSGSSTGTSETENI
EIIKKEIHSWISYIDETLLPIIDYGKGKGLFRVNTYIFADNSATLLKLGNTLKSLSSGKK
GNKRPLEYYRLDNVKDKKIINNLVNFQMNKIQNDIEKDEFYTVNSIEIGNGFVNDFYSSK
ELSLIAGLPRKEVNGLKVTKQVEFGLNTTDEKMKEPLELGNLVQSGKILENSEVNIDKKD
LNKHIFVAGVTGTGKTTTCQRILLESGMPFLVVEPAKTEYRIMKLSKKTEDMVIFTLGQD
NIAPFRLNPFEFFPHESLTSRVDMIKAAIEASFDMEAAIPQLIESTIYECYKDYGWNVNT
NKNTKFENPFADDVYAFPTFNDILKKVDAVAEKQGFDERLKKDYIGSIKARLQSLTLGSK
GLMLNTPRSIDFVGLLDKKVVLEIEEVKNTGEKSFVMGLIMTNLREALRAKYKENKHFKH
ITLIEEAHRLLSKFEPGDSVNKKQGVEIFADMLAEVRKYGESLIIADQIPNKLTPEVLKN
TNTKIIHKLFAEDDKESVGNTMILEKEQKEFLSSLPTGRAVVFSQGWSKAVQVQIKLLTN
TTSDEEVDEQILKNSCINYYRENYRREIFSESNIFDREPTFEEMKTIIEFSRSDLLSSFK
NMYAALENFSIRDIRDRSNIFKKANREYVKNIRIATENEKNLLVKYLKEKYFIKKKHKLE
EVNRVEELEKNIIEFLSEEITDEKIDVENPLKIKKIWMEKLGKGDE
>SEQF2502_00454 hypothetical protein
MVFGLIAAAIGGVVGAISTIGSSILGLSVSPFLGIVSFAMGIAKLLSPKNQIEPRDYERF
SYTADIKDKKPENYENVSSYINDVKNSMKELTPVEEQKLENLSEEEKKRYKSNTVATIFQ
AFGEEIGLEEPISFGAIKGAAEIKMNPTEFKKMIEDYKNNKIPTMDVDAYLDNELDADDD
VAMYDYLKEKLDKMG
>SEQF2502_00455 hypothetical protein
MGFWSFLSGVGHAITGAIRAVGTAIAGVGRALFSGIANLAEGIVKLLSPKSQIEPRDYER
FSYTAEVRDIKPENYESVASYINAVKGSMKELTPEEEHKLENLNETEKKKHKSNTISTIF
QAFGEDLGLEEPISFGAIKGAAEIKMNPTEFKKMVEDYKNSKIPTMDIDAYLDNKLDADD
DVAMYDYLKEKLDKMDEELEKLNEKI
>SEQF2502_00456 hypothetical protein
MTVKISIAIYVSEQGILTEYNGNVKKYQGEKFCNREVKEFLSWLKKNFRSKNVFDLLIFG
TDFEKVKEIYNGFNDFEVLEDSDFTLETLEKILLENVNLKENVVLKISNNENEKIFITKK
GKQFIRTKEEENFGNEILVITNNKKFFKVSSKKSRIVSKKKENLNTVAKDEVNLSSIFAK
KLKGN
>SEQF2502_00457 Chromosome partition protein Smc
MNDGQTGKILNDSIEKIKGILSIIAKISTRVDGLEKRISEIEKLNNIYSPKETISDEDKK
EVKEQNDLEFGNENQGIELKKENKKLEEENLDLKERLENFKNEKIKEIEEKDQRISELTE
KNIELEEKNKKLEEEKNEKIDEIKKISKDLNQEKDNFDNLKIEFSNFKKGAEAEFLKLNG
EIKSRDVKINDLNFKINNLLREKTNLEKNVDDLRREILSKNQAITRLENQVSSLTKDVRN
RDYKISDLENDNNELKNDKNNLISRLADFKDLEELEALYSEYLKIPENDREKYDAILKPH
LGKDMFLYLVTTKFSNYKDFLKNDFIENADFYAVLVKIYDYVINVMNKEYDEEVYEFVNP
EIGERYNPISQIPSSNSVSNGDVARVIVKGYQRRRDKKLLYQSIVLLK
>SEQF2502_00458 hypothetical protein
MSKKFGDERNRIQDEIERMVENIAERENCFMNDIKIKEYYKKSEYKRANLNELLESELTD
INGGHWDVFENSKGSESVPFVQEENVKVYGRNPENDVEKSAIVAIDFGTKSTVAIYRDNT
ETVYPLEIGSNSANESYKEKNFENPTMIEFGDFEEFLRLYNAKEGRPYTEWNDLQVSHHA
QNDFVNSNKPEVLNSILSDVKQWASGNRKINIKDRKNEYSIKKFLEGSEDDITPVELYAY
YIGLNLNNMCNKKIFLRYVLSYPVTYEKAIREKIRLCFEKGIKKSLPITILNNEKIMKKF
SVKNFNSEPFCYAATALEQYNFFNKVKDEEVFYGIFDFGGGTTDFDFGIFRKLEDDDRYS
YEMESISSGGYKYLGGENILSALAYETFMSEENIENLRKGNFQISLPLNKKVPLKNYDMI
NETKEAKSNLIKIAEGLRFIWENSDMPDNYNDDLGELSINLLDKFSNQTTVNLIVDIDRL
KNRIREMIKKGVNEFFANLISTVESKTVNEINIFLAGNSSKSEYIKEIFEAKKVEMVDGN
EKFSEKVKIFPPLGTEEAEEKQREMGYVIDRNKFIPNGKTGVAYGSILLRKNGEIKTESS
VEEVPFNYIVGRKRNGEFKNILDKKIGYDEWKKYIVANEIENEIYFTDNYSNLLKDVELE
NIKTIMIDLDDEYDDDEYIYIRSISPNKIEYCVSNSEKIKKDEYIEEPKEIDLSNE
>SEQF2502_00459 hypothetical protein
MLKVNNKVVYLHKDTIKKEELYNYISRLYIDNKEKIIELFKNIEKRLYLEYFNTKIETET
KIIDIKRKLIIYKLKDPIFVKNKNEIIERKEEYEEKLSKYGILDFNSSIPNEYLFKQIKN
ENYYIQRKIFENGKIRISNNNFQKILMNRNNNYEIYNIEFEMFTEEEGNSIIFPIKEISL
NTNATIEILNLLIERKNGKFYIFDQELDISKNLANMMFFNVIGMAQKGTDEYIVIVKNVK
GLRKLIEKGEIIFEKGFLEDKILEEENDKSKVEYLKPNLKDMNLGLWSIYDKRKFSKSED
FRKVYSDESIYGENPLNDVDKNAQVLIEFDNEMVRVLIKDSDGRIYPKSIFSKRNEDSTE
NLSIMKFCNIKKFLEDYEKFESRPNTSKNDILFSYDAFKEYENTENKENFYWIDFQNPFK
NTIYLEELDKEINLIEIFAYTLGLYLNNEIDKKIFLRYSLSFSNVRTKEELDFIKYNFEK
GIRKSIPTSVLKDKVMSKYKVEYRVENTTSLLAGILSEQSSKKIEISDIPTSYIVLKLDK
NEYTYSMGYYKKILDNERYDLEINKKVANGFLNKEFDGKEFWEIQELIWKKLEILFLDIE
NNKNIFSKKVKIIFDVMPEFKDFVIGKVSKKMEEYEFEIDIIEIFEGDKIVLENGIELNK
NFFKVYGLLLCQRSGWIKMYKEKIVDEEEFLYKVGIKRNEEFQVLLDNNSEEEWIKTLSA
DEKEICLNFMNKKGEIYNLILEIERSYADADIFIKSRGKDTIDYTVINKRGQQLEEIRTE
ILD
>SEQF2502_00460 hypothetical protein
MVAVIIVILIAVIIFLLWIIKNLSESLKSKRNQVSKKSGIVNETKMKAENDGLKIEIRNL
RSQLGSLQSSSSNEETLKNEIRKLNVKIKKFESNRNDGEKEKLEQQIKILNFEKENLKNE
ADKKEKNLTLKIDELKKELNQEKQKAKKVVKNSSSNGSFNNNFEKIFNDFKKISENEKKR
IEVIITEKKGKEVFLGLGLQASNLKLLWEQIEFNIQKNENSKDTEILIETYYYFFELYNS
LFSAPVYTFLDNKIGDRYNPITSIPVNTGYTKNEVKKVVFKGYKNRKGDIVKQSLVILD
>SEQF2502_00461 hypothetical protein
MSVISIRFNDEEEKVIKKFIESKGFSVSQYIKDLIFEKIEDEYDLEICKEYLKAKEEGKL
VTIPFEEAAKEWDLE
>SEQF2502_00462 hypothetical protein
MGFRVEILEELNKKIKKLDKSTKRTLYSYIKKNLVDVENPRIKGKALTGNLKGLWRYRIM
DYRLIVDIQDEILVIVAIDFGHRSKIYK
>SEQF2502_00463 hypothetical protein
MDIREVRKIKVGLGENTTDKFIEDINVYVEIDKYRFNGQTYENEIEDINKGSWDVFDDLD
EEGNLCFTEEEESEIIEIEDEIYARNPKYDIVESGVVGIDFGTKSTVVVSYRDDNAGINN
SKTLPIRISGNMNDIERTENYENATIIHFSDLERFIKWYNLFKGRPYTFYEDIQVSLEAE
NELKRNTEDFDINEFMLDLKQWASSKNKKKKIRDEEGFLHTINGYLDLKEGEFDPIEIYA
YYIGCRINNMAQYSIFLEYYLSFPVTYELEVKNRILNSFRKGIMKSLPNSILNDEEVMKR
FRVVFGASEPASYAITALKKFCVEPDLENEIGYSVFDFGGGTTDFSYGIYREKENSRKYD
YEIQELESGGDKYLGGENLLSLIAFDVFLQNREKLVNGKYFISLPANKKSEIGFETFVSE
ASQAEYNMKKMMEAMRDYWEGKLEESLKDSGKVTVYLSNKENQYKNEELDVDYDRLDEIL
KKNIYGGIISFLEKFDIVFKNKKLKEIYIFLAGNSSKSKFVEEIFENELTEEFKQKYNII
LKNAYSIEEETEGKVIGLNSKTGVAFGLVELREGNGEVEYIPFRNIAKNEEINFKYCLGY
SKKRRFIPVINFNTKYNEWIKYDDVEDEKIIEVLYSGNTRAEGKEFPASECSRIRILVQD
DDKGSLFIRLKNPSTIEYVICEDVEKIDKGKIVEREL
>SEQF2502_00464 hypothetical protein
MNQELKISVDIPESYQNKIREAYCDYKKTYNDILSQIGDVGELEVLSSKKLYENFTDREL
TVYFSDNEKYYNDDIAYYEEDIYNKDILWLQKRLFFFHYYDGNIEIEFNDEKQEKIKDIL
KKLREVSSKHDDKFINLVKKIPNTLENIVIKSEGKIWGVGRKDYVCLSSGAYVKNKNRNN
VVYLIENMFLRYYTGNFIKMKIFNSKVEKKLDDLKKAEKKYFKIKEKILREAELKEVSVR
KQILEFSNVRSIFDKEIKKFERVNEKVFEETYKEISKKIKLSVEKEIKKILEDTVELDEK
EKVKYEKMIKLKYEKFEEKEIENLKNKPKEIIQNLNSEIDDYIRNGKIYIERLEELTIGK
IKGLKEKIILELNKFLKNLPNEFKKVRKKIRIEKLVSIFVDKDFDRFRSKKYDTEIYDRN
KGSWDVFEATNENNDVVIDGEKINEEILDRKIYGRNPKNDIVKSGVIGIDFGTKSTVVVS
YKDDNEGINGSKTLPIRISGNLDAIERTENYENATIIHFDNIKKFITEYLSSEGRPYTHY
DDIQVSVDAENELKRTQNNFDINEFMLDLKQWSANKNKKKTIADKTGKEIILNGYLELNE
NEFDPIEIYAYYIGCRINNMAQYSIFLEYILSFPVTYELEVKNKILNSFRKGIMKSLPNS
ILNDEEIMKNFRVKFGASEPASYAITALKKFCVEPDLENEIGYSVFDFGGGTTDFSYGIY
REKENSRKYDYEIQELESGGDKYLGGENLLSLIAFDVFLQNREKMFEKGYEISLPINQKS
KIGFETFVSESNQAEYNMKKIMESMRDYWEGKLEETEKEKLKKTIYLSNKSGQYQNEELD
IDYNRLDEILKKNIYNGVISFLEKFKVVFDSKKLKEIYIFLAGNSSKSKFVEEIFENELT
EEFKQKYNIILKDAYSIKNEIEGEVIGLNSKTGVAFGLVELREGNGEVEYIPFRNITKNE
EINFKYCIGYSKKRRFVPIIDFNTKYNEWIKYDDIENENSIEVLYSGDTRAEGKEFPASE
CLRIRILVQDDESGSLFIRLKNPNTIEYVICEDIKDIDKTKISEEILK
>SEQF2502_00465 DNA ligase
MNLFNQEKNNENENIDNEKNTLFSDVQEKYTKLRNEIEYHNNLYYNEDKPLISDMEYDAL
MRELKQLEQEYPELLKNEENGESSPTEKIGGTASEKFSKVRHRVPMLSLSNTYNISEIED
FDKRIKKIILSENVKENSKELEYILELKLDGLSISLIYENGVLVQAITRGDGQIGEDVTE
NIMEIKTIPKKLKKNVSLEVRGEIILPISSFNRINQEREDDGEDVFANPRNAASGTIRQL
DKTIVAERGLDCYLYYLVNAENYGINTHLESIEYIEKLGFKTTKIFEKYTDFKELEKSID
KWHNDRKKLDYETDGLVIKVNNFALYETLGYTTKSPRWAIAYKFPAEQVKTKLMDVTFQV
GRTGVITPVAELEAVNLSGSVVKRASLHNFDEIRRKDIKIGDNVIVEKAAEIIPQVVNVA
FDDRTGEEIEIQEPTTCPVCNSELAHEEGLVALKCHNPLCPEKVKRQIAYFVSRDAMNIS
GLGDKIVEKFIELGKIKTIVDIYSLEKYREELENLEKMGKKSVDNLINSIESSKNRDFSK
VLYALGIPFVGKFNANLLTKTFKNIENLKNQSIENLLAVKGIGDKVAFAVNTFLNDENNW
KIITNLKNIGLQFAVDENNSEEIADNPIKDKNFLATGKLQKYKRNDIKDIILSKGGNYLS
AVSKNLDFLIAGEKAGSKLEKAEKLGVRVLTEDEFEKEFLEI
>SEQF2502_00466 hypothetical protein
MKIKNVTSLGKRLRKIRIDNDEITLNMAEKLGISISYLSAIEHGKRNIPNDFIQKLFDKY
QLSEEMKTLIQKDVVDYSGEMKLIMSQMNEQQQELSLLYARKINKLNDKQIKKMRRFLNG
EE
>SEQF2502_00467 hypothetical protein
MERNSATESKIKVKPLSRARIRKIAKDLKRDFCLTNGRIDIIKFIEGVSSILGMDYEYVE
DSQLPNKYAETDPLRKIIIIKESVCIRAANGSVRDRFTLAHELGHIVLHSLNNPEVKFCR
FDEVIKPYEDIEWQANTFAAEFLVDVEEAKNLTLEEIVEKYGVSQTVAAIQKKNC
>SEQF2502_00468 hypothetical protein
MTTRENITSLAGWMLDKDYKPTNQLVKSVAGSSLKCFGDKGYPSLETLEKATMIKTAGSK
VYKKDEVKLAKALLSYDRKKPN
>SEQF2502_00469 putative dual-specificity RNA methyltransferase RlmN
MTNINTVEKIDILGMDLESLQEKFVEIGLKKFNASQVFDWLHNKLVFDFDEFSNISKKDR
EILKEKFYVAKLEFKTHQVSEDGDTEKFLFELKDKRLIESVLISHKNRHTLCVSSQIGCL
IGCDFCATATMTYERNLSTSEILLQYYYVQKHLMKRGEKLGNVVYMGMGEPFLNYDAVLG
SINMLNSPKGQNFSKRNFTISTSGIVNGIKRFTENENQINLAISLHSVRDNVRSEIMPIN
KRWGVNQLKEALSDYQKKTKNRITFEYILIDDLNCEPEDARELAGFLNSFSCLVNLIPYN
PVGGKPYKTPSKQKQKEFYKLLKDKNVNVTLRETKGQDIAAACGQLKAKKQMDFSQGI
>SEQF2502_00470 Penicillin-binding protein 1F
MKMNNKKVKVEKPRKKFSLLSFFFKVFLFLFVIGIGAGAYLVYTVSKETPVDLIDGYAPV
SPSVIYDINGNQIDTIMVQNRAPIGIGEIPQHVQNAFLAIEDRKFRTHHGFDFVRTARAA
FLTFTGRRREGGSTITQQLAKNAFLSPEQTMTRKIKEAILAVEIERKYTKDEILENYLNT
IYFGQGAYGIKNAAIKYFNKQPKQLTIAQAAILASLPKSPTKYSKIENALERQRIVLNQM
KNYGFITDEEYNEAINEKIRFVNGNIKSRNEEEQISTSNVAPEFTTVVLSEVRKILKIPE
EDQKFLFDGYKIYATVDLDLQRAAYTAFNNNYNLKSRANLNGALLSIDPSNGFVKAMVGG
KNYKKGNFNRAMSSLRQPGSSFKPVVYLAALQKKMAMNSVMEDSPVKIGNWSPKNYDGVY
RDSMTLAKALEISNNVIPVKLLQYVGIDSAEKVWRNAGIVGGDFPKNYTLALGSISIRPI
DMAMFYAALANGGYQVQPQYIYKIENKYGEVIYEAKPKMKKVYDSKDVAILTYMLENAVN
YGTGQSAKVFKDGKLIPMAGKTGTTSDYVSAWFTGYTPTLATVVYVGNDDNKSMGPGMTG
GAAAAPIWKNYMQAVVDLPNYNVGVFEFIDDYITRKDLTTRDIDLQIGLLDRDGVNKRTA
LFKAGTEPIEYEGKFRKGVTF
>SEQF2502_00471 Adenine permease AdeP
MSTSNVQETSVLKRLFPLLANENVNMKKEIMAGITTFLTMAYIIAVNPNILSKTGMDAGA
LVTATCFSAALGCFLMGLIANLPFALASGMGLNAFFAFTVVLKGGISWQTALTAVFCEGI
IFIVLTLFKVREAVVNSIPENMKHAVTGGIGVFIAFVGFSGSGLVVLNESTKVSMGHFSP
AVIISFIGLILISILDKKNVRGSILYGIVLSSLLAWGYALLNPVHAKELGIYLPSGIFKY
ESMMPVMGKLDFSLFTDFKMFGNLFVIICTFLFVDFFDTVGTLIGVCSKANMLDENGNVP
NVGRALMADAIATTAGAALGVSTVTTYVESSTGVIAGGRTGWTAITTGVLFLISMFFSPI
FISIPGCATAPALIYVGYLMLSSVKNIDLHDVLEGVPSFITITTMALTYSIGDGLTLGIL
SYVLINLFYNLFSKKEDRRPISWVMITLGALFVVKLLFMS
>SEQF2502_00472 Magnesium and cobalt efflux protein CorC
MSEGSLLLQIVIIIILTGINAFFSSAEMAIVSLNKNKLKILIEEGNKKAILLDNLLKEPS
KFLSTIQVGITLASFFASASAATGLSQFLSEALKPLNIPYSSQISMILITFILSYVTLVF
GELIPKRIALRNSENIALSSVGVIVFISTIFSPFVKFLTFSTNLVLTILRMKEDNIEEKV
SKEELRSLVEVGKEHGVINESEQEMIENIIEFDEKIAREIMIPRTKVFLIDKNISIHELF
ENKEIGKYSRIPVYENEADNIIGILLTKDLMMEAYKKGFDDIKISDLVQEAYFVPETKNV
NELFNEMQLEKKHITILIDEYGGFSGIVTLEDLIEEVMGNIDDEFDDEDLSIHQISKNKY
LVNGDVSLYDLNDNFHFELESKYYDTLSGILIENLGYIPEDNENIEPITINGVVFKPQRV
RNKKIEKVVMTFDKEKLEEEKMKNKENEED
>SEQF2502_00473 putative oxidoreductase YhhX
MYGTRGCFIKETEDRQEEHLKLFYMPYHPDFGIDSPKHYGTLIYYDNKENYHEEKVISER
GDYGRVYDDLYEAIKNGKEKTIKDEEILYQIKILEEGSKNLK
>SEQF2502_00474 putative oxidoreductase YhhX
MLTVGFIGNGKSANRYHLPFVLQRKDKIKVKTIVTRNLENKTWKRIDGINYTDKIEELYN
DPEIDLVVICLKPDLHYRYAREVLEHNKNCLVEKPFTETLEEAQELFELAKKKRLIVQPY
HNRRFDSDFLTTMKVIESGKLGEILEIESNYDYYRAEVPENVKEYDGKAANTFLYGHGTH
VLDQVISRYGKPDKVHYDVRQLLRTNRMNDYYDIDLFYKRENGKSLKITVKGSYFRLHLL
CMEQEGVL
>SEQF2502_00475 PTS system cellobiose-specific EIIA component
MAEEVLDIEMIAMTLIGHAGETKSLAYQAMKAAKEGKFDEAEEFMKQSTEEMLKAHELQT
DLIVREAGGEKLDVGLIMVHSQDHLMTAILFKELAKEFIEVYKRLEQKIDKK
>SEQF2502_00476 hypothetical protein
MDIYAPINKHFLENKKIKISFSKVLNKKEKYFLKFLFMEYKLLEKFEKATILQDVDLNEI
LDVLKFSTFEQLKKFLDNLQVKKLEFSIFSNDKIVLYGRFPILVSYNIVYSKIEFQFARE
IQNARGNNTLFSLLRFDFLVFMGDETTYNFYTYLISDKNYNNDTVITLERLKEMFDTGDK
YERFFDFEKQILKKAIESINLFSDIKVVYEKIKVGEHINNKVEKIRFKIIDNSKSSEKKN
KELVQHINSIMDLIKNDVKDFHATYELIKKYILKKNYDYVYTNVIFTKKQFKNNIEKQLK
KVLLLDLGQSLKNNLKHESEVLNIKRKYRTPFFLQLDISNLMRQNHLENELRVLVDDGYF
NEILTLKNEQTMEQSFTDFKIYIKYFQNAKSQIKIIKFL
>SEQF2502_00477 PTS system oligo-beta-mannoside-specific EIIB component
MKKILLCCAAGMSTSLLVNKMKAEAEKRGVEAEIWAEPLDKAKEEFPKADVVLLGPQVKY
ALPEAQKIAEENNINIDVINMVDYGMMNGAKVLDQALNLIK
>SEQF2502_00478 Lichenan permease IIC component
MANIMNKFTQFLEEKLMPVAVKVANQRHLAAIKDGMVITLPFIIAGSVFLILGNLPIPAL
ANFYKYNAVGQIIAKWLSYPVDVTFNLLGFIACIGISYKLAQHYKLDEISSTILGVLAFL
LVTPFHNGIPLPSMGSGGLFVAIIMSLLAIEIVNFIVKKNIVIKMPDSVPPAVSKSFAAL
IPGFFVIMTALIIRILFEVSPFGNIHKVVEMVLTKPLTALGGSFFGMMGLSFITNLLWSA
GIHGSNLVTGGIAKPVLDTLMDQNRIALSAGKPLPNIVTTQFFDIFHNMGGSGTTFSLAI
MLLFLSKSKQLKEIGKLAIGPAFFNINEPILFGLPIVMNPILIIPFILAPLVTVMVTYLA
MYSGLVAKVTGVALPWTTPPFISGFLATSHWTGAAIQVVNFFITAAIYYPFFKLWDDKKL
QEENGTASIN
>SEQF2502_00479 Anthranilate synthase component 1
MLINKPTYYYSVIRQKFNNSYFAEDERQVIIGIDCEYFDSNEYSYDSLKKIYNSFVKQKK
VAPFAGLFGTFAYESIHFFEKIEKIEKEQFKFPQFIFANAKAYLHYSKTSKEYSFYGDER
KYFDFLNDEIEKRTENSELLYDIKTDFDEERSHFYGILEKAKEYIKAGDIFQVVLSEQLK
LATNMDSLDFYEKLSKANPSPYMYHFPTKYGDIVGSSPEILVDISSDNIYIAPIAGTRPR
GKDANEDAFLANDLLNDEKECAEHRMLVDLARNDIGKFAESGSVVVKNLMHIKNYEHVMH
IVTDVYGKKRKDVSIFEVIAQALPAGTLSGSPKIRAMQIISELEVFKRNVYAGGIGFLRF
NGDVQLAIIIRTAFFENKNYDLNKVDKVRNVFIQAGAGIVFDSVKEKEYDEICHKRASVL
NIFKKFCKEEREVEKVKNEENKNEKGEDVK
>SEQF2502_00480 Bifunctional protein TrpGD
MILMIDNYDSFVFNVEQYLKEMTDDEVITVRNDAITVDDIKKMNPDKIIFSPGPKHPKDS
GICLEILNNIDELGNIPILGICLGHQAIGMNFGGEIKRLENPLHGKTSEITVLSENSVLF
KNLPKKFKVMRYHSLYVENIPEELEVTARSEDGIVMAVEHKSKNIFGIQFHPESFFTEYG
KNIIRNFLNIEVSENLQKNKNFENSKKKGNFENMDKYLKKLQENIALTDTDFREICKIID
DKSYDIVQLGALLVLISEKSLYPESLTAFVNNILEYSTTFEDETPMIDVCGTGGDGFKTI
NISTAVAFILGAMGVTVAKHGNRAISSKSGSSDVLDKLGVPLEKSLATQIEKLHKKNLAF
FHAPFFHKLVGEVREVRSRLGIRTVFNILGPLLHPNTKLKYQLVGLYHEPVHRLYAETLQ
LLGREHALVVCGNDGLDEITICDDTKIIEVKGDQILEYTISPESFGFKRAFHSEIEGGTP
EENAEILIRILKGEEKSAKFDIVVLNAMFGLYTANVVDHPAKAKDMVLEAIESGKVYEFY
ENYVK
>SEQF2502_00481 hypothetical protein
MIKTLYKEKCLRYFIVPDIISIIIFWFDAPVDPLWILPYLLNNTIKNRFWNLPISWILFK
IIIIYFSFKKLEKINRIKDKEKRKKYKIKLKIIIFFTHVIVLGIFIKFIDKIIFY
>SEQF2502_00482 Indole-3-glycerol phosphate synthase
MDILEKIKIKRDIQLEAEIKSFKQPSLKEALKQDGVRIIGEIKRASPSKGKIAKDDFDLL
KQAQSYVDKGVAAFSILTEKEYFKGENDFIKIIREKFPEMPILRKDFIYTPFQVAHAKFL
GASAILLIVRMLDDKTLLELHKLAQDLEMDVLVETHDEEEIKRALKIPNLEILGINNRNL
NTFEVDIRTTEKLINKIPRDVLKNLTIVSESGFLSKEDVEYAEKLNVDGLLIGEALMKGL
L
>SEQF2502_00483 N-(5'-phosphoribosyl)anthranilate isomerase
MEKKENNVATDDFTENATKLKVCGIRSITEINELKTLDIDYFGCIFAKSARQVDTELAAK
IARTAHRHGKKTVGVFVNAMIENIVKIVEETGIDVVQLHGDESVEYCVELTKKLEKLYEK
SCFRKRKNFPSKTEIWKVFGVTDELPDIADYKQYIEYPLFDAKGENRGGNGIVFDWDILK
DLEKYSFVLAGGLSAENICEALECKPAILDVNSKVEVNNKKNKKLVEEVVNLVKKGK
>SEQF2502_00484 Tryptophan synthase beta chain
MGNKHFNEKAYFGQFGGQFVPETAMFALAELEAEYEKLKNDKEFFEEFDDLLKNYVGRET
PLYYAKNLSEYYNHDIYLKREDLNHTGAHKINNALGQVLLAKKMGKKKVIAETGAGQHGV
ATATAAALLGLECDVYMGAVDIERQKLNVFRMELLGARVISIEDGLKTLKEATTAAIQSW
VAEIETVFYVIGSVVGPHPYPTIVRDFQSIIGYETKAQLEALGKHADHVIACVGGGSNAI
GIFSAFINDNSTKLYGVEAGGYGIDTDMHAATLTLGKPGIIHGMKTYVLQNKYGQISPVH
SISAGLDYPGVGPEHSHLFDTKRATYVPVTDDEAMKALMLVTRKEGIIPAIESSHALAYL
EKLCPALSKDKRETIVVNVSGRGDKDMHTVFSVLKDKESGGENGIYELNGGFENE
>SEQF2502_00485 Tryptophan synthase alpha chain
MSKKIIDVFKEKEKVNIGYIVAGFPSVDFTKQFLQNLDNTVLDMLEVGIPYSDPLADGKL
ISHASFLASEAGVTTDTVFDLLTEIKDDISKPLIFLIYYNLIFAYGIDEFIKKCKKANIK
GLIIPDLPYEEAFEMSEKLRENEIALIPLVSVTSGNRIKKIVSQGDGFIYAIGSLGVTGS
KQVDLPRLESFIKEIRKVSDLPVSLGFGIKNNDNVNTMRKYADGVIVGTSIVDFTFKNDV
DYTIQKINELFK
>SEQF2502_00486 hypothetical protein
MEFYNFNYLENQKFVTDKFFLVVIILVIAFILFAFWKWFKGSISLRDKQLSLLGLMFIFL
FALYHYDNYRARNNEEKVYKNSASVIKKLSEKFKVSENDIFINTPEITEDTVYKIKDKYY
QIHWVGTNILVEQMTVPYVDEVKMLKE
>SEQF2502_00487 hypothetical protein
MDFIILVAIKLTIGFIALVLFMNLNGRSQLAPTSTEDQIGNYVLGGIIGGVIYSPTISII
QFLIVLLIWGLLMTVTDFLKNTNKRVKKMIDGQVVYLIRDGKMLTENFAQATLSIPDFYT
KLRTKGVTQISDIEEAFMESNGQLIVIKKGEGGYSNLLVSEGNIQEDNLKHIGKDDDWLK
EELEKYNITDLSELFIVEYSGDGKLFIVKK
>SEQF2502_00488 hypothetical protein
MKKIFNLILFFLTVISCQNNLKNVFTRTISNLDPNLSYQNELIMYENNIFSGKIELQSPL
QGYIEVKNGTLNGKVSIIDGTQKLEAIMEENNIQSIEHFDYQDQGNNHHTYKSNYRNGIL
TNLTNITKNTELNLIINSNGNINGTIKLNGNSFSIVNNEYSASNFGGFFPKKGGTFVYYP
NENIIQETYFYNTSAYTTSTFSAFAGKTNIPVFNKNYIKEFILTKIGLIKSTTTNNTNST
NIKTNENNDTESNYNYSDETSSSEKTTENTNSENELDLEDLNNLKYEVMDNENESAFNKY
NKKELRILRNMIYAEKGYIFKDEELSSFFNNKSWYTPEISNQDDIQLDDYDKQFILKLKK
YEYN
>SEQF2502_00489 hypothetical protein
MQEREVFKFEKSGMKSKGAWTFAVFGVIALFGGGFYSLIGILMLAYSIYLFNKKSKVIVY
TTGFIISEGKNLQNINFERILAIKGDIGQKVKILYLNKPFFEYSNNEMNKIYSDYKEINF
DDELLEKDFINVFNIIKEQFRNYVFEKYNNDLEQVINSPYLFEQIKNNNLNFMKAKLFGG
VTDTIIPLQYGDVVNVTTRKKAYVTNGQADIRQARQSFEPQWQFASTSTKCDTVNLINAV
LVQEILNKKYNIKFI
>SEQF2502_00490 Chaperone protein ClpB 1
MEQNFTQKSIEAISEANNFAIRYKHSDIKVEHLLLALVGQMDGLIPNVLKKMGIDTTDMI
KKIEGKLESFPKIEGGNSEPRPNGEMNRVLVGAGDFAKKMGDSYISTEHLFLASYDNNNF
LKEYGINKKQFETVLESVRGGRKIMTDNPESTYEALDKFGKDLVELARKGKLDPIIGRDN
EIRRAIQILSRRNKNNPILIGEPGVGKTAIAEGIAQRILKGDVPENLKDKTIFSLDMGAL
VAGAKYRGEFEERLKAVLEEIEKSEGRIILFIDEVHNIVGAGKTEGSMDAGNLLKPMLAR
GEIKVIGATTIDEYRKYIEKDAALERRFQPVMVDEPTVEDTISILRGLKEKFEIFHGIRI
TDNAIVTAATMSDRYINDRFLPDKAIDLIDEAAAKVKTEINSMPTELDEVTRRVMQLEIE
KVALEKEKDQASKDRLVTLEKELAELNEKKAAFKAQWESEKQEVEKIQNINTEIEKVKLQ
IADAQRKNDYNKLAELQYGKLPALEKQRADEEEKAKNQNPGANKLLKQEIDSEEIAEIVG
KWTGIPVSKLLQGEREKILHLAEQMMKRVIGQDEAITTISDTIIRSRAGLKDPNRPIGSF
IFLGPTGVGKTYLTKTLAFNLFDDESNIVRIDMSEYMDKFSTTRLIGAPPGYVGYEEGGQ
LTEAVRRKPYSVILFDEIEKAHPDVFNILLQLLDDGRLTDGKGKVVDFKNTIIIMTSNIG
SEIILEDPQVSEPTKEAVLNEMKHRFKPEFLNRIDDIIVFKALGKESVKSIISLILEEIN
DKLKEQYIKIEFTDKALDYIVNEAYDPAYGARPLKRFVQKDIETNLSKMILSNEVPENST
VVLDSDGEKLIYNVKK
>SEQF2502_00491 Sucrose-6-phosphate hydrolase
MDFKDVEKKEEESVLEKKEIVEKDFWRQKYHIQGIVGLINDPNGFSQFKGKYHMFYQWNP
LGTIHKNKTWAHSVSDDLLHWERLETALRPDTWYSKDGVYSGSAIVDDGKLYLFYTGNVK
DCDGNRESYQCLAVSSDGENFERWEPSIVNQPDGYTRHIRDPKIWKKDGKFYAVIGIQSE
DLEGKAVLYSSENIKDWKFEGEIAGANHGKLKDFGFMWECPDYFQLKDEKTGEIKDLLVF
SPQGLEPEGDLYNNKYQTGYLFGKLDYEKPEFEISSDFVEIDRGHDFYAPQSMEDDKGRR
IIVGWMGVPEEEDFPTVKNEWIHCLTLPRELKVINGRLYQLPIKEMESIRGEKIEFNEKV
AGEVKVGTGTTYELKAKFSNFNSDFGLKLRTSKNSETVLKFDYNDKKFVLDRTKGEQPDK
RLRKVYLGDISELELTVFVDNSSVEVFINGGQEVFSSRIFPEKGADGISVFADGDASVKI
EKWEWK
>SEQF2502_00492 Ribosomal RNA small subunit methyltransferase B
MVGNIKLDIINIIDDILYEKKYSNIQLNYYFSKKNYTQKEKTFITSVVNTVIKNLIYIDY
LIEKGTRNVKKRKIKQLLRISAAQLFFMESDNAGVIFEAGEVAKIINEHQAGFVNAALKT
ILKSKEKFDNEIPMDKREGIILSYPQWLVNKLKIDYPDNYLEIMESYKKRSYLSARFDKN
KMTKEKFEKLLKEINTEVLFSVDEVYYLSNANIFDTEIYRNGEAVIQDASSYLAVKNLAV
KDGEIVLDACAAPGGKSLAILQLFNPEKLISTDIHEHKVKLLNELKNKYGYGNFRVRLND
AAQIENLGVKFDKILLDMPCSGLGVLRKKPEKIYELTSNDIKNLKKLQKRIFESAYKCLK
NGGEIVYSTCTFSKNENTNNIQYFLEKYENLEVLDLEVPESVEIVKDEFGGAYISYENKY
MDGFYIAKLRKN
>SEQF2502_00493 CCA-adding enzyme
MQFDLDNDVKFILEQLNKNGTGFIVGGAIRDKILNRDPGDYDFATDIEYSELKRIFADYN
PKEMGAHFGILMIQVNGKNYEIAKFRKETGIYNSRYPKEIKFVKTIEEDLARRDFTINSL
AYSRKTGIVDLYGGRQDIRQKVIRFVGKPKLRIEEDALRILRAFRFVSKLGFSLDKKTAE
AIYKKRKFLSKISKERIFDELSKILMGNFVKKAFIEMKKLKVLEMLIPEFRYTYNFDQNN
PNNPDDLFYHIIKVIHLCDYDLITRFAALFHDLGKINVKIIDAKGIFHFYGHEKESTLIA
EEELRHLRASNEFTNSVKKIVKNHMLIYQDVSDKTLKKLIIEMDERNLKRLFNLFSADLN
SKGIRTRTENDEILQNFRNKIENIKKQGEVPQFNDLDITGIDLINLKFSNREIGKVKNRL
YELVLGDEIKNEKEELVKYVVKYYNLKDNFEYENSCGAIVFNENTEKILLVKMHNGNWGF
PKGHIENNETKEETAIREVFEETNINIKIIPGFERLIKYIPNERTIKKVTIFVGITQDEN
VKIDTSEIEAFQWCTYEEALKLVTYKLQKDVLENARKVFISSKIIKKEI
>SEQF2502_00494 hypothetical protein
MNKEKILGYEVHRKKVKNINLRIKPNMEVYISVPMNLHRNYIENFIRSKEEWIKSVLKKI
EDVKEKQKRFEYKTGEIHKFLGKEYILTVKIGHFNSVSLKNNTKLNEIILTINENIFENV
DEKKKIMEKWYFENAKKLFPKFMEKWLEILDEHVEKVVIKPMKTRWGSCNYVKKYVNLNT
ELIKRTPFEIEYVVLHELTHLKYPNHGKSFYNYIERYMPNYKIAEKMLNAKHYY
>SEQF2502_00495 hypothetical protein
MFCTLVCCMDGRFIHILNEYIRNNYRYTFVDTITDAGAVNKIINNENYLKSIEDKVVLIS
VNKHKSDHIFVAGHSDCAGCQTSDEIQKKYICQAAEKMHTDLPHEAVTGLFVYENGEIEV
LVDYDMDN
>SEQF2502_00496 Carbamoyl-phosphate synthase small chain
MYALDKQLVLEDGSVYKGYGFGADVEMAGEVVFNTAMTGYQETISDPSYNGQIITFTYPL
IGNYGINRDDYETINPSIKGIVTREICRKPSNFRNEFTLDEVLKDLNIPGISGIDTRSLT
KKIREHGTIKGIIVSADKNPQEVVENLRSNSLPTNQIEQVSTKKAFLSSGRGMRVVLLDL
GMKSGIMRELNSRDCDIVVMPHNATAKEILRQKPDGIMLSNGPGDPTDVPETIVTLRELI
GKVPIFGICMGHQLISLACGAKTYKLLFGHRGANQPVLNLQTGKVDITAQNHGFAVDIES
LKDTDLELTHIAVNDRTCEGVRHKKYPVFSVQYHPEASPGPHDPNYLFDIFIENMKKNRS
>SEQF2502_00497 Carbamoyl-phosphate synthase large chain
MPKRKDIETILVIGSGPIIIGQAAEFDYAGTQACLSLREEGYKVILVNSNPATIMTDKEI
ADKVYIEPLTVEFVSKIIRKERPDALLPTLGGQVGLNLAVELHESGVLRECGVELLGTKL
ESIKQAEDRELFRDLMNELGEPVPESDIIHNLKEARRFVEKIGYPVIVRPAFTMGGTGGG
ICHNDEELEDIVTNGLRYSPVTQCLLEKSIAGYKEIEYEVMRDSNDTAIVVCNMENIDPV
GIHTGDSIVVAPSQTLTDREYHMLRDVSLKIIRALKIEGGCNVQLALDPHSFNYYIIEVN
PRVSRSSALASKATGYPIAKIAAKIAVGLTLDEIINPVTKNSYACFEPALDYVVSKIPRF
PFDKFEKADRHLGTQMKATGEVMAIGRTYEESLLKAIRSLEYGVHHLGLPNGDEFNSEYI
LKRIHKAGDERLFFIGEALRRGVTPQQIHEMTKIDMFFLDKMKNIIDIEVELKANVNNPD
VLLFAKRYGFSDKVIAHRWNTTEDEVYKLREKYNIKPVFKMVDTCAAEFKSETPYFYSTY
EQENESVIGDKKKIVVLGSGPIRIGQGVEFDYATVHAVKAIKESGYEAIIINNNPETVST
DFSISDKLYFEPLTEEDVMAIIELEHPEGVVVQFGGQTAINLAEKLSKHGVKILGTSLEE
IDNAENRDKFEALLHKLNIPQPLGKTAFDTETAVKNAAEIGYPVLVRPSYVLGGRAMEIV
YREEELRQYMENAVKVSPDHPVLTDRYLVGKEIEVDAICDGETVVIPGIMEHIERAGVHS
GDSIAVYPPQNVSEAHKRTLIDYTVRLAKGLNIIGLLNIQYVISDGEVYVLEVNPRSSRT
VPFLSKITGVPMANLAMKGILGESLKSKGYETGLIEESKNVYTKVPVFSFQKLKDVDTTL
GPEMKSTGEVMGSDENLEKSLYKGLVSAGIKVKDQGSVLFTISGTAKEEAYGLAKRFSDL
GYHIMATKGTAKYFEDKGLRVETVGKIEEEGKYEHDVLGLIYKGLVDMVINTAAKKKTAR
NDGFKIRRAASEQEIACLTSLDTTDALLKVLESISFNVSSI
>SEQF2502_00498 hypothetical protein
MNSNLKAFIEGIADIVYQPEISLKRNSNFEKDDYKALKSDWEKVGNDIRSAIKEYSKCQK
VGK
>SEQF2502_00499 hypothetical protein
MVKRNKKQIAKAPKNHKTETQIQSVSIRSAPIPTYQELQGYENIEKGLASRIVAMAERQQ
KNRQKIEMQESQTFQRNQEKLVNGAIVSKILGQIIGGIAVLSAIIGSIYLLSIGKSLEGY
ASMIGAIGMLAVSLGLRNKDKGNKEKE
>SEQF2502_00500 hypothetical protein
MEKKEEFIDFEHLGKAVKFFRKSRKMTQKELAEKLNKTPYTIKRYEKDGKIPLEVAKEII
EILHIPKLLLAGFIIDIPGLSNEVLDVETRKELFFDNDKEKMEKENREDILEKLIVSFGY
KIYMNADTLGEENNLYIKRNEEKYATSLDNFGCILEKLIDIIEYHFKLELSNYKVEELPP
DDNEPVIPAESLKNFLFDKMNEALYRSTNKKEKDTD
>SEQF2502_00501 hypothetical protein
MVNNKLKGKLKEYSFNYDNFSKVIGLSKTAFTNKINGKGFKDKEIARMKKIFNLTNDEVV
EIFINE
>SEQF2502_00502 hypothetical protein
MIQKNILKSKLSLKEKTQKDLAKALGLSKVSVSKKVNGLLRFSLPEVKKVKDYLDLTNDE
VVEIFING
>SEQF2502_00503 hypothetical protein
MKELAILAGNNKIMINGIEIETKEYKGQRVITAWDIAKLHEREPREITQNFKYIKDKMIL
GLDYFTISRNEISKSKIMIQDFIPNNVKKIQLFTERGYLKLTKTFTDELSWKIQDMLVES
YFIVVTGKIQPKQLTKIEVLKMALETELENERLRNENKAQCEIIKGLNGELEPYQLEDII
NRIIRATGGNYGAKYNEVYRVFKERYHIDLKTRMTNYNKTVRAKDRFKSVLKYALANNYG
KDLLNVVTTLFPESVRIVMDGINQNTGLGKDEPLLLD
>SEQF2502_00504 hypothetical protein
MKTVRNAKVIFSKMGNGKGVRLNLSVPLLKSLGIDENNRDVTVEYDDETKTVIIKKS
>SEQF2502_00505 hypothetical protein
MKHKFEALEMVNKNSEKAREKEAKKIINRLKRMIKGIN
>SEQF2502_00506 hypothetical protein
MKMNERKEFFEDVVMEVTDEILESGTHGESESRLLKKDEKIKDKLAELFTYVKIAINEMR
DETSRKSEKEIYEKYRKNIEKMYVDEVLCNSVIAVDILEKAEKITKKAFNK
>SEQF2502_00507 hypothetical protein
MEAKAEGMEESIIEWASFEFEVENKEKLDIIFNELKSNKKASDLLVHLINGVQDTFFELG
KQVAKIENMKMRG
>SEQF2502_00508 hypothetical protein
MKAIQKNKTITSLELLKKINELREKEYLEKAKAGTLTEAERKKGKAVKLKHKSFLNVIRD
EFENEITGQNILLSENLESNNEKTGLQNILETSQQKLLSVNKKITNVKIYVSKYKDKSGK
ENEMFVLALNQAKQVLMRESKYVRKAVIGYIDYLENQNRQLEELARLQARELAKATRNIE
TLNIKALLYYGKVSKPKQKFHYIHYTNLARDIAGIPKGLKRDELTQGQLGILQQVELIMS
AVINECINEQIPFTLIYQEVRERTEIKARVLLKALQKIESVDNGPVWSLEYSENKGGNSY
EQ
>SEQF2502_00509 hypothetical protein
MNSNERAKVIIEGFKKLTLEQMEQMLIKLGIPTDRKIGSDENGGKEYAKR
>SEQF2502_00510 hypothetical protein
MVEKNMQSVKRSVKRIMDHKNYNEDIQAVLDKLNEEIDDYRLYERHLRSVYELMELGIRI
TVAAYN
>SEQF2502_00511 hypothetical protein
MIEFEILKEVTLAINQDREKKKAEKIKEWKARANNVSEYICSLPISHSQRNQLVDKIPIY
>SEQF2502_00512 hypothetical protein
MEKKGNYPKRYRYTEAETDRIIEILEIIEEYRKTNEVDEIMECINNELLYGSGEINYVTR
CKRQTCPLCRENRKYKTYLKLKEKVAKQNGIRYILMTFNGREIGDLTKLSDEVGENNSIV
ARIVRKKSIQAIMLGYIKIVEISYNKYSKRLLPHVHLLLAVKEDFKEHWIRKKEIDKLEK
TWKKWKKETITNAIDVKIVKDTEKDIDTVLKYITIVNKKRIMNLNDMEIRAFFEMINERK
RLFTTSGIFK
>SEQF2502_00513 Tyrosine recombinase XerC
MKRKKKANRQGSVTKTKKNKPYWVRVTDPATGKRKSLGMYATRTEAQEILNNYLVNPYEI
DNSKIIFSELYKLFISNQREMVKKATLDSYKNSYKRCEPLHSLVFREIKGPQMQQAINNL
NTSSATKQITKNFLTTLFNYGMELEIITVNRAKYIKIPKESVQKEKNIFSSYEIQKLWNN
ISTQWVDYILIMIYTGMRIGELAGLKKENVDLLQGFINGGNKTEKGKHRQIPIHKDIFQL
IKGLYEKSPTDYLLYNQNWVFKKKEKENKPLRINFFREHFYKTLESLGMNHKPHDCRKTL
STLMSRQQLTTTAITNILGHENIETTNKFYIKTDKENLKAEMNNIKFYSDESNMTN
>SEQF2502_00514 hypothetical protein
MIIKTVIIAIIAAAIVFAVFRKIYKDYKKNKNLCGTDCCHCSTGSTCSPHKENHAK
>SEQF2502_00515 Fe(2+) transporter FeoB
MINVAFVGNPNVGKTALINQISHASLKMGNWPGVTIEKKEVFFKVGDEDVKLIDLPGIYN
LSISTAEERVSRDFLLDEEVDVIINVLDSTSLEKNIYLTALLKELDIPVVMALNFEDEFK
RIGYQLDIEKFEKQLGVPVIFTSGRSGAGVDKLMEKAVELYKKNSSDKKIQHRLPFEKEI
EDNIKSLKDKLENDKSYEKVLEKYPVEWLAIKILEDDTNVAARVKTEFGVSVSNIGETEK
KNIENRYGLEPQDALARERYGIVRGIISMNLKRGTGDKFALTDKIDKILLNKFFGGIAFL
AIIYAVFVIVFDGSSPFIDWIDGFFSDFVIKYVGHAIEGVPDWLSSFILDGILAGVGSVL
TFVPLMFFIYFFMAILEESGYMARVAFILNKMMTKVGLSGKAFIPMLIGFGCTVPAIYST
RTLEDEKTRRLTGVIATFMSCGARLPVYSLLAAAFFSKNAALVVVSIYVFGVFMALLVAF
VLKRFKYFKGNNTELLIELPPYRLPSAKAVWSNMRSRTFSYIKKATTIVLGILLIIWFFQ
YFPNKGDAESSYIGQAAKVVQPVFKPTGFGDRWEPVASIVPSIIAKETVVGFLGQILLSQ
GDDDKKEYNFVSDLKDQVVGLGGAAVESVKSLGHIATFKIATLEMKSQEELDQDAGGNII
PAIRSLWNDKYGQLRAYSFMLYVLLVVPCAVAMGALKQEFGWKLLAFQVSMLLILPYVVS
TLFFNIARLFI
>SEQF2502_00516 hypothetical protein
MTLVEGKVGDKFLLKDIDQKKLDTRLLSLGVCRGDACTIENIANGNVLIKTVETKIVIST
NLANHIQIEVVK
>SEQF2502_00517 Isochorismate pyruvate lyase
MKCNNLEEVRENIDSIDDKIIKLIAQRSDYVKQAAYFKKSKTDVKAADRIEKIIKKVREK
AKIYDCSPDVVELIYRNMINYFIGEEMKIFEKNK
>SEQF2502_00518 Aminopeptidase PepS
MNNFEEKLNKYAEVIVKIGANVQKGQKVWVNCTTDALPLVYNVTELAYQVGASDVHVKLT
DDKLSRLHAEYQSKEVYSHIPQWAIDERNDYLDNNVVFIHILSSSPNLFAGIDAEKLGAL
TKNAGEAYKYYRTCIMTDVNSWTIASYPSADWAKLVFPDETDTDIAQEKLLDAILKTVRV
DKADPVKAWEEHRNNLNEKAEFLNSKNFVALHYTSKGTDLTVGLPENHIWVAAGSVNAKG
DDFLPNMPTEEVFTAGDRDRVDGYVSNKKPLSYQGNIIDNFKLTFKDGKVVDFEAEEGYD
ILKQLLDTDEGSRRIGEVALVPNDSPISNSGLLYYQTLFDENASNHLALGAAYPTTIKDG
TKMTEEELKEAHINQSISHVDFMIGDAEMDIDGILEDGTRIPVFRKGNWAF
>SEQF2502_00519 hypothetical protein
MKKLFLMFMLLTPFTMAYGERNEIIISPIYGKQKNNNDKNAPVKGVTGSGIKISLEGKGG
VDDDVVMGLGMGLTYNSLKVKGKDINSNSGSLVSIPVYFMIGTGTDNGIYSKLSFGASLA
GGSVKWTDKNGGSGRIKAMPLNGYAALGIGVQKNRFSFGLNVATTPKLKREYYSPAKKYK
SKFTDGTVSLEFGYQPNYKD
>SEQF2502_00520 hypothetical protein
MKKLFLVFMLLTPLTYGDRSEIVVSPTYVTQKKENGSKVGKYALGSGVKVSKEEIASFGD
GSNTVIGAGIGVSYNSLKVKGNGVKSDSGNLVSVPLYLIFGIGTNNGIYTKISAGLAVRN
GSVKWTDNSGGFGEIKARPLTGYAAFGIGVRKDRFSIGVSASTSTKAKRTYSSPTKHYRD
NIMLSGAAISLDFGYALKYE
>SEQF2502_00521 UDP-glucose 4-epimerase
MKTILVPGGAGYIGSHTVLDLIKKGFNPIIVDDFSNSSKKVITILEELSGEKINFYELDI
KNKEGLRKIFSENKIDAVINFAGFKAVGESVEKPLMYYENNLFGMITLLEVMKEFNVKNI
VFSSSATVYGVSEKVPFVETDPMGEVTNPYGRTKVIIEHILMDLAKSDNTWNIIALRYFN
PLGAHESGRIGEDPNGIPNNLSPYITQVAVGKLEKLHIFGNNYDTPDGTCIRDFIHVNDL
AAGHSAALNYLFNNENLGFDAINLGSEKGYSVLEILSNFEKAVGKEIPYVIDGRRAGDIA
VCYADASKAKKLLNWEAKYTIEDMCRDSWNWQKKNPNGFKD
>SEQF2502_00522 Thioredoxin
MSRIINYAGEDFDNEIILQNGLTLVDFFAIWCGPCQMLEKVLVEVANNSECKIVKIDVDD
YPEFGAKFKIRGLPLLLLFKDGQIVETLKGFQTFDEIMEKINLHN
>SEQF2502_00523 SsrA-binding protein
MPVLARNKKAFHDYFIEDKLEAGIELVGTEVKSVKAGKISIKESFIRIIRNEIFVMNMHI
TPYEFGNINNVAESRVRKLLLNRREIKKWSEKIKEQGYTIVPISVYTKQRLVKMEIGLAK
GKKMHDKREWLKRKDIERDMKKLQKNFGR
>SEQF2502_00524 Ribonuclease R
MGNKKKKERHRNIENNNKDFHKEKRFGKKNYNPKKENQKTPKMELKEERELKYLKQVLSE
YEFTFQEILQLLEWSQKKRKMYKQLLNAWEESGEIYLKRNGKYTLPEKEGFVKGEISISS
GNFGFLDINGQASVFIPGAYLNTAMNGDTVLVRILKESSDNKKREGEVYKVIKRNRDVIV
GVFEHNLSFGFVRPRNSPKDIYIPKKLIKGAKTGDLVAVKVDFWGDEERKPEGGIVSILG
SPKDTEALISSLLLNEGIEEKFPNEVLQELDKIDEDFSDELENRKDLRHLDIITIDGSDA
KDLDDAVYVEKTEDGYKLFVSIADVSYYVRENTELDIEALKRGNSIYLVDRVIPMLPRKL
SNNLCSLNPNEDKLTFTVEMDLDKRGKVIKNDFYKSVIKSKYRMTYENVNTILEKNEESE
EYRNLYDKYRKIDDMLKNMLELSKIIRSNKKRRGSIDFELPEIKVVLDENKAVKDIVLRS
RGEAERIIEDFMVIANETVAEKLFWEEIPAIYRVHEDPDKAKVQALNETLIKFGYSLKGL
EEIHPGKFQNIIERTTGLPEGYLIHKLILRAMQRARYANKNLGHFGLASKYYLHFTSPIR
RYSDLIVHRMLGRSIEKFMSEKEKAKYGANFEAIASSISRTERVADKLEEDSVKIKLIEY
MQDKIGQVYVARLSGMNKNKIFMELENHVEVVYNVTTARDNFIYDEENFKIVDKRNNESY
TMGSTMKVSIVSASYAKMEIEVIPYVEEKVKIDEVEEE
>SEQF2502_00525 hypothetical protein
MNMEVIKADVRNFLDEKRYEHVKRVAKCAVELAKIYGVPVEKVEASAWLHDVAKFFNLSV
MIDLTKGKYPEVADKMSQSTAVLHGFAGAEFVRQNYELFGIDDEEILDGIKYHTIGCENM
NTLAKIVYLADAIEEKRSWEGVEKARELAKTDLDEAIKFEIEEKLKYLLAKDSIIHPNVI
KFRNSIIANKI
>SEQF2502_00526 hypothetical protein
MKIEDLSLFLTKVSLFKGLNPNEILKCLTKVDFKIKEYKKNEIVFFRGDILKKIIIIIKG
TAHGEMQKFNGDTIVINQMKAGEVLASAFLFGKDNVFPVDLITLENSEFLFLDKEKYLDL
IQLDKRLLLNFISEISNKSQYLSKRIWFNFTHKTIEEKVLSYIKENAQDDKIKFLPSISA
LAKKFEVTRPALSREISDLCKKKVLKKIGNNVYLINF
>SEQF2502_00527 hypothetical protein
MENNVLLATFKNQLSAFEALADIKEKYVGENYIITQAAVVKKESDKLSFKDGFEVNKNGN
IGFLNGGLLGSFIGIIGGPLGVIFGGTIGALIGGSHGEKADKKVVGIFEDVSKHLVNDYY
ALILLTSESNTSELDNFLNKYETETILRKDAAVVRKDLELAEEYERKLKTDIEYKELKEK
FENKSKEIKNNLNDFSEKVKVNAEAFTEDLTKFVLDLKNKLKK
>SEQF2502_00528 putative protein kinase UbiB
MVDFMQKTRRLMKLSSVIAKYGFDELFKRGELERYIPKNVKRKYSDKIDEINSCTFYERI
RMAIEEMGPVYVKFGQMLSNRKDILPEEMIIELQKLQDNVEVEKVDVKNKMNLELGIEID
DYFEEIEEEPIASASIGQVFKGRLKNGEKVVVKIQRENIKPVVEIDLEIMKNLAKTLENY
YEDIKKMNIGNIVESFEKVLNEELSLNNELRNMQRFANNFKEDDRIHVPTVYKQLSNDRI
LTMEMIEGFKITDKEKIIEIGQDPKKIARIGLDLYLTQFLKYGFFHADPHPGNIFLKENG
QIVFIDFGAMGKLYPNEREFLINLIIYSLKKDVKKMVEAIQELAIKFEVPDERKFERELY
EIIEMIDENSLENIDIVTIFEKARKIFSNNQILLSEDIYLLIKGIGQIEGIGRHLDPNLN
INEVMQPYMDKIAKERINPINIFKKETRKLETFSENWLTLPTDLKTILEKIQKNELKHRH
EIIGFEKFQKTFEELVLAIIISSLFVGSSILALANIPPKIFGISGLGLLGFIIAGIMGIN
LFLKSKK
>SEQF2502_00529 Regulator of sigma-W protease RasP
MGIIFTIIILGIIVFIHELGHFATAKYFGMPVTEFAIGMGPRIFSVKKKETVYSIRILPL
GGFVNIEGMQPEKFDLKAFKKEKMDEIIEELKDEKNNENEIKDEEFISEVEKRLDTAVKQ
ELKRQENIQKNGFFTKSPFSRFIVLIAGVAMNFISALIALYIMLSIAGIVPPQYSQAIVG
EVEQSSKANGKLKVNDKILAVNSKNVANWSEMTKKIGEISQNYKNEDVILKILRNNKEIT
ENIKLTYSEKTKGNILGIHLLSQKSTFGERIKISFLMFGDYFKMTLNGVKMLVTGKVAMK
EMTGPVGLPKVIGEAYGQGGLFAMLGVFILISINIGIMNLLPIPALDGGRLIFIIPEFFG
IKINKKIEEKIHFIGMIFLLVLMLIIVFFDVTKYF
>SEQF2502_00530 Cell division protein SepF
MLLGLKRKLMEFFGDDIEDEDEDELSEEMSENEKKEVTTEQSQQNQQSKVQHKTTTRVES
EKQPEEKKGIGSLFGVGKKEEITKMPTSKVNVSIIRPKVFEDSRLIADAIKENKIVTFSL
EFLEYEVGQRVIDFVSGAAYAMSAHLSKVTDKVLTSIPMEIDYEDIDASLGEDEGDGTYL
>SEQF2502_00531 hypothetical protein
MELNDVKIQQNYRKIMEDIKKYSPYPEKVKILFVSKYLNVEEHRTLIEMGYDYFGENRAQ
LYRDKLNEFSGEKYKNIKWDFIGRLQKNKIKYIISSVNLIHSIDSYELLEEINKKAIENN
KIINGLIEINVSKEESKTGVYIEDFKKDSEKYFSMSNVKIIGFMTMAPFEASEAEINSYF
SNMRDLKEEYQKKYDYVTTLSMGMSNDYVEALKNGATIIRIGSKLFK
>SEQF2502_00532 Oxygen-independent coproporphyrinogen-III oxidase-like protein YqeR
MIETKNIKASKGKNVDAIYIHIPFCSKKCEYCDFCTFIRMEKEYRKYTDYLIKEIRMYPK
IKYDTIYFGGGTPSLLPTEMINEILNELDWSENAEITLELNPTDMTFEKLKKFRKIGINR
LSIGIQSFQDHVLKFIGRQHSSKDAVNIYKMARKAGFLNITVDLMFGIPNQSIEDLQRDL
NILQELKPENVSIYSLIWEEGTVFWSKLQKGILSEIDQDLEALMYEKIIDFFEKNGYCQY
EISNFARIDDKDVEIYEMTNFEDLKKLQKNAGRHNLKYWQNQKFVGVGMSAASYFDNNRY
SNIRTFEKYYNLIDEKNLPIDENTIEIVDEVESEKLKKMLGLRLIQEGIEYFEDEKIEKL
IENGLLEKFIIEKDNFINKKNKEFEKNECFDKNLAKNFYETRIRLTKKGMLLANNVFVEF
I
>SEQF2502_00534 Queuine tRNA-ribosyltransferase
MSIEKENQDFNNPIKYKLEKSDGNARAGVITTPHGEIKTPVFMPVGTQATVKAMTKEELE
EINSQIILGNTYHLYLRPGDELVNDFGGLHGFMRWDRPILTDSGGFQVFSLGDLRKIKEE
GVYFRSHLDGSKHFLSPEKSISIQNNLGSDIMMVLDECPPGLSTREYLIPSIERTSRWAK
RCIEANRNKDRQGLFAIVQGGIYEDLRDKSLEELYEADYGFAGYALGGLAVGEPREDMYR
ILKYITPKLPENKPRYLMGVGEPADMLEAVEHGIDMMDCVQPTRIGRHGTVFTKYGRLVI
KNAIYSRDDRPLDEGCDCYACKNYTRAYIRHLFKAGEILGQRLATYHNLHFLLKLMDNAR
EAIIDGRFKEYKEELLKNYAMGKESEWIKPKSI
>SEQF2502_00535 Trifunctional nucleotide phosphoesterase protein YfkN
MSMKNIDACLEKKENKREVNIKILGTSDVHGRVLAWNYGADEEDRSGSYAQISTLIKKIR
KENKNVILVEVGDAIQDNWIEKFAMVPKHPVPQILNYVGYDVFVPGNHEFNFGMPTLSNI
LRDMKFNKLAANLYYNENAENDTNFSKNKKRYLNASVIIERDGIKIGVIGLSTPMSAQFE
EDTGYLKDFYFVSPINETRRQIEKLKSEGANAIVVVAHMGIENENNIPETGVRDLANAVP
EIDVIVAGHMHQNVPKEIINGVLITEPHRYGTFVSEVDLKFEIENGKISLISKDSTTVPV
KDEEPDPEIEKIYKPFHNRLCKIANEKVGETLNDMVPKGKFHGVSAAFAKDTGLSSFITD
VELYYSGADVVSFAYNYENVRLNKGEIRRKDIVYNYRYAGGDVTIYKMTGKQLKDYMEWA
ADYFDTIQPGDTKYRYNSERAGRKYVTFDIFGGVKYKIDLRNEKGNKITNLMLVNGKEIT
SEMELKVGMNAYRFEQLARKGGIFDGQKIPVLWASKEKIGEIDGTIQNMMIDYIRNVKNG
VIEGKSHNNWEIVGL
>SEQF2502_00536 hypothetical protein
MKSNAEDMTLKEVQYLIKRIEKGTLDESRDKEKSQQKRENGQRLVLKLIEEFGELAENIR
KNVRFDGKNIKGTIEEEVFDVFYYVIAIANDYGIDLEKIFYIKDELNKVKYGREFSIYEA
REKWKNIMENKKNKKEEGK
>SEQF2502_00537 putative nicotinate-nucleotide pyrophosphorylase [carboxylating]
MSLRKIDKFQMDNSIKLALKEDITSEDVSTNAIYKDDRLAEISLYSKGEGILAGLDVFKR
VFELNGSPVFTEYKKDGDEVFKKDLILKIRDDVKALLSSERVALNYLQRMSGIATYTKKM
IEALDDKNICLLDTRKTVPNMRIFEKYAVVAGGGYNHRYNLSDAIMLKDNHISAAGSITK
AIKLAREYSPFIKKIEIEVEDLEGVEEAVRAGADIIMLDNMGIETIKKAIKVIGKKAIIE
CSGNIDINNINRFKGLEIDYVSSGAITHSAKILDLSLKNLRYIE
>SEQF2502_00538 L-aspartate oxidase
MKAENYDVVIIGSGVAALICALTLDDSINICLITKKELKDSNSYLAQGGISVCRGKEDRE
DYIEDTLIAGHYKNDRKAVEILVDESEEAVKTLIEMGVKFTGDKKGLFYTREGGHRKFRI
LYCEDRTGKYIMESLIKKVLEKKNIKIIENCEFLDIIEENNNCFGIVVKNKEIFSIKSKF
TVLATGGIGGIYKNTTNFSHIRGDGIAAAIRHNIELKDISYVQIHPTTFYTKDNERKFLI
SESVRGEGAVLLNQKFQRFTDELKPRDEVTRAILEEMKKDKSEYEWLDFSTIKLDIEKRF
PNIYKQLIKKDINVLKDKVPVVPAQHYTMGGIKVNMDSKTSMKNLYAVGEVACTGVHGQN
RLASNSLLESVVFGKRAAHSINAENNVSNYNNVTADNAFKNIEKEVFEIENKIKENKNII
EQRIKEDEFEKNR
>SEQF2502_00539 Quinolinate synthase A
MKERIKKLQKEKDVAILAHYYVDGDVQEIADYVGDSFYLAKTATKLKNKTIIMAGVYFMG
ESIKILNPEKTVYMVDIYADCPMAHMITIKKIKEMREKYSDLSVVCYINSTAEIKAHCDV
CITSSNALKIVSKLKEKNIFIVPDGNLASYIAKQVKNKNIILNEGYCCVHNLVHLENVKK
LKEEYPNAKVLAHPECKEEILKLADYIGSTSGIIAEALKEGDEFIIVTERGIRFEIYKKA
PNKKLHFADTLICRSMKKNTLEKIEKILTEGGDELKVDDEIAKKALIPLERMLELAGD
>SEQF2502_00540 NAD 5'-nucleotidase
MKKLLLLGLVLALLPVANVEAKTIKKAAGKNSQSTFELNVAHINDHHSHLEEEKMPIKLD
GKTVTVHIGGLPRVGQEIKNFRKNNKNTLVVHAGDAVTGTLYYTLFEGKADAELMNAINF
DAYTLGNHEFDDGNKVLGAFLDVLKIPVVSSNVVPDKGSILEGKWKPYIIKNIGGQNVGI
IGIDVVKKTKESSSPGEDIKFLDEVETARKYAKELQDKGINKIVLLSHAGYEKNVEIGQK
VDGIDLIISGDTHYLLGKEFEQFGLVPEADSYPKKVNSPNGNPVYIAEAWNYSYLLGEMK
AKFDKNGVITELTPAPKLLIGDDFFEVKGADGKAVQLDEKEKSKILNSIKNNKNIVAIKN
DPALAKLLERYQKEKTELGKRKIGKITEEIPGGSDNRVPSEHNKDGSFATTLVAESVLYK
LRNTGTGNVDFVIGNAGNVRITLNPGDFSYDLAYSLLPFTSNTVFITDVTGAEVKQILED
AIDYVLNGGSTGAFPYGAGIRYEATKEGTLGTRVKKIEVFDFKANKWIPIDAKKTYMLAV
NSYIAKGKDGYTTLGKITAQKRGNDTHLSDTKMFIDYLKEKKELGKPKSTNVIFKY
>SEQF2502_00541 hypothetical protein
MNIRNLIKKMILIFGVIGISLTSFAAPRRNNRVVYVKKEPTRKVIIRRRYIFVKVPRRRN
SKVVYVKKEPTRRQRAAARARAARRR
>SEQF2502_00542 Adenylate kinase
MNIVLFGAPGAGKGTQAKELIKKYEIPQISTGDILRAAIANKTPLGLEAKKLMDEGKLVS
DDIVNGLVEARLKEDDCKKGFILDGFPRTVAQAKELDKILAKSNREIEKVIALEVSDEEI
IERITGRRVSKKTGKIYHIKYNPPVDENPEDLEQRADDNEETVKKRLAVYNEQTAPVLDF
YKNQNKVYSVDGAKKLEEITKDIIDILEK
>SEQF2502_00543 Methionine aminopeptidase 1
MIIYKTLDEIKKIKKANEIIARLFEDVLPKYVKAGISTYELDQIAEDYIRSQGAIPGTKG
YDIGSPYPPYPAATCISVNEVVVHGIPSKKQILKEGDILTIDTVTVLDGYFGDSAITYAV
GEIDETSKKLMEVTEKARAIGIEAAHAGNRIGDIGHAIQEYVESFGFSLVRDFAGHGVGK
EMHEDPIIPNYGKAGTGAKIEDGMVITVEPMVNVGTYKVKILPDMWTAVTKDGKRSAQYE
HSFAIIDGKPVILSVRD
>SEQF2502_00544 hypothetical protein
MSILAFILILFVAIEHYYILILEMYLNESKSIQKNFGLELDFLKDEHVKKMLANQGLYNG
FLASGLMWSLTESGEFQFQIAIFFLICIICAAIYGSVTVSKKIFLLQGIPALMAFILLLL
PLIIS
>SEQF2502_00545 hypothetical protein
MKKLFILLSLPLFFSLNSKSLAYTRAELIQDRLSKIGIKQDIIDETIKFQYDIKDEKNFF
TEDGKENDDFLKLKEIYEKDERNETLGATIAGAYMIGDQKDFKKARQYMDKISKYSSKFD
RLSNEWSYYKLKGDEKIAKKYYNLLKRSYKGTPVMDLVEILNDNLEMISFINTLGDYLNE
EDNSTNNEANDLPDGFLYDEKNGIIQNKNEDESDDLDEAEDTEEDSKTYSESIKEILDDG
KDTIKSQKEETSKYKRIVDYFKIDKNQKEFGIPNDYVRGFELKIAEIEIAKNMMNYGVGS
AVKYYLDNVSTKDVSYEDVYFNEQSELELYLAVAQMLAVADESVVNKYRKDFENTRVIKL
LDEVLKNERKKEKDKIENPDKNSKKHIKG
>SEQF2502_00546 hypothetical protein
MRKLFLILGIFLMINFEIYGFTQKEKIQETLSKLGVKQELIDETIALDYEIRDTQYFEED
EKIIRERVAKLEKLLQKDKRNYIAAQALITIFESKISGDYKKYLDLFEKYTPYEYTKTFS
KMMYALEQGNMPEFEKYMDEIPKKYSDPSIIALSKIFVAKNPEEKQMLTEKVLKLLKDES
ERKKIGVSDEEYHLMKLTYYLNKIRGLFDKREVKQAVAEYLDNVVNDNVSDEIRNYNLRA
EVILYFNVVIMNEEIREIMLKISNGAKLEDTWIAKKIQEETEKDKDFLAKMVN
>SEQF2502_00547 hypothetical protein
MKKLKDYYDRFKSLNPRYSGIKLGIIVAVIAYFIARIFFVVEISRDMIISLAVFVISMTF
HEVAHGYVAYKFGDNTAKMNGRITLNPLKHIDLTGIILPILILLSGFKFLVGWAKPVPVN
FDNLRPHRLGLFCVAIAGITVNFIIAAVSLLLLKYLGKYLDIENIFMTVLLYTYLINLLL
GMFNLIPITPLDGGRIIYSFSGKRVRKFYDKIEKYGILIIFAIVYFGSRILMNGFIVIVE
FLLKLAGINFNLMF
>SEQF2502_00548 hypothetical protein
MPKKQQKITKISQKNAILMSEKISVTPINKEFSQKYGLK
>SEQF2502_00549 hypothetical protein
MKFDDLKKGAEDALKKTVDGAKDLADKAADKTKEIAGSEVAQNIKKGTEEVFEKTVEGAK
DLANKAANNKIVKDVEKGAEKAVDKTVEGAKDLAGKVTGMFKK
>SEQF2502_00550 Glutamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGIVGYIGAKNAQDFVIDGLEKLEYRGYDSAGIAVNTGSEKFEIVKKVGRLKNLADELE
KHPLKGTVAIGHTRWATHGKPSDENSHPHFNKDKTLVVVHNGIIENYLELKRDLIAKGYE
FKSETDTEVVAHLLDELYTGDILETVKKLLKVIKGAYALGIMSVKEPDRIIAARKESPLI
VGIGKGENFIASDIPAILKYTRDVYLIENNEIVEIKKDSVKIMDADGNEKKREITHIEWD
LEAASKGGYEYFMEKEIFEQPEVLVKTLNSRVDGNYNINFDNAGLTKEYLSGINDIYIVA
CGTAYHAGLAGKHIIEKKTRIRVDVDIASEFRYRNPVIDDKTLVIVLSQSGETLDTLEAM
KEAKRHGARVVAITNVVGSSVAREADHVIYTWAGPEIAVASTKAYTTQMVILNLMAIDFA
YKFGKITKDEAAENIKKLYEVEQSIQRMLEYDEKIKDVADKIKDSESMFYLGRGLDYVIA
VEGALKSKEISYIHSEAFASGELKHGTIALITDGVPVVVNATQSDLFEKSVSNIKEVTSR
GAYVIAVAKEGNTVVEEVADEVFYIPNVEDDYAGFPTIVIHQLLAYYLSKLKGNDVDKPR
NLAKSVTVE
>SEQF2502_00552 hypothetical protein
MNNKLKMGIITTLCIFALSCGNGQNGKVLFESADKKIKVYENEVDIELQKNLFSNGLTQK
DLTPDQIKQMKQSIIKNIALNRALAIKGKEEKLDKDKKYTENQNVIKEQLLASLTLVNEV
NGKVNVTDEEAKKYYDANPAAFTLQEDSAKLQIIAFKAADSATANQVLKDVLANPNNFTT
YARKYNANIPGVPENGETPEIPESRLGALGAAIKNVPAGQIVNSVVKVDNALYIVRVLEK
NSKGVIPFEKVKEAIKTQVKNQKRQIEQQNYLKSVSDEFKLSNMDDAIKNIK
>SEQF2502_00553 hypothetical protein
MKILKYLLSAVLLVLVIFLFGIMFSSNIVSFMARSKHSEFENVKYSVKNSRMVFDNFVVN
GKNLGKGHATVGIVRTGLFKLVPKLTISNLKLEDVNLDSIYKEKNSQIDTFTEKINSLSA
QEKADKTTADFIKETTDKVATLTTNTDSLINSKWRENIEKINVLKKNYAELTDLKSKAQK
IVELNNEIKPLVKSINSEKENIEKNISEIELERDIALANVSDNLTKLEKEISLNDFNNNS
NSNVQNMNLYIFLDKGKDLETSLNTALKATALIKEIKDLNIRISDIDINEGKIVAKGLNG
DISQVSGEVLLQNNSKALIKGQNNGYEITYNKDNFTSKTLFSINKIGSLIEYSKNDLIEG
KTIKLSSELVMENDNFKNLNHTVLTDEEKTLLTQKIENLRNNNYQQIMTKYEEDNKNIET
LIDTVYAQKDKLDKLQRDLLSLGTIIAVEQPAVINNENTPQNNSSAINILNNNASSSNTN
NNNSNNNNTDSSSNNANNNAEKQNGNQNTNKINIGNR
>SEQF2502_00554 Phosphate-import ATP-binding protein PhnC
MLLSVKNILKEYNNGTTALKNVSFEVEKGEFISIIGPSGSGKSTLLRSINKMIDISQGSI
LFKNRNIEKLKKKEIELVRREIGMIFQNYNLVERLTVIENVLHGRLGYKSVFAGILGIYS
EEEKKEAFKFLEKVNMTKYAYQKCNELSGGQKQRVGIARAIMQKPKLLLCDEPIASLDPK
TAENIMDYLKKIVTELKITCIVNLHQVDIAKKYSNRIIALNKGEKIFDDKPEHLTDDMIE
FIYKDEELD
>SEQF2502_00555 Phosphate-import permease protein PhnE
MNLNEKDIFKQRFHSKIVFILIIISLYVISSIISGFQNGTAFSSIPAGIFWLLQKFIPTQ
NALQYFPEIINSALKTVLLAITSTIISAIFASFLAIIGSNSTGINIFTKIITKVIASFFR
NMPIVAWSLILVFSFKQSQFTGFLALFLITFGYLTRAFSETIDDVAGDVIEALKSVGASY
FQIIFCGVIPSISSQLLSWLLFFIETGVRESTLVGILTGTGIGFTFSLYYKSFRYDAAGL
VILVVTVIVVGVEMLSNKLRSELM
>SEQF2502_00556 Phosphate-import permease protein PhnE
MEKIKIKKLTKSRIYLYTTLSVLSVITVYTLATMDFGGVNIIEATRHFFKDLKTMFFSPS
LSDRYTYAQVFQSLAVTIALAVLTTIIGSFIALFLSFFAAQNLSNKHLSKTIKLGLSFIR
AIPTILWVMVFSVVANVGVEAAIIGMTFHSIAYLVKAYSESIEEIDSGIIEALRATGASF
WKIIFQGVLPSTVTSILSWTFIRFEINFTNAVLVGAAAGAGGIGYDMFMSGTMYFDIREI
GVFVYLIFGVAIILEFISYLLRKKYLKN
>SEQF2502_00557 Protein translocase subunit SecY
MTLAEAVSSRVKAIFNIPELEKRVTFTLLMIMVARVGIHIAVPGINTEAFKNFQQGNAIA
QFLNLFSGGAVERASIFALGIVPYINASIVFQLLGVIFPKIDEMQKEGGKERDKITQWSR
YVTIVLAIIQSFGIAILMQNQGLVLEPGPKFVLSTVVLITGGTSFLMWISERISIRGIGN
GTSMLIFLNIVAGLPSVISNMYAGLPSGMGKVLLGLSVIVFIIFIALMVIVQLAERRIPI
QYAGKGSLGFGGGQSTVGKRTYLPLKINMSGVMPIIFASVLMAAPSFLVSMMKSGNLKNF
LAAQFEPKGVFYLLLFAILITVFSFFYTLTIAFDPDKVADDLKQSGGTIPTIRAGKETAD
YLEKVATRVTFGSAIFLSLLGIMPNIWFGYILNLPVMLGGTSLLILVGTAVEILLQIDSF
LAVKHMKSFVNRRHR
>SEQF2502_00558 50S ribosomal protein L15
MNLNELRPAAGSKRERRRVGRGHGTGWGKTAGKGHNGQKQRSGSYVSPIFEGGQMPIIRR
IPKRGFSNAPFKKDIIAITLSDIVEKFNDGDVVSLETLVENGIVKNPKFIKKYSDEVLRN
IKGRRAVKEYLNSNIEAYVKEKEFTSLLKIIGNTEVNKKLTVKAHRISKAAKELIEKAGG
SVELLEIKSYSAKAGNNKKEDGDK
>SEQF2502_00559 50S ribosomal protein L30
MSKVKVTLVKGINGRKPNHVATVKSLGLRKISQSAVHNKTADIEGKIKLVSYLLKVEEV
>SEQF2502_00560 30S ribosomal protein S5
MARDRDNRERESEYKERLLRISRVSKTVKGGRRISFSVLAAVGDEKGKVGIGLGKANGVP
DAIKKAIANAKKNLVNVSLKGGTLPHEQIGKYNATSVLLKPASKGTGVIAGSATRELLEL
AGVTDVLTKIRGSKTKDNVARATLEGLKQLRSLEDVARLRGKSVEEILG
>SEQF2502_00561 50S ribosomal protein L18
MVKKFDRNKLRQKKHRSIRKKIVGTAERPRLAVYRSLQNIFVQVIDDTTGNTLVSASTIE
KGAKIEKGSNIEAAKQVGERIAKKALDKGITAVVFDRGGYIYTGRIKAVADAAREAGLKF
>SEQF2502_00562 50S ribosomal protein L6
MSRIGNKPITIPAGVEVKQDGHTFTVKGPKGQLVRELSSEIKVNIDGNEITFERPNDLPS
IRALHGTTRANLNNMIVGVSEGFSKGLELVGVGYRVQASGKGLTLSLGYSHPVEIEAVDG
ITFKVEGNTKISVEGIDKQLVGQVAANIRAKRAPEPYKGKGVKYADEVIRRKEGKKG
>SEQF2502_00563 30S ribosomal protein S8
MYLTDPIADMLTRIRNGNMAKHAQVAVPFSRIKESIANILKNEGYINGYEIKEEGAIKNI
VVSLKTVDGEAVIKGLKRISKPGRRVYTSVESLPKVLGGLGIAIVSTPQGVITDKECRKH
NVGGEVLCYVW
>SEQF2502_00564 Alternate 30S ribosomal protein S14
MAKKAMVERNLKRQKTVDKYAAKRAELKARAKKGDREAVLELSKLPRNASPTRVRNRCQI
NGRPRGYMREFGISRVMFRQLAGEGVIPGVKKSSW
>SEQF2502_00565 50S ribosomal protein L5
MDQKYIPRLQKLYKDEIVSSLMKELNLSNVMQVPKLNKIVVNMGIGEAVSNPKLIDAAIT
ELAQITGQQPVARAARKSEAGFKLREGQKIGAKVTLRKEKMYEFLDRLISITLPRVRDFE
GVSPKGFDGRGNYTLGLREQIVFPEIEIDKVDKIFGLGITIVSTAENDEQGRALLKAFGM
PFAK
>SEQF2502_00566 50S ribosomal protein L24
MAKPNLKSVPRKLHVKTGDTVIVISGRSKDLLRNENSTQTGDKGKIGKVLKVFPKTGKII
VEGVNIKKRHIKPNAMNPQGEVVEREMPIFSSKVMLWDETAGKPTRVRKEIRDGKKVRIS
VVSGNEI
>SEQF2502_00567 50S ribosomal protein L14
MVQQQTMLNVADNTGAKKIMVIRVLGGSRRRFGKIGDIVVATVKEAIPNGNVKKGDVVKA
VIVRTRKELKRADGSYIKFDDNAAVILNTALEVRGTRIFGPVARELRAKNFMKIVSLAPE
VL
>SEQF2502_00568 30S ribosomal protein S17
MENKRNERKVREGIVVSNKMDKTVVVLEETMKLHKLYKKRVKTSKKYKAHDENNECGIGD
RVQIMETRPLSKDKRWRVVTILERAK
>SEQF2502_00569 50S ribosomal protein L29
MTINEIRELSLEELEVKVNELKQELFNLKFQKTLGQLQNTAKIRDVKRTIARLKTVVTEK
TGK
>SEQF2502_00570 50S ribosomal protein L16
MLIPKRTKYRKQFRGKMGGVATKGNKVDFGEFGLAAKEFGWITSRQIEACRVTINRTFKR
EGKIWIRIFPDKPYTKRPEGTRMGKGKGNAEGWVAVVKKDKVMFEVGGVSEEKAKEALRK
AGHKLPIKVKFVRKEEVGGDK
>SEQF2502_00571 30S ribosomal protein S3
MGQKVDPRGIRLGITRTWDSKWFAEGKEYVDNFHEDLKIKKYIKKNYYHAGISSIQIERT
SPTEVAVIIETGKAGILIGRKGQEIEALKVKLEKLTGKRVQIKVQEIKNPNKDAQLVAES
IATAIEKRVAYKRAVQQAIQRAEKAGIKGIKVMVSGRLNGAEIARSEWTLSGRVPLHTLR
ADVDYATATAHTTYGALGLKVWIFNGEVLSTTKEGENE
>SEQF2502_00572 50S ribosomal protein L22
MAVVAKLKYQRLSPQKARLVADIVRGKNALQALNILKFTNKKAALYIEKTLRSAIANAEH
NNNMDPDKLFVSKILIDKGPVLKRISPRAMGRADIIRKPTAHITVEVDEKVD
>SEQF2502_00573 30S ribosomal protein S19
MARSLKKGPFVDAYLLEKIEALGGKKQVIKTWSRRSTIFPEFIGHTFAVYNGKKHIPVYI
TEEMVGHKLGEFAPTRTFYGHGKDAKKAK
>SEQF2502_00574 50S ribosomal protein L2
MPIKKLKPMTSGTRHMSILVNKDLDKVRPEKSLVEPLSSSYGIDNYGHRTGRNRHKGHKR
LYRVIDWKRNKIGVPAKVATLEYDPNRTANIALLHYVDGEKRYILAPNGLKKGDVVLAGE
GADIKPGNALKLKDLPVGTVIHNVELMPGKGGQLARSAGTAARLVAKEGTYCHVELPSGE
LRLIHKECMATVGAVGNSEHSLVSLGKAGRNRHLGRKPHVRGSVMNPVDHPHGGGEGRSP
IGRKSPVTPWGKPTLGKKTRGKKPSDKFIVRGRKK
>SEQF2502_00575 50S ribosomal protein L23
MHITDIIKKPVINTEKARILLENNEYVFIVDKRANKLQIKDAVEKLFNVKVQGVNTLNIK
PKNKRFRMSMYKTSAIKKAIVKLKAGESITAYEG
>SEQF2502_00576 50S ribosomal protein L4
MPVLNIYKLDGSQAGTVEVNNEIFGIEPNKHVMHEVLVAELAEARQGSASTKTRAEVRGG
GRKPFRQKGTGRARQGSTRAPHMVGGGVVHGPKPRNYAKKVNKKVRILALRSALAQKISE
GNVIVLDDFALETPKTKTFVEFAKTLNFNGAKQLYITNDDTDTVDRDYFLYLSTRNIEKV
AAINTRDLSVYWLIKQDKVVLTKEALATIEEVLA
>SEQF2502_00577 50S ribosomal protein L3
MILGKKIGMTQIFEDEKLIPVTVIEAGTNFITQIKTEEKEGYNAITLAYGDKKEKNTTKP
LLGVFKKAGVTPKRFLKEFKVANPADFTLGQEIKVDVLEGIEFVDISGTSKGKGTAGVMK
RHNFGGNRASHGVSRNHRLGGSNAGGAASNSNVPKGKKMAGRLGAEKVTVQNLQVIKFDV
ENSLLLVKGAVPGPKNGFLVIKKSVKKY
>SEQF2502_00578 30S ribosomal protein S10
MDKIRIYLQSYDHKLLDQSAKKIAEVAKKNGSELAGPLPLPTKIKKYTVLRSVHVNKDSR
EQFEMRIHRRFVEIKNSSQQIVNALASLNLPSGVGVEIKQS
>SEQF2502_00579 Elongation factor Tu
MSEKGLAEKVDFENIDQAPEERERGITINTAHIEYETEKRHYAHVDCPGHADYVKNMITG
AAQMDGAILVVSAADGPMPQTREHILLARQVGVPYIVVYLNKVDMVDDEELLELVEMEVR
ELLNEYGFPGDDVPVIKGSSLGALNGEQKWIDAIVELMDAVDEYIPTPERPIDQPFLMPI
EDVFTITGRGTVVTGRVERGVVKVGEEVEIVGIKPTSKTTVTGVEMFRKLLDSGQAGDNI
GALLRGTKKEEVERGQVLAKPGTITPHTGFKSEVYVLTKDEGGRHTPFFTGYKPQFYFRT
TDITGEVNLPEGVEMVMPGDNIEMTVELIHPIAMEEGLRFAIREGGRTVASGVVATITK
>SEQF2502_00580 L-cystine transport system permease protein YecS
MDFNFIIENIPKYLEAMRLTVIIGIFGIVFSILIGIVCALVLYYRVPAARQIVGIYIELS
RNTPLVIQLFFLYFGLPKIGITFNSHICAVMGLSFLGGSYMCEAFRSGLESVTKGQRESG
LSIGLTESQLITNVILPQAFTVSFPAIAANIIFLLKETSVIGILALMELMYLTRDLIGLY
YKTNESLFMLVAAYLIIILPVSFVLTVIERRIRYATVGN
>SEQF2502_00581 General stress protein 14
MKTLVILAHPDMENSRINKKWKEELEKYPDKITVNELYKNYTDWDIDIEREHELLLSHDN
IIIQFPLYWYTYTPLLKKWLDDVLSYNWAYGNEYKLNGKNIGVAISIGGFENDYSKTGSV
KFSMDEILAPFEATVEYIKANLTSRYLLFDTENISDEELSENAKNYTRHILSL
>SEQF2502_00582 hypothetical protein
MKKIKENVKKLLLHFKSGFERFPVTIILAFMHFITGIYIAEVRSFQSDEFVEVNLLLFGS
IFITAMFEMLYEKYFYKKNRWLVRGAYSVLTFVVSVIFYVEYLRTNDYYNIYYFTLIPIS
IVLFLLIPILRKKESREKYLQSVFSNFVITGIFAAVLWIGIEIILATVNYLFFYSGDSLF
FRLTTYSFWFITEVFGASLFLSLLKKPNDNLENYEFPFIFNLLIKFVIIPLIIIYTGVLY
IYMTKVIISMHLPKGLISHLVLWYTAFSVFMMILITPFTQKDKFFENFKKYFPYFSIPLI
FASLFAVFQRTYQYGITENRYYVLISIFWLLFCMILYIRNMNVTGVFISLIICFIISVYT
PLSAKNVSNFSQSQRLKRMLIKYGALKDGKISKITQKLTNRQGSQIHTTIQYISNNSTIA
KLNFKNEKGEVYSTLGDLEKGLDVKESWKDYYAYESEDGEIPEKQKVITYKIKNIENAEV
ISDTTGYDNFISYRKIDNIEPIDQENESEKYKITIRNKIITIKSKDGMELAKINYEDAIK
QIVSKLKTLKLQDKKDEGYEVSQKDLEYIGTAEKINYKISLKRIDEQIVDGKTKDLYYEE
FDFMFSEKK
>SEQF2502_00583 hypothetical protein
MKIKYVIIFVMLLIVGNFLRLLIEDKNTPEIEISREKNYKKDKVKKDTDLTKSNVKFDIN
SIEYKDLLKLGINKNKAEKFVKYRDEVGIIKDINEVKNVSGFGKSGLEIAQKFLFVDDEK
IQNPRQNYGREITKYNINKLNEKELKKIGFANKEIKKLLPETEKNNIKSNVDLEKIIGKE
RYLEIEDKIKFIE
>SEQF2502_00584 Monoterpene epsilon-lactone hydrolase
MSLLSDIAVPIAKLVNMKKYREKDFLNPRRDTDFLNKNNFDKSLTTDEQFIDGYQILTVY
SEKSCNKHIIFLHGGAYVMRAVRGHKNIIEKLVKKYYLKVTFIDYPLAPENTVEKAHKVV
MEAYKEITKKYQSDKFYLFGDSSGGGLALAFLQRLKTEKQLPFPEKTVLMSPWADVSMTN
DEIEEFAEKDPLLPLNGLIVTGKQFAGRLDVKDPMISPIYGNMDNLGEIFLIFGTNEILY
PDCLKLSDMLEIAIGTSVEIKIGENLCHDWILAPLKETEETIDEIGKFFLK
>SEQF2502_00585 putative N-glycosylase/DNA lyase
MSEKIEEKNNENKINERINWEKHEEILEIYKKIKAGIEKAIKGYKKAWKGTEKEVFAEMA
FCILTPQSKAKNAWLAITNLVENGLLYNGKAEEMVEFLNIVRFKNNKSRYLVELRELMTR
NGELQPKKILSEIGDTFEKRKWILKNIKGMGLKEANHVLRNLGFGENIAILDRHILRNLK
ALNVIEEIPKSITEKKYYEIEEKMREYSDFSKIRMDELDLVLWYKEAGEIFK
>SEQF2502_00586 Extracellular serine protease
MTSNLKQLKEDIKKHNFAKSSIILGLAALLVSCGGGGGGGGGVGNSGGTSAATPTPVNPA
PVTTKPTVTATTSGIGWNSSTISYDKNNPHNNSNTALTGNDVKIGIIDVGFENSSFNPDL
TEKFGSRLTKLTIPGFTSEATANDDHGIVVADLAAGSSTGIAKGASVYVIDAAKRNTDKN
VTYPSVKLEMYQKLKDNGVTIYNQSFGIDGEVTDFNADNTSSHYYGFQIGSSMLDFYRNE
VNNGSLFVWSAGNDSSDKQPTLEGGLPHFESGLQKGWINVVALTSKYESKLGDTSWDNLT
PLSPAGVAKNWTVTAVGDQTFSMKGKNYVGGGSSFAAPIVTGTAALIKQKYPWMDADLIR
QTILSTATDIGTPGVDDVYGWGLLNIDKALKGPALFSKQLALADNVTINIPSGSYVFSND
ISGDAGVIKNGSGDLILSGNSTFTGPTTVNDGRLQVNGVYTSSINVKRQAILSTNNAVLK
NDVINSGTLENTGSTEVDGNYSSLENSRIVTGLNSNIHVKGKVSLNNSKLEVKPEENGER
KYITSNGITQNIITSDDKIEGNFNSVNTDEMLNAKLNQTENSVSAKVSRKNVLNYVEKLS
ESDEMQKNTAQNLETAFQKLDQDIENGTAGNVTQFERKAARLQALTSSNRAAVLDSLSGQ
IYASAQALTFQHSQTVNKDLSNRLVMLGTLDNVGDKFGLWISGLGANGKLKQDGYGKGDT
KVYGGQVGVDKQFGENLILGTALSYSKADVKFDRYGGKSDANNFGISLYGRLGNKDIPVY
LQGRLGIGFVDSDVERNIILSNNDYTRAKINHNDKVYSGYLETGYDVKNANGDFVVTPFV
GLTHDTVQRGSFSEEKSQFGLTADKKNYNQTAALVGLRVGKAVNWKSGSKTTFQGYVTHQ
RAFNKQDLSFDARYTGLPGATFKVKGIGLAKNKTWAGVGALTEVNKDFGWYVNYDGSVDG
GKGKGNNNVFTTGVRFNF
>SEQF2502_00587 Biotin transporter BioY
MKQNTLISNIIKIETKEKETFKNILLVLGGVAFLSIMSQILIPLPYTPVPISLGTFGVTL
MALLYGRKLGTATILSYVAAGSLGAPIFAGGKAGSLFSPTGGYILGYIAATIILGYLADR
GVTKSYVKTILSLILSSAIILTLGSLVLSLFVPGKNAFMIGVLPFLPGDALKSTTVTLLL
PTLWKFIPKNDK
>SEQF2502_00588 Iron-dependent repressor IdeR
MSRSIEDYLKGIYTLKKKKEYSNKKLAEYLNISPASVSEMIKKLANDDYLTIDKKTVKLT
EKGNSFALDIIRKHRVWEVFLFEKLGYEKKEVHKEAEILEHVTSNKLLQKLEKFLFYPKE
CPHGSPIFYDLENLDEENIIKLSEAEENDEIVILSVEDNIELYDYLRDLDINLKEKYIVE
RKDPFNGPIYLKSEQNNGKIVAFNAADMIEVYKKNKDLEETDNE
>SEQF2502_00589 Periplasmic zinc-binding protein TroA
MSKNNVLTKLNLVIAVCVAMMLLISCGKGGASSGKKIKVTTTTTMLTDLVKTIGGDKVEV
TGLMGEGVDPHLYSASAGDIEKLGNADIIVYGGLHLEGKMTEIFEKLTSQNKNILNVGDK
LDKSKIHLVDQNTPDPHVWFNTELWEKEAEAVEAELSKFDPKNSDYYKENLKKYKAELNE
LTTYVKTRISEIPEKSRVLVTAHDAFNYFGEQFGLEVKAIQGVSTDSETGTKNISDLANF
IVQRNIKAIFVESSVPKKSIEALQEAVKARGKEVKIGGELYSDSLGDKAHNSETYIKTVK
ANADTIVNALK
>SEQF2502_00590 High-affinity zinc uptake system ATP-binding protein ZnuC
MNQNVSDDIIIRVEDLTVAYEDKPVLWDVELDIKKGVLMAIVGPNGAGKSTLIKAMLDLL
KPVTGEVRFYDEKYSKVRDKIAYVPQRGSVDWDFPTTVFDVVEMGRYGKVGWLKKVRKID
KEKTKEAIHKVEMDEFSDRQISQLSGGQQQRVFLARALVQDAEIYFMDEPFQGVDSKTEK
SIVNILKKLRDEKKTVIAVHHDLQTVKDYFDYVTFINVSVIASGPVEEIFTPENIEKTYK
SKKATQNNGNLSEIEKER
>SEQF2502_00591 Manganese transport system membrane protein MntB
MNILNLLITDHTFRTVALGCLLLGMVSGILGCFAVLRKQSLLGDAVSHASLPGVCLAFLF
TNVKNTEVLLLGALITGIVCIGLIQLIQNYTKIKFDSALALILSVFFGLGLVLLSYLNKL
PGANKSGLNKFIFGQASTFIKRDVNIIFITGIILLIIIILFWKEFKIVSFDSDFAKTLGF
PSKKIEILISILIVTTVIIGIQAAGVILISAMLISPAVAARQWTDKLSIMVILAAFFGGI
SGLLGTLISISESNLPTGPVIVIIISIIVIISILFSNKRGIVFKIIRNQKRKKEFREKLE
NKKSELNSLKMNNLERGK
>SEQF2502_00592 Manganese transport system membrane protein MntB
MNFSLEIQLIAIMVASACSILGTFLVLKSMAMVSDAITHTILLGIVVAFFAVHDLNSPLL
IVGAGIVGVLTVYLVELLNSTRLVKEDSAIGVVFPLLFSIAVILISRYAGNVHLDVDSVL
LGELAFAPFNRIQIFGFSIAKGLVATFIVFLINLSFVVIFFKELKISVFDKALAITLGMK
PILIHYMLMSLVSMTAVSSFEAVGSILVVAFMIGPPITAYLLTDKLKVMIGLSLVLGAVA
SIIGFHFARFFDISIAGSIAVIIGVIFLLTLIFSPKKGLIFTINRKRSQKMIFSVRILLI
HLSNHANTKHEKDECGTETIDNHLRWNKSFLDKVIEKAKKEKYIYVDNDVFKISEKGEKY
LLNI
>SEQF2502_00593 Anaerobic ribonucleoside-triphosphate reductase
MQPQLTENLKNIIAGIVNVESNDTCNENANMSSMTPAGQMMKFASEVSKIYALENLVSPR
FKKAHEKGLIHIHDLDFYSSKTTTCLQYDLADMFENGFYTKHGYIREAQSISTYATLATI
IFQTNQNEQHGGQAIPAFDFYMAKGVLKSFRRHLKRRILSFVEIKNGVEITQEYEKNAKE
FLKKNVSSIKCNENEIKLLEEYFKINRDDLIKLLVEAYDDTQNETYQAMEGFLHNLNTMH
SRGGNQVVFSSINYGTDTSEEGRMVIRELLKATSSGLGKNETPIFPIQIFKVKEGLNYSD
NDYELARSDFDGILETVKKQKISYDDNSENKKSLFETPNFDLLLLSCETSSRRLFPNFVF
LDSEFNRHEKWRMDDPERYKYEIATMGCRTRVFENINGEKTSLGRGNLSFTSINFPRIAI
LTRKNVEKEIAEMEKDGKFANEEEKNNKKVELLTEEFQKRVLEATYLVGDQLYERYNFQR
TALAKQFPFMRSNNLWKGLGEKDGNDEVGDAINTGSLSIGFVGGANAMYALFDAEHGTSE
VAYKVLYDTIEKMGAVADEFRDKYHLNYSILATPAESLAGRFLRIDRDEFGVIKNVTDRD
YYVNSFHIDVKKEISLFDKIRKEAPFHKLTKGGHITYVELDGEARKNMGVMLKIVKVMKD
SGIGYGSINHPVDRCRDCGTEAIIYDKCPICGSHNISRIRRITGYLTGDLDSWNSAKQAE
EHDRVKHGIK
>SEQF2502_00594 Anaerobic ribonucleoside-triphosphate reductase-activating protein
MNKLKTEKEKILEKNFSKTPKNDFTLKILTTYKETIVDGIGLRYSLYFAGCSHACPGCHN
EYSWNPNHGNTLTYEILEKIAKEINENTLLDGITISGGDPLFNPVDMLKVLKFLKEKTGK
NIWLYTGYTIEQIRCDDLRKKCLEYVDVLVDGRFVKELYDPKIKFRGSSNQRIIKKEDFF
IK
>SEQF2502_00595 GMP synthase [glutamine-hydrolyzing]
MKEKIIIIDFGSQYSQLIARRIREMEVYCEIVPLIDIEKIKTGKEKVKGIIFSGGPASVY
EKDAPTVNPEVFNLNLPILGICYGMQLITHLNGGKVEKADSREFGKAVLEVKNNDNPLFI
GVKKSSNIWMSHNDHITELPKGFEVIAKTDSSIAAITNNNGIYALQFHPEVVHSECGTQI
LENFVFNICKCEKNWKISNFIAEKTKFIKETVGDEHVLLALSGGVDSSVAAVLINNAIGH
QLTCMFVDTGLLRKDEGKKVLEYYKEHFDLNIVFVDAKDRFLNKLKGVDEPEAKRKIIGN
EFIEVFNEEIRKLKGQEGAKFLAQGTIYPDVIESQSIKGPSHTIKSHHNVGGLPEDLQFE
LLEPLKELFKDEVRKVGHELGLPDTIIKRHPFPGPGLGIRVIGEVTPDKVKILQEADDIF
ITELMEKGLYDKVDQAFVTLLPVKTVGVMGDQRTYEFVAAIRSVNTIDFMTATWSKLPYE
FLEEVSNKIINKVNGINRIVYDISSKPPGTIEWE
>SEQF2502_00596 hypothetical protein
MKNLKITVSAMMVIMSISGMSASFRFFKKKNNDDNNKPAATVPAPTKASANSASQFCVDK
GGKSVTVKSSKGNYGICMLKDGTAVEEWEYYRQHNTPRNTEAAVIGMPNPASKFCVDKGG
KSVTEKDKNGNERGVCRFNNGTKVDEWDYYRENN
>SEQF2502_00597 CTP synthase
MDKQSTTKYIFVTGGVVSSLGKGIVASSLGRLLKERGYKVTIQKFDPYINVDPGTMSPYQ
HGEVFVTEDGAETDLDLGHYERFINENLTKYNNLTTGKIMSKIIAKERRGEFLGGTVQTV
PHVTDEIKYNVIKAAEENNSDIVITEIGGTIGDIESDPFIEAIRQLKREVGRENIAYIHV
TLLPYLKAAGELKTKPTQHSVKMLQGLGISPDVIVVRSEHPVDENIKKKISLFCDIDEEA
VIESLDAESLYEIPLTMEKLGLADVICKHFKIKNKKPLLIEWTKMVEKFKNPKKLIKVAV
VGKYIELKDAYISIHESIEHAGFNLDTKVEIDYFKAGEFDVRKLADYDGILVPGGFGDRG
IDGKVEAIKFARENNIPFFGICLGMQMACVEFARNVLGYKDATSTEFDKDTDYPVISLME
EQKGLKDMGGTMRLGAYPCVLKEDSLAAEVYGKTEIAERHRHRYEFNNAYREEFEKAGMD
IVGLSPDGNYVEVIEIKDHPYFIASQYHPEFKSRPNRPHPLFTGWIKAALKKQSEK
>SEQF2502_00598 Fructose-bisphosphate aldolase
MKYHYKDLGLVNTKEMFAKANKEGYAVPAFNFNNMEQLQGIIEACVEEGSPVILQVSTGA
RKYIGKEMLPWIAKAATAYVEASGSDIPVALHLDHGPNFAEAKDCVEYGFSSVMYDGSHH
PYDENVAEARQVADFAHQHDVTVEAELGVLAGIEDDVKAAEHIYTQPEEVEDFVSKTGVD
SLAIAIGTSHGAHKFKPGEDPKLRLDILAEIEKRIPGFPIVLHGSSAVPHQFVEMINQYG
GDIADAIGIPDSELRKAAKSAVAKINVDTDGRLAFTAGIREVFAKKPGEFDPRKYLGPAK
DYIKEYYKDKIRNVFGSNGAYKAGAAR
>SEQF2502_00599 Lysozyme M1
MEKFIKFLIIVIIVGGLAGFLEISGYLYHNEILAHMAGYKTQGLDISHHQEKVNWTRVDP
KYKFIILKATEGQNFLDTDFLYNWNNARLNGFVVGAYHFFTMTSSGTAQADFYISKVSAS
DKTLPPIIDLEISTKKYKKKDVVKNLEEMVDKLEEHYKKRVIFYVNYNTYNAYIKNEFPK
NKIWITDYKYFPKIKEDNRWIIWQVSKRGRIDGIPGFTDKNVLRKGMTVEDLIEQNKIN
>SEQF2502_00600 Serine--tRNA ligase
MLEMRYIRENADKIKEYLKNRNSDFDLDSLLKLDEDRRNLLQEVEMLKKERNESSSLIGK
YKQEGKDPAELLARMQTVSAKIKELDQKVAEIEEKQVQLTYTIPNKLHESTPIGKDEDDN
VEIRKWGAPREFDFEPKSHDELGVNLGILDFERGAKLGGSRFTVYKNAAARLERALIAFM
IDVHTQEEDFEEIFTPQLVKKEMMVGTGQLPKFAEDAYKIEGEEMYLIPTAEVTLTNLHN
GEILDEEELPKHYCGYTACFRKEAGSGGRDLKGLIRQHQFNKVEMVKIVKPETSYDELES
MVNSAEKILQKLNLPYRVISLCSGDIGFSAAKTYDLEVWVPSQNKYREISSCSNTEDFQA
RRAMIKYRDKETKKSHFVHTLNGSGLAVGRTLLAIMENYQQDDGSIVIPEVLVPYMGGMT
VIK
>SEQF2502_00601 hypothetical protein
MTENKKLESKNVFLDTENFSQFILKYKNNFEKRKYFQLDKNFKINIKEPSFILELAYIYF
DENKENENIKKIVNEQFLETFKEKGKKIGRISKIKMSKLVDGFRRSIFNRESIFAVKLGN
ELLYRDKSKFFEILYNYSLISMDVNKFVKTFFAEKMIEKIKIENNSKFNEIHDKIDEIIK
NILNYFTKSDLTFLNFENTESLNYFMENQVDELYKKIYVENFDKIVEKYNIQNVKKMKFY
KSYDFQNLSESKKILYKYIESI
>SEQF2502_00602 Tetraacyldisaccharide 4'-kinase
MKLLSIIYGFIVFLRNKLYDLNIFKEKKADGVEIICIGNIVAGGTGKTPAVQYFVQKYLE
KNKKVGILSRGYKGKRETDLLLVRDEKKIYATSKESGDEAYLHALNFQIPVVVCKNRYEG
ATFLKEKCDVETIIMDDGFQHRKLKKDKNIILIDATNPFGMDDYLPKGRLRESLDALKRA
DEIIITKSNYASEEEIAKIKERLEKYGKPISVATFEESYFYKLNFENKKKFGKMNNKNNI
RNEKFPLEIIKNKNVLIFSSIANPAVFYQTIKKLNPNNIEEIKFSDHHVYTNEEILEIKK
KSKNYDYVLTTEKDIVKIDENIENLLILKMEFKIVEK
>SEQF2502_00603 Putative sporulation transcription regulator WhiA
MSYSANLKREIFNLENSDKESVYSELFGIFIAKNVITENGIYFSTENVSLAKRIYSNLRA
VTGIPIQLKYVISKRLGTHKLYEVILFPTQHNQQEYKSFLKKIYFHKNFSVVENEKQLAG
IIRGFFLSCGYIKSPEKAYAMDFFVDSEDSATYLYYLFKQMGKKVFQTEKKNKSLVYLRN
SEDILDIIFLIGGINSFFEFEEVTINKEIRNKINRNMNWEIANETKKLSASEKQIHIIKV
IDQKLGLSELTDILSETAKLRLENQEMSLQELADLMEISKSGIKNRFRRLETIYKGLVEN
>SEQF2502_00604 hypothetical protein
MKKNNSKKILFIAGMMILSAVAYGKDVFANYGTNFGKVRLSQLSSPNMEDVKRLDSSTYE
LTGSGEYRIMEEGGRRLVVNLNNGILNGKYDEYYANGNRFTLGNYINGKKEGEWTVYTEN
GQVWKKYQYKNDQLDGRYTSYYAKTGAQETVGNYENGKMTGTWTEYYENGSRKSQGNYSD
GQKNGLFTEWNMSGGKKSEIDYVNDEINGKMNVYYENGSPLYEANLNGETGTVKGYYTNG
SLGFDGSFRGRRRTGTWTYYDKAGNPRKVSY
>SEQF2502_00605 hypothetical protein
MFWRNDFRDEVGKSKVFTLLIMILGLFFINQINYSVGNSQVKKIQIEYFGRKDCKNCANL
EKFLKELSTKRDDFEYVEHKIDESKEEKAFFDETATKLKLVKGTPIIYVDEHIIQGFNTA
ETTGKEIEELIDSGKTKDKILSLKEYLESGQAGKGNVSSNGAVCTGDKVCEIPGLTKRAE
RQVLVNIPIINKTIDLTNYSLLTMSIVLGTIDGFNPCAMWVLVLFLTALIAVGNKVKMFR
VAGLFILAEAVMYFLILNAWIYTWDFVGLDKWVTPIVGIVGIAGGIFFIKNYLKKGDTLE
CEVTDFEQRAKISRKVKDIANKPFTLLTALAIIGLALSVNVIEFACSIGIPQTYTKILQI
NEVPFWARQFYTFIYIIGYMIDDIIVFWFALMSINKLQLTTKYSKWVNLFGGILMIILGL
IMLIKPSLLIM
>SEQF2502_00606 Holo-[acyl-carrier-protein] synthase
MEIYGIGTDIIEISRIEKAIKQTSLFKRKVYTEKEIEHVEKKKHPYSSYAGRFAAKEAVS
KAFGTGVHGFSLSDIEILNDELGKPYVTLYNVIKEKAQGLTIQISISHSREYAVSTVIIY
KK
>SEQF2502_00607 Tyrosine--tRNA ligase
MTELEIKQEVERQFNILSRGCDEIINENEFKKKLEKSISTNTPLRVKLGIDPTGSDLHLG
HAVPLRKLKQFQDLGHDVFFLIGTFTGRIGDPTGKSETRKMLSEEQVMENIKTYLEQVKL
ILDLDKINVVYNADWLEKLSLSDALNLLSQFTVSQMISREDFSKRLSENKPVSLIEFMYP
ILQGYDSVELHADVELGATEQKFNLLRGRDLQKNFGQEQQICMIMPILVGLDGVEKMSKS
LGNYIGVKDTPNDMFGKVMSISDELMENYYTMITDVPFERIEEIKAQIADGSLHPMEAKK
QLGAEVVKIYYGEKAAKEARDWFENVFSKKNLDVDLPEVEVPYGEINVIDLLVKEAKLLG
GTSEARRLISQGGFKINDEPIKDIKASVNIESGMIIRAGKKKIVKVK
>SEQF2502_00608 Phosphatidate cytidylyltransferase
MLSRLFIILLFVPFLLWIFLKGNLMFLVFTLVIIGISLFEFYKMLKDKGFEVASRIGMGL
GLFLPVAIYFQENSKNIFSYFKFELFKQINFDMGGFIVFAIILLSLRQVFKVKIHNAMAE
ISYTLFGIIYVSYLFSHILLIKYEFPNGKILVVMTFMLIWACDISAYLVGMAIGGKIFRH
RLAPKISPKKSIEGAIAGILGVFLVILSFDKIYLFIANFVCGISFLSKNCSVNYDYVAIG
GLKAFILALAIGIFAELGDLVESKIKRELEVKDSGNLLLGHGGFLDRFDSALFVLPIVYY
FMKYVAYL
>SEQF2502_00609 Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)
MDRDKLAIPKHIAIIMDGNGRWAKERGKIRLEGHRAGAASLEKILRYAGEIGVKYLTVYA
FSTENWKRPQKEVNGLMDLFGKYLDKEKKNLKKQGVKLVVTGEKENISPKLLKKIEDTQK
FLEDCSKITFNIAFNYGGRREIVSAVNKILSENETKKIEKVTEEEFSKYMYRPEIPDPEL
VIRTSGEFRISNFLLWEIAYSEFYITDVFWPDFDENELDKAILSFNKRDRRYGGLNVK
>SEQF2502_00610 L-cystine import ATP-binding protein TcyN
MIKVENLKLSFGKNEVLKGINFKIEKGQVISIIGPSGSGKSTFLRSLNFLETASSGTITF
GNETFDLSKINKKDINRLRKNTTMVFQNYNLFKNKTALENVIEGLLIVKKMNKNEAIEIG
LKMLEKVGLKDKAEFYPNQLSGGQQQRVGIARAVAMSPEVILLDEPTSALDPELIGEVLK
VIKDMVKENMTMIIVTHEMQFAREISDYIVFMDSGKIIEEGVPEEIFKSSGSKRLQNFLR
RYYDNEIDIYSI
>SEQF2502_00611 putative amino-acid permease protein YxeN
MNNNVPFLNWGFMVRAIPEILKALPMTLNIAIVTMIFSLILSFFIALVRINKIPVLTRLA
TIYVSFIRGTPLLVQIYLAYYGLPKILDYIHLKYGFNIDVNNIPAIIFVYVAFILNVSGY
LSETFRAAIQSVDKGQVEAALSIGMTKWQAMRRIVLPQAIIITFPNFGNTFISLIKDSSL
AFSVSIVEMIGKAKIISASGLDIFEAYIVVSGIYWVVCIIVEKVMGIVEKKLRVGGL
>SEQF2502_00612 L-cystine-binding protein TcyA
MKNILKLTGILLIGLFLISCGGKQENGKSGSSEGKQKVKVGTEGVYAPFTFTDGSGKLTG
YDVEVVEEIGKRANLDIEFVPTPWDSMFLGLESKKFDFIANEIAKNPEREKKYTFSDDYL
VSAAQIIVKKGRTDIKTLEDLKGKRVMTGVGSNYNKTLTDFDKNKEINYAYFDGNVSIAL
EEIAQGKADATLNDRLTVGYFTKQRGNLVEIVGEPVTKTPVYFTFRKDSEELKNKINKAL
AEMKADGTLAKISEKWFGGDYTK
>SEQF2502_00613 L-cystine-binding protein TcyA
MRKIKLLLGILLMLILAVSCGNKTNAGKKRVIKVGTDGVYAPFSFKDESSGKLTGYDVEV
IQEVGKRINADIEFTTVPWDSIFLGLESKRYDIIANEIEKTKEREEKYIFSDKYLVSAAQ
IIVKEGENNIKTLKDLEGKRVISAVGSNYSKTVEEYNKTAAKKIDLNYFDGGITLTLVEI
AQGKADATLSDRLVVSYYKKQQGDKVQLVGEPLSTTPTFFLFRKDSEELRNEVNKALAEM
RADGTLAKISEKWFGGDYTK
>SEQF2502_00614 hypothetical protein
MKRFIIAVLLLIFMSFSIMAENTGNVSFSVSEIKSNNDILLKCSNMAGENAQGTGITENN
GNNIFLKCINSETGSENIIGTNKISSQNILLKCLNTSESTEDELTKDVNTAEKLLKCSNI
VRIIKIDELSQIESANAVQLKCSNTVTNNIVLKCSGTSENLLKKETTINSGTVNTAEKLL
KCSNIVKVIDGNKVFSDNLGNYDAVILNCTDTTEKNSNIIGNIAQPKVNIGSLGGNIGGK
VPVGPIIGGVAGASAVGAIAGGIGHHKGGGKGGNPGHQNGRNDGGKDDNPKKQKKDDTKI
HNVKGIGIQPVNPFWRSNLREAEDSYSKIAGAGFQWVRITASWHRIQSSKNGRYDWQDID
DAVALAKKYNLKVLMQISGAPEWATGADKLSAAEKNALNARKIWVASFAPLPQYNNEFSN
FVSALVKRYAPKGVIDYEFWNEPGNPEFWHDTIQNPRPNPEHYTDLLKIAYTAAHDAHND
VNVMAGGMTVGASNSTTGYVGPMEFLERMYRAGAKGYFDGLSHHPYGIYARTFRDNGWAN
MIGDVVAPGGGEKTLYQIMSEHGDGNKKIWITEVGIDAAYPGVEETKQANVISKILDQYQ
KSNIYGPLIFYQAKDRKPYITSGILDRDSNGDGWLDVNIDTNGDGVPDANIDTDHNGRPD
ILDAADPENYFGIWKSDGTEKKAVDVIRRFINNNHPAPSPTPAPLTNGCDSATDASGQWK
SVKCWEFKGRNIPSDWVSKRIINHLGSHLTYLPSSISLDGDHAILTTRRHCVNRKGDPLT
DANATTGVCPAGKVTQYSSGRLESGNIVDASKPFRAEIRAKMNWNHLQGMRTALWMQKQR
NDVDTPACKVPGGNAPYGSLLILEWFSSTPSYAWPATNISCYYSQVNHEWTPRGFTHRLE
NIVGGHTTSLTHEWHVWAIEFDGTKVRYYMDGRLIPVVHYRIKDAQRISVVDNTRYDQYG
NYLSTMPDEDFSKLNIPSALVKQGFENDRWHFIINDYVEWEPALNPPSEHSPFPVQTTEI
DYVRLYQK
>SEQF2502_00615 hypothetical protein
MKKLHILSTMMLSAATAMAQEIKINGGWDFDRAYKNDLTKHQKGLSNTIYDYKFKNGPVA
GIEWLFDNQGRLELGIGAEHKFSVKSSALKDKNEMKMYEITPMYLTSKYNLVTSKEGNDL
VYLIGRVGYAKAKAGRDNKEDLNDKNFRGGLYYAGGLGTQIGPISIEALYERSNLRYDKV
NLGNINRNNISTLNNFKKTKDNINTVGVRVGYSIGNIKNLPKKKNETVPFDPFRTDIFAK
TGDMQYTTDKIQKRKWNGGELRLNAGYNFKNRYNIQPEQFLGTGMKNNKWQSAKSDFDIK
KMPVVGLEYLFDNQGIVELGLGVEQKFLDITAFFNDKEQKHVLRTYPAYATTKINLVNNK
GNNLLYAVGRIGYVHGEIKEENFNKKDLHGGLYYAGGLGTELGPVSIEALYERSNFKYQP
KDTVSPIKTKGKIDTFGIRAGYRIGSIKNKPKIKEVKTAGYAYNDIPEEDRIDIINNLRD
KSKEVLTSRKNPIKRQKSLENEIKQARVAGYNTYNDIPEEDRIDIAGNLKGKSNTVSTLK
KGTVKREKYFEDEIKKENGKTVSEEDSIDIINNLSFNRL
>SEQF2502_00616 Hopanoid C-2 methylase
MKVKMILPALTEAESPFWRPVKYSLFPPLGLATLAGYFSEDDEIDLQDQHVEKLNLEDYP
DLVIIQVYITNAYRSYKLADYYRKKGSYVVLGGLHVTSLPEEALEHADTIMIGPGEDIFP
KFLQDFKNRNPQKMYISTHRTLIGAPPARRDLIKRNKYLVPNSIVVTRGCPHHCDFCYKD
AFYQNGKSFYTQLVDDALKEIDRLPGRHLYFLDDHLLGNPKFAAELFEGMKGMNRLFQGA
ATVDSILTGDLIEKAAQAGLRSLFVGFETFSPENLKSSNKNQNLKRNYEKAVNRLHSLGI
MINGSFVFGLDYDDKDVFKRTVEWGVKNAITTSTYHILTPYPGTRLFKRMEDESRIITKN
WDLYDTRHVVYKTRNMTADEIEQGYNWAYKEFYKWSNIFKASGNHEISKHKLKHFFYTAG
WKKFEPFWNFIIKTKHLNNMTPVLESILSNVRKNK
>SEQF2502_00617 Processive diacylglycerol alpha-glucosyltransferase
MAHINTVALKSYEVLKQAKKKGKPVIYHTHTTYEDFRGSIKGSYVLSPIIKFWTKKLYNE
ADYLISPSEYTKNLIKSKYLEKEKEIRVISNGVNINKFNKNEVLKQKFLNEYKSVYDINK
PLIITAGLPFERKGIKDFVKVAQECSDYQFLWFGSSSVKSMLPDKIQKIIENPPENLIFP
GYVDTDILIGAFSAAKAFLFMTYEENEGIVVLEALSAKLPLVVRDIPVYEGWLENGKTCF
KARTNEEFCQKIRNIVENNVENLDEITETAYNIAVERDLLNIGKKYKEYYEYILNQKNR
>SEQF2502_00618 Alpha-monoglucosyldiacylglycerol synthase
MRIGIFTDTYRPQVNGVVSSIMTLEKELRKLGHKVYIITTTDPDAPQVEPNVLRLPSMEF
KPLPQYRLGMIYSAKIIKKIKRLELDIIHSQTEWGVGTFARFAAINLEIPLVHTYHTLYE
YYTHYIFGSRFVKAGKKIAAAISKFYCEKCNALIVPTRKVEDILYSYGVDKTMNIIPTGL
ELDKFYRGNYSEEDLRFMRESFGIDENEFLCVYIGRIAEEKSIDLLIDMFSKIKDEKFKF
MIVGRGRILDDLKKQAEKLGISDRVIFTGEVPHDKVAAYYQMGDVFLNASVSETQGLTFV
EAMAAKTPVVARYDLNLEDLLVKNEAGLVYRNEKEFIDSIMLLKENKEFREKIIENAFVA
SQDYTAQKFGERVEAVYKKTIEEYDSRESFTIFRGEKFLQQIRRWTSLKSSGRSPWSK
>SEQF2502_00619 Ribosome biogenesis GTPase A
MNINWYPGHMKKTKDLIVENLKIIDVVIEILDARIPISSKNPDISKLANNKKKIIVLNKV
DLIDSKELKNWEDYFLKNNFSDYFVALSVEKGTNFNELRKITDKIYAEKLEKMKKKGLRK
TEVRAMIVGIPNVGKSKFINKFVNKNKARVGNTPGFTRGKQWIKIDEKLELLDTPGVLWP
KFEDDEVAYNLAITGSIKDNVLQLEQVAMKFLDKLKDLGKIDNLVKVYNLEEYITNEEIL
EFENHKILEILEKRLGVSKNDEHNYEIISRRLMKDYRMGKIGKFFLEIPKN
>SEQF2502_00620 Ribosomal RNA small subunit methyltransferase I
MFYVVGTPIGNLEDMTFRAIKTLKEVDYIFAEDTRVTKKLLTHYEIEKTVYQYHEHNKLH
QITNIINLLKDQKEIALVTDAGTPCISDPGFELVNEVLKAGIKVIGIPGASSIVTGASIS
GLDMRRMAYEGFLPKKKGRQTLFNKLKEEERTIVILESPNRILKTLKDVREYLGERYIVI
TRELTKIYEEIIRGNVSEIIGKLEKKPIKGEIVLFIRAINDDGIYLKNKNIE
>SEQF2502_00621 Carboxy-terminal processing protease CtpB
MKKNKIVQTVLGLVLVSMPLFAATTIVKTSRNDKDTSAGYTKDATELNRIVDVINIIENN
FVGKEATPSKNDLYEGAVAGVVSRLKDPYSEYLSKADLNDFSEDMDGEYVGVGMTISKKK
GEPLEVVSPFIGSPAEKVGIKIKDKITKVDGKDILPLTANETVKLLKGKEGTKVDVEVVR
EGKKDPMKFTLTRAKIKLEMVESKMLENNIGYVSLLKFGNHVGAEVEKAIKDLQAKGMKG
LILDLRSNPGGSLQEAQDIASLFVKEDLIVYLKYKNGQQRNYNRTLKNLGNFPLIVLTNK
GSASASEIVTGAIKDYKRGTIIGEKTFGKGIVQQVIPLRTEDAIKLTIAQYFTPKGNYIH
EKGIEPDIEVKMEELLALKGYSNDGEQARKNREKEIEEILTKDKGKEEAAKIISAGDVQL
KRAIQEMNKKINGTGKRK
>SEQF2502_00622 Hemolysin A
MKKRLDLILVERELLETREKAKREIMAGNVIVNEQVVTKAGTMFKDDDDLNIRIKNKLKY
VSRGGLKLEKAIKTWNLDFKDKLVLDIGASTGGFTDCALQSGAKYVYSVDVGKNQLDWKL
RNDERVFSIEEMHIKDLEEKDINNKKVDFIVIDVSFISLTKVIPYFEKFLAENGKIVMLI
KPQFEVGKEKIGRNGVVENEEYHDEAIKKVISFSKECGYELIGVEDSPIRGAKGNKEFLM
LLKFS
>SEQF2502_00623 DNA mismatch repair protein MutL
MGYIKILDEKVSNIIAAGEVVENPASMIKEMIENSLDAKASMIKIEVFKGGVDVKVNDNG
VGMDKDDTLLSVERHATSKIKEKEDVFNLNTYGFRGEALSSIAAVSKLTITTRSENSPMG
YKIGCYGGVVRKFEEVSRNVGTEMEVRDLFYNTPARRKFLRKMSTEYGKIRDIVLKEALS
NSNVAFSLELDGKSTIKTSGKGIENTILELFGKSVLKNLKKFEYGYLGNVEILRSSKDFM
FTFVNNRYVKSATIERAVIDGYYTKLMKGKYPFAIIFYNADPKEIDVNVHPSKKIVKFSN
DKIVYNEIKSAIDDFFYYNDRENWQPNIDLIKKNININENIAVEKDDLFSDDILKGENQK
ILSLETFDGKECSEKSEGKNEFLKDNVEKSNENNGFTNNEEKKDKEENNLNLDEIWKKMN
GNLDKSVENNVENSQNIENSNLLKSKKDNRNWSKNSNFENYENFNERKNSNSVNENTASE
YYKVGTFEKHIGKQIHYDILGQIFDTYILVRKDEELEIY
>SEQF2502_00624 hypothetical protein
MGKLRKFDIVTGILFGIATIILIYLFFNNEIFFTWAFQRHRNILSWYIRPLFIVPIIWSA
YKKLFSGISISIFGLFTSMFWFSKPNITNPEIVKFLNFESNYLKSGWTIDKIVLFFTVII
FFIFIIISTWTKNWKLLLVILIAAAFFKIFNSYLLTGKSAFSMLMPAVTGLIVCVMAVFF
LKKKN
>SEQF2502_00625 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase
MWSGKYLGRENLIKNKGEKMVKVKSYANIAIVKYWGKKDAKKMIPATSSISLTLNDMFTE
TEMEFISDEDIKISVEKEMKNGDYKDKFSDMADLFYLNGELQDSVHTEKISKVVDLFREN
RSQKVKISTTNNMPTAAGLSSSSSGLSAVIKACNELFGKNYTQSELAQISKFGSGSSSRS
FFGPIAAWDKDTGEICEVKTDLKLAMIVLVLNENKKKISSRNGMELCAKTSTYFDEWVKQ
SEIDFINMKKYLAENDFEKVGTLTEENALRMHKTTETANPPFSYFNEKTYEAMDFVKNLR
NNGKKCYFTMDAGPNVKVLCLEENLEKLAGIFGKKYKVIVSKTVKL
>SEQF2502_00626 Galactokinase
MREAETKIGIGKSHSKIILIGEHSVVYGYPAIAIPLKKIEIECVVEKAKNSFFCNETDTL
SVAIFTALKYLRKENVKIKYRVISQIPQKRGMGSSAAVSIAAIRAIFNYFGENLEDELLE
KLVNTAEIVAHQTPSGLDAKTCLSDKAIKFIKNKGFSYIDLNLDAYLVIADTGIYGNTSE
AIQNVKNLGSKADVPLKKLGELTDEMAKILSENSEPKGEKVDKIGKIMTKANTELKNLNI
TIKKTDLFVKTAIENGANGAKISGGGLGGCVIALAKNLKIVEKIKDGFTKCGAENIWVEK
I
>SEQF2502_00629 hypothetical protein
MMESFKNFIKVTLIGAPLLNKMIGIFLISMLPIIELRGAIPIGAAIGLPWYLNMIVSIVG
NMLPVPFILLFSIKAFEFMKRRNILVKFIEKIENRAKKRSEGLATGEFIGLMLFVAIPFP
GTGAWTGALIAALLQFERKKSFFYIGLGVIIAATVMTLASYGVISFFAPKH
>SEQF2502_00630 hypothetical protein
MVKIEMAKPINFNELITSKEAEVVSMRILNQPNSYISLFSLAKDEEITAEAMLGNRYYYC
FNGNGEIFIESNKKIISSGDFLEITANHNYSIEARDNLKLIEIGEKMGDKNMENKTLKML
ESANAFNLAEVVEYQEGKIVSKNLVAKPNLVMTIMSFWKGESLDPHKAPGDALVTVLDGE
GKYYVDGKPFIVKKGESAVLPANIPHAVEAETGNFKMLLILVKE
>SEQF2502_00631 Glyceraldehyde-3-phosphate dehydrogenase
MAVKVAINGFGRIGRLALRLMSEQTDKFEVVAINDLTDAKMLAHLFKYDSSQGRFNGTIE
VKEGAFVVNGNEIKVFAEADPEKLPWGKLGVDVVLEATGFFATKEKAEKHVKAGAKKVVI
TAPGGNDVKTVVYNVNHEILDGSETVISGASCTTNCLAPMAKALNDKFGIVTGTMTTIHA
YTGDQNTLDAPHRKGDLRRARAAAVNIVPNSTGAAKAIGLVVPELNGKLDGAAQRVPVPT
GSLTELVSILNKKVTVDEVNAAMKEAANESFGYTEEPLVSSDIVGIHFGSLFDATQTKIV
QNGDAQLVKTVSWYDNEMSYTSQLIRTLGYFASKIAK
>SEQF2502_00633 hypothetical protein
MKKLLFLIMMIVAGNAFTAGTQANEDMAIKRALQSRLNSFFFTIVNEGIRDNERNLEKEA
YSKLFKKDYIISNSLKREIVEKYAREISRITANETKLKFDVKQIDYLSNGEAEVVYDIKS
KSLKSVPDMLEVDDETERIILERAKMSESELEAIMKERGNEPAKRNYYNIAIEERINMYE
KEAKKVTDEEVILQDLSALMVKVDGKWESENLEKALRGIKE
>SEQF2502_00634 hypothetical protein
MKKLLFVLMLAVMGNALAGTTVQKNRNTSMNMVSGSEKIKIENAFQKDMENIKKIVENQT
LAEVIKDSFSNNADLLFDKDYKISDLNKKKILEKFSKGCSDIYLKNMKLRFEVKNIKSID
NKNVEVVYNVKMKDFDKALEGIEKRFEENVRINVLKKSGYKSEDEIEALMVKNGNESEKV
RIYDIMVDEILDIMGKALENTSLETVISANEKAVLTEVNGQWELSELK
>SEQF2502_00635 hypothetical protein
MKEKIQQDLSKAGVKQEIIDETVKLDKKFGEGFVEEDGDGKRATESKDEWEKLYQKDKRN
YVALERLIESYFVTGIPNDPQKKKYVSEYLKMDIPEDRKNFVLGKDFWNCSKNKDTKNEY
FEKVKKISNNQYYLKGIDFFEYISKETENIKEDGNSKLMKQKIDEITQKMDEIDKILDNK
NLLEKYRISDEEAYSDQLTFFMVCGILKAFTGDTEGMVNDFINKIANKKISKEVAEYNKN
KEMMTVMTIQMVMALKGFFGEMSEKEITKLEKLTKKLQGTEMFKRIMENSEKGETIENDS
YLEEKRKNFESLSDDDQIKQIVNQKKFDYIETRIDKEKKIFDWTFGCSGLNCKLIFLGKN
KDFEKKIKLKDLKEKEKIVRILIFGKKEEDEEISEGVFLRRGTDSKDNKFYVYDDKNEDK
ILTVFAAQNENLDFFKFVNEILGEDYRNIEAKYGGRD
>SEQF2502_00636 hypothetical protein
MEIYKLSFIAIVLFMIHEFEEIIFVKKFIEKNKVVKDMKNELFVKKKGNYPSTETISLMI
AEEFIILSTLLFIASEISMYEMVLSLFIVYIAHLVPHMYDALRYRKFSPGSRTSFIIFPL
GILTIWNVILNKEINLVILILCVIIIGFLMILNLLFLHKISKKIDRYLWK
>SEQF2502_00637 Cobalt-precorrin-5A hydrolase
MRTAVYCVSKNGYETCLKIRNNVYKNLHIYVSQRVANMLNLESENVENLFVINERVPILL
EKTFDKYDLHIFVAAIGAVVRIIEGKFKSKDTDPAVITIDDHANFVISLLSGHLGGANEE
CKKIADGIGAIPVITTASDVGGKIAVDTLSKKIKAKLESLDDAKRVTSLIVNGENVSIHL
PKNIVESNKNCAGAIIVSNRKNIEISKIIPKNIILGIGCKRNTAKEKIIEKINYVMKTQN
LEIDSIKKVASAWVKSDEVGLLEAMTELNIPIEFFEKEKILEVEDLVEERSEFVKNQIGV
YGVSEPCAYLASSRKGNFLVKKVKLEGITISIFEEEM
>SEQF2502_00638 hypothetical protein
MKIKLFKIFKYFKDIIFWNREKYNKYYKALKKFYPEYYLSINDYEEDDVDEEIEETILET
EKFQYFKNGEVEKLLKEYYESSNISFSFLERKNFFDKLKKECTTQDINKIYSLIFEGDKC
VETDNLRFANKIDKILNQNKFDKDFFKYNLMNNGKSELKEILKKYEANSEKGIKKFIKKY
FFLKYNKILGLCINSNENILKNWIFSKPFFLNIENMMFKYKMKKISNEAISGYVFYITLI
PLCLQFTGIMLMLMGSLQINYWIISLVIGIIFLILDWDALINYREIEGGFSAGMTNCYLF
FEPIIYLIYHLKYQNFSYESFYQLLGLNLIFIIYFIIKQRIVYLRVKKVSKYFIDSILGK
TYTKELIVENEIQEIKKSDLIENWIKLLKSKLSKLVLKKYVFRKVPEYEGLIEDFIHFES
DDKKKILEILKSKEIIEKSKIPKKEKKLLYKRLKL
>SEQF2502_00639 8-oxo-dGTP diphosphatase
MITTLCYLEKDEKYLMLHRTKKENDINKGKWLGIGGKLEAGETPEECLKREVQEETGYEL
NSYEFRGLVIFNYNDDESLFMYLYTSSDFSGNQHECDEGNLKWIPKKEIFDLKLWEGDKI
FLELLFKNTPFFYLNLNYENDNLLSSKLEFKEKYSCFEVFVPENYVEKIVENLQKYNLLT
EGFYADVYSTIDGIGHWKTLEGGNPFDGEVGKSSVANEKIMKFRVKKEFCELAYYLIKEV
HPYETPVINVFEMEV
>SEQF2502_00640 hypothetical protein
MPRNKKEGIIFGVTMCFLIVCGMSAYNLTLVEKLRLHKVMDTLLKSFDCTFQIFVIFIFY
CSFIYAISLIS
>SEQF2502_00641 hypothetical protein
MMNLVKDVIKKGVQIMKRQFFKIFVLLFFIGNLSFTGNVSNKWKVFGNKEYDIEISKGRR
RLNDEISVDDEGVYYLGIKVKNSENLVNIKQEKLKINFKNLELIKPNVKNIVEKKYFLKD
GERIFAIYGTLINELKGVDYNTFKLISEDVALDKDKIYIFGIGEIIVEQGYHGPYFSMEK
ITGTPPAEDFKFINENLKHNKMFFENNKKLYFLSDGWLNEYRAKELKNIDKKTFKPLEYE
FIKDKKSVYYYNSEIDDFVKLEGADTKTFEVIGNGYAKDRNKIYFYDIFRINKYPIKVFA
DKNSFTIFENMDAEGFSYAKDKDHIYCNGKILEGADYESFKTSRDERYSINKGTVKDKNH
EYLKCTIKTF
>SEQF2502_00642 hypothetical protein
MEIIKLENQKNDSFFEAECFLHIGEAKEDKNYVAFDLRREDDLLYSCSYYDFEKEKGDKI
FHCFDGQDYSWKCYENEVTNDEKLKNEIFGNYDILRNSTIRYLKEIIHKNKVDFSKKLIE
LLEKIKAGEKIDKKEFRIELKKVGLYKSIWKEKTEIFDDVVTREIGFENIMKFIEENNVN
RVIFEDGKFLEKEEIRKYIKEYTIVEFRDFKPIKDFDMIKMTLEEWNNLKKWKKLEVENN
IIEIEEKDFEKDVSIYRLNGKKINAKIEVTDFVEIKNKFLRYFNKWFSKGKDDNLREKVV
IKGVIRDGRKFYNWIFLDKNNKITTREEYDEFGKRCD
>SEQF2502_00643 hypothetical protein
MKKLITIILFIFSMQIFAEQYQVIKQKNVTLSKEQIDLENKKIEETVSKYPKKVLQEMIS
YYFSVASKVNNEMSKEEKESMQLLSKELPSFFSEIFDNSKFNVKTIKYLSNTKVSVTYEV
VIPDSDKILDDKEMKKRFFKKYGYEMKDDEDFLSPSEVKKRKDIINEMLREGVRNPKNYM
TDKVTNELNKIGNEWKFKDVEKFEEMLNKMK
>SEQF2502_00644 Cobalt-precorrin-4 C(11)-methyltransferase
MKKVYFIGAGPGDPELITVKGQKIVKEADVIIYAGSLVPKEVIDCHKDGAEIYNSASMNL
DEVMEVMIKAQKKGKLVARVHTGDPSIFGAIREQMDILDEYGIEYEVIPGVSSFVAAAAA
IKKEFTLPDVSQTIICTRLEGRTTVPETESLESLASHKCSMAIFLSVQMIDEVVKRLLKH
YDKTTPIAIVQRATWEDQKIVMGTLENIAQKVKDEKITKTAQILVGNFMGDKYSKSKLYD
KTFSHEFRRGVEE
>SEQF2502_00645 hypothetical protein
MSKIEKGIESSMVYLQIKELMENAKKQVFVKINNILVQTYWEIGKIIVEDEQKNKERAEY
LIENKKI
>SEQF2502_00646 hypothetical protein
MKKILFILLLGVAIQGLAETIVKGTYDTKKKRYIELSQIFEKEINLSYVLPNDKKNIVTY
KTENFDIIVRKSDLLELYNKNRDKKEKNIKNSISDKDKKLDYVRNYIAELVENNKAVIYE
RKTKKEIKNIVKIKYNNNTYYDAGRGSNYDGYKFYTDKSLSQEIMKFDIITQFGVALHSS
LGDNPYNRELTEKEKEYREKNGNHFEELKELYKKAVQNPNVEQKISY
>SEQF2502_00647 hypothetical protein
MEEISKNTLKKIELAKFIILQILFFVFYFFIGKYDWDYGFDLPFRLFFGGMFSIITGIIF
GLMFYFMGKKTEYENDKILKLPIFFIILSVVLLFRIDIIGVIKLCFFNGLFILGIFRSKI
KRRSYLSKVSKIILWFITMYFLIPSFAICFGVQIFTIPMESYEDRMQFSILIPFVMINIC
FGFFIKKFFNDEEIELVRMLTIVGCLVIMGIFIFMGFNWYKEDYYAIIYTFPYKVLMYFK
ETQISIEKIGIIKTLESRYFVYAIVVNMGFYLGTLKINNKNERGNCVENKIDGDI
>SEQF2502_00648 Cobalt-precorrin-2 C(20)-methyltransferase
MKKGKFYGIGVGVGDPENITVKATKRLHEVDVIVLPEAKSGEGSTAFNIVKEYVKPDVEQ
LFLEFPMIKDVEARKVFRKNNADVISAELEKGKKVAFLTIGDPMTYSTYTYVLEHISDDV
EIETIAGITSFNSIAARLNIPLMIGDEDLKVVSVNRKTDVYKEIENNQNLVLMKISRDFE
KIKKAIIETGNKENAVIVSDCGKENEVFYWDIESVEKVPYFSTMILKKGGVKEWKRFLKT
L
>SEQF2502_00649 hypothetical protein
MKFEIKWKRAYEKIEKADGFRILVDKLWPRGLKKENAKIDYWAKIITPSKELRQNYHKGI
IDFENFSENYRKELEENSDFKEFEDVILEELKKGNVTMVYASKTPELSHIPVLKKFIEEK
LGK
>SEQF2502_00650 hypothetical protein
MELRKIKSIKQIRNIYKLYQNSFPKEEKKPFGLILIGVLRGNFEVFSIEKKKTDEKNRNS
YEFKGLAIALKHRDLVLLDYLAITKEARSYGYGSKTLSFLKEYYKNYRFFLEIENAEDEN
AKNYEERQSRKKFYLKNGFSPFPFNVELFGIEMEILGYNCSCEFSEYFELYKNQFGGIMK
KKISENIFLVEK
>SEQF2502_00651 Sporulation thiol-disulfide oxidoreductase A
MKKLLIIISLFMTSILGFANVKPLDVDVTEGAKLPNFELRDFQGKYTKSKKLFGDGKPTL
FIFAAEWCPYCQRELSAVQKFYEENKDNINVVVVFTRRKTNLSSTKKYVEENKFTFPVYY
DSTDSLMKAFKVKTVPYNLIIKDSKIQKDLGGSKTYEELKEAFYLNY
>SEQF2502_00652 hypothetical protein
MVIEIFKEVKFMNKKYQNMIVIMASISSAIIGGRIIDEYGWVIGLITAAITGAIVVLLGK
IILKFLKINR
>SEQF2502_00653 hypothetical protein
MKKTFYLFGILTVFLFSCIGLSTKVKKRTVYNLNKTSWELSQISKKGQKLPIPEGANITI
NFSDGKISGFSGVNSYFGGYKIKNNSILTAETAATLMAGPEELMKIELKFFDILQNSPRI
NYNNTTLSLRNKNGEVWTFKKLDLSKKLKNTKWKLVEMGQTSFPEKEGEITISFAENKIN
GNSGINNYFGNCEIKNDSIKIGPVGSTKMAGPENLMKIEFEYLKLLQDSKTIEFNNNLLI
LTTNDGKVLKFEKIDDRAYHY
>SEQF2502_00654 Extracellular serine protease
MKKTLLLISLITVLSSCGGGGGGGGSSQTSQATPIPNPSRPSENPSQIPGNIGGKSNFNP
SQNIGNSESNNNSSSGQSAGNSTTNNSSNSGQQSQVPIPNNFEKPANQGVMTGKGVQVAV
LDEDFITNNETMKYYKRGQTFEKVKEDEFKGRLNSNYAVATGHSPSKNDHGLRVATILGG
ESGNGAKGATIHGVSLGTQSAGLIINVDRYKELHAKGVRIYNQSLGIPQEFSSTTYRKDL
WESIKTVGNWTQDKMDQKVDELINFYKKAVNEGSLFVWAAGNYKADKTELTAVSVQSGLP
IAIPSLQKGWIAVVGLEEQADGSAKDFPKHFAWAGESAAYWTISANGRCELPGCSSPGSS
NAAPRVTATAAKVKERFPWMTGHEIQQTILTTATKINTLLIGNGDVSSRYGWGYLNEEKA
LKGPAQFDNILLVGKNASDNGLKGQFNANIGNSMTSIFENDIKGDGGLRKSGNGTLILTG
NNSYAGDTTIDEGKLEIYGNNTSDITINSQGTLVTYPTAIINKKDGVPKSVYNNGGTFEN
RGSGAVITGNYIATAGSITKAEIGSKLIVNGTVNLNGESATLQTLSNGRYITAKPLSMTV
IEAEKGVEGNFWKVETPELVNGTTEVKGNKLSVKLSRKNVLDYVKKIAGTDEMQENTAQN
IETAFQTLDKKIENGTAENVSQFEKKAAKLQSLSSTARAAILDSLSGQIYASAQALTFGH
SQTVNKDLSNRLVMLGTLDNVGDKFGLWVSGFGANGKLKQDGYGTGDTKVLGGQVGIDKQ
FGENLILGTALSYSKADVKFDRYGGKSDANNFGFSLYGRLGNKNNPLYLQGRLGAGFVDS
DVERDIILGSNDYSQAKINHNDKVYSGYLETGYDIKNKNGDFVVTPFVGLTHDTVQRGSF
SEKDSQFGLTAEKKTYNQTAALVGLRVGKSVNWNSGSKTTFQGYVTHQKAFKDEDLSFDA
RYTGLPGAKFKVKGIGLSKNKTWVGAGALTEVNKSFGWYVNYDGSIDSGKGKGSNNVYTT
GVRINF
>SEQF2502_00655 Cobalt-precorrin-6B C(15)-methyltransferase (decarboxylating)
MYHIKDKDFIRGKVPMTKEEIRAVSIAKMEISDEDICLDIGGGTGSVSIEMAKFAKNGHV
YTIEQKEEAVDLIKQNMEKFEIKNMTVISGKAPEDLPQGITFDKVFIGGSGGNLSEIINY
SYENLKESGIIALNFIVLENTFEALECLKKSKFEDIDISQIIVAKNRKVKDFNMMMSENP
IYVISARK
>SEQF2502_00656 Cobalt-precorrin-7 C(5)-methyltransferase
MEKIQILGLGPGNLDYTLPIVLKKIKESEVIVGGKRHIESLGECVENKEYCYISADLQKV
LDFINENRNKKISVIVSGDTGFYSLLTFMKKHFESEELEVVPGISSVQYMFAKISEYWYD
ACIASVHGKEFDFVEKLNEYEKIGLLTDFKENTPQKIAQKLLENNFDNVEIFVGENLSYE
NEKIYHFKAKELANYEDKFGMNVVILKK
>SEQF2502_00657 Cobalt-precorrin-5B C(1)-methyltransferase
MGNYVYFNGRKLRYGYTTGSSATAATKAALLLLLGKVEKIEEVEIDVPAGERIKIGIKSF
EKTKDYAMATVVKDGGDDPDVTHGLEIVSKVSFRKDNKINIFGGKGVGKVTKVGLPVEVG
KSAINSTPMKMLTNIVEEFLPNGKGVDVEISVPLGEEAAKKTMNAKLGIIGGISILGTMG
IVRPMSEESWKASLAIELKQNLTYFNTKTAIFLFGNRGKMFLSKEFPERAEEGVVISNFV
GYMFDKACEYEVKKVYFIGELGKFVKVAGGIFHTHSRVSDAKMEILAANALLVGEKLENV
YKILESNTTEEASGYIEKKEVFNLLAEKAKQKCEEHCRKNGWDLEVETLILSAEKKVIGQ
SKDFFKDF
>SEQF2502_00658 Cobalt-precorrin-8 methylmutase
MSYIKDPKSIEVRSFEIITEGLAGKADHFSEEEQLIVKRLIHTTGDFDYVNIVEFQNNPI
ESAKEALEAGNCRIYCDTNMIVNGLNKNGLKKFGAEAYCLVADPDVAKEAKERGITRSMV
GLERALKDPQTKIFLIGNAPTALFTLLEKMDKEGENVPKLIVGVPVGFVGCPESKAELSK
YDVPFIRTNGTKGGSTVAVGVMHGILYQMYERDKYFNN
>SEQF2502_00659 Cobyrinate a,c-diamide synthase
MKKILISGTMSGSGKTTVSSILMSALENVAPFKVGPDYIDPTHHEVFTGHHSHNLDIFMT
DDEDAVRQIFEMYSQGRDISVVEGVMGLYDGIGNEKDNFSTAHLARVLDIPVILVVNAKA
ISTSIAAEVLGFKMFDERVNIKGVILNNVSSQKLYESLKEAVEKYTGIECLGYIPRNEQL
ATESRHLGLKQAFEEDNARKQQLFKEIAQNCLNLERIKEIAQEFESSRNMDNYAKIGHLK
DKFKGKRVAIARDEAFSFYYEANIDLMKFCGVEIVEFSPIRDKKLPENIDFIYFGGGYPE
LFSKELSKNISMKNSIVEACKNGVRIFAECGGFMYLAKKLRLLNGEIFDMCGIFDIEIGM
RKRLNIGRFGYINIETANGIKLRGHEFHYSEILENNEVSENDSEGYFYNIYKNNGKEWNC
GYVKNNAIAGYPHIHFYSNVEFFEFLLDVKRD
>SEQF2502_00660 Energy-coupling factor transporter ATP-binding protein EcfA3
MLKLENITFSYDNETEALKNVTLNIEKGKKTLFLGENGSGKSTLFLIMNGLLKAQKGGIY
FEGEKVKYKKKNLEELRRKVGIIFQDPEIQIFAPLVFQEVAYGPENLGYSEEKVEENVNR
AMKEINIEDLKDRPCHHLSYGQKKRVSIAAITAMEPELLILDEPTAWLDSKNTKRVSEIL
DNFSEAGKTLVVSTHDTDFAYEFADYIYVLDKGKIVRQGSRDEVFEDFEFLKKLNLNVPN
ILKIKSYLKYKNLDENDYYKFLEEKNLL
>SEQF2502_00661 Cobalt transport protein CbiQ
MLIDKISYTNPIKNINPGIKFTLSMMTLVFLLYTGSKVVFIFNLILFNLLLLFVVKVKAK
DLLKLNFIPALFILTTVISLWLIKADIWIFLLRSFSSISVIYFLICSTPVVDLDYIFEKM
RFPKIFREMFLLIYRYIFLLFDNKEKLKNAQEVRLGYSSFRNGMKSFPMLVVAILKKTYY
YNLNSIKAVESRLGKEFIFSHRKYKKIGFETIFVIIIVVINLYLVVK
>SEQF2502_00662 Cobalt transport protein CbiN
MEKNKNKSVFKKNIILLVLILLIGVVPLLLVKSEFGGSDDKGEEVIKTIKPNYEPWAKNL
IELPGDETESLLFALQAAIGAGVVGYVLGYFKGERKNANR
>SEQF2502_00663 Cobalt transport protein CbiM
MKKRTLLFLVLTSMLLIGVNGYSMHIMEGFLPINWVIVWFVVCIPFWILGIKKLQAVSKG
SVKDKMTLALAGAFIFVLSALKIPSVTGSSSHPTGVGLSAILYGPFVTSILGTIVLIFQA
GLLAHGGFTTLGANTASMAIAGPIVSYLIYKGLAKKNRAVAIFLAAAIGDLATYVVTSFQ
LALAYPSPEGGVLASFIKFGMVFAVTQIPLAIIEGLLTNVVMNILDKYEVKGVEV
>SEQF2502_00665 Sirohydrochlorin cobaltochelatase
MKKAILVTSFGTSHKDTRKKCLDSIQREVEEKYGSENVERAYTSGIIRRIIEKKEGVHIF
DQEEGLKVLKDKGFEEIITMSLHILDGIEYSKLDDKFGKISKPLLADDEDFKKIVENKEF
NDLEGDDAIVFMGHGTEIEADYAYQKLQEEYLKAGKSNIFIATVEGEVTIKDIIEKMKGK
GFKKILLKPFMIVAGDHAKNDMSSDNEDSWKTMLKNEGYEVTSVLKGMGEYKFIREMFMD
KLKEVYI
>SEQF2502_00666 hypothetical protein
MMKRLILVLFIIFGTLSFSAFDKVVIGVINDNYENPIISGTINRGGLANLLFGMKKDGDF
ARQMYQNLSDADKIEFIIEKHDESALISLLKIFEKRKYKGQMEITEVASSENKNIRQIAE
KNKWTYNVYPFAREISGTVKISGNDMNKGEFVEGLFQDAKSKLK
>SEQF2502_00667 Signal recognition particle protein
MFNNLGDRFKDIFKKVSGQGKLTENNMKDALREVRLALLEADVNYGVAKNFVAKIREKAL
GEQVISGVNPTQQFIKIVNDELVEVLGGSNVSIAKAEKNPTIVMLSGLQGAGKTTFSGKL
AKHLKSKGEKPFLIGADVYRPAAKKQLKVLGEQVKVPVFTIDESTDALEIVKQGIEASKA
EHATYVIIDTAGRLHIDEQLMHELQDIKDSFNPNEILLVVDGMTGQDAVNVAKEFNEQLD
ITGVVLTKLDGDTRGGAALSVKEVAGKPIKFISEGEKLDDIAPFHPDRLASRILGMGDVV
SLVEKAQEAIDEKEAKKMEEKFRKNQFDFEDFLKQFKMIRKMGSIAGIMKMIPGVDSSMI
DMGMAEKEMKKVEAIIFSMTVQERRDPKLLKNGSRKMRIAKGSGVQVNDVNKLIKQFEQM
KQMMKMFNSGGIPGLGGGFMKGRRK
>SEQF2502_00668 Periplasmic pH-dependent serine endoprotease DegQ
MKKMNFIKKENKKFTLLSILFLVLSCSNKTGNNSGNTNNTANTEQQKTVSPEELKKYTKN
AVQTQDAFVSVHNSVQDSIVNIRTKKTVTVNTYNPLEELLYGRSGGQEKRESGSLGSGFV
VSKDGYVVTNNHVIDGADEIYVKFSNGREYRTKLVGTSPEVDIAVLKIDSNETFKPLEFA
NSDQVQIGQWSIAFGNPLGLNDSMTVGIVSAAGRSSLGIEEIENFIQTDAAINQGNSGGP
LIDITGKVIGVNTAIYSQSGGSVGIGFAIPANLVTTVKDSIIATGKFEKPYIGVYLGNLD
ADKVKALNLKSSNGVFVAGAVPNGPAAAAGITKNDVITAVDGKEVNSAGAFVGEIAAKKV
GQSVKLTISRNGKTTEVSVTLAKTPNTIEQQRILQQKQQQLEQEQFGR
>SEQF2502_00669 Uroporphyrinogen-III C-methyltransferase
MRKGKVYIAGAGCGDEGLITLKLKNVIEKADCIVYDRLVNENILQYAKPDVEMIYMGKEN
TAGGKLQAEINNKLVEKGKEGLAVLRLKGGDPFVFGRGGEEIEALVAENIDFEVIPGITS
SIAVPAYAGIPVTHRGINTSFHVFTGHTQFNGIELDFPVIAKLEGTLVFLMGLSNLEKIT
ENLINNGKNPKTPVAIIKDGTTTRQKTYTGTLETIVNTVKEHNVKSPAIILIGEVVNLRE
KMKWFENKPLFGKNILVTRNREKQGNISNKINELGGQALSLPFINIEYVDFEMPDLKEYS
TLLFNSINSVIGFMRKVKDIRALGNVKIGVVGEKTAEEIEKYKIIPDFYPEEYTVERLAS
ESVNFTKEGEKILFIVSDISPVNEKKYSDLYNRNYEKLVVYKTQKVEVEKEKAEKYVKES
DILMFLSSSTFKAFADSINLSENEEIKEILKNKVIASIGPVTTRTIEKYGVKVGIEGGKY
TENGLFQEILQYVAFK
>SEQF2502_00670 Porphobilinogen deaminase
MKSNKIIIGTRGSILALAQAEKVKEMLINKYDELRENENFCEIEGLDKKSPLEIELKVIV
TKGDKDLRDFTKIKGTTQKDLFVKEIEKEMLENKIDLAVHSLKDMPQNTPEGLLNACFPM
REDNRDVLVSKNGKKLKELDGNSVIGTGSIRREKELLNLRNDVKIKAIRGNIHTRLKKLD
DGEYDAIVLAAAGLKRVGLENRITEYFDIDSFMPAPGQGILCIQCRENDNKIRHLLKIIN
DDEVTIMCKAEREFSKIFDGGCHTPIGCSSVIEGNTLKLKGIFNDNGVRIFKEVEGNREN
PKETAQKLAEEIKKEEMKNEKR
>SEQF2502_00671 Glutamyl-tRNA reductase
MKENLVKNFYILSFSYKNLSLEEREKFVKEGYRHILGKYLEKRIIKGYVAVETCLRIELY
LDVSKEFEIESLKRDFRIEKMKDYKGAEAVHYLLRVICGLDSIIKGEDQILVQLKKAYFD
ALDKNVTSSFLNIMFNQAIETGKRFRAESKINEKNISLDSIAVKFIRTKFESLENKKIFV
IGVGDLSQSILALLHKMNNCHLTMTNRSLRRSIELQKVYPDVQTAEFNEKYNVIKNMDIV
ISATSAPHLILETAKIQNILNDGKKRFFLDLAVPRDIEASIGEFENASLYHLEDIWDEYN
KNVEKRDEIVEKYSYIIEEQLKKIAEKLEKRRKYTNQKNIEIGENG
>SEQF2502_00672 Threonine-phosphate decarboxylase
MDFHGGNIYKIFREKNITEILDYSSNINPYGVPESLKRKITENIGILERYPDPDYVELRE
KLAQLNKVELENIVLGNGATEAIFLFIKVIKPKKVLIVSPTFGEYERAVRACKNSESQKI
EIEYFELEEKDEFRLNIGKLKKELEKKYDLVIICNPNNPTGKFLKMAETEEILRECNRYD
TKLFIDEAFIEFLEDGLKESIVNSGENKKNLFLTRAFTKFFAIPGLRLGYGIYFDKNLEK
KIAEKKEPWSVNNIAEMAGITVLDDTEYIEKTLNWITEEKRYMYERLNEISGIKPYKTEV
NFICVKIKDELISKGLNVKKLREKMMEEGILIRDASNFKFLDERFFRLAIKDRKSNDKVV
RALKEILE
>SEQF2502_00673 hypothetical protein
MKSEYDKNDDELVERYKNENLEIYNYKGITLGDSIEKIYPLMKIYHTEYCKNDRRERYNL
IMEIENSYIHIDIYSRKVVEIEIYDENYLLGEFKVGSEMTTELCEKYDLLDVDDVDTGEI
YYYPEKGFMHAEFCVNPEDVISKINKITFSIYVETPSENNVKDTLKAQKIEDIYYSLYNF
GEIEIDIENKEIIGRLEENIFTFDLLNGNLKNIEIKK
>SEQF2502_00674 Cobyric acid synthase
MGRKHKNIMLLGTGSNVGKSIINAGFCRIFYQDGYSVVPFKSQNMALNSFITKDGKEMGR
AQVVQAEAANIEPQAFMNPILLKPTTDRKSQVIVNGKVYKNMDAREYFAYKHNLKKDIMA
AYNHIRDNFDICVLEGAGSPAEINLKEDDIVNTGMAEMADSPVILVADIDRGGVFASIYG
TIMLLEESEKKRIKGVIINKFRGDKSLLTPGIEMIEELTNVPVLGVVPFVPLGIEEEDSL
GIDKYNVEKEGKIRISVIKLKHISNFTDIDALSHYNDVSLKYVTKSSELGDEDIIIIPGS
KNTVEDMKDLIDKNISREIIRLAKRGTIVFGICGGFQIMGQKIMDPQNIESNLKEISGLD
LLDIETVMETAKTTTQYENKIKNADGILAGMDGIEIKGYEIHQGYSYPVHEEKTKIKCIF
DDEKLKGAVKGNVVGTYIHGIFDNSEFTNHFLNEVRKLKGLDKVDEDFSFKEYKNREYDK
LAQILRENVDIDKVYEIMGME
>SEQF2502_00675 hypothetical protein
MEKNENKFTLKPKDFLVLILYTIIYLFFQITIYPALAFLFWLIFTMRIEEIIFNALEFLN
LSKGTISIIDIVITGIALLTVLMFVFYLGYLCSKFFKKINKTLLGSVMIAILIYFLYKVF
TETDESTAMFAPTAREIHIFCTASHISYTVGVFFSDKVKKILDRIKFKRK
>SEQF2502_00676 hypothetical protein
MFADTNITWGFVLLSPFIIPILILLTFWFFVSKRKFNFLIAFTILSLLFVRYLRFPYDTV
NRNSEIKISQNFLIKRTLSSDSEHEVYKLVDKTKPEDLILYLNGLAKINNTWVGYIEETD
SYEGKYGVKPETYFFINDNKIEYNLDEKTLEKRLGLKEIKLQDAEYFVDKFGSKKEILYQ
YQLDKTGDLDENISLNSELSKKLETKYKKDRIFYLMFWSVVLLMEIIYLFIKNRKITKSN
KD
>SEQF2502_00677 putative HTH-type transcriptional regulator
MKKNEQKIMQIKEFSEKTGLTPYTIRFYEKKELFRVKRDEKNRRIYDETDIEWIKMLKRL
KDMGMKLSEIKKYSDLRYEGNGTIKERMKILTNHKKYVNIEIEKWQKYLQNLDDKLEIYE
SFLKSISEK
>SEQF2502_00678 putative oxidoreductase
MKTKYTVITGASSGIGRAVALKFAERNKNLILIARRKNLLEDLKSEILEKHPNLDILAID
FDLTDVNKIPELYSKLNNYHIETLINNAGFGSYNNVKDESLSKILDMLHLNVEALTLLSS
LYVQDYHNEKGSQLINISSAGGYTIVPNAIVYCATKFYVNAFTEGLALELKQNNAQLKAK
VLAPAATKTNFGNIATGKTNFDYDKSYPNYHTSEEMANFLIQLYESDKTVGYISRETFEF
DLSDGFFQNAFSSKNNVNF
>SEQF2502_00679 hypothetical protein
MKKFIFLFSLLICSLSFSDTNIDQISSEVWRCPHSVDRTFKGLTYIKFLNENGKPSISVS
ILDNRAALKTGKVTLELSQLDYEVKEDENSIYFTNLNDKTQVFSNYKLSYSFDKKNRPKM
DLYRISDNKKLCSLITN
>SEQF2502_00680 Ribosomal RNA small subunit methyltransferase G
MENIDFKEYFISLLEKSEIKVENEKIEKMMEFLELLYKKNQVMNLTAIRDKKGMLEKHFV
DSLFLTKVINDTEKSFIDVGTGAGFPGLVLAIYYPEKNFLLVDSVRKKIDFINEVIKELN
LKNVNTSFERSEELIKNNREIYDIALCRGVANLRIILEYMIPFIKVNGRFLPQKLNLNEI
EESKKALKILNAKINNIFEFKLPENEDKRIILEILKLKKTSEKYPRKTGIPAKKPL
>SEQF2502_00681 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MRNYDVIVVGAGHAGSEAALASARLGLKTAIFTITLDNIGVMSCNPSVGGPAKSHLAKEV
DALGGEIGRNMDKSFVQMRILNTKKGPAVRSLRAQADRKIYAREMKKTIECQENLDTVQD
IVTELIVDEIEIVENGSKRIEKVVKGIKTKTGMEFLAKAVILATGTFLRGLLYIGDKRVK
GGRMGELSADDLTSSLKSLGLKMGRFKTGTPPRLDIRTLNLEKLEEQPGITGVPLKFSMR
TPNNEILEKPQLSCYLTRTNETTHKIILDNLDKAPMYNGSISSTGPRYCPSIEDKVVKFN
DKDSHHLFLEPEGFETAEVYISGLSTSYPASLQQKIVNTINGLENAHIMRYGYAVEYDIV
DPSELDYTLETRKVKGLYLAGQVNGTSGYEEAAAQGIIAGINAALKIKGEEPFILDRESS
YIGTMIDDLINKELFEPYRMFTARSEFRLILREDNADIRLSEKAYKIGLLDKKYYDIVEE
KKKNVKETIEKLENIKLGISNERLVEILDKYNESLKSGTTLKEILRRPKVTYQDIKYIAE
IIENAPNLSFDAETEYQIEVQTKYEGYIAKAMQIMEKQHKLDDKKIPKDFDYEKMKGITR
EAKQRLKENQPYNVGQASRMSGVTPADISVLLMYLDGVLK
>SEQF2502_00682 Transcription-repair-coupling factor
MNFNLSFLNKLKNKEKKILQSENNFYRGAIPWFLLCSEKKKIIYISTSNRNLENYHAMLE
NYYEMSEKQKDILMEKSKTGKKNSKENVNKLEDKKIIDIFENILQNKEDITGINIKLLDI
LKNQEKFILFVNLQITLDIFFEKVKFFSFEIGKEYSFTKIVEFLVENGYENSYLIEKKGQ
YSRRGDILDIFPPDLEHPVRLEFFGDELESIRVFDIDSQISVEKMEEIKVFGNLLSGNNY
ELIELIDELRAEDVTIVIENEELLDYKMEEFILLDRSREEIYRKRYENLKKKSIFVQTKN
FSQEQIETFRDKNRLEKLSKIEDIYIFTNNYEKKMSEYGQILTEKENNLEIEKYELFEGF
IFNDTSENPDNKNRKNNFIVLTDRELDGYIYERKKKTTKAIKYKKVNQIIEGDYVIHVQY
GVGIYKGIQTMEERDYLKIKYADEDILYIPVEKLDRLEKYVSNDTEPQLFRLGTRGFKRK
RKKLEEDIQKFAAELIKIQARRQSQNGFVYQKDTVWQEEFEANFPFEETEDQRNAINDVK
KDMESPQIMDRIVCGDVGYGKTEVAMRAAFKAIDNGKQVVMVAPTTVLAEQHFERFKRRF
KNYPITIENLSRLTKSKSKDILKNLKSGIIDLVIGTHRLLSDDVQFKNLGLLIIDEEQKF
GVKAKEKLKSQREKLDVLTLTATPIPRTLNLAMLGIREISIIDTPPTNRLPIITEVLDWD
EETIKMAILRELSRDGQVFYIYNDVKNMKEKLKELKEMLPDFVKIEFINGQLPPKEIKDK
LLRFENGQFDILIASTIIENGIDVGNANTILIENFTGLGLSQVYQLKGRVGRSNRQGYCY
LLKTRNITKQGRQKEESMLKVEGIKSGGFQISMEDLKIRGAGEILGDKQHGTIETFGYDL
YIKMLNEEIRKQKGEFVEKIENVEIILNERGFIPETYIQKDERLNIYKRFAMLETDGELN
DLLDEIRDRFGKIPEQMKKFILSIKLKLFAEKHKIQRILETRNHFELYFLENARAKQNEL
NEKIEMKKVVKIINSAVLTGKNKKEDIVDNFVIMKVKKNEFIKNL
>SEQF2502_00683 Electron transport complex subunit RsxD
MKFNMFRSKRRELQENIAKTNIDILISLIPMLLVAFLVYQVTPILVILSAVIGSELAEVI
FSLLIQRKKDTLKDFSGIVIGALTGLVLAPFTPIYVAAFAGAMATLFGKTIYGETEKKIF
NPVILGKLFVLTFFPAVLASNSAAWANPEVLNISESISGLPSLILTDRGIIGELSIIAIV
LGGIYLIFRSKITWHIPVSFFVTIFFGFYIASNQNINVTTSLGEVIFMGVFVLTDTFTTP
QHGFGKVFFGFLAGASTIIFWFMGIQAEAIVYSVLILNPFTRPINTIYKPNVFGVETVSF
AEIIQGLGLAILIIALVFVVSYLHTLGFVPYIVYIYIVYGIWRLYNNR
>SEQF2502_00684 hypothetical protein
MKQIKGIFLFLMSVVLVAFGSQDSKNSKGLVKKLEDGTKEVGKNIVSKKDKSVKVDNKKV
EAKKEENKKVEQKPAQPQPVQQPAPAVAVQPQQPQQQQPQQNAAPNNQNAVQNKAVNPEY
ALNTNNKTGGKKGNKKHKKGNQYNFYKEPKHSRLKNNTSSYKSSQVKPQDSSTKTSGGGN
SGGNSSSGGTSTGGGDSTSSE
>SEQF2502_00685 Putative multidrug export ATP-binding/permease protein
MKKIKIDFGEIFKLKKYIKKYYVLIILNILLATMSSLVSSAPIALIKRLFDKGISGKSEK
DILYAAGAMIILAAVGAVLMYWNTIFSTVISASIYKDIVTDIYNKIQTLDMEYFSGKKIG
DMMTRIMTDPSNINSIILEAFSMIPEVIKLILCLGIAFYIDFDLTLGVMIVTPILIITVR
KYAKRLKRSGKQRQEALDSLNSKLQETLSGIRIIRAFATEKYEISDFKKKNVNLKKIAVK
SAKYNAKANSIMEAMNYIIIALLLMFSGYRVLRAKNFTPGDFITIVGAISSMYTPARRAM
TRINSISVNMSSITRVAEILEEMPSIVNRENCIKFENFVSDITFENVDFKYKDSVEKILK
NINLDVKKGETVAFVGNSGGGKSTLVNLIPRFFDVSSGSLKIDGIDIRDYEIKSLRKAIG
IVPQETFLFSGTILSNIKYSRQNATFEEVVEAAKQANAHEFIENLSDSYNTEIGERGIKL
SGGQKQRIAIARAILENPQILILDEATSALDNESEKLVQDALEKLMEGKTTFVIAHRLTT
IENSNKIVVIQKGEIKEIGNHNELLNKNGIYKALYNKNFDFNVKS
>SEQF2502_00686 hypothetical protein
MEKTKKVVFLESAYSLLLYIMMNDNFEEDSIFVYHGKSINEVFEHSKVNVETIYIPREEY
INVTEVKNLFKRKIAKKKYKKYLKEKLLDLIKEKTYGYKIEYFGNDNEVEPKILWKEIEK
FTVIEDGWSNYRSDHFEAYLKRFKNKFKKKEDLKRGLSPKVEKIILSGLTKVPEIISEKV
EIIDFKKLWMKKTEIQKQKIYNFFGMETADIEKISRKKVIFLSQPLEEDESLTHEETVEL
YQKIFKNYNENDILFKLHPRGIFTYKNEFPQIEIFTSKIPFQIFEYMGVDFDTVATIYST
AVWNIKNAKKIDFFGTKVHPKLLAQFGNIER
>SEQF2502_00687 Poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase
MIYLFLIILLLFLVFILYNKTRKNFVLCLMYHSIDSEKNKGGIFIDEFEEHIKWIKDKKT
FKMEELKGLDYTLPPNSILITFDDGYKNNYTLAFPILKKYNIKATIFLNTKFIEKDETYL
NWDEIREMYESGLIDFQLHTHSHQLTVKDIEVLAFYDNESSPYFKRESYSLFFDGNYDEK
KDAKKLNGLPVFKLRSKISIPGYKPKKNFVEKYRSIVELQENEFEKEKKKFLNRLFKEKK
DEFFDKISEEQFKETVKFEILENKKIISEKLGKVPDCLAYPWGHRYKGNREDIKKLGVDV
FITTRKGVNSLKLNKNWIYRVSGDDFENFDEFKKELKNGSTAIYRKIFKKR
>SEQF2502_00688 hypothetical protein
MKEVTLVITSCGRFDLLEETLDSFFEYNTYPIKKIIITEDSTEGKKLKKLISKYDNRNQN
FRLIVNETRLGQLKSIDKAYREIDTEYIFHCEDDWKFLKRGFIEKSMEVMEEDEKILVVG
LRSKDNFKEDFFYDEDYVSKKGEHYYSVKGEIFTYNPALRRKKDMDLFGSHEKLENQRYE
EVLSDFYKEHGFKAIFFKEPYVTHIGNKRHVHFSNRRKNTVLNFKIDRLIKKIRAKILKL
RGKL
>SEQF2502_00689 Chondroitin synthase
MKLSVGIITFNEENRIGKTLDSVKEIANEIIIVDSESTDKTVEIALSKGAKVFVEKWKGY
GPQKNSVLEKCKGDWILLIDADEVISPQLKEKIKIIINSENPSSDVYKIKLRNIAFKREI
KFGGWDDYVIRLWKNGKVKISSREVHEQYQTDSKIKKIKEMIIHYTYDSIEEFLEKLNRY
TSQSAKEYIKKGKNPSFLKIYSKMMFRFLKMYILQLGFMDGYEGYLLAKYSSIYTMTKYT
KLREEYYNNLGNDTSLIITTYNWPKALEVCLNSVLEQTVAPKEIIIADDGSKQETIDLVK
RFQQSYPQSNIIHSWQEDKGFRAGMSRNRAINKATGNYIIIIDGDLILNRHFVEDHIKNM
ERGCFIQGSRVITSSIMAKEIMEGKKINLFSKGVKNNINMIRSKILSRIFTKVNRNLRGI
RSCNMSFFKEDLIRVNGFEEEIEGWGREDSELAVRLFNIGCKKKKLKFEALTCHLYHKEN
DRSRLKKNDEYLAEAIKSRKTMAKKGLDRYEGSNAGNN
>SEQF2502_00690 Lipopolysaccharide core heptosyltransferase RfaQ
MNKINWKFYRPYRDKLIDKKNEILSKIFDKRKKDVDLDPLKINKILFLRTDGKIGDFIIS
SFIFREIKKHYPNIKIDIVSDKSLEDLLKLNENIDEYYIFDRKKIFEWRKVAQILRKNNY
DVLFDSTEGLKYKQFYLINRVNATVNVGYNKDGYKIYNKNVRQNNTLKMVEIYKQMMKKV
NIEIEDTIYDVPVSKDSERNVKKFLDENNVDEKIIALNFFGASRGRKINEDIALIIIKRL
SEIYKGYRIIILDSPNDRETIYNILEKTDNKNILFFEKSRTVLDSISIIKNSDLVVSLDT
AILHIAEGLNKKIMAFYGPKINKNKWRIKEEGNILIDYTEKRINDVDFEKVFDKLSYKNN
LSAI
>SEQF2502_00691 hypothetical protein
MSIIDGIRSKIIIWLFGTKRRYKDINLKNIKTILINPKDFIGDTLISFCYARQLKEMYPE
ANLGLAVTDRNLEFANFCNKNEKVIDSIVKRKDMFKNRKKWDVLLDFSSKENTNKMIWKK
ILSPKITIVFGEDNEGHYYNRKNVKNYDFICTPSIETHITDYLINSEFSKYFKIEKQKPY
IELLEKDVAKMEKFWKSDSEKINEKTQKIKILLVPQGRDRKMKPEEVAELLNNIEDEKIK
NIKIIMGRTVGSEEYYKRLVGNINKNLDISLSEKLSINDFILFVATADLVIGVDGGAIHI
ASSLNKPLLSFYANDKYNLCRWSPKTTADSLQVISNIKGSHNQTYNFSLSEPIKWLNNKI
KEIEKDKGN
>SEQF2502_00692 N-acetylgalactosamine-N,N'-diacetylbacillosaminyl-diphospho-undecaprenol 4-alpha-N-acetylgalactosaminyltransferase
MKILVLHGHLSMGGEERVLLNVLRNLIELGYNVDLLITWNHGENNLFENEIPKKVNYEFL
FDNYNGKSKIIKEIYRLRTKTTYLKKVEKIIEEKKYDVIIDYSSNLLKYKNFDIKVPIFA
WIHFSLTFGEKLSGEKVEKYKKQYKKYDKILTICDTMRDEFVEILGMDKTKVELVYNPIN
LEIIRKKAEDVNPKYGNYLKEDYFLQVSRLTQQKQPEHLVDIYYKLKQRGIKEKLYFIGN
GEKVKLIRQKIKEYNLEDDIILLGQIENPYPFFKNAKLFLHTAKYEGLPTVLLESLAFGT
PVVAYDCPTGPKDILGKNSEYGELIPLNDKDTFVKRVYELIDNNEKYENYKKMSLIRAND
FSMETNKLKLKKLVEKNK
>SEQF2502_00693 hypothetical protein
MEKYKFSNSRIYKINEKLNKKPYKYIYKELLPKKVYDRLQSEIYLLNQKIIAKDWDNILK
DYFENKVRGKEIKAKKILTGEKIIWQFWGQGWDYEKLPSVVKICFKSMEKYGRDYTVIRL
DNESIKEYLDIPEYILEKLNDKRMGYAHFSDILRFALLSNYGGVWMDATILLTDYISEKY
FQMDYFLFQRDENLENKKEWEDYDSIYFSWSKKSKVRMLSSVIFSHKNNKVINTLLNMLM
IFWENNDTVPNYFILQILYNELIENYYKNEQCQIISDTFPHEMFRVWFDKYSEERLLEIM
KKSDIHKLSFKIENSKRKKDRTFFEYFEKMYRIN
>SEQF2502_00694 hypothetical protein
MSNEKINLIINKAGFIFCLLLGVSLFLSEKFENNVVIPVLLLIFVISMFLKKNWKEFFSK
IDMKFSIFLIIFVVMSFMIAVFDGGIGSRLDNYNLRYLIFFPLVYFINNNKRIFDFLKSF
LFGGTVILILAIFNFIKNYNEWVHPKGFDYPRVTAILTVQDFANIMCIIFLYLLSFLLFY
KNEDNKKNKIIKIYLAIMSVLVLFIVIVNRSKMVYICLIPTILYIMYKKRKRYVLAVILM
CFAGYFMLPVSISNRIQYIVKYKNDPSSNLRVIFWKTGIEAFKQKPLYGWKAEERKKFNL
DYYKKTGVSDYVYKYFLTGNKLRTQHYVASHNSYLQYLLDFGILGFVFFILMIISLLAKL
FKMNFYKYDKNTKIIAFEIGTKVSFLAWIIQGMTDDNLNDKHLIITLTVLIFFIDYLYRN
IKNQKNLNLESIE
>SEQF2502_00695 Lipopolysaccharide core heptosyltransferase RfaQ
MKILVIHTAFIGDIVLSTPLIQELKDIYPKSEIDYLTLPTNKSVISNNPNLNEIILYDKK
GKDKGIKGFLRILKILKQKKYDYAIIPHRFIKSILLAKLAKIPDIVGFDVATGSFLLNKK
VHYDMKKHEVERLLDLVEYKGKKIPIRIYPAKKDFTKIDKILENNGYFGNKGQKLILIAP
GSQRSEKMWPIEKYRKVIEKLKKNKDYFIGITGSKTEKGLSLNFENDKNVIDFRGEINLV
EFGALTSKADIVVGNDSSPIHIASGFEKPFVIGIFGPGKRALGFFPWKEKSNVIEDNEFY
ENNIVKVPKNQHRYRKDYYKGIPEISVERVYKEIIKHI
>SEQF2502_00696 Putative metallophosphoesterase MG207 
MKVLICSDSHKRLDYFQQVMELENPEIVIFAGDHSTDAIDMSLVYRDVLFAIVKGNTDMD
DFETRDTRIFDLMGKKVFLTHGHLYSVKQSLEELEKKAHLEKAEICVFGHTHKEYFAEKN
GIIFVNPGALQDKKYVLYYGGKRFEQKTLK
>SEQF2502_00697 hypothetical protein
MLQKKALFLVTAENEIQPLVNFAQIFKKKYDVDIDVIYIKDVLKYEVFPVSIEGMGLNIG
ANYAFKEYRELEEKTVKKIKEKMTADISNFYTKDGETSEIILEELKKYDLLVLVKNEKVT
PVLKEILRSIFKPLIILPNVENFRLDNLVLLDDGAYNANKTLFTFFYIFGEQKMNVLRVN
VEEDDENSLAQRFGENYNLIHKKGDTFKTIMNESQNYDLVLMGDLRYTVMVERITGKLGV
RILENLQKPIFIV
>SEQF2502_00698 DNA gyrase subunit A
MSDDFKNDDEREDEITGMDDNDDREIVVEGMPKATDLSNESNVYIEDEIKAAYLDYSMSV
IVSRALPDVRDGLKPVHRRILFSMSEMGMSHKTPFKKSARIVGDVLGKYHPHGDSSVYGA
MVRMAQDFNMRYELIDGHGNFGSIDGDEAAAMRYTEARMAKITEELLADIGKDTIDYRKN
FDESLDEPVVLPAKLPNLLLNGANGIAVGMATNIPPHNLGEVVDGIIALIDNPEISIDEL
ITYVKGPDFPTGGIINGKQGIYDAYRTGRGKLRVAGRVEIETSKTGKKSIIVTELPYQVN
KSRLIEKIADLVKQKKITGISDLRDETDRDGIRVVIELKKGEESELILNSLYKFTDLQNT
FGVIMLALVDNAPRVLNLKQVLQKYLEHRFEVITRRTEFELKKARNRAHILEGFKIALDN
IEEVIRIIRASKDANVARAELIEKFEFSEIQAKAILDMRLQRLTGLERDKINQEYNELIQ
LIKKLMGILSDDSKIYGIIKEEALKLKEDFGDERRTEIRNARAEISIEDLIKDEKVVVTL
TEKGYVKRVAIDTYRSQKRGGIGVNATNTVEDDVVKDMYIAKALDTLLIFTTKGKVFSIK
VYEIPETGKQARGKLIGNIINLDNDEKVSTIIKVREFEKNKNLFFVTRNGVVKKSELTLF
SNIMKAGKRAIRLNDDDEVMFIGLTSGSGEDEIFAATRNGIAIKFSEKDVRSMGTTAVGV
RGITLRDKDKVVGAAIINSEMDNNKMRILTITEEGYGKRTKLSEYRLQSRGGKGLINAKL
NDKTGKIADVKIVRENDEIMLITSEGTLIRTSINDITVRSRSATGVRIMKVRNNEKIASV
VKITEAPDFSEEDK
>SEQF2502_00699 DNA gyrase subunit B
MANNYGAEAITVLEGLEAVRKRPGMYIGSTSSRGLHHLVWEIVDNSVDEALAGVCDKITV
KILEGNIIEVTDNGRGIPVGMHKTGKSTLEVVLTVLHAGGKFDNDNYKVSGGLHGVGVSV
VNALSEWLEATVTRDGKVFRQTYRRGVPATPVEEIGTADENEHGTVIRFKADDEIFETTV
YDYSVLESRLKELAYLNKDLKIELVDERNADDIKTEEFLFEGGIKDFLNEIIDDEKIIDD
VIYMADKMQIEEAKEVETVDENGNTVKKHRSAKFVEVEIAMNYTTSQRENVYSFVNNINT
HEGGTHVSGFRTALTRTINDIAKQMNLIKDKNGTFQGTDVREGLVCVISVKIPEPQFEGQ
TKTKLGNSEVTGIVSNIVGGNLKFYLEDHPKAAEKIIEKMVMSKRAREAAKKARELVLRK
NTLEVGSLPGKLADCSSKDPAESEIFIVEGNSAGGSAKQGRDRRFQAILPLRGKILNVEK
SGVHKALENAEIRAMITAFGAGFGDDMDIKKLRYHKIVIMTDADVDGAHIRTLMLTFFYR
HLRELINEGYIYIAQPPLYKIQAGKAIRYAYSDDQLKQVTKVLEKDGRKYTIQRYKGLGE
MNPEQLWETTLDPEVRTLLKVSMEDASYADKMFNILMGDKVEPRRKFIEDNANYVRNLDI
>SEQF2502_00700 tRNA modification GTPase MnmE
MLFDTIAAISTPKGEGGIAIIRISGDKSFEILDKIFVKKNPNADLGFYKLNYGFIKDGEK
TADEVMAVRLKAPKSYTCEDIVEINCHGGTLVSEKVLELVLRNGARHAESGEFTKRAFMN
GRIDLSQAEAVMDIIQGKTEKSVSLSLDQLRGDLRDKVNQFKKALLDITAHVNVVLDYPE
EGIDDPLPAELRNNLEKVYEEANRLIDSYDTGKKIKEGIKTVIVGKPNVGKSTLLNALLH
EERAIVTHVAGTTRDVIEEIINIKGVPLVLVDTAGIRKTDDIVENIGVEKSKQFIGRADL
VLLVLDASKELENEDIEVINQIKENKKKVIVLLNKIDLNKKINLAGHNLENIVEISAKDN
VGIEDMQEKIYSYIVEEDVENSSEKLIITNIRHKTALEKTKDAIKNIFETIDMGLPMDLI
SVDLKEALDSLSEITGEISSEDILDHVFGNFCVGK
>SEQF2502_00701 hypothetical protein
MEKIILKAQNEEELKNMISRSLTLKEDETYQVKVLKYPKKILFINIKGEYEIEIIKKSEL
RTNKIETEKLKVQDESKFVKKDEKNYDLHKENNRNNNKRSYKNESFENDEKFNQENYSDT
NIDKIRVFFKEFIIGIRLDIRIINIKKENSGKYLVILDGKDMRFLIGEKGSALNSLEYLI
STTKKFKHLKISIDSNNYKEKREHSLRDLARKKGKAVLLTGNAIKLNPMVSHERRIIHEE
ISFMKGLKTESVGEDPKRYLIIKKLDEKN
>SEQF2502_00702 Membrane protein insertase YidC 2
MFKIQALVDFVVHILNAIYGVVGNYGIAIIIVTVLMRIIIFPLTLKQEKSMKKMRELQPE
LEKIKEKYKDNPQEYQQKTAELYRESGVNPLGGCLPLLIQMPVFVALYWAFSGNAIPADA
KFLWFTLKQPDRLFMIGNFAFNLLPILNVGVTYIQQKIMTSATSGQESNQQMQTMLYMMP
LMMLFIFYKMPSGVTLYYLVSGALSLVQQYFILKGRSDDGKDNIKSSK
>SEQF2502_00703 Putative membrane protein insertion efficiency factor
MIKKILLFVIKIYQKGISPYLGRRCRFYPTCSEYSRQAITKYGAIKGSYLTIKRLLKCHP
FHKGGYDPLK
>SEQF2502_00704 Ribonuclease P protein component
MSINKIKKTKDFSLIYNKSKKMHTKYAIIFIRENNKQRFGFVASKKTGNAVQRNRIRRIF
REFVKIHKDKFKENTDYVFVGKSILKDNLKNLKYKDIERDIIKVIK
>SEQF2502_00705 50S ribosomal protein L34
MTKRTYQPNKRKRKKDHGFRKRMQNKSGRNVLKRRRAKGRTKLSA
>SEQF2502_00706 Chromosomal replication initiator protein DnaA
MDVVKLWEKVKKIMKRKINEGEFELFFENVKAVKIEDNVFTLTCNSKLIKESVEKYKSQM
EEIVEIVTDEEIKMNFEVKKQDVMLYKSETHRLPKETREKAPIHTGLNPRHRLDNFVVGE
NSRLAYNACLAVVKNPTVYNPLFIFGSSGLGKTHLMQAVGNAILEKDPTKRVYYSTSEEF
ANEFFKVLNSGRIQHFRDTFRALDVLLLDDIQFFEKVFGRGEGTVEEEFFHTFNKLQELG
KQIIMISDKSPKEIKNLSKRLESRFLSGLTVEIQSPGYETRMMILKNMAEAQGIEIDDSI
LEYISDSLNTNVRELEGTLTNLNARAKLLNEQITLELVQEMLMHNVKREQSKVTAQKVIE
MISTHYNVSVADMKSKKRQKKIVETRQIAMYLLKNNDDLDLSLTAIGGLFGGKDHSTVIS
SIRKIDKKTKEDIVFKKEINTLNKKIFKK
>SEQF2502_00707 hypothetical protein
MKNIDSEIEEITINTEFIKLDQLLKWANFTGSGVEAKMFILNGEVKVNDAVETRRGKKIY
DGDIVEFAGEKVVVRARH
>SEQF2502_00708 hypothetical protein
MKKGIGIGVEDFSEVIKENCYYIDKTKWIGEILEDKSKIKLFTRPRRFGKTLNMSMLKYF
FNVENKEENRKLFNGLDVEKSEYMSEQGQYPVIFISLKSIKAKTWEEAIQEIRLLVLELF
SEYKYLLEDLDEYDLPRFKKYLMGNADFSELKNALLFLTRILFQKYKKEVILLIDEYDSP
LISAYEHHYYSDAVAFFKVFYGEALKTNQYLKMGVMTGIIRVIKAGIFSDLNNLNVYSIL
ENEYSEFFGFNQGEVEETLEYFDVKYELFDVKAWYDGYKFGDSDVYNPWSILKFLKSKKI
GSHWIDTSGNFLINQILKNTDSEIMETLEALFNGETVEENIGGNSDLSSLLGQEEIWELL
LFSGYLTINEKIGEDYEDVYSLRLPNREVREFFRKKFIDVNFGESSYR
>SEQF2502_00709 DNA replication and repair protein RecF
MYLDQISFNNFRCLVDGKLKFDRYFNLIYGKNGQGKTSLIEAVHFLATGKSFRTKKVKEI
RKYNLNRLIVFGKYRHKDLSENAIAIDVNEDKKDFYIDREKNKYINYVGLLNIISFIPED
IELIIGNPGVRRNFFNYEISQAKKEYLQSIVNFEKILKVRNKLIKEKKTGEEIYKIYNEK
FIEEGLNIVLNRQEFIKKISILLNLNYRKLFDENSELKLKYDCFLGDVEKKTREELKEKF
EMLCKRKSEREKFLGYSLLGPQKDDFIFELNGKNAKAYSSQGEKKSIIFSLKISEIDILI
KEKKEYPIFIMDDIASYFDEVRKKSILSYFANKKIQCFITSTEDLGIEGKKFIVEKGKVV
EKK
>SEQF2502_00710 hypothetical protein
MEEIKELKSLALEAIEKQSSLLKNEKYIFLKIKKSWKQIVNGPIGEKTYPKGLFNRNLIV
VINDNVIYHTTIMCKEVIKEKINTFLNGEFVENIEFMKINYKVKRDLLDELIENEENRGT
IRIGEIPKGNVRKKEVNIEAENKITGRIEDIILSSEEIKEIHENIDKIDEKYEDIARNLE
KIAIKLKKREKYLKSIGYIECENCKILFLQESNEKMCFECRMNEKNQKFQKITDLIRNKP
YISEKQAVRMTNTDKSTYYKARDILAQQTYNDMLYYCLEKNREISLNEDYEFEIRSESRE
DVEKFIKNYVDYKVGSDNEEVFKIERKWALRRLRKDMKFRLENSRRY
>SEQF2502_00711 hypothetical protein
MKKIFLMIGILLGINGFSDKNINKDNVKIKQSVIATTYTYPDGKNSFWNDILILGKEKVP
YVLINPNNGAGKKVEVNYAAQIKKNKEAGIKNIAYIPTNYQKRNIGKVKDEVDRYLEFYG
KDNINGFFFDEIASDTLQQVNYMKEVFDYVKNKSKNNFVIANPGAPITDAISPYADIFVT
SEVSANVYINKFEKPKSNFENNKANAKHIWHIVHSANPKDYAEIIRLSKERNAGWLMITD
DVMPNPYDRKPSKFVEMVNMVNMVND
>SEQF2502_00712 Lipopolysaccharide assembly protein B
MYIKELLKEADKSIENYKYNDALVYLKSVLEIDESNYSALMTLSKIYTDFGMFEEAKEYA
EKLYKKYPESKDTLFTLGLIYQSLGRLKKAILLYKKFLEIEKNYFVYLNMGMSYALLKYY
RKAIENINIAIEMEPESSEAYVEKGDCLTMMGKYDEAISEYEKLLNFKFNEVEEFSLYAR
MGDTMAYANNIKEVIKYYNIAINCENVEDYIFEDYFEILFRAGEYSEIKILLLNYENATN
ENKKLSRIKMLNLQGRFFVKVADYESAQKVCDKMIILEPENFRHYVNLAYILELQHKYDR
ALECVDKMEKIMEDKEFLKELRKRIRKNKRKFEREKKKNSEE
>SEQF2502_00713 hypothetical protein
MEEKKYEVNRKYDEKKLINVLKNFDKAGEYVVESGRNEIKRFEIDFENNLERVNLKRKKN
NKIDDFKAKKMINVKKFKRKDFITNFFYKFKGSKAKRSYEYAKKLLEYKIKTPEPIAYFD
DFMNENNKKNSYYISEELKYDFTCREVFWPEDIEEEKAKQGGNYKISEEMERMLTKVEKN
REKIIKQFAKFSFNLHENGVEFEDYSPGNVLIKDKSGNYEFYLVDLNRMKFNVKFNLNRR
MKNVSRMMENEKIARIFANEYAKYYKQREETVFRYLRYYIRKHKKYVDFMDITRPFRNIF
KRKK
>SEQF2502_00714 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MRNYDIIVVGAGHAGVEAALAAARHGLKTALFTIYLDNIAMMSCNPSVGGPGKSHLVSEL
GMLGGEMARHIDNYNLQLKNLNHTKGLASRITRAQADKYWYRIKMREIIEKQKNLELVQG
IVVDLIVENKKVMGVEDNLGIRYGAKAVVLCTGTFLGGEYVMGDVKYSSGRQGEPASVDL
PDRLAEYGFELDRYQTATPPRIAKSSIDFSKMQELKGEDKPRYFSYETKKEYNSTLPTWL
TFTTPETIRVGQEMLKYSPIVTGVVSTKGPRHCPSLDRKIMNFPEKTNHQIFLEQESVES
DEIYINGFTTAMPPFAQEAMLKTISGLENAKIVRYGYAVEYNFVPAYQLKLTLETKVLDG
LYTAGTINGTSGYEEAACQGFMAGVNAARKILGKKEIVIDRSEGYIGVLIDDIINKKTPE
PYRVLPSRAEYRLTLRQDNIFIRLLEKAKEIGLLNAEKLAELENTCKEIENEIERLKGIT
VYPTKENNEKLFEIVEKQNQSESAEVEKNSKNSMNSPVSAFEFLARKEINYDNLSEFAET
VELSDLVKEQVEINAKYNVFIEREKAQIEKFKKLEKMIIPKDFNYESVKGLSNIAISGLM
YGQPETIGQASRISGVTYNDISLLIAILKN
>SEQF2502_00715 Multidrug export protein MepA
MKESIKEKNSLADNKKTRFGTESIPKLLISLAIPAIIANLVNALYNIVDQVFIGQKIGFL
GNAATNVAFPLTTICLAIGLMTGVGAATNFNLELGRKRPKRAKSVAGTAVTMLLLGGIVL
CVLINIFLKPMLTVFGATNQIFDYAIEYTQITSLGIPFLLFAIGANPLVRADGNAFYSML
AIVVGSLVNTILDPLFMFGFDMGMDGAAWATVIGQFVSAVMLALYFFRFKSVKFELRDFK
IRIREIGILFALGTSPFIFQCSALIIQIVTNNLLKIYGAKSIYGSEIPIAVAGIVMKINV
IFIAIVLGLTQGAQPIAGYNYGAKKYGRVWEILKLTLKVAFVISLVAFAVFQFFPVQIIS
IFGSGSELYFKYGTKYMRIFLFFIFLNGVQSAITMFLTSIGRAFQGAFLSLVRQIISLLP
LLIILPYFMGVDGIMFAFPVADLVAFIVSVIILKKEMKKIPKIDEVD
>SEQF2502_00716 Peptidyl-tRNA hydrolase
MKLIVGLGNPGEEYKLTRHNIGFIFIDEYLKKNNINDVREKFKSLFVQTNYNGDKVFYQK
PTTFMNLSGEAIGEAVRFFKIDPKTELFVIYDDMDMQFGKLKIKQNGSAGGHNGIKSIIS
HVGNEFVRIKFGIGKPKTKEETLGFVLGKFSPEEKEVLKDSREKIFNLIDDIKDDMTVQK
LMNKYNTK
>SEQF2502_00717 hypothetical protein
MEDNDKNFEIEVASKRETESQIKEAERVEDTENRIGHTDNSNHGNQDLNHDNQYNQNNQY
GNINGYQEINEMEFMSSVNWIINIHKIFGILGIIQGVLASLSIVGVITGIPMIIASMKLM
DTSKILFNYKITREESNLKMFFDEYKKYWVILLVSMLISIILIIIGFVVFAGTIAALLGT
FSGGHTGYEY
>SEQF2502_00718 hypothetical protein
MDNNFSDNRNSFLDMTFLNSINWISVIHKIIGIILMIQGVLASLTIIGAIIGVPIIFAGK
NLFASGGNLSDYKFSKSINEIKKFFINYKKYWKVIFMIYIAGIVSIFLFIVILVFSVINA
SKALPKSNPNDGMASISTTNDNNTNTTNTTTDQSSNDQSAPELDELHKLMEEVVTNGDTD
ALNKYSKEQLRLLRNTLYAEKGYIFIGDLKSYFDSKPWYHGTVADQDTIRLTDYEKAFIN
AVREKEGLPNINNDGSVSQTQTSNDSGEELDELHEVMDEVVNGNESVLENYSKEKLRLLR
NTLYAEKGYIFTGDLKGYFNSKSWYHGHISNQDSIPLSSEEKVFVDAIKKYESQ
>SEQF2502_00719 hypothetical protein
MLNFIQNIDIFIIKQFYNFQHSLNSKLLSNILIFFTNLGNYGLVWIAITLFLLSSKKYRK
IGYLAVISLIINAIIVNVILKNLMHRARLFTEISDIILLVKAPKDFSFPSGHTSASFTMV
YIFYKHLKNTFQLC
>SEQF2502_00720 hypothetical protein
MEILISVLVVVIGIVILIIMNFRNRKKMDEFDDFSREMQEREKRKRKVREIQKYEAEERA
SFSESAYDENRISSESEPKQNGKTANVDKFGVKIVSLDDIVTEDYGKDFIEYDKKESEEY
QENIRTANIFIMSGFFGEARDRIAESLKFSQRANYELGKYYYYCEKDNQSAVNTLNLAYN
SGIKEAMYYIGLIEEESGNDEIAKGWYVAGAENGEINSIIRLGKIAEEKKDYEEAESIYL
KIANTKNAELIYNLVRIYFKQNKREKILEWQEKLLNEKQIMGLNSEIIKNIEFMLGNEKD
RKYMELINQGNELLEKKDYGNAQKLFLEAAQYNERGYLLLAKSYYVAGNGEKAKDMYKKA
YSLGVKEAAYELGKYFDTVEENKKEAEKWYKIGQEMGDVKSIYELGILYECSREFAKSEE
EVYKLYEKAANMKYAPVISDMIYYNNRQENGNKSKEWAFKVLNETGLIELGRETIRDAQN
FLQEMGEYAGDKISEKNYEIEYDNDLIYFIEKNSKGRNIKEETYERKKSNFWMIFGIIIF
ILQLIIKCSEY
>SEQF2502_00721 hypothetical protein
MEKLVRRGGSGHSHGGGHSHSHGSSGSYHYSGHYGGEHSSGEHSSGHSDGEGNGKSKKSG
DDEQENSSSFWRSHGSHSGSSRQRNCESIVDAKERQDCIDNSNNANNLVSFFIFCAVIVF
IFLKIKDFGRK
>SEQF2502_00722 Adenosine monophosphate-protein transferase NmFic
MVNNKYILENESDKILKRLVSQDKEEFLSKRRARELFDNRILKNIQVGTFEGLKEINRYL
FQECYGTAGKIRKHDIRKGDTVFCRAMYLEDNLKTVSKMPENTFEEIVEKYVEMNIMHPF
YEGNGRATRIWLDQMLIKSLGMCVNWQNISKNNYLSAMKRSVINDLELKMLLKENLTEDV
ESRDMFMNGINQSYEYENMGKYDVKKLEVSNELEKISE
>SEQF2502_00723 hypothetical protein
MYKEYKEKGYKELENLVLKNDYYAINELGERKFQEGNYKEALEYFEKASKLGSDMAINNI
GFYFLEIENNFEEAEKYFNKAVKKGNIVAINNLGVLNIDKNNYEDAEKYFLLTIDKKCSF
AYNNLGGLYENVYQKYEEAEKLYQKCFEETEDTDCLINLAYLYLNYYENKNEAIKYLKLA
ISKGNKEAEHVLFHVLNDEVCSCNND
>SEQF2502_00724 hypothetical protein
MGAVVTWQCSACGNIIHSSLRPSGKAGGRCPDTSSGNHMWQQQG
>SEQF2502_00725 putative ABC transporter ATP-binding protein YheS
MSLVQFNRVYKQFAGEYILKDINFTIEEKDKIGLVGVNGAGKSTIIRMLLDRERIDGAED
NLNEVGNIVKSASMKIGYLSQNHEFSDEKNTIYEEMMSVFAEEREIWHELQKVNLLLGTA
ENDELEKLINKSAELSSLYEAKGGYDIEYKIKQILTGLELTEEYYNLVLKDLSGGEQTRV
SLAKLLLSEPDLLILDEPTNHLDLVSIEWLEDYLKRYAKAFLLVSHDRIFLDNVCNKIFE
IENKKLHKYDGNFSAFIIQKEMILKGEMKRYEKEQEKIKKMEEYIDRFRAGIKARQAKGR
QKILDRIERMDDPVFNPQRMKLKFETDTITGDNVLKVKGISKSFDGKKVLNNVSFQLFRG
ERVGIIGKNGIGKSTLLKILVNKLKQDSGTVEYGSRVKVGYYDQNHMDLTPANNILQEIN
NSLNLTEEYLRTLAGAFLFSGNDVLKKVEKLSGGEKVRVSFLKLYMQRANFLILDEPTNH
LDIYSIEVLEDALEDFDGTMLVVSHNRHFLDTVCNTIYYLDENGLTKFKGNYEDYKESLK
TAKSASQGTDIETKEEKKLSYQEQKEQSRKIAKLKRDIEKLEKEMEKITEMRENLNAEYE
KAGKENNMEKLMEVQEKLDRLEEEEMEKMEEWDVKSGEMEEIEL
>SEQF2502_00726 hypothetical protein
MNKKKINTIVGSIGAFIGVFVFITYIPQIIANLGGEKAQPWQPLTASISCLIWVIYGWTK
EPKKDFILIVPNLAGVILGFLTFITAL
>SEQF2502_00727 hypothetical protein
MIKREQYLKEIRKFMDKPIIKVITGMRRSGKSMILKLISKELEEKGINKENIIFINFESL
MFAEFANFQKLYSYIIEKSKNLAGKIYILLDEIQEVASWEKMINSLLVDLDCDIYITGSN
ANLLSSELATYITGRYVEIKVFPLSFKEFIDFSKIQNPEKIYSNEEYFEKYLQFGGLPAI
HNFNQDKTSIYQYLTDIYNSVLLKDVVARNNIRDIELLERIILYIFDNIGNIFSAKKISD
FLKSQGRKLSVETVYNYLKALENAYIISKVQRYDIKGKSILETQEKFYLLDLGLKHSQLG
YKANDIAGHLENIIYLELLRRKYNVNIGKLKTKEIDFIAQKGDKKLYIQATYLLVSENTI
EREFSPLKNIEDNYPKYVLSMDNLDEYNINGIQRKRIIDFLLDL
>SEQF2502_00728 hypothetical protein
MTGSMIYKETMESEFFEEWFRKIYLRDIEKLKENAIIVMDNARFHRKRVLKKIIKETRQH
LLFLPYNPIEKVWTNIKKKLKEITHNFNTLEEAITAVLFDKSVQF
>SEQF2502_00729 hypothetical protein
MEEQFYKLYPDSDKNSILSEISEAEIFRNYLKYKYNLQPDFLEIYSTNCGNNITNLLKLL
KEENITFKNIIISQDATMQLRMEAILKKYFSENIKIINFAVYSSKVCVKDGKLCFENDIF
GMWDIDRYITLLMGEIPRLTDDENGYGPRGTGYIAHIDIPENVKNAFLILKQIHGDKVRK
ADPSFTST
>SEQF2502_00730 hypothetical protein
MDKKISKYEIANCINVLGNFCGKRDIDELTAFELIKKYGVEKADVMVLFGGSILAGGDVL
ANAMKK
>SEQF2502_00731 Glucitol operon repressor
MLASERFEKIVQMVNEKGIANTKELAQILNVTETTIRRDTEFLEKQGKIIRVHGGAKSIN
QKTVMSNQDEKDMKDRTENYEKKDEVCKKVASFIKNGDCIFLDGGTTVAPIVKYLKGKNV
KIVTNSMLVVKAFNDSDSELFVIGGKYIKEYDMSVGSIALNNLSNFNFDYAILGCAGLDI
ERQVVYTTEMETMLIKEKAMGLAVKKYLLLDDSKLSIRGFYTFVNTSDFDAIICNNSENV
NEEELPNNFIIV
>SEQF2502_00732 putative transaldolase
MKIFINQLIGKNIKTNDDWKKMVKKGRKLANINLDKIVEIPMSLQGLKACKVLSGEGIKV
NITSISYSAQALLAARAGADYISPVIENIKGVDTVKEISEMFKREKIKTKILFEKKEMPL
DTGNYA
>SEQF2502_00733 Deoxyribose-phosphate aldolase 1
MKKLTKKANEMNLKELAEYIDYSVLKPEFTEKEIVKLIKDGVKLGCATICINPAYIELCE
PYVKGSDTMLCPVTDFPFGTSSTESRVKQIEAVAKYDTVKEIDIVANFGLIRSGKYEEVT
KDIKACVKVAHKFGKEIKIIFETDALNEEQIRKTCKCCIEAGADFVKTSTGFLTGHENKG
AIPKVIKIMQEEVGNKCKVKGSGAIRTREHFLELIDMGIDRMGIGYKSVPVVLNLNVEND
NSTGEY
>SEQF2502_00734 hypothetical protein
MKKILEKIGKDELLEYWRLSKGRFDAGNFVGINGEFAIFTSISLYGKNGGFRFIKIDDLK
KFGKNTEYLELMKEKIEERKSSDRKIIELEKNKFFKELFKYFKKNKIKLRLFYEDDYQRE
GYLVKESKEILHFQWCDEGDRESEEFIRKSEMKSIEIGKNVVKDIIVKDDKIQKNKIVIA
RNDIQGSVIFQDENYTLIYENDLFWADCKFIIIKTSDIWEITEKVYRIETENVSLEEILP
DISNMEIKEILKKCFENKILVHFEYEKSYFEKFGIIEKFENDRLILREIDKGSGIFVSKS
EILIEDISFLFVRNCRVLRVVG
>SEQF2502_00735 hypothetical protein
MREITIIYIIAITILLIYCFLTVKFWGKNFFKKDVLPKLKVPKSISAMGVGILNNSRTEK
NFHIGIFSLVEKNFITAKREKLFENMDFQSDILYKKNLEKSKSNYYRQDELFAEERWVLD
SLSDSENGILSDYQSFGNREKLPKMDEKNIDKRKEIFREVLQVLITFLVAFLINVILKGS
SDSSSYNSSNGSSRSSYNQKSLDPFFEKMFEIYKRTKKKFLGSFWSPEKLEEFIIYKKNS
GFYIFYFGVILASIIMTSKDVKFGSTEGNFGLIVLAAIIVFFLESLWLRILFLPIFSKYI
PKILKIFIALVFLFSLYSFMLPNIAFIFGLRFYILIPLTFIILFFIYKKLIARYTENGLL
AMNEIESFRKYILNFEKLEVPTFSSENELIENFQQMYIYAFALGIEKRFLKFLDVTLEKN
NFAEKKEFIYEKLLISTVFCDKKLLGELKLNVMGR
>SEQF2502_00736 hypothetical protein
MNRERSIENTKKYTILEVMFFNGYSVGMQSFVLLSLAIYFNMSSFFISIVSSLPTAGYLL
QIFTSKVNNILGSRKKTMAIVAGIFGGILGKFINNGVIYIFGEQFYTIRFAFVIGFILRL
FSLLELTRVYSFEKTFVYAGGSGSMKSMFSKIMFSGSRYVLNSSKSRDEWNDEKEVENDK
E
>SEQF2502_00737 hypothetical protein
MNLEALLGLLQGQDLEKLAQQAGGSSKEVKKGVAAALPAILAAVNKNANNSEKAQGLNKA
LEQHDGAVLNNLGGYLQNPDLKDGAGILNHLFGGNTQDVANAVSQSSGLDAQGSIKILET
LAPLVLGVLGQQKKENNLDAQGISNLTSNLAANFAGEGGIMSMITNLLDANKDGNVMDDL
TGMIGKLFGGNK
>SEQF2502_00738 hypothetical protein
MLNKKMNIILLFLFIFLIGCDKKESVKKEKKNNLENIQSKTAKENIFSNNSIEKIIETFS
KKSKENKISIENFEKLTYENKNYYYAKIHSRGDAIYALDYSGISATSIFLKVNNVNGANL
GIIENMVVNLIQVSDENIKDSEARAIYTKILSSLGEKELTSLLTYTNGIIYGIRIDSVTG
ELIFFARESEDEKAVTSIQRLNFINKKKVDEKTLAKLGENK
>SEQF2502_00739 30S ribosomal protein S18
MRAKPVTEFKRRKRRPKVKFKVEDINYKNVELLKNFMNDKGKISPARVTGLEAKVQRKIA
KAIKRARQIALMPYTRIEK
>SEQF2502_00740 Single-stranded DNA-binding protein A
MNVVMLMGRMTRDPELKYTSGGKAYANFTLAVQKTKDDAEFIDCVAWEKTAETIAEYFRK
GRKILLQGRLNVSSYEQNGEKRKSTKVVVNSFEFVESSGSSNNGGGYNQNQSYSGNNSNK
PVHNDTYENDDDTDDNEDFPF
>SEQF2502_00741 30S ribosomal protein S6
MRNYEIMFILSTQLTDEEKQAGVAFVEDTLKAAGATEVKTEVWGDRKLAYPIKKKENGYY
VLTTFQADGTKFTEIESKLNINESILKYMIVKND
>SEQF2502_00742 Cell division protein FtsZ
MDNFSNAAKLKVVGVGGAGGNAINDMIESNITTVDFIAINTDQQDLDRSKASIKVLLGKG
MGAGADPEKGRIAAKESEEKIKDVLEGTDMLFITAGMGGGTGTGASPIIAEVAKAMGILT
VAIVTKPFSFEGPLKKNNAAIGIDNLRENVDTLIAIPNDRLFEIPGMNISLMNAFKEANG
VLKMGIKGISDLITKQGIVNLDFADIKSIMQNSGIAMLGFGEANGDEKAKSATAQALNSP
LLEKSIEGARKILINVTAGPDIGLQEIQEVAQTISEKAGHDKANLLWGYIMEPELEGTIS
VSLVATDFEEESFSNNTKSSQTIRFAPSEEKVKEEENNEKINYQNEENDYEDDEEKVEDP
GDFVLPPFFEE
>SEQF2502_00743 Cell division protein FtsQ
MKNPVKVLILLFLLAGIMFFGKMFIDTDYFKVQEVLVEGKSDLLRQDITAQLEQMKGKNI
IYLNTDEIENHIKKDVRVKKVSVKKLFPSKIKVVLEEREPYVYIKKGDETLLADKDLKIY
GDILEEPAKNIPIIDYTDDESLNAMKTILSKIKNKDFYAMISEIRQSEKNYEILLTNNVR
IITETTVTEKKYEEAYRLYEKIRKKRPVISMDLRFIDKIVVK
>SEQF2502_00744 UDP-N-acetylenolpyruvoylglucosamine reductase
MEIVKNAKMKEYSNMKVGGTAKELIFIDDKNELKEVLQTRNNIFLLGNGTNTLINDGNLD
ISFLSLKRLKNITVEKKVRNENKENNYDLVRVEAGLDLDDLIEFMEKNDYSGLENITGIP
GSVGGLVNMNGGAYGTEIFDCIEEVEVCKNDGEIIKIKTTDLNFKYRTTEIKENKWIVIS
ALFKFGFGFDKAASEDKRQQRKVKHPLDLPNLGSTFKNPKGKFAARLISDANLKGYRVGD
AAVSTKHPNFVTNLGNATFNDVISVIEHVKEVVFEKFGIKLETEIIILKK
>SEQF2502_00745 UDP-N-acetylmuramate--L-alanine ligase
MLSKVNNVYFSGINGIGMSGLAKILAADGFNVAGSDLERKAVTKDMEDLGIKVYIGQVEE
NVKDKGIDLFVYSTAIKETNPEYKYIVDNNIKKVKRGQLLAEIMNRFDGIAVAGTHGKTT
TSSMMSVALLEKEPFIVVGGIIPEIQSNSKIGNSEYFIAEADESDNSFLYIKPKYSVVTN
VEADHLDHHGTFENIKKSFEQFIDSTERIAILCKDTVGKVGLNLKNKNIVWYSIKDKTAD
IYAKNIRVENGITSFEAVKKGENLGTFSLSIPGEHNVANSLPVIYFAHEFNCNMKKVKER
ILKFKGAKRRYQVIYDNNLRIIDDYAHHPTEVKVTINAAHKTEKGKVTVIFQPHRYSRTK
FFFDDFVTSLKEADDLVLLPIYAASEDNTYGVSSELLAEKIGGNVRVQTQEEIEDIIKND
RNSGNTYVFMGAGSVSRVAHAIADDLKKMEK
>SEQF2502_00746 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MEKVVFTTGGTGGHIYPALSIAKKVRERGIDTLFIGTKHRMEKDIVPKENFRFIGLDVLP
LRSIKSVFKMMAATIGTIKLLKKEKPTKIIAFGNYITIPVLVAANILRIPYYLQEQNHTM
GQANKWFYKGAKKVFVAFENTLESVKGKYKSKFVVTGNPLREEFYGKNKAEERRKLNIKD
DEKVILVIGGSLGAKNINEAILKKWKTILEDGKIRLFWATGKDNYEASTYRIRDFGTAVV
EPYFENVPELMAASDIVICRAGASTISELIQLEKPSILIPYDFVGQKENADVLEYANGAK
IFTNETAEEAIDEALSIVCQASMLEFMSENVKTLKKGNSAEIIVNEMGL
>SEQF2502_00747 putative peptidoglycan glycosyltransferase FtsW
MNRKKILGTGFVIVILILSSLSIITMASLSAPRAQNEYGVSYYFLLRQIIWLTVGWLGFL
FTANFNYKKYREITKYLYVAGAFSLVMVLVIGKTVNGAKRWVDLGMGVVIQPSEFVKLIL
IIVLSTLVYNLKIQNKISKYPWLSSIVIMGTTGIYMFLIFFEKSFSNTVQIAIIGMTYLF
VSELKFSIIALYTALGGILGWFGIMKVGYRASRIAAHASKDVGFQTTQSLIAIANGKIFG
KFYGNGFQKYGFLPEIHTDYIFAGYAEENGFLGVVFLLGLYAALLIIIGITLKKIKDLYA
KYLLAGIFITIATQVIGNVAVASKIMPSTGIPLPMMSYGGSTMIGMMMILGVVYNIIRTL
YKQEMGSQLDELNEIDYMM
>SEQF2502_00748 UDP-N-acetylmuramoylalanine--D-glutamate ligase
MDKKGIVFGAGLSGLGAKELLEKNEYKVYLIDDKAAMPSEEGIRLLNEEEIEFVVKSPGI
PWKAELLKVAKEKNVKVISEIDLAYKYVDKNIKIISFTGTNGKTTTSTKMAELLNFAGFR
AKLAGNAGFSFAKLVADEEELDYIVLELSSYQLENNPQIHSNIAGIINLTPDHLTRYNSV
EDYYITKFAIFDKQTENDFALINLDDEIFAKLYERSELKKKIKAQKIYLSTKAKGNVFVY
ENNIRIIKDLNKRIDEIQNFSEKIDEISEILMKTDELSLKGRHNLENMLFLISSAKILNV
ENEKLVKFLKSTTALEHRLENFFVKENTTFINDSKGTNVESTLKAIDSFNNSIIMILGGD
DKKIDNMPLIERVKEKVDFVYLIGDNAQILIDDMEKVGYKNYKNLETVENVLNYLKEKVD
FSKDQTVLFSPATSSFCQFKSFEHRGKVFKELTEKIIGK
>SEQF2502_00749 Phospho-N-acetylmuramoyl-pentapeptide-transferase
MLYLLQGLFINNWGVLRIFKSIMLRASVAFMIAFLFMLIFGKPFITWLKKKKYGDTAREE
GPKSHFDKSGTPTMGGILIIGAILFATAVAGNFTNKFIIFLFIITILFTTIGFYDDYLKL
TRHKNGLSGKKKILGQMIITALTFWFVYKYGLVNKTIDFSIINPIIKNSYIYITPILFFV
FIAFVIIGSSNAVNLTDGLDGLVSGPIIVVSITLLIITYLTGNVKYARYLNLYYVPQAAE
IIVYLAAVIGALIGFLWYNFYPAQVFMGDTGSLTLGGILGIVVIFIKQELLLPIAGFIFI
MEALSVMIQVWHFKTFGKRVFKMAPIHHHFELLGLPETKVTIRFWIVSIMTCLLTFVILK
LR
>SEQF2502_00750 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MNKSEVFQRLFNKEKTLDLEIKNVSIDSKKLEKSDVFVAIRGGNNFVNEALEKGAAVVYD
SEAVKIDEKYVDRAFFVKDSIEFLQKFAKEWRKNLDIKVIGITGSNGKTTVKDMIYHLLS
QKYKGKKTEGNYNNHIGLPFTLLRAEKDDEFIILEMGMSGFGEIDLLGQIALPDINVITN
IGESHLEFLKTKENVFLAKTEIIPYIKSTLVINGDDEYLKNVKTENIEVVRALSLKNNEF
RDKTSDFYYGDVRFNESGTDFFLKYFGKICQSTVERNYKTNVLGEHNVLNLVMAIAVAKQ
FGMEDKIISEAIKNIGLTGMRFQIIENGNTTYINDAYNASPMSMEKSLETFSQIYNDRLK
IVVLGDMLELGENELKLHSNLFDTIKNTKFDKLYLFGKRMKSLFEKIKENVDDKNLNNEN
LEINKALKNGKFEHFDEKKKIKEKIRQISEKKAVLLKASRGMKLEEIIEK
>SEQF2502_00751 HTH-type transcriptional regulator GmuR
MDLLVSEGLIIKRRGSGTFVKDMRDDDAIEIAMKKQFMGFKATHGSKKVTSNIIKFKVIP
ASAEIAKKLKIERNDFVYYIERVRYLNDEPCVIEYTYMPISTIKGLKEDVLKDSIYEYIE
NTLNLSIQSAHRVIKADLPTDLEKKYLRIKEPIPILEVEQVAFLSNGQIFEYSKSRHRGD
KTEIKMIEVR
>SEQF2502_00752 putative HTH-type transcriptional regulator YurK
MLKYREIVQELRNKIINGDYIPNEKLPNEKEMCEKYKASRITVKKPWIYWFQKG
>SEQF2502_00753 PTS system oligo-beta-mannoside-specific EIIC component
MTGVIPTSLVGAQGLFVAIFVSIISTTIYGFLLNKNLTIKMPKDVPPAISKSFSAIIPGF
LTLSVFMIINILFKHTKFESIHTFVYEFLQKPLVGLGTSFFATIIAATLVQFFWFFGVHG
HLVVNPIMDTIWNVASLENLNAYNAGQPLPHIVTKQFMEMFSVSIGSMGALSALTAIFIV
SRIKQQREVAKLGFIPGIFNISEPTLFGLPVILNPILAIPWILGSPITISIAYFATKIGI
MPRTTGVAVPWTMPLGISGTLATNSIMGGVVQIVGFVVMVLLWIPFILYSQKQYEEEKRK
NKNEAKERE
>SEQF2502_00754 PTS system oligo-beta-mannoside-specific EIIC component
MERTFKEKLSEKLMSFAGIIRKNIYLLSLRDAFMLSFPLTMFGSILLVVTNFPGFSEKAR
EGLGALMGHSIESSMLLMSIFVSIGIGYYLYLYKNPKRTQDAIYSGAVALVSFFIVTPFS
VKLENGN
>SEQF2502_00755 6-phospho-beta-glucosidase GmuD
MAKLKFPDNFWWGSATSGPQSEGRFNKKSRNIFDYWFDTDKKAFFDGVGPDVASNFYNSF
REDIRLYKEIGLNSLRTSIQWTRLIKDFETGEVDEDGVRFYKEVIEEFEKNGITLVMNLF
HFDMPIELQEKYGGWESKHVVELFIKYARKAFELFGDKVKYWTTFNEPIVPVEAQYMYQF
HYPLIVDGKKAMQVLYNTALASAKVIEEFRKTEMLKKDGEIGIILNLTPSYPRSENEEDV
KAAKISDAFFNNSFLDPAIYGKFPELLTDILEKDGVLWENTEEELKIISENTVDFLGVNY
YQPRRIKARETEFDISKNGWLPDKYFENYDMPGKRMNIYRGWEIYPQAIYDIAKNIQDNY
KNIKWFISENGMGVEGEEKFKNEQGIIEDDYRIDFFREHLTHLHRAIEEGSNCFGYHTWT
PIDCWSWTNAYKNRYGFISVDLPTQIKTIKKSGYWIKKVSETNEIDSWDI
>SEQF2502_00756 hypothetical protein
MSEYTTIWEAVRFGTLKNVIEIFKKGDEKIGDASGDSILFDALANTNSFARYEITNFLIN
KGADVKAVTEDGISLFFPLFSYGWTDIVKTTILCKTLLEKGADITTIYKKEKTVSFKELF
NIGAPEMEMLPLYQLIFSQPGLPLLVKDKWGLTVIEFARRSNRPIAVKMMEDYVKKYNLK
EDS
>SEQF2502_00757 hypothetical protein
MAMRTKTLVFVGLLLVSVLGISSQVNYALSNSMQGNFNYILNAKIFDYGQNIISIEIDTK
GRGRTIREKEIDKDTFKVFAKGTLPTDTGIVLDEKTKSLGIFEVEREIKNIFVNDKGNIV
INLKYGKDVAGANTLSYVTGGVSRNVLMDLEYRVEQKKLMKTGPGTHGFFGIYRQGKIVD
EEADKFVAAKSKSGVNYQYFKPVNKDDGKKHPLIIWFHGNGEGGYKDYRNNVSQKLANRG
AVAFAEDKTQKIFGGAYVVAPQADDTWYNNYTKGYIKSVKAMIDEFASKNNVDKNRIYVF
GASAGGYMSFRMMIEYPDYFAAFSTSAAALDKAATSGGVATTTQDLMKIRNKPLWMVHAQ
NDPTISYENTSKRVYDVLSKYGAILSSYPDVKIGKTEYNGHWSWIYSLRNMPVNDKGEHL
FEWMARQHLKIRYY
>SEQF2502_00758 hypothetical protein
MKNYKELEKILFSMDGKSYSAYKSLKGEYRFEKYVLAIDHVQSDPYAPPSKMRVTMDRKI
CGIPYELTDTKDKNIAVSDFLTRNFYREIQKSGNDSTGTGGSGRIFIDRCGQEILERTSV
LIKGDKVEVRFEMGMPARGRRIMGKAAQKIIFEQLPEIVEKSIIYDNLNKKALNEQVILV
LDQEYARKILKEKGLVAFVANDSVLPRESGVSDKPMKNAVKFKSPEKFEITLKLPSGKEV
SGMGIPKGIALIVGGGYHGKSTLLAALERGIYNHIAQDGREFIISESDAVKIRAEDGRNV
EKVNISGFINNLPQNKDTRAFSTENASGSTSQAANVAEALEYGTSLLLIDEDTSATNFMI
RDGRMQKLVAKEKEPITPFIDRVKELYYNFGVSTILIVGGSGDYFDVANHVIMMDEYVPK
DVTEKAKEIAKLDENKREFSSNDKFQGVTQRIPLKKSFSQSGKLDKTKAKGKYSILYGKE
SIDISGLEQLVDDSQTNCIAVMIDYFKNKVLDEKLTLSQATDRIYEKIEKDGLDSISSYT
GHPGNLALPRKQEFCAAVNRYRKLRIK
>SEQF2502_00759 hypothetical protein
MTKFNLKDFRETYLKLTQNELAELISVRQDRISRLEQNLDTISLEELVVLAKRTGKSLDE
LANYKKDIPHELTINDCWDKVRYIKNTIINYIKDFFPKNNQNYISKIEDLRKNIEGITRK
PRIVFSGKSDSGKSTMINALIGKEKMPTNWTPTTSIIVYVKDILERPDYIEDELWIFRKG
KNTEWDDTRLYDEKYCREWKIASGNAEILSQYGVRKGHDYNKDVGSAVLFVDSPILKNCD
ILDIPGITAGIESDNIAANQAQLKADVLVYLSQASGFLQIEDANYLKEALEVLSPLEETE
GTGLSPMSNLFIVATHAHHINPRTDLKNICDSGCDRFADTVADSFWERYSYNSKKIFTKK
DLRKRFFTYAIDIEDLRENFEKELKNTIENLPKLLEKKVFNITKDYIKNESEKMKKEVQK
YEGLINERERYSKLLEEIKKNEPKRKFLLEENNRNVKNKIFDLDNETKQKFKEDYNRILT
EENIIKIIDEREYKNKKTDLEKLGSYISSEVQDVYRKNLEKTTEKFKNIMDEYLLKTQKS
LEIDNFNSMNINLNFDFKSAFIGGLAGVATLGGLAFWASTLGNLGAYILVAKGVSILSAL
GISIAGGTATATAFVASIGGPITLGIAAAILVGLAIWGIFSGSSWKKKIAEKIIKEFNKN
IYKYDNAITQYWNDTESGFNIAKDKMEEEWQNYINNLEKELYHSDVNELKETLKNAKEVE
DFFLNTPL
>SEQF2502_00760 hypothetical protein
MFKKLEKNGFYYGFPVLLMTTKDKETGKSNVTPLSSSFVLGKSIVVGIGFGNKGFKNIEG
GSDVTFNIPDENLYESVKKIEKFTGDTEISEVKQNLGYTYCEDKFKIAGFTELAGEMVNS
VRIKECSIHIEAKVTDVQKKDWFAIVTCEIQGIFVDEKIMKDDSHIDTQKWKPLIYKFRE
YTSTGDRLGLNFNFQEV
>SEQF2502_00761 Metallothiol transferase FosB
MKINHVAIYVKNLEKTREFYEKYFEARANEKYHNKNTGLQTYFLTFPDSEARLEIMSRPE
LSERNDKIMNEGFIHLAFSVGNKENVDKLTKRLINDGFKCLSGPRTTGDGYYESVVEDCE
GNLIEITE
>SEQF2502_00762 hypothetical protein
MVLFGPLLGMFMPRIEKLYEKWDLVDGKSQIEKEIEGLE
>SEQF2502_00763 Aryl-phospho-beta-D-glucosidase BglH
MGFRKDFLWGGATAANQLEGAYNVDGRGLANVDFSPVGEDRLAVITGERKMLEFDDEHFY
PAKGAIDFYHRYKEDIALFAEMGFKTYRMSIAWTRIFPNGDEETPNEKGLEFYENVFKEC
RKYGIEPLVTITHFDFPIHLIKEYGGWRNRKVIDFYKRLCTVIFTRYKGLVKYWLTFNEI
NILLHAPFMGAGIVFEEGENKNQVLYTAAHNELVASAWATKIGHEIDPENKIGCMLAAGK
FYPLTSKPEDVWTALEKDRENYFFIDVQARGYYPAYAKKFFERENINIGITNEDEQILRE
NPVDFVSFSYYTTRCISAEADRLGEGNLLKTMRNPYIEVTDWGWGLDPLGFRTTINEIYD
RYQKPLFVVENGLGAVDVPDADGYVEDDYRIDYLRNHIKAMKEAVELDGVELLGYTTWGP
IDLVSAGTGEMKKRYGFIYVDRDNDGNGTLKRSKKKSFDWYKKVIASNGEDLD
>SEQF2502_00764 hypothetical protein
MDKLDDFLKYSVLFSYYGELFPKKKREYLELYLEENSSLSEIAEQCGVTRQAVFDNIKKG
VRKLDEYENKLGIFKKEKELKKKLEYLKKNFTMENLDKIIEDFDYAE
>SEQF2502_00765 hypothetical protein
MTGKEKEVKENRIQELLVKREEYLNNGEIEKEIEVLRELRVLFRRIFGQESEENVKILTE
LGNALKYVGKFDESVRLLTKAENIILEIYGENSLPYVTCNANLAEVYRVMMNYEKVEEKY
HKAIKIYKKNNFQNGYIFAGICNNLGLFYEENGRYQDSVKWQKKSLIILQDLEDSEIQGA
IILSNMVKPYLKLDEKKMAENIVDEVLKILKRRVGEGSNLYLNILNNFINAYFENKNYKK
TLELLEKCEKISKDVFGIENENYKAILEKIKIVKNKIDKNKMEKYVWKKQIVKKVKK
>SEQF2502_00768 hypothetical protein
MSNNLRQAKKDLKAFAKRAKDVKYTESLLFSYLITGMITFSIGLNTSTNVLYERMNKELV
MSADKTRTAIKKKKKVNEEAIEELNLELIQLMEQGDQVVKSPWSSWQFGANTFISSSNGT
YKGRGDKAEKYLFNGIYNRGNWADTGILSNRRKSYMTSSLSTSTIGKQSYGLASLLHVQE
PEVEIQIMANVRPKSVTKEEIAINPQIDMPREVVRPAINLNVTTPITAPTILLPTLNPVT
IEVPNPQEPATPPTVTAPTISMNLSAPTIGVNITPPVLSMNVTAPTPTVNTLTITPPNIS
EVSAISVTKPTAPSVTPPNPTANPIVFSIPRLDSYGNSITADNTMNANTNLLNSSYTLSQ
APVGHRKAIGEYMTNNGSFYSGENTEMHVDITKQRAITLDPGLPSGRGGRDNPSFSFENK
GKIYLEVMEVAGIEVQPDTWNNPQVTGINGSTGLISGNKSLQVALLFTDEGTGSSTTNKH
TLRNEGEISLSGNISAGFATSDFKSGVNISTIAINNGNVNISGDNSHGMVVSKTTNALGP
DSSFVNNGTINVTGNDSGGMTVLGKIQGGATNNGTITITAKNSFGLYSQVDSNVKNTKDA
NIDIENGSQGSMGIRVGNTSATNMKNEGTITINSTDGKNIGVYSSSAKFVNEGKIKVNGA
NENIGMYFNGTTGTTGNQGTITVAGNKVYGVILNNATFENEKKIEVTSDGTDSIGLYLSN
GSTATNKNGATISNAAYHAVVQNTGTFTNAGVVSVEAGGKVGLYSENGTFTNESNGEIKS
SNGGIAIFTSGSTGTIKGKITVGDSANGNTGIGVYSDGSSTATTFQGSDAQLTLGAGTVG
LYSSKASDFGNVFTITNLKTSIGNGAVFTYFGNTGNTADDTVSITNTTLQNLTVSSMGTN
SAIFYGAKDTTVNITAAITADSTKFSNIDDSAQFLVSDNGNVNITSTGTLTSGLKTTISG
LNGAVVTNDGKLILSGKDGAIGIYSNASKVTNNNIITTANNSSIAIYGKESSTLTNSSTG
KITTSGTSSVGILANSSTVSNAAGGEITTSGTGSAGIYGITNSTIENSGNITTGETGSAG
IYADNSDVTNETTGKITSKKGSSAGIYSTSTSAKNVKNKGTIEVGVASSTETQNVGIYAE
GNQNVENDGNINIHIGNSIGIYGKGADVVIENKKKITSDTSASDAIGIMSEKAKVTNFAG
SEIKLQGKKSVGIYGKESEIENSGDILLTDTTATSASVGILANKGSATNKGNIEMNGGAS
AGMLGLDGATISNDAATGKIIITGDKSAGIYVENSSPSNAGTISVESNKSAGIFAKISDA
ASRTITNTGKIELKGTGKTKSAGMYVEIESTATGITTLQNEKDIIVGQEESAAMYLKNNA
GDNAGIVVNEASNGKIDLDVKSTVGIFVDKATGKNKNIINVKKENSAGMYGSNDSNITNE
KTINVSHENSAGMYASDSNATNTGDGTITLTGSTGATSGSAGMYGKITSSSQKDYSILNE
GIINLTNVIKNVGIYGESVSGAPKKLTLQNNKEINIANGSPQSVGIFASNDVNNNVDKIE
AINSATGTITVNSEESIGISAVKSTVNNSGTITMNDKKSAGIYGKSGSRVTNNKKIEIKE
EESAGIYLEDSNAVNAAAGTIDVHKGASAGIYGKFTKNATENSTIENSGIITLKNTAGQV
KSAGIYGELEAAASKTLTIENKNIIDVSMKESVGIFAKNATGSRGNLTADNTGEIKVNSE
KSVGMLSDNSVTNNKNKITVNNKEAVGMYGKNGSEIKNHEGATIEILSTGESAIGIYATG
KNTATSNVTEGINEGTVTVKGKKATGMLATDKAKITNNKEIIGTAESVIGMYGVDDGTAV
INAKNATIKLTGEKSTGIFSKDDATAENSGTINLTSSSKNSVGMFGSASTAGKKISLTNT
ADGVINVESESSTGMFTKNNGNLADSTIKNEGTINLKQKSTVGIYTPKSNITKVGTIILN
DDADSSVAVYLKDGATVTDTTTGTINLGTKNQNRVAYYIKGTSASNTGKINGANIGNISG
YGVGVYLDGGILNSSTSKLDYTTGSNTGNGIIGLLMKGATADISGYNQGVKVGNSVLSGS
NDFYAIGIYTDEQGSSGSPKAISTSITAGVNGVGLFAENSSHIKYTGIMNIGANKVAGTG
IYIGNGGDGNKASEVTIDSGADIKLNGINGVGAIVTTNATVDFKSGAKIEFGGDGVGIFA
QKGGHIIDNGGTLVTNGHSVERTRVTEGSSVTSSDLTVALGNALDTGNILSHVINGEAIL
QTGVTVEAKSATKNIIGLMADGNSNPALTWVGTAGYDAENKGKLDLSNAQTSTAMYLDSA
RGLNSKDILVGDKSTGIYGIYKNTTPIYSAAPAGTVNIGTITTTANSKITIGDESSAIYS
IGYDKVENKGEITGKDKSVGIYAKNTAASSKVINVVNEGNITLGKGAAGIYIAPETSNVS
NATVVNSGNITVGDSTFNSSGNVDSTSVGIFAKNKTNLTTTGDITVGNKGFALYGNDSIL
TVNGGNYNFANNGSLAYLENNAVLNYNNAGTLTASSESMLYVINSKAQMNNNDIIVSSKG
TGIYMAGTSTFGGWNNMTLNNGSTGIYVDNSNAAIDGKKITGVSNKAKGIVSINSNVTNK
ADMKFSNDDSVGIFSQNKSGVAKMTVNSGNIDITGKRSIAAYLEGTSDQTFENSGTINVD
RTATSVKNDSTVGIYAQNGSAINIRNSGTINVGEASFGVYSLSENGNVETTGSSVINVAD
KAIGVYKKGGNVNLGGTVNVANHVATGANNEPVGVYGTSGVTINDTTSNFTIGDKSYGVI
LANPGMNKTNVYSNSASSNVTLGKEATFIYTEGASKVTNNAAITSGTNGKIIAIYGKDGA
NIVNNGTIDLSQGIGNQGIFVTGASNAVNRGIIKVGKTDKSDPNNIVYGIGMAAVGGASI
SNERDIYVSGHLSIGMYGDDRGTTLRNSGNIYLDASRATDSDKIQTMMGVFVNNGAKFVN
RGNITTTGSYHGNSNVQGLVGVAVLNGSTLENYGRINIDADSSYGVLIKGTATNKSIIKN
YGEININGSKSYGVRYDANSQGTAGDLPIAANATPENVLPALNSGAGSIISGNGAKDYYA
PTDPSKTVGGVGIVQLPNGRLAIQRNGVTLDESQVQTIDYTTPSTNYAFSNFGVYVDTLG
RTRPININGANSLGINSDLLIGTEFSVLTNAKNVIIGKQILQPFLNQINAGIFNFTPYSA
SLTWMATPEVDPSTQQITRVLMTKIPYTAFVSSTSNEFNFTDGLEQRYDINSLDSREKTL
FNKLNTIGNSEETLLVQAIDEMMGHQYANVQQRIFETGNLLNKEFGYLRNEWETKSKDSN
KIKVFGMKGNYKTDTAGIIDYTNKAYGFAYLNENETIKLGESSGWYAGAVKNKFDFSDIG
DSKEEQTMVKAGVYKSKPLGRDHNNGLNWTVAAEGFVGTGDMDRKFLVVDDIFEAKSQFH
TYGLGLRNELRKNIRTSERTSISPYGSLKMEYGRFGGIKEDSGQMRLEVKSNDYYSIKPE
VGVEFKYRQPMAVKTTFVAKLGLAYENELGKVGDVSNKARVRYTTADWFNIRGEKDDRRG
NGKADLNLGIENTRFGVTVNAGYDTKGENIRGGIGFKAIY
>SEQF2502_00769 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MKKRPVVLIILDGWGMNHHDNEVNGVKLANPVNFNNYLKEYPHTELRADGEFVGLPKGQF
GNSEVGHTNIGAGRIVYQMLPKITKAIEEGTILENKVLSDIIETTKANGRALHITGLTSD
GGVHCHIDHLIGLVDMAKKKGLTEVYVHAIMDGRDTAPESGVEYLAQLQKALDELGVGKI
ATVMGRYYAMDRDNNWDRVELAYDALTSGEGNLAATADEAIRNSYAEGITDEFVKPVKIG
SKDNGLIKDGDGVIFANFRPDRARQLTRTFVDPEFNGFTRKVYPKVNFATMAQYDATFTS
PVAFPPETIVNGFGEIVSKAGLTQVRTAETEKYAHVTFFFNGGKEEPYPGEIRLLSDSPK
VATYDLQPEMSAYKVKDRLIEELNTGKVDTVILNFANPDMVGHTGNVGAVIAACQAVDNC
TGQIVNKVLELDGAVLITADHGNADLLVNPETGEPHTAHTVNPVPFIFITNDMKDAKLRT
DGKLADIIPTMLDLLGLEKPAEMDGSTLIVK
>SEQF2502_00770 30S ribosomal protein S20
MAHSKSSKKRVFIGERNAARNQAIRSRTRTFIKKVLAAVEAKNVDEAKSALNAAYKELDK
AVTKGVIKKNAASRKKSRLTLKVNSLAN
>SEQF2502_00771 HTH-type transcriptional activator HxlR
MEKIEKIEPNLCKIDDGLDTLTGKWKLPILLHIMKNGTMRFSDLTRAIPAITQKMLTKNL
RELEEDDLISRFSYPTIPPKVEYSLTEHGKELELIIDALHEWGIKHREHIMKLFENKM
>SEQF2502_00772 Putative ring-cleaving dioxygenase MhqA
MKNTGIHHVSVLGSDIRKAYNFYHNILGLKLILKTVNQDDSNMYHLFFGDETGREGTEFT
VFEMKGARENKFGTNAIERTMFLVPSEESLYFWEKRLDEFDVLHYGIEEYNNQKILRFED
EDGQKLGFVYRNEKIGEMNPFVKEGIPKEHAILGIGDVYLRIRYTEPTQKILEDYYGFKK
YGKTKFYDWKISLFKSENSPFKHEIHIIEDKDSAVERNGVGGIHHIAFGVESLDDLEELQ
QKIDEKNYLSSGTKNREFMVSTYFRESNHLLFETATPLDRSSKDLPEQGQDFDEIPLFLP
EFLERKRERIEKNLNFKFQ
>SEQF2502_00773 Putative hydrolase MhqD
MLFLTGELDSHASVISFLGNVGIGKNRRFFNPLINGKVDKKDYSERIDEFLKNWDLMDIS
KYKNITFIGYSNGANFTLGLLEKRPDIANTTILLHPSNFDWQFTKKPEKNKIIATTGALD
LMAPAADVVKLKNQLSGIGYEEFQIIMLDSGHEITNEEIEKLKEIYKK
>SEQF2502_00774 Alkanal monooxygenase alpha chain
MLELGISSFGETTPLEGSKKVISHDERIRNMIEEIELADKLGLDIYAIGEHHRPDFAVSA
PEIVLAAGAVNTKHIKLSSATTNISSNDPIRVFQNFATIDAISNGRAEIMLGRGSFTESF
PLFGYNLEDYEELFEEKKEMLLEINENEILNWKGEKFTHDVDNKGVYPRPVNEKLPIWIA
TGGSIDSTLKIAERGLPIVYAIIGGNPLAFKKLIELYRAFGKEIGHSSEKLKVAAHSWGF
VWDTTEEAIEKYFWPTKTLVDQISKERPHWIPLSKERYLNSVGPDGAMFVGSPEDVANKM
IKVIEELGLNRFMLHLPVGSMPHEEVLKSIKLYGEKVVPIVRKYFEKKEK
>SEQF2502_00775 hypothetical protein
MKISIINGSPKAGKSNSEILGNYILSLLKENEIKKYYSISVRLDNKIKNEIHSSDILIFL
FPLYVDGIPSNLLKLLVEFEREKVIKSGTKIYCIVNNGFYEGKQNRLPILQMKNWCEKIK
ADWGQGIGVGAGELLPHLKKYPLGRGPLKNLGKVLDKFSANILTLKSDEDIYVNPNWLKS
LYFFQATISWILKGRKNNLRVRELFKKTF
>SEQF2502_00776 hypothetical protein
MELIIHDLDDEKLENLKWKIEKKEKITDKIKDSINQKKIIVDEDVSIICDSGRIKSCMGC
FECWIKTPGKCKIRDGYESLAKLYSKADKVVIISQCVYGSYSPFVKNVLDRTIPYLLPFF
KFKNKEMHHITRNKTKFDLNVYFMGNICCQMKRQPLKK
>SEQF2502_00777 HTH-type transcriptional regulator BetI
MEKIKKSYHHGNLREELIEKGIEVINEEGEEKLSLRKVAKMCGVSNAAPYTYFKKKSDLL
YAMSDYIWGILAAELDRTRKKYENQEDLLVKLGKTYVMFFCGNHRYYHFMVSRKNMKIDL
FSKFSKIENNNEKAFSILKMEAIKILEKMGVPNQAMQDKIIAMWALVQGLTTIMITNDIK
YSESWEEKIEEIIKSVCIAK
>SEQF2502_00778 hypothetical protein
MNRKIRIKFNWEIGGWEDNKTVVPVIASFFIGDYSGYLKESVKYFFGEKKIQLNFNYKNY
LYNVLFDGGYDSYFSIIPPLKKCIEEVEKIKSGVSENFFLEMGEGFGAEIRKEGVLLYFL
YDYEKYGDYDIIPFECFYETLIGWINFLETQPDLNKEIVTEYDIDK
>SEQF2502_00779 hypothetical protein
MEKFIIKKIEADFDERWLRVKKIDDGKKFGIYFMEFSEDVFMMNNISMKRKIGDIIEGNL
FISWITEFERTDEELMYIQKNGYDGIAAVVEITEVINEFTYYAKNSIVNRDIILDMEKDM
NLKKGDRIYIEGSLQIELEEYKERLGLLED
>SEQF2502_00780 hypothetical protein
MGILKKIWDMLPEGRPICVPKPEAWGVKQEEDKERDKNLKKKEDVEKVKK
>SEQF2502_00781 hypothetical protein
MIYFIGGKKQREFKYFELLEKIRKENVGISESFFDVDLKENEKFLEKININSIFSSQELV
VLKRAEKLKNIEEILKYIANLEIVNKEIIIDYDKEDGKFGVKLKKLLDEFSKNKQMEVFL
FQKETEEEIRAYVVNELDINARDVAMLLEMIGNNPFKVRNEVAKIKIFLDGEKFDIEKIK
NIVSIEKDYQIYEMTRNILLNNPADVMRYLEQKKEYMGILYSLYNELEIMYKISSLKVKG
RKFSKNYNTFKIEFEEIKEIFKSNNRIPNSYVIFKKIELEQNYTNASLKKLVFRCWEIEK
DIKTGKIEMETGVEMLIMEICSLFRKK
>SEQF2502_00782 PTS system glucose-specific EIICBA component
MVYAMKNNGIFAVLQKIGRAFMLPIAVLPMAGILLGVGGSFTNPVLIKTYNLTFLEPGTP
LNYLMQLFSNVGLFVFANLPLLFAVGVAIGLANKNKETAALSAVLGFLLFHTIIGTILSF
KGITPDSVTYDALIGKGLSEAAARGTAALYAKELGIFTLQTGVFGGIVCGIVASAITNKF
SDKKLPDYLAFFSGNRFVPVMTIILFIPLAAIFPFIWPTIFMGIVKAGEMFAATGAIGTF
FYGFTMRLLNVFGLHHAIYPLFWYTQLGGYQEVAGKMVAGGQNIFFAQLADPSVKHFSAA
ATKTMTGGFLPMMFGLPAAALAMYRTADDKNKAAIKGILLSAALTSFLTGITEPIEFTFL
FVAPALYVIHALLEGLAYMLMYVLNVAVGITFSRGIIDFTFFGLLQGNAKTSYFWILILG
PVYALVYYFVFKTLILKFNIPTPGRGDSENKLYTRKDYNEAKGNTELIDDIVVSLGGAEN
IENIDACITRLRVTVKDASIVADDARWKELQAKGVIRSGKGIQVVYGTQAETYKNQIREK
YRI
>SEQF2502_00783 Putative N-acetylmannosamine-6-phosphate 2-epimerase
MNKEQLLKKLKGKLIVSCQALPGEPLYIENGTIMHLMAIAAERAGAAGIRTNGIRDIEEI
KKNLDLPVIGLIKKQYEGFPQHITVTMKEIDDLVEAKADIIALDCTMRERPEAKTINEFI
KKIKGKYPDVLLMADISTFEEGVNAEKAGVDFVGTTLSGYTPYSKKSEGPDFELVGNLSK
TLHIPVIAEGKIHEPKQAKKMLELGAFAVVVGGAITRPLEIAQRFVREME
>SEQF2502_00784 hypothetical protein
MILIFGTKRKFKNLGTLENCHCSRCNNTSDWNFVEYRDWFTLFWIPVFPISARKEYLECP
ICHQAYEVPKN
>SEQF2502_00785 Aspartate--tRNA ligase
MYRNYKLNELRMENIGEEVTLSGWISKVRDLGHFVFIDLRDRYGITQILLNEEVSGSELF
EEARKYKNEWVLKVTGVVAERSSKNKNIPTGDIEIEAKKIEVLSRAKQLPFEISETGNLS
ENMRLTYRYLDIRRPKMLNNIIKRNDMLFSIRKFMNKNGFLDVDTPILAKATPEGARDFI
VPSRTNKGDFYALPQSPQLFKQILMVSGIDKYYQLAKCFRDEDLRADRQPEFTQLDVEMS
FVEQEDVISMAEELTKTVFKDVTGIEITEKFPQMSYDDAMNFYGSDKPDLRFDMKLIDLS
EETADCGFGVFENALKDGGNVKAIVAPNAEKFSRKYIKDLEDYVKTYFKAKGLAYIKMNE
NGEINSPIAKFFSEEKLTQIIEKLGIKNNEVALILADKYKVVHDGLGALRLKLGEELELI
DKNAFKFLWVVDFPMFEWSEEENRYKAQHHPFTSIKEEDRKYLDTNELAKIKTDSYDIVL
NGYEIGGGSIRIHDEDLQAKVFEKLGFSQEELEDKFGFFLEVLKYGVPPHGGLAYGIDRW
LMAMLKEDSIKEVIPFPKTNKGQDLMTGAPAGIEEQVLEDDLRLKLLEVEKED
>SEQF2502_00786 hypothetical protein
MGNLVNCAAIILGSLIGFFIGHKFKEDMKNIMMECAGLFIIIVGVKSTINSKRDIIVLIY
LIIGSIIGQIIDIDLKLKKFGIFLEKNKEIKI
>SEQF2502_00787 hypothetical protein
MKSEYRKRKNELRYCFNILEKFENLKIRNDLGEVEETIIDFNYNTDNMNFSYNDFFKIFR
SSFILLLYNFIEASVFLFIDSIYQKFEYENITYLQASEVFQKLFIEYKFSDSFKKNSNFN
TYKDKVNEIIEGISNRIVLKFEIKNLSNLSGNVGAKNLREMCKLHGIVLNSRSRSQDPEN
HKFSLDNIKNERNALAHGRKSFIEVGSEYTVSDLKNYYDEIVLLMDDLLNAVKKFIDEKK
YKQE
>SEQF2502_00788 hypothetical protein
MNKDLEKIHKEIERYREKIKYDTVDYPIESICRRFENKKIIIPNYQREFVWTIDKQSKLI
ESILMGFPIPFLFFYEDKDKGILEVVDGAQRLQSVYFFLENKLKLEGLKKLKSLNNCYFN
DLPEKFKNKFENTALRVILLEEKTNNEFRKEIFNRLNTTSQKLEPIEVLLGTYADEEFIE
FLKRCSENEKYKKLCPISLEKQKKKENLELVLRFFAYSDSLDEYDGKVTLFLEDYVKKNL
RDFDRERLLKNFENMLVFVEKYFPNGFAKSKSAKSTPRTRFEAISVGVNLALNENKNLNT
NTEEWLESKEFKKVTTTDSANNKSKLVERITFVKNKLLGDNIQHEIRIQKKEK
>SEQF2502_00789 putative BsuMI modification methylase subunit YdiO
MKKIVAVDLFCGIGGLTYGIKKAGIEVIAGIDIDETCRYAYEVNNHSIFINKSVTEITKN
EINSLFGEKNIKLLMGCAPCQPFSNYRKDKKNSNKHKDWDLLNEFLRIIKISNPEIISME
NVPALQKENIFVKFYTSLKDMGYYVNYDVHNAENYGVPQRRKRLLLLASKFGEINFLKKD
IKKVTVREAIKNLFPIKAGEISKKDFIHRASKLSDLNLQRIRNSIPGKTWELWPENIKPN
CYKKKTGLTYKSVFGRMKWDDVAPTLTTQFYNYGTGRYGHPEQDRAISIREGAILQSFPK
NYKFVEHEKNFKITEVARHIGNAVPPKLAEYIAQTIINHLYERGILNE
>SEQF2502_00790 Histidine--tRNA ligase
MITALKGMKDRYSDDVKKYDAIVDASKKVFGKYGFERIITPILEETELFRRGVGDETDVV
SKEMYDFKDKGERDVTMRPEGTAGVVRAYLEAGFHKSSPIVKWFYNGPMYRYEAPQKGRM
REFHQTGVEMFGVRSAYLDAEIIKMGCDFLEELGITGLIVEINSLGNVESRKKYIEDLKK
FMLERLDKLSKDSQKRYEKNPLRALDSKDKGDQEEFKNAPKLYDYLDEESKKYFEDTKKY
LELLGVNYVVNDKLVRGLDYYSDTVFEIKSNKLGSQATVLAGGRYDRLLEILGNAKVPGI
GFAAGMERIAMLMDNSIISENEEKIYVIYFDDTKEYFVKTINELRKNGIKVNFDYNAKSF
GAQMKKANRENAEYVLILGEEERDENVITVKKFSTGEQKKYGFEEVLEILK
>SEQF2502_00791 hypothetical protein
MEKNSLEELENLMWKKYKKQISFQQLQKEFLKNDDERIEYIKTELEKAYNEKNGDSVDIL
ISAIYMFELYSEKFVDILCKLTKEEWHGKHEDIVFYLQQLELPSTIDCIYELAISNFEKY
RWDDNFALVRKCCFALGDINTPKAKEKLELLLQSDEEMIRKHAMEQLTRCDFTNKDVE
>SEQF2502_00792 hypothetical protein
MQEIIKVLQVLYKTIISYLISTKVKLMQNENKYLKNDIRLKKFKFTILKKMENEIRKLRK
VCEENKTKKNLKKLYYKRKKYLEIKNNQIKIMDFSQFFFEITVYAMLILTSLNIAWQIKV
LNYHIYLLIFVSWITFVIVWISLVFIRWASLFFVQMTKKFYIGAFYLHIKWNKIIVGIIL
LSLANLTFQNYTKKLLEKNQSFLILESDDIDDMDLLKNSTIEILNENYHFKWSVDKNGKI
IDSRNKIEGNYRVENLLVKENSSLMLYYEKNRNNFEEENGNLKSQKGEYIDLKNNVVKIF
SKNKIYSGNIISGKIIKLSNGIYLPLNSSYRYFQKNKGKEIFIVDKKLKIKKQINYVMFL
ISVIFMLLLTLKDRYFELEFITKEKIMYKILQREKKYSFEIRKLVLSILKIIRMATAIYI
PVQVYLLRNIVFSLFLEKSLYKINKNINLLFSLLFSQTFLLTILIFYGLRKLYKILRVIA
KIIYEEGSNDLRDLIEDEKNKIN
>SEQF2502_00793 hypothetical protein
MINFKEESYTSKASFFDGDDIPVYDKENDKTNYIFSGKRIKRGLYKTRKGKLINADCNGA
LNILRKSKIVDLSVLYNRGELNIPKRIRVV
>SEQF2502_00794 Sensory transduction protein regX3
MYKVLIADDNKQIVSILSEYCKKNNFTVSAVFDGETALKEIEKNKFDIVLLDVMMPKKDG
FDVCRETRKFSNVPIIMITARGEDYEKIMGLEIGADDYIVKPFSPGEIIARINAILRRIM
PKNDESEKIFTFDNLEIDLNNFTVKVNDEIISLTKKEIEILWTLATNQNKVFTRENLLDL
IWGFDYFGESRTVDTHIKRLRAKLDNYEHKKWNIKTIWGVGYKFDILEK
>SEQF2502_00795 hypothetical protein
MSKRIKKILFNGEEYPPETFRLGMMLCMVGGFMDAYTFITRGKVLANAQTGNIVYLAINL
GKREWEKSFDYFMPILFFALGILFTELIKTKFEKHKIFRWQQIVIIYQVIVMFFISFIPS
GNWNIIVNIIMSFIAAIQYQGFRKIRGLAGATTMCTGNLRSGMDNLVKYIKTKDKSHLQS
FWIYLGLDGFFLIGSLLCVILVNIYGIISLLICCILLIFVFIIMFKETI
>SEQF2502_00796 hypothetical protein
MAHIHGWDFSHIYGRYSEEENLLWDFRTVINKYLKNDMKLLDMETGGGEFLLSLNYPKHN
ISATESYQPNVELYKKVLLPLGINFKKADGDEKLPFENKYFDIITNRHGLIMLQN
>SEQF2502_00797 hypothetical protein
MKKDGIFITQQIGAENDRERVEILLPEYKDLPYSEHYLNIKQQEISEQGFEILESGETFQ
PIKFSDTVALVWFAKIIEWEFPNFSVKSHLDNLYKIQEIIEANGAVEGRIHRFYIVGKKI
>SEQF2502_00798 ABC transporter ATP-binding protein YxdL
MKNNDLINKLTISELSNKYPFAENFFTENHLPVETFQDRTFHEFIVTFAEDKIEDFALDV
EKIEESLVDYIEQMKLFLGMEEENSIDLLTILAGQDKSGNKEGFERLDIHKSEIISIVGP
TGSGKSRLLADIEWTAQKDTPTQRQILINGELPDKKWRYSSNNKLVAQLSQNMNFVMDLS
VKEFLELHAQSRMIEDIDETVEKIITAANNLAGEQFDLTTAITALSGGQSRALMIADTAI
LSSSPIVLIDEIENAGIDRKKALELLVSSDKIVLMATHDPTLALIADKRIIIKNGGISKI
ITTSAEEKKILKKLDEMDDVIQKMRSNLRKGEVLRNDF
>SEQF2502_00799 Urease accessory protein UreG
MNLIIFSGPPSSGKTSVILKTVEALKSQGMSVGVVKFDCLYTDDDKLYAKAGIPVKKGIS
GALCPDHFFVSNIEEVVQWGNSLGLSILITESAGLCNRCSPYIKDIKGVCVIDNLSGINT
PKKIGPLLKAADIVIITKGDIVSQAEREVFASRVNSVNPKAVTMHVNGLTGQGAYELSTL
LYEKELEIDSVQGMELRFPMPSALCSYCLGEKRIGEKYQMGNVRKMNLQQ
>SEQF2502_00800 hypothetical protein
MFNLDDTLYEIIKKYPEALDFFIANGFEQLKNKQMLEVMGKNIKLRMALMSKKINQKLFV
EKLETFLKKDADIDVSLDESKADENSDLIIEGVLPCPIRIPLLEGIKDWVNEQNEKNDYT
ISYTLKSANLGLDWVVEKVKTGNPDKVSDILLSAGFELFFDKNLMGQYMENGIFETHLES
MNKDFCNETIDLRDPKKRYAIMGVVPAIFLINKTSLGDRKAPETWADLLNDEFEDSVALP
MADLDLFNALLANLYKDFGMDGIHKLARSYKKSLHPAQMVKARTRTPEAPAVSIIPYFFS
QMIDGSGDLEAVWPKDGALLSPIFMITKKSKADKIKPFMDLFMSNEIGTIFSANGKFPST
NPNVDNHLEEHQNFKWIGWDFIYSHDIGKIIRECEEEFNNDVQKSFTE
>SEQF2502_00803 Elongation factor G
MARKVALKDTRNIGIMAHIDAGKTTTTERILFYTGVNHKIGEVHEGAATMDYMEQEQERG
ITITSAATTAFWNGHRINIIDTPGHVDFTVEVERSLRVLDGSVAVFSAVDGVQPQSETVW
RQADKYNVPRMAFLNKMDRVGADFDMCVNDIKEKLGGNGVPIQLPIGAEDNFEGIIDLVT
MKEYLFKDETMGADYEVVDIRAELADAAQEAREHMIESVVETDDELMEKYFGGEEITEDE
IKRALRVATIAGTVVPVLCGTAFKNKGIQPLLDAVVAYMPSPVDINGGKVNGTDPKTEEP
IQRTISDDEPFSALAFKIITDPFVGRLSFFRVYSGVLEKGSYVLNSTKGKKERMGRLLQM
HANKREELDIVYSGDIAAAVGLKDTTTGDTLCAENAPIILEKMEFPDTVIQIAVEPKTKA
DQEKMGTALSKLAEEDPTFKVTTNQETGQTLISGMGELHLEIIVDRMKREFKVEANVGKP
QVAYRETINGATDVEEKYAKQSGGRGQYGHVKMKVEANHGKGYEFINEITGGAIPREYIP
AVDKGIQEALEAGVVAGYPVQDIKVTLYDGSYHEVDSSEMAFKIAGSMAIKKGLRAANPV
LLEPIFKVEVTTPEEYMGDVIGDLNSRRGQVSGMTDRNNAKIIDAEVPLSQMFGYATDLR
SKTQGRASYSMEFEKYVEVPKNIAQQVIDERQGK
>SEQF2502_00804 30S ribosomal protein S7
MSRRRRAERRDVLPDSQFNDKVVTKFINGLMKDGKKSLAEHIFYSALQQITEETQEEGIE
VFRRAMENVRPQLEVRSRRIGGATYQVPVEVRKERQQTLAIRWLVRYTRERKEYGMVAKL
KKELIAAANNEGGSIKKKEDTYKMAEANRAFAHYKW
>SEQF2502_00805 30S ribosomal protein S12
MPTINQLVRFGRSTTEKKKKSPALKGNPQKRGVCVRVYTTTPKKPNSALRKVARVKLVNG
IEVTAYIPGIGHNLQEHSIVLLRGGRTKDLPGVRYKIIRGALDTAGVVNRKQGRSRYGAK
KG
>SEQF2502_00806 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase
MYKIFKDVSYKLLQEGENFEIRGIEYDSRKIEKDFVFVAMTGSAVDGHDFIQKAIDSGAK
MIICERDVNAKEYRNANFVTFVQVEDIRKKLGIIASNYYDYPQNKIKIVGITGTNGKTTS
SFILENILEKTARIGTTGNRILDEEFETVNTTPESLELIKLIDKSVKKGVDYFIMEVSSH
ALQIGRVDMLKFDSAIFTNLTQDHLDFHKTMENYFNAKKKIFSMLRNNGAGIVNIDDKYG
EKIYSEKKGGNNDYISISIKNEEADVWGDILNYTNHGMKIKINLDNYFERRNLVKNKDEE
EYKFEIELVGEYNLYNVLGCAASALSLGVKIDFIVKKLQEMPSVPGRFETIKNDLEARIV
IDFAHTDDGLLNIGKTLKQITDNQVITIFGAGGDRDHDKRPKMAKAATKFSDYIILTSDN
PRTENPIKILADIEKGLIAEKYPFDKYIIIADREKAIRYGMRLLKKGDSLLIAGKGHETY
QIIGTEKTHFDDREVVRKILAGK
>SEQF2502_00810 Lipopolysaccharide core heptosyltransferase RfaQ
MKILIIRFSSFGDVVLTTPVIRAIKEKCPKAVIDFAVYNTFSEAISLNPEIRNLIIFEKK
KSKDRKYIKDMINRLKTENYDCVIDLHSKFLSRIIGKSLENRHTQYCRYKKRKWWKTILV
KLKLITYNADCTIVESYFTALKKLGINFSDENIKNGLGDNLEFYIDKKMEEEFVKKYDLE
NGNYFVLAPGASKFTKKWPYYDELAKKILKNKNKFVNNEEKLRIFVIGGKEDANVVKTDE
DEQIIDLCGKISFKESGILLKYAKAAVANDSGPFHIARAVKAKTFVFFGPTDPKLFSFEK
NTFLLNNPSCPPHSLYGDNKFPKKYADCMTGISVETVFNKIVKEYN
>SEQF2502_00811 tRNA N6-adenosine threonylcarbamoyltransferase
MKILAFESSCDETSVAVVEDGKKILSNIISTQIDIHKEFGGVVPEIASRHHIENILPVFT
EALEKANCELSDIDYIAVTNTPGLIGSLLVGLMFAKSLSYANNIPLIPVNHINGHIFSSF
IDNDVKLPAISLVVSGGHTNLYYIYEENGKIITDLLGETLDDAVGETYDKIARILGLEYP
GGPHIDRLSVNGEDILKIKKPKVDGYNFSFSGIKTFITNYVNSQNMKGNPFSKEDIAKSL
QEIIVNVLYDKILMAVKEKDVKTILVAGGVSANRRLREKFSEFTNLKTDENEQIQVHFPK
LEYCTDNAAMIGVAAYYDLKNNSQINLEKQYDVDAISTKLEK
>SEQF2502_00812 Pyridoxal phosphate phosphatase YigL
MYKAVISDLDGTLLSRGHHVTKFTKDITKEIIKKGINFYIASGRSYDQIGYITEQLEVKI
PIIAANGARIFDADGNMIYEKGLPKEAAEAILGLDYESIAEGSHLNIFSGNDWIITKGTA
QKVYDRISRDVKVDFKEVPKNELKNLDILKIFYIGEHEQLINLEKAILKIRNDVNVIFVT
DYCMEIMAKGANKGAAAKFLLEREGLELKDAVAFGDGENDFEMLTMVGKGYAMGNSIDRL
RKLLPTDFEFVGANTEDGEAVKLQELFLERAKNI
>SEQF2502_00813 Pyridoxal phosphate phosphatase YigL
MFKAVVSDLDGTLLNAEHKVSEFTRETVELLLKKGIKFYIATGRNYLGAKEAMDELGVKV
PLITSHGSVAFDENGNEIFSNNLKREYLDKVLNIDYKSFGKDIIITGYSGPNWFVTEDLR
EYFYNKKPDRTRYPEQITPEEFKKHNFTKIFFLGEDHDELLGLENEIRKVVGDGNVSLLF
ANEGSLEVFSANCNKAKAAEVLLERDGLTLKDAISFGDGLNDYELITETGLGFAMGNSIY
LLLEKLSDTEVIESNAEDGMAKKLRELFNL
>SEQF2502_00814 Chemotaxis protein CheY
MNKIALVVDDTSYIREDIKDILEEQGYKVYEASDGLEAVEMYKKVNPSVVTMDINMPRMH
GLKAAQVITDLDKEARIMICSTMVMFPNYMKMGKEAGAKAFLSKPFNEEEFMNEFSKLFL
>SEQF2502_00815 Pyridoxal phosphate phosphatase YigL
MYKAVVSDLDGTLLNEEHKVSPFTKETIELLLEKGIKFYIATGRGYVGAKEIMDEIGLKI
PLITSNGARIVDENGREIYVNNIEQKYVDKIFSIDYKSFDKGIILNGFSGNHWYVTEDAR
DYFYAQKPNRKQYPEQIEWDNFKKLAFTKIFFLGEHKKLLEIEKEVRKVTNNEVNIVFVN
EKSLEIFSSDCDKAVAAGFLLQRDGLLLKDAVSFGDGFNDYDLITQTGLGFAMKNSIYRL
LEKLTDTEVIGSNAEDGMARKVREIFKI
>SEQF2502_00816 hypothetical protein
MGTFEDYLKFEVTEAQEDKKQLRIIEKISLSEETEKAIKGIDKDITIIAVAQVYCPDCRA
TVPFLKKFSDLNNKIKIDYRSRETAKEFFPNTDEKIKIPTLISYVDGKYNIFWNEFPAVV
KNEMDKNPENFEDIKYNFRIGKFNAQIEKELVDYLTSL
>SEQF2502_00817 hypothetical protein
MKKLNTNQLKYIALFFMFLDSVFFVFSGFLPSWIHLITRFVAPLFAFFTVEGFYHTRNRK
KYMARLWIAAILMQFGNVISFIILGERYQIIDNIFLSLAIGFTIIYFLQKGRSSKKVIYN
ILGIFLFILGLVFSFVPIVIGNYIMGLEGGIQTLFTMISFWAFYGNRKKQVITFLILNML
YIPLFTPSLNPAKYPNSRAWFDSFCYNSDGLTFLFLPFIFLYNGKKGSKAPIHKWFFYIF
YPLQFWILNILAFFLKIRS
>SEQF2502_00818 hypothetical protein
MKKIEFKIIQNNDYSDEIRNILDEEEMESLVQVKYEKVPNLFESLQKDSEKTPIIVVGID
TENDNLVGVGACSIFKNNIGYLNSFRIKKEYRNKVNFGKAYKMLITEAKKCGVKTVITTI
LEENKITQKILTKRRKSMPIYEFYKNIVFFSLKNSRKGDLAVNDEEILNYGNFEIHLKNK
ANKKYVVMDYKKIYKFLYKFRKVIAFFGYPEMPEINKISNFLYATFVLKDKNVDMEKNKK
EFRKAVKSIQNKGYNCDFFMIGSYENSFLEKNLNKMKVFKYKSKMYRVFYEKNCNCENNE
ETKDEDLEFLLWNL
>SEQF2502_00819 Hydroxyacylglutathione hydrolase
MIEKIKIGLNNLYLFKNKNDEYLLIDTGVHVKKKKILKRIIQKIGEAKKIKVIVLSHSHT
DHVGNLKILIDAIGDVRVIAHKNSENILETGKSVIPNGFYPFTEKISKKLKSKKNFTKNI
FPKLEKIDMEKVIFINFLQQERILLSKYGFGNMEIIETKGHSDDSISLAVFDEKNNEKYL
FCGDMVQNLCFKFPLIPLFGENKEELIESWKKIILNGYDKIFPATGKEITARDLIRRLGK
DEKNRI
>SEQF2502_00820 hypothetical protein
MKTTIDFIIFSIFYIFIKIFNFFPPKIRLKISEFIGVLLFYLIPKGRKLSYRNLNLILNE
QNSFNYSKKKIKEIAIKSYKNTAKSFLLPFWIYEYFENFPPKTYNSKLLEKLKSENERII
LVTSHFGFFHASLFPTGNDRMFIPIRIIPNKFIESYMDKIRFRNNMTYFPEQNYKSFLKN
KNSKGIFVLLSDVRKPGGDKITFF
>SEQF2502_00821 Levansucrase
MKKILLLLGVLVISANSFSAASIVGGGLNIHAGTSISGSSNYNLGTGSNTVTATGSSTIS
AGTKFTVPAGGTLDIVTDSGTIQTYTGPTVVTLTSPLSGSVTPATVGSVISSSGSTPSTP
ATPSTPSTPAAPTTPTTPSTPSTPAAPTPSTPTGSVPTFQGARSRVNYDLAKTITANGFK
DLEQAKKENGANLNLQYLGGVNSYDYDSRYSSKTNGVVLSGTKNFGNFTMGAGFGYEKTN
VKYKNSFDGVREKLDSYQASLSGKYDFTDNLDVASVLTYGSNKHKYKNYNNVKFDSDVLD
FQTRLGYKFRDDSDENTYVKPYVGLGVTSVKEDSFTVGNVNFGKAKRSSGNATAGVYGQT
RVGAVDLYGNIEYEQRFSRKSYNGERSISTNGVEVAKLAALDYDQGVFNLGLGAKYNVSD
NFNMSAGYELYDTKNSIFKVGLGLEF
>SEQF2502_00822 hypothetical protein
MKKLLGLLALTLVISGFAKADQDVLKNINISTEYRQNYQDKTGDDVNGIGFAGFKKDNRG
RTRVRSIFSGKIGLIDEGDWDLTFWTRWDKDQNRNRFNGQTITQYGTFRKNDRIYSKLGL
EKKLSDDVKLKIRWQNDIYRNKDLVTKEISTTGIGNEFAIGPTFNKKIWGQNVTLAVEGI
YFRFKGNRRGEYYLSGNDFKGSKVNGWGLNADLEVSNNIKKGEWGSLDYYTYFTNHYRDT
NKTQKNGKKAKPSVYQDYYANLSYTTPSVAGIYGKVVLENEFERYPRYYWENMFGVITEA
GYKKSFEAGEGKVSVNPFVKYRPYYRDSYKKSGSNRKTTETEEVRFGLSVGYSVN
>SEQF2502_00823 tRNA1(Val) (adenine(37)-N6)-methyltransferase
MSYIENLESVGKKMIVEEKGLKITEDAILLSKFMQEYFSRKCKNLKEKKSFLEIGAGQGI
ISLLLSELDVISKIFAVEIQKEVFSTLKKNIEINDLNEKIIPINKNIKSINGEYDFIFSN
PPYKKINSGKMPKNKTEQISKYEVLLTLEEIILEIRRLLKNYGEFFLVVPDSRLNDVFRY
IYENRLNILSVKVNKYKKIDLVVVHGKKGGKINSEIEIK
>SEQF2502_00824 putative parvulin-type peptidyl-prolyl cis-trans isomerase
MGFRSHKRGIQIASAVMMGMFGIAMLITGILFLKNNIFEASKGNREVIATVNGIKIYRDD
FERETYSLKNQLNEINQQKMQQLAQAGVNTDNIKNIPDEIVNQYVLQLLINKEILISSAK
NLGIRVSGSTVNKEFKAYQKQSKLGKDEFSQYLRSVGYNVTSFKKMIKDQKTVDKMREKL
FADDKVTDEEVKKAYERNKYTQAFENQEFEDVKDQIKENMKQDKDIMILNSFIAKAKQKA
KIEFKDEEFKKMYTNITTPVAQSGEYKYTNADVNEQIVNAVSQTQEGYSPKMVNDLKGML
KINLGKFIQIANKAKAAGIKADADLVGVDQLRDYSQKYYNYLIDTYKPDNATLQARFDSK
RDSYDTKNSIGGYVIGEEYQAGENDFAVAKKQAEEIMKTTNKDNFAEKAREFSKDPGSAK
NGGSLGETADLSKLVPEFANAVKNGKAGDIVGPIKTQFGYHIIYIQSKDPKNENVAKISH
ILITPTISEASKQKVIKKIQDLKAEIESKKVTWSTVEKQDKYNFSIKERFKKLVKTDAIP
GIGINKELMDQIFALQVNGFLERNDATGYYLIAKTSEIPFTQATFENSKERVRLELAHEY
ADKQLGITK
>SEQF2502_00825 hypothetical protein
MPKKEESKEEPKKKKGFFSSVFFIILLILITAAVVATNIYDRDNSEEIHVTVDKNLVKET
AQNEETQNKISIFVFDPGTRTIYEREIVIPRQVNLIEGDFINGIIRNSNYITDDMKFRSA
YNLRIDNVNTTVVKLNAAFANLKKNPELFNGFSQAVTNTILKNFPNIQSVIIQIDGETNT
Q
>SEQF2502_00826 N-acetylmuramoyl-L-alanine amidase AmiC
MKRILLFLLLFISAITFSDTLKNVSYNNGKVIGTFRENKQIIPNASVTKLGGEDLLMLSF
SDSKIESGVPAFINKNDQYISKIYTVENNGMVVVYVYLKPSVTYQVTSRSGEFQVTLDGG
KAATVQKSYNAPQRQNNNSNNTRITQTQSQSQSGNTSRGNKKYTIVVDPGHGGRDSGARG
NGYNEKDIALQVATRLANNLRQDYNVIMTRDSDFFVPLDTRAKIGNDANADFFISIHLNS
GSSSSANGTEVFYFSKKDQGSYATQVAKFENKVDGSYGDVPFSDFILNDIFYRKNQKTSQ
AIAESVLNNLINTTGLRRRGVFGANFAVLRGSNSPSILVELGFMNNYSDLSQYLTPDGQE
RAANAIGSAIRSYFR
>SEQF2502_00827 hypothetical protein
MNNNSIGVIIIYVVFLAVLILPTYFANKKKKKQKAELMENLKVGARIITVGGIQGTITNV
FTDTVEMKIDKNARMTVLKSAVERIETK
>SEQF2502_00828 Phosphoglycerate kinase
MAKKTLKDLDVKGKKVLVRVDFNVPIKDGVITNDNRITAALPTLKYILENGGRVIAFSHL
GKVKEEADKASKTLAPVAKRLEELLGKPVKFVPETRGAELEKAVSELKDGEILMFENTRF
EDLDGKKESKNDPELGKYWASLGDVFVNDAFGTAHRAHASNVGIASNIKESAVGFLVEKE
IKFIGGAVDNPERPLVAILGGAKVSDKIGVIENLLDKADKVIIGGGMMFTFLKAEGKNTG
SSLLEADKVELAASLIKKAKEKNVELLLPIDTVVAKEFKNDTEFKTVSVDDIEDGWMGLD
IGEKSVELFKKALEGAKTVVWNGPMGVFEMENFAKGTIGVCKAIAELSDAKTIIGGGDSA
AAAIQLGFADKFSHISTGGGASLEYLEGKVLPGVDAISEK
>SEQF2502_00829 Phosphinothricin N-acetyltransferase
MKLKKENLIFRFATEGDAEEILGIYKPYIENTTITFEYEVPAVEEFRERIRETLEKYPYI
VCTYDGKIIGYAYAHRIWSRAAYQWDVELSVYTDGNYAGNGIGKKLYKILIEILKLQNVV
NVYALITYPNENSEKMHNYFGFKKIAVFEKSGYKFGKWIGVTWFEKAISEHSKNPKPLKK
ISEIDKIKLRQTLEL
>SEQF2502_00830 Major phosphate-irrepressible acid phosphatase
MKKTFLIGAFLFASLVSFSAGKGNDVTTKPDVYFLKSSQVVSSYDLLPAPPAVDSIAFLN
DKAQYEKGKLLRNTERGKQAYNDARVEGDGVPRAFSEAFGYTISAQTTPEIFKLVTKLRE
DAGDLATRSAKQTYMRIRPFAYFKESTCRPEDEASLSTNGSYPSGHTSIGWATALVLAEI
NPARQSEIIKRGYEMGQSRVICGYHWQSDVDAARVVASTVVATLHSNSEFNAQLAKAKAE
FQRLSRKK
>SEQF2502_00832 50S ribosomal protein L28
MQRCEVFGKTVSHGNRVSHSHKATKRIWRPNLQTMLLTINNEEVRVRVCTKAMKTLKGKN
NDQVKKILLKNKETLSPKILKVLAK
>SEQF2502_00833 hypothetical protein
MKRKIESVEEFHRIYKLGNSKKPIGKLKDGLEKLRFDLMAEENGEYLEAAKKGNVVEVAD
ALGDMLYILCGTIIEHGMQNVIDDVFEEIHRSNLSKLDENGDPIYREDGKVIKGPNYFPP
NLKKFFEK
>SEQF2502_00834 hypothetical protein
MQDNKLSDDVEKFINDEITNSKIWVFCGILISVLLSQILNLHAEMYKIMYIFKMKQVLDK
ISFLFIGIIVLEIFLTFFLYKIIVNRSKKVIKLSFIIYSLLTGLNLSIFSSVIKVLFQKN
IGILPVILLIISLFLVIILIIFDSKKIKKMIKIKVLENNETEFLKKIRFYVAAVLYTDIV
KILILLIISTMILI
>SEQF2502_00835 Inner membrane protein YbhL
MKKDYDELETYNHNNDGYNEYGGQVRMTYDDLDRIVSSKVRGSMLWMVLGLLVTGITGYM
VYTGLVSGNPIAYGILKMYWLFAILEIAVVFGFTALVYKANSSTLRLMFLAYSFLNGLTF
SVLGMVYAPEIIVSAFLGTFVLFAVLAVYGYLTRENLTKFTPILVAGLIAIILVSIINIF
LQNSGVDLFISIIGVIIFTIFIAVDVNRIRNNIVAYAAQEDSEILNKIEIVGALNLYLDF
VNLFIYILRLLGRRK
>SEQF2502_00836 Threonine--tRNA ligase 2
MIEMILPDGSKRQLENPMTVVEFAKSIGSSLGKATVGAIIDGVQVDPSYIIDKSGEIEII
TNTSEKGIEIIRHSAAHIMAQAVQRLFPNTKVTIGPVVENGFFYDFDPERPFTEEDLTKI
EEEMKKIVKENYPFERSEMSAEEAKKFFAEKGETYKVEIIDDLGVDKVSIYKQGEFVDLC
RGTHVPSTGYLKAFKLMSTAGAYWRGDSNNKMLQRIYGVAFATKKELDDYLTMMEEAERR
DHRKLGKQLNLFFLDEHGPGFPFFMPKGVEIFNKLQEMWRVEHKKRGYQEIKTPIMLDRE
LWEISGHWFNYRENMYTSTIDEKIYAIKPMNCPGSIIAYKNNLHSYKDLPLKYGEMGLVH
RHEFSGALHGLMRVRAFTQDDAHVFCTKEQIEEQIIEIIDLYDKFYTLFGFEYHIELSTK
PDKAIGSDEIWEMAEANLKSALEHKGIDYKLNPGDGAFYGPKIDFKMKDSIGRIWQCGTI
QLDFNLPQRFEMSYIGADGEKHEPVMIHRAMYGSLERFLGILIEHYAGAFPFWLAPTQVR
ILTISDEQVPFANEVFEKLQNAGIRVEIDTRAEKIGYKIREANGEQKIPVQLIIGKNEAT
NNEVNMRRFGSQESKNISVDEIVNILLEESKVPFKK
>SEQF2502_00837 hypothetical protein
MNKDYCQIFEDNDCLKEANNDKETLSEKLNKYFSGKVVRKDLTKKIREGANVPIYVLEYL
LGMYCSSENEEDIEEGMKTVKRILAQNYVRPDEAERIKSKLRENGSYTIIDKVTVKLNFK
ENRHEAEFSNLSLKSVPVSDVYPSKYERLLGGGIWCIIQLEYYYDEDDKKGNPVIIKKLT
PVQMPEIDFEEFKDLREKFTDEEWIDIVLRSTGMESSKFDERVKWLHLSRLIPLLENNYN
FCELGPRGTGKSHIYKEISPNSILVSGGQTSVANLFYNMGRGTMGLVGLWDCVAFDEVAG
MKFKDQDGVQIMKDYMASGSFARGKEQKNASAGMAFIGNINQSVDVVLKTSNLFEPFPHV
MGRDTAFLDRMHCYLPGWEIPKYRPEFFTDDYGFITDYYAEIMRELRKISYADAYDKYFK
LGNQLNQRDVIAVKKTVSGMVKIIYPHGKFTKEKIEKILRFSLEMRRRVKEQLKKIGGME
FYDVNFSYIDNEKFNEEYVPVPEQSSRSLIPEGIGKPGHLYIVSSIKSGMIGLFKIETQM
TKGTGKFEKAGLGNNREAKESAEMAFKYLRANGKLISGEISTKNNDYVVNYQDLKGIGMA
SNLTLSTYIAICSAALNKPIISSAVILGDLSIGGTIIKVSELANVLQVCLDSGAKKVLLP
MTSASDLATVPPDLIGAFNLIFYSTAEDAVFKALGVE
>SEQF2502_00838 hypothetical protein
MNLEQITKVLNSEFKKEGRRIVFWYDEKQEFLSEIEELKLENVKLLRLKQDELFKTKLRL
EREDKESNYLIYAPFKRSEDRDNHLADTIMYSKLFSPDPISIIAQNLNLNDEFKEVMERH
RKFFAAKDRREKFEKLVEEKGVNKKEDIEIIMMRIITNSKAEIFKGFDDVVRILITDKNR
KESRYLVEFNKYNLEEKFWELCRLKFGYVDDDPSLTKLLIGIFLTYASEKITREIPVRFK
ELSIRSTVMVFLNRLRQISEYREIFKNLVSEVYSIIDGNKYFKNILPEYLLELDIFDFPD
EKITKWIVERIVDENFSAKLQDKSIEEIIELRREKNIDNLKLKIEYKILEYAYKGIKNTN
FETCSDLLEIIEKYAQKDYMIDTYYRKFCYYYDQLTENSEKYSRLLELLETKYTDKFLNP
ANIKFNDLLNYRELPKKINLQKDFYKNYVEINKNRIVVIISDALRYETGRELFYKMSRDE
TVDAEIEYQLGIIPSVTKLGMAALLPHDKIEIEVENGDFSVLIDGKACNDRVKREKILKS
YDENSVALDFDEVFRCSKNELREVFRNKKKLYIYHNQIDSIGDKSNTENEVFEACQKAIE
EIMNLIKKLRVESINNIIVTADHGFIYKRRKIDESDKIENFSSKNDVVNRRYIVTENEYG
EIGTNEINMSDVLNNKNENLKVISPNTSSVFKVSGGGQNYYHGGISLQELIVPVIKVKTA
KGSVDTELVKVGLISEINKITNLKISLDFLQKSAVTDIIKPTEFEIYFIDSNESIISNIE
NYKANSEETETVKRIKKLRFTLINKKYKKDEEYYLVVKNIETKIEERKKIIIDILFSDDF
GF
>SEQF2502_00839 hypothetical protein
MATESILLDALRIPVRYTDEVLEAMESKKKVKKLDVDFEIIDDLEKIRKMFGYSSKDEE
>SEQF2502_00840 hypothetical protein
MAQAMINFRIDEKIKKEMEKICREMGMSMTTAFTIFATKVTKEKRIPFEITADPFYSESN
MKYLEKVIADIESGKAKLVEHDLIEE
>SEQF2502_00841 hypothetical protein
MVYQFWFYIMLESEGIISFYWSTLGSWIYFEFSKIGMLENMKKTGVDTKFFDKNRFLLYS
VLAIVCIINIVVYKCIK
>SEQF2502_00842 Bifunctional NAD biosynthesis protein NadR
MLKNGIIFGKFYPLHIGHVDFIQQASGFVENLYVVVCSDVDRDKELFEESRMKKIPTIKD
RLRFVEKTFKHQKNIKIIHLAEDGIPFYPNGWKLWSERVQETLLKNNIKVDVIFTNETQD
VENYKNNFLTLPNFESTFNKNLKIQMIDTNRNNFHISATEIRKNPYKNWFFIPKYVREFF
VLKVAIIGSQHSGKTNLTHKLANYYNTTYVKEYKKEYVKDELQNNVDNLQYDDYSNIAYE
HNRRIMDSIKNAEKLSFIDTDFYSLQSFSILETGKKHPVVEDFVRHTNFDVLLYIRNISD
KANSSSLQDFEYDKILQNLLKKNNQKYIELPHKSNKSLTENYMKSIQIINDYLEN
>SEQF2502_00843 hypothetical protein
MLTILAIIVNTILVSIIIILLNKKNNENLEKIILNQISENNRQNFEENKRKFDEIEKSIN
LGTKNSLLEGTGNIGILLAENNEKMLLRFNELGQNINGTINTNNQLLSKNHTENSQRLTE
SMNNAIQKLSTGLNENNTVLTGVMTENNNKLTKNINEFKDMLNQNINENFEKLNQKVENR
LDLMNTKVEERLSKGFEETTKTFGNVLERLSKIDEAQKKIEALSSNVVSLQDVLTDKKSR
GIFGEVQLYQILASVFGEKNDKLYQKQYKLSNGTIVDSIIFTPEPLGNIAVDSKFPLENY
RKMYNNELNQIERENARKDFVNDLKKHIDAISSKYIIKNETSEQAVLFLPAEAIFAEINA
YHTDIIEYANKKNVRIASPTTLISVLTVIQVIMTNMERDKYASVIQQELEKLNIEFGRYQ
TRWNSLQKDIEKVSKDVKDITTTSNKISKRFTQISNVKFDKKTDNLFETVQSQITEN
>SEQF2502_00844 hypothetical protein
MKEKKELKGKREKKGEGLKKKIDEIKKMIYLIYRNYRDGETQILAISLTYYSLLAIFPVV
ALVLGITKGFGLDKIFIQKFFELWPGNNSFLKLIVDIAQKLLLSTESSILTGAGIVILIY
SAVKVLIMLENSFNKIWKINKKRSLTRRVVDYIAIIFLGPIFFVLLSALNSVVIEEIVKN
FPNNAVLTNLFIGFFGPATYIILFSYLFYLIPNTNVKIKPAIFAGIVTTALTFGWKLLFL
LLQSSITKYNIIYGSLALIPIFLIWVQYVWVTILLGAQIAFSIQTSDEFLYSEKIEMPIK
VKREAGILILSLIIKNFVEKKEAFTYQKLTDRLGMEVFFVKEVLSDLEKMGFINEVFYDK
NSDSQYQVAYSPESITIREFMKKFDTKNIEHYENIFDNLNEEDRKLLEKIREKLAMKKIE
NPEGENGNKSEIENIEQKSSFSETEHLENSGTSVKSRKPEELTIDFQISKEPKQKDENFK
VKDSKKIIEKEEIDSKNEEQEIEKQTEEAIEISEVEDSESSGKRVRYEDGTWKFF
>SEQF2502_00845 putative tRNA sulfurtransferase
MNNYTDKNLLNAVGLSYGELSLKGKNRGQFEKKLRNKINKVLKGFEYQLFDDLSKLYVFI
NPENLDEITDKLKKVFGIVGLNQSAKVERNDEFIKEKVLKFANYAYEQGARTFKIKVNRS
NKGFEKKSMDYARELGAYVLVNSPFEKVKMNDPDVMINVDIRINVYIYTDRIKTYGGLPL
GSTGKGLVLLSGGIDSPVASFMMAKRGMRLNFVTFHSFPFTSQQALEKVKELTDILSLYV
GKTRLYSLNILKIQEAINTQTKKDLATILTRRAMMRLAERISNTMRYQALVTGESLGQVA
SQTMGGLTCTNASVEKLPVFRPLIGMDKTEIIEIAKEIETYEKSIEPYEDSCVIFAPKHP
VTNPKLEDVLAEEEKIENYDEIMNEIFEEREYFNFG
>SEQF2502_00846 Cysteine desulfurase IscS
MIYLDNSASTKPYKEVIDVLVQTMEENYANADAIHDFSHKIFLKIKKARKIVADYLKVEA
DRIYFTAGGGDGNNLLLQGIVNANSRIKKHMITTKIEHPSVYEVFRHYENAGFEVDYLDV
DKDGYINLKQLEDLIREDTILVSVGAVNSEIGAIQDLEKISKIIWNKNRNTYFHTDFVQG
FGCTNIKFDKISVDAITVSGHKIHAPKGIGAIYVNKRVKIADVVFGSNVENGIVKRTMPT
ELILAFAKAVEILSKEDKKDMKHSQNIKKMLADKICEEITDVKLNSSLDPEKSSPKVLNV
SFKGTKGEVLTHFLGMYQIYVSTGSACSSKKGNSRILEVMGLNQSELDGAIRFSFSSENT
VEQIDEVVKRLKESVERIRKMR
>SEQF2502_00847 Pyridoxine kinase
MSIKKVLTIAGSDTSGGAGIQADLKTFQERGVYGMNALTVIVTMDPRNRWAHKVFPVELN
VIKEQIDTVINGIGVDALKTGMLPTAEIIEYVGSVLKDLKNPIVIDPVMVCKVTSGSTEN
LFPENVTAMKKYLLPYATVVTPNLFEAAQLAGIEKINTIEKAKEAAKKIYDLGAKNVVIK
GRKFFAGDKSVDILYDGKDFEFFESEKIDTEWNHGAGCTFSASITSEIAKGATVSQAVAT
TKKLIAEALKQSFKLNDYTGPLNHKAFALK
>SEQF2502_00848 5,10-methylenetetrahydrofolate reductase
MRIKDLFEKKEHLISFEIFPPNKNFSVEKLKDVTDELVQYKPDFISVTYGAGGKTKGGTI
EMASHIKNNLKTEVLAHLTCVGSKKSEINDYLQEAKKCNIKNILALRGDVPQGETEEIYN
RGDYKYASELISDLRKNSEFNDFSIGGAFYPETHYENNDLVDLFHLKNKVEAGTDFLASQ
MFFDNDIFIKFKEQAEKLDIKVPLIAGIMPVTNAKQIKRIIELSKCSVPEKLDKLLGKYG
DNPESMKKAGIMYASEQIIELLAYGIRGIHIYTMNKPEIAKEIVKNIEFAR
>SEQF2502_00849 Argininosuccinate synthase
MAKEKVVLAYSGGLDTSIIIPWLKEHYDLDVIACCVDVGQDDDMEEVKVKAIESGASKVY
VEDMKEEFVRDYAFRALRAGAVYENKYLLGTSVARPLISKALVDVAHKEGAAYICHGCTG
KGNDQVRFETGVFSLDPTLKIIAPWRIWDISSREDAIDYAQKKGIKVSATKEKIYSRDQN
LWHISHEGGDIENLENEHKEDVVYMMTTPPEKAPDKPTYVDITFEQGWPVKVDGEALEPV
ELLRRLNKIAGENGVGVIDIVENRLVGMKSRGIYETPGGTLLMEALKELETLILDKDTFE
FKKLVSQKYASIAYSGQWFTPLREGLDAFVDETSKNVTGTIRLKLYKGSIKIAGRFTDFA
LYDEEISSFGASELYSHKDAEGFIKLFSLPNRIRAYKKHK
>SEQF2502_00850 putative peptidyl-prolyl cis-trans isomerase
MIRKVSLLMLSFLMIMMAGVISYSREYKMKVKIMTEKGDININLLPEKSPVTVANFVNLA
KKGYYDGLKFHRVIDNFMAQGGDPAGTGAGGPGYQFEDEVNNGLNFSKAGKLAMANAGPG
TNGSQFFITTVPTEWLNGNHTIFGEVVSDDDLKVVKKLSNGDVMKKVVVEGDVDAFLKTQ
KNRVDSWNKILKQNFPNKF
>SEQF2502_00851 hypothetical protein
MKKSIFALFAISMTMFAAGESKKVHEVTAKLQKDSYCNVPKEDGEFKKVDGKDYSRMDVN
FEKCVFDGETYENVKVGVIVKDIEKAKNYLKKYKYMHLKAGRNLVYNSSDNSYYYTGSWA
FNNDKAYPTVFNGK
>SEQF2502_00852 4-hydroxy-tetrahydrodipicolinate reductase
MKIVVYGAGVMAQYVKESVINSGNEFVGFVDPLGNGDFKNLKENNVDFDAIIDFSHFSLL
EDVLEAGINKKVPVLIATTGHSEAQIKEIEEASKKIPIIKATNTSVGVNIVNEIVAFATK
LLKDFDIEIVEKHHNRKIDAPSGTADTLLEIVKENLDNNGKDYRTVYGREGHSKRAEKEI
GVHAIRGGNIVGEHTVIYAKNDEIIEIKHEALSRKMFSDGAVRAVEFLFGKKAGLYTMKD
VLGL
>SEQF2502_00853 Lactoylglutathione lyase
MAILNMLHACLRVENLETSIEFYEKAFGFKEDRRMDYPEHKFTIVYLALPGEHFEIELTY
NYGHGPYTIGDGFSHLAIASDDLEGDNAKHKALGYETTDIKGLPGKPGHYYFVTDPDGYR
MEVIRAK
>SEQF2502_00854 hypothetical protein
MEQARKNRKRTHYRNYINEKLVGNKRKSFKKVEEIVSFEVIEREIIERILVKCFLIKRSR
TFYRNFINRKLVGNFGKKYKRMFKSLNFDFEKISPDQIRRRYVETEINRSKFAKGVEYDG
NSNHEDIYFDKAPLPVAYFVDEIVLMPKNPTTLFMYWEIRDDTYERLSSNNGVIDNVVIK
LFKDGQEYRKIIRHERIGSHYITGIDVNQDYEVSIGYEDQYGNFSEVARSVQAITPNDKV
SDNFDLVWGTVRLDENTNQLIKYINTPVSTPEGRELLGIPEGSYVSEENDEFIIEVIERL
TKVGASESLIERRVVKGKLPGLRLDMSGARSS
>SEQF2502_00855 ATP synthase epsilon chain, sodium ion specific
MAAEFILEAVTPERLVFEKPVEFVKLRTESGDIGILAKHINYITAIGAGEMLVREKDKED
VTYYLEGGFLEVRQDKVVILGVNIVETTKAEAERMARQVAIEKAKNQKLKEDRDILGTKK
RIQSNLSKK
>SEQF2502_00856 ATP synthase subunit beta, sodium ion specific
MNKGKLVQVIGPVIDVKFEKTLPDIYNALEIYNENGKKIVAEVHSHNGNNVVRAVAMSGT
EGLRRGLEVIDTGKPIQVPVGRPTLGRIFNVLGETVDDGEKLDADVLRESIHRDAPTFEQ
QGTDSEILETGIKVVDLLAPYLKGGKIGLFGGAGVGKTVLIQELINNIAKGHGGLSVFAG
VGERTREGRDLYNEMTESGVIDKTALVYGQMNEPPGARLRVGLTALTMAEYFRDKEGQNV
LLFIDNIFRFTQAGSEVSALLGRMPSAVGYQPNLATEMGALQERITSTSTGSITSVQAVY
VPADDLTDPAPATTFAHLDATTVLSRQIASLGIYPAVDPLDSTSRILEPEIVGNEHYKIA
RETQKVLQRYKELQDIIAILGMDELDESDKLTVNRARKIQRFFSQPFSVAEQFTGMKGKY
VPLRETIRGFKEILDGLHDDLPEQAFLYVGTIDDAVAKARELMSE
>SEQF2502_00857 ATP synthase gamma chain, sodium ion specific
MAANMKEIKERIDSVKNTSQITNAMNIVSSTKFKRFQVLTLKSRSYARAVNEAFDNLVAS
LTGNKFVIFDGKPEVKRVGIIVMTSDRGLCGSFNSNTFRRLESMKKEFQKEGREVSVITI
GRKAKEYCKNRDINVDSEYTQMIPETMFETGKKISEDVVQFYLNDFYDEVYMIYSKFVSA
IEYNIQVEKLLPIEKKEGLPTKEYIFEPSEEEVLNSFVPQVLNIKLYQSLLENSASEHSA
RMSAMKQANDNASEMIKNLEVQYNRERQGQITQELTEIISGSSSVQ
>SEQF2502_00858 ATP synthase subunit alpha, sodium ion specific
MRIKPEEISKVIRSEIENYKSSLDISNTGTVLEVGDGIARIYGLSDAMAGELLEFENGTI
GMALNLEESNIGAVVFGKTQGIKEGSIVKGLGKVAEVPAGKELLGRVVDALGNPIDGKGS
ITADKYMPIERQASGIIARKPVTQPMQTGIKAIDGMLPIGKGQRELIIGDRQTGKTAITI
DAIINQKNNNVICIYVAIGQKRSTVAQIYKKLEEVGALEYTIIVAATASESASLQYLAPY
SGVAMGEYFMDEGKDVLIVYDDLSKHAVAYREMSLLLKRPPGREAYPGDIFYLHSRLLER
AAKLSDKLGGGSITALPIVETQAGDISAYIPTNVISITDGQIFLETDLFNSGFRPAINAG
VSVSRVGGSAQIKAMKQVASKVKLELAQYNELLAFAQFGSDLDKATRDQLNRGSKIMEVL
KQPQYSPYKVEEQVISFYCVTNGYFDDIPNEKLRTFEKDLIEAIKNDSNILSEILEKKSL
DDNLKNELDEFIINYKKEYVW
>SEQF2502_00859 ATP synthase subunit delta, sodium ion specific
MANDEIAKRYASAIYNIAKSSDSINEVREVLNVLLENYEEEEEFRKILEDPLKKFPEKKK
FLEKSFNHVSSEALGIVEYIVKKQRLSLISDIKEYFLKLYYEENNKLPITAIFAKELSEK
QRDLLVRKLEKKYGKKVVLDLEIDKGIIGGGILRIGNEVIDGSIKNQIEEIKKNF
>SEQF2502_00860 ATP synthase subunit b, sodium ion specific
MGGKLINIDFTMAIEIINFIVLVYFFSRTFSKKIGKVLEDRKKLALSEMEIVENEKEKLE
DQKKSIEKLKRESKRRANDILIKAERQADDRKDQIISLAMSNRERMMIKAEADIEKMRQN
AKFELQKEVGEMAVELAEKIIKENIDEKQDKTIEKFINEIGD
>SEQF2502_00861 ATP synthase subunit c, sodium ion specific
MAGVELIKAAALLGAGIAAIGGAGAGLGQGIATGYAVEAVSRQPEAKQDIMQTLITGLAI
TESSAIYALVIAFLLIFLKG
>SEQF2502_00862 ATP synthase subunit a
MKNKIFKFLGFLFLMMVVVNLILSIISTFLPVKFESPSSVVEAPHYFNFVLGGFKFSLSQ
TVVNTWVLMLIIMFIVRAGTKKASVENPSKMQIVMEEYYHFIENTFLTTFGKHKKTYIPF
FSALFAFIMFSNLSTFLFPYIMMVVSEDGVKMVKPFFRTPTADPNTTIGLSLVVIILFLA
VSIKQKGLRGYIKSLFEPMWFMFPLNIVDIFSKVLNTSMRLFGNMLAGLVIVGLLYSLVG
RGLLQSLTHDMLKGSFSFSVGWPMIIQLYLDLFIGIVQAFVFTILSSVYISEALGEEE
>SEQF2502_00863 Sodium/glutamate symporter
MVKINMDMIQTIGLAVILLLIGMKLRKKIQFFEKYCIPAPVIGGFLFSIIVFIFRQTNVA
QIKFDDTLQKFFMVMFFTSVGFNASLKVLKKGGKKVVIFLFVAAGLCVMQNVVAVALSKF
VGIPPLLALMTGSTPMTGGHGTSAAVAPTIEALGPIYKGANAIAIASATFGLIVGSAMGG
PIASRLINKYKLLPEHFIKDGTKHGDEDIDEEVLKRQKPYLDGERFSMAFFYILIAMGIG
SYLSMFIDYLMSFTGFEAHFPIYIGPMIIAAIIRNISDNVKALNAPIKEISILEDVALSL
FLAMALMTLRLWELIDLALPVFVLLIAQVILIYFYLNWITFKAMGSDYDAAVMVSGHCGF
GLGATPNGISNMKAVTEKYIYSKMAFFVIPIVGSLFIDFVNISIITVFTQFFK
>SEQF2502_00864 hypothetical protein
MKTILRKVSLLAITVLTAASLNASSIIMGNRNNAAKVNNQKVTKNRELRGVWVASVSNID
WPSKKGLSVEQQKKEFLTILDNVKKWNMNAVFVQVKPTADAFYPSKYSPWSEYLTGTQGV
NPGYDPLKFMVEEAHKRGIEFHAWFNPYRLSTSGSRDKLSKDNIGRKKPEWTVSYGGQLY
LNPGIPEVDDYVVDSIVEVVKNYDVDGIHMDDYFYPYKVKGQEYPDSAQYQKYGKNFATV
GDWRRDNVNRLIEKLHNAIKKENENVEFGISPFGVWRNASTDPSRGSATTAGVQNYDDLY
ADILLWMNKGWIDYVAPQIYWNQGFKAAEYNTLVKWWSKYAGQTNTDLYIGQAAYKVNDW
KNAKELINQVNFNRTYPEVKGSIFFSYKSLLTNPKNATNSLAQGPYANIENQ
>SEQF2502_00865 hypothetical protein
MTNNLKELKQELKSFAKKVKDFKYTDSALITFLLTGAIGRGASANLFSDGSEIENQSKVI
NTSIAQQKKDFKRARMENEKLIKKTNSELIQLMEQGEHVVKSPWGGWQFGINGFYNNWQG
HYKGRGDKVKDVKYTRDISYKKTGIIKTIVDDDNGHGTNGGDNITGQEETLVNRKSFLYT
RASNNPNDYVKGFIRLDMHSGADLESEKNKLGDKLGTASPEYRAFDDVIKIAGKTTNSAK
GNTFINSGTYVIEGGNVTFSNSYEHIGGKSDTTVASVVNTSKGNIVIHPYSVNGGIYDSN
SAAFMVSPSVIGNGNPQIFYNAGTVEMYNKKSAIFFLNPNGDYTRNHSNHNYGGFFEQPY
SNSIPNPSGTYYDDDTLNPREITIVNRNKINTYGEEDVGVYLKTGKYISSANLDFKTKSS
NGDWAPLTIYGDNSIGLYAPIDKDSKEIVKLIPNKASGPVVGNFAVNLGDSSGNSREIFE
TKNSINIDSQTTAGIPSRFVINNDKYIDKSYGIFASSTVDLETSTANKNIENGHQINLFK
NVKNSIGVLTGDGASIKLGAGEISLKGGFENTGIVVGGSNTSASGVQSTDGKVKGDVVSI
EGDGRNDRGNMAIYAGNKANNEVTVNAVVSKDATNSVALIADKGAKITVNDTISSPSIIG
TNAIKVTNAGVQISGLEFHYDPIRVDAKNVSVDNVGAAYADNGATITMNRTSLPSTQNIS
ITGGIDSQTKKSVGFGLFANNGGKINAQKNWIKVTDGATNVASINGAKIDLQGSKVEYKG
NGYALYTDSTSNSTSAIDMKDATLVLDGGAVGYIYDQAKPNVISFNNTTNIDVLSDDVIV
SDLRNSTSPLIINVENKAGNDSLKSRLLGGNVNVTSSNGKTNYKYALVDDATVQIKSAID
KANLISDSDSEVFTKRFLYQNSRLHVEAYGSVKAELNKAQMRAIDDRFLAPVGLAIAGSS
KSINNRTTEIGNKGRVFVDRTDAGQGGIGFYADYGWLNNYNAGKLEVEQGATHNDRAVGM
YGTNNSNMVSSGPINVGGKNSIGILGLSYRIDPSTGLAIDPSNEPYFKSAVHPENFGKID
IMNLPWGVITMDDDGAIGIFTKNNSIDPTIKSVPSTSKAWLVGVNEGTITINGNNHAIGM
GSSFGAVSNYEGEDPVTHVYHSGIININGTQSFGMYGTNNTDLKNFGIINVVATTPGNES
IGMYGDDPKTKVYVLETENGTRIRNNSIINVGRSSYGIFARNIEMNGGTINVGDDGVGIY
SQGPDVNLIAGKINVSNNNAVGIYIDDATVAPKPTIVKGNVDMKVGQNSVGYLITAANTK
TDLKTKASSDVHIGEGSVYIYSRAPQSLGGKIETESKIVTDGKNSYGIYSSQDFINRGDI
NLKSGTGNVGIYSSQGIGQNYGTIEVGPSDAVNGKYGIGMATGSTTASMGTIENYGTINV
TKDNSVGMYASGSGSKAINRGTIDLEGNDTIGMYIDDHAIGENHGTIKTAPTPSGTGIKG
VVVANGGIIKNYGTINIVGGSNTGVYTNTASAYQEHGTNNSTNKSSVGTAVSRTVAEKLV
VKVPAHPSPVSIPIPAVQAGMSRVDTDIALPQIPKMPVSDFTGVTTLNMPVEQTGHNLDN
NSNNNNSSNNNTISTREVSTIGMYVDTSGINYTNPIQGLNNLPGLTDINLIMGTEVANSL
NAKTIQIGDNILQPYNNALGSVGAKVNVDSASLTWKAQMVESGNVAAPIKTVYMEKIPYT
DFANKNDTDTGHFLDGLEQRYGVENVNSREKQLFNKLNDLRKDEKKIFVQAINEMKGYEY
SNTQERINSTGNKLDKEIEYLRNEWKNPVKQNDKIKVFGMKDEYKTDTAGVIDYDSNAYG
VAYVHEGEALKMGNSSGWYTGAVTNRFKFKDLGKSIEQQSMIKAGVFKTISPANDHNGSL
RWTIAGDIFGGTNYMHRKFWVVDDVFESKANYYTYGASVKNKLGYDIRFSERTYLRPYGA
LKMEYGRFTSIKEDNGQMNLEIKGNDYFSVKPEVGVEFKYVQPLILGMQLSVGLLAAYEN
ELGKLNRLNQARVHYTTADWYNLRNEKEDRKGNGKFDLNIGVENTGFGVTANLGYDTKGK
NVKGGLGFKLIY
>SEQF2502_00866 Putative reactive intermediate deaminase TdcF
MKKIPEAVGPYSAFRKAGDFLYISGQIAINPENQKVEAVTVEDQARQVLENLKAILENNG
LTTGNVIKTTVLLDNIDDFITVNNIYAEYFSEPYPARSAFAVDKLPKGVLVEIEAIAYFG
K
>SEQF2502_00867 putative NTE family protein
MIGKKRVICFFVIFLLVNIFGFSKNKESQDEKIEKSENYIVLENGNDKDLKNNNDNRNNE
EQESGLRKDVDLKNNKNLKNNLKNEESDINKKNVVNQEDKKIGLVLSGGTAKGLAHIGIL
KVLDEEKVPIEYVTGTSMGSIIGGMYSVGYTPEEIEEIAISMDWMSLFSDKIERKDKGAV
RNSIEDKNSTVIPIKNFMPKLPSGVVGGKTASQRLNELFYGALRVEDFRKFPRKFAAVAT
DLESGEGVMIDKGSIATAIRESLSIPSVFAPIRDGKRLYIDGGVVRNLPVQDVKVLGADY
TIGVNVGDGFTKRDESKMNLIDVITDTTTIAGRQEVERQIRMLDLYMKPDLEKFESYDFS
KVKEIIAAGEAVARANIDKIRKLSNPELYEKLEEKRKEFRRTWKDEYNITGIVIDGNKKY
TRTYFDKFFPKKLGTLTRLDMEKIVNNIYQNGDFTTVYYEVKDNDLIINVQEKPSDYLTL
SGNINNEDLATVNVGFQGSKLLNNTNVRYSVKGTVANEYGVKGKATAELGKNSKAVIYGE
FEYKRDIIENQKYKNGYFSFENRKFKIGTGIGVEVYKNLLFSIGGGYQISDVEKHENNAE
NVRKPFPYYEAKLNYDTRDSLKFATRGVYFFSNYTLANSKHAKFNSLDAGGEINIPIGEK
ITITPGIAYLTSYGKDIPETYRPKMGGIRTADNSLEFAGMPSDKIRGGSIFVGSLKAQYN
LSKLVYLDTTYSRANISGKSYSFGNDVKESYRFGVGVKALTIPIYFGFAKVPGESWRYLL
NFGYSPE
>SEQF2502_00868 Proline--tRNA ligase
MRLSKAFLKTYKEAPKEAEVISHKLMLRASMIRQLTRGVYSYLPLGYKVLKKIEKIVREE
MDRAGAQEILMPVLQPASLWEESGRWFAYGPELMRMKDRNEREFALGPTHEEVVTDIVRN
MIGSYKELPVNLYQIQTKFRDEMRPRFGLMRGREFLMKDAYSFHLTKESLDEEFLNMKNA
YSRVLERMELKFRAVDADSGSIGGDSSNEFMVLAENGEDDILYSDSSDYAANVEKATSII
ELKESTEEKLPKELVETPNTKTIKELSEFLNIPEEKTVKAVMLKEVLEDKVNYVLALIRG
DLDINEIKLKNAVNASMELEMMTEEECEKFGIVPGFAGSYEKKEGLTVVIDETVKYVRNF
ALGANKKDYHFINVNLEDLHYDVVADIRTARAGDISPDGKGVLKIARGMEVGHIFKLGDK
YSKALDAKVLDENGKQQVILMGCYGIGVSRLMSAVIEQKNDEYGIIWPKSIAPYIADVII
ANVKDETQVNVAERIYEALKNENIDAVLDDRNERAGFKFKDADLIGFPLKIVAGKGVSSG
IVEIKDRATGESVEVKVEEVINFVKNFMKN
>SEQF2502_00869 hypothetical protein
MKKLVLLGLLVFSAFGIAEPYRDERGVLFMSEEEWVKFYNKEGQDVPVCLPIGSMIMEES
YIKDGKKMPHTLTEVQNAIKQFNEILGETGLRDINGEKDKIHEFYYAAVCKQPTQKQYDL
VGSPTFKKEMDRIFETHKFEEDN
>SEQF2502_00870 hypothetical protein
MSPKKDYNGALQWTIGGDVFVGINDMKRRYLVVDDVFQAKSDYHSYGAALKTDLGYDVRL
GERTHFRPYGALKMEYGRFNSIKEDRGEMRLEVKGNDYFSVKPEVGMEFKYVQPLAVRTN
LTVGLTAAYENELGKVGDVNNKARVRYTTADWFGIRGEKEDRKGNGKFDLNVGVDNTRFG
VTVNAGYDTKGNNVRGGIGVRLIY
>SEQF2502_00871 30S ribosomal protein S15
MALKQKKEIIEAFGKNAQDTGSAEVQVALLTDRISHLTAHLKIHPKDIHSRVGLLKMVGK
RRRLLNYIKNRNVDDYRSLIEKLGIRK
>SEQF2502_00872 Lipid A biosynthesis lauroyltransferase
MEYKVSEKITGFFVILLKKVLSIFSLKIRYKIFEGFGILAYYLVKKRRMLAINNIKNAFP
EKEKKEVVEIAKESYKTMGKMIMTSIFLEEITKDGNTVVENEELMRWACENNEKAVLIVS
LHLGGFEAGSKMRNIRKFYAVFRNQKNKKINDLMEKWRKEGGLNSLPLHNNEALSGAINE
KSIIALASDHYGKDVNVTFFGRETTGVAGPVLLSIKYKIPIVLAYAVFDENIVKVVNKKI
IQIEKQNKLKETMQFNMQKIYNEFEEIIREYPGQYMWQHNRWRNKKKLRKK
>SEQF2502_00873 hypothetical protein
MKKYLCLFILLILTSCTTLSSTVNNVSQVEAGKINAEITKITEDFKNAASLNEYDKLKEV
FLPTFKNNIIVKKIQEYDLSGLTFVFSDVNVVSKNKANSMMVINFATSSNYYKLTWKRTD
DNLWKISNVAEKK
>SEQF2502_00874 Ribonuclease Y
MSISIAVLLIVIFSFLTFFIAYFFGSSIFKKKYGDLNELELKIVDAKRRLETSKKEVERE
IESFRKEETLKVKEELLNEKKIADDEIKKMKSELAIKEERIAKKEETLETKMERLEEKEA
KSDKHREKLFRREKELEEMIASEEKELERISELTQEDARKIILTKLENELDHDKAVLIRD
YEYNLDREKDRIAKRIISTAIGKASADYVVDSTISVIQLPSEEMKGRIIGREGRNIRAIE
AATGVDLIIDDTPEAVVLSSFDGVRREVAKIALEKLISDGRIHPTKIEEVVAKAQHEVDE
SILDAAEQAILEVGIPTLPREVLKVFGRLKFRTSFGQNILQHSIEVAHIAAALAAEIGAN
VDIAKRAALLHDIGKAFSHEQEGSHALNGGEFLRKFSKESEIVINAVEAHHNEVEQLSIE
AVIVQAADSISASRPGARRETLSNYLKRLEQLEEIANSHEGIESSYAIQAGRELRLIVRP
DNIDDDKATILARDVAKEIEEKMQYPGQIKVTVIRETRAVEYAK
>SEQF2502_00875 hypothetical protein
MKFLIIGDVVGRPGRNTLFKYLEKRRQNYDFIIVNGENSAGGFGINVKIAKEMFERGVDV
ITLGNHSWDKREIYPYINEQKNLIRPINFTKEAPGNGYTIVEKNEIKVAVINAQCKVFMP
PIACPFLAVEEVLPKIKEKTDIIVLDFHGEATSEKQAMGWNLTGRVSAVYGTHTHTQTAD
ERILPGGTAYISDIGMTGGHDGILGMNRRESIQRFKDGMPTRYSVCEENLRINGIELKVD
EKIGKAVSIKRVNMGYDEI
>SEQF2502_00876 Ribosomal protein L11 methyltransferase
MKWIKVKVDYFSDSLEKTKAKLVNMFNEIGINQVEVIDYFSENELDYNANFSSKNDVWSI
IGYIVDNRFANTKLNIIFNNLKEFMESENEFIYEIFTAKCNDEDWQDEWKKYFHTVNITD
NIVIKPSWDEYEPSDNEIVVEIDPGLAFGTGTHETTSLCVEFLEKYAKNKKKLLDIGCGS
GILMLIGKKLGVEKVVGIDIDEKVNDVVLENFSKNGINDNFQVIIGNLVDNVNEKYDLVV
SNILVDVLEKLLEDIEKALEKGAIVIFSGILNEKEEAFLKKAKNYNLKQIDRKDKNNWVS
LVFKYES
>SEQF2502_00877 Cytidylate kinase
MIIAIDGPAGSGKSTIAKLIAKDIGLVYLDTGAMYRLVTLKALNEGIFGNGKLSDLEKIK
KLLDNLNIDIKENGFYLDDVDVSEEIRKPIISENVSDIAAVREVREKMVDLQRKFSKSKN
VILDGRDIGTVVFPNADLKIFLVADAKERAKRRYKELVEKGENVEIEEIYDNILKRDKID
STRKESPLKKAKDAVEVDTTFKSIKEVKNEILKMINVNI
>SEQF2502_00878 DNA-binding protein HU
MSKKEFVDAYAKATGETKKRAEELVNQFLDSVEEVLLNGDSVQFVGWGTFEVKERAARTG
INPQTKEEIQIPAKKVVKFKVGKKLADNVAEGK
>SEQF2502_00880 3-deoxy-D-manno-octulosonic acid transferase
MVLYNLLRNLLYFVIMILAIFNIKLLKFFKSRLFQKMENDDFLNNGEEAIFIHFSSVGEF
NLTKELISEILEEKKTGKKEKVILSVMTNTGFEAVSKEYSENGNVRIFYFPLDDFLAIRK
IYKKYKIKKTIVIETEIWPNLYYFAAKNGELFIANGRLTEKKLKSYLKFGWIIKKTINRA
KKIMVQSISDKERYERLGVQRGKIKVYKNLKYSIKYNKISEIQKKEYYDTVVDKNKKIIV
CGSTRLDEEKIWLDILKKIDTNNEYQLIIAPRHLKRISDIEKMILERYSRDDYSLFTKIN
KNKKNDKITKYKKIVIVDKMGILTDFYQLADFVFVGGTLVDIGGHSILEPLYYGKKPIIG
KYFQNIEEIVKDAKELGFVKIVENEDEIVEYLKKFENIDTREFFEKNNEIGKILDEILY
>SEQF2502_00881 tRNA (guanine-N(7)-)-methyltransferase
MEDKSEVKINIIGKNGQKIEITEAEQKRRNKIKKVNDEFKLVNAEKSRIINEKEIWKYFF
EKPKKNYNKYMYEMLEFPKHLMYNNKSVDEYCGKWNEFFGNKNDIYLEIGCGSGNFTVQN
AEKYKDRNYIALELRFKRLVLGAKKSKKRNLDNILFVRKRAETILDFLGKDEIAGVYINF
PDPWEGEEKKRVISKSLFFKLDIVLKTNGKLFFKTDHDQYYENVLELINELDNYKIIYHT
NDLYNSEKASENIKTEFEQMFLSKHNMKIKYIEIQKNR
>SEQF2502_00882 tRNA (guanine-N(7)-)-methyltransferase
MHKILKGERSKNLSLKNKNSYIKVMENKNTYSELLYKSNPFNYTIPALLEAHGRLYGLTP
KDSRKARVLELGSSFGGNIITQALYNPEAEFIGIDLTSEQVKKGNEIIEKIGLKNIKLIE
KNILDINKDLGEFDYIIVHGVFSWVPKDVQDKIVKICNENLTEEGIGYISYNTYPGWKEP
DKIREMMIYANKYFPEISLGDKNQRGKAFISIVAEQMKLYDDISKKKGDFIKQIEEVVGM
QDYYVAHEYLESFNHPLYLNEFVDLMKKENLEYISDVALRLSIISTYNKNTVEKLQQLSQ
GDHVIKEQCLDYILDTKFRRSIICKNSQAKKLNFSESFPNEILDSFLLSLRYTKEELETL
NEDNVKTIMLHLVETPNKSFVIKDAMKYWESIAKDKNDEKRNEVISNLRKFVLNSMINGK
IKFYCSENEVVPYEENKVYILKKFRNYLKTLIIGEGAGVVGIANSRNELINDLNDVDVIV
ADILSEPKTEKEIIEELSKTTIYRTMPDGERKEVEASDYLPESIRKFEFLGYFSKR
>SEQF2502_00883 Small-conductance mechanosensitive channel
MKELEKFLELDNIIRFLKTNIFKLFIIFLIVKIGKIFKTRIEKILKIILDKSNIDKSVAS
FLLSIYSILYYFILIYSSVGILGINTTSITTFLGATGIVLGIAFKETLGNFCGGLIILTF
KPFSVGDTIEYNNYIGTVTKIELFYTKMLNPQNELVIIPNGIVTNTEIRNIRQNGERRLD
LEVGVSYNSDIQKVKGTLERIIKEETMNEVEETQIKNNLLVKLQNTILEKREKSKINLFA
TIFSRKKMKEAEDEANKKTEEENYESDKNTQSISNTSKVVNDKKMILASKPSIIGVGQLA
DSAIIFYVYVYTRSENYLDLKMKLNEKIKMEFDKLGIEIPYPRMDVHIQNNK
>SEQF2502_00884 Hydroxyacylglutathione hydrolase GloC
MELKRFLNDNAVQSNCYVISHGKDCYVMDPGQEKMTEVIEYIEKNELNLLGVLLTHGHWD
HILGIPSMLEYKKVPVYVSEGGYEFLFNPELSLFAWREGEFELNKEDVKIITLKENDKIG
KNGIISENTDNEEIYFEIIETPGHSRGDICYYDKKDKILFSGDTLFTGTYGRVDLPTSDP
IQMGKSLKKLLNLDPDIKVYPGHGFDTTIGVEKRYY
>SEQF2502_00885 D-aminoacyl-tRNA deacylase
MKIIIQRVNFAKIFVNNEFKGKIQKGIVAYVGVANGDCEKDIDFCIDKLINIRIFDDENG
KLNLSVKDIKGELLIVSNFTIYGNTKKGRRPSYTDSARASEAQKIYNLFLQKLKNTDIKF
ETGEFGQYMKIVSENDGPVNLILSSDL
>SEQF2502_00886 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MVRKSTLTMACMLLTVGCTGLQTNNENDSKTRKNNNDFSSNSNDDNKDDNIIIEIVGDNK
KRNTGASQSSNIERKYNNHDKNNESKFDMSEVSEKNSQTNKNSDDFKITKLFDENNLVDR
SMPNSQLVLQKLSELKRKQQEILRNGTSSQKKTVKLQNDLLKSYSHWKGTKYSLGGDSSS
GIDCSALTRRVYREVYGYELPRQTVQQIKVGAHVAKENLKPGDIVFFKPEDTNNHTAVYL
GDSLFINASSSKGVVISTLENTYWNKYFKYGIRVRMT
>SEQF2502_00887 Aspartate-semialdehyde dehydrogenase
MKNYKVAIIGATGLVGRTFLKVLKERNFPVEKLYLYASANSAGKKIEFNGTEYTVMELTD
ENIANDIDIALFSAGGGVSLEYAPKFKAKGAVVIDNSSAWRMDKNIPLVVPEANPEALKN
HPGIIANPNCSTIQVMPVLKVLQEKYGLKRVIYSTYQAVAGSGQKGLNDLEANLKGEPSK
GYPHQIAFNVLPHIDVFLDNGYTKEEEKMINETRKILNLPDLKVTATCVRVPIRFGHAVS
VNVELEKPFELEDVIRAFEEKEGIVVQNDGKNNVYPMPINAQDTDEVYVGRIRKDFSADN
ALNLWVVADNIRKGAATNTIQIAETLIKEGAL
>SEQF2502_00888 L-cystine transport system permease protein YecS
MKVSTIKNKILVLLVFMATFIAGYSDDIKVGMECGYAPFNWFQNDSKNGAVKVDGGYCGG
YDVEIAKVIAKKLNKKLVVVKTKWDALLGPALTSGKVDLVIAGMSATPERRQSLKFSKPY
YESDLVVVVKKNGKYANAKTINDFVGAKITGQLNTLHYDVIDQMKGVKKQTAMESFPAMI
VALNSGKIDGYISERPGAMAAQFSNPNLKFISFDKKDGFKYDTEEVNVAVGMKLGNTELE
EKVNKILDEDLTPKVRQQIMEKAIQNQPNETSRSFFGWVTFFVQNNWKTFLKGTAVTLFI
SVTGTIVGFFIGLVVALFRYSEAEIDGQNKKYKKGGLKILNRIFSIYIAVFRGTPMIVQS
MVIYYGLSQVFNLNLSPLLAALFIVSINTGAYMSEIIRGGIDSIDTGQFEAAKAIGMTNF
QLMKSIIFPQMFRNILPMIGNELIVNIKDTSVLNVISVTELFFISNSVAGTYSRYYEVFI
ITSVIYFFLTFTLSSILKQIEKRIDGPQNFEFLDDVNGEEK
>SEQF2502_00889 Glutamine transport ATP-binding protein GlnQ
MGKKVIEIKNIRKDFGKRTVLKDVNFDVHEKEVVSIIGSSGSGKSTLLRCINLLEKPTSG
QVLIHGKDAMAGDISLVTLREKVGMVFQQFNLFNNLSVLENCVIGQMKVLKKSREEAEKI
AKEFLAKVGMERFIHAKPNQISGGQKQRVAIARALAMQPEVLLFDEPTSALDPEMVGEVL
KVMKDLAKSGLTMIVVTHEMDFAHDVSSRVVFMDQGIIVEDDKPENIFENPKHERTKEFL
SRMLSK
>SEQF2502_00890 hypothetical protein
MAKKKAEDTKLTLTDEEREGLDNEGIKRILTSKAILKVAKEYKFSDEEKEEFEYLFTNEK
HKFFIAKLIEDKISVNENDVTKLYTDNKANFDAQNIPFSQAREIIQRDLLNQQVATLEAE
ELNKLVEGMEDKIEVTKKEVLFSRGDAEVLKTLIVGKIISKKMADEKFEDQEQNKKDLEV
IRDNVYINYYLDLEVRKNVKVTQEEVVEIYEKEKAKLGNVTPNSAYQQITNSLFNNRAIE
ERNNLINKIVEDYKVDEIAKEYAEAE
>SEQF2502_00891 Glycerol dehydrogenase
MAKIINSPSKYIQGKNEITNLATYYKLRGNNGAYLLVDKFIFDNFKDKIVESFKNEGINY
HIEVFGGECSKIEINRNIDILKEKKCDAVFGIGGGKTLDAAKAISYYENIPVFIVPTIAS
TDAPCSALSVIYTPSGEFEEYLFLKANPDMVIMDTDIIVNAPVRLLVAGIGDALATYYEA
KACVDANATSIAGGGITKAAIAIAELCKDTLFEDGLKAKISVENKVVTKALENIIEANTY
LSGIGFESGGLAAAHAIHNGLTILEEGHHMYHGEKVAFGTITQLVLENRCLCEIKKVVDF
CKSLGLPTTLAELGMGNVSKERLYEVAKASTAEGETIHNMPFKVTADDVFAAILVADELG
KN
>SEQF2502_00892 Riboflavin biosynthesis protein RibBA
MAENKAKFDTVEAAIEDLKKGIPVVVVDDEDRENEGDLIIPADTVTYETLNFIINEARGL
MCVPMSRKRAEELELNPMVQHNTDYFGTAFTISVDSLEGTTTGISTGDRLNTIKDLANPA
KTAKDFRKPGHLFPLIAREGGVLERKGHTEAAVDLARLSGFSEVAVIMEILKKNGEMARR
NDLFEFCQKHSLKLITIDGLIVYIKKNEKLVKNEATVDIPTQFGNFTFAGYSDKIEHKEY
IAVMKGEIKNKENITVRLHSECLTGDVFGSKRCDCQEQLHRALHELEESGEGLLIYLRQE
GRGIGILNKLKAYKLQDEGYDTVEANHKLGFSDDLRDYAVAAQIIKDLGIKSIILKTNNP
KKIEGLEKYGIRIAGRKEIEIAANDVDKNYLKVKKEKMGHLLKQDL
>SEQF2502_00893 Riboflavin synthase
MFTGLVEETGKVINLAKKNASIEITIRGKKVVEKAQIGDSIAVNGVCLTVTKLKGSDFTA
DVMFETIERSGLKRAKAGDIVNLEKSLTLATFLGGHLVMGDVDCEAKILSITDKGIAKVY
EFQLDENYRNNMKYIVEKGRVTIDGASLTVIDVNDEDGIFSVSLIPHTIENITVGMKKTG
DFVNIETDLFGKYVEKILKFDNFDNLKNKEKKSKLTMEFLQKNGF
>SEQF2502_00894 Riboflavin biosynthesis protein RibD
MSTNKNNEIDKKYMQIAIELAKKGAGAVNPNPMVGAVVVQDEKVIGTGYHKYFGGPHAEV
YALEEAAQNSNDLSNATIYVTLEPCSHYGKTPPCAEKIVKMGLKRCVIGSSDPNPKVAGK
GVQILRNAGIEVRENVLKSECDKINQVFFKYIMAKIPYLFLKCAITLDGKIATKTGNSKW
ITNETAREKVQLYRNKFMGIMVGINTVLVDNPSLTARVENGVNPYRIIIDPHFKTGKNHN
IIKENSDEKTIIVTSKNNENSEKQLDFSENSKVKFVFLNGTKFSFKEILRKIGEIGIDSI
LLEGGQSLISQAFEENVIDAGEIFIANKILGDEKGKSFITGFDREKMDEAVILENVKYNI
YDKNVGIEFLQKNYN
>SEQF2502_00895 6,7-dimethyl-8-ribityllumazine synthase
MKTFEGKFDGRNAKIGIVAGRFNEFITSKLVGGALDVLKRNDVSEENIDIAWVPGAFEIP
LITKKLAKTGKYDAIIALGAVIKGSTPHFDYVCAEVSKGVAQISLQTDLPVIFGVLTTNN
IEEAIERAGTKAGNKGSDAAFSAIEMINLIKEIEK
>SEQF2502_00897 Internalin-A
MKNTLKILIFLVFMACSNSKSEELKENKSTNEQMAQINTIPKQDKSCIELGKYNISAEKI
ELKNKGLEEINCITDYRNVKVLDLRWNKIKDVKPLKNLKKLEVLKINFNQIEDIKPLLNL
INIKELWLHNNKISDIRGIGKLTKLEHLDISFNPLKNGIKEISGLKRLKRLELREVPKEI
VDYVYEDYHNFMIPEKIFIEQRYPELAKKRENEIKYPNFSKFEDKINGFETVKIIRELST
KEVALNKLPNEVYKIVDEYDKNSEEADDKVEGAAFFTNNVYSIYTLTYPFAYAGQSNSET
VFVKNGKVIARDTVNLDSQLESIDGNNLFLSAVAASGGTNYAITDMKSGQMWREEFRDFG
LTSSKGMGKVFVTSSKENTVNVRESNDLDSSIIHKLANNVEVEEISDEKDWKYVYFYNKE
GGYYMKGYIHKSQLR
>SEQF2502_00898 hypothetical protein
MVNRKFNGVDIGDSAVAFFEKLAKLESGGKYNLADQKYYIGKYQIGTDVLMDMGWLPKGS
TWANARFIGEGATKWKLKGKQSFLNNPAAQDEVIMRSVKMRWATLKKHKDKICKNISVPK
NAVYIAPGKVRASESKVKTIIMKKRNQGYKAEDLRGKSFLLTSSGMLAASHLCGQGAMSN
ALGNNFKGVWGIPVDGNAMPSLLYAVNLAGHDLSVIIGFKDNCEVDHKVVEKNHTQTDNK
NINKQATIQSKPKSNVSSNSLQTQKEVLTLNNAKTESDESNKEGVFSFNGQKFEEVWDSE
EYKRDRAENGKAPELAFVNPDEAILKRLQAKFQDENIYNEDYVKYLETKTGKKVLEENTE
DINVILKMYDEATKDNDKIGNVIRQHGFDILRGREENNEILRIQDIVYYIYSYPIPNKSA
IESLEYVLGQYSARYVKYPDKKPVNKFKEDKNYVDKIQSVIQIYVKDGKTKVEKNQLPEK
YDKYMQGIKDIDEIVIKVAKKPALELQKTRCENLIRELGENAAEYEKTYSIDENGVRQFP
LSRRLIDNIIIEFLKVQTGFKEENETKYFDNHEYKDSNIVRNYLLWYIKRQKGIDIPSKI
ESGLFNRLEKIGKDIRVTTVLNDWITSKSAIKVRNIRKISDLIDEVYENYRDNSDFEKDK
DIILGLFKNSKELRDYAANVDSMDLYSFYKLFYDLQNIINPTGELFVNTNCMLKCTLGRD
ISRLIIKEDSVMLEGGKQANINDTNIQPFKSCSAIGTCQPALMGMWEKNTDVKVRNKPAL
LDISTIQCQHGGTISIDDAGQKEAGTAVTKDKEVNEAVRDADCQYKLLINICSDVNNDFM
QTQLKKEAQKFSKWNRFKSSTMNGANKTKIQIAEKETSSEKEKYLREKILDAFKEAYKSV
KQKSGPELDTKGIIKKHGLSLCDYEQKNFYSGKMLPVIAYGYLMRAGNLTITENEKKQIE
AELNSDIKTSNTEQIELKDYKIQNNVKQTKEATDHKINSSDITSWIEIGKTLYTSTEYPP
TEVDVLNAIRKNGKRVAVCPFSQREWSETHNSSKGLNNVDGVQDDVKKKVEQDSKDKNKE
ERNKNTDNLENNVSKGQVSTVKADKKLERKSEKCDIDNCPHKEVKGRAPWIKVAEEEMKK
YKGQKESSRSLYNRIQKTYFPYANFGTDKKPTEIAWCAAFVTYCMKTAGYKNSSDPSVGG
YDWGVAPRPKLPKRGWFEGEKTKPFVGAIGIFKFRKGYSHVAILVGKRKNGMYVFLGGNQ
NNEINKTAFEPSRIDYFMKPKSYTVKPEEQELPIITDSKNTGTVG
>SEQF2502_00899 hypothetical protein
MIKLLIKIIILALISCCSKNNDNLFNNIKYKENIEKKPQKILQKMSFDNKKLNNKEMTVS
LKRIIDTVVTARKSKSYTLEKYDEDIFKKYREYFDDTQNNSEFFEKTSNLLLELKSELSN
LNYVKNIKKSVKIKGANYSCSIQITKKPEKLGYVDGDVYGTVSCSSEYDSMSRFEEIYLK
KVGEKYYILDLLIS
>SEQF2502_00900 hypothetical protein
MRNKNVINQTNRTILFEEINPEKMDILTLVNDARNMDSLDDENIIEINRHLLVGSFEEFL
EKFDPKVYSYFDAESQSIKYILKKPEGVPEDLVTEIKINNGNTFFKMLSTLIEARKSQGN
RNVDFKFENILELISPKKVIEDIKQTRKEIAHIFQKYEELDDENPKKLELGDKLNTKFEE
ASENYSNVLGMLPLAIEDIKTRLLIGNDSNNFKSEKIKLGMLQVGEKGELEVIEYKQENQ
NSLAMIEEKNTTALVEAFRDDYENVTDEPNKYISDLVVRTFVPLAKTFVDVDPKQEVQNY
NNYLAFYKSAQEDFIKIAKPLIEKILGVKMFFEQYDVRMGLMKPTLLITNVKPEMIVKAG
NKDKLRAFLNTTNEKNDFDNTVWFGIYPNVDLDMKKSEKKVRERFMGTKNEEKTEKNTIE
VLTNLMTVLAEYKVQVFFNFEGKPETSFDNLATTGVDKYIEKTQILENQKYSEYLVPVIP
NFTIIPKDKSGVMLDYKMKFEEETGVLLSKEQEDLLKFWIEGVYIDASYVAAGIISAIQC
PNYLKERFSNVSPLYPGVRFDIEEKDNSYHAKTTMSKEISGFTNTIKDRINQFNYGFVFS
SDNANVAREKIRNIVVYKARTLLKNLDGGYEPLYKTLTTTYIERTLRFTTTDFKEDKLNM
FFSTNPESQKSIWLKDTKFVNGIMQKGDDLSHVIDADNGICQLNITFAGNLKNLQVEINK
NY
>SEQF2502_00901 hypothetical protein
MIENKYPIFGNGQVINKEALDLLRDNPAELTDLLYLDKKDGIISGFDLITDLDNKKVTVT
RGIIKYNEKIFWMNEDYKFNMPEIENRYILKLKLFSDFEERKFYIRSADFSLEILDIGAS
NSENTEIENKISNGLEIQEENNNKTKELWKSKIGEIEITRFITRIGAELRNDYNSFRDLR
RDFNLLELINIKYSSKHELGTLHPKILKLFGKEASKKENLDIYDVNFYVNCLNGSVERDA
IIAYINLKLQMEQENYTNEELYQYLVKILDNLGKDRKITEKKRVIPRKITIE
>SEQF2502_00902 hypothetical protein
MNLKKYILLGCLAIFAVISCGKKEAKQDEDQDEIQIEQQSVDNTAANNSNNSQENTAASS
EVQPAAQAAEAANKTTENINESANIQPPSQVKAEEVKASKTLQHVDKLIGKEIPMEDRVL
VFSKQNNQYKITYKGESENGMQVDTKNLTFNEKNDSLTDGNYTFKLKKNKLGLYAGSQFL
FTVD
>SEQF2502_00903 Cold shock protein 2
MLGKVKWFNEKKGFGFISGEDGNDYFLHFSKINKEGFKTVNEGEEVSFDVEEGPKGPQAT
NVISQ
>SEQF2502_00904 phosphatase YcdX
MLVDYHMHFEYGSYNENYVNPFFEKAKEMGLTEIGITEHTHGFKEFKDLYYDELILDDSE
TGNFQKKWLEQKTKFVHTLDEYRDFINKLKAKGYPVKFGIEVCNFRNQEKVKEILSKYDF
DYLIVSIHFIKGWGFDFSALKHKFTDGNLVQIWKDYAKEIEDVANTGMYDILGHPFNLRL
FKNIPEKKDVDKLLESTAKCLKKNNMIVDVNTGTFYRYPIKEITPYRDFMEYVKKYDIPV
ILSSDSHYSEHVGMKIKEAGEYVKEFGITEMVTFDKRKRKMVEIG
>SEQF2502_00905 hypothetical protein
MDNKNQQAIDANMIIKILYKDKALIALTTILVVILSTIFVFVHKSFKSEIILYGNDKVLT
EIGENSQFSLTSFDFFNYLKKNSKTLKNVNLPDDKFLKEMTTRLTAQSETNDPMVKVKFS
TNSKSEGENFAKEYPILAQNYLLERKNNFLDSQIKLLEQQYSFLTKNVDIRTTKDSLTDT
LVSRLAYYRLLKNDPNPVVKFINSTTKPSLNKKLVIAGSLFLGIFLGILIAFMKEFSTTL
DWEDIKKRKN
>SEQF2502_00906 Putative N-acetyl-LL-diaminopimelate aminotransferase
MYIDPIIKGIEISDIRKIHERLSSYKNVINMTIGEPDTDAPKKVKEAIAYHALNSPIKYS
PVGGMPELREKIAKFYNEKFGGNYNKDNVLVTVGSTEGLSSTLKTILAEDDEVLIPTPAY
VGYEPLIRVARAKTIFMDLEENNFILTEKILEKYITPKTKLIILTYPNNPSGITLPKEEM
IKIVKFLKDKEIYLLSDEIYASIAFEKFTSFAKYYNELKEQLIVVNGFSKSHSMTGHRLG
YTLANEKLQAQIKKISQYTVTSASTLSQYGAIAALDYCSDTTELSEIYKKRVYYFVKELE
KLGFKCLKPKGAFYVFATYKTIDKFKDVGSFDFILDLLEKTELAIIPGITFQVEGYVRFS
IVHDLPVLEEAIARLKKYIESK
>SEQF2502_00907 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MENKEKKILKKGDKIQLKIAGLNTKGRAYGFYGDDENRIFPNINAAEGQIVEGIFVKRRR
KYELIRCEIIDFAGRKNAIYDKIARQNGGCNYQYYSYDEQLAMKNSNIEKEVKKIAKYDF
TFEEPVRSVEVEKYRNKMEFSYGNAMKDGPMILGLHKQNSFHDIVEVDGLKLMDDNFNKI
YVFCNEFSKTTGLDFYHRLDHIGFFRNLVIRKADFTKQILVNMVTTTQIEDEKKLEFQKG
LVEGLLALKLENGFEITGILHTFNDNFSDSVVSESEEILFGKRDLEEEILGLKFKISPYS
FFQTNSKTVEKLYEKVLDYLDEIEGENIHNSIVFDLFSGTGTIGQIVSKKAKQVYGIELV
EEAVEKANENAKLNGVENAHFIAGDVFEKLDEFDKNGIKPDIIILDPPRAGVGDKTLNKL
LKYGVKDIIYVSCNPKTFNTDLKVLHENGYELLKMITVDMFPVTPHIEVVSRLKKSI
>SEQF2502_00908 Cadmium, zinc and cobalt-transporting ATPase
MKSNECMLSVEGLDCPNCAAKVERKINTLEGIKEATVDFLGKKIVVLADEISENELVELI
QTEVDKIEDGVKVFVPKVQAGESSSEGEDTGKIKKKLLIGGVLFVLGIFVPKTLFIPKLV
IFLVSYLVIGGDVLLSAFKNILNGQVFDENFLMAIATVGAFAIGEYPEGVAVMLFYQLGE
LFQGIAVNNSRKSIVSLMDIRPDYANIKVGEGIKKVSPEEIKVGEIIVVKPGEKVPLDGK
IVKGASTFDTSALTGESLPREAKAGDDVLSGFINKNGLIEIQVAKVFSESTVSKILYLME
NAGSKKSKTENFITKFARYYTPVVVITALIVAIFPPLLIQGATFSDWIYRALIFLVVSCP
CALVISIPLGFFGGIGGASRHGILIKGTNYLEVLNNLESVVMDKTGTLTKGIFKVTEVNA
ENNIKINDFQNNKTELTKPLLLKYAAHIEKFSNHPIAQSIVSEYENSASKVDENVVKDFE
EISGFGIKVNINNHQFLAGNSKLMNLGNITFDKKENLGTAIYLAADGKYIGNILISDEVK
EDSARAIKGMKENGVKEIVMLTGDNEAIGKNIAEKLGIDKVFTELLPNEKVEKLEEIYKT
KSEKGKVAFVGDGINDAPVLARADLGIAMGGAGSDAAIEAADVVIMNDEPSKIVTAIKIA
KKTKEIVWQNITIAFAVKIVVMALGLFGDATMWEAVFADVGVALLAVLNATRVLRYNPES
SNK
>SEQF2502_00909 Aspartate carbamoyltransferase
MENIISMNDMKKNEILDILRLARKIENCSEEEKLKFLHGKIISTLFFEPSTRTKMSFESA
AMRLGANVLSLPPVEQSSVKKGESFTDTIKMVEAYSDVIVVRHPFDGAARLAAETSKKPV
INAGDGSNQHPSQTLLDLYTILEEKGTLENLKIAFVGDLKYGRTVHSLTKALTHFNPTIY
FVAPQILQMSNYLLEDLKKNGIKYEILEDFRNCLDKIDVFYMTRIQKERFPDVEDYEKVK
GIYVINRENIVGKCKDDMIILHPLPRVDEIDKDLDNTKYALYFKQAKNGIPVRQAMMMAV
LGKDKEFFL
>SEQF2502_00910 Aspartate carbamoyltransferase regulatory chain
MSEGRELLIRAIKNGIVIDHIPSEKVFAIVEILKLKEYSERITVATNMPSSSLGRKGIIK
IEEKILEEKELNNIALLAPNVTINIIEDYKVIEKTKLDRLDKVIGLMKCDNPKCISNHEN
IETKFIRIKEGSEKNNSGEKEKYKCFYCEKVILEDEIQIQ
>SEQF2502_00911 hypothetical protein
MPKILIESKMLENNKNGVLKLRINNERVEELKNVKNEIDLDYGEQILQVYNNFFTKTPKK
VINVESADQKYKITLHYKAWGITAFLHLVMMVLIAIFKSNPLFTVFPIVTIEFLFLIFIG
AFEIREVKRKDS
>SEQF2502_00912 Orotidine 5'-phosphate decarboxylase
MARIDEKAKERIFVALDYDNMEDAKKLVEELGDNISMYKVGLESYLNTDGKLVDYLHEKG
KKVFLDLKFHDITNTVKMACANAIKKNVFMFNIHCSNGSKTMKEVAELVKESKSKSLLIG
VTVLTNLGENDIFEMFKSELKLEEIVLNLATLTRESGMHGIVCSPQEAKNVKEKLGKDFI
TVCPGVRPKFTLNADGKSNDDQTRIMTPSDAIKQGVDFLVIGRPITKAADPVESARLILE
EISEVL
>SEQF2502_00913 hypothetical protein
MRKKVLLLVLGILGAYQLGYSENTDTKNVDTKVETTQDVDVKQDQVNSDETEKAETEKET
ESNQTVETEEKPQTTAAPVQKEAPKAKKLTPAQEKRLEAKAKRNKEKNMSLDEKLDLQIL
KMERLLKSLEGR
>SEQF2502_00914 Dihydroorotase
MTKNKIIILKNGTDVLGNKIEILINGEIIEEISENIDESKFKNNENVRIIDVEDKLVMPG
IIDVHTHMREPGITYKEDFTTGSRACAKAGITTFYDMPNTIPTTTTLENLLEKKKLAGEK
SIVNFGFHFGGSKNDNVEEIKKVLKNGDANTVKIFMNVTTGEMLIEDDEVLKKVFGNSKL
VLVHAENEMIDKAIELNKNYGRGLYVCHIPSAEELKKVINAKRNNELNTKEHPVYAEVTP
HHLFLNTEIRESTERNKMLLRMKPELREKSDNEFLWKAINRGEVDTIGTDHAPHLISEKL
EKITFGMPGVETSLALMINASNEGKISLEAIQKLMCENPAKIMKIEKRGKLQEGFFADII
VVDTQKEWIVGVDDTIESKCGWTPYENWKLKGKNTMTIVNGKIVYENGKINDSHNGKEIN
FLK
>SEQF2502_00915 Orotate phosphoribosyltransferase
MVNLTLEEKVAKALFDVKAVKINVGEPFTFASGIKSPIYCDNRYVLGFSDERDTIVEAFV
ERIDKNVDVIVGVATAGIPWAAFIADRMKKPLAYVRNKPKDHGVGKQIEGAEVKGKKVVV
IEDLITTGKSSLIAVDVLQKEEVKELEVKSIFSYGFDSAKKNYAKYNCKFSSLSNFDVLI
KLLAQTDYLTQDEAKIALEWSKNPEKWGR
>SEQF2502_00916 hypothetical protein
MKKIQFIIIPTILSFGLIISSALISNAMNKANKDENRITVKGVAERRIKADKALINIVIS
EKSENIDELKSSVSEKEKLVTDLIKNLKINENDYNVGNLRIQPNYIENTSNTKQQIAVNS
TAVVPNTKISDYDGVETISIVTKNIDKAEEFFEKLSELKLQSDNIQINEPEYFITNIERY
KKDMVVDASRNAEVRAIEMLKVNNNEIGGLKNMSQGQFEVLEDTEDVRKINENEANQIYK
KMRVVVTATYLIKY
>SEQF2502_00917 Elongation factor P
MKPAAELRQGSTYRKDNIPYLILKAERHQSTSGKRQRAAEVKFKTKELISGKIQEITVLA
TELMDDIILDRNQMQFLYEIDGEYNFMDQETFEQIALRAEDLGDAVNFLEEEMIIQVLMY
EGTPVGVELPNTVIREVTYTEPGLKGDTIGRATKPATIANGYSLQVPLFVVIGDKIKIDT
RTGEYIERAN
>SEQF2502_00918 Deoxyribonuclease
MKNKIIRGLFFVFLFFGVFSCFKKGKINEETGINQDESTVLVASFNALRLGEKQKDYKAF
AQILAKFDLIGLEEVMNEKGVKKTQAYLEKLTKEKWDYIISENSVGSENYREYFAFIYRR
SKFSEARGLGFYKEKDENEFMREPYGAYFKAGNFDFVYIIAHSVFGDKEKQRLLEAASYV
NVYEYFSKLTDEDDVIIAGDFNTSADNMAFKNMLDKYGISYILNPEENLTTLSDSKLVSS
YDNFFINKQKTKEFTGNFGVYNFIKNNNYAIIKKYVSDHLLIFSEYSTLEDLD
>SEQF2502_00919 putative FMN/FAD exporter YeeO
MKAEILNKKLVYKKVINIGLPVAIENMIYALMNFVDMFMVGNENVVLGLGTMAVAGLGFA
NQIFMIFMTSLFGMNSGGGILAAQYFGNKDYKNLKRCLGITVIVGFLFSLLFLFAGLFIP
EAVISVFTNDSKVIKIGADYLRIVAWTYPLVGVGFAFNIQLRAIGKTKYSFYSSVIGLLI
NVVINYVLIFGHFGFPAMGVRGAAVATVIARIISTFYIIYIIYKLKLPIAGKINELFDLS
MDFFIKVMKISLPVFIHEILWVLGASMYVMIFGRMGTDFAAAVQVVKSISSLVLTLLFGL
SSATSAIIGNEIGAGREDKAYDYSIILLKVAILSGVIIGAIVFIFSPFILIHVNAKSYPL
AKEIVKAEVFVIFIKAISLQLLVGILRSGGDTLWTMFTDLIPLWFIAIPITYFSGLYSGL
PVAIVYLLSCSDEVIKIFPCVIRLRSRKWINNLVN
>SEQF2502_00920 Cardiolipin synthase A
MDLARRKKYLLVGILAVFTMSCSTIKTPPLGVDYESPLRDSDNVEFHYDLTYLDKDGNIR
YDRKIWDATYKVVDEAKDYLIVEMFLFNDIYNKDKEHFPEFAKEYTRRLIKKKMENPNLK
VYVLSDENNNLYGAFEHPFVTEMKNAGIDVIVVDIFKLKDTFPWYSPIWRTLIEPHGNPQ
GKGWIGDFYGPMWPKLTLRNLFRALNVKADHRKIFLNEKNVVISSANIHDPSYFHENVAI
SADGEITKDVLNGLQHVAEFSGGKIDVNEKQENKVNNSQIGNLIRNENSGANNLAANNFL
EDENERKVREIEKKREDFVEEETRRFAQTGEFPEKSQESDHQNNMKDGDTITRFDDENNK
YKLQFVTEAKIGEHLDKDIDSTRAGDEILMGMYFLADRGVIDRLIKAANRGVKIRIIFDR
SRDAFGMSTNGLPNKPVSKKLKKKTKNKIEVKWYFTNNEQYHTKITLIKKTDGNVIIQTG
SANLIKKNIRGYIMDANFRILTNKDSKLTRDIYTYFDRLWENKDGLFTVNFDDEPTTKAS
TDFMYKILDATQLGSF
>SEQF2502_00921 hypothetical protein
MKRKIMLVVVILAIGMMSVSCFKKKKNNKKNTQTQQQQQTKDINTDIFNLGGQAQGNPDI
KNLTPEEQQKLIDNQIDPVKVSEALTKAQNGDKESIMSLAQLYYNLKDMDKVKQILQYGV
DRNYPEAIYNLAVILKQEGNTAEANKLIAKLPRGAVTSTGNAGVVGGQRVRQIRMRPGAE
AYNRGVDLIKAKRYKEAKAEFEKAYNAGIKEADVRVALLNKELKNDSEALKWFKKAANRG
VKEANYEIGAILYDGGKQSESRPYLLKAYNSGNKAMAMPIAMSYHQQNNMSEALKWYKIA
AKNGDKNAAATVERIEKGGVINEKKSSEKRVKTFLGNNNSSSLTESTLNDVKSKNKAEES
IKTETKPEDKQPKSQVAKPSEKSEDVNIDEIMKKKAAEYNK
>SEQF2502_00923 S-adenosylmethionine synthase
MAKKIYFTSEFVSPGHPDKICDQISDSILDACLADDETSRVACETFATTGLVVVGGEITT
KTYVDVQKIVRDKIYEIGYRPGMGFDSDCGVMNVIHSQSPDISMGVDTGGAGDQGIMFGG
AVNETEELMPLALVLSRGIIQKLTKITRDGTLAWARPDAKAQVTLAYDENGKLLNVDTVV
LSVQHDENVTNEQIEKDLKELVIKPVLEKYDLNIENVRKFHINPTGRFVIGGPHGDSGLT
GRKIIIDTYGGYFRHGGGAFSGKDPSKVDRSAAYAARWIAKNIVAAGFATKCEVQLSYAI
GVVEPVSIRVETFGTGTVEETRIEEAVAKLFDLTPNGIQKSLNLRKPSFRYQDLAAFGHI
GRTDIDLPWEKLDKVEELKKELL
>SEQF2502_00924 Oligopeptide-binding protein OppA
MKKNIFFTLIIFVFLLAGCSKNSKNNKETVVFNLGSDYNTLDPHLFTEMIAVQVDSSIYE
GLLRLDEKGNYTGGVAKSFKESGNKLIFKLRDNAKWSNGQKIVANDFVFAFKRVLNPKVA
AQFSEMLFPIKNAEKYYNGKVGADALGVKAIDDETLEIELEHPTAYFKYILTLPISVPLN
QKFYESRENKYAVKLDDFLFNGPYKITKLQEEEILLEKNEDYWNAKNIKIPKIKYVISKD
FRVVDDLIKNKEIDMSRVEPYSLSKYKKNKVLDTYFNGRVWYLDFNLSNKYLKNSKLRKA
ISIVIDRKKYVNEIKKDGSIVAKSIISNEISGYSKKYRESYPDKDYFKDNDIKTAKKLYL
EALKELGVNRLRLRLLSGNSDPEVKEIQFIQEELRTKLGLETDVSTVPFKERLSKTRSGD
YDTVLNTWSPKYDDALSYLDRWKKDDNLNMNVWSKAKYNALVTEISKIPSSKERDKKINE
AERILIDENVISPLYFSVENHYRNPKIKDVVRRSVTGIADFTYAHFLK
>SEQF2502_00925 hypothetical protein
MAFDFKKEFKKFYRPSEKPEIIEIPKMNFIAVRGKGNPNEKEGEYQKAVEMLYGVAYTLK
ISYKTEYKIEGFFEYVVPPLEGLWWQENVENENYLLNKELFNWISLIRVPDFIKEEDVEW
AIKCATKKKKKDFSKVEFFSYNEGLCVQCMHIGSYNDEPKTIQRMNEFVQESGYSIDLTD
KRHHHEIYLSDPRKADINKLKTVIRQPVKK
>SEQF2502_00926 hypothetical protein
MNILLEIQNEEWGQRHFIFEGPDNLLIDVIQIIKPTEEFLKQYKQIDKGGIIMKYEIVEI
KEKTLVGFKTRVKDDETMSEKISNLWEKLYSEKGAKNIKDRTNNNAIGVYYNYSNENGFE
YDCLTGCEVKNKIDEIPEDMTSLEIPEGRYAKFVIFGDPVKAVGEFWYKFWEEFGKEKSD
IRNYTYDFEEYIAGNHYENMEIHIYISIK
>SEQF2502_00927 hypothetical protein
MLNSFYPVILSNNIEETGNFIKKHFNFKETFVSDWYISLKHENNFEIAIIDKNHETIPER
FRQQSKGIILNFEVEDVDKIYERISEDKI
>SEQF2502_00928 hypothetical protein
MIKFGKKYKNNNMPYILNINDNVDNVLKIIVSLPYSGEKGSEASNAGNKDLDEILKKAYP
ILIDYNEIYEITFESYIMYQTRNESFAYPDENSNVLGEYFTIIKNSSYLKMVENITFYYD
MFGDKYTHYGILSWNHVVDIISAEKPKIVKLENYAEE
>SEQF2502_00929 hypothetical protein
MKINRLFEIIYLLLEKRTITAKELAAHFEVSIRTIYRDIDILASASIPIYFQRGKHGGIK
LMDNYIMNKSLLSQKEQNEILYALQSLNATNYFNNDKTLSKLSAIFNQKADDWIKIDFSR
YNNDDDNTLFEKLKEAILTKQTVKFDYFNTKGKHSERTADPLTLWFKEKAWYLFAYCHKK
NDIRQFKITRIKNLTLTNEYFEKTIKDFEINNKKNTVENIKIIVEIDKSQAYRVYDEFSE
ESINKMENGDFEIIMEYPENEWIYGYLLSFGEHLKVKEPERIKKILFEKISKMKENYV
>SEQF2502_00930 putative endopeptidase p60
MKKILMLAGALIISAVSFADLESTIKNHYSNKTIDLTVVSKPRQEVTSSGAASTAVRDQI
ISFAQTKLGSPYVWGATGPNTFDCSGFVGYVFKKAANVSLPRVSSSQATFKPRISSMNMT
KGDLVFFETTGKGRISHVGIYMGNRQFIHASSGSRRVTVSSLDSNFYNKTFRWAINPFS
>SEQF2502_00931 hypothetical protein
MKKFILIGVAAISILAAADVNTKKILEEYRKEALKREAAPKPEKIIKKRINVDSITGTSG
TAVEDENVAVEVVEEGTQATPDIIEKVNFYLRNNPEKRQKLERRYRAVVGQE
>SEQF2502_00932 Cell shape-determining protein MreC
MDFSEKKGTGRTILIIIIIVIILFAFKNRITSSFTFLDGVTQAVNFRLVKVKSMLYTQIL
KLKSRINDISYIEEYVENNKNRDFELQKNKVQNMEFAYLKGENEKLRQMLEMRQKNPSEF
IAADVALVESGNSSEKMYINKGSAQGIKINLPVMFNGYLIGKVSKVSDEYSEVTLLTSKT
SKLSVVLNGTDQQILRGNGNGTFSILNYNEGKVDKNTVFDVETSGVSDILPRGLKIGSLK
VTNLNDFNKMKEIRFKPSFNVFDIQSVLVYKWSVNDVINTHIQNQVKAEEEQQNKENSQI
N
>SEQF2502_00933 hypothetical protein
MLRQLTVAKKVILLFLLVSVFSFSKDFWEKRNFTVNVTEDATINGRKRSKSYVMAYNSGT
MKLTITAPSVNKGEVYTFSGSKKTIYYPKLKQTVTQRVEKSEASILSVFNKLRGITSKKT
QTRNGDTFTFSNNWLTAIRSNGNTVNFSDYKSSNGYYFPTKISVKDGSSQIIYRLSNFR
>SEQF2502_00934 DNA repair protein RecO
MKIIKTNCIVLKKKEMKEADLLVTLFSKYYGKIMATAYGIRKSKKRNIVSLNPLNEVEIT
LLQRNNYYVVKDVEIIKNFKNILKNIEKLEISLYILDSIDKIYYMTEENGDFFDKLVEIL
SFIDALPYVKKGYKYYVTLSFLRRIMIEHGIYDINEISIMIGKNKEENIQKYRELLKIQR
NSANMNETQEKMENYISFLKKMIVIFENFINRNLQTELEIRKFIMEEFYGN
>SEQF2502_00935 PTS system fructose-specific EIIABC component
METKNIADYIKVDTINLNLESKNKSAIIKELYNNLKKTNLIKDEELGLNDIFAREEMGST
GIGRKIALPHAKTKAVDELIATFGISRNGIDYESLDNENVNIFFMFLCPEDKTQEYLKVL
ARISRLIRKDRFIDNLLKAGSNKEIIEIIRDEEING
>SEQF2502_00936 Transcriptional repressor NrdR
MRCPFCGYENTKVIDSRAYFEGNSIKRRRECEKCGKRFTTHEKVAELSLIVIKKSGIKQP
YSREKVYNGIVRAFENRNIDIEKIEETIDKIEREILTEYSGEIKSSELGEKILSYLINLD
EIAYVRFASVYKKFDSLDSFIKEIEKIRKDKK
>SEQF2502_00937 hypothetical protein
MKKLQFIGNFIFFSLVVYFMGQSVNVFLGKKAMLASLTTTDNEIKELQNRKNKLLAQKKN
SDEDEKNEKYARNNLNLKKEGEEIYKTTE
>SEQF2502_00938 hypothetical protein
MMNNFMNIENLKNKLDKYEIKDEKSKYIFRANFKYMISSSIFFIIIAAIAIHSLYKGISG
AERLTFIKIIFIVILLGYVVVAVFLLFNFKIVIENNEIFLRKIHISMENIESASVKIMRV
NSSKVDKFLEIITKDKKKIQIRLNINNELLFLKLIQNQIGEKMDIQSI
>SEQF2502_00939 Putative serine protease HhoA
MDIKKIVFIINLLLCGFIFADDSSVKKALVKVYAAHQMFNYASPWQNGQDFNSTATGFII
DGNRIITNAHAVLNEKFLQVRKEGDSRKYKANVKFISEEYDLAMIDVEDKAFFNGTTTLK
LGALPKIEDNLTVYGYPLGGDKLSTTRGIVSRMEHNTYTLTNQKFLIGQTDAAINSGNSG
GPVLSNGRVVGVAFAGLTQADNIGYFIPVNILNNFLDDIKDGNYDGPPKLGIQWAKLEST
SQRKMLGLKNDSKGIIIKKVFQNSPFNGVLKRGDVLLKLDGKDIESDGTVEFRKNEKTDF
NFVNQEKKYGQNLSYEIIRDKKIEKGQVTLKKTDIKYSVVKSTKLQEAPSYYIYGGLIFE
PLTTNYITSVSQEHPTDTLPAIYDREELFKDYDGLVILVRVLPFDVNLGYSDLENKIITK
INGEKYKDFNDFVKKVKNTNSEFVIFEDEEGNEIVLDVAEVKAQKEALMENYNISHEMSS
DVK
>SEQF2502_00940 Lipoprotein-releasing system transmembrane protein LolE
MVEFFIAFRHIVERKFQSIFSILGVAIAVTVFIVSMTISNGLNKNMINSLLTMSPHILIK
NKKTTFFENFGETVENIKKIKGVKAVIPQMNSQSILKNEGLAKGVLADGISPENVKNELN
LRIVKGNNNISELNSVLIGEQLANEMDLKVGKEISIVSAENKEIKLIVRGIFKTGFLDYD
SNLVIVPLETMQILSDQGKVATEIGIKIEHPERVDEVLNQVRNAVDPKEYGVISWKTINQ
NLLKAVQFEKFVLIAILSLLLIIASFAVSVILNMIVREKIKDIGILKSIGYTNKNVRRIF
TIEGLIIGVFGMILASCLSPLVLIALKALFKEYMKGGTYYLEELPLYISQKELLIIYGVT
FVVVFLSTIFPAARAARLKPVEALKYE
>SEQF2502_00941 Lipoprotein-releasing system ATP-binding protein LolD
MNKIIELKNVNKIYKTKVENIHILKNINLAFNKGDFISIQGKSGSGKTSLLNILGLLDEP
TDGEIYIGGEKIHYRDEKAKTAIRNEKIGFVFQFHYLLNEFTALENVMMPALINKNMNKN
GIKKKAKELLALVGLAKRTKHKPMELSGGEKQRVAIARAMINDPDIILADEPTGNLDTET
SNLINELFMKINKERNQSIIIVTHSLELANLATYKYKIENGEFNMILPTIQF
>SEQF2502_00942 hypothetical protein
MKKLLILASALMLMVLSCGNSGSESKSSGNAGTGSKKYRIGITQIVSHPALDSAREGFKA
AFKEAGVNAEFDEKNANGETTNSNLIANNFVSSKEDLIFAIATNAAQSVSQATNDIPVVF
AAITDPQSAGILKNNVTGVSDRMDVKQQLELLKKIGPNIKNVGVIYNSSEQNSKIQVEDL
KKAAKELGLNIVEKSVVQANEIPQTVDNLVREADAIYLPTDNLVASVVSLITDKATAAKK
IVFGAEAAHVKGGALITQGVSYYEIGKEAGKMAIEILKNGKKPSEIKFKTMPLNEIVVNG
KTLAALGISLPEDVKSKAKMVQ
>SEQF2502_00943 hypothetical protein
MKKILLMMIGILMLACGNSNDTVNGKKDSKDSGNKQVYKIGITQFMEHPSLNLTKEGFKA
AFKEAGINADFDEKNANGEVTNANLIATNYKADKKDLVFGIATPSAQALVNNISDIPVLF
SAVTDPASAKLLNPNVTGTSDKLENVAAQFDLLLKIKPGTKKIGVLYNPSEQNSAVQVQE
IQKIAKQKNIEVVLQGINNFGELAQATKNLLGSTDALYLPTDNLVVSGMNLIASEAVNAR
KPVVVSENSSVKEGALFTMGLDYYALGKRTGEMAIEILKGKPVSQIPFETSKQMKLYVNS
KTAQALGLDVKNPAFSGAEFVGK
>SEQF2502_00944 hypothetical protein
MNELLVFLQSLPEAFKTGFIYSIMVMGVYLTYKILDFPDMSVDGTFPLGGFVFAAFALSK
NGFLGITSPVMGLVLAVICGMVAGYVTGALHVYLKINGLLSGILVMTGLYSINSRIVGMP
NVFITPDRSIYEIISYKKDFIPFVIIFVILLVLKGLYDYKIKENKYMIRTLAVYIIFTIA
LIIYVVKTQDVKLMLTVLIAFIIKMIIDYILTSKFGFALRALGNNEQLVVSLGVNEKRLK
IFGLMLANGVVALSGALFAQNIKVADLQSGVGTIVIGLAAIILGLGVMKKSRVINEVSIV
TIGSLMYYFIINLALMSNSWTRSIYESLHFSDDVIKILEVKPTDVKVITAVILAVILWNE
LINKSKKGKKKVKLIEKGEA
>SEQF2502_00945 Methionine import ATP-binding protein MetN 2
MIELRNLYKTFFSELGTEKQVFKGLNFTINDGDFITIIGSNGAGKSTLLNVLNGQVIPDG
GNVILNGKDITNVVQHKRAKWISQVYQNPTMGTAPSMTVLENLSMAKNKGKRFNFTFGLD
VKNIEFYKKQLESLGLGLENQLYTQVGLLSGGQRQCLSLIMATLNRPDILLLDEHTAALD
PQTSEIILEKTKEIIEKNNITSLMITHNMQDAITYGNRLIMLHAGEVIFDIKGEEKKKLT
VEKLLEMFRTKDAKLSDKDIF
>SEQF2502_00946 Exodeoxyribonuclease 7 large subunit
MEETGKVMEQTVFSVSEINREVKMFLEGTRTFKNIFIEGELSNITYYRSGHLYFTLKDSS
ASVKCAIFRYKYRNVPEDLKEGDSVKIRGNVTLYEANGSYQIVADFLEKSNSLGLLYEKM
EILKKLYFEKGYFSDEIKKKLPQLPINVGVVTADTGAAIRDIINTTHKRFPNVNIYLYPA
KVQGEGAAHEVSAGIEFFNRMNEEKQLEIDTLIVGRGGGSIEDLWAFNEEEVIEAVYKSE
IPVISAVGHEIDNLLSDLVADKRAATPTQAAEILIPEKGKLADELENKKNLLSKSLLNRV
AMMKKELEYRKNNYYIKNFANILDNKKFDLMEKEQKLSRELKRILQKSKEQLDYRKQRFD
RINLEKVILSEKENLRGKLAKLNEIMLEFFENRKNELKYKKAQLSKYSVNDILKQGYTIT
RKNGEIVKRGIELSKEDKLEIQFLDVRKKAIVK
>SEQF2502_00947 tRNA-specific adenosine deaminase
MSKRQDYLSWDEYFMGIAFLSGMRSKDPSTQVGACIIDEDKKIIGIGYNGFPQGSSDDEM
PWDREGDFLETKYPYVVHAELNAILNSIKSLKNCIIYVTHFPCNECAKAIVQVGIKKVVY
FSDKHKSLDSTKASRKILENAQVEMVHLEVEKEEINIRFKG
>SEQF2502_00948 hypothetical protein
MEATAIKKVVAMGIGAAVYIVLSRFVAIPTPIPNTTLQVTFAFVALMAFIYGPAVGLGIG
FIGHTLNDISGYGNVWFSWVIASAFFGMGIGFLGKIIKIENFNGAKIVKFIVGEVIISLI
SWVVLAPIIDIAIYKEPQAKAFAQGVVAALGNMLVVAILGTILIFAFSKTIISKGSLKEE
>SEQF2502_00949 Putative HMP/thiamine import ATP-binding protein YkoD
MEEKEKKEERKIAINFENFTFKYESQSKPTLHNINLKIYEGEKIVIVGPSGSGKSTIGHC
INGLAPYFYKGEVSGKLEIYGKKCKEIFEHSKYIGTVLQDSDAQFVGLTVAEDIAFALEN
NEVETAVMKEKVKEIAQFVRIETLLDLKPHDLSGGQKQKVSLAGIMVDNAKIVLYDEPLA
NLDPLSGKYAIELISELHKDKKLTTIIIEHRLEDVLHREIDRIIVVDKGRIIADDTPDNI
LKGNLLSKINIREPLYISLLKYSNDNLERCDNISIFERIDFSTAKENILNWIKYNSSPKK
AESNKTLLKLENISFSYDEKRKILKNIDLTIKKGEMISIVGSNGAGKSTLSKVIAGFERQ
DEGKIYYKNLDISNESIAKRAEKIGFVLQNPNAMISKVTVFDEVALGLKTRGVLEDEIEK
RVIEILEICKLKPFRKWPIKALSYGQKKRVTIASVLVLEPEIIIVDEPTAGQDLFHYREI
MEFLKRLNEYGITILFITHDMHLMLEYTDKAYVFNEGKIIKSGNPSQILADRNVLKQANL
RETSLHYVAEKIEINSEELISTFVHYEKNCEKEQKKAGG
>SEQF2502_00950 Energy-coupling factor transporter transmembrane protein EcfT
MENTFLLEYIEKDSVIHRLNGAAKLICFILWTVAIMLTYDTRFLAALTLLGFVLFKISKI
KFNEIKIVFYLIAIFLVLNLIMIFLFSPFEGTKIYGTRHDILKIFGNYVVTWEQLFYEFN
IFVKYFSVIPVALLFIITTNPSEFASSLNRIGVPYKFSYAVSIALRYIPTVQEDFIIISK
AQQAKGIDISKNVKLMTRIKNVSYTLMPLIFSSIEKIDIISNAMILRGFGKRKKRTWYQA
RKMKVADIVAIIVTAIFVGTSIVLVKVNGGRFYNPFV
>SEQF2502_00951 Uracil-DNA glycosylase
MVNIGNDWDEIFKNEKEFEKDYYLNLRKFLISEYKTKTIYPDKYEIFSAFKLTSYKDCKI
VILGQDPYHGENQAHGLAFSVKQGVALPPSLKNIYKEIENEFGYKMSRNGFLESWAKQGV
LLLNTALTVVAGNANSHSKIGWEIFTDNVIKYLNRREDPLIFILWGNNAKSKKAFIDTDR
HYILESVHPSPLSASRGFFGCGHFKKANEILKELGKDEINWQI
>SEQF2502_00952 hypothetical protein
MNFRKSTFDDIDIILEIIEKAKAELKKMGLDQWQKGYPNREVIESDVKKGISYVLEETAE
NNEKPGEKVSGKIVGTIVLSPEKEEPYSKIEGKWITDDDYMVVHRLAVDSDVKNKGLATK
ILEFSEGVCIENKILSLKADTHENNEPMKRLLAKNGFSFCGLICLDREPDLGAKRIAYEK
IIKIPHKLL
>SEQF2502_00953 Cystathionine beta-lyase MetC
MKFETKTIHGVREGKKKELWGTNVNFASTFPVAEFGVTQEFEYSRVSAPTRNELEEIIAA
LENGKYAYAFSSGMATTTSVFTMFSAGDHIILGQDIYGGTYRVLHDIYSRFGIESTFVDT
TDLENIRKALKPNTKAIFIETPSNPLLDVTDIRGVVKLAKEHNLITIADNTFMTPYLQKP
LDFGIDIVVHSATKFLSGHHDLLGGVAITNDEELAEKIKFSQVAAGALISPFDSWLLMRS
LKTLKLRVQAAQENAKKLIEFFQKHDAVDKIYYPTLDTNKGKKIHESQATGGGSVFSFTL
KDDSKVKTFFESLNVALFAASLGGAETLVTHPSTITHAEMPEEEKEARGFTHSLIRIAAG
FENIDDLIADFKQALEK
>SEQF2502_00954 SPBc2 prophage-derived endonuclease YokF
MAKKIDDGKSQIVLIAAIIIIAAVMISGMFSKGGKGSEKSAGKAKNVKISQNNGKKISKT
KKSKEKKEVEPEILDGYQVLKVSDGDTINIQKVENGKFVGEMLRIRMYGMDAPEKTQDYG
SESRQALEKLVTGKNLSVEVKNKDRYGRIVAIIYANGKNVNEEMVKTGNAWWYQEYAKKD
TQFEKYQENAKQKKLGLFSRKGYTEPWNYRKEKKAAASSRTKSK
>SEQF2502_00955 GTPase Obg
MFIDESVITVISGKGGDGAATFRREKFVQFGGPDGGDGGKGGDIVFIADPNINTLVDFKS
SKKFKAQDGTKGAAARSTGKSGEDLIIKVPVGTMVRDFETNKLLLDLDIPNEKVIFLKGG
DGGRGNIHFKSSVKKAPRIAESGREGAELKIKLELKLLADVALVGYPSVGKSSFINKVSA
ARSKVASYHFTTLKPKLGVVRMGDEESFVVADVPGLIEGAHEGVGLGDRFLKHIERCKLI
IHIVDISGLDGRDPKEDFLKINHELKNYSEKLSKKRQIVVANKIDMLYEDEKYDEFEKFV
KENGAEFVYPVSVIANDGLKPVLSKAWELIQEIPREELEEVYSVEELISENNKKEDWIIR
KISDNAFEVDGRIVDDVLRKYVFIGEEGIINFLQKMRSLGMETELEKAGVEQGDIIIIAG
YEFEYVI
>SEQF2502_00956 tRNA dimethylallyltransferase
MSIRLAKKINAEIISADASQIYRELNIGTAKITDEEMQGIKHYMIDVVNPCEDYSVGDFE
RDVNNILNENSQKNGKSIIITGGTGLYIRSITDGFAKLPSKDEKIRKELESKSLDELQET
LKKLDEKSYEEIDLSNKLRLVRAIEVCLLTGGKFSELRTQNIKDNNYEFLKVFLTRDREE
LYDRINRRVEIMIAKGLVEEAKKVYNRHTEKLYKISSIGYKELFMYFDGKISLDEAVAEI
KKESRRYAKRQMTWFRREKDYIIYNLSRMSENEVLDMILKRWENFRKEIN
>SEQF2502_00957 PTS system fructose-specific EIIABC component
MKILEYLVPERVNLDLKGTTKAETIKEMAQLFVKSGIIDSEDFEEFVSEINEREKLTPTG
MQDGIAIPHARTPLVKSLSLAMGISSKGVDFESMDGEPSKLIFMIAAPEGTKKEHLDLLA
EISKLSFEEELVEQLEEVKTIEEIFEKLKNI
>SEQF2502_00958 hypothetical protein
MKKTIFFLVGIMMVSSIGFSAEKKSLESNLNSIESQFNELMKKEEAQKQSYIQQKAQLEA
EVEDLKEKQTSREKLVEKLKVDSEVRWHRDKYKKILKNSETVYKNINKSIAEKEKKIAEL
DALLSVMN
>SEQF2502_00959 hypothetical protein
MKAKKLVLCGIVAALSVPMMADSAQNVLKQAREDYYKSLKAPKEREMTTEKLVTIDEDGV
VEEKERVKPKSSIEKLEYNAAKAATRVDFYERVVRSVQREEKELGEFDSVLGRDGVKNAP
KKTRRVK
>SEQF2502_00960 hypothetical protein
MKKILGLAAVMVLAMSQLSFSAKSDTDAAVQRLVRVAKQRQAKQAKDAAKGVAVEEEVVV
VPVEETVTTSDTAVQDARERAEAARAQAQERAAKAREAAQQRKTKTRDIRAQRRNMSESK
MMDVEIQRIRKRVDQINSNIEKFHKTNEMLDQMEQRLDAIQDRMN
>SEQF2502_00961 hypothetical protein
MKKLALILLGLGALSCTNAKLVDYNTTRLNHIEDYLDENKPNPGSHKYRSLEREAEKWVD
EQQPQQQQ
>SEQF2502_00962 Outer membrane porin F
MGRRTTTTTTTIIALGLLVASPLMARRLTTTQMRENTIRINALELEEPAPEPIPEPAPEP
KKDDTWVFDSGKLNFDFDKSVVKPQYFELLRNVKDYAEQNDFKLTIIGHTDSKGSDAYNM
ALGMRRAIAVRDKLIEFGLDPSRILGVESRGESEPIATNDTPEGRFENRRIEFKATK
>SEQF2502_00963 Calcium-transporting ATPase 1
MWFTKSSKDVLKELNVSAETGLSTEEVKRRLEKYGPNKLKGKPKKSLLQLFLAQLQDMLI
YVLIGAAVVNIIAHGKDGIADALIILAVVLINAVVGVVQESKAEKALEALQQMTTPKSLV
RRNGEVIEVNSEELVPGDILVIDAGRYIPADVRLIESANLQIEESALTGESVPSEKDANF
ITTDAKIPIGDKENMAFMSTMATYGRGEGVVVETGMNTEIGKIAQILDEDNNTLTPLQIK
LEELGKILGYGALAICGIIFVIGLIQGREAVEMFMTAISLAVAAIPEGLVAIVAIVLSLG
VKTMSRKNAIVRKLPAVETLGAVNIVCSDKTGTLTQNKMTVVKTYTLDNLRDISSQDGQK
ANNDETELIRSFVLCSDASVENGQDIGDPTEVALIVLGNKFDLEKNALNAKYKRVSENPF
DSDRKLMSTLNEEGGKYRVHTKGAIDNILTRANKILVNGEILPLTEEEKNKILKVAEEMS
DDALRVLGVAFKDVDSQILPEEMEKDLVVVGIVGMIDPPRTEVKDSIVEAKKAGITPIMI
TGDHKNTAVAIAKELGIATDISQSLTGAEIDEIPDDKFAKEVNKYRVFARVSPEHKVKIV
KAFKEQGNIVSMTGDGVNDAPSLKFADIGVAMGITGTDVSKGASDMILTDDNFTTIIHAI
EEGRNIFNNIKKTIIFLLSCNLGEVLCVFIATLFGWAIPLVATQLLWVNLITDTLPAISL
GMDPGDNEVMTRKPRDPKESFFSEGAGMRSIVGGVLIGVLTLVAFYLGIIHSGTVPISVV
KDSNPATREILTYGRTMAFIVLTFSQLFYSLSMRNSKKTIFEIGFFGNKFLIGSIIIGMV
LQIGLTSIPSIAQMFKVTAIDSSHWGMVIGLSLVPFIVNEIIKVISRRNND
>SEQF2502_00964 DNA-binding protein HU
MSKKEFVDAYAKATGETKKRAEELVNAFLETTEESLVKGESIQFVGWGTFEVKERAAREG
RNPSTGAPIKIDAKKVVKFKVGKKLADKVAEAK
>SEQF2502_00965 DNA polymerase IV
MKKKKIYLHYDMDAFFASIEQRDNSELRGKPIAIGYGIVTTASYEARKYGVKSAMPTIQA
KQLCPNLIVVNLRKGVYFEEGRRIQELIKKVLEKCEFTSVDEGYIDITKFIRSENVKLNK
IDEILKIKKFIKRFKKYIFDNSRLTCSVGIGFSKISAKIASDIDKPNGYFIFKDRDHFLD
YIYDKELGIIPGIGKKTREILKLFSITKVFQLYEIGKNELIRRFGESKGEYLYNSIRGLH
ISEINTGRKRQSYGHEITFHREENDILTLHAELKRQSKRLSDKLIEKNEFAKTVTIKIRY
SNFITHTRSKTLKSATNDVNTIYEATLENLEFFKKKNEVRLIGVQLSSILKSNVVQLSFD
DLK
>SEQF2502_00966 Cytidine deaminase
MDLVDFDEEKKEILGYIDEVNLLLERAYVPYSKFPVAALLIDNNGKKYKGVNVENASYGL
TLCAERNAITTAVTGGMKKIKLLVITGNTPEPISPCGACRQVIREFSDKDTVIILANKDG
KYESTSLEKLLPYSFGPEDL
>SEQF2502_00967 hypothetical protein
MKKIFLVSILSVIFSAISMGATFITSSKDNAINIRQAAGTDSKVIETIKNGHILESSEKS
GEWYKVTYYDSDIKKTFTGYIHNSQLKEIVGKLVITSSEGYSNIREKPTTKSTIKTRLKT
GQTVYAISKTADDWYYIRYNGNEYGYIYSNQVAKK
>SEQF2502_00968 putative ABC transporter ATP-binding protein YbiT
MISTSNLSVQFGGRKLFDEVNIKFTEGNCYGIIGPNGAGKSTFLKVLTGELDSTSGEVII
EKNKRLSFLKQDHFAYEDEEVLNVVMMGHAKLYDIMMQKNALYAKTEFTEEDGNLAAELE
GEFAELDGWEAETNAEKFLVGLGIPAEMHHKLMKELTEPEKVKVLLAQAIFGNPDILLLD
EPTNGLDLHAVKWLEDFLMDLENTTVLVVSHDRHFLNKVCTHIADIDYGKIKMFVGNYDF
WYESNQLMQELIRNQNKKMEQKKKELQDFIARFSANASKSKQATSRKKQLEKLQFEDMQV
SNRKYPYIEFKPEREAGNNMLKVENLTKTIDGEKILDNISFTVNTGDKVVILSKNDIAKT
TLFQILAGELEPDSGKVEWGVTTSQSYFPKDNSEYFENVDLSLIDWLRQFSEDQHEEYVR
GFLGRMLFSGEEARKKAKVLSGGEKVRCMLSKMMLSNANVLLLDNPTDHLDLESITSLNK
ALERFDGTILFTTHDHEFIQTIANKIIEITPKGILEKEMEYDDYLNDETVETRLNKMYRL
>SEQF2502_00969 Histidinol-phosphatase
MNKTNFHTHNYRCEHAAGNVEDYVKVAIKEGYTELGISDHAPMPEYYENNRMKEENLDGY
LKEIEEAQEKYGDKIKIYKSLEIEYFPEFLEKYDKYRKKLDYLVLGLHAFRKPGDNTNYN
AWKIKTGEDVLNYAKYMAEAIESGKFDYIAHPDLYVINYRNWDESCERAAHIISEAAEKM
NVPLEVNANGIRKSFERHPDWDRYMYPYKEFWDIVKQYNVRTIIGSDAHDFNRMEDKEME
IAREFAKEIGLNVIESIF
>SEQF2502_00970 ADP-ribose pyrophosphatase
MIHPTTGITLEYLDKSNAVCFVLFNETKEKAILVKQFRPGPKDYTLEVCAGLIDGDEDPR
TAAFRELREETGYLEKDIVDVEELPQGLYVSPGYTTENLYFFSGRLKSDDIEPLEQSLDN
GEDVKVVWVDVKDILKLSNDMKTILAIIYFSRKK
>SEQF2502_00971 Magnesium transporter MgtE
MDQNDKINLDKENIDINADIDTKKITQEESTQLNVEKLKDEIRNRMSEEDVQNFEEEEEA
SPEEMAEEIQKIETEKELEEYFEDNHSIDIAESFEELDDDELLRVFKLMSDENKASVLEQ
ADEELQTRIIDLLSDEEDIDILGYMSPDDVVDILGYIDIQKSKSILDKMKRSQANKFREL
LGYEEDTAGGIMTTQYIAFKQNLEIKDVMAKLKIIAPKTEVIETIFVTNEKKELVGEADL
RDILISSEETKLENIMDENIKYVYVEEDQEEVARIVSKYDLHVIPVINHKKNILGIITVD
DIIDVIQEENTEDILKLGGISEEEEIDSTFLFSVKQRLPWLVINLATAFLASFVIGLFSN
TVEKVVILSSIMTIISGMGGNAGTQALSVTIRALALGEVDLKDTIGIIGKTLLVGAINGA
ILGLLCGGILWALYGNFYMGLIVFLAMIGNLVIACMIGFLIPVTLKALKIDPAMASAVVL
TTATDCFGFLIFLSLATVFLNKLT
>SEQF2502_00972 hypothetical protein
MQINLPLPTIILILYIIYVIFSIIMNKIKFNAENLEELDGEFIFTFIPKIKKQQIYFNIN
EVKLCILTRIFIRQGTFKTINFNILLNDGYSLRLKKKRECLLFLKVCREKKTELYQKILS
MIPADMTVISILEKELDNFKG
>SEQF2502_00973 hypothetical protein
MEVNISEKNVKIRKKWDIIRRIVAIVMTRLAA
>SEQF2502_00974 hypothetical protein
MTLTCFARKCEIRSQSKILDMLDYLYRLNWANVEIKLEGYDKIVDEGILYFSRLALEWVV
QEGKSIEEIIIHI
>SEQF2502_00975 ATP-dependent 6-phosphofructokinase
MKKIAILTSGGDSQGMNTAIRAVTKAAINKGMEVYGIKRGYKGMLEDQITPLTLLDVSGI
ADKGGTILLSARLPEFKDPEVRAKAAANLKKYGIDGLVVIGGDGSFHGAHYLYEEHGIKT
IGIPGTIDNDIAGTDYTIGYDTALNIILDAISKLKDTATSHERTYLVEVMGRNCGDLALY
SAIAGGASGVMIPETESSIDDLAEVIKKRRAEGKLYDIIVVAEGVGNVVQLKEELSKRID
TSIRVTILGHIQRGGAPTAFDRILATRLGVRAVELIEEGKGGLMVGIQSEEVTTHKLSYA
WENYSKASAADYAIANMLSL
>SEQF2502_00976 Pyruvate kinase I
MKIKMTKVVCTIGPKTESVEMLTKLVESGMNVMRLNFSHGDFAEHGQRIKNIREVMKKTG
KEIGILLDTKGPEIRTGKLEGGNDVLLETGKKVIMTTDYDFVGNASKFAVSYPGIVNDLK
VGSTVLLDDGLVGLKVEAINKEAGEVECVVTNTGELGETKGVNLPDVSVGLPALAEKDIA
DLKFGCEQGVDFVAASFIRKASDVAEVRKVLDDNGGKNIQIIPKIESQEGVDNFDEILEL
SDGIMVARGDLGVEVPAEEVPFMQKMMIRKCNKAGKPVITATQMLDSMIRNPRPTRAEAG
DVANAILDGTDAVMLSGESAKGKYPVEAVKMMATISKRTDEFKKFKPVETPGADISVTEA
ISSGAVSTTQSLDAKLIVCWTKTGRSPKMIRKYGPTVPIIALTDNEQTARQLALVRGVRA
YVEKGLDKTDDFFAKAREIAANHEEAKKGDLVVLVTGISKEGTTNTFRVERVGE
>SEQF2502_00977 Recombination protein RecR
MKKLDDLIDVFAKLPGIGRKSAARIAFDVLDRSEADVDRMLEIIKDSHTNIKHCKICGNL
SENDICEICTSKKRDKEVICVVEGVRDVIAFEKSETYNGLYHVLGGKIDPLNGVTIEDLN
LRKLMNRLDGSVKEVILALNPDLEGETTSLYLTKFLKEKNVKISKIASGIPMGGNIEYTD
MATLGKSLEGRVNVDDAD
>SEQF2502_00978 PTS system EIIBC component
MDAKKTAKEIYQILGGKENIASNAVCMTRLRVKVKNEVDLEKLKKVDGVLNVVNAETLQI
ILGPGKVNAVGDEFSKLSGIALGFSDSNVKDVASENKKVNKQKHNGPVQRFLQKIANIFV
PLLPGIIASGLIMGLTNVINVATKNAYNTVWWFAAIRSIGFVMFGYLAIYVGMNAAKEFG
GTAVLGGIMGSIFITNPALPLLLKVEDKSAVILPFTGKPFAPGMGGLLASLFMGIVVAYL
EKNIRKIVPVMLDTFFTPLLTLIIGVFIALIIIQPLGTVVTGFIFAILDFSYKKLGILGG
YILAAGFLPLVSVGLHQALTPIHTLLNDPTGPTKGINYLLPILMMAGGGQVGAGIAIYIK
TKNQRLKNMVRDSIPVGILGIGEPLMYAVTLPLGKPFITACLGSGIGGILAVLFHLGTIS
QGVSGLFGLLIVVPGTWIYFIIAMLGAYAGGFALTYLFGIDDEKIEEMYGK
>SEQF2502_00979 hypothetical protein
MRKLGISIYPGKTTEEELISYIDKSFEAGFSRIFSCLLSSTEDKEIILKKFKKVNYYAKE
KGFEIILDVNPRVFDDLGISYDDLTFFKEMGADGIRLDIGFTGLQESIMTFNKENLKIEI
NMSNDTHYINTIMDYRPNKNNLIGCHNFYPHIHTGLGLEFFKKCTENFTKYGLRTAAFIT
SQSKNSFGPKPVTQGLPTLEMHRNLPLIVQFKHFIALETIDDIIISNCYPTDEELEEFKK
VRKDMVSFSIELEKNVPEIEQKIIFDEFHFNRGDISENLIRSTNSRVKYKKHNFKIFNAP
EIIKKGDIIIESSEFGHYAGELLIAKTEMKNTGKSNVVGKIADEEIFLIDYIKPWQKFSF
VKK
>SEQF2502_00980 Lichenan permease IIC component
MAVLEQLSIKMAKISEQRHLRAIRDGIVSTLPLIIVGSIFLILAFPPFPKEWAISVLAKK
HAVQMLLPYRMTMFIMGLYAVMGIGYSLAKSYKLDGITGAILSVCAFLLTIMPKMINPIE
VINQTIGGKAVQIIVEEGTKGSQIIQEDIGYALQMSRLGSAGLFVGIIAAIFAVEVYRMT
TTTGFRIKMPEAVPESVARSFEALTPAAIIIFTLTILTYWLNIDLHDIIGSIIKPVLKFS
DSWFSVILIVFMITFFWSFGIHGDSIVGSVVRPLWLMLLEQNATALANGQNIPHIAAEPL
YQWFIWIGGSGTTIGFALLLLLKSKSTYGKTLGKAAILPSIFNINEPIIFGAPIVLNPTL
LPPFIIVPIVNASITYFAMVAGLVNRVTSTPPWTLPGPIGAFLATNGDFRAVILNILLII
ISVAIYYPFFNAYEKKLLAEEHAEAQE
>SEQF2502_00981 PTS system cellobiose-specific EIIB component
MKVLFVCSLGMSSAVAVKALEKEAKSKGVEIEVKAVSTQQFEDEVKNGYDVAMVAPQIRH
RFDILSAQAKEAQVPCAMITPQGYSPLGGPKLLKQIQELLSN
>SEQF2502_00982 PTS system lactose-specific EIIA component
MDKEQMELVVFEIVNSAGMAKGLAYEALGEAEKGNFKKAENLLKEADEALLSAHNIQTDI
IQAEVNGEGITPSVLFVHSQDHLMTAIEAKTLIEGMIKMYKRIDKLEKK
>SEQF2502_00983 putative 6-phospho-beta-glucosidase
MGKKDGIKIVTIGGGSSYTPELIEGFIKRIKELPVREIWLVDIEEGKEKLEIVGNLAKRM
VEKAGIDCKVYLTLDRREAIKDADFVTTQFRVGLLDARIKDERIPFENGLLGQETNGAGG
MFKAFRTIPVILDIVNDIKELAPNAWLINFTNPAGIVTEAVLNYGNFEKVVGLCNIPVHT
QMDCASLYEKDISEFKFQFAGLNHFVWYKVWDKKGNELTADLWDKRQDKENLGVKNIVSI
NYDYDQIKNLGMLPCDYHRYYYLQDEMLAEGLKSYKENGTRGEIVKRVEAELFELYKDVN
LKEKPKQLEQRGGAYYSDAACELISAIYNDKGIIMAVNTRNKGAIADLPYNSAVEISSYI
TASGPKPITFGKFPNAGQRGYIQLMKAMEELTVEAAVTGNYYTALQAFTTNPLIPGTTIG
RKVLNELLDAHEKYLPQFKDYYENREKYQKGGK
>SEQF2502_00984 N-acetylmuramic acid 6-phosphate etherase
MMIELEKLSTEENNPSSKDIELQDSLEIVRRINEEDKKVAFCVENELGSISRLINAILSK
YKKETRIIYIGAGTSGRLGILDASECPPTYGVSFEKVQGIIAGGNEAIFKAKENAEDSPE
LGKQDLLNINLTENDAVIGLAASGRTPYVLGAIEYANSIGAVTGSITCSKNSELSKVSQY
SIEVPVGAEIVTGSTRMKAGTAQKMILNMISTTIMIKLGKVFSGYMVDVKTSNQKLVERA
KRIIMKTTGADYEIASSVLKKAGNDVKTAISMILLDIDKDMAMEKLKQYDNNVAKLIHEY
SEKNI
>SEQF2502_00985 hypothetical protein
MSQNNINSKKSIIQNIKNFKIYLNERFPLGKNSIFVLIFTLSGYIYTGLLYNSKIINQIF
SKEIKVPMPWHKIVALFIIIFMFFLQLRITDEFKDYEEDLKYRAYRPVQRGVVTLKALGK
IGIATVIIQIILAYVIDFKIIYFMIIVWFYMFLMAKEFFIKEWLTKRILIYALSHVVIMI
FITLVIVNATQYIILGEAENIFKFGALQWYRHNIDIALIPLFALNYLNGIVLEIGRKTRR
SDEEEHGVQTYSKLWGRKKAVVILSLLFIIEYFLVILGLAHTYEKYFFFGGLTLLIILIV
SIYFMVKFLKKDLSGKIVETVSGLWIIFSSMCMGFLPYFVFSLIK
>SEQF2502_00986 hypothetical protein
MKTEAKELIQEGLKLFSLYDRRSLKRFYLSAEKSEADLSYLDEKYQTHIRSKARGLFFDF
LGGIIEGIASSGSPFSHSLDRAMTIEKREQYNEKKLILRYKIKDFIESTPVDSNTGYLLS
MIDFYCQ
>SEQF2502_00987 Long-chain-fatty-acid--CoA ligase
MTIVDKIKELRSLYPDKSALFDLHTGKKVTFTQIDEKSNYVCDYLRKKNFKKGDKIVVFI
PIGVEFYLILTAIFKMEIQAVFIDPYAGIEHINKCCEMISPDGIIGSRKTLLKGFFLKGI
RKIGKKINYIKVMKYSEKFLINEKIKNYEKIEENTPALISFTSGSTGFPKIIMRTHKFLL
GQHNVLEKNIKFEKKTSVYSSFPIFLFSHIATGTTTFIPDLNWKKPAESNFKNIVQQIME
NNIQNVILPPAIFQNIVKFCKDEKITLENVQKVYTGGAPVFYSLMKKIKEVFTNAKITAL
YGASEAEPISVLNFDDITKEDIENMKNGKGLLAGKIVNEIELKIEKLKKSNNVKDSSELK
GEILVRGENVVNGYLNVEKNPDENWHRTGDMGYINKKGQLMLLGRVKGLIQIEENIYYPF
TIETAFSFCKNLKKSVLTSKNNKLYLFTERNPEFKGDLSEDNEIKELKEKFGIFKIIETE
IPMDKRHNSKTDYKRLEEIVEKL
>SEQF2502_00988 hypothetical protein
MKIKQYTITENNQINKINLEKYIMENNISQNEVPKIQIERPSEIIVFYNENKEIAGSLNL
WHNRPNYNGRKTSYIGNVNIHEKYRKNEDKLFNKVFKELKKKGIKTIIGPLNGTTWNTYR
YVTDKRNHPPFLMEPFNEEYYVELFKKIGFEPLAYYISTIMENMNPVQRGHLSKKIEKLK
KFDYYKDTTVKSAENNDLITVLNKVYDLTIEAFKNNFLYSELDREIFLKIYMNYEDKIVK
KFFKMLYLKDELIGYVFGIPDYAELEYKGKIETMILKTIAISPQYNGKGMGYILIDELVK
EAEKSGYKNVIYALMYEKNISKNIGLLLGDELRRYTLFVKEL
>SEQF2502_00989 Phytol kinase
MILVFIGFIMFFLLLNKLEKSETLNSELIRKILHIGSGFGGLALPFIFEKKSSVIILGVI
FLTVLISIRLIKNKIAGFRKVLETKNRKTFGDIYFIISILGLWIASSEDKIMYSLPLIIL
MFSDAFAALIGEFYSKYKFDTGFGTKSVEGSVTFFLTTYFICINFFLFFSNIKSINIVLV
SLLLSILAMILEMISWNGLDNIFVPLFVYLFLKLNLYLTARELMYKLWVIVMLLIIIILN
RKKTTLTKVAQTASLFFLYIVMIIGGIKWVVPPLIMYLGYYHFTPKVRGQVKDSLKGLLT
IAFTTSMWLAMSIILDKNKMYLIYIFTFSLHFGIINLIRDNAGNVKRETFRMNFLMESIG
KAFVFFIINYLALSKMLDFKMLIGIIIFIFGGIFIYETSMKFFYIIEKEKELSGESKVFI
ASGIVFICSMLLLGIGML
>SEQF2502_00990 hypothetical protein
MKSEVKENKVDFSLIRYSQCWEDTEILLESLDISEKDVCFGILSAGDNVFSLLAENPEKV
VALDVSFPQIALAKLKREIFKNFDYEEMLEFMGVKDSSERIGMYEKIREKLEKDVRDYWD
LNREAIETGVIHIGKFEKFFKIFREKILPLIHNKKRVEGLFEKKSRQEREEYYNKHWNNF
RWKLMFKLFLSKSIVGKFGRDKEFFRYAEKDISEEMNKRSKYALCELDSYENPYIHYIMM
GNYRLDCLPYFLREENFENIKKNLHKLEIVQNSVEEYLDGVDFKINKFNLSDIFEYMSLE
NYRKLMQKIYDNADNNAILAYWNLIVERNSAKLNYTENEMKENIENKKNNIGKNFQRMEE
FDKRLHKKDKTFFYTDFVVEKVIKYGNN
>SEQF2502_00991 Prodigiosin synthesizing transferase PigC
MKYIYSVDKLKNHNENTVFEEKIGKKAQNLLELAANGFNVPHFSVITNRYFKEIILKEIE
IYNQEAGNNDEIKDWEAVFSENTERKIENIIRIIKNHKIKEEFEKEIENALNEESYYAVR
SSSIEEDSSNFSFAGQFETYLYVKKENMLEKIKEVWISSFSNHVMKYRKEGKINNEINVP
AVIIQEMVNSEKAGVGFSVNPVNNNYDEVVISGTYGLGTSIVDGDENGDLFIYNKKTKEI
KKEIRTKKIRQVLDFENKKIKTEEINIEKEILNDSEVCELGENIINIEKYYGKPQDMEWA
FEKEKLYILQSRPITTLEKTDKKTYNTIIWDNSNIVESYPEITLPLTFSFIRKAYSDVYK
RFSEITGVPAKVVESYQDIYDNMLGLLKGRVYYNLINWYKLLMLFPNSKGNSKFMEQMMG
VKKELSKENLNENLLEAEGKMTGFEKFRNKLEKYKAGFILFMNMFLIEKKAEKFYKIIDE
NLNGKNSDLSNKNIKELKKYYKFLENKFLKNWEIPIINDFLVMVWFGLSKKMAEKYIKDD
FEKAHNTLIAQEGNSMISVEPSKYIKKMSLMIKNDKSLKDEIRNIINKNEKSLIEIFKLT
QNAEFNSTLNEYMEKFGDRTVHELKLEAPTLREEPLFLIKMIYSLSITENVQEHAKRNIL
EEQKKIYDSLKINPIKKYLLKKTLFYAKKFIRLRENLRYERTKVFGTVRKIMKKMGVHLK
NNNLINNEKDVFYLTVDEIFGLVDGSIIDVDLKKLIELRKEEYKKYETEAILPDRFLTRG
FLGENFYYEDLAGNSQLDENTLQGTGCSKGIIKGKVKIVLNPMDTQVEDGDIVVTKSTDP
SWVMVFPLLKGLIVEKGSLLSHSAIISREMNIPAIVGVQGATSILKTGDMVQFDGSTGII
KKLND
>SEQF2502_00992 Membrane lipoprotein TpN32
MSKKLLISLAVICVLILAFVGINLKKDNVIRIAAAGYPMDEIVKIAAEDLKKEGYDVKIT
VLTDYVTANVGLNAKDFDANFHQHEPFMQVFNKKNNGKLVKVKGIYDVYVGFYSKKYKNK
AEIPNGAKVAIPNDVTNQDRALRILSDEGLIELKPKDGLYNLNDVINTKKNFKFMAVPIP
SLVQAYQEADLAFNWPSHMLKIGVHVKDALFIEKNTNGKYAVSLVAREDNKNSKKIQDLT
KAMTSEKVKKFIKEKYAGQGFPVF
>SEQF2502_00993 Methionine import system permease protein MetP
MIDSELLIAAKDTFIMVLIPTICAVFLGIPLGALVFLTDKGGIRENKFINIPCNIYINVV
RSFPFLIFVVILIPLTRLIFGTAFGLFPASFPICFVAVALYARFTEQSFYDVNSGIIDAA
LSMKASVFQIVWHFLLVEARSSLVLGLTSAIISFISYSTVMGVVGGGGIGDYAMRYGYNE
YNYALVYRVVAIMIVIVFSIQIIGNRISKNLDKKRRIY
>SEQF2502_00994 Methionine import ATP-binding protein MetN
MVELKNIEKNYIGFDLKINLKINKGEIFGLIGQSGSGKSTILRIIQGILKADKGEINIAK
NTEIAYIFQEFNLLYNKNVFDNVVLPLILKKKFSAEKIEEVLKFVGLSDKKKSFISSLSG
GERQRVAIARALVTNPQLLLCDEVTASLDKSVKDEILDLFEEINKKYGTTILVVTHELEV
VKRLCNRVAIIEKGKITDIFNVNQKDYEKSNKSYADYVREVLK
>SEQF2502_00995 hypothetical protein
MKKVRVTISDFMNEIIKSDSEYFKMPVGRIGNIIFKYYMDKNLNKVELGNFSGEVLQFNL
NKNNDEIFMDTFVRSRVETEAEYWRNIIFTYINNLRYKREEILFEKIFRKIKEGMESKRK
IKIKYHKYIRLVSLYFVKVADDENRSYLFCYCEKNNDYRNYRVSEIEEVWFTNENIEIKD
KKYIDDVHKNFAPFLSYKNTVKVEFTEKGVELYEKVLTNRPRLLNKKDGIYIFECDNKLA
LVYFAQFFSNVKILEPIELQEKLKNELKRTIEIYETEEEKNV
>SEQF2502_00996 hypothetical protein
MFRLRGSRRRKTEEIIKKFLKSYAQNEKSENKKDLRSWLIFELQNELADKNIQEIEKMAD
ELMAGVEIYFDKKKEVEKYQKVGISSSDYVGDVILDKISKDVINAEIVDRKQIIRDMKES
SEILANYNEAMIYEAAAINDPQIVENTLSANRANTYVDNVNSAIGKSNEEILSALTTKTG
EISQNPNLDGFIFEERHAGTFNIDAAVKEKNYYAKALKPEIGETYGKNSIDMTIEDSGKI
VRKYQAKAYKNANETAKSFYDRQQGYKYKFQSKLVPSDQTGDIPNSVDKMKFGEVESKNI
SKEEIKNIQEKYQSGDKEAVKFSFEKDVDALAISKQLGKQAVINGTMGVGIGMALDVGIK
LVSGEEVEVAEVIEAGVKTGTSMGLSTAVAGGIRVAVEKNVVPKVFAGVLANNNAVGAVA
ASSMDIIGTAFKLGSGEISLGEATKRVGTSVGSAYGAIVASNAGFIGGMAVAGAIGLGAL
GVAGAVVGGAVALAAGAVCGIVGSKVGGAIAKGVGTIAKPVIDGSTEIVKKGTEAVKSVA
KGAWEGVKAVGTAVASGVKAVGSALSSAVGAVGSFIGGLFGW
>SEQF2502_00997 ATP-dependent zinc metalloprotease FtsH
METNLSKYLRARRPIIWVHSGDYKEVDTIVTEATKEYKSKAIFEYRAFGAVNFETKVKSD
EIMDLYSFLNILFSEGVKTNVFLIIKNAEEEMKDAKNIALIKKIAETRYSNSDYNFTVIV
VTEAETVPKDLEKFTSILDIPNMTKDEIEKYIWNFAKENNVNVDKNDVGEVAISLKGLTK
LEIDHVLNMINESKNNISISGRDIIIREKGQIIKKSSILEIIDFKEKIEEIGGLEGLKEW
LSSKAQVFRRLDEAKKFGVDTPKGVLLVGMPGCGKSLAAKASARLFNVPLLRLDIGRLLG
KYVGESEHNMRVALKTAESISPCILWIDEIEKAFAGIDQNGGASDITKRLFGQFLTWLQE
KENTVFVVATANDITAFPPEFLRKGRFDEVFFIDFPNEEERERIFEIHLEKRGKMSDDIN
LKELAEETEGYCGADIEEIVKNAVENKFILETENEEDKKITTNNLLEATKSIDSLSNILS
DKIDVLKKSYKKFKIKSASQKIKNGKRIAGRPTFKDMVIVNGGKYTPSFFNEEREVCNLE
VCKYQTTQDMWMEVMENNPSEFKGGRRPVENVSWWDALEFCNKLSEKHGLKPVYDLSRKE
EGILRIHQSNGKIEYPNVVDFRKTEGFRLPTEVEWEWFARGGEIAIQDGTFNYKHSGSDN
LNEVAWYYANSENRTHDVGAKRPNQLGLYDCSGNIYEWCYDTGSDGYISEKTPYIYDETE
ESRVLKGGSWNNLNYKDIEYEIFERYSDKAENSQKYYYVLKASYGFRIVRTI
>SEQF2502_00998 Translation initiation factor IF-3
MNERIRVREIRVVGDDGEQFGVMSTRDALALATEKELDLVEISPNATPPVCKIMDYGKFK
YEKTKKDKENKKKQKNIVVKEIRIKPHIDEHDKDTKISQIEKFIAKEHKVKVSLRLTGRE
RLHAESAIKVLDEFASHFEEIATVEKKYGKEQVQKFILLSPKK
>SEQF2502_00999 50S ribosomal protein L35
MPKMKTHKGTKKRVKVTGSGKISLRHSGKSHILTKKTHKRKKRLGQDVIAPKGAERKIKK
VLAGQEGR
>SEQF2502_01000 50S ribosomal protein L20
MPRVKTGIVRRKRHKKVLKEAKGYRGAIKTNYRKANEAVKKAMAYATEHRKLKKRKMREL
WIIRINAAARLNGISYSRLMNGLKKAGIELDRKVLADLALNNPAEFAKLVEKVK
>SEQF2502_01001 Hypoxanthine phosphoribosyltransferase
MNRDFEFGIKKQLITKEELQKKVKELGVKITEDFKNENEPLIVIGLLKGSIVFMADLIRE
IKLPLEIDFIEASSYGEGTQSSREVKILKDLRSTISGKNVLVVEDIIDSGFTLKKVLQIL
GSRNPKKILLCTLLDKPERREVEVDVQYIGFEIPNEFVVGYGLDFNENYRNLEYIGVAEP
SVFE
>SEQF2502_01002 Ribosomal RNA small subunit methyltransferase A
MKGKNKKYKKRDKNFENEDHKAKKKYGQNFLNDSSLLDEILNVANIDEETEVLEIGPGLG
FLTEKLIENSKFLTAFEIDDDLIPFLSKKFENKQNFELVHQDFMEADLKTFFENKKDVKV
VANIPYYITSPIINKLLEYRENIDEIYLMVQKEVAERIASKPHSKNMSLLTHAVQFYAET
EYLFTVPKEKFDPVPKVDSAFLGIKILKDKKYESQISEEKYFKYLREAFSNKRKSISNNL
SNLGFSKDFVKECLKKVGKTELARAEEFSVQGFIDFIGILEG
>SEQF2502_01003 Iron uptake system component EfeO
MKKMGILLLIGALMAISCSKDTGTKEGGKAGTTAGKTAEQGKTDLSKETSEYKKYVEGQI
DMLLKDTENFAQLLKTGKLDEAKKVYPLIRMAYERSEPIAESFGESDVKIDYRLVDFKEE
FKNEEGWKGFHRIEKILWEQNTTKGTEKYADDLVNDIKELKAKIATIEVTPDLMVTGAID
LLNEVSTQKITGEEEVFSHTDLYDFRANIEGAQKIFELFRPKLEQKDAKLVTTLDTEFKA
VNQLLDKYMTDDKNYKLYTELKPEDTKALAEAVTKLGEPLSQMGIVIDATPKK
>SEQF2502_01004 putative deferrochelatase/peroxidase EfeN
MSDENDKKWFDKKISRRDFLKKAGMVGAGAAIGASGAGAIFANMFSSKANQVVGNEGISF
YGEHQSGIATPVQKNVYFAVLDLHSTDREEIKQMFKDWTDYSEKLMKGELVAPELANHLV
PPIDTGETVGLNPYRLTITFGISPSFLDKLKMDNKKMEEFKNLPHFPRDQIKDKYKGGDI
CIQACADDAQVAFHAVRNLVRKGRALITLKWTQAGFLPIGNGKETPRNLFGFKDGTENPK
NNNDFKNVVWYDKNNWLKNGTFLIVRRIQMHLETWDRTNLQEQENTFGRYKESGAPFGET
DEFATIDINKKGPDGKPVLPIDSHVYLAKKADVKIARRAFSYSNGIDEVSGQFDAGLLFI
CFQKHPDQFIKIQNSLGNDDKLNEYITHVGTGIFACFGGIKKGEYIGQKLFE
>SEQF2502_01005 Ferrous iron permease EfeU
MLFFVNIIAEESYSGLYIKITDTTTAIKNNNQNEAKKLFSEVRDEFKKVKNADSTQGKKV
QELLNKEKAVLSEDDLREVTTALLAFEKEQNPVDDNAEKKKFQSRMNPALDMLEKAIQSK
DVELMKKEYLKFNGVWTRNESFIRSRSIPYYGKVETAMSFLRSSMEVEPFDYDNTINSFN
DLKSTIQDYLDGKKIENNVSSTITLKEAVDMLKDALEAFKNGNRSKGQSKVKEFIQVWPT
VEGDVSTRNSALYTKVETQTPIIMVKGSEKEYQEQLQGLITELSQIDTKAQYTFIDAMFI
LLREGVEALLIVLALVSSLKAANQKKGLRWVYAGAAAGIFASVVIAFALQALFPAVSSGT
NREILEGFVGIFAVIMMIGIGFWLHSKSSLKSWKDYIDRKMDIVLSTGSFVSMFVLSFLA
VFREGAETILFYVGILPLISLQNLIIGIVSAILILIVIALVLIYASSKIKIHQVFFVLTW
TIYFLAFKMLGTSIHMLQVVGILQLHVVHFIPTMEILGIYANMEVFISQLILIVIIVIAA
LIKKRKDK
>SEQF2502_01006 Sec-independent protein translocase protein TatCd
MAKIDEQTLVEHLSEFRKRLIITIIFFIAAFLVSLIFCSDIYKLLTASFKQKLIVLGPND
ILSIYLMLAGICAFSLTLPFTSYQLWAFIRPALKEKEAKAILSYVPATFILFVIGLSFGF
FVVTPALLNVLLSFGNDLFNIQLTANNYLTFVLHTSLPLGVIFELPVIVAFLTSLHILTP
QYLIKNRRYGYFILLVVAVVLTPADFISDLTMAAPLILLYEVSISVCKYVYKRRRDD
>SEQF2502_01007 Sec-independent protein translocase protein TatAy
MGIFQDIGAPGLIVLILGALLIFGPKRLPELGEAIGKMIREFKKSVSGIDSEADNKNVED
KKEKKCK
>SEQF2502_01008 hypothetical protein
MENNEKEMKSWEYIIQTKKEHIDFINKIIEAYDGLGNVRTLDNQNGLIKILTNSYLLDDM
DKAIETLKQKNIEMEVLEKREWLGVL
>SEQF2502_01009 tRNA 2-thiocytidine biosynthesis protein TtcA
MNLENDLDDKNTINNETNADKIASTSLGSAVCETVLPSVPLQPLETIERSIQKKYRSALW
TPFVRALKEFEMVKDGDRIAVAISGGKDSLLLSKLFQELKRASRTNFEVVFISMNPGFNP
ANLNNLKKNLKHLNIPCEIYDDNIFEIAEKIAKDYPCYMCAKMRRGSLYTKATSLGCNKL
ALGHHFDDVIETTLMSMFYMGKFETMLPKLKSDNFNIELIRPLFYVEEKAIIKWVRNNGI
LPMNCGCTVAAEKTSSKRRETKELIAQLVKNNPDIKKRIIQSTQNVNLEKILGWKDSNGK
YSYLDKF
>SEQF2502_01010 hypothetical protein
MSKYFETVDFWIENLLDSTESYTIESNEKGKFVDITINVTKEDMGKVIGKNGRIITALRV
LMSSIGKKDKKSIKIEVKEM
>SEQF2502_01011 Putative esterase
MKTYDLRKKSFKLRVYYYDTDKMGVVYHSNYLKWMEMARTEYFRDVFPYKNMEDMGFILP
VKTLNIEYVNSAKHDEEIEIFVKIEEINNIKIRFSYEMYNLDGILKAKAETVNVFVDENG
KLKRISNELLKKIIK
>SEQF2502_01012 Putative sugar phosphate isomerase YwlF
MKIVIGNDHAGVEFKNKIMQALRSKGYEIINVGTDTLDSVDYPDIAKEVSKKIINKEANF
GILICGTGIGISIAANKINGIRAALCHNEYTARLSRLHNDANIIALGARVLGEDLGLACV
ETFINTEFEGGRHARRVGKIEQ
>SEQF2502_01013 Purine nucleoside phosphoramidase
MSTVFKKIIDKEIPANIVYEDDEFLAFHDINPAAKVHVLVIPKKEIKSLDAATEEDALLL
GKLQLTVAKVARILGIDKDGYRVITNIGENGGQEVLHIHYHILGGEKLPVKLK
>SEQF2502_01014 hypothetical protein
MVNKFSKIVVLVFLLANLGMAEYIKKDDAVYYMDKISQTDERKVEDADFKTFVKLNDIYG
KDSKNVFCIDKKLEDADVKTFQVIGEVNGKDKKYIYNYDEKMEINPKDFKLYKNKNKLLY
FRNNGKLYIGGSFFEVEYVQDLDSFEAIDESYSKDRYNIYYAGTPIYDVDKSTFQIIMPD
YYAKDKNNVYSGSDKIKDANPDTIKILNQVYLKDDKNVFLNFGQKMENVDVATFEAIEGN
VAYGKDKNNIYFLGEKIKGADVKSFEVILEPSDLVQMYSKDKNSVFIGGRKIKEADSKTF
ERLPKTTYYSKDKNNLYYREVKIDKIDNKTLKILYSDGIDVVKNRNRIFAEGKKLNIKSP
ETFEIILSKYYNFPNFIYGKDDKNVYAISKFDETYSSKIIKNADVNSFEVMKNSMYTKDK
NNIYFTHSDVVQMKNVDKDSFTIGENGFSHDKNSVYFYGKKLDRISPQGFKIIDLTVNSG
DSEKIAFLTDSRNLYKFTYGFDDERYNLKNIKLSNVTNVKVDAPSFELVKEYTGSYYRDK
DNVFYYDMNKKELKKVEGSDRNSFVEMDNFFAKDNKKVYYLGKQIENISSEGFKFVGSDI
VKNKNGVYFWKDETGTGDYEIVPLNFDSASFDIANKDTSNYFKDKNGIYYLDYGKLLNSE
AKDVQNAFIKLEGADIPTFKAFGYGYSKDKNRAYCKYKEFKGVDVSSFTVVLEDEGVVVK
DKNRVYKNDCE
>SEQF2502_01015 hypothetical protein
MKSKFFKIIAGVFILANLGMAEYVKKDNAVYYKYSEEDDSEFKIENVDLNTFKILNDKYA
KDDKSVYFSGNKSFEDVDSKTFEVLPNYYSKDKNNVYRPINEWIHKINGANPKTIKVLNE
FYSKDDKNVYYDSDKISNADVNSFVVLEADHSYAKDKNAVYYSGEKIKGANPKTFKIIGD
GMYSKDDKNVYAAVDIIKDADPQTFRRIPETNYARDKNNLYYYFGDVKNLGKINEKDFKV
LDSNLVKNGNEVYYLGEKVNIKNPEKFEIIENYLSSPSMVVYGKDDKNVYVMTPYKEAGY
LKIIKNADKDTFEVMENSDYSKDKNNVYYAGYNVVQLQDVDKNSFTIGEENGFSYDKKNV
YYAGRKLNDISSAGFKVTRLVNRPNLPVNFLNDNKNIYKLITVFDEETGELKNVKTAVVK
NPKVDSKTFETFSYSGNYFRDKNNVYYENELYKMGLKRIAGADRNSFEVLNDEFSRDKNN
VYYYGNKMKGINPDGFEFVGRDFKNNEDIIYFLKTKDKVYVLKNKAGKEVYEIVPLNFDA
NSFKYSNADNSYESESVGYFQDKNGVYYFDVFRLDELNPNKVFAKVKGADTSSFVQLMFG
YAKDKNKVYIEDREIKGVDPESFKIIETSDGVTIRDKNKIYKEFKK
>SEQF2502_01016 23S rRNA (adenosine(1067)-2'-O)-methyltransferase
MRDVIASSDNKFYKLLKKLDKKKYRDENSIFKAEGEKFLNENINFNKIIVKESRFEYFDE
RYEISKHDNLTILKDNLFDEVSTQENSQGIIFLYSKNLNTIEDIKGDVVILDDIQDPGNA
GTIIRTMIAANFQNLILTKGSVDVYNPKTVRATMSGIFKLNIIYETPENIVKFLNDKNYL
KIATALHEDSISYEKIELRGNNAFIFGHEGGGVSEYLIENSDIKAIIPIYGNIESLNVSV
ATGIFLYKMREKLQRL
>SEQF2502_01017 hypothetical protein
MENNIQIFEGKKIRSVWDNEKEEWYFSVVDVVGALTDSVNARDYWYKMKKRMTDEEKSEL
STICRQLKLKAPDGKMRLTDVADIQGIFRVIQSIPSPKAEPFKMWLAQVGKDRIDEITDP
ELTIDRALETYLKKGYSKEWINQRLQAIQVRKELTDAWQEHGVKKGIEYAILTDEISKAW
SGLATREYKDLKGLKKENLRDNMSTLELVLNMLAEATTTELTNIHNPNGLEENKKVAKRG
GTIAGNTRKEIEADTGRSVITTKNAVDFSKLIEDVVKDIPDIVKNSKDEEKSKE
>SEQF2502_01018 hypothetical protein
MASSKEYLNFVLEQLSEVENIRYRAMMGEYILYYREKVIGGIYDDRFLVKAVKSAKELIP
NALHEIPYEGAKEMLLVDDVENKEFLKNLFEAIYDELPVLKRKKKQ
>SEQF2502_01019 putative endonuclease 4
MLKKEIFKIGSHVGMSGKDMFLGSVKEAISYGSNTFMIYTGAPQNTRRKPIEELNIEAGL
KLMGENGIDINDIVVHAPYIINLGNAVKPETFEIAVQFLRTEIERTDAIGAKRIVLHPGA
HVGEGEEVGINKIIEGLNEVLTKEQKTTVALETMAGKGTEIGRSFEEIAKIIDGVKLKDK
LTVCFDTCHVHDAGYDIVNDFEGVIEQFDKIVGIDRISVIHLNDSKNPVGAHKDRHENIG
FGKIGFEVLNKIAHFEKFSHLPKILETPYVALSDDKKAKKVPPYKFEIEMLRTGEFDKDV
MEKIKNQ
>SEQF2502_01020 hypothetical protein
MNIWTQKSIELANQRNYLDLLYKIYPMSNNLRREMKKEDIQKLNEYYEMRDKYKLLNLLL
KQEVFPIKDSYISYLKRDKSAINRNPATVDRIVGMLYEMGINKIIDRTTAPKETNRQIGP
LFKN
>SEQF2502_01021 hypothetical protein
MQTFAKNHLGYLREKGLDFIGKFNNTYVIGEAKFLTDFGGHQNAQYEDAMATLDTSLLKT
DKKVLKIAILDGVLYISSQNKMHSSLFSKDGIIISAILLREFLYSI
>SEQF2502_01022 Modification methylase DpnIIB
MELIYRNKKKEKEILEIINKKYKEVENNKLSFITENSFYINEDNFYAMIKLLKNYKNKID
LIYIDPPYNTNLDFSYDEEKVSTISQTESGVIAYSDKMNLENYFEFMRERLILISQLLSD
KGTLYIHIDDKIGHYIKILLDEIFGRKNFINSIARIKSNPKNFARKAFGNQKDVIYVYAK
KNKNNIFNEIRSELTEEEKIKNFPKVDEKGRRYNTVPCHAPGETKNGNTGKMWKGMFPPK
GRHWRYSVEELEKLDERGEIEWSQNNNPRIKKYLTEHKGKKIQDVWLNYKDPQYPVYSTE
KNREMLEMIVLQSSNKNSIILDCFCGSGSFLKAGLKYGRKVIGIDKSEISLKVVKESEEL
KNIDIIENDSNDENFNQIKLKQDLQELKLFKI
>SEQF2502_01023 Putative NAD(P)H nitroreductase
MLKDKELTKKEMLEIFNRRYACKKYDKTKVVSDEDFMAIIEVGRLSPSSFGLEPWKFILV
KNEEMLNDMREFAWGAINSLNGASHIVMVLARKGVTGDSEYFERIGKEIKNISEENLKIR
KEFFTKFQKEHFKLLESERALFDWASKQTYIAMVNMMNMAAALGIDSCAIEGFNKEIAEK
YFSEKGVFDLKEYGISYFVSFGYRDEEITPKTRRELSEVYEVVE
>SEQF2502_01024 Putative NAD(P)H nitroreductase
MSKDIELKRKEIIEVFNRRYACKKFSTKKRVSDEDLKTILESARLSPSSFGLEPWKFLLL
RNEKMREDFKEFSTGAINSLNGATEIVIILAKKGITADSEFFRHSYKDVKKLPYDVFEIK
KNSFSMLQEKNMKLLENERTLFDWASKQTYIALGNMMTVAAYLGIDSCAIEGFNKEKAEK
YLSDMELLDLSEYGVSVMVSFGYRDEELPKKIRKPLSEVLEIIE
>SEQF2502_01025 hypothetical protein
MKRRLLIALILLLTVSCGENKIEKIYEEELMNLKINGYDDSKQLSKNDIKEIKKMLKKNF
KNLGVTAVTKDGRFFISKYVTNPKNKEQTAKEVAIERPDITDTIGEWCKSKGIKFKVIFV
DFFDKEQDKRISQSMYHSHILEIEYEDKDYKKALQEGFSKYARATRF
>SEQF2502_01026 hypothetical protein
MKKIFLIMSLVMAFSCGNKNKNSVDKNKKIEKNTTAEQVKQNQEEKTDFDKLSKKE
>SEQF2502_01027 hypothetical protein
MELKIPEFNKSQTNDSKQLTEEEVKEIKDVLRKKFKRIGLTAATKDGRFYIIEVITDGKN
KEQTAKEVALQRPDIIDTIGEWCKNKGMEFKVIFVEFYDKVQKKKISQSAYHSHLLEIQY
EDKEYKDALREGFSKYKRATKF
>SEQF2502_01029 hypothetical protein
MKKISGKLTFFFENPFWVGIFENFENDNLSVCKVTFGSEPKEYEIYDFILKKFYNLRFSN
EMKSNFREKAKNPKRRQREIKKELQSKKFLKKSEEILKLQYEENKKERKVKTKQEKELEK
QRKFLLKQEKKKQKHKGK
>SEQF2502_01030 hypothetical protein
MDLKKENLKEFILKLNQKDINELMANSEKEEDIIFYNKLFNLILETKQDELIKKGVF
>SEQF2502_01031 hypothetical protein
MKKVLYIFAGVNGAGKSTLYNSENLDNNIKYSTRINTDEIVRKIGDWKNNSDQIKAAKMA
INIRNDCLKHGKSFNEETTLTGKTILKTIDKAKKLGYELQLFYVGVNSPEIAKKRIKNRV
EKGGHNIADEIVEKRYYESLENLKQVILKFDEIYFYDNSEKYKNIFSVMNNKIFYKDKNF
NWSKEAIEVIENREKNMKML
>SEQF2502_01032 hypothetical protein
MKEQKRLINQRKENVKDMLMNVPRVNPDYGKDMDKDLFNARDNALTEQLNKDFPRNNPYR
NINPDEGLNMPKPEINREKSQNINEQLKKLRERVGN
>SEQF2502_01033 hypothetical protein
MKKLKFILLILVSIFCLNSCLTTAFVIASMQGDGLLPPPKPQYNTYHGNNKKINSVIFSE
NKKKMRIKNTNKEILVPEGFDLRESPIFLFNNSLSSVKPLRFYLYYKNEERPLPLYIYTE
NFEEFSKKENLVKINENTYFNKFEDNSKKIKLDQIIKKIDDNIFAVVNIADMKDISKNFF
LELMKDW
>SEQF2502_01034 hypothetical protein
MNVPRNNPYKNINPDKSVNMSKPQINREKSQNINEQLKKLRERVGN
>SEQF2502_01035 hypothetical protein
MKKLKFILLILVSIFCLNSCLTTAFVIASMQGDGLLPYPEPESPYYYGDNKRLNTLILSE
NKKKIEIGNSKIQISIPEGLWLKNSDNSLLNETLNKKKSFELSGYYLGKSLLLPIHIYNE
NFEEFAKKENLVKINKNTYSNKFEYGSKKIKLNQIIKKINDNAFAVTSFDDTKEISKNFF
LELMKDW
>SEQF2502_01036 hypothetical protein
MDIDLWKKYGTGPTDKTTKKLRYRLGDLKLGAYIQANYDNLKKRANKNNGRISLTELENE
LVKTIIDIYELFNWGK
>SEQF2502_01037 hypothetical protein
MLKKIETILLANFGLLIYILFWKINININKLTNMFIINVVIIIFSVFSEKIIKIKIDMIF
YFLLIDLIGIFLLSK
>SEQF2502_01038 hypothetical protein
MLTETPVAQKIINKMNGSNSIYQNYTEKATKNANSTSVMLGIYNQDGISYIKAAGNKHTY
>SEQF2502_01039 hypothetical protein
MWKINKKFLEQQLQQRKIFYFSHDPMKASGYFQKEVNFLKDNGFKFIKDRDF
>SEQF2502_01040 hypothetical protein
MQREEYLDQYMKFNISKKEERKWLKEKVEKILSKMSEIKNINLKYDKYWNILYILTKTLE
DNHLLDKTISAFEKDLKYLDIFSINMILEMIRDNKKIWKNFKKKLKKIIQNNDISKNEII
SKEHNKLNGTQFLTEDEVIKRYREILSKLQS
>SEQF2502_01041 hypothetical protein
MKKSYTLNSEKSNWKFKPEIPRTAVKNSEGNYTLGRGNEWSVNNTVTSVKRISENQNNIY
NVELNNGMTPGYTLIRKSDIKVTANENKINNHNETWELRMESRYKNSPIFGCHTIECMKN
ILKEHPEIQFNVKEVSNGVKSVKYRVPRRNSAQATEQNNGVVEYREFVKNPKTVYDTRIY
KTEDLTKQVINEVKNVITPNDIQRAYSNPNYNVHLDIKINNQKIRVNIKFDASTGGIEID
GYYFHGN
>SEQF2502_01042 hypothetical protein
MKIKKIRTDSYSILKISKYDFLVKLIKEIGNFPYVVSNIYEDNSTKTTIVEDQGMYINNG
WNETDETALYISEYNSDSEIRVYYGYEELFSYFLIYYFENIANYANLISFVEQELHNYIE
YMEKFKNFRINVDLENLFKRDKLRNFLLKYNEKENKYNLEFINCYTKYINYWDINIKKKF
FSCLLGKDRLKEFMLNKKRIFRINGVDYFQIEEKEKYSEIYRIEIENDIKIEYYSKDLEY
ESFGNVGFLYKEKNFDIENKSLKGEKLNFERYRDNRDEMNVERISKEDFLKELEIIVDAY
KNIYNDNEVQEMFENFKENF
>SEQF2502_01043 hypothetical protein
MKGWIEEYEILRKFIEKYCEEQDKNRLIEILNMKDRFLFKYFVNEFSKLKIPNKMTEEEL
KEYKEKIMIYI
>SEQF2502_01044 hypothetical protein
MKMKFYYYISKNGELWGEFCSIINGEKYNIGYSVFLSRKLTEIKSEGIDYFLKEIEKIKN
GEKECVEGYGETLDFFIFKDRVDFIDWFGDYDDWSCTIEEFTKALLGKKKFLEMPRDINS
YLEVEINNL
>SEQF2502_01045 2-dehydro-3-deoxyphosphooctonate aldolase
MLIDKVKKVKITDDITIGNDKIFLIAGPCVIESEDLVMEVAGKMKEITDKLGIQYVFKAS
FDKANRSSISSFRGPGLEKGLEILSRVKSKYGVALATDIHEPYQCKEAAKVIDLLQIPAF
LSRQTDLLVAAAKTGKAVNIKKGQFLAPWDMKNVVKKFQEVGNENIMLCERGASFGYNNL
VVDMRGLLEMRKFGYPVIFDATHSVQIPGGRGETSGGNRDYVYPLARAAVSVGVDGIFAE
VHPDPDKGLSDGPNMLKLDNVEKILTKLLKYDKLTKEL
>SEQF2502_01046 Serine-pyruvate aminotransferase
MSSKLLLTPGPTNIPEEYLEILGNDIIHHRTPEFRRIMKENNENLKKVFKTTQNDVAVLT
SSGTGSMETAIVNFFSKGDKVLAVNTGYFGDRFRKIAEIYGLNVINLQYEFGESYKLEDV
KKVISENPDLKGILATHSETSVGILNDIKSLGDLTKNTEILLVVDTISGLVVNEFNFDEW
HVDVAIAGSQKAFLIPPGLAFVAISDKAKKAMETSDLPKYYFDLKQYIKYFEEKGETPYT
PAIALILALNQSLKDLIKNGIENTIKQKHELRKYVEEKAEKLGFKLLVKNEENRTNTLIS
VYREGIVIKSIIAALEEKGYTVTGGKGKYAESLMRIGILGQISKEQIDDFFVIFEEELKK
QL
>SEQF2502_01047 Prolipoprotein diacylglyceryl transferase
MRPYLFKIGGFELRIYSLMYILAFLFGMFIALSDDVAEKRGVNDRKIIEDFAFTTIVSGL
IGARLYYVIFKFADYIGNPLSIFYIWEGGLAIHGGIIGAFIGACFYAKKNKMNLWVLTDM
AVGPLLFGQFLGRFGNLANGEVHGVPTFTPLSIIFSGKFNEWWIKYQSMSTTAQAQFKQL
VPWGLVFPLNTPAGSEFPNLPLHPAMLYEAFLNLIGFTILWFYFRKKEYNPGVLSMIYLI
MYAIIRTFVSTFRAEDLLIFGIRLPYLISIVMIIVAIIGIKFFSNPERKFVPAKNEEKQ
>SEQF2502_01048 hypothetical protein
MGRKSKVSNELKIELVKKILEGKGTIQGLSKEYNVAKSSLMTWKKKYLEIGEESIKVENK
NRHYSRETKEKAVKSYLNNEGSLFEICKKYDIASVSVLNYWIRDYRRSIDENGKISLLKK
HIRKTIEAKVEAVQFCQNNNHDYNLTIRKFGISYQQIYSWVKKYENGGVDALIDNRGKRR
SKTEK
>SEQF2502_01049 hypothetical protein
MKKKNKKNNTLHEIHKRAENFSHGEEIANFVSHTVGAGLAILAFLILTIRASWTRDAGTI
MSFMAFGFGLIVLYTMSAIYHGLKPGTAKSIFEIFDHSAIYILIAASYTPFLYLVVNSPM
NKIILTIQWVVCILGIVFKVFFTGKFKLFSTLLYLVMGWMIVFAWKDLINNINRVSLIYL
ILGGVLYSLGTIFYSWKICKFNHMIWHIFVILGSISHFLAVYYLI
>SEQF2502_01050 hypothetical protein
MAKTQAGWYSKFKAFGPGILMASAAIGGSHIVASTQAGALYGWQLAVIVILVNIFKYPFF
RFGTQYTLERKHSLIEGYEEKGKIYLWVFFIMNIFSAIINIAAVGILTAAILANILKLTI
LPSLTPAAMASMINMLTTIVLVGSLAMMIFGGYKLLDSSSKFIVISLTVATIIAVIIALF
KHHPMAPDFVAPSPWKLKALPFIISLMGWMPAPIEISAINSMWTVEKQQEMKVPRKIAML
DFNVGYFVTTVLAFVFLALGALIQYGTGTAIKGASAAYIAQFIKMYSSVIGNWSGLLIAF
IAFMCIFGTTITVVDGYSRANAESLRLILRKKEVTTAHFNIWMIVTVIFAMIIVFFFAGN
VAAMMNFAMIFSFVSAPVYSYLNFSLVKDNSKLPVWLWFLSVAGIVYLAGFTIFFLVYLL
GILK
>SEQF2502_01051 GTP cyclohydrolase 1 type 2
MKLWQIMGELQTIFSPKIAEDWDNVGLLVGDNTREINKILFCLDVTEKAVQKALDNNVDL
IISHHPVIFSGLKKITNETVHGRKILKLIENKIAVYSIHTNSDFAINGLNDFIMDKLNLD
GEKIIFNEHEFEDYNPIKNKMEHVCGGLARIKILNEKMKLGDLIERIKDSLGIGYVRYVG
DKNSYVRKIGLVTGGGSSFMYEVANKIDVFLTGDLRYHEALDALEEGRILVDIGHFESEY
LFVDLMMEKMEKFFKGEMIRHFEDEVFKLG
>SEQF2502_01052 RNA polymerase sigma factor SigA
MLKKIFEDIRKKGSFSFEKIIEHYTMSDDEFFEFLKFVHLENIPEVRNSTDGSDFIVLED
ENVFIAEKDTIKSYLENIKEKYEEFEKKSDDEREKEELIDKYLKIAVRESLLYSKYGFSF
LDTVQEATLGIMSGLSYYSQITKITKEPEFFIKNFAVKYILEYQKELLKDIKSSELSYIL
YLKVKVDKSMGLSMEEISRQMNVTTEYIEQLEMLFDEVEPEELMENTQIFEKADKITQMY
ILENIPKKLNYLDEQILVMTYGLDDKVYTEKEIAKSLNIAKHNVKILKEKALNKLSIDMM
RNDFVENSEEVNYTVN
>SEQF2502_01053 RNA polymerase sigma factor SigA
MSDKKQNLKNSLANFIKQAREQKVVSYEEINSVLSIGFSTEKIDQLIKKLTDDGVQIVDT
IKEKEDLLKIPDSMEEIEKMELSDFEDSHDEFVENEIDDSEVDKLLQTDLLKMAESMDVD
EPIKMYLREIGQIPLLSYEEEIDYAQRVLNGEEEAKQKLIESNLRLVVSIAKKHTNRGLK
MLDLIQEGNMGLMKAVEKFEYEKGFKFSTYATWWIRQAITRAIADQGRTIRIPVHMIETI
NKIKKESRIILQETGKEPTAEELATKLELPVEKVKSILEMNQDPISLETPVGSEEDSELG
DFVEDDKFSNPYDATTRVLLKEQLNDVLKTLNEREEMVLRYRYGLDDGSQKTLEEVGKIF
NVTRERIRQIEVKALRKLRHPSRRKKLEDYRS
>SEQF2502_01054 DNA primase
MFYSKKEIQKLIDNLDIVQVIGEYVNLKKAGSDYKGLSPFKEEKTPSFTVSPVKNIFKDF
STQIGGNVISFYMKINDIGFVQAVEELSQKYNIPLKKNRRYETVNQEIEKKKTVNREYFE
IMKEAQVFFKENIEKHNEALEYMKERDFSLEEVKKFGIGFASSSRDDLFQYLLKKDFPEE
KIMELGLVKRNENGEIYDSFRNRVTFPIYNADAQIVGFGGRIIEKNTNLPKYLNSPDSPI
FKKGNELFGIKYRGENIRKKGFAMLMEGYLDVLTAQKNGFENAVASLGTAFTEEQAELLR
RYTDKVLISYDNDEAGKSAVIKAGYILKRYDFDVKCLVMDGSEKDPDEFLRKNGKKSFIE
VVKKSEEIFDFLTKEISKDLDLNNINGEKNFIERLKPFFSNITNNLSKNLYLQRLSVNFG
INEFVLEESLKNISSETLRRKKRKNYGSQKVQYKKLKEDLNIELEEQTLMYILEFYDSER
KRCEELLNKKFSHSLFNELIEKLKLVNFDIVRLEKNGINEESREIVTQLKLQADKDIKYK
DSYFKDRYFMEVYSGWFEREIREESKKSEEENNKIKKIELRKLLLKIKNINKIDEIKKLY
DEFILIRRLGYV
>SEQF2502_01055 hypothetical protein
MKKEKITIDELLTKVPNKYELAIISGKIAKKEFAEGKPKSEIMDEVFKDIMEDEVVIIRE
NDEKNEEI
>SEQF2502_01056 Guanylate kinase
MKGKLFIVSGPSGSGKSTVTKLVKDRLNIPLSISATTRKPRNGEIDGKDYFFLTKETFEQ
KIKNDEFYEYANVHGNYYGTLKEVVESNLNKGLNVILEIDVQGALIAKKKKNDAVLVFFR
TKDMETLEKRLRNRNTDTEEVIQTRLKNALREMEYEKKYDYTIINNDIEESCKELINIIN
S
>SEQF2502_01057 DNA-directed RNA polymerase subunit beta'
MSIRDFDSIQIKLASPEKILEWSYGEITKAETINYRTLKPEMDGLFCERIFGPSKDYECA
CGKYKRMRYKGMVCEKCGVEVTTSKVRRERMGHIKLATPIAHIWYSKGTPNKMSLLLGIS
TKELESVLYFSRYIVTDPGETELEKGQILTEREYKLHESQFKGEFTAKMGAEGVLALLEE
IDLHELEVKLQNEMDTEHSTQKRRKVIKRLKVVRDLIEAGNRPEWMILTVLPVIPADLRP
MVQLDGGRFATSDLNDLYRRVINRNIRLKKLMSIKAPEIVIKNEKRMLQEAVDALIDNGR
RGKPVVNQSNRELKSLSDMLKGKQGRFRQNLLGKRVDYSGRSVIVVGPSLKMNQCGLPKK
MALELYKPFLMRELVKRELASNIKVAKKMVEEEDENVWELIEEIIKNHPVLLNRAPTLHR
LSIQAFEPILIEGKAIRLHPLVCSAFNADFDGDQMAVHLVLSQEAQMEAKLLMLATNNII
APSNGGPIAVPSQDMVMGCYYMTKEKKGSKGEGKLFSSRNQLITAYQSGKVSVHAVVKVR
VDGNLIETTPGRLMFNLILPKEVRNYGITFGKKELKNLIAELYKRYGFEKTSKLLDDIKE
FGYHYGTLAGITVGIEDLKIPETKKEILENAEKSVAEVEKQYKAGEIINEERYRKTVSIW
AEATEKVTKDMMDNLDEFNPVYMMANSGARGSIAQMRQLGGMRGLMADTQGRIIEMPIKA
NFREGLNILEFFMSSHGARKGLADTALRTADSGYLTRRLVDISHEVIVNHDDCGCEHGIV
VSDLMDAGEVIEKLSERIYGRTLAKDLVHNGEVIATRNTLINDELIKKIEELEIREVEIR
TPLTCKLEKGVCRKCYGLDLSNHKEILKGEAVGVIAAQSIGEPGTQLTMRTFHTGGVATA
ASVQSDYKADVSGKVKFRNIETLVNEEGKEIVVSQNGRLIIGKHRYEIQSGSTLHVKDGD
TVKKGQVLVEFDPYQTPIITSEEGKVEFRDIYVKENIDVKYGVTEKIAIKPVESNDVNPR
IIIYTDDGRKVEYAVPYGAYLMVNEGDTVKKGQTITKILKTGEGNKDITGGLPRVQELFE
ARNPKGKAILSEVSGRIVFSDKKKKGMRLILVEDPETGELIQEYTVPVGEHLVVTNEMLI
EKGAKITDGPVSPHDILKIKGLVEAQQFILESVQQVYREQGVAVNDKHIEIIVKQMFQKI
KIKEAGDSLFLEDELVDKKIVERENEKLIANGKRPATYEPVIQGITKAAVNTESFISASS
FQETTKVLANAAVEGKTDRLEGLKENVIIGKKIPGGTGFKDYKYLDATLKSDIIEESEVD
VEVNTDEENEFVETIESTEGTEV
>SEQF2502_01058 DNA-directed RNA polymerase subunit beta
MNKLIERYSFGRIVDRGEMPHFLEFQINSYEDFLQTKVPPQKRENKGFEAIFNEIFPIES
SNGLLKLEYLWYEIHDNDEPLNDELECKKRGKTYSGQLKVRLKLTNKRTGEIQETLVHFG
DIPLMTDKATFIINGAERVVISQLHRSPGITFNKELNIQTGKDVFIGKIIPYKGTWLEFE
TDKNDILNVKIDRRKKVLLPVFLKAVDFFHSNEEIMNEFFEPKEAELSEFYSKYSDTELE
EILRSRLEGSFVREDILDEETGEFVAEAEEIIDMPVIQRIIDAKVEKLSIWEVKPEDRII
ANALVHDSTKNSDEAVIEVFRKLRPGDLVTVDSARSLVKQMFFNPQRYDLADVGRYKVNK
RLKLDVPADVIVLTKEDVLQTIEYVKNLVSGEGFTDDIDNLSNRRVRGVGELLSIQIKGG
MLKMSKMVREKMTIQDITTLTPQSLLNTKPLNALILEFFGSGQLSQFMDQSNPLSELTHK
RRISALGPGGLSRDRAGFEVRDVHNSHYGRICPIETPEGPNIGLIASLSTYGKVNKYGFI
ETPFVKINDGKADFNDIRYLAADEEEGLFIAQADTPIDKDGNFLTDEVVCRYGDEIVHID
KSKVDILDVSPKQLVSVSAGLIPFLEHDDANRALMGSNMQRQAVPLLKTEAPYVGTGLER
KVAVDSGAVITSKATGTVTFVDARKIIVTDEDGKEYSHRLLNFEKSNQSMCLHQKPIIDL
GDKVQKGDIIADGPSTAGGDLALGKNILLAFMPWEGYNFEDGILISERLRKDDVFTSIHI
EEFDIEARTTKLGDEEITREIPNVSEEALRNLDENGIIRIGAHVTPDDILVGKVTPKGET
EPPAEEKLLRAIFGEKAKDVRDTSLRLPHGVKGTVVDVLELSKENGDDLKAGVNKLIRIY
IAEKRKIMVGDKMSGRHGNKGVISRVLPIEDMPHLEDGTPIDVCLNPLGVPSRMNIGQVL
EVHLGLAIGDINKYIATPVFDGASEEDVKNYLEEAGYSRTGKVKLIDGRTGKPFDNPVTV
GRMYMLKLHHLVEDKMHARAIGPYSLVTQQPLGGKAQFGGQRLGEMEVWALEAYGASNIL
QEMLTVKSDDISGRTKTYEAIVKGQEMPEADAPESFRVLIKEFQSLGLDVALYDKDGKQI
ELDKNVDA
>SEQF2502_01059 50S ribosomal protein L7/L12
MAFNKEQFIEDLKAMSVLELKEVVEAIEETFGVSAQPVAVAGGAAAGGAAEEKTEFDVIL
VSAGGAKLAVIKEVRAITGLGLKEAKELVEAGGKAVKEGASKEEAEEIKGKLEAAGATVE
VK
>SEQF2502_01060 50S ribosomal protein L10
MPAQEKLEVVKGLVEKLKDAKAVVFVDYKGISVNEDTELRKNAREAGVEYFVAKNRLFKI
ALKEAGFDTNVDDLLEGTTSFAVGYEDGVAPSKLVFDFGKKLKDKLIIKGGLVETERVEV
STVEALAKLPSRDELLGQIAYGLLSPVRMLAVALTNVAEQKGTGAAAE
>SEQF2502_01061 50S ribosomal protein L1
MAKRGKRYDNISQKVDKMKVYTPEEALDLVFETKSAKFVETVELAIRLGVDPRHADQQVR
STVSLPNGTGKTVRILAITSGENIDKALAAGADFAGDDEYINKIQGGWLDFDLVIATPDM
MPKLGRLGRILGTKGLMPNPKSGTVTTNIEQTVQEFKKGKVAFKVDKLGSIHLPIGKVDF
TKEAIVENFKVALDQIIKLKPASSKGQYLRTVAISLTMGPGIKIDPLLAGAFVAK
>SEQF2502_01062 50S ribosomal protein L11
MAKEVIGKIKLQLEAGKANPAPPVGPALGQHGVNIAEFCKSFNAQTQDKMGFVIPVEITV
YADRSFTFVLKTPPASDLLKKAAKVKKGAGNSLKEVAGTITKAQLQEIAETKMPDLNAGS
VEAAMNIIAGTARSMGIKISE
>SEQF2502_01063 Transcription termination/antitermination protein NusG
MTGAKEKVEDEVAYEKKWYIIHTYSGYEKKVAADLEKRIESLDLTDRVFRILVPEEEVLE
EKRGKMVKVPRKLFPSYVMIEMLSVREENELGLGYRVDSDAWYVIRNTNGVTGFVGVGSD
PIPLSDKEAADLLSKIGIDIDGEEKPPRLDINFKVGEVVAVKGGSFDGQQGEISEIDHEH
GKIKVMLEVLGRLTPVEVEHTEIEKIDY
>SEQF2502_01064 Protein translocase subunit SecE
MSKFNLEDAIRNLREEYKKIYWPDKIEVYHVTVIVILMTAFIAIYTLLFDTAFNFVLAKI
SEVLRNILGGA
>SEQF2502_01066 50S ribosomal protein L33 2
MLTKAIEYGIINELVYSGNTNILLGGIETMRVQVILECTETKLRHYVTTKNKKTHPERLE
MRKYNPVLKRHSLYREVK
>SEQF2502_01067 hypothetical protein
MESFIFLGIILLVGAITNNKSIVFATIFVLILKSLFNITEYYKIKGINIEEFMTQFRKEG
ISWGVLIITIAILIPIATGEIGFSHLLSAFKSPVGWVAIISGITVSILSSKGVGLLSGQP
EITVALVIGTIMGVVFFKGIAAGPVIASGITFCILKVLELFLRH
>SEQF2502_01068 hypothetical protein
MVATIQVNKQSIKRLLESGKEQMFLIPEYQRPYSWTENETKTLFYDLLEFTENESKKNSE
VEGTYFLGSIVSYENEEGEQEIIDGQQRITSLFLLLRAIYTKLTSYEEKTVEQENFIRQI
QPALWKQEKLTGEVDYTSVLITSRVIDNEGNKILQDILETGIADHKRMDNYSKNYILFQR
LFDKLCELSPTLMLEFIYYTLNKVVVFPIKTDSQDDALSVFSTLNDRGLPLSEADIFKAK
MYNRIKKEYKKMFIKQWKNLSERATYARENVKQLFYYYMFYLRAVEKDIATTTLGLRRFY
SKNGFTRLYKSNLLKHLDQILDLWVVMNRHESIDDKPWTENVNIIKILDTLSAYPNESWK
YPVVVYYLSHGEKENFEACFLKFLRKLFLELTANYLVTPSVSAVKADILKLNVDIIDNIS
PKVAFKNIPITILQERVKTPNKNLVRMILKMVVYNNQDELLPEKWEVEYILPQKWSDRFT
ESVENKEVKEHINYIGNKIPFERRLSIKATENFFEKKKVSYKKSKIKYVRELIPDDKNDW
TFEDIENRNKKVAEELVKLFITWNGEYEF
>SEQF2502_01069 hypothetical protein
MFEKFRLKKLSKVIQSAISNLFDQIIKKDYFGTFSKINFLNIENVALLYKKNKNIVISKS
DGFLKALDKYISNSGIDLSFLENVDLKKLVEKFEKLCANGYKNFIENDIRNKIFERIKKI
LEVLQKLYLFFYILLNYASISSNTKICRAPPYNFYKNNY
>SEQF2502_01070 Nitronate monooxygenase
MKEISEVKKENSVNLNEEKANENKKIELKGIKIGKYFIEKPIVQGGMGVGISWDRLAGNV
AKNGCLGTISAICTGYYQNMKFVKKAVNGRPLGTENTYNREALFEIFKNARKICGDRPLA
CNILHAINDYARVVKDALEAGANIIVTGAGLPLELPKLVKDYPDVEIVPIVSSARALKII
CKKWKAAGKMPGAVIVEGPKSGGHQGAKYEELFAPEHQLEAILPPIKEERDKWGDFPIIA
AGGIWDNNDIKNIMALGADAVQMGTRFIGTYECDASDVLKQVLLNAKEEDIVIVSSPVGY
PGRAVKTNLIKTLEPNTKKIKCISNCIFPCERGKGANRVGYCIADSLGDAYLGRLQSGLF
FSGANGWRLNKIVHVKDLIDELMTTN
>SEQF2502_01071 Electron transport complex subunit RnfC
MVRRISFRRIANILFSKNIDEDEKTIKKNTNKEHQPMKPMTKNTKIKEIEDPNLLYIPLS
QHIGSPAIPTVEIGDRVKKYEKIGEISGNISANIHSPVSGDVVDVVEHLVANGKKVKTVI
IVNDFQNTEETLTKRKLSDLRLIKKEEILKIIREAGIVGLGGAQFPTHAKYDIKFKKVET
FIINGAECEPYLTSDYSVMKNFTKEIFQGLKVIQKLLNPKEIVIGIEEENKELIEIFEKI
QKEEKFEIKVKLLPAIYPQGSELQLVNTITGKKLKKGELPLEKGVIVSNVSTVKAIYDAF
FEGKPLIERIITISGEEAKNIGNYKLKFGTPVYHIVKELKITNEDKIIFGGPMMGTEVFD
SRVPTVKGTSGILFLDVEKIERKNCISCGYCVETCPMNLMPFEFADYYKNGKYEKMVTAN
IQNCIECGACEFVCPSRVPLMESIKTGKLLLSELEVKNNEK
>SEQF2502_01072 Electron transport complex subunit RsxD
MKNKEKSLMEEILNREKSNGKNGLLDNDDTLLNSTVKNLPEAKKTEQLQNNYFKNSEIYK
TDSEIKNLNNLNTIEKVKKNENKKETETIKKIFSKKETTESDEEIKRKKIIKKFFKKRKL
QVLSFTPYIRTEIEIRNIMKDVIIALFPAIISSALVYGTRALLLIAFSVLSAVVTEKLFS
KYFLNDNNSVHDLSAVITGILLAMTLAPLTPLPIVIFGACMAVIFGKLIYGGIGKNIFNP
AVIGREFMTVFFSSTMSSGAIWFSQELLQLSGIKFFTGFTNSPFTNYLDGLLLTSSGSVG
SYSVFSLILGGLYLLLKNRISWHIPVSLFATFFIITIFGNIPVSIGGLLLTGIFMATDMP
TSPSSAPGKIYYGIMLGLIIGLLSMFGIKNEILSYVLLILNPFARIINKVFRPVVFGYDV
KEEILKQSEKMILLTLGIFAFAIIFLGFHKIGAMPYLVYLYILISTLNLISSKNKNKIIH
KNLKNAI
>SEQF2502_01073 hypothetical protein
MKKIAKHNHENEEIIFTVLKGKMEIFLNETEKHILVPGDILYFDGVNFINGFALEDSEVS
VTLIKK
>SEQF2502_01074 Transcription termination factor Rho
MLKKEKEIEAEKMLEEQSETVRPRRGRPRKIEIDKSLENVESTEEKKQKYDEEDSSKKSA
PENSNHEEKMIKDILSENVTKLKKMAKEYKIEGFSGMSKLELINAILIKKGEEKGKTYGF
GKLDVIGDGNYGFLRDTSIGPDVYVSISQIKRFFLRNEDIVFGELRIPIGTEKNYGILKV
LLVNGDLPEKSLERPYFDDLVPSYPDEKLNLGGGEISSRIIDLVSPIGKGQRGLIVSPPK
AGKTMLLSTLANDIIKYNPEIDVWILLIDERPEEVTDIKENVKDAEVYSATFDEDPRVHT
EVTENVLQMAKRQVERGKDILILMDSLTRLARSYNITIPSSGKLISGGIDPNALYYPKRF
LGAARNIKNGGSLTIIATALVETGSRMDEVIFEEFKGTGNMEIILSRTLEQLRIFPAIDV
LKSGTRREELLIPRKNLEKIWKLRRELSEMSEVEGIRNLIELIKKYKNNDELLEDLYKTK
KINK
>SEQF2502_01075 tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase
MEKRATIITYGCQMNVNESAKMKQMLQTMGYSMTEDIENTDLVFLNTCTVREGAAVKVYG
KLGDLKRIKEEKDGKMIIGVTGCLAQEVREEFIKKTPYVDLVLGNQNIGRIPDLLERIEA
GEETHIVMVDDEDELPTRVDADFGDDIVASISITYGCNNYCTFCIVPYVRGMERSVPLNE
VVKDVEQYTKKGYREILFLGQNVNSYGSDFANGQDNFAELLEQSANVEGDFWIKYVSPHP
KDFSDEVIDTIARNPKIARMLHLPLQSGSTKILDAMNRGYTKEEFIALAKKIKEKVPDIG
LTTDIIVGFPGETDEDFQDTMDVVNEVGFENAFMFMYSKRTGTPAATMEEQVDEHTKNER
LQQLMRLQNMKAKEESQKYLGKIVKVLVEGPSKKNPEMLTGRSSTHKIVLFKSDRKDLKG
KFVKTRIYDAKTWTLYGELVEE
>SEQF2502_01076 hypothetical protein
MALSNAQLNVKRSFKNFFQKRAKFSRFKSKKNNVKSYTTNCVNNSIRIEENKYLVLPKLK
RIKLKCHREIPKDYRIKSVTLTNSNGNYYVSVLTEFEKEIQKMPSNDKVIGLDFSMSELF
ISSENQRADYPKYFRMLEKKLKKLQKLLSRKVKFSKNWYKQKAKISKLHEYIKNCRRDFL
HKLSKKLSEAYNAVVVEDLNMKGMSQALNFGKSVGDNGWGIFLRMLEYKLMFLGKQFLKI
DRWFPSSKTCSKCVNIKEKLKLSERSYKCECCGIEIDRDYNAALNIKNIGKEMLKY
>SEQF2502_01077 hypothetical protein
MCKMGMLCSLDLMFKKKIIFLFLLLFSSIVIFGNTDNQTLEVCKYFKGGDSKKKFNPYTG
KTNIPFKNGIYKCENTNVSFRVFILRYLYVDDLDISGTLTFEIKNGRMVKFEARDSKTGK
LEFSAQYNQSGPVGEMYVDKSFGFGNENSLKLNYKSGKPVGEMEEYYDNGKLYRKSTLRK
KNNFHPFSNPDDFKDYVEYYEIYDINTGEIVKKESLANKTGIIWRYNSKTGKLEMESHLE
NGKIFLEKEYGEDGKVIQEYN
>SEQF2502_01078 Ribosome-binding ATPase YchF
MIGIGIVGLPNVGKSTLFNAITKTQNAEAANYPFATIEPNVGLVSVPDPRLKALEKVINP
ERTVGATVEFVDIAGLVKGASKGEGLGNQFLSNIRNTAAICQVVRCFDDDNIIHVEGSVD
PIRDIETINAELIFADLETVERAIQKNQKLARGGNAEGKELLAVLERCKAHLEEFKLLKT
LEFTQREEELIKVYQFLTIKPMMFAANISEDDLTSETENDYVKKVREFAKQYDSEVVTFS
AKVEAELIEIEDEEERQMFIDELGIKEPSLNRLIRAGFKLLGLITYFTAGVKEVRAWTIK
QGTNAQKSASEIHTDIEKGFIRAEVVSFDKFIELNGWNGAKEKGAMRLEGKEYIVQDGDV
MFFRFNV
>SEQF2502_01079 hypothetical protein
MWNDLKLEIDICTKCVLEKTRINPIVGEGNKKAEVLFVLDSVSEEEDIKQQLLADKNGKY
FKRFLEYSKLDLKKCYFTTLTKCSSHGNIIEQESILQCNEFLITQIALINPKYIVTVGER
ATKSLLENDEKEDIKDLVGKVFDFYGEIKIVPIYDISYLFKATDKEKWKLIKILEKL
>SEQF2502_01080 Putative metallo-hydrolase YycJ
MKFSSLGSGSSGNSSYIEMGNKKFLVDAGFSGKKIAEKLNNIEKRIEDIKGIFVTHEHSD
HIQGLGVVSRKYDIPIYLHEMTYGVIREKIGKIDKKNLNFIREDKIIIGNCVINNFEVMH
DAKKCLGYTFEYEGKKLSYASDVGCVNNIIKENLKNSDVIVLESNYDYNMLMTGPYHWEL
KNRVKGRNGHLSNSEASKLIAQVLNEKLKKIYLMHISKDNNTPELAYNSLYEILERENKS
HLEIEVIDEEGTEIYKI
>SEQF2502_01081 hypothetical protein
MAFDNDYYYGNNRAKITRKIISRGVVFLIVLFIAIFNVVILFSRKVDKLINADIQVETVK
LQNAVKKFKEMTGANPKLAGLEDNLRSVKSADGKYNFETFYGNEKIYEIPESLKDDREQS
NRIVIKKDRKGGWVYDEAKGTISPNI
>SEQF2502_01082 Ribosome biogenesis GTPase A
MIKKKCSGCGIELQFEDKNKEGYVPKEKFVMQDDLLCQRCFKIKNYGENLVNNFSREDYL
KEVSKSVKKSDVILPIFDIIDFEGSFTEEILDYLRDYRSIILVNKIDLMPDFIHPTEISN
WVKDRLAEEDIVPDDIAFISAKSKYGINGIVRKIKNIFQNKKVKATVLGVSNVGKSSVIN
LLLGNNRITTSKYSGTTLKSINNKIQNSEITIIDTPGLIPDGRVSDLISVESGLKLVPVG
EISRKTFKLEENQVFMFDVFCRFKILGNELLESGSKPIFSAYASKSVKFHVTREERVEDL
LNGNFFEILQGSEKKKYFQNEFVTCEVEIEENEELAIAGLGWVNVKRGPLKIQLEIPKQV
KVIVRPSIFKNKK
>SEQF2502_01083 Tyrosine recombinase XerD
MENDINDELTKKNNENVQENIKNENLVMYVDKFLYYEEVILGKSFNTIRGYRRDLLQFME
YLEEYEEIHNFEEIEMMTFRSFIAYLNSPKRLEEVEKNDKNVKSIENMENSDKKAKLKPI
SKRSINRKISALRTFFKYLQEIKVIETNKASYINVPKFEKELPNVINRDDLNNLRHVINT
EKITGIRDRLIIELLYSSGLRSIELINLSEFMIDIEEREIRVVGKGDKERITFFSENAKK
WLIKYIEEKKRQYANYTREVLIVNSKGKKLTTRSLRRLISAHAHEAGIQKEITPHVFRHS
FAMELLNNGVDIRYLQELLGHSSIAATQVYTHVSKTFLRDIYMSTHPLAKE
>SEQF2502_01084 Ribonuclease PH
MRNNNRKNDEMREVKVTKNYIIHPEGSVLIEFGNTKVICNATIEEKIPRWLKGTNSGWIT
AEYSMLPRATHTRVQRESAKGKLSGRTMEIQRLIGRALRAAIDLEKLGERTVMIDCDVIQ
ADGGTRTASITGAYLALELAVEKLIDQGKLKEIPIKSKVAAISVGKVHNELLLDLEYEED
SKADVDMNIVMNDKGEFIELQGTGEEATFTQAELLKFIELSKNAFDKLFSL
>SEQF2502_01085 Serine hydroxymethyltransferase
MSYIKDFDLEVYNAIVEEENRQEEGIELIASENFVSKAVMEAAGSVFTNKYAEGYPGKRY
YGGCVNADVVESLAIERLKKIFGAKYANVQPHSGSQANMGVYVGLLEAGDKILGMSLSAG
GHLTHGYKINFSGKNYIGLEYGLHPETELIDYEAVREIALREKPKMIVAGASAYSRIIDF
KKFREIADEVGAYLMVDMAHIAGLVAAGLHSNPLEYADVVTSTTHKTLRGPRGGVILTNN
EEIAKKIDKTIFPGIQGGPLVHIIAAKAVAFKEALSPEYKEYQEQVVKNAKVLSEELTKG
GLRIVSGGTDNHLMLVDLRPMGVTGKLAEAKLEEAGITCNKNAIPNDPEKPFITSGIRLG
TPAITTRGFKEEETRQVAQFILTVLGNIDDSEKIAQVKEQVFKLTEKFPLYKGK
>SEQF2502_01086 putative phospholipid-binding lipoprotein MlaA
MAGKNKLLMLGAMFAVTVIGKAELMDIKNEDTIMFLEESNKEANDDLFVEFVDGKTAQKP
DKSIDLVAQTNIKTKKNKPDKNKYIALEQDGYGVLAENLEELDEDYIVSSQVFQLTGIDD
SLEPFNRRMYAFNTQLDRKVLYPVSRVYSAVIPKPVRKGISNFYNNFKEIPTFVNSVLQL
KPGKAANALGRFVVNSTAGLLGVTDVAKNIGLKSDPETMGDTLGYYGIKTGSFLILPALG
PSTVRDAVGTAADTAIGGAARGVAEEKLFFDTGVFDKNVYGFTRPVVTGLNARSMFNLRY
GDLNSPFEYDFVKALYYNYRKIQVVK
>SEQF2502_01087 hypothetical protein
MLKKILGLIIIFTFSVIGLAETDVTQIASDYPYKESAIMATVLGTPVEQQYKFKNPKGPK
VRRFTTTKKIPEILRQWKDYEYGVWTQKDKKAPLMILISGTGSVYNSGMSLYLANVFYDK
GYNVIAFSSPTTMPYIVSQSKNIYAGYIKDETVQMYDLIQKAILKEKSNGMKIDKTYIGG
YSLGGFQSLLIHEMDEKNNRKIGIEKSLLLNSPISILTATNKLDGYLVKNGVYDARSLEK
YLDTIFSKLMYDKSIQIKDIEFSNLTTSLGKLGLGEKDFEMLTGLLFRFYSANMTFAGEV
FSGNNAVGRLSNKKSYKRFDSVSNEFREGLSVSFDEYAKEILYPYLKKYKYPNLDFNKFI
SDFDLRSSQDFINRNNKNIIFITSTNDILLKEKDLDYIKNTFSNRVLIPFGGHTGVLWHK
DVANLMVDKLEEK
>SEQF2502_01088 Chromosome partition protein Smc
MYLKALELTGFKSFANKTIVEFDDGITSIVGPNGSGKSNILDAILWVLGEQSYRNIRAKE
SSDIIFSGGKNKKPKSMAEVSLIIDNEDRYLDVDFSEVKITRRIFKTGENEYLINNRKSR
LKDIHNLFMDTGIGKQAYSIIGQGRVERIIGSSPKELKEIIEEAAGVKRAKIEKDESEKK
LQDLKNEIEKIDYVEKDLKQRVDYLKGEQEKAKLFKEYSKKINIQRFMVLEYDVNEKTSL
KYEYEEKSQEVKEELEKNEKSFSGKQAELEKTNEIRVKLQENLESQKNRRNKNFENLEIL
KEKYSKLMNQNSNLETEANEKAKRKGILEKDIEEKEKILNDSRNELELITKDLTEKEQEK
TELEVKVKDVKKKRNEIALELKERIQKNSDFEVDKIKVAGENEDLEKRVFGAKNENKRQI
AEKMDLEAEFDKISQEKKAYEVEKSEKEKQKLEREQKIQKLNEKTDELRKEYSKINRGKN
EISYKLENYKVRQKAIANAIEKNETFNQSVKHILNEKIDGVIGAFVNLIDVPSGFEEAVQ
TLSGGMFRDIVVKDSEIGKKCIEILKRKKLGRASFLPIENIRVSKMNETLPIIDKTLHQG
DFQNKMSKEEIQNIILNTNGENGIIDFARNIVKVDAKFVDKNIKKVIQFVYGNSVVVENL
EVGTELLKKGFNDRIVTLEGDIIASRGRMTGGHSFKGKDEILERKKELKRLEAEIETNRE
NLDKFKKKLSEVVLEAEKVEKEKEEKEKLFENFKNNYQSFNNNYDDFSVKFSRKQREINT
LNYEISESGKFILEKETKIKENLKLIQNIEKCIKENNLKMKNLNEELKKLENIDEFVQKL
NVADKEYEVLKVKTDNNKNRFREIEIDYKKLLSEKAELIEFEKKKELFGSELIDKISNMK
SEIKANEKSKVNILKEIQETEAKIQEVEGSERKLIAEIKEIEMNILKSKNEYEKIIEKIT
RNESELEFKTSEFKELENDEIFNDEEYFEIISEEELAATKRKLSLNERNRINIGPVNMAS
IEEYEHENERYQNIVAQKRDLFESRESLLGFIREIEEEVTSKFFMAYEQINKNFQYMCET
ILNGAKGIIKMTDPENVLTTGLELSVKYKNKPEQTLLLLSGGEKSMLAVSFIMAIFMFRP
SPFTFFDEIEAALDEKNTKKIIELLHQFINKSQFILITHNKETMKGSHRLYGVTMNKEIG
ETKIVSVDV
>SEQF2502_01089 UDP-N-acetylgalactosamine-undecaprenyl-phosphate N-acetylgalactosaminephosphotransferase
MAVRGMKKNYSYLFGILTVVMYLVGLLLINRGLGFTNVIVIVCSMIIYYVANVYNMTGRY
KLRDIAIIIIINFILVIVIKLFKIFLLNEAIILFGLITMFQIIYRYIVMIGLAEKKKVVF
VGENGYTNDLLESIKKDSQYKLSDVLKEKKDITILTKKLLDLCENKKVDIIVDFTNNLLY
DTKLVDKLLQYKLNGMQYYNYLEFYEMYENKLPVSNLSPKWFLENTGFEIYYNSFNLKAK
RILDIIFALLIGVCVIPIMIIAAIIIKLESKGPIFFIQERIGEGNKPFKIVKFRSMTTDA
EKDGPKWATKNDNRVTKFGKFMRLTRVDELPQLWNVLRGEMSFVGPRPEREFFIKQLEKE
IMYYNLRHTVKPGLTGWAQVMYPYGASIEDAYRKLQYDLYYIKNHDILFDMKILLKTVTI
VIFGKGR
>SEQF2502_01090 hypothetical protein
MIWKFYLLNEIVSLDKFVIKEKMKKGSVI
>SEQF2502_01091 O-acetyltransferase WecH
MVKSKDRFFNFDILKCIAISMVLFIHIVASELYSYGEISRNRWMTANIIDSFSRMCVPLF
VMVSGFFLLRKDEDVKVFFKKRFVKIIPKFFIYSVVFFIFVIIFKDVKNDELFLVFFRKS
TYKTIILIFSKKESYHNFFSDFFQGKIYYHLWYIYMILLLYLITPFLRKIVIKVDRKSID
YLVYIWIAFIIVIPFLNAVFRKNIKIYSPVGQYIGYFLIGYLLFEKPLNMKKWQKYIIFF
MMIFSIIFLTYIFTKSNSKFFDYFYDYHSIGVFGATVLFYDFFVNTFDGEKNLAKVKNVI
KSVSAKTYDIYLIHPIFLFFCEKILKFKVNYFLYIIVTFVIVFLLSFFTSKILKVLYNLL
TGINRQFYKKIELK
>SEQF2502_01092 hypothetical protein
MKIKLNNISETMLITLHARAKDAESKNPILNDKKSSEILSQLDYDFSKFEKAWASYYGIL
SRAKVMDNEVKKFMEKYPDCAIVSIGCGLDTRFLRIDNGKIRWFNLDLPEVIEKRKLFFE
PNERVTDIAKSAFDSAWTKDIKLEGKKLLIISEGVLMYFEEQQIKQFLEILTDNFDSFEA
QFDLLYKGTVKMSKKHDTLKNMEAKFSWGVKDGSEVVKLNPKLKQTGLINFTDEMKHHLP
GWKKLFIPFFYIFNNRLGIYTYEK
>SEQF2502_01093 Putative multidrug export ATP-binding/permease protein
MKELKYLLSLSGKHKMKLIFSAIFSIIGTTLSAVPYLLVYQIVLELFKANIDYSRIKFCV
FIAIFFIIVKIIMQILSGVFSHIAAFSILYKIRIDLIEHLSKLNMGFFKKNMSGKLKKII
NEDIEKLELFIAHQIPDLSSALVTPIIFLGIMIYFNWKLTLVLFIPIILSIMAQGKMFQS
YGSRVEHYYTLLANLNATIMEYINAMNVMKAFNLTAKSFKDYRDITQEYADYWIELTELS
VPFYSIFLCLTDSGLLFIIPVGGLMLFYNQISVSVYILFILMSTIFLSSLKALFDLAHHL
SALTKGLGKIMEINGEQEQKSGNTNFPSNFSGYIKYENVNFAYKNKNVINDFSLEIKAGT
STALVGPSGSGKTTIGLLLGRFWDINSGKITIDGTDIKDFTYTGLADNVSFVFQDTFMLH
DTIFENIRMGRDYSLQEVENAAKKAQIHDFVMSLPQKYETVIGEGGIKLSGGEKQRISIA
RAILKNAPIIVLDEVTSYSDIENEAKIQEALRTLLKGKTAIIIAHRLYTIKNADNIVVMN
KGRITEQGTHKELLQNKSEYWHLWNLYSDNDLMENKEI
>SEQF2502_01094 Lipid A export ATP-binding/permease protein MsbA
MINDIRNIRTLAGNKYKNLKKPIFFLTIDAIFYMMNYAMFYFTIIDLMNNNFTMKKLIIY
TFIMIFAIICRFVLNRIGYIGIQSEGAKIIQDLRIRMGDHLRNLNLGYFNSHNIGNIINI
MTNDLQDFEQVITHSTSEIIKLSILTIYLLLIIFEISPLLAILQLIISLTGLIFVILGTK
KGAKIALKKKHTMDNVVSRMVEYIAGMELFKAYNLTGEKFKRLKDSFNDLKKESINTEIA
LAPYVMIFQLITDISFALLLLVSTQLFMASSINKVEFFSYIIIGLSLSNVLKAFSTQYTF
IQYLKLATDKLINVHNEKEISYELEKVTLPNYNIKFQNVSFSYEKDTPVLKNITFEAKQG
TKTALVGSSGSGKTTVTSLIARFWDCQSGEITIGGINIQKIYPEELLTNISMIFQDVYLV
NDTFENNIRLGKPKAAREEVINVAKNANCHDFIMESENGYDTVIGEGGSTLSGGEKQRIS
IARALLKDTPIILVDEATASLDADNEYEIRKSLNILTKNKTVITIAHKLNTIKDYDKIIV
MSDGIIEEIGNHEQLMENKGRYYKMYTEMEKAQSEFELI
>SEQF2502_01095 Amino-acid carrier protein AlsT
MLNVIKDFNGFFWGVVLIILLVGTGIFYTFRLKFIQIREFKSGLKQLTGGFDLSGEKADS
NGMSSFQALATAIAAQVGTGNLAGAATAIVSGGPGAIFWMWVSAFFGMATIYSEAVLSQI
FKQKKDGEMTGGPAYYIQTLFNGGKAAKFLAGFFAVSCILALGFMGNAVQANSVGDAFHN
AFHIPTVVTGLFLAALSGFIFFGGVKRIASVTEKIVPIMAILYVVTCVAIILLNIGNTGM
AFKAIFINAFSTKAVLGGFAGAGMRKAIRFGVARGLFSNEAGMGSTPHAHAIAKVKNPED
QGHVAIVTVFIDTFVILTLSALVILIADGRANGTGISLTQQAFQAVLGHFGVIFVAVALF
FFAFSTIIGWYFFGEANVKYLFGKKALNVYRALVMACIVAGSLQKVDLVWELADMFNGLM
VIPNLIALIGLHKLVVEVTKKDPLLKD
>SEQF2502_01097 Adenosine monophosphate-protein transferase SoFic
MKNYILETLLEEKNNNLKGMLYHNLQIKFAYNSNHIEGSTLTEDQTRHIFETNSFFAENE
TVKVKDVIETLNHFKCFDFIIEHANEKLSEKYIKKLHFLLKSNTSDSQIEWFKVGEYKQK
PNTVGGNRTVSPKQVEAKMKKLLENYNSQTEITVEKIIDFHYEFEKIHPFQDGNGRVGRL
IMFKECLKNDIVPFILEDKYKMFYYRGLKNYESEKGWLYDTCLMAQDEMKKMLDYFEVKY
>SEQF2502_01098 Putative teichuronic acid biosynthesis glycosyltransferase TuaG
MEKEKVSIIVPMYNAEKFIGKTIESVLSQTYENWEMLIMNDVSTDNSLAVASEFVKKDKR
IKIVNTEKNVGVVKGRNFLIELASGKYIAFLDSDDYWHSEKLEKQINFMKEKNASISCTE
YMRVRENGEKINEVVIKSEISYTDMLKNNYLGCLTVMYDAEKIGKRYFKELEKNEDYVLW
LEIVKDVKTIYGLKESLAYYRVLDNSRSSNKAKTAKVRWEIYRKIEKLPLLKSIYYFIHY
VVRAVLKSK
>SEQF2502_01099 putative oxidoreductase YhhX
MKLGIIGSGMIVQEFLPSLVKLEGLEIVGMQGTKASIGKVEEICTKYGIPNFTDDFDELC
EFGIDTVYIAVPNFLHFEFCKKALEKGLNVIIEKPMTTNYKEAKELSDLAKAKKLFLFEA
ITTLYFENYKKIKDWIGEIGDVKLVQSQYSQYSSRYDAFKRGEILPVFDLKKAGGALMDL
GLYNLHYVLGLFGKPENVKYYANLERNIDTSGVLMMEYENFNAMCVCAKDSEGERIGVIQ
GSKGKIISEEAPGLVGKVTLKMYDGTMKSFDDGFSKDRVVPEFKAFIRAVNEKDLEFCYR
QLEKSLLVSEVQTKARIEAGIKFPQD
>SEQF2502_01100 hypothetical protein
MEIRHIVNEGFFIFGENGDELAKLTYRKEGEKLFFESTVVSPELRGQGIAGKLFEAGVKY
ARENNYKIVPVCSYIVKKFEGGKYDDLKA
>SEQF2502_01101 Putative phosphoserine phosphatase 2
MKKTLYLMRHGQTLFNLRKKIQGSCDSPLTNEGIRQAKVAGKYFKDNEITFDAAYSSTQE
RACDTLEIVTNNKMRYERLKGLKEWNFGLFEGESEDLNPKHPNERTYGDFFVNFGGESNK
DVEKRMQETLTRIMEKDGNNTVLAVSHGGACYNFFLKNAPDIPFTGLPNCAIFKYEYEDG
KFTFIELIKHDFTKEI
>SEQF2502_01102 hypothetical protein
MEIRHVVNEGFFIFGENGDELAKLTYRKEGEKLYFESTVVSFELRGQGIAGKLFDAGIKC
ARENGYKIVPICSYIVKKFESGEYDDLKA
>SEQF2502_01103 Taurine import ATP-binding protein TauB
MKKDKKLEIKDISISFKNKKVLENVSIDLYENELVCILGVSGAGKTTLFNIVAGLLEPDG
GNVKMDGEDITGKCGKVSYMLQKDLLLPHKRIIDNVALPLVIRGENKNKAREIAKPYFKD
FGLEGTENLYPSKLSGGMKQRAALLRTYLFSSKVALLDEPFSALDAITKHKIHSWYLNIM
NKIKMSTLFITHDIDEAILLSDRIYILAGSPGKIVAQINVELKNSQDKSYNNEDVIMSEK
FIQYKREILKYL
>SEQF2502_01104 Formylaminopyrimidine-binding protein
MRKVSKILILCLILILIVSCGKSKDNKKIRIVLDWVPNTNHTGLYVAKDLGYFKEEGVDV
EIVQPPEGSTTALIGAGGAEFGISFQDTLAKSFAKENPVPVTAVAAILQHNTSGIISLKE
KGIDSPKKLEGKRYATWEDDIEQAILKKLVTDNGGDFSKVKLIPYTVTNVVTSLKTDIDA
VWVYYAWDGIATEKAGLKTNFLKLRDYGKELDYYSPVIIANNDYLKANSEIAKKVLRAIK
KGYEYAAKNPEESAKILVKNSPELDINLVTASQKWISKEYQADAKEWGIIDGNRWNGFYE
WLYKNKAVKREIPKDFGYSNEYLK
>SEQF2502_01105 Riboflavin transport system permease protein RibX
MKKFQNITDKIASSIIIAVLLMIWQILSMVNIIPKFMLPSPFEVVKAFVSDFPLLMKHTE
VTLVEAFLGLGLGIILGFVVAVIMDRFEYAYKMIYPVLVITQTIPTVAIAPLLVLWMGYG
ILPKIMLILLTSFFPITIGLLDGFRSVDRDMLNLLKTMGATSFQNFIHLKLPSSLGYFFA
GLRISVSYSIIGAVVAEWLGGYDGLGVYMTRVRKSYSFDKMFAVIFLISGISLLLMYFVK
KIQRWCMTWEK
>SEQF2502_01106 hypothetical protein
MEKKEINASVAIQVLPNVVGSDEVVRVVDEVIEFIKSKGLKINVAPFETTIEGDFDELME
IVKECQVVAVKAGAEGVMSYVKINYKPKGDILKIDEKISKYNR
>SEQF2502_01108 hypothetical protein
MINCYKETVLKCKEKRDEKICKNVEQAQNELAQEWWSKMKPEISKKVDKISKDAMAGDAS
SSMENVPEKLWEWEAKHLSTTSQKAKEMTLQLLKDVTQNMKFEKYEYDLENVKTGQTSAG
RNYAIIPAKSIILAQGQKLELNQKTLVFEDKNKWYLVNIDDKTKIILKELYSDLADVKTE
>SEQF2502_01109 hypothetical protein
MKKIKLLLLISVSTMIFTSCGNKYSIENLKKNDKLL
>SEQF2502_01110 Demethylmenaquinone methyltransferase
MIRTDKEKFLEKIKENIDIQNLKGDGKIFSYVNRDYLAGDNKKYMNMYNKLSFWYDFGEK
WIGLFRYGNTISEMRKNLMEHLEWRNGISVLYVSIGTGKDLNFIPQNVDLKSLDFTGIDI
SYGMLKKCHSIWKKRTNLTLVNCCAEDLPFKDNVFDIVFHVGGINFFTDKALAIKEMIRV
SKPGSKIMIADETADFIKNQYKKSIFTKDYYKNTDFDLSEIQKCIPEGVKEKKTDFLWNN
RFYCITFRK
>SEQF2502_01111 hypothetical protein
MKKIKNIPLFLCLTSFFYIIFKIINEKYIVYFENSKVYCITDTVIYLVSFFPVIFYLKKT
MKENQYFFKRKNLRFNNLIFYLGIIVFVNFIMINVRIGYNNESKIIYNYESTTYYIITNI
ILSSLIAPILEEIIFRGILMNNLMKHGYKVAIIMNSVLFGFYHININAIGRVILAGIILS
YITYRYSLKYSIKLHIILNIIANLGKYSYYNDYIMIAMGIFIVVLIIIFIIGLIRKKYKE
IFSIFKLNSGDRKNIIKFVKDNALYLFVILVIVISNLLFNYKLF
>SEQF2502_01112 hypothetical protein
MKIVELNKMELMTIDGGEKKKNCKREWAVVIKRV
>SEQF2502_01113 hypothetical protein
MIVDENNVVKYIEYVPEEGKEADVEKALKFLENNLMKK
>SEQF2502_01114 putative murein peptide carboxypeptidase
MRTIKINKILIISGLIGASLTLNAATYRPSKSSEINTRIRNAASPENTKNTTSDEIIIPK
GLKPGDTIGLIAPANYTNENSNAEVEYLKSRGFNVVYGQSFYSKWYGFGGTDNVRAKDIN
DMFANPNINAIFAVRGGYGGIRIVDKINYDVIKKNPKIISGFSDNTTLLLAINEKTGLIT
FQGPMADNLKNIPPVTENAFNKAFMSNESYNLLDFDDTYSIMKNGRGSGKITGGNLSLVV
ATLGTDHEINTDGKILFLEETNEASYRIDRMLQQLRLAGKFDKLQGIILGDFKNPKQADP
TDMTIDEVFYDNFGKLNIPIIKNFKSGHVRPFITVPIGAKAKIDTYNRQIIIEKATK
>SEQF2502_01115 Lipopolysaccharide assembly protein B
MKKLLLVGAILVTGAISFADGKSDYEKAVKLAGENKVAEAVKVLENVAKGTDTSYAQKAN
LELGAYYLKDNKIAQAKPYLQAAWGNGQSTTPEAIEAARLLYLVGIQQKNKADAEKYIIW
TDEKSGGNNADVVSSLIIFYFDNNEQSKGTARYNKAVQSANKDFVAEVNYNIGQYYLTKN
NTAQAKSYLQKAYTGASDRVNGAGILLAELAMNEKNPAQAEKYLLEMNTAAKGKNAQILE
ILGTYYLQQNNPTKAEEYLTKTVALNPKNSAAKILLLGIYEVQNNTAKVNSIYSQLKSAS
PKVTNRQIGTYFGSVGAGSLAEKYLKKAITEDKDNNAKVVLGQVYAGQGKKDEAIKILQE
AVNNKVNGAAEVLKQVQAMK
>SEQF2502_01116 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase
MTELEKSKAIIQYIADAKKTTPVELYTDEEIKNVYSCKVIGKEGLKIVFGDWEEIDKIIK
ENNLTNYYLKNDRRNSGVPMLDIKNINARIEPGVFIRDKVSIGDRAVIMMGAVINIGAEI
GEGTMIDMNVVLGGRAKVGKNCHIGAGAVLAGVIEPPSADPVIIEDDVVVGANAVVLEGV
RIGKGSVVAAGAIVTENVPEGVVVAGTPARIIKGVDAKTASKTELVDALRNI
>SEQF2502_01117 hypothetical protein
MKKILIFLLVLSNLSFATQNLPVNSKEIEKIIDETFENIDRGNTQKAVAILKKKISEDPS
KIIYKAVLGLIYDRLGKKNEAEKEFNEAVKLQEKYPFIAEDGEKYDIRFMIGMLYGLTAD
YTNALKWLNQVNEKEYNEMFKDEIWLKDFLLGIFNYNNDNPEEAKKYFLKSYIYDEDGSS
ENILGMIYLDEGNQKEAQKWLLASANKGSLGGQGNLGSLYYQLGDKKMALEWLQKALETA
KKEKNSEQIKEIQETIKEVKNSQK
>SEQF2502_01118 Photosystem I assembly protein Ycf3
MKKYLILLVLIANLGLGIQSFSAMTRQERENLEKQISEAYDKDDQKKLLPLVTKYVNEFP
DNADYLNKLGVLYDNLDNYSEAEKYYLKAIERGNYNAISNLAYVYYEKEEYGKALKYYKE
YQKIADNTDNYFWIGASYAELEDYKNAKEWFLKVTKFEKDGSSENRLGLIAENEGNQKEA
LKWYLASIQKGNLWAYDNLAVLYVDLGDYDNAEKLVKKGMELAKNSDDEDLKKEFRETLD
TIQAKR
>SEQF2502_01119 hypothetical protein
MSLLILVLSLLLTIEILGIKVVQNRKYVALKVSDDDFVASVNDKKNDD
>SEQF2502_01120 Dihydroxy-acid dehydratase
MQGKKRSNNLTEGAARAPHRSLLKGLGFISEEMEKPIIGIANSFNEIIPGHVHLKNLVQS
VKDGIRMAGGVPMEFNTIGICDGLAMNHIGMKYSLVTRNIIADSIEAVAMATPFDAIVFM
PSCDKVVPGMLIAAARLNIPSIFVSGGAMLAGVYKGKKIGLSNVFEAVGAYNTGQITRKE
LNSVEEMACPTCGSCAGMYTANTMNCLTEALGMGLPGNGTVPAVFSERARLAKKAGMQIM
EVLKADLRPSDILTREAFENAVAVDMALGGSSNTALHLPAIAHEAGIDLTLSNFNEIAQK
TRQICKLSPSGEYFIEDLYRAGGVTGVMKRLLENERLHGDAKTVALQTQGELAKDAFIND
DDVIKPWDKPAYKTGGIAVLKGNLAPDGCVVKEGAVDPEMLQHTGPAKVFNSEEEAVEAI
TGGKIVAGDVVVIRYEGPKGGPGMREMLSPTAMIAGMGLDKDVALITDGRFSGATRGASI
GHVSPEAASGGNIAIIQDGDTVEIDIPNRTINIKISDEEIEARKAKLEPFKLQVKGYLKK
YAMHVSSADRGAIEILD
>SEQF2502_01121 Carboxylesterase NlhH
MENDCESKILDIELTQEKIKSMVNITYSQPVSYFGKKIKLEMDILKPYKAEKYPAVLFVP
GGSFAHSYKENYLQQRLEIAKAGYVVASIEYRTIPDGVFPQSVEDVKAAVRFLKANADEY
GIDKERIAIMGESAGGYLVAMAGATNGTRDFDKGENLSENSDIKAVIDIYGVTEFGEEAD
FEIPDDVEEGYRATFLSVKFWLDDVRNNIEVTNPIPHISSKTPPFLLMHGDKDTLVPPVQ
TEKLHKALIERGIESTRYVIKGAGHSDEYWFQPEIIKIIIEFLDKKLKNKNF
>SEQF2502_01122 L-threonine ammonia-lyase
MHKLYDFMEARERLNTVITKTKLIYSNIFSNETGNDVYIKPENLQRTGAFKIRGAYNKIA
KLTEEEKKRGVIAASAGNHAQGVALAAQKLGIKAVIVMPKHTPLIKVEATKRYGADVILT
GEVYDEAYEYAKKLQEKEGYTFVHPFDDEDVIEGQGTIALEVLDELPNADIILVPIGGGG
LISGIASAAKLKNPLIKIIGVEPEGAASALEARKNKHVVELAEANTIADGTAVKKIGEIT
FDYIEKYVDDIVTVSDYELMAAFLILVEKHKIVAENSGILSVAGLKKLNVKGKKIISIIS
GGNIDVLTISSMINKGLIARGRIFTFAVDLPDKPGQLVAVSQILSKQNANVIRLEHNQFK
NLDRFHEVELQVTVETNGEEHINKITEEFKKRGYRIKRLNSQAIIDD
>SEQF2502_01123 Acetolactate synthase large subunit
MSETKMINGGRMLLESLHRLGITDIFGYPGGAVIPIFDEIYSYDKINYYFARHEQGLSHA
ADGYARVSGKVGVCLATSGPGATNMVTGIMTAHMDSVPMIAITGQVRSNLLGRDAFQETD
TVGITMPITKSNYLVQNVKEIPRIVKEAYYIATTGRPGPVLIDIPNDIQVHKIPYAEFER
LFEEKIELEGYSPTYEGHPVQIKRAIKLIKEAKKPLIIAGAGVLKSKASKELFEYAEKTQ
TPVAMTLLGLGAFPGSHELSLGMLGMHGTVPANYATDEADLVIAAGIRFDDRIAGNPNKF
IENAKVIHIDIDPAEIDKNKRADVPIVGDLKHVLTDINAEIEPQTHEEWVKKVVEWKKEY
PLGHREVGEDKLLPQEVLKAIDDILQGDTIVVTDVGQHQMWAAQYFTYKNPDSIVTSGGA
GTMGFGLPAAIGAQIGAPDKKVVLIVGDGGFQMTLQELMMIKQYNLPVKVVILNNSYLGM
VRQWQELFKDRRYSFVNLEVNPDFIKIADAYGIKNAKLTNKEDLRTKLKDLILSDEGVLI
ECVVEKEENVFPMIPAGKTVSQMIGKKGELENE
>SEQF2502_01124 Acetolactate synthase small subunit
MNREHEILIIAKNTDGIVSRIMSLFNRRGYSVLKMTAGVTNKPGYARLTLTVDGDDKTLN
QIQKQVYKIVDVVKVKVFPVENVIRRELMLIKVKSAPETRAQIVQVADIYRGKVLDVSPT
SLVIELTGDVKKLRGFVEIMHNYGILEIAKTGVVAMSRGEKL
>SEQF2502_01125 putative methyltransferase
MSVSQHWEKEKYEKNARFVSDYGEELIEWLSPKKDEYILDLGCGDGVLTKKITEYGCKVL
GLDGSQKFVEAARKIGVEAVQGDAQNMKFENEFDAVFSNAALHWMTNPEKVMEGVSRALK
KGGRFVAETGCKGNVGKIENAMFEVAEKHNFKTVKCWFFPTEKEKTELLNKYGLKVKRMI
SFSRPTLLPTGIKGWLQTFSAPAFVNIPKEMHEKLIDEIAEKVEKELEKNENGQIIADYV
RLRFEAVKE
>SEQF2502_01126 hypothetical protein
MKLKTIGLIGGMSWESTVTYYKIINETVKEKLGGLHSAKCILYSVDFQEIEECQANGN
>SEQF2502_01127 Aspartate racemase
MTAEKILEKGLKNIALLGTKYTMEQDFYKSKLIEKGINVIIPDKNDIEIINKVIYDELCL
GTINSNSKKKFLEIVDKLRSKGAEGIILGCTEIGLLIKNEDTDVPLFDTAVIHAEEAAIY
SIL
>SEQF2502_01128 hypothetical protein
MNIDLIKEAVEFSELQSKIFHNNLYGVTDGKKVGTYIEKLFQKFLEDKYGDLGTGNSAKG
IDLPGLNTDIKATSIVQPQSSCPYRNARQKIFGLGYNLIVFVYEKKDYIDNDQRLCKINF
KYITFIEKHRTADYTTTQMLINMKNAGANKEDIMSYLNDRRIPEDEIEHNMIAEEILKKT
FEQGYLTVSNALQWRLQYKRVIELNNQIEGVYNYVR
>SEQF2502_01129 hypothetical protein
MLDNKKEYGDYQTPLDFASTVVKYIKNNYDFTPDFIIEPSCGIGNFFEASKKYYKSEMFG
IEINKNYSDTAKKNNPKAIIYNESIFSYKWDKDMEKFGKTLILGNPPWVSNTELGKFGSK
NLPQKTNLKKYKGLEALSGMSNFDISESIILNLLNKFSKRKFILAMLCKKSVAINIFKEL
YRTSYKSGNIKIINFDSKKIFNISVPACLLIIDCSSDTKVQNEVNIYNFNNSYVDTIGYA
DNKFFLNTNYSSDLDGKCEFEWRQGIKHDCSKICELELNKKIYMNGLKEKVEIEEDLVYP
LIKSSHIKNFKENVFKKYVLVTQKKMKEDTLWIKEKYPKTWNYLEKHKDNFMKRKSSIYK
KMPQYSMFGIGDYSYMKYKVVISGFYKDPIFKVIFSEKPVMVDDTCYFLAFENKKDAEIV
CDVLNSTETIRFLKSISDMTAKRPFTKKVLSRIEFKKFNYEILNYTEKEILDFKIRNGLY
INKLF
>SEQF2502_01130 2-isopropylmalate synthase
MRHIKIFDTTLRDGEQTPRVNLNAQEKLRIAKQLESLGVDIIEAGFAVASPGDFEAVKMI
SENVKNSIVCSLSRAVRKDIEAAGKALEGAAKPRIHTFIATSPIHREFKLKMTKEQILER
VKEMVELAKSFVDDVEFSSEDATRTEKEFLVEVYETAIKAGATTLNVPDTVGYRTPNEMF
ELITYLRKNVKGIENVDISVHCHDDLGLSVANSVAAIQAGATQIECTINGLGERAGNTSL
EEIAMILKTRKDLFEEYYTNIDSKQIYPTSKLVSLLTGVTTQPNKAIVGANAFAHESGIH
QHGVLANPETYEIMSPESVGRNPDSLVLGKHSGKHAFVQKLESLGFDHVGSDRVEELFAQ
FKKLADKKKYVLDEDIIALVAGDAAKIEGRIKLTHFEISRQEGKKPKATVTIDLDGEKLV
KEALGDGPVDAAYNAVNLAVSDTFVLEEYKLEAITGDTDAQAQVVVIIEKNGNRFIGRGQ
STDVVEASIKAYINGINRLYSN
>SEQF2502_01131 hypothetical protein
MIMMQYKVKLPNDFDMNNIRKRVQENGFKTDGFEDLFFKAYLISEENKEYSPLYFWKDNK
GMNKFIFDGFYDNILNSFGWQTINIGIPLLQEFNENFSKAKYLLEIENETKPMEKMKRME
FSISYDKIIGKALVYNPENWKYTEYYFFEDAPKEIENSKVYEILHVSQ
>SEQF2502_01132 hypothetical protein
MEISNNYINEIKKILKNARQKAYTAVNSAMVEAYWEIGRRIVEEEQNGKERAEYGKEIIK
NLSKELTEEFGKGFGERNIRNIRQFYVLFSDYEKWKSLISKLTWTHIQKVLRVSDEKARI
FYLTEAAENMWSVRTLDRNISTLYYNRIVASIDKKIVENEMKEKTKKLQAKEFIKNPVVL
EFLDLPTNMSYTENELEKALTDDIQKFMMELGKGFAFVERQQHIRTENSDFYIDLVFYNY
ILKCFVIVELKTGKLTHQDIGQLDMYVRMYDDLKKQENDNPTIGLLLCTDTDSTVIKYSV
LNDNKNLFASKYVNYLPSEEELINEIERQKILFEINNEVDM
>SEQF2502_01133 FMN-dependent NADH-azoreductase
MKTIVFAHPWNGSFNKAILDKVVEKLDETKEKYTIIDLNKDKFNPVMTEEELSLYSQGKS
IDPLVKKYQEILKNTDELILVFPIWWMSLPAILKGFFDKVMLRGFAYENTQNGIKGFLTN
IKTAKMITTATAPKFLLNITGFGITMKKANLGGVGIKKTKWIHYSLRMQGKDEDRKKFLE
KVGKFVGN
>SEQF2502_01134 Phage shock protein C
MKKKLYKSVKDRKLTGVCGGIAEYFDIDSSIVRIVWLILVLCAGTGLLAYIICAIVLDDN
PNE
>SEQF2502_01135 hypothetical protein
MKKIILKSSYFIHLLCFNVLASILLPELLESVLSSFKIDETAYFGISYLVLVLFNIFLSY
FYAKVRIGKKTLIILTIAGVAIKILLFLLWAQEAFSEVGDDKMGIFMVAIVYGYFAYIGS
LDVIFLIGLGVNLLIRRKNEKKKLDS
>SEQF2502_01136 hypothetical protein
MKRKSWILNVLYVFLTIIIVFLIDSHYEYKQIKIKMIEIKSKDIPKEFDGKRVLFVADFQ
YDTMTRFNRVQEKKAIELINAQKKDMILLGGDYTTWEKNIPKFYEDAKDIKIPELGVYAI
YGNHEYPGEKETAENMKKLGFNLLVNENRKITINNENIYIAGVTDLWHGKPDAKKALEGI
KKEDFVLFLTHNPEYFEQMSEDEKEKTDVILAGHSHAGQVTFFGKIIMSAVKDKKKYGYG
MKEYGGHKIYITSGLGGAFLEMFIRFFAQPEIVIFELKRG
>SEQF2502_01137 hypothetical protein
MGLKNVIRTRMFVTDISKWEEYGRAYGEFFRDIKPVATMVEVFSLIDKELMIEIEVSAVV
D
>SEQF2502_01138 hypothetical protein
MPKIIIESKISSNGGGDKFKLKINDEKIVEVKFNEKTEIDVDYGEQTLQVCNNFLIKTPK
KVINVESDNQNYRITLHFKAWGIIFIFQILMAVLIMNIHQTAVFIVIPIFILEILILIFM
GMFEIKEVKRKED
>SEQF2502_01139 hypothetical protein
MTRIDERVKDRIFVALDYDNMEDAKRLVEKLGENGYKNYKL
>SEQF2502_01140 Adenosine monophosphate-protein transferase SoFic
MDIKTINYEYFLDLSVRMTYHSNAIEGNTLTLNETATIILDSTIPGSKSVREVFEVLNHK
KAIDYMLTELANDQKLDIYVIKNINKEILDRLNDNAGNFKNSSNAIIGADFQTSTPSQAP
VLTKNWIENLNYRLELCKTDDEKLLEILNSHIEFERIHPFSDGNGRTGRLTMLYLCFQEN
ISPFVIEKKDRALYMNYLRKQNADIIFDKVKELQQFEKKRMEQF
>SEQF2502_01141 3-isopropylmalate dehydratase large subunit
MSEIKNEAKKPKTLFDKVWEKHVITGEPGEAQLLYIDLHLIHEVTSPQAFSGLRIAGRKV
RRPDLTFGTMDHNTPTIMADRMNIKDKVSKAQLDALAANCKEFGIELVDMFDENNGIVHM
VGPEQGLTQPGKTVVCGDSHTATHGAFGALAFGIGTSEVEHVLATQTIWQKKPKTMGIEI
TGKLQKGVYAKDIILHIIKTYGIGLGNGYAFEFFGDTIRGLSMEERMTICNMAIEGGGKS
GIIAPDETTFEYVRGRRFAPKGEEFDKKVAEWKELYTDSVDAFDKYIKVDVSNLEPQVTW
GTNPEMGINVTEKFPEIRDHNDEKAYEYMGLKPGQTPFDIPLKHVFIGSCTNGRLSDLEI
VAKIVKGKKVAPNITAVVVPGSQVVKKAAEENGIAQILKDAGFEWREAGCSTCLGMNPDL
IPAGEHCASTSNRNFEGRQGKGARTHLVSPAMAAAAAIYGKFVDVRELDEVK
>SEQF2502_01142 hypothetical protein
MNKNEMINEVQQQFGYDENFSQKVISIFESCSEIGQKGKEQVVSRYVKELNIGETEANNI
FDCVFNLIKKGIKDKLKNPFKK
>SEQF2502_01143 3-isopropylmalate dehydratase small subunit
MKPFTKYEGTIVPIMNDNIDTDQLIPKQYLKSIEKTGFGIHVFDEWRYNEDGSDNMDFNL
NKPEYKNGTILITGDNFGCGSSREHAAWALQDYGFHVIVAGGYSGIFYMNWLNNGHLPIT
LPEADRIELSKLPGDVKVTVDLENNKLIANGKEYVFELEESWKQRLLKGLDSIGLTLQHE
DEIRKYEESHK
>SEQF2502_01144 hypothetical protein
MKNWEIIDGEHTRKVMWINHEIEMKLYCNGEDDIDEEKIDEIKVEEMVEKILEKKEYRDT
KCKDLFANEFVDWFNEEKWVKPEYAEIYYETNSIDEVEKKLLKIIEKEDTEKIMKNNFLT
KEAFKKLLDNDEIEIVIDYGEVEENSNFTIAMHKKLFFVDKMFYTCCNFNGEIDEYYMG
>SEQF2502_01145 hypothetical protein
MEIQNFRESSHSSYFKEWYGKVIWKGEEIRVSLTISKKCGNVELEKEKMLKILEELYLNQ
DEWNKKVKDTMVKYFYDVLNDDFFDDGAFPEYPTCYDMLFEILKDDFTKEEAEMAYKNNI
FPLDKFKKYIFVESIEITSEGNFYFEVVDDYIVVGDNWIWLKGNIDKGFLAASFNALFEF
VVDLELNDKFSTIFREKTKIHSMWLSKWGEPKEGLAKFYYSNHNLAITGNYKAGKKEGIW
EFYDEDGKLTKKVNYVNDVAENEVVY
>SEQF2502_01146 hypothetical protein
MFSILGAVLFGVIAIMTVLVACGLPLGEFTMGGQHKILPKKFRVMAVISVAIQIFAMIII
LQAGGFISLWLSFKITKYICFFFAAYLSLNTIMNMISKSRKEKYVMTPLSLIAGICFWIT
AFQM
>SEQF2502_01147 hypothetical protein
MAEKSKEQLKVEEYFKQNGIEYDKNFIYGIKRERNLNSFLMMGLIGLIMKAGMKPCYILF
KENEILFFEVGMLGGIKGLLTRIDVDDIEKIDLKKGIVNYKFTISVRVGDKIKKEIINFA
QINGKAWWMQNRNNLIEGGYFDRLKEKVDRKNLLN
>SEQF2502_01148 5-methylcytosine-specific restriction enzyme B
MYRANDEDYLNFFEMLKFWISQTDKNIANSGERVKIKNIKSKDMESLERSEKEFLNPKFD
EKFIKYSDFSININFVTSGHYKGENTNFIVYQSKIENIGCWINIVYQYDNKKVVAYYKGY
HEDNKESEEFKRYMQEKGYTKGFEESISKLGLNEKEPNQNVKELFDYFYKMIEESENYSK
NKLKDSRIFDLKEKLKKNYNIILRGAPGTGKTYLARQIAAEMIGINVDELDNNEQFEFVQ
FHSSYDYTDFIEGLRPIIKNNQLGFELKKGIFYEFCEIAKISEVLRKLNSKEFTLQGFEI
FLKELGGNRAKNYIPKIEQLLGKKKYTGDKTSEIKTYGNLREILENSEEISKFDKENNFS
NWYSTPVNYLKKYDDEIKKEHNSVNKNYIFLIDEINRGEISKIFGELFFSIDPEYRGKKG
SIKTQYSNMHEDSQEKFYIPENVYIIGTMNDIDRSVDTFDFAMRRRFLFEEIMAEDSQIM
LKNGKIKEQMTRLNNAIIDQKIGNLSKDYQIGGSYFKALDEGKVNQDELWKNKLEPLLKD
YFRGERDSEGKLREIKKYYDGKNDTN
>SEQF2502_01149 hypothetical protein
MMEKMILTDNADITEFRKNEIIEELLNITLSQLNEDNFIIFPPILKESEDLEESNFIFES
KNKKVYTRNIVGVIGKGHDEVKIKTRFFNNSESQSDYFLKYMFQKVLNYNVIKNETKSDN
LGMYYDLLIYLFPFYLKRAMKKGLYKEYKTKEYNNLNVRGAINIIKNINKNIPFNGKISY
TTREFSFDNRVTQIIRHTLEKIKQNYNFDFFNDMFLKEDIQILVQNTKSYKNSDLVKILK
DNILNPVRHSYYEEYYDLQKLCIQILKNEKIDFGNNDNKIHGIIIDVAWLWEEYLNTMLI
NKKFIHPKNKKSEKGISLFSNRQRMVYPDFYNLDEKIILDAKYKKLGKNKKEIYREDLYQ
LISYLHIIEGKKSGVIYPDIDKSESNEIGQLNGCGGEIFKISFKIPQEISNYKEFVVEIK
KSEKIFLNKIDCIKKIIK
>SEQF2502_01150 3-isopropylmalate dehydrogenase
MNYKIALLKGDGIGPEIVDEAVKVLDKIGEKFGHKFEYTQGYLGGESIDKYGIPYSEETA
KICKESDSILLGSVGGPKWDNVEPDKRPEKGLLAIRKDLGVYTNLRPAVLFKQLKSASPL
KDEIIGEGLDVMIVRELTGGIYFGPREYSDEKAVDTLPYTKGEIERIAKKAFEIAKLRGK
KITSVDKHNVLDTSKLWRKTVNELAKDYPEVEVSHMYVDNAAMQLIANPRQFDVILTDNM
FGDILSDEASMLTGSLGMLPSASLGDGKVGLYEPSHGSAPDIAGQNIANPIATILSAAMM
LRYAFNLTKEADAIEKAIEEVLEDGFRTADIYTDGLKKVGTKEMGNEIVKRI
>SEQF2502_01151 hypothetical protein
MKKSMPIGISDFKKIIKENYYYFDKTNLIEKILTDNSEVKLFARPRRFGKTLNMSMLKYF
FDIKEKDENRELFKNLKISKSKFFEKQGSAPVISISFRNYSEKNWENGFKTVKTAIADIY
AEFKFLMDKLDKRELKKFENIWLETDEGDWKNSLLMLTKYLYEYYGQKVIVLIDEYDHPI
VDSYVKGYYDDAIDFFKSFYGMVLKDNNYLEMGIMTGILRVAKENIFSGLNNLEVHTILD
NEFTEYFGITEEEVNQAVKDFDLEYELEDVQKWYNGYLFGDRKVYNPWSIVNFLKRKKLK
PYWVNTSGNELIKLYLRKLKNEIFDDFSQLLNKKSISKRINDNMIFENLETNFSKNIWNL
FFHSGYLTLAEEYDENRNDVSLKIPNEEILRMFSEMFIDLYFENYDIFLEVTKALKKGDA
EKFKRELNKILLENVGIFDVGGIYKEQFYRGFMLGLVIMLKNEYEISSNNFAGKGRYDLL
LKPKNLEKRKEGIILELKIVNSSQKLSENEIQKELEKECDIALKQIEEKKYSSVLKNAGI
DNILKIGLAFLGKEAEVKFEREI
>SEQF2502_01152 hypothetical protein
MLNKKIENLLKSNKKYISEKNEILKAKVYEDAVNINKELIELLLSDGKVKKTYFTEINGV
LVFDKQGFLNFLESKDFLPDSYTAFKNKIGLTDRNGNYLSDNDDVVLSFPYKDCVLVGGQ
DKDDQKREEKMYNEILASEEISTLFSPKVLTNIKRFGKISSQSVSQSVSQSVSQSVSQSV
SQSVSQSA
>SEQF2502_01153 hypothetical protein
MTKDEKQKEIDVTSEYTDVYNLRIPNKEIRKYFGNMFLNRFFGTEVKTNTLIKALENGDI
KKFEKTLGEIMINMLSHFDLDKEMEKIYQVFMIGLVGFLMGKYEIISNDESGYGRYDLAM
IPIKSNEKAYLMEFKISKTKKGMEEKAQKALKQIDEKKYDTKLKARGIKNILKIGVAFYG
KEVKVVFK
>SEQF2502_01154 hypothetical protein
MELEIKSKKIDYHYSEFRMLLIAYICVYFMSPIFIFFIKSDIKHYYILLINAVFVMIFYI
FVVILQIFFKLLIKLKRKKIIFSENYLEIFFGTESKKIEYDKIEMIFLRKNLLNSADIII
NFPTNNTSLFNRQEELFKGDKNSIVISNVINYEEIFKELKQRLFFFESKNEKVLEYKSFI
ENKIVIIFLILLFYFFYKIKISICLIIMLFVKIKRYNYKINYLNNDQIKIFNANKEIYIK
NNNYFFDKDDLKLKIKNVDRILLSSNSVFLPMHYKIKIDSDV
>SEQF2502_01155 hypothetical protein
MEKAVVNFRIDKTTKKEMEEICEDIGISIGTAFNIFAKKLIRERRIPFELDSDPFYRKEN
IERLKKSIEQMEKTGGTVHEVDYD
>SEQF2502_01156 hypothetical protein
MKHGLAGNQGTRQAYHTGNLSQSEVRNASANNNFYANIGVNAGYSTSKNSNNSHNESAVV
TTMKPMNENSSITYNNVNNITYQGTQAQGGTYLQQC
>SEQF2502_01157 hypothetical protein
MTLSGFNQEGRKVTGNIGKLVVESRQNTSTTTGRSSGASIGISANGVPSSLNVDGSRTSG
SRAFVDNQSSFIVGEGSNLHVGTVENTGAIIGK
>SEQF2502_01158 hypothetical protein
MTTTGISVGTSLGKSPRVTNIGFNQDDRDKQGITRNTVVGNVEIGETSGSPINRDVTKAN
EVTKDEHHSTNVNVETQTIEYATNPAKLKEDIGKAKEEINDIKWVIKESIHDRGDDNRNF
FGKLSEVRLDKSLENITSERLIGKTVDTEIAGIFKDAYKDLGYDINIIFSDPKNSPQLLD
EKGKLKTGTAYVDDYGVKTIIINAQDSKNTTKAGLIGTIVEEGSHVIGKVESRQIETGTD
EKGLESTGRASNEYFAQKYKDDNPNISIKSDGKDYSNVDFGENVGNIAVADDALIIVAGV
TIAYIAGAYIVQ
>SEQF2502_01159 hypothetical protein
MIEFLKNIKSKIGIYHLEDDAISIGKILKISGKYLFLDSYDSNNKKEGIKVFLISEIKRV
ILKSDYIEKLENKKNYTESFSFLKDNKINSFDDVCQKIIEKKCIVTLKLKNDDIEKGYLT
KKIEKYYYFEILNDELKIISTEIFDEHYIEEIQIDTNDKINKNVPLNIIKLYSDNIYIGN
VLFDRKEIIIFKEIVEFSEDSRILILKKEDIEEISELYKEENIRYNSINKYIQNIKDITL
LFLLEICLNFKFIIFIDNKKFSETKVGIIEKILNNRILELNTLNENYHFIEKIRIEISEI
EILRIKNYSLFE
>SEQF2502_01160 hypothetical protein
METAYVSKDGVHTMIININAKENSTKSGLIGTISEEGSHIINGVEGRQIATGTEEKGLES
TGRAANAYFQEEYKGSNQNMTYKSDGKIDTSKLGTNVGDKLLLDTSVSLEEMEELLRYVQ
SKTQDTLELIDAKTKSKCTKGSGDNCEIKVVQKHKGKDTLTGTKMVREILDNPKRVFITN
EKGNKRGDIRRGSHYNANTNTLTIVRNQEVTVLGKDLNTGEITTKKQNLNDTVGHELVHV
HNDIKKFVRDEYISNFLKIGEQVFYDGDSKENIIDQRVSNMTGGVPWKNIQEISEMKKQI
EEECKGKKDCNVENKLLTKLAEKGYSNLQGLSHINQIIKNGEAEKKRTENALKTCGTNLC
VYREEAATSGIERFSWPKQLTNENILRQEMKNRLKELQDKGIVDKNIKPEDLNYERIFYY
SPRKELIDSLKTSKPNKENIIK
>SEQF2502_01161 hypothetical protein
MIKKILFIMIMISNIVYSEEYFRDLKYFEYAYINPPISISERNYVIKHKNENKTVFYFRL
KGLYRGITRSRDKDEILKYMTLENLENYYSRFNPKDKSYYGQFLYGKWTITNNNKTNVEL
YIVTVDENGNIHENRYNKFPNLGQAYHIHWYINEIDENNAQGYYSVPDYGEMMTIMTPNK
IIFKNPDFFAPEENRLYEELISLFYNELPESFFKQRKENRAYEIRRIMSKYNLNLKDIEN
IY
>SEQF2502_01162 hypothetical protein
MAKKKIDNKIFKTLIEDYNIKDTNDIKDILKDLLSGTIQTMLEAEIEHELGYAKHSMKDK
ITSNARNGHSKKTVRSEYGNLDLDIPRDRNAEFEPQIIPK
>SEQF2502_01163 putative thiol peroxidase
MAEIKNKVTFKGNPITLVGNEVKAGQAAPDFTVLSPELKEVKLSDYKGKVVVIAVFPSVD
TGVCALQLARFNQEAASFGDDVQLLTISVDLPFALGRYCADKGIANALTASDHKDLDFGI
KYGFVIKELRLLARGVVIVDKNGIIQYVEYVPEIGEQPDYERALKVIKELTK
>SEQF2502_01164 Transcriptional repressor SmtB 
MAKIMEEENENCEVKAIHKDIVEKVEKTMPKEEVVYDLSDFFKILGDTTRMKILSALFQE
EMCVCDIAYLLKMTQSAISHQLRVLKQGRFVKYRKEGKVVYYSLEDEHIKHIVEQGMTHI
LEKR
>SEQF2502_01165 hypothetical protein
MKKNKCKLLILTSIMVISVVSFGMSGKNPDKSPSKPKTEDADTAVSTNDNVSTVGKKAGL
KISKAELNAVADKIFKNEAGGKKEDIVYWNIGEDFPSLGIGHFIWYRAGQRGKFAESFPQ
LVAYYRAHDVKLPKIIEENDYSPWANRDELFRLKRIMDNDITELTNFLYDTKDIQVSFIF
ERLENSLEKMMAIADDPENVKKQFYRVAQSPNGLYPLIDYVNFKGEGTTRTETYNGEGWG
LLQVLENMKGTGSGKAALEEFSNSAKAVLERRVKNADPDSNERKWLQGWLNRCDTYKN
>SEQF2502_01166 Dipeptide transport system permease protein DppB
MKNILKFLFKRIAMGLVTLWLVITITFFLIHMLPGDPFQSEKAIPPKVKENLMAKYHLDR
PLGEQYVEYLKNIAKGDLGSSMKVRGRTVNDVINQSFLTSADLGARSIIFALVLGIPLGI
IAALKRGKYQDRLAMIVAIIGISVPSFVLAGLMQKYFVDIHNGFLIDNGFLPEFFRIRLS
GWDSPEKKILPVVALGLYTVALIARLLRDKMIEVMGQDYIRLAVAKGVKPKNIVFKHALR
NAILPIITIMGPTIAAVLTGSFVIEKMFSIPGLGKYFVDSINDRDYTMVLGVTVFYAIFL
IIMMILVDIIYVLVDPKIKLGKGDEV
>SEQF2502_01167 Oligopeptide transport system permease protein OppC
MAENIEKAVTENDYIPTPEDFKIVGPDTTQSEEIYKPSLTFWQDGWRRFKKNKLALTFLG
ITVIFLFLAIFGQHMTKYSYRAQDLSAKFLSPTKGFAKGHYLGTDNLGRDLFARLSQGIR
ISMELSIITAAICVVFGTIYGAVSAYFGGIIDTIMTRIVEILLIIPSMIYIILLMVVMGN
SVKTIIIAMSLTRWLNYSLLVRGEVLKIKENEFVLASKSLGGNFLWITLKHLIPNTLSVI
IIRLTTDIPNIIFTEAFLSFIGLGVPIPQASLGNLVFDGFVNMTSYPYLFVIPSVVISLI
TLAFNIVGDALNDALNPKLRD
>SEQF2502_01168 Oligopeptide transport ATP-binding protein OppD
MGKKLLEVKDLSVSFNTYAGEVQALRGISFSVDRGETLAIVGESGSGKSVTVQTIMRLIP
MPPGEIKNGEILFDGEDLVKAPLERMRELRGGKIGMIFQDPMTSLNPTIKVGKQIMEGIL
IHKKVTKEEAKQKAVEMLRKVGIPKPEERFHQYPHEFSGGMRQRAVIAIALSCEPDLLIC
DEPTTALDVTIQAQILDLINELKKELNIAVILITHDLGVVAETADRVVVMYAGEKLEEAP
VRELFKNPKHPYTWGLLKSLPRLDMKIGEKLASIPGTPPDLLNPPVGDPFAARSEYAMKI
DYERKPPLIDLGNGHFVKSWLYIKGAPKIKSPFESEEENKGTEGK
>SEQF2502_01169 Oligopeptide transport ATP-binding protein OppF
MASNENKKEKLIEMKNLKKYFPMKKRQVLKAVENVTMDIYKGEILSLVGESGSGKTTLGR
TVSRLYSKTNGDILFNGKPVESYGRKEFTKKVQMIFQDPQASLNPRMTVGDIIAEGIDIH
KLVSSKQERMEKVYKLLEIVGLNREHASRFPHEFSGGQRQRIGIARALAVDPEVLVCDEP
ISALDVSIQAQVVNLLKELQSERNLTLLFIAHDLSMVKYISDRVAVMYRGKVVELGTPEA
VYGDPVHSYTKSLISAVPIADPDYKKTQKIDMDESYLRSPMGDVSEIGVIPETPELTEYR
PGHFVETSFLEEKGLI
>SEQF2502_01170 Dipeptide-binding protein DppE
MKKTFLIICLMLSMFVVSCGKGGKGSGNSVSFNMEAEPTSLDPQILTDMSGLFVTSMTYE
SLVRLNEKNEIIPAGAESWTKSDDGKVWTFKIRQGMKWSNGDPVTAKDYYNGIKRGIEPK
TASEYAFLAYYIENAEDYNTGKLKDFGKVGIKAKDDYTLEFRLSQPAPFFLKTLIMPIYF
PVNEKALATNGDGYATEAKKSIYNGPFIIEKWVHNNKVVMKKNPNYWNAKNIKVDTLTGL
IVTDFEAATNLFENRELDLTKISVEKMANYEGKPELHKFPNGRVYYLGFNTSNPVLKNQK
VREALSLAIDRKELVSSILNGAGIVGSGIVSNGTAGEKGDFRAEAGDLFAGFAKVNAKQL
FDEGLKELKMTPAQVKLHLLVDENGTGKKEAEFYQSQWKDKLGIDVDVEVLTKKERIARA
KAGDFEIVRYAWGPDYADPMTYLEIFHSKAKDINFAKYSNPEYDELIDLAKVNQDNKTRM
DAMKKAEKLLADNFTYSTLYYEVGVYLINPKLKGVVIRSVGDSIDFYNASITK
>SEQF2502_01171 Oligopeptide-binding protein OppA
MKKILLVFTILLAFIISCGKSSDSETLKLNLKEEGKSYDPQLANDSTGEFVDSLVTETLT
RQSDDGKSLPGVAEKWEHNADSTVWTFHLRKNAKWSNGDPITAKDFRDGWVRALDPKTAG
EYADKLFYIKNAEQFNAGKIKDENQLGIKVIDDYTLQVTLNNPLTYFDSIVRIQTYAPLN
KKFYEKVGDKYMTSPETSISSGVYVIKSWTRDSEIVFEKNENYWNKDNIKLKYVKMLFIN
DPSASVNAFKNKEIDSTNISIEQAKEFKNDKRKILTKDGSVWYMTYNMKNKVLANKKIRQ
ALSLAVDREKLITDVLDNTGEAAYTYTTKGVGIIGISKDFSEEAGKIFPAYNPQKAKQLL
AEGLKELGLQKLPELTMIFNDSGNNKVISEYIQESLRTNLGVNINIEGMTFQSRLDKMQH
RDYEIALAGYNGDYNDAITYLDRFLTKDGNNYSDYSNPRYDELVKKVKSSGNQEERVKNM
IEMEKIIAEDMPVGLLYYRQNTKLLNPRVHNIVFSPIGKDFVLDNTYIK
>SEQF2502_01172 Oligopeptide-binding protein OppA
MKKIIILLAMLIFAISCGKNGGSGKTFTLNLIDEPKSIDPQISTDVNGGTVDDLVTEGLT
RKGKNGTFVPGLAKSWDKSADGLKWTFHLRDGIKWSNGDPITAQDFKNGWLRALNPQTAS
QYSYMLYPIKNAEKYNKKAVSAEKVGIKVINDKTLEVELEAPVPYFDSLVAFKTYMPLNQ
KFFDKTGDSYFTEANKTLSSGAYTMEKWTHGSEIVFKKNPNYWDAANVKVENIVYKIIPD
NNSSLNAFNNKEVDVTSITAEQAKGFKDNPKMISKNDGSVWYLLFNFNNKTLANLKVRKA
LLMAIDREGLVNNVLNGYGTAAKTLVPKGIGIKGLDNKDFTEGVSTSTLGYNPVEAKKLL
AEGLKEVGETNFPKMSMLLNESGNNKVIAEYIQEQLRKNLNIDLDLEPMTAQERWSRMSQ
KNFDIVFAGWSGDYPDAITYLDLFESSGGNNNGSYSNPQYDALVKTVKGTDDQKVRMDAL
VKLEGIIAQDLPVGVLFHREKQYLVDKRVKGLEFTPIGGEYYFGNLSLK
>SEQF2502_01173 Dipeptide-binding protein DppE
MKKIFLILTLLVFALSCGKKSGRGSTFTLNIVTEPSSIDPQITTDIPGGTVDELILEGLL
RKDKTGKSVAGIAQKWEKSKDGLVWTFHLRDGVKWSNGDPVTANDFKAGWIRGLNPDTAG
SNASMLFVIKNGEKYNAKKVSENEVGIKVIDDKTLQVTLESPIPYFDDLVTFKSFMPLNQ
KFYNKAKDKYFTEAEYTISNGPYTLEKWTHDSELKFKKNPNYWDAGNVKTDNVELKIIAT
DSAVNAFKNKEVDVTAVTFEQAKEFAGKPELVKANDGGIYYLLFNTKENVFKNAKVRRAI
TMAINKEELVNKVLEGSEKLTKTFTPSGIGLNGVSKDFPAEVATDQPKFNVAEAKKLLAE
GLKEEGLSELPRFEILFNDTGSRKAIAEYIQESLRNNLGANVELDMVSGKERIERTKKRD
YQISLQNWTGDFLDPITYLDLFDSTNANNRGDFKNVKYDELTKTVKSSADPKVRVPAMIE
MEKLISEEQPVTILFQKQKLYLVNPKVKNLGFVSIGGEFFIRDVVMN
>SEQF2502_01174 D-glycero-beta-D-manno-heptose-1,7-bisphosphate 7-phosphatase
MKNKFVLLDRDGVINVEKSYLHKIEDFEYEKNVVEGLLKLRDLGYRFAIITNQAGIARGY
YTEEDYLRLQSFIEDDLFKKGIKIEKSYFCPHHPNVSGKYGIECNCRKPNTGNFELAIKE
FDIDVKNSFMIGDKITDLIPAEKLGIMPVLVKTGYGLKSLEELGGTGLDPMVVDDILDFA
DNIEKYK
>SEQF2502_01175 hypothetical protein
MQESKNLNTDNEKNYFYKTYEYKNKKALKIFFGFTREKGKNSLKVSKYLERDFPELNFMN
ITKYKVIKYMPLHIKIETVLENINKTFNGNFISYYDYLVGKDDFELTYKTIDLWYKFEKN
FFEKGYYHMDFSLGNFFIDKNSGKIAFIDFDDIVRKPPFFRKRLYLTKSIRSFEGSMKFF
LSVKNFSREENKRIIDKLEEIKKIYHVVSREKDIRKTEKILNR
>SEQF2502_01176 Phenylalanine--tRNA ligase alpha subunit
MLEKLAHLRKEVLEKLDKVGNLEELNELRVKILGKKGEFTAIMKEMGNIAAEKRAEFGKT
TNEIKNVLLAKFDETTTGLKEIAKQERLKNETIDVTLPGRKANVGSLHPLTKTVMEIKDI
VSSMGFDIVDGPEVEYVKYNFDALNIPKTHPSREITDTFYIKENEVVLRTQTSGMQIRYM
EDRKPPFRMISIGKVYRPDYDVSHTPMFHQMEGLMVGENVSFANFKAILENIVKKIFGED
RRVRFRPHFFPFTEPSAEMDVECGVCKGEGCRVCKGTGWLEILGSGMVNPKVLSGVGIDP
QKYQGFAFGLGLERITMLKYGIDDLRAFFENDERFLDQF
>SEQF2502_01177 hypothetical protein
MDDKEIKIDDEYVQKFYEEIREDYEKKSPTKTFAKIKLVEDKLKITDSKIVGLPYLPKGA
EFPKAPNGEEMLMIAQINCEDLKGLKDFPQKGILQFFVFDDDDAMFGLDFDSPTVQDTFR
VIYYDKIEEFYDEKELENIYKPHNYEESFLTNNNESYKIEFELRTEKERFEEAIYNVFDK
LCKEKKLEKHQEDWLYRKILNIEMEYSEEPHSQCDGFAFFTQSDPREFEEKYKKYDTVLF
QLDSEYDENTKKWKVCIGDAGVLNFFINREKLKKKDFTEILYNWDCY
>SEQF2502_01178 Phenylalanine--tRNA ligase beta subunit
MSYKNRMLISLNWLKQYIDLDGIEINEMENALTMIGQEVEKIEVLGENLENVVTAQIIEK
EMHPDSDHLTICKVDNGKEILQIVCGAPNHKAGDKVALAQVGAKLAPDFVIKKGKIRGVE
SNGMLCSEEELNIGKDSDGIMILPEDTPVGVPMKEYLGINDTVFELEITPNRPDCLSHIG
IARELGAYYNKEVKYPGFVINSESSEKTADNISVEIEDSNLAKRYVARIIKNVTVKESPK
WLKERVESIGIRSINNIVDASNFIMMELNQPNHTFDLDKIEGGKIVVRAGHENEKLVTLD
EQERKLNSDDIVISDGVKAVALGGVMGGQNSEITENTKNILLEVANFNSQNVRKTSRRLT
LFSESSYRFERRVDEENAINVINRLANIIQEVAGGEILEGVVDNYPVPYKKKTATLNFER
LNRFVGKNIPRETVIGILTRLEIEVVDNGETLTLTAPTYRDDLENEQDYFEEVIRMYGFD
NIENILPKLDISEKPVIDTTKLSTQVKLIAANAGLKEVINYSFVPKDAMEKIKYTSVERE
NLIDLLRPITEDFVTLRPTLLYSLLKNAKENMNRNATNIRFFEVSRTFVKAEELAKEEVK
LGIILAGENNKTLWNPKPVPYDFYDLKGIVEEIFTQLKFNNYMIKRSEQSQYHPGRSVDV
FVGRELIGSFGEIHPDVLENFDLGKTSVLVGEFNIDLIQKYIGKKIKYQGIVKYPAVPRD
FAFVMREDILVGDVLKTIQKVDKKIEKVELFDIYQGAGVLPGMKSVAISVILRDKNKTLE
EKEIVDISNKIVAKVEKDYGAVLRK
>SEQF2502_01179 hypothetical protein
MITNQDYLKNLVRELTKLPYETEWVEFKVNNIEPQMIGEYISALSNSATLFGRTKGYLIW
GIEDKKHEIVGTDFDYRNAKKGNEELESWLTRMLAPRLNIKFHEIFYDKLKVVVLEIPNA
EREPTKFSSEEYIRIGSNKKNLKGYPEKERRLWQLFDNTPFELHYAKENIKKEKIFEFLN
YIGYYNLLNQPIPKNEEKIIEDFINEKFIVKNEIGNYNISNLGALLISKDFKKFDKLSKK
NVRVIWYKKNNRLETIREQVFSGGYAVDYENIINYILTIIPQEEVIVDSIRKSFLAYPEI
AIRELVANILIHQALDQTGTSPMIELFENRIEFSNLGAPLVPVDRIVDTVPISRNENIAG
FMHKCGICEERGSGYDKVIDATNKNILLAPKIENQDNNFTKVTLYSKVPFELIKKEDKIR
TCYMLSCLKYVSEGAISNSDVREVFGFSEKDKAKATRIIKDTLNAGLIKIVDKNTAPRYV
KYIPFWG
>SEQF2502_01180 Ribonuclease D
MLKIVTLPFNERTEEFEQGKLERILGNVQIVKYQAELVKIEGKYYWTAFVEYEKVENIDK
NLEKNNFLQNGRDIDIKEVNKNHEEYLSEEEAELYKILKEWRAGEAQILGYPPYIVASNQ
LLVDIIKANPTNVEELSQIRGMGKRKVRDYGEELLLILENFYDMKS
>SEQF2502_01181 hypothetical protein
MSVFLKELSKSYNDDIVILVCDGAVWHKSKNLEISGNIIMTHIPPYTPEMNPIEQIWKQI
RQMGFGNKIFSTLKAVVDRLCDTINLLTDELVKSITLREWIYSAI
>SEQF2502_01182 hypothetical protein
MQSIKDKQKIEHITLRQKRIVRKRNNRINDYLSKAARIIINYCLNNDIGKLVLGYNENFQ
RNSNIGSINNQNFVNIPYGKLRDKLIYLCKLYGIEFKLQEESYTSKASFFDGDEIPVYDK
ENPQEYIFSGKRIKRGLYQTSTGKLINADCNGALNILRKSKVVDLSVLYNRGELNTPKRI
RVV
>SEQF2502_01183 hypothetical protein
MRVRAQLFFRDKYIRGFFIDTKSAGSYNFVVKNAGKTLKTMRDFLGNEKIVRNKPVLSLK
RVLEWFKRKK
>SEQF2502_01184 hypothetical protein
MKKNLKFLFICFVFLISFNVFSDGMVFAKKVPLEELPETVESDMRNGTMGYLSNQQCFVS
TYRSFYKNSGLDHVNIYATCIDTYPNRKIEWDNPKIPKGTEKKTIHIMGKNTSQRMLDEM
KKGKNAFLIKKLYYYKSSDKNYKKGEYYYFD
>SEQF2502_01185 NAD kinase
MEKLENGNVVKKNKVEKVRIIKSGYGNEELLKDFYSYLKERNIQEVFGVEQADLIISLGG
DGTMLISAKEAIRGNIPVLAVNMGSLGYLAEVKPQDAVKMMQDYENGNYKIEERSFLEVK
YEDNIFYALNELVITKGGHEAHLIQVEVYSNDVFVNKYRADGIIVATPTGSTAYSLSAGG
SIVHPGLNALTITPLAPQSLTARPIIVNGCEVLSFKATSRDDAVHLNIDGNQWFQIKKGD
LVSARISKKKVRIVKPVSSDYYSILRQKLKWGDSVL
>SEQF2502_01186 DNA repair protein RecN
MLRELRLNNLAIIKKLDLEFNDKFIALTGETGAGKSIILNGISLLIGERSHTDMIRNGAQ
SLFAEGVFELNENQKKRLNELGFEIEDDELIITRYFDRNAKSKITVNGSRMTLSRLKELM
VNIIDLVGQHEHQFLLNSEYHLHLLDRFLDDGGKILSRRIRENVNKIKKLNLQIGNIEEE
KTRIAEKKDILEFQLNEINSLELKENEDNELEEEYKILFNAGKINEKLEETSQFLKEGEF
SILTALGRAKRNLEQLSDLSESYNELYEKIESVLYEVEEISYSVDNFAGDVEIDDKKLEK
IVERIDNINKLKLKYGSTIAEILEYRDKIEKDLSLVNFENEELENLKTEKNKLVGQYFQD
SEKLSEIRMKIAENLQNTVDVQLDDLNMENAKFKVEIRKTQEITMHGTDNAEFMIATNVG
ETFKPLAKIASGGEISRIMLALKTVFSAVDNISVLIFDEIDTGISGETVRRVAEKLRELS
RNTQIICVTHSPQIAGRAQQQFFIKKEIENNFTETKVHELNTEERIREIARIISGDNITE
ASINHAKEIMGLWDKKVLI
>SEQF2502_01187 Tyrosine recombinase XerD
MGQESTDIDNLEKDLKVEENTEVKKNNEEMMEGQKEQKKKIKKDISRENKMQIREFLDFL
EYEKGSSQSTVDGYNRDLVQFFLFVEKNYNEIEEHDVFDYIEYIVEKLRKNSALRKISAI
KTFYKFCYLNKVVKKDPTGMVKSLKREHRLPEILTIEEMKRIVDNCPYTPKGMQNRLIIK
FLIATGARISEILNLEIKDVENQEYEFIKVLGKGSKYQIIPIYDSLENEIKNYLAVYRPK
LKNANNSFKIFPNTRREKFWKDLKIIAKDTGIKKNVYPHIFRHSLTTILLGNGADIRVVQ
EILGHANITTTEVYTHVEKSKLKMIYNNIKLGDD
>SEQF2502_01188 hypothetical protein
MKEKSELRKQKDEKIKILMTTIIAYFVFFILTEIGIITEYLGIILLILLYMYANYNLINM
FFTSKRTTFKVYAFLLLEVIYLFTGNISLLGAIVYIVLFSLLIFSIRKDEGREEIPKIMK
FVNIFLIFKVVFVLSMLIF
>SEQF2502_01189 hypothetical protein
MEINNVNRNSGTDVMKSVEDVTDRAASAQVEKNLFLGEYKERIIKALTFEEIKEKGIYYE
IEEALENKSVAKMVISRHANFEDIKKYIEIAKKKKIPYKMIDNLVCSGDIALVVVAKDAI
VHEAGDEIIITSKLEMCHLKHLPDVYYEAMESPICDFHLNIIKEEMPEYAKNYKELTFMD
KLFGSKCPICQKLGGKKRG
>SEQF2502_01190 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1
MVDGFRIKGKTPLNGVIKVSGAKNAALPIIIATLVAKGEYILRNVPNLRDIRVTMRLLED
LGMETEKLDENTYKIINNGFKRTEASYEIVKQMRASFLVMGPMIANLDEAVVSLPGGCAI
GSRPVDLHLKGFELLGADITRVHGYVHAKADKLKGAEIPLGFPSVGATQNIMMAAVKTPG
KTVISNAAREPEIVDLGNFLNKMGAKIKGLGTPNIEIEGVEELHAVEYSIMPDRIEAGTY
VIAALVTEGDLKIQNARLEDLGVFKSELEAMGVKFKQDGELLSVIGKARDLKPSKIKTLP
HPGFPTDMQPQMMLLQVLVNGGSSMEETVFENRFMHVPEFNRMGADITIRHGIAFINGGL
PLTGAEVMSSDLRAGAALVLAGLAADGVTVVNRVYHIDRGYDKLELKLNTVGAQIERIKL
DI
>SEQF2502_01191 hypothetical protein
MPMTSTEMIKLLKKNGFVQIAGGKGSHKKFYNQSTGKSTIVPDHKQELGKDLEHRILKQD
GLK
>SEQF2502_01192 Antitoxin HicB
MVVYPAIFHKSVEGGYVVVFPDFDYGATEGKSLEEAMEMAEDYIGTWLYDDFVNNRKLTV
PSKLNDISIEISEDEKEFYVEGESFKTLVALDMLKYVSECKNTVVRKNVSIPSWLNEMAK
NQNLNFSQILQSALKQELKIGY
>SEQF2502_01193 Thymidylate kinase
MGKLIIVEGTDGSGKQTQTELLCKKLKEIKGEGKVKKISFPNYESKASEPVKMYLAGEFG
KTAESVNAYAASVLYSVDRFASFKTEWEKFYEDGGIVISDRYTISNMIHQVPKIQDKAER
EKYLDWLIDLEWGKIGIPKPDVVFFLDIPFEISQKLMEDRENKITGKKEKDIHEKDKKYL
KNAYEVAKELSVRYGWNVISCVNEGKLREIEDINDEMLEIILKNI
>SEQF2502_01194 Protein RecA
MARKKAEEKDDKGLSEREKMLNLALKQIEKDYGEGAIMKLGENQKMNIRAISTGSLNLDI
ALGVGGVPRGRIIEIYGAESSGKTTLALHIIAEAQKAGGTVAFIDAEHALDPVYAKALGV
NIDELLISQPDTGEQALEISDMLVRSGAMDVIVVDSVAALVPKAEIEGEMGDQQMGLQAR
LMSKALRKLTGSIAKSDTVMIFINQIREKIGGFSFTPGPQTTTSGGRALKFFSTVRMEVK
RVGSVKQGDDVIGNEILVKVTKNKVAPPFREARFNIMYGTGISRIGEVLDAAINLGIASK
AGAWFSYGEERLGQGRVNVENMLKENKELYERLEKDVLEAIRPKQEEDKKENPEAVENDQ
TQNDENGKVENNEN
>SEQF2502_01195 Regulatory protein RecX
MKINKIYRNKMYLDTGEIMDISPFIRQKYDLKVNDEIERFYDEVSYEASLEKGIFLISLK
DRTKKEVRLKLEEKYRNKAAILRAIEKLEEFGYLNDLNYAMSYIEGRTYGKNRISYNLFQ
KGIDKDIVEKAYLALEEEREENVEDVKLEKLIEKKGKKVNVNNERDEKKIKEEQKLIQYL
ARQGFSLDKIFKKLKEYKGNFE
>SEQF2502_01196 1-acyl-sn-glycerol-3-phosphate acyltransferase
MRTIFYHLVLVGTFIYGSIFHIWYLIFNRGEKRYRYVCRVAKNWGKNLIWGSGSKVNVIY
KNGSEEEVRKIRENNEAVILISNHQSNVDIPALLGYLPLDFSFIAKKEMKKWPAIGRWMR
SFDCIFLDRKNARQGMKDMKDAISKIKKGHSYVIFPEGSRSKDGKIGEFKKGSFKLATDT
NARILPITIVGTYEVQSRKSLKITPNKNIKIIVDKPIELKNMSREEKKDVHNIVNEIIKD
NFKKEKNL
>SEQF2502_01197 Non-canonical purine NTP pyrophosphatase
MKVFLATKNKGKIKDFEKLTEGMDLEVVTILDGMDIPDVVEDGKTFEENSRKKAREIADY
TGIVTISDDSGLCVDCLDGGPGVYSARFAGENASDRERNEKLLEVMKDVKKEDRQAHFVS
VVSIAFPNGEIHSFRGEVNGEILFELRGSNGFGYNPLFYSYELKKSFGEADDEERKKVSH
RARAFRKLIDSGLLKEK
>SEQF2502_01198 hypothetical protein
MEITDGKKIELNGLIHKGVDKILILMAILSVVYGVVFSIIEKTYHMQVVAAFLPVVAIVV
WILFIFLRIDRLKLENGKLSLNNENLDKKNVSGYMDKYVGTPRIHFTVDGEEVLFEPYVN
RYSRSDTSNKITAIGFFLKENGIPEIKYQRLYRKILLLRLVVVLGIVAPVIFTV
>SEQF2502_01199 Alanine racemase
MLVNLEIKKTNLEKNLKIARSINENLICVIKDNAYGLGIENILPILLENKCDYFAVAYIE
ETLKIQEVLENLKLKNQNNKIKVMTLNYVKPENVEYAIKNNIELTVFNFSQLLDYLKILD
EFFENTTLKIHIKVNSGMNRLGFDENEILELVEIIKKYEINFLNNKSKNKTSKNRLEIIS
IFSHISDAENQVETENQVEKYEKILKIFSQNNVRYKYSHLQASPLLFKYGKKYNYDFARI
GMALYGMEPLSTDVGLLDVITVKSKIINIRNVKKNDKVSYGSKGIVKHDSKIGIVAIGYA
HGLQKQIENSGEAYILVNGQKAKIIGEICMDMVFVDLTDIENVEVNDEVVIVGSQKNIEN
GITKRITLRQVAKWARTIQDDILTKFGGIKKTVD
>SEQF2502_01200 Peptidase T
MYNTLKDRFLRYVKFETRSDEKSETIPSTPTQLEFAKILARELEEIGMENVYVNDACFVN
ATLPGNIDKDVPVIGFIAHMDTADFNATNVNPKIVENYDGKDIVLNEAKDIVLSVEEFPN
LKNYVGKTVITTDGTTLLGADDKAGIVEIVEAMKYLIEHPEIKHGTVKVAFGPDEEIGRG
ADNFNVEEFGADFAYTMDGGPVGELEYESFNAAGAVFKIKGKSVHPGTAKGKLINASLIA
AEIVNSFPADEVPEKTEGYEGFYFLDKINSNCEEAELSYILRDHDREKFEAKKEFAANVA
KKINEKYGKELVSVEIKDQYYNMGEIIKDHMNVVEIAKKAMENLGIKPVIEPIRGGTDGS
KISFMGLPTPNIFAGGENFHGKYEFVVLESMILATDVIVEIVKLNGEGK
>SEQF2502_01201 hypothetical protein
MRKALVKTYIYELIFLCIYLIVMNKLLEIFEEKFILGVFIILIINIVVFFYLIIYLIISL
KSQYHVYKLNLSKSIVMEKKLYKMTKINIKKDIHRINLSAYYRLLNKEEEALRYLNEVRI
SRFTFPIVRYCYYMNLAEYKYYNGKKEEARKILDENIKKESNKNLLEIFLDYEDNPEQKV
VELEKILPKHKNRLYKLQVENALAITYEEIGDFEKAMEFYKKVAEKESEIYFIKVAKEKV
LELSLRNKEI
>SEQF2502_01202 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MFDLAGEVALVTGGAKGIGKGIAKALKQAGAKVIIGDIDKEKGEMAANELDGDFYYLDVT
NKEQVKDVVQNICEKYGKLSILCSNAGIFPQVTIENMTEEDWDKVQNINIKGTFLIIQAA
LKHMREQNYGRIVLTSSITGDITGYPGWAHYGASKAAQLGFMRTAALEYAKYGITINAIQ
PGNILTDGLIEAGEEYMNKMKSVIPVNVLGKPEDIGYTAVFLASREAGFITGQRIVVDGG
QILPETPDFQ
>SEQF2502_01203 Inosine-5'-monophosphate dehydrogenase
MSQKDKVVISEGLTFDDVLLIPQASSVVPHEVSLKTNLTKNLVLNIPILSAAMDTVTESK
LAIALAREGGIGFIHKNMTIERQADEVSKVKRYESGMITNPITLKENAVLKDAHDLMRNY
KVSGLPVVDDEGNLKGIITNRDLKYREDLSLRVVDIMTKDNLVTAPVGTTLEGAKSILLE
NRIEKLPIVEGTKLKGLITIKDIDNVINYPNAAKDKEGRLRVGAGVGIGTDTVRRVAALV
DAGVDIIAVDSAHGHSIGVINKIKEIRAAFPDLDIIGGNIVTPEAALDLIEAGVNAVKVG
VGPGSICTTRVVSGVGVPQITAVMNIAEVCKDKGIGVIADGGIKLSGDVVKAIAAGADCV
MLGGMLAGTDEAPGEEILYNGRKFKTYAGMGSLAAMKRGSSDRYFQLEAATEKLVPEGIE
SMVPHKGALKDTVYQICGGLRSGMGYCGTPTINELKENGKFVKITGAGLKESHPHDVIIT
KEAPNYNNSNN
>SEQF2502_01204 hypothetical protein
MNKVKKIALLSVLVMGISVLSYSYEDYYQKVYIVKISKEDLFKVVNATKNQQKKLSKIFD
EYQKKAEGVENDLVQFDKKKDKIGKIEQDRYRAIAKILSNEQLEAYNSYINSQKELFNEK
NDKVKNLVDSLNLTNVQKSRVLKYERDFKRAVGKLRDQRLTENEFVAKYNELRQERNEKM
RTVLLDEQVKLIENF
>SEQF2502_01205 30S ribosomal protein S2
MAVITMKQLLEVGAHFGHQAKRWNPKMKPYIFTERNGIHILDLHQTLGATEAAYEFVRQI
SEEGGKVLFVGTKKQAQEAIKEEAERAGGFYVNHRWLGGLLTNLETIKKRVKRLKELEEM
DADGTLDTAYTKKEAGLLRKEMAKLSKNIGGIKEMNTLPAALFVVDIKKEFLALEEAKKL
GIPVIALIDTNVDPDLVTYKIPANDDAIRSVKLFAQVIANAAIEGNGGIENVAEGAEVEV
PASEEIVEEVVEEVVTEE
>SEQF2502_01206 Phage shock protein C
MKKKLYKSLKDRKIAGVCGGIAEYFDIDSNVIRILWVIFASAFGTGILPYIVCALILKDN
PDEY
>SEQF2502_01207 Elongation factor Ts
MAITTALIKELRERTGAGMLDCKKALQENGGDIEKAIDWLREKGIAKAAKKSGRVAAEGL
VFAAVSEDRKKGAILEFNSETDFVAKNDEFKSFGEKLVDLTLNHDLTSEDELKAIEFEGK
TVETHLTELIAKIGENMNIRRLKVISTDGFIETYIHLGGKIGVLLDVNGEATPENVEKAR
GVAMHVAAMDPKYLDKSEVTADDLEREKEIARHQLIAEGKPANIIEKILEGKMRKFYEEN
CLVQQKYVRDDSVTIGKFIAPSTINSFDRFKVGEGIEKEEVDFAAEVAAQISGN
>SEQF2502_01208 Uridylate kinase
MFKYKRILLKLSGEALAGNKEFGFSNEVLKSFAKQIKDVHEKGVQIAIVIGGGNIFRGIS
GMEKGFDRVTGDTMGMLATIMNGLALQNSIESLGVPTRVMTALQMPQVAELYIRRKAIRH
LEKGRVVIFAGGTSNPYFTTDSSGALRAVEIQADVLAKGTKVDGIYDKDPMKFSDAVRYD
TVTFDEVISKNLGVMDTAALSLCRENQMPIVVFNALEEGNILKMAQGENIGTTVKK
>SEQF2502_01209 Ribosome-recycling factor
MLDTILKEAEEKMAKSVENTKDKFSHVRAGRASVSMLDGVTVEAYGSPTPLNQVGTVSAP
EARLLVIDPWDKSLIPVIEKTILQANLGFNPSNDGKVIRLVVPELTEDRRKEYVKMVKKE
AEEGKVAIRNVRKDINNKLRKLEKDSEITEDELKANEEKVQKTTNKFIAQVDDALNKKEK
ELLTV
>SEQF2502_01210 hypothetical protein
MIKFTKAKKILMGLMVLGQLTAIPTIATAAPSAKEAAEIKKYDSLNTAAQDYAKALQEIS
NYGSREILKSINPDVDKYVAKINNPTLKKQWEDSNTMLIEQFEVSVYKVNENGNDGEVVF
LIKGYDEKALDKYLGDNASQYAKVDSGKDEVEVDIEKYIKLQYNYLKNTKKINLATSTVK
FAKGNDNKWQLVK
>SEQF2502_01211 FMN reductase [NAD(P)H]
MNELIKQLQNRRSVREFTGEKLKEEDLQTILETAQRAANSVNGQQTSLIVIRDKEKLAKI
AELCGGQKHIAQAEAFIFVLIDFHRGVYASNSLGKRNIAPKSADGILVGAVDAGIMVNAL
QTAAFALGYGGTVIGAIRKETKEFIKMLGLPKYVFPIVGTTIGVPAERSLTRVKPRVPLD
TFVFEDTYNAKKVEEGVEFHEKDTIKWREENNTPQLPSYKEMLVKIYENFHNKSKQDLEG
QGFKFTDDLEQDL
>SEQF2502_01212 Phosphomevalonate kinase
MLENKIMTNKTCGKLYISGEYSILTAGQSAIIKNVNIFMESRISFSNMDEYMVFSDMFDY
KLTLEKDTFNNENILQNFDKNYSLICEAISVMSEYLKLKNFEIKPFELEITGKMERDGKK
FGIGSSGSVVILTIKSILNLYNLEVSKEMIFKLSSYVLLKRGDNGSMGDIACISYESLIF
YRSFDRKKIRELIEKETLKDVLEADWNYEVSELYFDEKKLNQNNLSCEFLVGWTKKPAIS
KDLINIVKNSICESENFLENVEEVVKKLREAIRNGDKLTIKKCIGENGKLLENLNENIYN
KKLKELVNATKNLDICAKSSGAGGGDCGIALSFNEKDTRIVVEKWRELGIELLYSEKL
>SEQF2502_01213 Isopentenyl-diphosphate delta-isomerase
MKNRKDEHIKYALEHRSEYNSFDDVELIHCSIPKYNLEEIELKTQFAGCEFEVPFFINAI
TGGSENAKKINQKLARVANECGLLFVTGSYSAALKNAGDDSFEIVKRENPGLKLATNIGI
DKDYTAGVKAIKALDPLFLQVHVNLMQELIMAEGSRNFREWENNLREFARNIEIPIVLKE
VGFGMTENAVKKGIKLGIKTFDISGRGGTSFAFIENMRRENGLHYLDNWGQTTISCLLNL
KKYVDKVEIIASGGVRNPLDIIKSLVLGAKAVGISKVILELAVNYEIEKVIEILESWKNE
CRMIMCALNANNIEELRNVKYVLYGKTLEFAIQQK
>SEQF2502_01214 hypothetical protein
MRKEEVGKKKIIVYDFDKTLYDGETGVNFSVFYLKKYPIRSVLFLMKYSKDLIFYLLKII
DLTTLKERYFEFLERHSKGEVEKLVAGFWETKRHKIYSWTREELEKNKKECEMVIVSSAS
PLFLIENFLLSLGYDKVFGTNFVNDGKDDKVTFVAKIDGENNKGDEKVKKLDEWAKENGF
EYEIVKFYSDSLADEPLYNISCRKYWIKKGIKIEGMPKRKTLFDKLFWK
>SEQF2502_01215 hypothetical protein
MAICSRMKEKEEEVITFHFDKLKKLINYSDNTPATFVKDLESTYDKLISIKLKVGDERRF
IKFVLFTRYSVDIEEKIVEIAVNKEFAWVLNALNVSFTAFELKEFLSLKSSYAKEFYRRM
KQFKSTGIWRVSIEEFRKMLDISEKYKIGEIDKWVLKPIQKELGDRFNLKIKKLYNKKSR
GRPSVSGFIFTFLREDLEQRKERSIENKKIDKDSFISYFLHRKVRMYDRMTKMFNILAIE
SMRIKEDETVLIRVQNMDDMYKQVFEFESIRHFENWFSKYGI
>SEQF2502_01216 hypothetical protein
MNKIIILYLLLFSYTLSKGKELLDVEIINLRNQRYALTSKIKSSDYKLPFTKIIYNSNGI
INIKKFTKEKNGSFKSYIENKNYDSTELKEILKNVFDKNFSNKKLFVSCTICNILQNDIE
LTTEAMVQPPKNIVKLYKKILEEEREELFLNNVSVSAVGRLYKVEYENTAIILYEDENFY
KDETIKNLIIFINTSLNYTPQREYMKNYIKNISK
>SEQF2502_01217 hypothetical protein
MVLNGFNQEGGKVTGNIGKVEVISRQNTSTTTGSSSGISLGISANGVPSSVNINGSRTNG
DRAFVDNQSTFVVGEGSNLHVGTVENTGAVIGKEGNSTFKIDTYAGKDIQNYDTMTTTGG
SIGASLGGKPGITNVGFNQDSRDKQGITRNTVVGDVEITKTEGSPINRDLEKANEVTKDT
HRSTNINVESQTIEYATNPGKLKEDIGKAKKEISDVTTAIKESINDRGDDNRNFFGQLRE
VRLNETVNNIAGKRLNEADKSEDVVSAWKDAYKDLGYNLDVKYTTGEDTPEMKNKAGTAY
VSKDGVHTIIININAKENSTKAGLIGTLAEEASHIVNGVAGRQIATGTDEKGLESTGKAA
NAYFKEEYKGSNQNMTYTSDGKIDTSKLGTNVGDSVVLKEKKNNDGTRKIDGDLEKLSNY
LGEQLVYKELSSDAQKELAKDISADTFDTYGIKLDENGDTILYLKKKGKLPKPKTDLDKE
KIAKTLAMRELIEKEYKVYVQSIGDSEKLKNMGGAYINIPDENNEDRNKNGIIFLHPQPE
YEYFNKNRYFEKEQTIKTTDEEGNIVDKKVKYVYFEDQVKIEKDKNTGKIIYKFFGVPVS
EANSIYMENVGRKNQDKRRLYMPDDSQFIIEVQSDKEKENLFKGVK
>SEQF2502_01218 hypothetical protein
MDRQQKKNTQPKRQIGHKGRGKYNKQQEKGKQITAEAQKKIQKVDAEDNMARKLGILEAE
NDLLRNADPKTALNYYAHNGRRNLMISKLNPDEKKLGKALAQSTYVRDNYSYVYYGGERT
GKIYRDSDIFKTTEISRM
>SEQF2502_01219 hypothetical protein
MNNNSFTKIFISIWLFSFLFILITLISLGAFKEDIDVKNIKDKILEYIDEKDTEIYLENQ
KIEGKEKEIINEIFTGKNYDVSPFQEQVSSDLKDMKGIEIKLKRKNTEISFEIFNNFDCV
DSKDSKGNICDMDDILKISYNGQIKKIKLYVADEANEILKKYWSVSQILNK
>SEQF2502_01220 hypothetical protein
MEKVVVNFRIDKDTKKEMEEICKDIGISIGTAFNIFAKKFTRERKMPFELDAAPFYSQKN
IERLKKSIEQMEKTGGTVHEIDYD
>SEQF2502_01221 hypothetical protein
MANEIVKFNNQFNNVALKGFTSQELNLLITIASKLKEKEGEKVTFDFFDLKKYIKLNKNE
TTKEFIKNVMNVNKKLLKINFTFYNQNKIIQFALFKSFVIDTDLQTLEVSVNDEFLFLLN
ELTSNFTRFELEEFVKFKSTYTKEFYRRMKQFRHTGVWKISIDDFNRLLGISESYKISDI
DKRVFQPILSELGEKYNLKIIKKYSKKTGRGRSSVSGFEFHFKKENRRVVEQENLEEIKQ
AGFDIEKVREHKIKEKIQKEEKNRINKVSDFYLYRKVKMYDSFYEQYNYLEILAFNQKND
KLNVKIRNVDDSYVQDFTFDSFKNFENWFRKYAI
>SEQF2502_01222 hypothetical protein
MNYLKKIIIFFLIGISVNCKEIARINNNIRDDKNWLNMEIEKDEKIKILKTKQKLSLCLK
EYNLSNFLVSNCSLLIDKDKIKEFTIKEDELKNYSDEIKNLVKQLDKKMYLSKGISVIPR
ITTTDLPETTFFNKKIIDSEVIIYLSKDFNYYLDLHEYEKMKKKMEKIDDFQDKLKKIEK
VAEYIYSKKEEYESIVNFNSNFRIYSDLHKYLNFSNEVYFEDWFLDTYYYSLNEDLIKLY
NLLENNKK
>SEQF2502_01223 tRNA nuclease CdiA
MRGKSKILRKLTAALLLNVFSFNILADGLQVDPNSRYNTSLDRSQNGVPVVNISTPNGRG
VSINEFLEYNVGREGQVLNNADNIGRSHLAGIINANPNLGPNQAANLILLQVNGANRSQI
EGYIEALSRQKVNVILSNENGIYLNGAGTINIKNFIPTTGKVKLKDGDVIGIDVEKGRVV
IGANGFDATNTDYVNVIAKAMELQGNLVGNKVDVTLGENTVDSSGTVTSKNGINSVAIDA
SNLGSMYAGQIKIVSTDKGAGVNSNGLIYSRDTKLEITADGKINVAKIKGNGIEINGTEY
AQSELASSDKGININAAKIKLDGETQANEDINLNGNVENKSNIYTGGNLNTLDMINSGNI
NASGNITAKDFRNSLATVLSGGNFNVKNLDNSGNIQVSGITDINGKFDNTGALTSVKRIS
VLGNVASTGNILTNEDLTARNTVTSGTVAAKNLKVDNLTNDGKISANGNLLAKDIKNTGE
ILTNGNLTAKNVSSMGDITVVGKVSADSLKSSGSLRTNEDLSINGKFDNDGTVETSKNVA
VSGDINNTGKILVSGNLSGKNTVSSGVIASKNVVVDNLKNDGKITAGENITAKKVTNTGD
IAAAGTVSSDDMATSGTVKANKTVTVSGKLENDGTVETAEDVKVSGSIRNTGRIASNGDL
TGKDTINSGTISSKNVTAGNLQNDGKIIANGDLKAKNVKNTKDITAVGTVSSDDLVTSGN
VRANRKITVSGKLENSGAVETSKNISVAGNIKNDGRIAANDDLAGKNTENNGNIYVKNLE
VNNLKNTGKVEGVNLKTDDIANSGDITAIGKVSGENIDNSGKLLANDTISAKNIKNATSS
SKIAAGKGITGERIDNSGTFATNGDIKGTNSLVNSGTVDGKGIDILGADFVNSGKINADN
IKANVTNTRNDGFIYSGKDIDLTTNTLINTKEITAVNNVNAANANVTNSGKIASNNRVLL
DGSAIANTGEILSGEILMRNAQRFDNTGTIKGNNVELGINQDINLTGNLHGQHRLKISAN
NITNNGNTTGTGLIEINSNDFTNNRELASDTVIVNGRGEVVNNSMITGNNGKVSGRNITN
NDLIAFDNYLEMNVQGKVQNNKGKAIYGGQALAIKANEIMNDEAEILGGNMDLNAAKITN
NVGTIQSTGNITITSSDFQNIGRVSNLGSYEKYYETWDGRRLSEAEVLNGWIVNEPDFQH
RSRDRGSVKRHQRSWLESMIAKHSGNSLLFSQYADLARAKLGQRRKLTRTNTPEVPGNTL
TGKIDSRATTEYGKVLASGNITINSGNFKNRDSIISGGGLVNINATNFENSVTLGNAVQL
KNGQEKLYLTYRHGSRRSSANGTYSRYLENGGIGYESGQPSIIEGAVVNVNAPNIIKNPI
EAGNGKVLNNGGATGRALISSTSVGMNKGTSSANGQVQAAGNTLLSKVNSSFNGNSQVNG
STNLNNPVNNGFDRAIQIAGNNSGIKDIKNTGRIDVNPILSSAMFTTNMNPSSKYLLETR
SRYISLGQYFGSDYFTSRVGYSEIWDRTRRLGDAYYENQLLTRSLAEKLGTSFINGKSNQ
ELIQSMMDNAATEGTRLGLTVGQELTQDQINNLNEDIVWYVTKNVNGVEVLAPQVYLSSK
TRESISDDTRNRVGGINGTYVKTKDFVNDGTKWGNGGVTYVEANTVRNETTNNLLSEISG
DKTYISSVGNIENIGGRINGEEAVALISEKGNVINNTTKRTTGFNYGEYDKSQREEIASI
GGITSKGTTFIKADSYNSVGGMLKTDHLALDVNSFNTSALSLSGQSTLGISGSNYSKYAE
TTHFGGGAVANSAEGRIGNLNLRGSSFIAEDTTGLAVGNVRAESVINTYDIESRQSNKST
FASNSNYIKSHQEENVASNLQLGKNAVITGNVEGIGSNIVLGENTFVGGKVTTDSRELHN
SYYEKNKSKGFTGGVSHGTISAGYGKSQSTYDEKSTINAKSNFQVGDGSVLNRGAEITAT
NFEYGNIQINNGDVKYGARIDTRDVHTSSKSSGFTISAGINSPIKDRIKQAAGAVSQVKN
GDAAGGAMEAVNAVTGTIKGLADNQGTRQTNYVNGSVGAKGARDAQANSNFYANIGVNAG
FTRSQSSSSSHTEGAAVTTLKPMNENSSITYNNVNNITYQGTQAQGGTFIYNNVANIQKE
AVELHNSYSSSSSSRGINAGATIGYGHKIQTTGNGGSISTSRSNQNTVETVYANGNFKNV
NEVHNNTGSMVLNGFNQEGGKLTGNIGKVEVVSRQNTSTTTGSSSGMSLGISANGVPSSV
NINGSRTNGDRAFVDNQSTFIVGNGSSLHVGTLENTGAVVGKEGNSTFKIDSYVGKDIQN
HDTMKTTGGSLGISTGKPRITNVGFNQDSRDKQGITRNTVVGDVEIAGAEGSQINRDLGK
ANEVTRDTHSSTNINVESQTIEYLTNPAKLKEDIGKAKDEIEAVGAVAKAAFNTIGSKEK
NGFLDFLRTERVQETVRNLGYIDTKGKTKEQIAQEMQDKYGEIFAKNGKKLEINFYVNSE
VSQDDPNAKNKMNAAGFVAEDGSIWLNADNISSVSNFNLNSVFGHELTHNVTGKDTELLA
NFGEARASGFIEKAMDKGYLARTGGGLNWNSETLTREQKDRLASYQDIEEKLKISNYLRI
YRSAKQNEVVHSAEDNFIEVGKDMNLISKLEKEIQDKLGIKSYNLPNSIKSLDLEGKELL
AKSVTGDLQSELQNKLTDYKNASGDNKKKIGEEIIQKYGISNSDLATAEKNIPEIIRGTI
LKSSNAENNLKEILNNKNLNDDEKVKEIGRKFGISVTIEDLKNNSQISQDIIKNASLERI
VAQDTDKIANKMRWESQFFKDFYANTQKLTNRPLVIDEDDFVWYAGNDGKLSSSQIVWEK
GKVKSPSAKHSITGKVAFINENYMYKGEDKAEILNSWNGEPEIKNSNETFDTKVWDGKNY
TSENNLIERVIKDQNTIFVRNTPGNAYVNSVSPKDAVIDNGIEGKGSDSILGIDYHIDKY
KNISYKVYDGIDKKTGLIKVRDQDETFIPYVAYSHELNHGSHNQEGINEVLTPHYQIYRD
GNGIHFSGERKFEVPVLADSLDDFYNKIINNLKNKNFTAYNKEGKIDTVHSEILKKLEDK
NSDYYKFFRIELEEKMNKAKKNSQTTVNLNIPFFDYPTNKEEINTTGIKGSKYEKSSTPN
STEVKTMINHGKENLKRGVY
>SEQF2502_01224 Filamentous hemagglutinin transporter protein FhaC
MGYKKIIIFGTFLLANLAFPAPVNEANRIIDIQQRQIEQERTRQQQEKIQKEFENTKFDS
PKPQVDKNIESNNLNTNKFLIKSVNIKDNDRLLSQREKNKIIEKYVYLELSSDDIRNLLT
DLTNKLISKGYTTSVVNFDRNNDLTTRTLNLEIVAGRIEDIRINSGNGLDKYKEFFMFSK
NKGKIFNIRDIDTATDNFNSINANNMTMEVLPGRKENYSRIEVKNRLKNKYTVGILANNY
GDSKQNGIWRRGINLNIDSPLGIGDNFYFTYMTVPKKDPDRSWKKTIEELKPGEILPIGP
VGYDPANGDTLPYKRRLDMFNFGYTMKFRTYTLKLNSSKSIQESSFYTANTVYDMYSSNH
ILSADLEKILFRNQKSKVSLDLGIRRRHNQSYLEKSVLSDRKLTVGTVSLNTTTSLFGGI
FGSSIGYERGLKIFNAERDNGKIDTTPKAQFHKYNVNLSYYKPVTNKFIYRANVYGSYSN
DVLYGSERQTIGGIGSVGGYNTRESIQGDKAIEISNELAYNIPVKKFAVVSPYVNYGYGA
AKYNRDKSKYRTGYVTGMTAGIRFDTKMFDFDFGYAKPMAHSEYLSPKKQEMYFSGSLKV
NF
>SEQF2502_01225 hypothetical protein
MGRFDSLKKIDELTIENIKQYESNFDFSAYEITDDKFISEIRSIENNLYMAWNLIQNRTK
EMCKYLYEAQEKFKTQKDGSFMAWYKSMGFSKDQVSISIMKYKQYLEYGENPMALKSSKR
TVKYINQNSENLSEEKIEEILNNPKEAPNIIKELKAKAEIDYTKRLEEINKEIKKFQRKI
RQLKIEKMEIKSQL
>SEQF2502_01226 Sporulation initiation inhibitor protein Soj
MKVISIVNPKGGAGKTVTAVNLAYAMSLKGKKILLIDTDPRNAVSTYLNLKNDNTIFDLI
KECYETMKFDRAKYITSKNKVDVIISDEKLLQLEMLFASYSDNQAIFNIFSNITEQLKQD
YDYIIIDTEGSINNTVRGILNATDYIVAPSKCSLIDTNGINDLIKIYFIGKRNNPKLELK
KVFFVQVEERTRVFADALKEYTDFFNSNDLGLSPNILSKNYIRKDSNINNAMLENLDIIT
YKKSSPSSTDYRNIANELIKELE
>SEQF2502_01227 hypothetical protein
MAIKIFESRENLKNKLRNRGLEFDSDKLDNVLKKYNYFDLFNGFESLLLSSSHPKKYINI
KLEDFLNLYEFDELFTARLLRYLNRFEKSLKSSISYHFTSMYCNTINDTMQYTNKENYMN
PKETDINNRKYCRYSNNYPFAGYQNKGIYNEFDNFCLFKPYFLTNLVDKNDHIKIDFYTD
TNYNAPSNVAIYRDINHNLNYNVAVPFWVAIETLTFGETLRILHYLKDEIMEKVLEDFKL
SLPKRTIFLNMVDFLLCLRNSCAHNSLVNRFRTPNKYKVNAFLVSTFNLNPSNTDNSQYS
ILKLFDVMKLLSYFENIYELKEILDDMIRKNRDCLGFDKGDKLNKKILKRMGCEDYLQWE
ELFLRKFEYM
>SEQF2502_01228 hypothetical protein
MSLLDVMENESDCIESIFQSYISSKSKKDIFLFFEGKDDFKYYVSRVSSHIGDKEYGVFH
CNCKMNVLTIQEMIANQTAIQDDKKNLYFIDRDYDDNEDIPDSIYITSSYSIENYYFTDS
AIKRMLIGVVGFSEESEEDSLDFKIVFDHIVNKRNEIIEEIIYANAWYSLQIKKSKDCGK
FPQMTPLKEYSVVKNLNQICDFERLVKDSIETTEWEMNNAIEVLKTNPVNEIRGKYFTQA
LTPIFRNIFQDAGKKHNRKLFSKKRKIHLNLSDIICELSAYADTPPGLISYIKERLSV
>SEQF2502_01229 hypothetical protein
MRRYGSIDEIAKEYALTNEQLLDYLLSNDIDAISDLDKIDLNNKNIMAILDRINRNKKLN
NHNNLTSFESIEIEGLFGKYNYLINFRDDISIWVSENGIGKTTILNIIVAILTGDKNTLM
DINFKKVIVNISGESYQIDREQYFQVNSNNNRYSSERIEALLEELSMYVPKKYSMKLRND
FAHKKYIDLEFIEELSYRFFNNDIDLIKDKKIMYILRELKELQYKDLSRTLYKIKEVLEE
DILFYPTYRRVEVGLDKVFLNRRGEYNRYELSPKYMGFGMNDVKNRISSVLDKMRKDANT
AYIKMNANIISELLKKNVSYYLDEYNPIDLHKVDVIIKRIGEERIDNIDSLKSFLDKSSR
RKTIPNIEFLSYYLQKLVKIYDAQKPLDSKLRNFSDVCTKYLSGKKIIYDETLLTMNVYD
CNDKKIDFEDLSSGEKQVISIFSKVYLDVVTPCIFIIDEPEISLSIEWQKEFLKDIFNSE
KIGLMIATTHSPFIFKNEYRKFVIELDKYKEV
>SEQF2502_01230 hypothetical protein
MTNNELMEKAKVSKSTFYKMKNGQNVTTDVLLRICNASDYDMDEIVEINDIKEEK
>SEQF2502_01231 Toxin RelE
MEKKCYEVKFTESAEKDLKKLNKSIAKLLKKWISENLIGTQNPKQRGKALTGNLKGLWRY
RVGSYRIVAEIKNDILLILIIEISDRKETYKDKKRKTYKDGKIK
>SEQF2502_01232 hypothetical protein
MPTLSLRMEKEDLEFLKEYSNINNLNMSSFVRNLILDKIYDEITEEDEKRILKRWEKSKS
EKTSDAEDVFKRLGL
>SEQF2502_01233 Putative transposon Tn552 DNA-invertase bin3
MKFGYARVSTAKQDLTRQIASLENAGCNEVYCDIQSGKNMKRDELQKILSKIRENDTFVV
TDIDRLGRNFTEVTELYTKLKDMKVNIAVINQELLNHNVNDKKDEIVNVVVIPLLIYLAE
RERSILIERINDGIKNMPLGKSGKRYSRKTGNVIGRPVKVLNLSKEEQDMLKRVRNKEIS
VKSFCRFMQISRSSYYKYYRNSYLD
>SEQF2502_01234 hypothetical protein
MTDEFFEAENVDDEENNLEYDRDIFDIEIEFDDEVVKRIERTETTREFEKLIENEE
>SEQF2502_01235 hypothetical protein
MTNITQNKLKYIFSNNNILLDFLKFYKKNNIGDSHLEYIKLSIDKFLACRDISKGFVKFK
CPHCPVTHLFPITCKSRLCPSCGYRYSMTWTENIQKHILNIEHRHVLFTIPQECRKFFFY
DRSLLSKLSAAVNQVFKFIFHNVSRKRKRKNKISEHSKYYFTDSDIVHYDLISVIHTFGR
DLKWNPHVHAIVSLGGFNKNLEFRKMRYFNVDTIDGQWKYHVLKIIENGSYPSRKIEKDA
RNTATKLYKENRRFFFNVGNGDINSTKGIIKYLGRYLARSPIAEYKITDITDKEVTFFFN
DLANNKKETYIAMPSERFISHILIHLPPKNFKMVNRYGFYSRRISDKLKKAIEPFKRNVA
VSKYSFYQRQVYKTFGMNPFYCPACKVKMIVWEFYHYRYPPLKKYY
>SEQF2502_01236 hypothetical protein
MKFYIISVILNIMILFIPVVYYTSNSSKKENKQNEPITVNLSEGVFQDSSQETAGNENIG
EKNNKSGNNESVKNIDDTKNNGNSEKIEVSKNDEISNSQSESNSKKINNLNNQKEMKKAK
NTKSISQNEQEKEELKVFPLENKKKDISQAISGISSISPLESILSSKNTEKILQKNENLK
VISKENLTNAVSTSTNISKNISENAAGNHKNDSRIYKARTNSVAGKNENQGDGTNKNSKS
NSFVQKGRNNGNNGKDGNNRGNVNGKGQSGDNSKTGNLEKISKNSSKNHNIERKRSTEKG
EEGNENVCNEGKDFTVSYNPNLSYPIAARRLGNKGIVTVSVKIQFNSSGSVSVISVSGGS
SIFQQEARRAAGRIRVKIKNPETLKCTITKPFTFELK
>SEQF2502_01237 Fe(3+) dicitrate transport protein FecA
MTDIYNCHAGMKFMLKKIAILSLILASLSLYAEGKYEGKLEETVVTATGFNDNIDNQIKN
VTIITSEDIQEKGYNTVEDILKQAPGVNITQTGFGSAVDMRGQGRFGLGTSANISKAVSS
VKILIDGDIAMDTIDTSHAYIPLNTISVNDVERVEIINGGGTVLYGSGTRGGVVNIITKD
RTKEGASGKAYYQNSSYGTNKLGFDAGINYGNKFIIDLGYENVNGKGYRRGSKEAYEYLN
GSLKYNITDNHSLKFKAARYNSEETLASDLTKSQLLSDRRQSGTLSDLDIDRKEYSLGYE
GKVTDNLKLSLTGYKQDTNKIMYGMPKTKFEDNKKGINFKGNYGLENGNIIFGYNYIDHK
GNREQTIFGTPIMNVDLAKETNSFYLLGRHKIVGNLEGTAGYRYERAEYKTNREVPSTRM
PIPGGRGFVNIPSREMHGSRKDNNSAYELGLNYKYSDTGNVYAKYERGFRSPAATEFVDY
APGARNYTLNNLKTEKFNTYELGFKDMLWNSFVSATAFHTRTNNEIYLNMDHGVLGGPST
ARWTFHNLKATERTGVELFAEQYLGKLRVNESFTYVNAKIKKVGDDVLTSTTYNFKDGQK
IPGVPSTKVTLGLDYEIADGLRTTANLNYYSSSVDTYNEKIPSYSTTDLGLKYKHQSGFG
INAGVKNVFNKKYNVAQGKDPLTGKTVYSPADERTYYIGASYEF
>SEQF2502_01238 hypothetical protein
MKFSNRRNRQNAEISMLNLIDVIFMLLIFFMIATTFNKYSQFQLSIPKSDAKFDKKEETK
AEIIVNREKKYFLKLGNNVKEISGENIHNEILRLPKEMLENMTLTADEHLEYGYIVEIMS
KLRNENVKNVSLNIQKNDK
>SEQF2502_01239 Biopolymer transport protein ExbB
MLLHYFISGGIFMWGILAASICGVAVILEKLWVFFTMEKDFTKEYRKELYKALQTKSKEE
VIKITNSKRDSVSRIITKTMENIDLDLNKIEESEKEYLEEIIREAVLAQTGKLEKGMWLL
GAVVNTAPQLGLLGTVTGMITSFSALSASVESSKTVAAGISEALYTTAFGLIVAIPTLIF
YNYFNRRIDATALEMERAALHIMGRVKK
>SEQF2502_01240 hypothetical protein
MEKANMKDHLNINFDLIEKMTEIKKDYIEGTADVETTKRRIKETFKDKKITPAEFAYSEQ
KIKDLGFDDETVHDKMNDVLDLFDEIIEREKPSLPEGHPIKTYLRENEAARKLIAEMKEE
LNKKFIKNRWLEFYDKLYTFNLTHLARKQHQLFSILESKGFDRPSRIMWTFDNAVRDNIS
EARKLLMEDKMEEFYAKQEIALELTLDIMHKEEEVLFPTSLKMITEEEFRNMRSGDDEIG
YFLIEKPKGFLPEKKEEKIEKEENANINTSQTGNFMNDLAGLLSKYNMNAGGEKSDVLDV
KQGKLTLEQINLIFQHMPVDLSFVDENEIVKFYTDTKHRIFPRSAGVIGRDVKNCHPRES
VASVLEIIDAFRNNEQDEVDFWLEMNGRFIYIYYVAVRDENGIFKGVLEMMQDVTRIRSL
EGKRTLVTWEKPKKSEINQENQKNSKEDKNPYGLTENTIIGEIIDKYPYIREFMPTLSPT
YKKLLDPIQYMIMSKVATLDMIAMRGGFPLDELIDKISDEIKRHESKK
>SEQF2502_01241 Phosphoglucomutase
MDYMKKYEYWLNSDAIDEKDREELKSIAGNEKEIEDRFFKDLSFGTGGIRGVRGIGTNRM
NKYVIRKVTQGLANYMLSFDEKAAKEKGIIIAHDCRIGSREYALNTARVMAANGIKAYIY
ESLRSTPELSFGVRYKGCMSGIVVTASHNPAEYNGYKVYWDDGAQVVDPHAPAIVEEVNK
ISTLEEIKVISEEEGREKGLIIQLDHKIDDDYIAAIKKQTIHTDIPGKEDFKIVYTPLHG
TGGRPMKRILSDFGYNFEVVKEQIEPDGNFPTVVYANPEEVAAFKLGTKLGNEIGAQLIL
ANDPDADRIGIAIRDDKNEWYYPNGNQVGLLLLQYLLNYKKDIPADAQVITTVVSTPMID
VVAPAKNVGVMKTLTGFKYIGQKIRQFEHKELEGSYLFGFEESYGYLIGTHARDKDALVT
SMVISEMATYYHSKGTSIYKELQKLYEKFGYYLEGIKSVMLKGKDGIEQMAALMSNLREN
VKDELLGKKIKIKRDFFSHKEHNLETGEEKEIKLPKENVLQFVLEDNTFITARPSGTEPK
IKFYFSVNADSSENVKAKLDKTMEEFSKFIGL
>SEQF2502_01242 DNA translocase SpoIIIE
MNRRKVEGIIWFVAGFILILLLANKSKMLSDNVGENIFSLILSGITLFFGKMTWFIAIVS
MLYGIILFFYEKIGINITQGKVVALTGLFLSWGMILIRGSVVHGKTLSGNFTEAGRQLLE
IGFNRESGGILGALLSMPFFKVLHFQWMFFILLILALLFVAWLVRDLIELGYEVLKEIIK
YYKSDDYKEKKRKLAAKKYAENLKRTDYKRYQKEMLKAKIIQSRNEKLSFEIAKKPKKNF
LQKTEVYSKGELAEKEKEWIEIFEEKEKGNFIKDENARREKIKEKRKKEDTLDAVVKPLE
SVKKTEILEKSEDNGENTLNTEKEKITEDKKEIKKEKELEIENVNENNKKETKLEIVTPL
KRAEINSVNADPNFQQFPKLEAFENGDGKEKGLEEELRKVNAMFDNNQGYDDVVKKSIAE
IFKSKPMDVEKKKEIEENIRENVNHLENVLKEFGVDAKVVNYEYGPTITRYEIIIPKGVK
VSKVTGLSDDIAMNLAAESIRIEAPIPGKNTIGIETPNKIKEPVHFSNIIKNKELDTGEL
KVILGKDIVGRDKFIDIVKMPHLLIAGQTGSGKSVCVNTLISTLISKKSDKEVKFIMVDP
KMVELMPYNDIPHLLVPVIIDPQQAAIALKWAVNEMENRYKKLMENGVRNIKGYNSLSFV
EKMPYIVIIIDELADLMMVASGSVEESIARIAQKARAVGIHLVVATQRPSTDVITGMIKA
NLPSRISFALRSQIDSRTILDSAGAEKLLGQGDMLLLANGSSKLERIQGAYISDEEVKNL
TDTLKSTKKVKYKNEILKEPEEEIEDDTDPYFENAINIIRQENKVSISLLQRKLKVGFNR
ASRIYDQLKEHGIISYDDQIIVDNIDEND
>SEQF2502_01243 Rod shape-determining protein MreB
MKFFDLFKTNIAPKTTRDIAIDLGTANTVMYVKGEGIQVDEPTYVAINKKTEELEHIGEK
AKEIIGRTAKHTEIIRPLKNGVISNYEVTERMLEEFLHRIKKDKFQSSRVIICVPSGVTQ
VERRAVIEVVKDAGAKEVYLIEEPIAAAIGVGIDLFEPKGHLIVDIGGGTTEIAFIVSGG
AALSKSVKIAGDHLNEDIMEFVKDEYNLLIGERTAEELKINTISQDDPELEYEIRGRELG
VGLPKSMKIKTSAINGAITRHIDAIIDEVRLTIEEIEPEVAADIYETGIYLSGGGAGIKI
LKERIEKELLLKVTVGDDAIHAVVTGIAEVLTDFKRYKNIIISPTHEY
>SEQF2502_01244 Segregation and condensation protein B
MEKFEKKENKKEEEQENIIGVQRKIKISEIEEKVEAIIFLAKETVTVQELAQFYAMENFE
MEEVLYNLKEKRKNSGINLKIEDGAVYLVSNPLFGFDVKRFFNSEMKLKKLSRSAMEILA
IIAYKGPVTKAEIEQIRGAGSDKTMANLLERKLIYISGKKKSIGTPNLYEVTEDFYSYLN
IHGREELPGSEQFQKINSLYKEDEKMETESSDNENTEK
>SEQF2502_01245 Ribosomal large subunit pseudouridine synthase B
MRLNKFIAETGFCSRRKADELINEGRVTVNKQEAIIGMDIKPEDVVRIDGERVKLNTRYE
YYILNKPKRVLCSNEDKFGRKLAIDFIKSRARLFTYGRLDFMTEGLIIISNDGDIYNHVM
HPRKKLYKSYIAKVSREIDDKDLEALQYGVVVDGKRTAPAKVKKIDKKELRIAIFEGRNR
QIRKMLETLGYNVNSLKRIKVGELTLGHLKVGEYRALNEDEIKYLKNL
>SEQF2502_01246 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase
MSKKLIFLIDFDITISKKDSTDTLLSVHQPELKTNIRKKYRSGEITMKEYLQTGIESLNI
TKEQFLETLKLIGIDETFVDFVKSGIEFRIVSAGTKLNIAGVLRNYGINLDEKEIISNDI
KFDGNKITVSFPYLDKEQYYGVDKKEAVQKYQDEGYTVYFVGDGPSDYRAIEVADFSFIR
TGTRAIKFCEENEIDFFEFENFDEILDYLKKQG
>SEQF2502_01247 Acyl carrier protein phosphodiesterase
MNYLAHSVISLEIDKKMSESTLYGNFAGDFYKGKVDKIDLQENLKNGIILHRLIDKISDR
EENFLNEILREKFGIFKGIVSDMYVDHFLCKNFENIFCENPDFENVEKVERKIIKNIEKY
DEFFPSDFKSFFDWLKREKVLARYKNLDFLERVFLGMSKRVRKGEILRSAIDELKRNYGK
FEEKSLREFLFVKKEAEREFGLVEINKNT
>SEQF2502_01248 hypothetical protein
MGKKEYSIGIIKKISVEKGYGLVNDGKDEKNFIFGNASLAEGFKLEDLKAGDYVYFVPNE
VDDTKRYANDINLVPSENEVLKGKIRSLKKLDKKGRKYKHIFPENFERTFILYSSFPINY
LDGLSFDGLTNDQEIFFKLKVMRSKNGYILSVAEISKSNETPTIKITGNNLIEKTSNEII
NVLKTNLDEIKKGETFEDYCALVLNLLGVELYQYSRKKQAGRADGIIKT
>SEQF2502_01249 hypothetical protein
MYDCTLREDFEDYKEMQIDNYVSQINQNTIRVEKMEIALKEPKKQVWIITKGGNSKTRSI
KEKERVKIKEINIENLIELLSSKITNPRVDISDKLGRLGDME
>SEQF2502_01250 hypothetical protein
MKKFKIVIEEHVSGEFEIEAENTGKAFEIAEKNYYEGKFVLEPGNVTSRLMSVETTDGEE
CSEWIEF
>SEQF2502_01251 hypothetical protein
MKQYEAVILTLEKLGGVATLGELNHEVFKIEECEWKTKTPFASIRRIVQQRKEIYKIKPG
LYGLEQFRKENELRGIIQEDEKNKNSEEMIKFNHSYYQGLLLEIGN
>SEQF2502_01252 hypothetical protein
MDTFIPNQDKNKNFINKKLGDLRSLEKIPKFSYPEIVNRTSTIDVIWFNNRFFDDKEVKL
PHSFFEVEHSTDIQNSLLKYNDLQDFYTEMFIVADEVRKKEFEKKIRYLAFKDLKVNNRV
KFLSYNRLVELYEITKKNLQGINF
>SEQF2502_01253 Glutamyl-tRNA(Gln) amidotransferase subunit C
MLSKEDVLKIAALSKLEFSENEIEKFRVDLNKIFDHMEELNSVDTSEVEPLFNVLDLKDV
LRKDIVKDSGIKKEILENAPNSDEEFIIVPKVVGENADN
>SEQF2502_01254 Glutamyl-tRNA(Gln) amidotransferase subunit A
MSLYKKTASEIAEMIKNKEITSEEVTKSFLDRIEKTEEKIGAFSNVFPEKALGEAKKYDS
ENNEKGRKNYDNELLFGVPVALKDNIVSKGDLTTAASKILKNYVGVYDATVVEKLKKAGT
PIIGKANMDEFAMGSSNENSSIKSVSNPWDLTRVPGGSSGGSAAMVAAGQAPIALGSDTG
GSIRQPACLTGTVGIKPTYGRVSRYGLMAFGSSLDQIGALAKSTEDLARLLQIIAGYDEK
DATSVNVEVPNYLENLNNDLKGLKIGIPKEYFAEGLDENIKKVIMDSVEKLKELGAEIKE
VSLPYSKYAISTYYIISSAEAASNLSRYDGVRYGVRESNEDVEKMYVESRTKGFGDEVKR
RIMIGNYVLSSGFYDAYYKKASQVRRLIRDDFSKALKEVDVLLTPVSPTTAFKKGEKITD
PVQMYLGDIFTVSINMAGLPAISVPAGFVDGLPVGIQLIGNYFREDLLFNISHKFEGVRG
KIEYPEF
>SEQF2502_01255 Type-2 restriction enzyme HpaI
MKYTDLDLKKPVESENYKLESEFVISSVKQIFEEKRESGNNKIIIKTNLKMGLPLENINK
FAAPLIEAWAFETFLEIRDESENKYRLINVEAQERLGMSDIILQFRKNKNVITGNIDVKA
TSNNIKNSGKSPNITSFSRIRTAYIQNPDFIFIILSIKHKVYNEKNPITSIINGIMELTE
FNIYDLKYVSEKDIAYNPSLGTGQIQIKDIHYVEYEYRTAWEMCQLLDKKYLNSSRRTIE
DFYREAVKNKWIKE
>SEQF2502_01256 DNA adenine methyltransferase YhdJ
MDKGITLILGDALEKLKELSDKSVDLIVTDPPYNLNKDYGFTKDNLEFDEYLEFSRLWIN
EAVRILKDDGTLYIFMGMKYISYIYVMLEKEFNLYFNSWITWFYTQGIGKTRGFSPRHDD
ILMFTKDKKKFKFNLDDIRIPQKYYRSVNNIRGANPGNVWEVSHVHYSNKNRKKHPTQKP
EALFERMILASSNEDDTVLDPFLGSGTAMRVCQQLSRKGIGIEINREYIEMSKKRLSEPF
LGFDSIDERMKRIPNDLNDEKLRKEYIENHKNWFLKNHNLEIEEFEKLYLEKYKDNNLKN
KNHLKLFSE
>SEQF2502_01257 Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B
MSMEYETVIGLEVHCQLKTKTKVWCSCDADYDNKHPNTSACPVCTGQPGALPKLNEKVLD
YAIKAALALGCEINEESQFDRKNYFYPDSPKNYQITQYFKPYAENGTLKITTNSGKEAVV
GIERIQIEEDTAKSIHTTSETLLNYNRASVPLIEIISKPEIKNAEEAYAYLNTLKDRLKY
TKVSDVSMELGSLRCDANVSVRKKGEKELGTRTETKNLNSFKAVMRAIEYETNRQIEVIE
NGGRIVQETRLWDEENAVTKPMRSKEEAMDYRYFPEPDLPTLVISDDRLEKVKGEMPEFA
DEKARRFVNEYKLHEMEAATLSSEQELAEYYEEIVNDTKEPRLAANWVLTEVLRVLKEKN
ISISKFNVTPKNLGKLIKLIQAKTISSKIAKDVFEILLTEDKDPEIIVKEKGLVQITDDS
AIEKIVEQVLAENAQSVEDYKNGKSNALKYLVGQAMRLSRGKANPQMINEMILARLEG
>SEQF2502_01258 Stage V sporulation protein D
MKEGKKKDNIIDRAKSNVKKNRKEQKVESFFKVLLKYLNTFRGRFGLLVLFTTIGFAMII
GKVYQLQTKGGEKYRKQGEKQYTSLSFTKAKRGRIATSDGQVLAYDDEKFIVNLDPSLIE
QKNIDVVLGMLKKYIPELEVEKYKSEYLEDKQIQKKYLKVEHIIPYNTKIAIEAEIDTDF
KNSKDKEKKKEGYKRKFKGVTFETLFTRNYIQNNAFQETIGYVNNENKGVYGIEKYYDKE
LSGKTGIITGLRKIPKALQGIMKLGNIKKSEDRKEEEGDNLVLTIDSFLQYALNDELEDA
YVKYNASSTMGILIEVETGKILAMSSYPKAEEKAEIKNRPITDYFEPGSIFKPITVAIGL
ETKAINKNTKIYSSGSIKVYDTIVRDHDSSTIGTLGLADIVAHSGNVAMVKIQNEINKNT
FYHYLADVGFGGKTGIDTYFESMQKLREFKTLKDEVRRANISFGQGIAVTQIQMIMALNT
VINNGKLMKPYLVDRIEDSNGNTVKQNKPDMIKKVFSDEASRLNRKYMEASVNRGTGGGA
YIPGYRVGGKTGTAQKAGKDGYKNSHVGSFFAFFPADKPKYAILITISEPKGEKYYGAQV
ALPSARNVLQKLIEYKRIQPDGKIKTIDIKNTESVQKEKKKDLGKIKQDFNKNIMPDLSG
ISLREFLSIYPQGKFSDYEVTGSGIVVSQFPEKGTKLDKKSKIQIMLE
>SEQF2502_01259 Primosomal protein N'
MYYYEIYVENNRGIYTYKSEEKYEIGQWCIVNFINRDKMGLVIAITAESKIQFDVSKIKR
IKAAAPVLSIPDDIMQLIKWIRSYYISDYYSVIKAVYPGALKLNYSKKAIYQKDFWVEEC
WVERDDSEKNLEEIKKFNEYMKKRKEVTVTTLKKNFSSEIVEKAINEKIISVEKKVILNS
KISKKENEKGEIIEKKIILNNEQKKAVNTIKNSEKQIFLLKGITGSGKTEIYIHLIKEAL
KQGFGSIFLVPEISLTVQMIQRLEEEFCNEVAILHSKLTDKEKREEWTFIRNGEKKIVIG
ARSAIFAPVQNLKYIIVDEEHENTYKQENNPRYHVKNVAIKRAFLKNEKLKKDNDLEKNK
ELRKDVDLEKEETEKNKKIKVILGSATPSFETYYQAQQGDIELVELTKRYKNARLPKFEI
VDLNETTENFSERLLDKISQTLKKNEQVILILNRKAFSNLLKCKDCGNIPTCPNCSISLN
YYKYDNCLKCHYCGYERRFNNTCDECGGHKMRQIGAGTEKIEEELAEVFPSARIVRVDSE
SIKTKQNYKKVYNDFKNHKYDIMLGTQIIAKGLHFSNVTLVGIINADIILNFPDFRASEK
TFQLLTQASGRAGRGEKDGEVIIQTFNGENNVIKKTIESDYEGYYKNEMIMRKMLNYPPF
GRIVILVISTTEESLVKEKAQMLREEIIRNINVVMKLTSNDFISDAFKSPIYKINGRYRY
QIFFKFERKDILKIKKIIKKCVGKFREMEKKVRVTIDVDPVNMM
>SEQF2502_01260 1-deoxy-D-xylulose-5-phosphate synthase
MEKKSTRVAYGETLVKLGKINKDVVVLEADLSKSTMTAYFKKEFPERHINVGIAEADMVA
TAAGIATTGKIPFASTFAHFAAGRAFDQIRNSVAYPQLNVKICPTHAGVSLGEDGGSHQS
VEDIALMRAIPGMVVLSPADAIETEKMIFAVADYKGPVYVRLGRLNIPVLFDENYKFEIG
KAITLTQGDDVAILATGLMVSEALEAAKLLEEKGIKARVINVSTIKPLDTETVLKAAKEC
KFIVTSEEHSVIGGLGSAVSEYLSEAYPTKVIKHGIQDVFGQSADGETMLTNYGLRAKNI
VEIVLKNI
>SEQF2502_01261 Transketolase
MKIENLQKKAKTLRKDIIEMIYGAKSGHPGGSLSIADILAVLYWKEMNIDPENPKMENRD
RLVLSKGHAAPALYAALIEKGFLGKEGRDLIPTLRKWHSPLQGHPDMKKLAGVEMSTGSL
GQGLSAANGMALSAKIYKNDYRVYVILGDGELQEGQVWEAVMTAAHYKLDNLVAIVDYNN
LQIDGKVSDVMDVAPVGEKFKAFSWNVIEIDGHNYEEIINALDTARTVKGQPTVIVANTV
KGKGVSFMENNAGFHGAAPNEEEYKKAMEELS
>SEQF2502_01262 Inner membrane symporter YicJ
MSLVLSNIKNRKVENLMSSRLTKKSYIIYGLGVSYFMIDQIYNQWLSYYYLPPETEKNLV
PLLKPQYLVLAFIFARIIDAISDPVVGFLSDNSKFRFGKRSIFMLIGGLPLGILTIMYFY
PVKSSQLATLIYLSIVGGLYFTAYTLVAAPYNALIPDLASNKEERLNLSTMQSTFRLIFT
GVAMVLPGILISKLGMVNGVLNTEVGIRKTVILITILSVLGIYACVFFLKEKKLTQNRPK
TESLGFMKSISHLKDKEIILYFLGYFFFFCGFNILRGDLTYYLSAVMQKDIKYLTVISVV
LFGMAGLFFPITNKFGKKYSYKKILIVDMMLLIIGTFGLLFINKNNSIFAYLLFVICGTG
LSGAAFIFPQAMLSEISAKLSETKKVSLEGFMFGIQGMFLKLAFLVQQVVQSTLLVAGNQ
NIQNGVKGATELGVKVTLVVALALFGVSLFFYNLKKED
>SEQF2502_01263 hypothetical protein
MGAELLIIVNVLFMIFFFVIAYLSIRYFINQIEKYPRITFEEVYNSKKLRQKYNIENNKA
NPYDYGYNFKEIEYKSGKIQLYGWLIENKEAAKTMIISHGRGVNRLAALQYLGMFKDIGL
DKEYNFFIPDLRNSGKSDVARTKMGYCFGQDIFHTMEMLKERFGKNNFTLYGFSQGGMGS
AIASKMYIKTLRKKGIIIEKLILDSSISNIRKRIKEDARKRRVPKFIVSVIVRIFNLRVG
SHLDKLRLSYLLKRIPTLIIQSKNDKATTYGMLMEEYNELAQNENIKLKVFEKGSHTRIY
ADPECKDEYAEAVKEFLTN
>SEQF2502_01264 hypothetical protein
MLKIGIVAEYNPFHNGHLYQIRKIREIFGKDVFIAVVVSGDFVQRGEISFLDKWEKTQVN
LEYGVNLVAELPLYCSIQNAEIFSKMATRILDYLGMDIQVFGAEEENIELLQKVLDLQKR
QDYKDKLMGYMKKGNSYSTSQRLALKEYELDGIVKSNNILALEYMREIEKSNLKIKPFIV
KREISEYNEEKVEKEREEFASASFLRNELEKILEEFCGDKNLKSKKLILEKLKKIQKFVP
EKSFEIILENLEFKIKNGIDGGKIKEEIFKIVKYKILTEKKEKIMKIYDINCEIYARIYR
GAEISKNYREFLENTKSRNLSNRRVERIILNILLNIKAEMMDFEINYVRILGFDKKGREY
LKKIRENNNFENIEGKNSFEKKNIFVNWKDIEKFGNFFENNGNIEKKENIKNFKIQENFF
EKIKIEKNGFLLKELFLGKREKLNPIVYLNNQN
>SEQF2502_01265 hypothetical protein
MKIHFILHETFEVPGAYLAWAALSGHDVTMTKVYQDEKLPENADSFDFLIIMGGPQSPIG
DNSEFPYFNPKAEIDLIKKAIKADKYIVGVCLGAQLLGEAYGGTTEKSPSCEIGNFPIEL
TEAGLEDENIKHFGKQAITGHWHSDMPGLPDTAKVLAKSEGCPRQIIKYSKKHYGFQCHL
EFTKKVAELLIDSDKDLEKKSQTLPYVQSPQTIRDNDYNEMNNLLYEFLDNFTKK
>SEQF2502_01266 hypothetical protein
MKKLFFSIFLMFCINVFSNVNYNVFVIMDNNATKNVENISKGLKDVGIESLYSKGYAVHL
TLYLTEYKPETLKTIKDTVNKIANQTKPFDIEFYRLRKTGGNWFMLDAQNNEAIQQLADE
ITVSLNKYRAKDAKVPDWAKSIPEKVKSFNLYGSPNVFTSFDPHITLLTPEDSAKIDAFT
SKYDFKPFKSKVIGIGIAQVDDLGQAKNIIYSVKFKK
>SEQF2502_01267 Thioredoxin-like protein YtpP
MKKLENYEQILNKIKEEKYFLLYVSMNNCSICQIDMPKVEKIVNEQNFTAYYIEASEIPE
AVGQLSLFSVPVVILFYEGKEIHRQAKIIDFEELNYRMEQIHKK
>SEQF2502_01268 hypothetical protein
MIKKIFFLAFILFCFNIFSNADYSTSNDNSNVSASDQSFSDAEIFFIIIGGAILFNFFSS
NSSTNENYNVFIIMDNSATKNIKNISKKLEKNEIESLYTQGYVIHVTLYLTKYEKNSLYK
IKETVEKIASQTKSFDMEFYKLEKTERKTLAVYAKNNQNIQQLADEITVNLTKYRKKDIE
TPEWVRYFPEKEKLFNLYGSPDVFINFNPHVTLLTQENSSKINSFILNYNFTPFKTKAIS
IGIGKANNLGQIKEIIYSQSLIS
>SEQF2502_01269 Pyruvate formate-lyase 1-activating enzyme
MEAKGYIHSFESFGTKDGPGIRFVLFLQGCPLRCLYCHNVDTWEIKDKKMVMTAQEVMKE
ILKVKGFIKTGGVTVSGGEPLMQPEFLMELFKLCRENKIHTALDTSGYIFNEKAKKVLEL
VDMVLLDIKHINPEKYKILTSVELDNTLKFAKYLNEINKPTWLRYVLVPGYSDDENDLHE
WAKFTSQLKNVERVDVLPFHQMGQYKWEKVGKEYKLKDTPTPTRELVEKAEGIFRSYGLK
LLDK
>SEQF2502_01270 Formate acetyltransferase
MDAWRGFKEGNWKDNIDVTEFIRLNYTEYLGDDSFLEGPTEATTKLWKELSEKFKVEREK
GIYDAETKIPSQIDAYGAGYIDKDLEKIVGLQTDAPLKRAIFPNGGLRMVKNSLEAFGYK
LDPETEEIFTKYRKTHNDGVFSAYTEQIRKARHTGIITGLPDAYGRGRIIGDYRRVALYG
VDRLIADREEQYKNLDPAEMTEDVIRLREEVFEQIKALKALKRMAAAYGFDISGPATNGR
EAVQWLYFAYLAATKDQNGAAMSIGRTSTFLDIFLERDLQEGTLTEKEAQEIMDHFVMKL
RIIRFLRTPEYDALFSGDPVWVTESIGGMGADGRSMVTKNSFRILHTLYNMGTSPEPNLT
VLWSEKLPETWKKFCAKVSIDTSSVQYENDDIMRPQFGNDYGIACCVSPMTIGHQMQFFG
ARVNLPKALLYAINGGKDEKSKIQVTPVGQFEPIKGEYLEFDEVWEKLDKVLDWLASTYV
KALNIIHYMHDKYSYEALEMSLHDINIRRTEAFGIAGLSIIADSLAAIKYGRVKVVRDED
GDAVDYINEKDYVPFGNNDDATDQFAVDITRRFMNKLRTHKMYRDAIPTQSVLTITSNVV
YGKKTGNTPDGRRAGAPFGPGANPMHGRDTRGAVASLASVAKIPFEDANDGISYTFAITP
ETLGKNANEKQTNLVGLMDGYFNQTGHHLNVNVFGRDLLEDAMEHPENYPQLTIRVSGYA
VNFVKLTREQQLDVINRTISNKM
>SEQF2502_01271 hypothetical protein
MGLDFNESDILKDILNFKIVNRRKLEEKYEFKIIDHTIGHINKFLSRNNNGIIHKSKNYL
YYFGKYHEKLFKMDDRDINMKMSFRRELITLILLLGKEKLNIYKFNKQIRRNEQNTKNIQ
NDLKQILKIYNIKHSEYVKSANIEKLFENKNYDLKELRENYLREILMRRMEKIYIGKSTY
QENFYFKILQEILELKGIKYMKKLLFLYIDQYTDIISMDEKYSILTYFILNMKNTNIKFK
YRIKRTDKNEEFFIMIDKICKREKLKMDYKFITLFYRKLHRKKRNPEKILSEINKAVMIE
KSQETSKIKKVETRRKKEDKVEVYSIAEISVNFENENLLNKKLVKKYIHLNEAAKIKTLV
LVDVEENQILKSFNKVMRFFNFLEVVKVEHLNNFKKVITKKNTGYEQVLIISNSKFLNTI
RNFSDIPIFNFVLGKEKGALQSRTNILKQMIYLRRMMFQYLEFKKDRKIIHK
>SEQF2502_01272 Monoacylglycerol lipase
MKKQYFESFDGKKVPYLFFESKRYKYKNNIVIFHGMTESIDRYAEFGEFLASNGYNVFVM
EIRGHGELKDSEIGDFGKGGIKSVFKDIDSFFKKVLSKVGATPNNTTIFGHSMGSLIGTE
WGIRNKYKYFILSGFPLKSQLIAIGGKFATFLEKVIFRKVSVFNKISEKWNANFEPNKTK
FDWLTRDEIENKKYENNELCGYSVTPKFYSGIFSTIGFINRNYKKLDEHVRILSVYGTDD
KVIDIPYINQIFNTLRKKKRRINILENKNGRHESLNETNKYEIYDEILKWLNAKDF
>SEQF2502_01273 Rod shape-determining protein MreB
MGVFDFVKIFRVNKSISIDLGTANILIYDKQRKKIVLNEPSVVARDRKTGRLIAVGKEAR
EMLGKTPESIQAIKPLQDGVIADIDSTKEMITYFIHKIYGNSLFKPEVMICVPIEVTSVE
RKALFDAVKGAKKTYIIEEGRAAIIGSGVDISQPEGSMVIDIGGGSTDIAILSLDEIIAS
KSIRIAGNRFDEDIVRYVKRKYNLLIGDRTAEKIKKELGSALKVQSPEVMEIKGRDLETG
IPNTVEVNANEIYEAIEDSLFQIVNSTKEVLEKCPPELAADILDNGIVMTGGGSLIRNFI
DMMEKEVGIKVFLSPNPLDSVVLGGGAAFDNKKLLRTLQMKEN
>SEQF2502_01274 DNA polymerase III subunit tau
MKLQKITEKFKNEANQDKVSASYLFYGDKRVDLLSYALMFSKMIMTKNIQTDAEKEKIER
LIDISQHPDIEIINKNNENIKIDEVREIIYSSIESSFNSPKKIFILCGIENLRNESSNAL
LKILEEPPKNVYFILLSRTLNIISTIKSRTIKFHLSGMNNDELGVSKEIYYFFDGNENDI
LEFKRQNLSLDGIQFQVNTVEDILQIIFEMKNYTAGELAIKNNLDLTIKYNKSVELLARR
IRFWDIENVYFFVNEIENELKKEKEFLINFLSKIIINVKYSVNSEDLKKLINLKNSIRNN
VNVKSVIFNFFDILQSS
>SEQF2502_01275 Right origin-binding protein
MIKAFNETMKYIEETLTDRINERKIALLSGYSYPLFSRMFSIMVGYPLSEYIRFRKLSCA
AIDLRETDEKIIEIAFKYGYESQDSFSLAFKKFHGHTPKEVRKGSAFQIFSPIRLSLSVE
GGKNMDIKIIKKSAFKIAGVAERVEEGGDFPNVWDKLFKKVSEEKLESLGNGQSYGACYE
IEKNEKENPESKYTVSYMAGYDVQNIDKAKDLGLSILEVPEAEYAVVKLKGIVPNCIHKG
WKYVTGTFFPEQSYRHAGTPDFEVYSEGYMYSPNYEMELWVPIVKDRN
>SEQF2502_01276 ABC transporter glutamine-binding protein GlnH
MKKNFERLVKIIAILVLGVFTISCGKGGKGSAEPGSIEAIKKAGKIRIGVFGDKPPFGFV
DENGKNQGYDIYLAKRLAKDLLGDENKIEFVTMEAANRVEYLLSNKVDITLANFTVTDER
KQKVDFAKPYMKVSLGIVSPEGAPIKDVKELKGKKLIVNKGTTAEIYFTKNYPDIELLKY
DQNTETFNALLDKRGAALAHDNTLVFAWATENPGFVVDIKQLGEQDYIAPAVKKGNKELL
DWLNTEIDALTKEGFFEKAYKATLEPVYGNKVDPKTVIIENK
>SEQF2502_01277 D-methionine-binding lipoprotein MetQ
MKRKSLVIITLLSVFFLIIGCGKKTEGNKTNSGDKKVIKYGKASGPYTVLFEKAIIPILE
KKGYKFEVVEFSDLLQNDTALNEGDIDVNVEQHTAYMNNFNDSQKGNLVALSPIPTVPAG
IFSSKHKSLNELKDGAKIAIPSDASNAARGYNLLQKAGWIKLNENINVAKATQKDIKENT
HKLEIVEMDSANIPRSLDDFDYAVIPGSIVYSAGINPSTVLLQEDILNHLLLQVVVKKGN
ENSNWAKAIVEAYHSDEFKKYMEQNNKGLWFIPNNK
>SEQF2502_01278 Methionine import system permease protein MetP
MIENWLKISSDKLMISAGQTIYMVGWSLFFGAVIGIPLGLILVLTKKDGLRENKIVYLLI
NTTVNLVRSVPFIILLVFIAPLTKVIVGTRIGTNAAIVPLVFYIAPYLARLIESSLLEVK
PGILEAAKAMGANIWQIIVYFLLPEAKASLILAFTTGTIGLLGATAMAGTIGGGGVGDLA
LTYGYQRFNNTLMLVTVIILIIIVQAIQSFGNYIAGKLRENN
>SEQF2502_01279 Methionine import ATP-binding protein MetN
MIEISNVKKVFKNKKVKVHALKDVSLKVEKGDIFGIVGYSGAGKSTLLRLVNLLEKPDSG
SVKLEGKEIIGLSEGELNELRKNIGMVFQQFNLLETQTVYQNLKIPLVISKTPKSEINER
IDELLDFVGLKDKKNVSVSKLSGGQKQRIGIARALATHPKILLCDEATSALDPKTTKSIL
ELLKKINQEFGITILLITHEMEVVKEICNKVAVMQDGEIKEQGNIIEIFTNPKERITKDF
ISSVINNDIPVSLLKELDLTLPIVRLTFLGENSGQSLISEINKNFDITTKILSASINELG
DTILGVLVIQLGGNLELIGKVEEFIVKSGVKVERMEII
>SEQF2502_01280 putative hydrolase YxeP
MKTIENLQEILEKEFKWFHQHPELSLEEYETTRRIKEILKRENIEILDVPLKTGVVAVIR
GQESGPVVAIRGDIDALPVYEETNLSYKSEVDGKMHACGHDYHLTSIIGTTLLLRDNADK
IKGTVKLVFQPAEEVFAGALQIMESGVLDDVELIFGIHCTINFPVGTVGIREGSVSAAVD
RFKIELKGFGTHAAHPELGKDPIVAGSALVNSLQTIVSRNIDPFSVGLVSITHFSAGNTW
NVIPEKAFIEGTVRTLDKEQRKFIKERVIDMTKYISSTYQVNPEIEWITGPPAANNDKKW
SEFAKKVALDRKLAVEPSSDTLGGEDFAFYQEKIKGVFIHIGTDESYPNHHPKFKINPKA
LSLTSEFLSDLLIKVTNEIRKGGENKK
>SEQF2502_01281 Glutamine transport ATP-binding protein GlnQ
MVFQSYELFDHMTVMQNLLLGPLKVQKRDKKEVTEQAEKLLERVGLLDKKNSYPRELSGG
QKQRIAIIRSLCMNPEIMLFDEVTAALDPEMVREVLDVMLELAKEGMTMIIVTHEMEFAK
AVADRIVFMDSGEIVETNYPLEFFRNPKTERAKKFLNIFNFEKKDNVESALLI
>SEQF2502_01282 hypothetical protein
MFLKMLEYKLMFLGKQFLKIDKWFPSSKTCSKCGNIKEELKLSERSYKCECCGIEIDRDY
NAALNIKNIGKAMLKY
>SEQF2502_01283 Pyrrolidone-carboxylate peptidase
MKILVTGFDPFGGEPINPAIESVKKLPDNIAGAQIIKLEIPTVKGKSIKKIEKAIEEHNP
DVILSIGQAGGRFDISVERVGINLDDFRIPDNEGNQTIDESIFPDGENAYFVDLPVKAMV
KNIQKNKIPASVSYTAGTFICNHVLYGTLYLINKKYKSKKSGFIHIPFLPEQVINKKNTP
SMELNTIVKGLIAAIEAIVKNDKDIKETGGTIC
>SEQF2502_01284 hypothetical protein
MEIKALLKLLTQIIYILCGLVSISTGIRGLKNEKAKIGTFLFWTILGIIFIFGEAIPYKV
TGGLLVILAIITVTKQLHIGKFENISSQFKIAQSEKLKNKIFIPAVLIGIAAFLILQFKI
GKTAIPPALGIGGGSLVALLAAAIIIKPKFSETNEDTSKLLMQIGATAILPQLLAALGAV
FTKAGVGKVIAASISSVVPTGNIFVGIVIYAIGMVIFTMIMGNAFAAFSVITAGIGIPFI
IKNGGNPAIIGALGMTAGYCGTLMTPMAANFNIVPASILEIKDKYGIIKVQAPMALLLLV
THVILMLLLFGVK
>SEQF2502_01285 hypothetical protein
MNLWILIGIVIIVVGFSLKLDVLAVVLTAGIATGIAAKMNFFEILGIIGKAFVDNRLMSI
FLISLPVIAVLERYGLRERSAALIEKLKNATAGRILGLYMVIRSIASALSIRIGGHIQFI
RPLIYPMSEAAAKAHKNQDLTEKQTEELKSLSAAIENYGNFFSQNIFVGASGLLLIQTTL
KENGYAVSLKQLALSSIPIGIIAIIFTFIQVYIYDKKIILSKGGKK
>SEQF2502_01286 putative isomerase YddE
MKQYVVDAFTDTVFKGNPAAVCIMDSWIDDDLMLSITRENNLSETAFAVKENEKYRLRWF
TPGGEIDLCGHATLATAFVITNFYEKNIDKIVFDTLSGDLTVHKKGELFELNFPSYNLKS
VEITKEIIDAIGVKPLEVFIDRDLVCVLENSELVEKFEPNLEKIKLLDGLLLHITAKSDE
NSEFDCISRSFAPKLNVAEDPVCGSGHCHLVPLWSDKLGKNEIVAFQASKRTGILYCRLN
REKNRVSLSGKAILFAVSEIFI
>SEQF2502_01287 Chromate reductase
MNVEFLNYRDVPLLEQDTEFPAPQSVRDVRDQVGKADAVWVVSPEYNGSYPAVLKNLLDW
LSRPLVAFDRETPTVIAGKPVTVSSIAGSTEGKFVRQNLSTLFLYIRMNPMEGTGTGLIV
LAEAWGTGILNLTDEHKEALKKQVKEFLEFIK
>SEQF2502_01288 hypothetical protein
MNKFINGNLLKMNTEEFLSNIKKAFNDVFSNGNIEKINLMNYLSEKKWLSIKKCGLLLPF
LPEKFGGRKNSQLEIQEVLRIAGNYGVPVTLRTGIEGALVLQPLLEYGNEEQIEKGLEMI
FNGEGGGLAITEPETSGSAIAKEMQSYYEYVDENTIHVKADKYWQGNSQSDFLLIAAKEK
KEGKLSKVISLILVPREYITYDVLNSEGLKAVRYAVNHVDAKIPAKYIIKLSENRANCLR
EFQNIFIRSRLQLVGMTHGIMEYIVKNINKFARKEIPFVQNELNEIENTYDISKIMYSYT
CNNVSPDKSVSDKLMEANIIKSLATEYTYKASRIAQKLLGAKGFEAGHPMSNVAIDFRPF
TIFEGPNDMLYSEIYDQFSKATAVEKKEGIRINKNSTIYERFILDKRFENISVNNIVNKV
DDLISFLKHHTLNEMDQIKKVFVGKILARLFLLIQTESDNLIKFLIRDIRKDILDFEYNS
>SEQF2502_01289 hypothetical protein
MSNVKLVKNDAFYNAEFDTDIFLYWMIKWLNVETTNNSSKVALKNMAKKFIEEILGEKLT
TEDIEIHFSNKNYYSENGTFIDRILGDCPILLILNRNQNGNRKYIYFRDFSYYEYSKDFN
EYNGKLIKLLKKYENLKENEENNVKIVHFSSDLISRYEKEEVEEINILYDKEKFLTLFEN
SKKYIDDSIFDSYYNQINQENKKNFGVNINENLSLYLVLESYINKKFEDYDVYRCFDYIK
WLKHEFFIECFCVNLIAEDKKTNNYFLLKWFNNNKVEEKTIKLIQKELKDIFPDFKEVNY
EDIDCENNEIPLMCFAVNLDSSLKDIKKMVDKITEKIEKFNKMKNCRDIREEYVEYFEEK
RLKKRFRSKRKIRKKF
>SEQF2502_01290 hypothetical protein
MKNENSEEKSIRILKIMKRLNQKEIVNRSDLANEFKVDKKTIQRDIATLRNYFFEEGESD
IKYSSSKKGYYLEKNDKIAFTNEELLAISKIILESRAFNKEETEKLITKLVNNSSINDRE
IIKNLINSEKVNYIPLQHGQKLLESIWKLAQCIKNQEWVHLNYTKKDKQYKEYRIKPLSI
MFSEYYFYLIGYIENKEEYPAIFRIDRMKKIENTGRKFKILNYSDKFKDGEFRKYIHFMH
LGPLTRIEFKYRGYIEYVLDKFPTAEILDEKIVKENNRETTVYTVKIEVYGSFGAEMWLR
SQGDYVIEYKILK
>SEQF2502_01291 Cell division protein FtsZ
MEKIPKIKIISLGETALSTIEKEIITHENISIITIKNDYKDLKINFQDTDVILIILNTYF
ENDKNFALEIIRNTEKNDIFTGIYDIENGYTDLFDSKTDFIIKCKSSEDLKNGINGITKT
LTAKGMVTLDLADLKTVFQKTSKSFVIFEKGNLETFDDFLQNLKLKLETFDKNKTYKIFL
NITAGKNIELTQIKDIAKIMTNILNERAFLWGLQIYPENENFINIIAYIVEDSVK
>SEQF2502_01292 hypothetical protein
MENTQEREKHYWGYRIDVKNQDFFFKELEQGRLRQGWGYDKNQELPDTKDSGARKNLSMY
HNVKKGDILLIPRLPDWGSVAIVEATQDWDDKEKGYKFEIDDEKKDYGHIFPAKYIGCFN
RHGKDVSGNIQSTLKARNRFWNISRFSEDIEKIIKNLEGNRESTSVIENIKNIISEQVKS
YFNLKECCDKIVDEYNQKFVASQWEEVLKDILEKIYPRYKIKKTGGSKEEEHGTDVLVNI
PGISISESYNIAIQVKNYKGEISDENINIIIDQVNKAEEYGWEDGKLIDKILVITPAKEE
ENPKLIEECQKNEIRVIFSEELKKLIFKSIIESIDLKEIFDEMLQE
>SEQF2502_01293 hypothetical protein
MINNVMSTTWGKSGICEKIGEYRYNLLIAFVQSTTLSMYKQWITDGKKISLEEIISLTSD
LLIDGMKKFF
>SEQF2502_01294 hypothetical protein
MENDKNTNIKRNEIKDLRVKRTLENINNAFNELIFETDFEKITVKSLSEKAKINKKTFYT
YYSSLDDLLLEYQEKTSSEYIE
>SEQF2502_01295 hypothetical protein
MLKKLILGVSILLLGALSTSNVSYSAGKNQNNGKSLLENERELGRLVDDFSVLADKKDAH
SQTFLFTENATVEIVRDGKVSLKLTGRKEIGDTFNKTLTSYDTVYHFNGQKVFDIQGNKA
TGTVYCMTVLIGKNDKGQLIKNTMGVRYNDEYVYENGKWLISKRTSNFDWRTSEEMK
>SEQF2502_01296 hypothetical protein
MKNNLKKKILKSIFTVILALISATGFSAEKNINLKDMGSFTVGGKVYQEKNGSTFHGDHA
YVQYFIPVHARKYPLVMWHGIGQTGKTWETTPDGRDGYMQIFTRRNWSVYIIDQPGRGRA
GRSKLKFMAPDMIPTTAGEMGTWNAFRLGEWTPEKGRTFFKNTKFPKDEKSVDQFMRWQV
SDNGEEVSEFVDNSDDMVNSVSELFKKSGPAVSHSASGILGWKTAMKNPNSVKAVVAYEP
GTYVFPEGERPADISSKNELASKFSEPNMIPKEEFEKLTKMPILIVYGDNIYESPIFGIE
FWRLSLERGKQFVDAINRHGGDAKLVHLPEIGIKGNTHFPFADLNNVQIANQLSQFLKEK
KLD
>SEQF2502_01297 putative FMN/FAD exporter YeeO
MTGEVIENKNRIFLNKDLFKLFLPLVIEQGLEYIVGMADSIMVAQVGEAAVSGVSLVDFI
MALLISIFAALATGGAVIAGQYFGKKDISKAKETGRQLLKISVWFSVFIMITVYMVKPLI
FKYMFGGISTEVQKAANIYFLIVLPSVPFLALYNSGAAIFRTTGNSKLPMQIMLSMNILN
VIGNGILVIIFHMGVAGVAIPTLVSRIGAAIIILYLANKKEMKLSIKGWMKTKFDKKIIK
QILNIGMPFGFENGMFYLGRLVVLSVVASFGTASIAANSVGGTIVMFEVLPGMAINLGLS
VIVSRVYGMGDYEQLKYYNRKIIRIIHGTFIVSTLIVLGLMPLIMKVYNLSPEATEMAWF
IVVSHGVLMILIWPAAYSLPVIFRGVGNAKFPMIVSMTSMILCRIVLAYVFAFGFGMGMI
GTWVAMFFDWVVKAIIFGVYYLKNMWIKIKK
>SEQF2502_01298 Glyoxal reductase
MKYVTLNNGVKMPILGFGVFQIDDMKECEEAVYNALKAGYRLIDTASAYGNEEAVGRAIK
KSGIPREEIFVTTKLWVSDVNYEKAKSAFETSLKKLDLEYIDLYLIHQPFNDVYGAWRAM
TELYKEGKIKAIGVSNFYPDRLVDFILNNEIVPAVNQVETHPFNQQVKANEIMKEYGVQI
ESWGPFAEGKNGIFTNEILSKIGKKYNKSVAQVVLRWLIQRNIIAIPKSTRKDRIEENFN
VFDFELNSEDMGKISELDKKESLFLNHDDVEIVKWLNGRK
>SEQF2502_01299 HTH-type transcriptional regulator GltC
MIELEQLKQLIAFATYGTLSKAAEELYISQPALSRSIQKLEKTLGVELFDRKKNKMELNG
NGKTVIQYAEKILNLVDEMEEKVNKNNQVQNNFSIGSCAPAPLWDMISLFAKFYPEKYIL
HKIENNLQLFEKLKNDIYQMIILSEPIDNSEFFCIKYKTEQLFLSVPLSHPLAKKKEIHF
SDITDDRMLLFNPIGIWKDVVLEKMPNMNFLIQSDRIIYQELAEMQNLLHFRSNFTLERE
DNFKNNISIPIADKEAKMTFYCVCKKNIKNEIEKLFDSFSKNF
>SEQF2502_01300 hypothetical protein
MKKNLILLMAIGILSATASFGFQKPVTIKEQGSFMAGGTVVTSPGEYKDSEPMNFDGETL
HGDHAYVFYQKPVKAKKNSIVFLHGYGQSGKSWESTPDGRDGFQNIFLEKGYSTYIVDQP
RRGRAGQSTVPRNLTARPDDQLWYNNFRIGQWPGIYDNVSVPRDNESREQFFRQMTPDTG
DFDQKVISDAMVKVFEKSGNGVLVTHSAGGGPGWDTAIASDKVKGVIALEPGTFPFPKGK
LPEVEKTTSPFPASGYEVSDAEFKKLTKIPIVVYFGDNIPTELTDNWGLDNWRIRVNLAK
KWEKMMNEAGGDVKVVMLPDIGIKGSTHFMMADLNNREVANAMEKWMKEKGLAK
>SEQF2502_01301 hypothetical protein
MKKIKKYILTFIIFLLGGNLIMANSVNNLSITKKENLKYIKADPKYFSGEAEFAILPQID
ISKDSVAIVDFEVGVVNNWHSHSKGQYLYITEGEGRVQEWGKEIQYVKKGDVVWIPADVK
HWHGAGETTSMSHLVITPDTENNTTTWFEKVELNEKPTEERLKISIEKHKQNTSLTEKQL
AIVSIAANTAKGDLNKLKVALNKGLDKGLTINEIREILNHQYAYIGFPRALNGMLTLNKV
LEERKVNGKKDIEGKVPTNKGDINYYEYGTETLSILSQRDSSGLLQNFDGVDYALKAHLF
GYLFSRDNLNYVNRELTTVSTISTISGGEAQLASHVNLITNLGIKKSDLEKVVNILNKEV
DSDSSNRLKGVVEK
>SEQF2502_01302 Para-nitrobenzyl esterase
MKKMLLVALFLLQIGTGNLLFSETNENKNVVKKIENTVNQNTNTIATTESGKIQGFIQDE
IYTYLGVPYARAERFMAPKKVEKWNGIKQTVTFGTYFSQGESMVSSGGWFAGPKLEMSEN
SHNLNIWTPGIKDGKKRPVMVWLHGGGFRSGSSAENYIFDGKNLSKKGDVVVVSVNHRLN
SLGFLDLSAYGEKYKNSANAGIMDLVASLEWIRDNIEEFGGDPNNVTIFGESGGGAKVLT
LMATPAAKGLFHKAISESGAVEKMGMTLLPEKATRRVAELTLENLGLNAKNVDEIQKIPY
EKVMEATEKALAKTAEEQGYKNVLTGQPGLDWAPKLDSYIPVEPVGEKYSEQSREIPLLI
GTNLTEWETMPFVLSNNKVENKNTFTNAEIKKKMQEKYGDRAEAIAKEFKKAYPERKAVD
ALYVDALLRKQTLKTTRLKADQNGAPVYSYIFAWDNPMIDGMAMSFHTAEIPFVFNNIDK
VEGTLKGRGKDAYKLAGKISQAWINFARTGNPNVKGLPKWLPYNTKNGAVMIFDDKSEVK
YKHDEELMKLLAPDYNF
>SEQF2502_01303 Acetylxylan esterase
MLKKEYLNKDSTIKELLTYPSIKEFSKFILPLEHGYNPNSKLKDIAYLLPYHNNINTDTT
LKSINYIIDRSEKGEEIFYKIYTDKEIKEDKSKANTGIFFFKGNKNAPFAIINAGGGFSY
VGSIHEGFPYAIELNKRGYNAFVLQYRVEDGYRATQDLARAISYIIENKDLFEVDINNYS
LWGSSAGARMVAAIGSRGLVSFGEKNYTKPNTIVMLYTGLASFTLNDPPTFMAVGDRDGI
ANPRVVENRFNEMKKAGLKVEFHKYKNVEHGFGLGIGTSAENWIDSAIKFWEKQSVKYEK
>SEQF2502_01304 Para-nitrobenzyl esterase
MSFHTAEIPFVFNDIDKIEGLIKVREKEAYKLAGKISQVWINFARTGNPNAEGLPKWEPY
NRKNGTVMIFNDKSEIRHKHDEELMRLLAPGYNF
>SEQF2502_01305 hypothetical protein
MANYRNNPFTFVYDGAITKNEKGKVNVEKVSYKINGIDIAANVYKPANYTPNGKFPAIVV
AHPNGGVKEQVAGLYAQKLAEQGYVTIAFDAAYQGASGGKPRYVDKPANRMEDIRAAADF
ITQYPGVDKNRLGLLGICGGGGYSIKVAQTDKRFKTVATVSMFNTGDVRRNGYNRTQMDT
IQTRLKDASDARAQEAAGGEVRYTPAFADGMTKEEIAALPFELYRDGYEYYGVTHKHPNS
QTNNTVSSLLDLMSFDVNTNVDLINQPLLMIAGDKADSLYMTEEVFKNATGTNNKELFLV
KGATHIQTYWKPEFVKEISGKLTQFYNKNL
>SEQF2502_01306 hypothetical protein
MKNFVNRFCKVILNMAVLFGFVACGNNSSAVNNQNSRKNGNAKKGNGKVLVVYYSQTGTT
EGVAKIIARETNADLVKLEVKNEYTSDDLNWTDKNSRVNREHDNPNSRNVELKNAVIPDF
SSYDTVFIGYPIWWREASWVLDDFVKKNDFTGKTVIPFGTSMSTGDGTSGNRLKKLTKTG
NWVDGQRFSSSYNESEVVDWVKSLKY
>SEQF2502_01307 hypothetical protein
MSEKNLKILGWLGTLLSVIMYVSYVPQIMGNLHGHKTFFLQPLAATINCAIWTSYGLLKE
QKDYPLSAANLPGVIFGFLATVTAF
>SEQF2502_01309 putative lipoprotein YiaD
MMKKLIIFLMGIVSVNTFTGEILEEKEKIEPPMTTQIICGFPPCDITEGKCVILGFKVDG
EKMNEAESYNLKYIANMLNTYMEKGSLEIIGHTDSYGSKKHNLKLSLIRARNVAKLLREY
GLDKRFSIEKIIGKGGEMPMDTNETVEGRYNNRRIEIILNNLEYKKTRFINE
>SEQF2502_01310 hypothetical protein
MKKIGIIMIGLLVIVFLSMVSGKVEKKSLSGVSKEQEILSRNKDKYSKHIRFYNRILNID
KGLLYYFEDAGTDKKFRTIQNEDITADIAIDKNFIDKLKELETSKEKDELDKKAIAMIPI
LEKMMPITDEMRTYYKNKEYLKDNYEKAQVLHTQLLATLDKYNQVTKNYKNVFEKKSDEI
KKLMIKDYDKRRQFITYNQFMFIIEGEKIIKEIHKQELDASDFILKGNAKQFKKMEEKMD
KALIKFEKSLKNTKQLEKEGYTPGDHSEFVQKANKFNQSVNVFIQRIEKKEKASHSSVSD
SFFAQTEEGTPENLLANFNEVIKEHNKLLVKKTKK
>SEQF2502_01311 Sporulation thiol-disulfide oxidoreductase A
MKKILLIISMFMVFMIGYGKEKALDVNMEAGAKIPSFQLRDFSGKYTNSRKIFNNGKPTL
LVLAAEWCPYCRSELPDVQKFYEENKDNVNVVVVFTRRKTNLSETKKYAEESKFTFPVYY
DADDSIMKGFKANSIPYNIKIENSKIQEILGGTMQYDAIKSAFGIE
>SEQF2502_01312 hypothetical protein
MGLFGNQLANIIEWEQYNDETLFWKWSNKEIKKGSKLIIRPGQDAIFLFNGKIEGVFEDE
GSYDVASQIVPFLSTLKGFKFGFNSGMRAEVLFINTKEVTVKWGTKNAINIPAPGLPGGM
PIRAFGVMACKVDNYNVFIDKIAGIKQQYNIDDVKERVISMLDQLLMKWIVREGKDMFNL
QANSYEIGNGIKEDMDFEMRKIGLCIPSFTISSFNYPEEIKRMQEKAAGQSMVGDVNKYT
QMAMADSMENGTGAGNMAGNVAGMQMGMMMGQQMANQMNQQNQALNNNQQPSENNHPAGN
TAAPKFCPECGTKTNGSKFCPECGTKLY
>SEQF2502_01313 Phage shock protein A 
MAGILERFKTIMASNINAVLDKMEDPEKMIDQYLRDMEKDLGSVKAETVAVMAQESAAKR
KVLECEDEIKKMESYAKKALQAGNEADARMFLEKKESIKIKLESLEKEKMVAVENSLKMR
EMHDKLTSDIQKLNARRNEIKAKIKMAKSAQKISKLSSSTGISGKMDAFNSVEEKANRML
DEANASIELDSPKRDGVDDLMKKYDDAESKENSSAVDDELERLKKEMGI
>SEQF2502_01314 hypothetical protein
MKSDDFRCKNCGGMMRFDPKSGNLKCENCETEEELPKVFTHKRHDIDDYEKRIKSKISEE
KTIVQCSSCGAMVEMGPLETSKKCPYCDTNIVLSEKAVSVLEPDGIRPFIVDKREIGNLF
SNWIKRRWFAPNVLKNLYQSGKVTGIYLPYWSFDNSADSEYTAQGGIDRTETYEEDGKTK
TRIVTDWYYVSGEVENKFRNVIMRASRTLNDRLLKSLGGFNVENTINFDSRYLSGYNSEI
FKISMRQGYEEAKVKMEDEIYNTISSDVLRRYDRVRDIRYSVYWNDEYYRLLLLPVYSMS
YSFNGKSYQIVINGENGKIVGEYPKSAVKIAIVVILAVIALGLLFYYMNK
>SEQF2502_01315 S-adenosylmethionine:tRNA ribosyltransferase-isomerase
MKISDFDFELPEELIAQHAVNPRDHSRLLVSNKTEKTLEHKKFYNIIDYLKKDDVLVINR
TKVIPARLFGHKENGVVLECFLLKRYDLYTWEVLLKPAKKLKIGQKIIFLEGVLEAELLE
IKKDGNRVVKFNFEGRFEEILDKLGEMPLPPYIMEKLEDKNRYQTVYAKEGESVAAPTAG
LHFTNELLEKIREKGVIIAEVFLDVGLGTFRPVQVENILDHKMHSEKYRVPEETAKIVNE
AKEKGNRVIAVGTTSVRTLESAVDESGKLMADEGNTSIFIYGNYKFKIADAIITNFHLPK
STLIMLISAFGGKEFIFEAYKKAIEEKYRFYSFGDSMFIY
>SEQF2502_01316 hypothetical protein
MISDRRFFKRTGVSLLGLVYSIISFGNENIKEVSLKGNIESVSTPKKEPASVASTKTNNS
QLEKLIKNQYNNKSIDLNVNTSLKNMRDSGSYERPNANTYTANRKTQQGTPDMKLSREQL
LAVAEKIFQNETGGVRNNLVDWNDGENFPSLGIGHFTWFKASGGRSGFGDSLPDMIAYYK
EKGITLPKLLAEFKHSPWNSKSELMAKKANGDKDIQELIAFFDNTRDIQVMFIYDRLKNS
LDKMIQASSNKENLKNQFERMVNTPNGLYALIDYVNFKGEGLKGVSSYNNVAWGLRQVLE
NMKGTATGQSALVEFSNSAKDILARRVKNAPRNESRWLQGWYNRVDTYKTFEIGSAY
>SEQF2502_01317 Release factor glutamine methyltransferase
MNNLLDILNKSVNYLKKQKVKNARLTAESIIAEIMKMERIMLYAEFERILSEDELKKIRG
KLNEVVNKLKEKKISGDNNFENAVKSEKQLKLLLDKSIQYLEKNDIEESKLIAEIVFSHV
LNIDRMMLFTKYRDDIEDEKIEKIRYFIQKIGREKFPVQYLLNEQEFYKRKFYVDKGVLI
PRQDTEILVEKMIDILKTKISKNQVHPKILDIGVGSGIIGITAALEVESSYVLGVDISEK
ALETAQKNKEILKVSNIKFLKSDLFENVEFKQFDMIVSNPPYISLNEVGIMSDDTLLHEP
SEALFAENDGLYFYYEICQKAFDYLADFGYLLFEIGYKQGKNVSEIMKNFGFKNIDVIQD
LAGLDRVVIGQKIINKIEN
>SEQF2502_01318 Peptide chain release factor 1
MFQKLDDVVLKHEELTKMLMDPEVVSDPKKIMEYNKALNSIDEVVKKYTYYKDRKEELEG
LKEDLKSEKDTEMKEMMHEEIHLIEEEIPHLEEELKVLLLPKDPNDDKNVIMEIRAGAGG
DEAALFAADIFRMFTRYAERNRWKTEIIEKNEIGVGGLKEVTFLIKGHGAYSRLKFESGV
HRVQRVPATESSGRVHTSTITVAVLPEIDDVSEVEINPNDLKIDTYRSSGAGGQHVNTTD
SAVRITHLPTGLVVTSQDGRSQIKNKEAAMKVLVSKLYEMECEKQRSAVENERRSQVGSG
DRSEKIRTYNFPQGRVTDHRIKLTLHRLEGILDGDLNEMIDALIAYEQAELLKEVGSNNE
>SEQF2502_01319 Undecaprenol kinase
MGKNKNKKKKKSIFSLFRKKNRYNWDIKKERARDKRLVDSFNFAIEGLISSLKNEKHMKV
HILAAIIIVILAIIINASKVEILIISLSVSFVLITELINTAVEAIVDLVSPERHPLAKLA
KDVAAGAVLVAAINALCVGYLLFYDKLLDIFDGTNKLHIIAGRKGNISILILILVSILVI
VLKTFFRKGTPLEGGMPSGHSAIAFAAFGILVFMTSDVRILVLGFFMAALVAQSRVKSGI
HSIREVLLGGLLGFSVAFVILFIMMQFGILYN
>SEQF2502_01320 Endoribonuclease YbeY
MEKEVNAEKKIEIDITYNIEKIDSFFDEEKINKFVSYILKDEYSEDFDKNEYYLSLLITT
NEEIQKINREYRQKNAPTDVISFAYNETENIGAVNMLGDIVISIDRVKEQSSEYGHSDER
EFYYVLCHGMLHLLGYDHIEEEDKVVMRRREEEILSKFNYTR
>SEQF2502_01321 Cyclic-di-AMP phosphodiesterase PgpH
MKVNILGREFLFEIKEKKKKNNESQSYIKNRFIFRFAILAITFMIFGIIIEMSRLNVNYS
VGSIAKSDIVAYKNMSYFVDILDDSIEEKIMRTTQPEYDKINSVNRETVIALNKFLRDIR
NMNLSDDAAIGKYIKDNKYTFTNADIREIAARTENVEYSVNLDEIMSEIYSTGIYKMENL
PKIIRRKDIKADNLDMKVLQNFIKPNLVINEEATKKKIADNMMSLKDKEIKIYKGDIIVK
KGEIIDSDAFMKLEKLNLIRNGDKFKKAVGLTTTFSLLLILIHYLLKKNVRKVVESNAFY
PTLITIIIVNVIYVLFLNNQFFIYLLPFAMLPIISTILGNKTYAIIITFSNMIMLSQEES
WFFVTIAVSLIAIYKADDLVGRSDIIKLSFFLGIFQALLAFSYGLVNQSNLGLIMIMIVF
SVFSGILTGMMSLAILPYFEDYFDILTTMKLLELSDFSHTLLKQLLIKAPGTFHHSIMVG
ALAEGAAESIGANATFARIASYYHDIGKMKRPEFFVENQRDGINPHNKIKPSLSALILTS
HTKDGYIMGKENKLPKEILDVILQHHGTTLTQYFYYKALESGEKVVESNFRYSGPKPKTK
ESGIILLADTVEAATRTLENKSKEGIENFIRYLVKSKIEDKQLSDSDLTLGELEKVIQSF
INTLQGVYHERIKYPKMDERTKKNK
>SEQF2502_01322 putative ATP-dependent helicase DinG
MKISEFISEKAASGMRSEIKRYGGNEIFFRGIPDENGIISEFEVIARGNAGSVAALLNMM
RKNEVIIHNHPSGVLIPSDEDVNISSMYGEVGGASYIVNNDVDDICVVVPLREFIKIDID
DYFGENGIIHKNFGKFEVRREQYEMAKFIEKSMNENRKLIVEAGTGTGKTIAYLLPTLIY
AIENNLKVIVSTNTINLQEQLINKDIPLLKKIIDEDFSYQIVKGRGNYLCKRKLYNLEID
DKETDTEYEKKEKKVIRNLIEWDKNVTKTGDRTELKYEIPNSIWEKVNSEADMCKGVKCP
YYSKCHFFNARRNVSDARLLIVNHHMFFADLAIRNHTGFYTNYSILPNYDIVVFDEAHNI
EDTARNYFTFETSKISFGRLMGNIYNKRVVKSNNGGALVRLLTYLNESLSSEEYKEVDEL
REDVVEELNKFYDKGIDIFDKLTYLFSENNDNKEIKVKIDKEKMQRNKFFCEAMKLNSQF
KEIYGNLVIKINKFLNKVSNYNLEDKEGFLFEFSRYYERLKQYYKKFEFILEGKEEGYVY
WANVTTVRPNVKLYATPFDISDELNDNLFMKMDRMIFTSATLAVDNKFDYYKKSVGLMKE
KHKKIDEKIVKSPFDYEKQMKVYIPEDALNPTNIEFMRDLEEFIEGVIKSTKGHCFLLFT
SHSALNFLYNQLKTRFSEKEYTLIKQNDFPRHEMIEIFKNSKNPILFGTDSFWEGVDVQG
DQLKSVIITKLPFKVPNDPVTEAIIENIKKNGQNPFNDYQVPQAVIKFKQGVGRLIRSKS
DSGNIVILDNRIIKKMYGKKFLAALPQNRVVKSKNEILKRIK
>SEQF2502_01323 hypothetical protein
MKKAFGILLVGLLSMSLEAHSKDASRKVTKPVRIDQNISIKNNGNKDLNEDFPEQKMIGM
ANPASVYCVEQGGKSIIRKDKDENEYGICKFKDGKEVDEWEFYRQNHDLTEKGVPEINKK
>SEQF2502_01324 Chloride/fluoride channel protein
MLKNIKESYQHSYFLYLKLIIAGIIIGFIVGIIDTIFGRGLIWIGDIRKEYLYYFVPFLA
LAGLLIVFIYQKFAGKTGKGMGLIFEVGHGTEKEIPLRLVPILTVATWITHLFGGSAGRE
GVAVQLGATLSHRFNKYFNFPDKSKVFLVTGMAAGFGGLFQTPIAALFFGLEVLALGNLQ
LYALLPAVVAAFTASWTSSFLGLEKFTHIVNTTLSITPTTFVKFAILGIIFGFAGNLFVY
LQSFLKKFAAEKIKNPYYRIFIIGIFLSIILLLLHEGRYTGLGTNLIENSFLGKPIFGYD
WILKLLLTTLTLAAGFQGGEVTPLFSIGASLGVVIGIFFGLPIEFVAAAGYISVFGSATN
TLLAPIFIGGEVFGFNNLPFFVIIVIFAYLVNRKISTYGLQKNYFEEIE
>SEQF2502_01325 hypothetical protein
MKSTKKMILATLIGVLAIGSIGYSAVSKTSRKKAVNKTAVTSKNLTRKFSCSSRNVTVEN
LSTNKVRLTDDSGKVYNLKLTRSASGELYSGNGVSIQIKGNDAVFTASGNDESCNLTSDS
NSNSGNSNKAASGNLLRKFSCDGYQDITVENLSTDKVKLADGYGSIYNLNSTSAASGEKY
SDGNISIHMKGNDAVYTENGKDKSCTLKSTGHGSIEE
>SEQF2502_01326 hypothetical protein
MYCIKCGVELEDGVKRCPLCETAVPEIKETEEEFAREYPIININLYEMKMKKVKKAIFLS
FFTISIISILEVFFQNLIMYGKLEWGYYAIPSILVFDLGLFVFLDSYRMRTNLFLILTGL
TVFFLILDFGDKKLTWSIGRGIPIVFVFYLISFVFSYVWDKHKSDRMKILNFFIFFVGIF
LLVLELIISKKMTWSIFSSIPLFILSIMLRYAYKSYKEEFKRRLHR
>SEQF2502_01327 hypothetical protein
MKNEKIWYELDAFAKTYSSIISEGRTTCFRLSVLFSENVDLIILEKVVILLEEKYPFYNS
ELKKGIFWNYLQQKKTHFMIEEEKTYPCTDIQKDNPLRIIYFNNKLSIEIAHFLTDGKGA
MLFFQDLIEEYTEKKYFSKNIRNENFENKRIIVENNGKSEDKNKFKIKNKDLVNDKNLKK
MIDFPKMIGSKIKNFENKSFLENKKKILKKNEEIFGNYDEENNVKENKYVDLYEKYMRKV
SKETTIKSAFHLPMKILEKGQYHITTGEIYIDDLKMESKKHKTTIGKYLLAVYFKILLDR
YSSAKNPIVIGVPVDLRRIFEEKTYRNFFINITPSIDASLGAYSLSEIITYLDNYFALKI
TKKEFYKSIYKAMNPMRNIIIKSVPYLIKRIFFPFIFDYYGERGYTTGFSNLGIFKIDKK
YEKYLKGFRFLPPPSKRCKIKMGVISDSQKVYINFGNLTADYDIERDFFVYLRKRGIRSK
IITNY
>SEQF2502_01328 3-deoxy-manno-octulosonate cytidylyltransferase
MKILGVIPARYASSRFEGKPLKDICGHSMIEWVYKRAKNADIDGLVVATDDERIFEAVKK
FGGNVVMTAENHQNGTSRIVEVINKDKFKNYDFVINIQGDEPLIDIESINVLANNYRSEK
SEIITLKQEIKSQKEIENPNHVKVIADFNDNAIYFSRSVIPYERNKNADFKYFRHIGIYG
YTTSFLNKLKNLKEGVLEKIESLEQLRFIENGYKIKVLETKSNVIGVDTEEDLREVVKFI
KENGIKLE
>SEQF2502_01329 Alpha-amylase
MENGVMIQYFEWNLPNDGKHWKRLKEDAKHLSEIGVTGVWIPPAYKGTSQDDVGYGAYDL
WDLGEFDQKGTVRTKYGTKQELIEAIEELHKYNINVYLDAVLNHKGGADETENFLAIEVD
PEDRTVEISEPFEIEGWTKFTFPGRNDKYSAFKWNYNLFDGIDFDNRTGKNGIYKIVGEN
KDWDEGVDSELGNYDYLMNADIDFSHPEVRKEVIRWGKWVVNELKLDGFRMDAVKHIKDE
FIAEFLTQIRATYGEKFYSVGEYWRNDLEKLKEYLDNVGYKTDLFDVGLHFNMYDASKKK
KGYDLREIFEHTIVAENPMEAVTFVDNHDSQKGSALESKVESWFIPHSYAIILLSKDGYP
CLFYGDYYGVGGEKSPHQWIIDKLLEVRRLYAYGEQINHFEDPNIIAIQRTGRDEWTGCV
AVLSNSDEEGEIQIEVGKERTGQVWQEVTGSGYEDVVINEEGNARFKVGSEKISVWIRKS
>SEQF2502_01330 hypothetical protein
MRKIKIIGAIIVLMMSLSSCTALALGAGAVAGGYTCVNTSLCNRLKK
>SEQF2502_01331 Glutamate 5-kinase
MKTINNREEILGNVQRIVVKVGTSTLTTEDGRLNIDKIKKIVMELSNLQNKGYDVILVSS
GAVGAGMGLLNINEKPKTLAEKQMLSAVGQVSLMQIYQTLFKEHNKIIGQLLLTKEEFSN
RKRYLNMRNVCNAFLKRKIIPIINENDAIVSNALKIKVGDNDTMSALVSGLIDADLLIIL
SDIDGLYNKNPRKYEDANLIHIVGDINEDIKNMAGSEGSKFGTGGMITKIIAAEMVTKIG
TSLVIASGDDPRNITRIVEKENIGTLFVKKNKKISLKKYWLAYGPNKEGALTIDDGAKTA
LKNGKSLLSVGIKSVEGSFDKGAVIEIENLEGKVIATGISNYSAEEINLIKGVKSENIEE
ILGYKYDDAVIHIDNVVVKK
>SEQF2502_01332 Gamma-glutamyl phosphate reductase
MNYIEELGEKAKIASRELLKIGTKTKNDVLLAIADELINKKEGIKAANKIDLEKGEKNGI
SFALLDRMTLTDSRIEGMAQSLREMAAFPDPIGEVVTGWNHKNGMSIAKKRVPLGVIGMI
YESRPNVTVDAAGLAIKSSNAIILRGSEDALNSNIYLNNLLNRVADAHGLPKNTVQLVEK
PDRELVKDLIRADKYIDVIIPRGGKGLKRFIIENATIPMIETGAGICHIFVDETADIKQA
LPIIENAKVQRPSVCNAIETTLIHENIAKEILPELTEMLLKDGVELRYSKEALEIVGNRS
DVKLATEEDFGAEYLDLIMSLKLVKNIDEAIEYINNHGTHHSDSILTKSIENAEKFLNEV
DSANVYLNASTRFSDGEEFGFGGEIGISTQKLHARGPMGIRELTTTKYVIRGEGQIRE
>SEQF2502_01333 hypothetical protein
MAKFQVTLRDRQTNEKRVVWIEAKNSQEAKQIAMRDFPNYRVQ
>SEQF2502_01334 hypothetical protein
MRVLLIKNLSCNFITNSNNFNSRILEITKKESLLWGLALF
>SEQF2502_01335 hypothetical protein
MIKKLIEIEGLHCENCAKKVKNALFGLPEVEDVEVNLSDKNAKVTLNEEVDDLLIADVVN
AAGHYKVKDVTEIS
>SEQF2502_01336 Ribosomal RNA small subunit methyltransferase C
MSHYFSEKQEVKSDRKIIRYEIENRNFEFITDNGIFSKAKVDFGTDVMLKVFLRENSNKK
NQKFDVLDIGCGYGVVSVVVKSFFKNSRTVSSDVNQRALELTRENLFKNGVVKNNNSENG
DFKNGDFRVIKSFVFDNIFEKFDVILSNPPIRAGKQTIFQIYEKSFLHLNENGEFYCVIQ
TKHGAKSTQKKLEEIFGNCETLEIDAGYRIFRSVKK
>SEQF2502_01337 Translation initiation factor IF-1
MAKQDVLELEGEIIEALPNAMFQVRLENGHEVLGHISGKMRMNYIKILPGDKVTVEVSPY
DLSRGRIVYRKK
>SEQF2502_01338 30S ribosomal protein S13
MARIAGVDIPRNKRVEISLTYIFGIGRSTSNKILGVTGIDKDTKVKDLTEEQVAQLRAAV
EEYKIEGELRKEIRLNIKRLLDIKSYRGLRHRNGLPVRGQKTKTNARTRKGPVRMAIAKK
K
>SEQF2502_01339 30S ribosomal protein S11
MAKRPATSKKKKLKNIPNGIAYIHSTFNNTVVTITDSEGKVVIWKSGGTSGFKGTKKGTP
FAAQIAAEQAAQVAIENGMKQIEIKIKGPGSGREASIRSIQATGLEVTRIVDITPVPHNG
ARPPKKRRP
>SEQF2502_01340 30S ribosomal protein S4
MARDRQPVLKRCRNLGLDPIVLGVNKKSNRNIRPNANRKLTEYGTQQREKQKVKFVYGVM
EKQFYKLYEEATRKEGVTGELLLQYLERRLDNVIYRLGFGATRRQARQIVSHGHILINGK
RVNIASYRVKQGDVITVKEDSKELALIKESVGQKAIPGWLSLEENTLKAQVLENPGRDAV
DFEVDEAMIIEFYSR
>SEQF2502_01341 DNA-directed RNA polymerase subunit alpha
MLNIEKIAKNVRLTEEKEDNYTAKYTLEPLYRGYGNTIGNSLRRILLSSIPGTAIKGIKI
EGVLNEFSTIEGVKEAVTDIILNIKEIVVEADEPGEKKMTLSVKGPAVITAADIHVEPGL
KVINPEQVIMTVTTDRQVDIEFLVDSGEGFVISDEINTDGWPIGYLAVDAIYTPIKRVNY
SVEDTMVGRVTNYDKLILEIATDGSIEIKDALSYAVELLTWHLEPFTNIGNSMSKYRDSE
EELTETEEENENNIEDMKIEELDFTVRSYNCLKKAGVNTISDLTSMTYNELLKIKNLGKK
SLNEIIDKMKELGYDLGDNVGSEE
>SEQF2502_01342 50S ribosomal protein L17
MNHNKSYRKLGRRTDHRLAMLKNMTISLVKHEQIETTVTRAKELRKFAEKAITLGKKYNN
STDTARRIHLRRQAFAFLRNEEAVAKIFNEIAPKYTERNGGYTRIIKTAVRRGDSAELAI
IELV
>SEQF2502_01343 hypothetical protein
MNKKLIVMSLLISAFSMATDNERGLADSSKYQKNAEVNKNEDKKPKMGAPMNKKAITEDM
ITNKTENGYNLNFDANKNYTIKTATVNGKTITYRAYENIVYVAKPVDIAYQTINIYIPEE
YFKNKSVGKYNAKSAPIFFPNTVGGYMPGAAGVPGNGRDEKPDASLVALPNGYVVASPGA
RGRTLEKDGKYTGKAPAVIVDLKAAVRYLRYNDNKMPGRADRIISNGTSAGGAVSALLGA
TGNSKDYEPYLKKIGALKARDDIYAVSAYCPITNLENANTAYEWMFNDVKTYKKIEISML
DYNVERKYTEGTLTDNEILRSNDLKKMFPDYVNSLKLKDKNGKLLTLDKDGNGSFKNQIK
KYYIDSANAALKKGTDLSEFDFLTIKNGKVVDLDYNKYIAYMGRQKTPGAFDNVDLSTGE
NNEFGDETTNNKHFTEYMLEHSTVNGTIADKKIIKMMNPMNYIGSSKVKYWRIRHGAIDK
DTSLAIPAILAIKLENLGKKVDFASPWATPHSGDYDLTELFGWIDKVVAEGK
>SEQF2502_01344 Sensor histidine kinase ResE
MWQKESKAKLIKKAKNIRFRNKIAIKLLSYFGVSLFLFSIVIGSIFGYIYIQNTVAMHKK
DLEERACKISETLSKVWFENKNRNEKSLDRDLRADGKRRTGNSEEDRNKFPHRENAKIVG
NIKGKIFENNIIEDIRKDEDERKPEERHKILENKLRKREDNRNIEDEKDNIPPEERRFHR
HRIVDEKDNNVKIFRSMRMIENLAMGEVWIVDAKTGNIVQGRSERNQSLSYLKLPPNAEN
TIKRALAGETTTTENFNEYLNENSITVAVPIKNGKIIEGAVLLHSPVKYMSSALKSGIYT
LIFSILAALAIASISAIWLSISFTRPLNKIRNATLKLAQGDYEVTTDVDQGDEIGELAES
IDKLAVQLDKSSKESERFEKMRQNFIANISHELRTPITVIRGSMEAICDGIISDPEQLKE
YNRQILSDSIHLQRLVNDLIDLTKLQNTDFSIDKSIIDLSEIVNDAVRSMKQISTKKNIK
INFFGNKVNQKMENYLFTGDYQRIRQMIIIILDNAIKFSSENQKIDIYLRKVNKKYELKI
CDYGKGIDPKNIGEIFNRYHKSNTEENKNGMGLGLAIAKEIAIRHNIEILAESEPDVQTV
FTFLIPFSE
>SEQF2502_01345 Peroxide-responsive repressor PerR
MHIENVGEYLKKNGIKPSIQRMRIFQYLMDNHTHPTVDDIFQNLSPEMPTLSKTTVYNTL
NTFVRSNIIQEIIIEENEVRYDVVTENHGHFKCKSCGEIMDFDVDLSKFDLSKLGNVEID
EIHFYIKGVCEKCLEKHN
>SEQF2502_01346 Bacterial non-heme ferritin
MKLNKELEILLNKQINMELAASYQYQAMAAYFDERALEGFSKWMSEQSKEEVEHSNKFYN
YVLKRNGKIEFFALDKPKMNFNSIKEVFEATLAHEEAVTASIENIHKLARELEDYGAEVF
LNDFASEQEEEEEQVQKIIDKIVSLDVDNNSATLYLLDKEMGTRE
>SEQF2502_01347 Trifunctional NAD biosynthesis/regulator protein NadR
MKKIGIIIGKFFPLHIGHVNFIQRASGIVDKLYIVISYSDDADDLLTSNSRFVKEITPKD
RLRFVKQTFKNQPNISSFLLDENHFSQQGENWEEWADTLKNEIEKREKLENEIKIDWKND
VIFISNRDEDKEYNLKHFGSKTRSIDKNYIEYNVNSKQIRENPSKYWDFLPREVREHLIP
IITICGGESSGKSVMIDKLANVFNTTSAWEYGREYVFEKLGGDEEALQYSDYEKIVFGHQ
SNVLYAARNANKFALIDTDYITTLAFCLTYEKKDNPIVREFVQNYRFDLTILLKNNVKWV
NDGLRSIGDNERREKFQNLLKQLYKEYNISYITVKSDSYEKRYLACKHIIKAYLDGADNS
RLQEIADSFI
>SEQF2502_01348 N utilization substance protein B 
MTRRGIREEIFKLLFEYELIDNNIEKRINDVIEKENLKKEDEIDFLRSYVTDIIANEDIL
IGRIKDVLEGWTYERLGTIEKVLLKISFYEITIKKIGYEIAINEVLEISKKYSYNDTKDF
LNGILAKLIKNIKEGKSNF
>SEQF2502_01349 hypothetical protein
MIAILGFLARLSVILGFIGIAFSSISDTLFRTDYLGQLDNFIDLSSLNFKILIGLLSIIY
LVIFLLSYINKLTKYSQNRKVKNKNGEIEVSIKTINETSKSFLNSVEIIKNSKVKSYPKG
RSVVIEATVDTYNVDNLNEKLIEIQNKLSEYIFHSTGITVKKSKVKLKKVLGETIIEKKI
IDSPAVQKEIEKGQEKVTEKSKVEMNKNNDKTVKNDNTKIETSPSGKEN
>SEQF2502_01350 Alkaline shock protein 23
MNELGNVNISQEVVATIAESVVSEIEGVNSLVGGTSKNEIVKFFQNVSSGGKGIEVEVGE
TECTLDLYIVAKMGYKLPALAGEIQTKVVKAITEMTGLKVQEVNVYIQKIVKDEKKDVAP
VTVAETAEIEE
>SEQF2502_01351 2-oxoglutarate carboxylase small subunit
MFKKILIANRGEIAVRIIRAARELGVATVAVYSEADKDSLHVRLADEAICIGTANSADSY
LKIPNIISAAQITQSEAIHPGYGFLSENQRFAEICDKNGIVFIGPKPELINMMGDKATAR
ETAIKHKVPITKGSDGIVPTLEEAKKVAEWITYPVMIKATAGGGGKGMRIARDEKELAEN
YIVAQNEAKANFGNPDVYIEKYVEEPRHVEIQIIGDKFGNVVHLGERDCTIQRRHQKLIE
ESPSAGIDAKTREKMGKFAAKLAKGIGYDSVGTLEFLVDKSMNFYFMEMNTRIQVEHTVS
EEITGVDLVKEQIRVAAGEKLSISQKDIHINGHVIECRINAEDSENGFLPSSGILETYIP
SGGIGVRIDSHSYQNYEIPPYYDSMIAKLIVKGKDREEAISRMKRALKEFIIEGVDTTIP
FHLKVLDNEDFKKGTVYTNFIETHFKEALGK
>SEQF2502_01352 hypothetical protein
MELKDIQELMKVLKKEDIAELKVRYGKIKLTLTNSENTKIVNTAAASPKIIKEKKNIKAV
LPVEEIVKSSNVGKIKLISSKSGTSVKKGQILAKINTMGIDNDVKSTVNGILKEVLVADG
SAVDFAKELFKIEVN
>SEQF2502_01353 Dephospho-CoA kinase
MVIGLTGGIGTGKSTVSQILKDRGFTVIDLDVISHEVVKFPSVVEKIIKNFGREVLVDNE
AENYIVSRKKLGKIIFSDKEKRFTLNSIMHPEILRVMRKKILECKLKKEKDEKGKNKIIF
VEIQLLFEVQWEEEFDYILLVAAKRDMQVKRILGRDKRSEKEAWDIINSQMSLDEKRGKS
DFVIENDGNIDDLNREVDKFLKILEQQQFQKIKIHER
>SEQF2502_01354 Transcriptional regulator LytR
MKKIFLILGVFLIAFIAWLSIPFNILVIGVDAYANQPTEGSRSDGLIVIRVVPYLAQVKM
ISIPRDTYAEIPCENYKQDKITHSHHFGGVQCTIDAVENLLDTKINYHVRFRFEDVMNIT
TLIGGVDVVSNHTFNQDYFDQEVFHFNQGQVYNLQGRMALAYTRHRKSDTAFKRDERQRQ
VIQGIAKKLVAPSGWKYVPQVYNYSKQHMDIAVNPIKALSVLPAFLMHQSNIDQYEITGD
GKMINGIWYFMPDEASLEQAREEFKN
>SEQF2502_01355 putative GTP-binding protein EngB
MEINKSEFVKSAVMEKDYPKFNNVVEFSFIGRSNVGKSSLINSLTKRKNLARTSKTPGRT
QLINYFLINNAIHFVDLPGYGFAKVPDSVRKNWGKTIEGYLMSDREKVVFLLLDLRRIPT
GEDMEMLKWLEHFGIEYYIIFTKADKLSNNEKFKQLKEIKKKLVFKNEDVFFYSSLKNTG
RKELLDFIGERVNEKK
>SEQF2502_01356 Competence protein ComM
MAISLFSCSYLGVDTYVVEVEVDLSRGLPVFNIVGMGDQAISESKERIRSCFKNVGFEFP
VRRVLVNLSPANIRKKGSHFDLSIFLGILANTGHISNIEILKKYLILGEISLNGKIKSIN
GAINATILAKETDFKGVIVPMENYNEAKLISGAEIIPVDEISELLDFLDGKIDVETLCKK
AVEMDTSKIEKDKKPEEAIDFSDVKGQLMAKRALEIAAAGGHNVFLIGDPGSGKSMLAKR
FNTILPDMLEEEIIETTKIYSISGMLSQKEPIIRKRPFRAPHYSATQVALVGGANRVGEI
TLALNGVFFLDEIGEFEGKTLEALRQPLEDGKIVISRANFSVTYPVKNITITASNPTPSG
YFSDNPLCSDSLKEIKRYQKKFSGPLLDRMDLYVEMHQLKKDEIFDESLSEKSKDIQKRV
IKAREIQKQRFNSNTLNRDMNKKQLNKYCKIDKESQEIMKAAIDNLKLSVRMFDKILKIS
RTIADLDGQENIKKEHLLEALNYRKKQ
>SEQF2502_01357 DNA protection during starvation protein 1
MSKTIEKLNLYLANLNVLYRKVQNYHWNIVGAGFFSVHAKLEEYYDALNEQIDDVAERIL
SIGGRPLGTLKDYLAVTTIKEAENKEISIADAVADVKKEFEAMLKLVKEVKETADSENDY
GTSAMVDEYISTYEKDLWMLNAYLK
>SEQF2502_01358 hypothetical protein
MKKIVLSLFVLLSLSTFTEKKYQVEVEPAVKLNQSILSDYNSQIEKEVSRIYSKEEMFGM
MNKMMNGVFAGSQKDGSNQMKEMMGSFFGEDYFSKMVDTMYKYYKIDIEKIDYINGEKAY
VKVKLGFPVNTDEMSIDKMFEKSGEMTKKMNESFKKKTGKTMEEYQKSISQNDEKAMKKY
FKIMGEIQLEMMDQELEQITKNGKYVGRKEILEANKKNGKWVIENPDFGY
>SEQF2502_01359 hypothetical protein
MKNYISELIREIFAEVNKEITKILNCKNNQKKSKIKEKELLENKSHESKKEIFKKNLINN
NKEHNIIDITNFKEEKIDYSKFKEDDTKIINNWEIKLGNIDNYYFSELKVPFLREKILEL
YNKIFEISDTELKNKNRILIKEIEKFEKENYVFKGETFKNIFYGGIRIINSKYNGIRKNI
RNYYYFQDFWNILQKKASEVVIDEINKYLEKLPKLNNEIMVYYNLTPNGLPYRYWDKNGK
FREEHKFSELEQRILEKTSFRQTKIWNNYEAKKQMILLYLDEWKIIEERVKTEEKLKKKS
KKIISAILNLQDHVYFEYNEIEGIYALLKMIENKIRSFIPNYKILETEKELESIKKFFPK
SMSNELLENIENFKISKEKIESILDYEIKNYPKDWKLKLGYIELFNEKKINLIIRFNNDE
NLEKIIKELLKKEQNSDDKLFYLFLLNKKRELKKTEVKMLEKIISANRFQDYKKLLDKDN
EITQKIYEELKLLKFQKMKKIDLNLEKVKVTKEKFAETVNILEEYLKEENEEADISKICN
EEQKDVVVENKEQEKIENFQDNKIKEVLKVIIETQKIGENDLKNYAKEKNMSLNAYIDSI
NKELYDIVNDQVIILENNTVKIDEFYIDDIKEWLKEND
>SEQF2502_01360 hypothetical protein
MIKINLKEADSVIKAIEGGITPRRGIQHLLVGRNNEVQEIVKILDKITEGDSEIKFWVGD
FGSGKSFMLRTIESIALQKNFAVSTVDLNPTRRFYSTDGKSKALYSEIIDNIVVQTAQNG
RAINTIIEIWIEKVKNQIINNKNLKAEELDKNPQFIEKEILNLTSSFTTSSISYEFGQAI
IQYYIGILEEDYDKKEKALRWLRGNIETKTEAKKELGIGKIINDDNWYEALKTFGELILD
MGYSGFVVNFDELVNLYKIPQSQTREKNYEKILNIFNECKSNKARGMFINFGATKKTVYD
KGRGMSSYEALKGRLGTENDNLSNLINTKKSVLLLKPLNNEEIFILLERLRDIYNVNYKT
SIELDANEIRLYMEGKLNLPGADEFLTPRAVIKDYIEILDLIRQNPNENIIAIIEAKLGK
MNKVEKDENNLDDEIEVF
>SEQF2502_01361 DEAD-box ATP-dependent RNA helicase CshB
MDTYNMLKKEIRRYIYDQKWQQFTKIQDHSIKLYSESEDNLILIAPTASGKTEAAFLPAI
NSIENWEEGIKIVYISPLIALINDQFNRISELCKYMEITVTRWHGEASQSKKRDILKNPK
GILLITPESLEALFVTKSDRVRKLFYNVENIIVDEIHSFIGSNRGIQLKSLLERMSLYIK
NNNPRMIGMSATVSEENYLDLKEIFQNKRITKIIRDKGKNELKIDCNFYSNEIAALNKIY
EYSKTETMLVFPNTRQKVEMIAANLKKKSQKEKKYISYFSHHASVSKNIRTMVENFAKES
NKNLFTICCTSTLELGIDIGAVDSIVQYNAPHSVSSLAQRLGRSGRRTGINNLHFISDEK
WDLLQGLSAISIYKKGKVDKIDVVKKPYDVMAHQILSLIVEKSEINLSEFKKIIQKYQTW
KNIEYEEFSNICNHLLKEKYIEILDNSIIAGVNLEKLLKKAEFYTQFKVEEMYSVYNNQS
KIGELPLDIRLNVNDNIYLAAGIWKIKKVEEEIKKIFVEKAKDGKPPMFLGEVGEITDEL
RKEMKKILFNSKTWGNYSEDIRKGLEVISKSIILKQKIYFYLEKNKKSIKTFRSTKIDRT
LMILLLIFLNLKDFRELNDMILSNSQVIEESISEIAINGIDREKIEDFLEKDIEKSIELG
KINIVDGYLSSNKYMFLVPNNLKIKYFIDNKLDIEGIEDFLDIKK
>SEQF2502_01362 Leucine--tRNA ligase
MIKEYNPNEIEKKWQDKWAQKDVFKSENKADGKENYYVLEMFAYPSGKLHVGHLRNYAIG
DAIARYKKMKGFNVLHPFGWDSFGLPAENAAIDHGAHPGKWTKANIDNMRRQLKLMGLSY
DWDREFSTYTPEYYKWNQKFFIEMYKKGLVYKKKSFVNWCPECNTVLANEQVEDGKCWRH
SKTDVIQKELSQWYFKITDYAEELLQGHEELRGHWPEQVLTMQKNWIGKSIGSEVDFILD
YKFENNGHTHLKLNDKGEVVISVFTTRPDTLYGVTYATVAPEHPLVEEVILKENPSIREK
IEAMRNEDKIARTAEDKEKEGVFSGLYVINPVNGEKVQLWVANYVLMDYGTGAVMAVPAH
DERDFQFAKKYNLDLKIVVNPVDKNGNLEEVSVEKLENALTVPGVLVNSEEFNGLNSNEA
KEKITEKLEKIGFGKKTVNYRLHDWLISRQRYWGTPIPVIYDEDGNIYLEEEENLPVKLP
TDIEFNGKGNPLETSEEFKNVILPNGKKGRRETDTMDTFVDSSWYYLRYLDSHNVEKPFE
KADADAWTPVNQYIGGIEHAVMHLLYARFFHKSLRDLGYVDTNEPFKKLLTQGMVLGPSF
YSQNERRYLFPREAEFKDGKAFSIETGEELVTKVEKMSKSKNNGVDPEEIVKEYGADSSR
VFTLFAAPPEKELEWNMNGLAGAYRFINRLYLLVSGTAEFSDHNAKSENHYGVELKKRNQ
KDEEIQKKLHQTVKKVTESIEDDFHFNTAIAAVMELLNDMTTYKQEVIDKENISSESKKI
WREVLEKTILLIAPFAPHVADELWAYLGNKTFTFEEEWPKYDEELTKDHTFNLVIQVNGK
VRDMVSAQIGISKDDAEKLALESEKAKKFIDGKEIVKVIVVPNKLVNVVVKG
>SEQF2502_01363 Modification methylase HaeIII
MNLISLFSGAGGLDLGFEKAGFDILAANEYDKTIWETYEKNHKAHLIKKDIAKVSLDEFP
NNIEGIIGGPPCQSWSVGGSLRGIDDPRGKLFYEYIRILKDKKPLFFLAENVSGMMAKRH
NKAVKEIIGKFEKIGYNVQIFQVNASDYGVAQDRKRVFYIGFKKELEVNFEFPKPYDFKL
TLKDVIYDLKETPIKALEKNKANKEKCIYPNHEYYLGSYSTIFMSRNRVRQWDEQAFTVQ
ASGRQCQLHPQAPVMPKIEKDKNIFAKGYEHLYRRLTVRECARIQGFPDDFLFYYDNIND
GYKMIGNAVPINLAYEIAKKIREVLEKKERSKINE
>SEQF2502_01364 hypothetical protein
MSSKSNNQGRAYEYIFLNVLFDEISKIREVWIEKNSSFSASEKAWETLSEEEKEIYKLSA
LTGVNTVLDLEPLILEKNNDTLNLKIQADDNGKKGDVRDIIIMRENINWEIGLSLKHNHF
AVKHSRLSKKLDFGKKWYNISCSEEYWKKVKPIFDFLEEEKRKKTLWKEILNKDNDVYFP
LLEAFKIEILKQNKEEIGLLENMLKYLLGKFDFYKVISIDTKRITRVQSYNLYGTLNQEG
VHKKRKIEIPIVLLPNRIVSLDFKPGSLNTLELYLNNGWQFTFRIHNASSKVETSLKFDI
QIVGMPTSIISIDSKWKM
>SEQF2502_01365 NAD(P)H azoreductase
MAKIAVTGVTGHLGGIVSKLCKKNGIEVRNLARNVEKAKKMGFYNVFKSSYDKSEDTVKS
LEGIDVLFMVSGSENPNRVQQHKDFIDAAKMAKVSHIIYLSFYNASKNSVFTLGRDHYAT
EECIKENGFKYTFLRDNFYADFFVNLCREYGEIKGPAGNGKVSVVVRSDVSEVVAKILEN
PTKWENQTLNMTGPEELTMNKIVKIVSEHFGKEIKYIDETVEEAYESRKIWKAEQWEYDS
WVSTYTAIAQGEQSGISNDIEKVLGRKATSLSEYLKNL
>SEQF2502_01366 hypothetical protein
MIDKLKELENLENKYKEIRKINSEIESIIANIKNEAGISREKELLEENERLSKDLKAFHE
KMKDREEEIGRLKNSNAVLIEELKEAKKIRRNGEIDKFQNILAEKINVELESGVTRRLSN
YAEEMKRKVKILERNLDGEFSDEADSLRDELKKINEKIGDFLEKSNRKTFENKVFLQEES
SVFHNKIKEEVTLKEGEFLFEREKKRFVFEKLIGLKGFNFLGIISIFLGVFLVFRTQFAK
ILANNYVKSSASYLLGMFFLFAGEKFYQKNKKHFAVGLIGGGIGILYLTTLLSTLYLKLY
PMTAGLFISVILTGLVVILSLRYDSQIIGVLSLIGGYLPYGAYIWVNKSNVQIYYVLAYS
LILQGIVLGVSWKKDWIYSKIFGFVTGIVNMMGLIYYLNYSVHDKITAFFYIVIFTTAYS
FIFLNSHKKENRQSNIIDYIFLSLNLIIKFSLIYSLFDKTTPSWLKVVLVGTVGIIYGFF
GDRLKDNKVAKIFYIVALGSFILIIPLIVPEKFVVIAWGAETALLYFFYRKYKNKEMRYG
TIAIYLVSLVSNLIVREEKYLLVYIQDLMIISFSFVLYFLIKQKSYKTEVRILNGIFKYL
IFAYSIFFINKVVFDVVTSFEAINYGKDVLFGVLFSLFILRTVTYKIKKLQDSFSLKFLV
IIEIIYLLFINMINFILYISGWSWNVQEEKIPISYLLSLILLIFVNLYLFIVAKNDIHLC
FFRKNEKKPLWILGESIYFLCVANIILRIYEHSGVLILGAGLALDIVGLLLCGYLVWKGF
RVPNRNVRRIGLGIGIFFVAKSFLWDFLRFDNSYKLIAYFSMGAILIGTSYIYQTALKKL
EQEVKESLSDKDFGKGEKNEENK
>SEQF2502_01367 hypothetical protein
MKKINKIILFLFLIAIVQLFSSQYFKTIKITGKSAYKQFFLTEDIYENSKNNLGDIRIID
KNGKEVPYVIESGKEQEKHSEKIVARAKIDEVLTKKDKMEFIVKFNSDSSLKDIIGNRLA
LIPSKNFYTEYTLLGSNNGTDWEQIASGEIYKTPDKSNLTIEFSEKRYEFYKVVTPLDKG
NIFSEAILKLSSSEAGKFRTIRKKLDYKVEQEGKSTILKIKSKFLPLKNIVLDVNDEFQR
NYTVRSGDNFYAEGIISKVGEKSNLIINLENVPKLSEIIVEIQNGDNSPLKINEVTGNYV
PDRIVFRATEGEDYKITFGDESLDKPEYDIAEFVDSIKERDEVFVGKLEKADGKKVSKPR
DYTVYYNVFIGAVVVILIGFMLNKINKNKK
>SEQF2502_01368 hypothetical protein
MNIVFVLIGILVILVLMAMGIYNKYIKLKNLNEEGWSGIGVYLQKRLDLIPNLVNTVKGY
ATHEKETLENVVKLRSQMMSIDTKDIDNIEKIQKLENEMTKTLRSIMMLQENYPDLKANE
NFLNLQSQLTQIETEIQSSRKYYNGTARDRNTFVETFPNNIFGGIFGFKKAEFFNAVEEA
EKVPEVKF
>SEQF2502_01369 hypothetical protein
MKSFNKQKLNNIFSIIFVFFTLFFLNTKSLIAEKITNYDVTVQINKNGTLTVNEVIDYEF
DDAAKHGIYRDIPLRSKKNGVDIYKSYIKMNSIKRNGLSEEYSTKNFNEGVRYRVGSADR
FVENGVNRYEFNYVIYNAVFEKDGIYQVYYNAIGQFWNVPVERASVIIRFSDGQEIKKNE
IKKLEVYTGSYGEKGENYDILENDVEIHIATKELEPKNGLTFMLNLKTDKISPTLADKLR
IVYLSNPATIILPFLLLFLTIYSIVTWNFFGRDPQGKSVIPEFNLPKDISPMFAAYINGE
RDTVEILNAGIFTLLTKGFIVANRVNGEIKYNKGFKTVYTQETELAEEERMLLDALSSEK
NNIFGGEKRIYNKANSIIEILKDKYNKIIYKNNGSFLVPFYCAAPVFIIFIFSQTNFEIF
NPFIILYILITLGSFFHRIWITVSKKLLTGLIIIAILGVSFYQGIEIFVFVTYFVILFIT
YSKLIGKYTNEGLRKKEYLKGMKMYIKTAEENQIRKFDNVKELIEYFNGILPFAVALGVK
NEAIKLMKKTIKLYNFDINESYINSHTHMYAYSNHSFTNAFSRSYSSGKSKIMSEKFSSS
KSGSGGGGFFSGGGFSGGGSGGGGGGSW
>SEQF2502_01370 HTH-type transcriptional regulator GltC
MTLQQLKYVVTVAEKGTLSDAAKELFVSQPALTKAIKELEDEMNISIFNRTNKGVIVSLE
GDRFLGYARQVLEQTDLLEKEYKKGNKITRHFSVSAQHYSFAVNAFVDVIKKFGENKYDF
TLRETQTNEIIEDVSKRKSEIGILYTSGANKTVIEKMIKRNNLKFIELFTAKPHVFISFN
HPLAKKESISLEDLKEYPYLSFEQGDYNSFYFSEEILSTID
>SEQF2502_01371 hypothetical protein
MEKAYKFRFYPTKTQIEKLNCAFGCVRYVYNHFLGLKQDLYNKEKKSMSYSECSKALTVL
KEKNKWLKDVDKFSLQNSLKDLDVAYKNFFSGKGYPKFKSKKDNRKSYRTSYTNNNIEFL
GKWIKVPKLGKLKIRDKMKPQGRIINATITQAPSGKYYVSLCCTDVEVKKLESTNKNVGI
DLGIKDFAITSDETLIENPKYLQKSLKKLALCQRELSRKPKGSSNRNKARIKVAKCYEKV
TNQRKDFLQKLSTELIRKYDIICMEDLQVKNMVETIN
>SEQF2502_01372 hypothetical protein
MFNLAVGLNGYTVSTGIISKELNGENIIARPLEVDEYMKVGIIMQKNTKLSVYGKVYVEA
LKEHLKYTEIL
>SEQF2502_01373 Transcriptional regulator ManR
MLNYRETEILNNLIKGKKYNFKLVSEKYGVSDRAARYYINNIDSILRLLDYKITKKAKNS
ISLDTNQDFKNLFEILEKIRKLSMEDRISILKLILFFDEKGLNITKICEELEISRTTIKK
DLKLMSKEFKMQKIELVYKNANGYRLNGNFRDILIKKIELLEKIFDSLNDKNSSKVAKAQ
VYRYFFKYIKQKNIENTKKFIVEIEKVMFLNINEESYNKIFSYVLILLNFEKIYENSNDL
TAKKFLINTEEYKKIEKILKNILNKNEIKTEILIEITDLIMGININSLKNNSFEDWINEE
LIIKKMISKVSKIVKTDLTRDEILYNGLLYHIKPAMYRIKNNIQITNSVFQELILEKDPI
LEVVNKAIKEIEGLFEVKFPEDEIALMGFHIKASIERNTSEKTKKVILICGLGYGSSKVL
EQSLKENYDLDIVDVLPYYLIKTSMPNYANIDLILSTIDLEENYDIPVVKINPLLKEEDF
ILLSKYGIRKNITKISLKQLMEIIKNNTTIIDKNKLVNELKNKFENKINDDLLEVGIILK
KMLNKNKFQFINKVKDWREAITKAGNILEENEIIRHDYISEMIKMIEKHGAYIIIEEGIA
IPHAPISENVLKTGISLLVVKEKVLFPNGKGANIFLSFATANKTEHLGILNDLFELITKY
NFIEKISKITKYEELEEYFRKELIC
>SEQF2502_01374 Ascorbate-specific PTS system EIIA component
MLEKILDGNIQIIDSVSDWKESIKIAGKPLLQKNIITENYITAMIESIEKLGFYVILREN
LAMPHARPEDGTLGTGVSLLKLNNPVYYGDSKVQLVFVLATKDADSHMEILMQLMELFQD
DESIEKLINSKDYDEILEIIKNIA
>SEQF2502_01375 hypothetical protein
MKIMAVCGSGLGSSFMVEMNIKKVLKKIGVEAEVEHSDLASALPGAADVFVMGKDIAESA
TVPADKLIVLDSIISMPELEEKLTDYFKK
>SEQF2502_01376 Ascorbate-specific PTS system EIIC component
MKGLLTLIVDILKVPSILVGLIAMIGLLVQKKPFTDIVKGTIKTILGFLVLGGGAGLVVS
SLGPMGSMFEQGFHVQGIVPNNEAIVSMALKEYGTATALIMALGMFWNIFIARFTKLKYI
FLTGHHTLYMACMIGIILKVGGFNGPLLIIIGSLTLGLVMAIFPALAQPYVRKITGSDDV
GFGHFSTIGYVLSGFVGSLVGKGSKSTEEMKLPKNLSFLRDSSISISLTMMMIYLILALV
AGKGYVEKELSGGDNYLVFAVIQAITFAAGVYIILSGVRLVLAEIVPAFVGFSEKLVPNA
KPALDCPIVFPYAPNAVLIGFLCSFLGGIVGLFMLGMLKWTLILPGVVPHFFCGATAGVF
GNATGGRRGASIGAFANGLLLTFLPVILLPVLGNLGFANTTFSDADFVTVGIVLGNMAKH
ISPVVISGIIVGITAILVAFGFVPSKKSK
>SEQF2502_01377 Transketolase
MNSDYIEKVKEMKKLAANIRINTLKSLTNLGFGHYGGSLSIVEILAVLYGGIMNINPKNP
HWEERDYFVLSKGHAGPALYATLALKGFFPLEEIYALNQNGTNLPSHPDRLKTKGVDATT
GSLGQGISIATGIAKALQMDKKSNRVFCIVGDGEINEGQCWEAFQFIAHHNLNNLTVFLD
YNKKQLDGALDEIIKPFSFEEKMKSFGFDVVTVKGNDIKKMYDILKVPRKSNEKPLFVIL
DTIKGQGVKYIEKMKNSHHLRLTDELKQEIEKAIKDLESEVE
>SEQF2502_01378 1-deoxy-D-xylulose-5-phosphate synthase
MIKIYNGTPKKDEIEMRKVYSSKLGELMGKHNEIVALEADLMNAITTDKVQKEYPERVIN
CGIMEANMIGIAAGMSIAGKYPFAHTFTAFASRRCFDQLFMSGAYQKNNIKVIASDAGVT
SAHNGGTHMSFEDMGIMRGLANTVVMEMTDATMFENILEQVATKDGFYWIRTIRKNASTI
YEKGSTFEIGKGNLLKDGSDITLIANGIMVAEALKTAEKLENEGINAAVIDMFTLNPIDR
ESIKKYAQKTGKIVTCENHSIHNGLGSAVAEVIAETGNAKLRRIGIKERFGQVGTLDFLM
NEYKLTVEHIYRAAMELLKD
>SEQF2502_01379 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MKTAIIGYPRIGENRELKFAIEKYWRNEITENELLEIAEKLRKDQWLKQKEEKISFIPGN
TFSFYDGILDTIILLNAIPKHYKDLGLNELNTYFAIARGYQGEKGDVKALSMRKWYNTNY
HYMVPELDDYAEIKLNADKIFNELEEAKKLGVNTHPSVIGPFTFYKLAKTIGNKEKKEYL
TDVVNVYVELLKKCNEKNINWIQIEEPQLVTDQTEEDIKLFEEIYTEILKNKKDVKVLLQ
TYFGDVRDCYKTITELNFDGIGLDFAEGRQTEKLITEKGFPKDKILFAGVVNGKNIWKCD
YKKVLNILNNLKEKVKNVVITTSCSLLHVPYTLRNEKKLSENILRHFSFAEEKLSELKEL
GELSQVLWENSLEKVQENKFYVKNQKIITSEKGMEDKEVRDTVKKLKDSDFVREGARKER
QKIQREELNIPLLATTTIGSFPQTKEVKLNRSKFRKGEISKEEYDKNVFNFIKECIELQE
KIGLDVLVHGEYERNDMVEFFGENLAGYIFTEKAWVQSYGTRCVKPPIIFGDVKRTKPIS
VLYSEYAQKLTEKPVKGMLTGPVTILNWSFPREDISLSEMAFQIGLAIREEVLDLEKAGI
KIIQIDEAALREKLPLRKEDWHKEYLDWGLKAFRLCHSGVKVDTQIHTHMCYSQFEDIIK
DIDNMDADVITFEASRSKLTILDFLKENNFETEVGPGVYDIHSPRVPSVEEIVAALEIMV
EKIGKEKLWVNPDCGLKTRGITETVKSLENLVEATKIVKSRL
>SEQF2502_01380 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MCTINAPHRHDVVGSFLRPERLKKARNDFEKGKIDREELTKIENEEIKKIVDKQIELGYT
SVTDGEFRRSYWHLDFFWGFNGIGHIHADKGYEFNGVVTRDDTAIVTGKISGENHPFVKH
FTFLRDLVRNKKGVEARFTIPAPAQFYAELVREDKHVKALLKVYPDFKGLEDDIVNAYKT
VINELYNEGLRTLQIDDCTWGCLVDDNFIASFIEKSDRDKEVIRREFAERFLNINNRVFQ
NNPEDLVINTHVCRGNYASTWFGQGGYDKIADELFGKEDVNAYYLEFDTERAGTFESLAK
VSGDKKVVLGLITSKNPTLEEKEAVIARIKEASKYVQLDRLYLSPQCGFASTEEGNHLTE
EQQWAKLRFIKEVADEVWGKN
>SEQF2502_01383 Oligopeptide transport ATP-binding protein OppD
MEKAETLIEINNLVTSFRIKDEYFPAVDNVSLKLGRNEILAIVGESGCGKSTLATSIIGL
HNPNNTKLEGEINFEGKNLLKLGEEEYNKIRGNKIGMIFQDPLSALNPLMRIGDQIEEGM
IYHTKLSKKEREERVLELLNHVGIKNAERITRQFPHELSGGMRQRVMIAIALSCKPEVII
ADEPTTALDVTIQAQILDLLKTLQSEINAGIILITHDLGVVAEMADRVAVMYAGEIVEIA
NVKELFDNPKHPYTRSLLSSIPQLDSENEKLHVIKGIVPSITKMERTGCRFSKRIPWIKE
NKHEKNPKLHEIEPEHFVRCTCWKNFHFEK
>SEQF2502_01384 Oligopeptide transport ATP-binding protein OppF
MSFIEVKDLKVHYPIRGGFFNKIIDYVYAVDGVSFTIEKGKTYGLVGESGSGKSTIGKAI
IGLEKIKSGKIIYEGREIDRKFRNRRSEYNRNVQMIFQDSLSSLNPKKRVIDLISEPLRN
FENLTPDEEKMKVSELLEIVGMNREDIFKYPHEFSGGQRQRLGIARAVATKPKLIIADEP
VSALDLSVQAQVLNYMKDIQEQFGLSYLFISHDLGVVKHMCDYMFIMYHGRFVETGEKND
IYKNPEHFYTKRLIAAIPEIHPEKRAENKRRRLKIEKEYLANEKKYYDENGRVFDLKKLT
DTHFVAFKDKNLRNNGNSEKGGK
>SEQF2502_01385 Glutathione transport system permease protein GsiC
MWKTVLRRILVMIPQLFILSVLIFILAKLMPGDPFTGLITPQTDPAALEELRRKAGLLDP
WHIQYVRWLKNAVSGNLGMSYTYNVPVKTLIGERAVNTFILSLLSLVLTYCIAIPLGMLA
GRYQNSMLDKFVTFYNYVSYAIPTFVLSLIMIWFFGYTLGWFPTTGSVTAGLHTGTLGNI
LDRLYHIILPAITYALLGTTWIVQYLRNEVIDAKNLDYVKTAKSKGVPENKVYSRHIFRN
SILPIAAFFGYSITGLLGGSIFIEKIFSYPGMGGLFVNSIITRDYSVVTALILLFGFLTL
LGSLLSDIILSIVDPRIRIE
>SEQF2502_01386 Putative peptide transport permease protein
MSNNEILKENNRKTEDFENIKKSDNKPTGISVITREILKDKLALASLIILVILFGIIFIG
SLFANQDEIMKISLLDKYAIPMKEGFWLGSDSGGRSILGQLILGARNSIIIGFAITILTS
GIGIFLGLIAGYYGKWVDNVIMRIIDFITILPTLMIIIVFVTIVPKYTITTFVLIMSAFY
WVGSARLIRSKALSESKKDYVLASKTMGTKDLTIIFREILPNLSSIIIVELTLGFAGNIG
IETGLSFLGFGLPLSTPSLGTLVGYAADPEVLSTKLWIWLPASILILIMMLCINYVGQAL
NRAADAKQRRG
>SEQF2502_01387 Oligopeptide-binding protein AppA
MKKWKLTIIFLVLIFAMSCSPGKKRSEMPGAKLNLSLFPIKTSNNEPAIEGGTLQVAIVK
DDPLVGVFNEVLYTDGYDGNIISTFLSSNIFEVDENFEITDTGAAILKVDAKNKKAIIKI
KDGIKWSDGQPLTADDVIYAYEVVGNKDYPGVRYTEESQKIVGMKEYHSGSAKSISGIKK
IDDKTVEISFSQLGQSIYAVGNGLIGNALPKHYLKDVPIKDLISSDKIRVKPVTLGPYNL
TKVSRGESLEFTANPYYYRGKPKINKAILQVVNSQSIVAALKTGKYDYVMSMPDSLYNNY
KDLKNIETLGQQDLYYSYLSFKLGHYDKSKGENITDPNAKMADVRLRQALAYGINVEEIA
QAFYFGLRQEATSSIPPVFKKYFPKDLKGYPYNPEKAKQLLDEAGYKDVNGDGYREDKNG
KPFEIKMAFMAGGDVAEPLAQNYIQSWKKIGIKAVLTSGRLLAFQNFYEKVEGDSKDIDV
FFGAWGVGTTLDPTSSAGRKSQLNYSRFVSEENDRLMAEILGEKSLTVPNYKAEAFKNWQ
KYYIGQAVEVPLMYRYKLYPVNKRLKNVYIGYDSSKKDEGIHKWELTAVAPMR
>SEQF2502_01388 putative ATP-dependent Clp protease ATP-binding subunit
MSRDFNSMDDLFNQLMGGMRGFNSENRRYLINGREVTPEEFAQYRATGQLPINDEAQVQS
QGQGVKKDGILAKLGRNLTEEAREGKLDPVIGRNKEIQETAEILSRRTKNNPVLVGDAGV
GKTAVVEGLAQAIVNGDVPAAIKNKEIISIDISGLEAGTQYRGSFEENVQNLVKEVKELG
NVILFFDEIHQILGAGNTGDSGSKGLADILKPALSRGELTVIGATTQDEYRNTILKNAAL
ARRFNEVKVNAPSAEDTYKILQGIRDLYEKHHNVILPDNVLKAAVDFSIQYIPQRSLPDK
AIDLVDVTAAHLAAQHPVTDVHAVEHQIEEQKKKQAEAVKSEDYEAALNAKNRIEELENK
IKNHTEDMKVTATVNDVAESVERMTGIPVSQMGASDIERLKGMNDRLKSKVIGQDKAVEA
VARAIRRNRAGFDEGNRPIGSFLFVGPTGVGKTELAKQLALDMFGTKDAIIRLDMSEYSD
RTAVSKLIGTTAGYVGYDDNNNTLTERVRRNPYSIILLDEIEKADPQVITLLLQVLDDGR
LTDGQGNTVNFKNTVIIATSNAGFGYEKGLTEDADKQEIMERLKPYFRPEFLNRFNAVIE
FSHLNKKDLSQIVDLMLIEVNKTLSKKEIDLAVSDAAKEFLTEEGYDEVMGVRPLRRVIE
QQIRDNVTDFHLENLDAKHLVADLEDGVLVIKEKNEKLEEKKDKE
>SEQF2502_01389 Glycogen phosphorylase
MKINKAELKDNILRELRRQYGKTLEEAHEFELYNAISKVALDYAMEKWYNTKKTYAKKQV
KQMYYFSAEFLMGRFMGNNLINLQINDVIRETLNELGIDINKIEDREMDAGLGNGGLGRL
AACFLDSLATLALPGHGYGLRYKYGMFEQKIENGFQVEYPDDWTKYGDPWSIKRMDRVFE
VKFGGQIEVHRDEFGKEYFKRVNTETVHAVAYDVPVIGYGNDTVNTLRLWEARSPEGFDL
KLFNDQTYLQASAKAVQAEDISRVLYPNDTEKDGKLLRLKQQFFFTSASLQDIIRRYKSV
FGNDFSKFAEKVAIQLNDTHPVVAIPELMRIFLDKEKLGWDEAWNICKNVFAYTNHTILS
EALEKWDISLFQPLLPRIYQIIEEINRRFVAELQEKYPGDWERINKMSIIGNGQVRMAWL
AIVGSHKVNGVAKLHTEILKNTELKEWNELYPEKFLNETNGITQRRWLLKSNPELAALIT
ELIGDKWITDLYELKKLEQYLDDDNVLNRVSEIKLHNKEKLAKYIKDTTGIEVDPHSIFD
IQVKRLHEYKRQLLNVLHIMDLYNKLKENPYLDVEPRTFIFGAKSAAGYRRAKGIIKLIN
AVAEKVNNDSEINGKIKVVFLENYRVSLAEKIFPSADVSEQISTASKEASGTGNMKFMLN
GALTLGTMDGANVEIVEEVGIENAFIFGLSAQEVENYQEHGGYNPFDEYNNVEGLKKVID
QLGDGTYNDNHTGIFKELQNSLLYGVDGSRPDVYFLLKDFASYREAQDRLQNQFKDRREW
TRKTLKNIANAGKFSSDRTIAEYAKEIWNIEPVEVEDYIVEDYIEK
>SEQF2502_01390 P-protein
MNTDKDLDLGKIREKIDKLDSQLVELLEKRLEIVQEVAQFKKQTGKRIFDEEREKEVVQK
NLKRVKNKELDHYIELILKDIMDSSKKYQKFKIGISTKYVNDLNLQNKKLGYTGVPGSYA
YEVLMNILKNNKNLDIDSIEENENIFHFNSHRDLVEAVHTRKIDIGILPIENSIVGEVRD
SIDLINTKNIHIIGEVRHKISHNLLGLKGSKIEDIKNIYSHEQAFMQCSHFLSKHEWHLN
RMTNTAISGKYIATEGKKENACIANMKTKEVYRLELLKKNINNEEENYTRFFIISSEDTV
IDGSDKISIVTSANNESGALIGLLQIFYKYGLNMVNLKSRPRVNKPWEYYFYIDFEGNMS
SEKVKMALEEIREKSNYLQILGNYKLYNLEIYSD
>SEQF2502_01391 Ribosomal small subunit pseudouridine synthase A
MRLDKFLANSGIGTRKEVKEILKKGKISVNSIFIKDGRIHINEKKDIIKYEDKVVGYKPF
VYIMMNKPAGVVSATEDNHHKTVIDLLNDKYRTYDIFPVGRLDIDTEGLLLLTNDGVLSH
NLLSPKKHVSKKYYVKIAKPLSENDVKILENGIKLEENFITKKAKVEIISEDLCENDDNQ
VYITISEGKFHQVKRMFKAVNNEVLYLKRVKMGNLSLDENLKLGEYRELTGKDLDELKF
>SEQF2502_01392 Shikimate dehydrogenase (NADP(+))
MEKFGLLGEKLGHSYSKEIHEIFFELTGKNASYKMIEREIDEVEELMKSIRNGKFNGINV
TIPYKLEVIKYLDEVSETAKKIGAVNTITLRDGKLIGNNSDYFGFLKTLELNGIDVNGKK
VLVLGTGGASKAIYNGLIDSGAENIFLATIIEHDPFKVRNQDRLIHYSSIAGLRNIELIV
NCTPVGMYPAVDNCPLEDKNLIDVNAVVDIVYNPEETVLMKKYKAKGAKVANGLMMLISQ
AIKSEEIWHKEKYDIKIVEEIHKRLSEKLYK
>SEQF2502_01393 hypothetical protein
MLKKIMIGVIVVAAIGFAKTNKEIIDEGNVRQKTIFDKYFSSANLKSGEAVGNSAYSEVM
ATLYSENRSYFDREFARLTGNRRSNFRSMYAYYSDYVVEYPKFLKSAFGSFLEDTGEFQS
YSYTNTYLLLETFNLNMNTYLEAEKDGKTVDENINAIYDYLYSSGDKISKEEYEKMSSTK
MKELVNNEYDKLERVLDIRGNEGKDKKKAASSAKSSLKKLRKLYGNYDKWFDNYIDSSSL
SYENKEKLKKLVKFENISNIKFIVQSIGNKQGK
>SEQF2502_01394 hypothetical protein
MDNSENLDGKKQEKKEEINEIETLNTRKKVNQNDILNHIDLSIYNELDDFAAEVLDTDNF
LKYIEARREYLFEAEEAVKKYLGEEFLNDSENKISTFSDFYYQYLVKYSDNYFYKFAAKG
YTEGFRELLEKKGINPDSLNVKWDNIRLKELEYDESLVDILYSIVNYELEHRGYSIFGIN
MGYESTLYFIVPEKTFLRIDNEPELFTIFDIGFLETIYNEIYEVVGELGTENVKVGDFLE
KRGNEYYTLFADSSKNIVIENIDENDESKVKIIL
>SEQF2502_01395 hypothetical protein
MINFETKDIMLLYSFVNMKLRDEFLDLDDFVNYYGVDKDSLLNRFLEAGYEYSKNENQFK
RI
>SEQF2502_01396 Shikimate kinase
MKNIVLIGMPACGKSTIGYRLSPKINYPFIDVDKYLEEKESRIISDIFLKEGEEHFRELE
TKYLKEVSKRQGVIISTGGGVVKKKENIDILKKNGIIIFLNRAIENILEENHENRPLLQN
IENLWKLYDERIKLYRKYADIIIKNDDDMNVIVERIITVLKGKL
>SEQF2502_01397 3-dehydroquinate dehydratase
MKKIMIINGPNLNFLGIREKNIYGNDDYESICSYIKDKFSDKKVRIDILQSNSEGKLIDF
LQSAYFRNFDGIVINPGAYTHYSYAILDAIKSISIPTVEVHLSNIQEREEFRKTSVTAAA
CIAQIYGKGRDGYVEAIKLLLEEESCQKDEK
>SEQF2502_01398 hypothetical protein
MEENNKSVEICRIALRMSISSRDEERKLMKEYKEQGIKTAAVNVGGAMPQSRFKFIESAL
MAAKRNNLIQDVHTHDGAVIGAMREAMSQIEAIINGLSVGGKIGLAREGEHLAVAIFLSV
GILQFNEVITSVAHRSVSILESEK
>SEQF2502_01399 Phosphorylated carbohydrates phosphatase
MGKKFFDEIELFLFDMDGLLFDTETIYVEYGREVAKKTGYTITKDIVEKTTGVTNDKARI
LFKESLGQDFPYDEMMGKVKNHILELAKKSEVPLKPGALELLEFLRENNKEMILATSSDL
FMAEALINGKDLKKYFSYFVTAEDVVHGKPDPEVFLIGAKKAGVSPEKTVVFEDSFNGIR
AAHAARTFPIMVPDKLKPTEEIEKLVYKKFNSLVEVLDYFKGNN
>SEQF2502_01400 hypothetical protein
MFFDMHADVWTDNFWEYKKGNKDVIRNKYKEKFLKGGLSGGIFVIYLNVNKVENAEEYFF
ADLRAMTEELHYAKDLVKIIKEPSDFEMIENWENLNEKDKKFGVVLGIEGLPGIGDKLDY
IYFLHQLGVRHIGMTWNETNAFATGQSGDKNRGLTPLGIDAVKIINGLGILLDVSHANDK
TFWDIAKYSKKPFFASHSNARSLCPAMRNLTDDQILCIGERGGMVGMNSYHNFVSQNESE
KNLEMLLNHLEYVANKIGLDKVGFGLDFAEYYTPEGEEISGLSGLHDVTELRNVEKALKK
RGYSQNEIEMVTYKNFIDFFGRVRNFK
>SEQF2502_01401 Putative glutamine amidotransferase
MNNKRKPLIGITTSLELNPNRLNDHKTIVSVDYSKAVINAGGIPFILPITENLEVIKEQI
QVLDGLLLSGGGDPDPVLYGEDCLQEVGSITPQRDEFELVILDEFMKTGKPVFGICRGLQ
IANVYFGGSLYQDVKYTGSTINHMQKWLPDLPTHDINIEEDNILFEIFGKKARTNSYHHQ
MIKDLGNGLTSIAKANDGIIEAFQNKNHKFFYAVQWHPEMMAVRGNQKMQKIFDKFIKSC
EK
>SEQF2502_01402 Thiazole tautomerase
MDKIKLNIISNRKLCANSNLKKQVEKIFSDYEKKIILKNFEITALTLREKDLDKSKYLNL
VKKIYPICQKYKINLILHQNYDLNLDEKYNIEGIHLSYNVFKSLEENIKTGLIKKYKKIG
VSIHSLEEAKEVEILGANYVVAGHIFKTDCKKGLEPRGLKFVENLSSVLNIPVFAIGGIN
ERNSQSVINSGAFGLCMMSNLMK
>SEQF2502_01403 2-iminoacetate synthase
MKLKNINSDILNKVINKINDYDYNSFSDEDIKKALNKDYLSTRDFQALLSPKAINYLEEM
AQKAKECRKRYFGNSVYMFTPLYISNYCDNYCVYCGFNSHNKIKRARLNFEQIEVELKEI
AKTGLEEILILTGESEKYSNIEYIGKACKLARKYFNNVGIEIYPVNVEDYKYLNSCGADY
VTIFQETYNEEKYQKLHLEGHKKVFSYRFNSQERALMGGMRGVAFGALLGLDDFRKDAFS
TGYHAYLLQKKYPHAEISISCPRLRPIINNLKIEQKFISEKDLFQIVCAYRLFLPFANIT
ISTREKPNFRDNIIKIAATKISAGVDTGIGAHSGCSNKKGDEQFEIADRRTVVQIFEKIK
SENLQPVMNDYIYLEDN
>SEQF2502_01404 Thiazole synthase
MKDSFKLGNKEFNSRFILGSGKYSNELINSAINYAQAEMVTVAMRRAVSGVWENILDYIP
KNITLLPNTSGARNAKEAVKIARLARECTQGDFIKIEIIKDSKYLLPDNYETIKATEILA
KEGFIVMPYMYPDLNVARDLRDAGASCIMPLAAPIGSNRGLITKEFIQILIDEIDLPIIV
DAGIGKPSQTCEAMEMGVTAIMANTAIATANDIPRMAKAFKYAIQAGRDAYLAKVGRVLE
NGGCASSPLTGFLNEVD
>SEQF2502_01405 tRNA threonylcarbamoyladenosine dehydratase
MNLKEEDLLKRNVKGTFEKLKKTKICILGLGGLGSNVAILLARAGIGYLKLVDFDIVEAS
NLNRQQYRISHIRMKKTKAIKNIIKEINPFVKVDILDTKVDKENISSIVKDIKIIVEAFD
RAETKAMAIEKLLTNKNKIVISASGMAGLGSSNEIITRRVRDNFYLTGDNYSDYEEYSGI
MSTRVMICAAHQANMVLRLILGEEK
>SEQF2502_01406 hypothetical protein
MAKINGKYEEINNINLLDYLTKNKYRTDRIVVDFNGNIIKKEDFEKINIKNTDKIEIVCF
VGGG
>SEQF2502_01407 Phosphomethylpyrimidine synthase
MYKTQMEAAKKGILTKEMKSIAESESMDEKILMERVAKGEIAIPANKNHSSLLAKGVGTG
LSTKINVNLGISKDCPNINRELEKAKVAIDMKADAIMDLSSFGKTEKFRKKLIAMSTAMI
GTVPVYDAIGFYDKELKDIKAEEFLDVVRKHAEDGVDFVTIHAGLNREAVELFKRNERIT
NIVSRGGSLMYAWMELHNAENPFYENFDKLLDICEEYDMTISLGDALRSGCLNDATDACQ
IKELITLGELAKRAWKRNVQIIIEGPGHMAIDEIEANVKLEKKLCHNAPFYVLGPLVTDI
APGYDHITSAIGGAIAAAAGVDFLCYVTPAEHLRLPNLDDMKEGIIASRIAAHAADISKK
VPKAIDWDNRMAKYRADIDWEGMFAEAIDEEKARRYRKESTPENEDTCTMCGKMCSMRTM
KKIMSGEDVNILK
>SEQF2502_01408 Thiamine-phosphate synthase
MDLKDCKIYLVTDEKACNGKDFYKCIEESIKGGIKIVQLREKNSSTKDFYEKALKVKKIC
KNYGALFIINDRLDIAQAVEADGVHLGQTDMPIEKARKILKNKFLIGATARNAKEAKKAE
LSGADYIGSGAIFGTNTKGNAKKLEMEDLKKIVNSVKIPVFAIGGINISNVSLLKNIGLQ
GICLVSGILSEKDCKKAVNIMLKNFI
>SEQF2502_01409 Hydroxymethylpyrimidine/phosphomethylpyrimidine kinase
MKNVLSIAGSDCSAGAGIQADLKTFVANEVYGMTVITSLTAQNPQKVKMIENVSIEMLKS
QIEAILDTIKVSAIKIGMINTKENGEIIYESLLKYKAENIVLDPVMIATSGNSLIKDETK
DFLVNKLFKLADIITPNLDETKEIVKIILKNENIEDINSIEKMKTYGKIIADFTKKWILV
KGGHLSNSAVDILINKEKVYVLKGEKISSNNTHGTGCSLSSAIASNLAKGYSMLDSVKKA
KNFVLCSIRNSVNFGEIAGTINQMGEIYKNIDIEKLY
>SEQF2502_01411 hypothetical protein
MLNEFEKKIRINELTNLRKELMQQGNVVEEVKVLKELAELTENVFGDESDENIKILNEVG
GTLKYVGEFDTAKDALLKAQGFIEKKYGKDSIPYATCSLNLAEVYRFMKKYDKTEDIYLN
TMKIYEANNLQNDYVYASVCNNLALFYQELGRFEEAIELQEKSLKVLEKVGENPIQYAIT
LSNLVQPYLKVKNIEKAEEYLQKSLKLIEKEVGKSHNLYAAVLNNMATFYFEENEYEKAL
ELFEESAEICEKTFGKESNNYKNILENIEIVKEKMV
>SEQF2502_01412 hypothetical protein
MDSNKIKGLELSKKYFEEIYLPVIKSEFPEVFEKMAAGLAGEGSECFGFDDEISQDHDFG
PSCCIWLTSEDYEKYGLNLQKSLNELPKEFLGFRALNVSEFGDGRRGVLNMDDWFFKFLG
DVKAPENLYDWRLIPEELLATAVNGEVFLDNLGKFTKIRSDLEKYFPEDIRLNKIATRCM
KMAQSGQYNYLRCMRRNEIVAARLAETEFINEAIHIIFLLNKKYKLFYKWIPKALKNLKI
LGEKTYFLIEELVKLPVGAVNRKFQIIEEISANVILELKYQNIVPRQLTSDFLQDYGPFV
QNKIEDEKLRNWNPAMD
>SEQF2502_01413 hypothetical protein
MEIEVSKKESFIRQILKREWEFFQNVHHTEGRAECQDNPQEFEIMRRSQWETLPDEILES
YLEDLILAKHRGENIVQDKYARMMKYSAPKEYEVIKNYLPEIPQEKKELIKKIVKIYLHW
EEEIIEKYPKLTAKGRPLHSQYDTPNYTSIETYLKGELSSYSIKTLKLYYEYIQNCVSNN
INLAENNLENIVLEKGYETIEEAEESL
>SEQF2502_01414 hypothetical protein
MNKNLSEFENKLPSVLEYDTQQLLDYYYESPEKMKIAEVFSEFLTEKGIKVKLKEIGEYQ
YIYEIETGYYLLPLFVGGGTTDKKMSVSINIHLFHEKYFPEGMKNWNGSQMNLNYKDSLV
QAFENWFNYDRLNYLKLVNPDKTDLRRIKINGKKKIIVSGNVKTIYNYDEEKYQEKEREE
NFLSNIFSLIKEKISLKDSKIDISLLKYPYNNYGSYLEEFDKGDFYVDCRIDGNRLYGNE
LNPEGNTELYYREILKNWKDYEYSKSQTFFVLDNKFEKSEWLKITEFEFLPKIKLKYVEK
PSWKKLEENFGNLKEMDRGHEGDFAFTMAEVLFDKMIHCGYNVRLMDDWVYDFDNECYLL
PLLSTKDYKTIPHDDIYQVVTTIQVHNKKYFPEGKLYIQKLIGEPLYDAIWINYRNWINN
DYKKLCKNI
>SEQF2502_01415 Very short patch repair protein
MKKKKPLTRSQNMARIKSKNTKPEIYIRKLLYKMGYRYRVNYSQLPGTPDIFILKYNTAI
FVNGCFWHRHKNCKIATFPKTHAEYWEKKFRRNVERDIEVREKLFEMDISVITIWECEIN
KMQRNEKYKEKYLKILKDRIERVFNYEEKDISVQMEIAEESMQ
>SEQF2502_01416 Photosystem I assembly protein Ycf3
MKSKILLIFSLFMLSLNAFSNPNSNEKFKLAKSYLEQKEYVKAEKIYLELAKEKDIHAMY
NLGYLYMEQGKIVEGEKYYKMAADMGYDDAMYNLAMFYDRQKDFVKEKLYLEKLAVKNQN
DAIFQLAIIYRQEGNYQKADELYKKLLKAKYQESEVFYNLGVSCYYQKKYDEAEKYFLKA
IELGNNDDPKYNLGILYKVQGKFTQAKKYLIPLAQKGKIDAMINTGAIYRDEKDYKNAKK
YYKMAMDKGSREAEAEYNTILIMEEHGL
>SEQF2502_01417 Adenylosuccinate lyase
MTDMSIYSNPLAERYSSKEMLHIFSPEFKFRTWRKLWINLAEAEKELGLDFITDEQIEEL
KKYKDDVDFEVAAKFEKKLRHDVMAHVHTYGEQAKNARKIIHLGATSAYVGDNTDLIQIK
EGLLVVKRRMLTLIEKMRDFALEYKDLPTLGFTHFQAAQLTTVGKRATLWLHSLLLDFEE
LEFRLENLRFRGVKGTTGTQASFKELFEGDFEKVKQLDELVTEKAGFSKKQGVSGQTYDR
KVDAQILNLLSNIAQSSHKFTNDFRLLQHLKELEEPFEKNQIGSSAMAYKRNPMRSERIS
SLAKYVISSSQTGALVFATQWFERTLDDSASKRLSIPQAFLAVDAILIIWLNIMDGVVVY
PKVIETNIQRELPFMATENIIMESVKKGMDRQEVHEIIRELSMEETKEIKLNGKPNRLID
RIIKDGRLGLKAEDMEGILVSANYTGFAGQQTEDFVKNEINPILDKYKDEIVEDREELRV
>SEQF2502_01418 hypothetical protein
MNKMLIILFGILTILSYSSKAQIITCCKNCYRENSQIKNKKYD
>SEQF2502_01419 hypothetical protein
MKKVLISIVFLISINVFADINSEIKNLKQLKVDNEFIEGYKKAVNEFSSTKKLSDKYMAE
YLNIGMIYLKNSKYDEAIELYNRILKSNLKNVSTNYWAYYGISSAYFYKKDFKNSFEYGK
KAIEMDIKQKKELPFIPKDEMEDYRRRNLAERIFLSGYSQEKYEEILNIFLETIKDENYK
NVISKDEVIIKTLVSATMQIRKKDEKLSDKYLKELEKLKIFKVVKVD
>SEQF2502_01420 hypothetical protein
MKKLLLVLMLVIGAISFSAKAQNVGKYKVKQSLKENVAQNLSFDTITLKLKGTKLSKTDK
NKIELEYENFKATGNNKKVYTEKDFQVNGKNPKIIINKTISTAMMENFVNSDEEIVVTGF
YENNEGIKYKPFNFSFSVNKDEVKKIYFKDGAIYIWDN
>SEQF2502_01421 Adenylosuccinate synthetase
MENNTFVIVGTQWGDEGKGKIIDVLSPKADYVVRFQGGNNAGHTVVVNDEKFILHLLPSG
IINSAGKCIIGAGVVVDIEVLLQEIDELEKRGKKLDNLFIDERAHVIMPYHIEIDKAKEE
AMGKNKIGTTQRGIGPCYIDKIARNGIRIGDLLEPERFRDKLTWNVNEKNDMLVRYGKGT
FNLEELYDKFMKLAEKIKFRIIDAVVEINEGIEEGKVVLFEGAQALMLDIDYGTYPYVTS
SSPTSGGVTVGTGVAPTKISRVLGVMKAYTTRVGEGPFPTELENKDGETLRKVGHEFGAT
TGRPRRCGWLDLVIGKYAVLIDGLTDIVLTKLDVLTGFEKIKVAVGYEIDGKVCYSYPGN
LRKSKDLKVIYEELDGWNEDITQIKNYEDLPENCKKYIEYIENKLKCRVSMISVGPERSQ
NIYRYDLGEFVK
>SEQF2502_01422 hypothetical protein
MNAINYQQMAFGFLGGLGLFLFCIKYMGDGLQMAAGDRLRYILDKYTTSPFLGVLVGILV
TALIQSSSGTSVITIGLVGAGLLTLRQAIGIIMGANIGTTITTFIIGFNITEYALPILFL
GAACLFFIKNNFINNLGRILFGFGGIFFALTLMSKAMEPLKHLPAFTELTIKLSHSPVLG
VFIGTMITMLVQASSATISILQNVYQEHLITLKAALPVLFGDNIGTTITAIIAVIGANTS
AKRLALSHTMFNVIGTVFFMIMLSPFSIFVETMSKILHLNPKVTIAFAHGSFNIITTVLL
FPFIGVLEYIVVKLIKEKDEDVVEHQPRFLDAALIHTPAIALGQVKQEMLSMISIAVKNL
SRSIDFFHEHNEKVAEKVEKTEEAINNIDQEITKYLTTLSQEHITEKDGEEISMYLDMCR
DVERIGDHAIGIVRDVRYEIKKKLVFTETAHKEVQKLFLISKEIIETAEAALKNDDTEKA
FTVVDLHNKLYAKEKEVRKAHIKRVSKQECDVKAGLYYIDVVSHFTRIGDHARNLVEKMI
ENKTVK
>SEQF2502_01423 hypothetical protein
MRKGILSKFIILMGFLFSFALNAGNKENFNNFEKFSARMSNNPDYISYEIISGNGNKYTV
QLNVGNYLAFMPSRYAAVNVYEFLSDTLKKDFKIIKINKKGKITNESKIIKYSPNDFFSN
YTENTDSEKAEMKSMGMVFAGVKNVGAGEYKITAYGNKGISGGIDSKGLNWLNLAFIPTN
SAFYIKINNDKNLVWSPNRDYRSIQYTFSIENGKIEVVDKKGKHYMSIYQKDNSLFVEMA
KYNVEFKINQAQNQLEYWINHKLKYVEKYQII
>SEQF2502_01424 putative lipoprotein YiaD
MKKVLAITMLSLLALVSCTTATDGTRKVSKTGIGAGIGAAAGAAIGQAIGKDTKGTLIGT
AGGAAIGAAIGNIFDRQEKELRDKLKGTGVDVKRTGEGEIKLTAPENITFDTNSYVVKPQ
FRNTLDSVATVLNTYPDSTIVVSGHTDTTGNDTINNPLSVNRASSVASYLESQGILASRI
TSRGYGSKQPIASNATEAGRAQNRRVEIAIIANQK
>SEQF2502_01425 hypothetical protein
MKIKNKIFMLGILVLISINTNAGWAKYRDKIVNGVKKSLKKDHSQNNHTSSNNYTQNYSN
IYYNDYDNDDDYYDNDEDDSYDNSDSYYDNDNYDDNEDYYDENNDEYNYDDDGYDTGDSY
DDYYED
>SEQF2502_01426 putative tRNA-dihydrouridine synthase
MKIYTAPMAGITDYSFRKILKKFEPDFMFTEMVNSNLLNREDGTTINELLKYDDKEKTGT
QIFGGDRNELVSGIFKLKDFGFRKININMGCPQPKIIKNGAGSALLENFELVEKVLLETK
DIEADISLKIRVGYKEFQNPDIFLKLANKYNLDFICVHGRTQEQMYSGTANWEIVERLSK
MPRNIDFFGNGDLFDPFEIKQKISFCNLDGIMLSRGIIGNPWLILQTREFLKSGKINTIQ
TFDETKSIVLEHLENIEENKGKIKAVLEINKFLRPYFKKFWEKNLNKNSEIVTVEDFYDE
NLKGKIDKIILEKEILEKIKMIKQL
>SEQF2502_01427 hypothetical protein
MARNNEKISLLIKKLKSINENIFFDLLIDNLNNEVLEKKFGKPFNKNSIFFEREIEIVKK
IDESNKEFLRKLIDINNSYIEKKYLNAKKNLNLVKEDCLKEFERDKILRVNGRGLNPEQM
IMYVLSTDNLVELLDFFKEEYFKYIEKLEENKRKILEKELFLKEVVEELENQDLEKEFQE
CLDTKYKNVKKRNLEKLSKKYNLEFNEKQRNFNVSAEFISFFDEKMKEYFLMRENFKRGF
EFFNINSYKVSEKERDLEEIITEIEGIEQENKFLNSGYDKLEKENKKLKEDLRKHRNKEA
EKTIEKQKKEIEKLNIQIKELQKEIENIEQDENVKVVENVNIKELPEGKAIDLTNQNVKV
VGGRWSQKVIEKAEKYAKEKGFKIEFIHATSVFRNSDKLKNSDIIIFDTSYNSHSAYYKL
KSYGLKIYRISTSNLDRIKNLSK
>SEQF2502_01428 Toxin-antitoxin biofilm protein TabA
MIFTNINDKLQNSSLTKDIQFCIDYAVKNRNKILLLENGSYDVDYNGIKMNVGKYFTKRE
EEKFWESHKKYLDVQIMIDGSERVAINDIRNMREKSFDSERDLVILDGDKMFDVIIENGD
VLVFFPNDVHKPELDILDFGNENEKKIVTKVVFKIEIGK
>SEQF2502_01429 putative murein peptide carboxypeptidase
MNFPEPLKHGDKVFLVCTSSPILEEDIEKCKEVVKKLGFEPVLGESLFEDIGGYIAGTPE
IRVKDLHRAFADDEVKGIFCVKGGFSASQLLDKLDYELIRSNPKVFVGYSDVTNLNIVFN
QKCNLGTFHGPMVKSNMFSDFNDFTKKSFLDVLNKKKGERWKFKNPMDVKSGMEKEISLL
YKKNFENKKINGEIIGGNLSIIVTTLGTDYEIDTKGKIFFIEEIEEEISRIDRMMTHLKY
AGKFDDCNGILFGNFAGCENTYGENYELMDLLKNFFKDYEKPVIYGLESGHEKPDLATIP
LGAKCIVEITEDKNEIYFEK
>SEQF2502_01430 hypothetical protein
MIKRFFSFKSKKVMVFPMMMVFGATSYGTNVDDLISQYEKNSYTTKINEKNMKKFDIKDK
VLKNGDWNEVTVNSDNNYTLHGEANGLTMENNVKYGVFYYRNGYNFRSKEVTQNKIGVSK
TLNDYFGYSDNNYNKKTNQISRNIQKITNETTKNSEIRDLIDLYKNYKNKEKEIEQEALT
MEDTKKDYVIQEKKYEVGTASKYDYELAKNEYENSQLKYENLGRELQILREQFTIYNIKL
PEKGKLDDLKKVELKKDDFYGLRLSEAETIELNTQLNAEQLKKEIIDYKYPKLTGDIGYS
LKNHSVVAGLSVSKSFKRYNDTVEDLKNEADKLKLQYEQKKNELISNVGQQMITYTTYQT
NELTAENTMNIKKREYEIYAKKYELGVDTYSNYVEKRNNYKKAVMDYETAKNELAAFTKK
IKYYK
>SEQF2502_01431 Putative efflux system component YknX
MKKNYILKDKKNIAKIFLIFVVLLFCLISCGKKEEGIEYEVTKVGMGDISLSVSKTGQVV
SDNVVSVYTSSSQRVKDVFFKTGDNVKKGDVVVTFYPADKNETLRKIQMKNLEIQKYERN
LASAQSSLRRKKETKSLEIQQKSRDLHNAEELYKVGGETRVNVDDARKALRTSRLESDTV
DSEERTNIEDARTALKTARLELATLQEDMTLIKNEITSPVDGVITEMTADENYKVNTEST
LFKVSDSKNMKVEVSLSDTQVKNIEVGQRVEITSDALPKGEKVEGYVSQIAGVAKKSENL
DESDTTVTIKMNDTKNLRPGTTISATIFYEEKRNVVKVPYSAVMNENGKYFVFTVGKDKK
ITKKEVKVGVSDESNYEITSGLNMGESIISVVDETLKDGQKIKIADPKKPKKDNKKIIKS
QDVESVPAGEAAPGGPEPM
>SEQF2502_01432 putative ABC transporter ATP-binding protein YknY
MIDVKNIVKTYKNGNLELTVLKGLNLSVKKGELVAFMGPSGSGKSTLMNILGCLDSLTSG
TYILDGQDVSKIKGDALAKVRNEKIGFVFQTFNLLPKMNAVENVALPALYAGVKKSERTK
RAIEALESVGLGDRIHHKPNEMSGGQRQRVAIARAIINNPSILLADEPTGNLDSKSTEEI
LEIFKKLNDKGTTIVMVTHEEDVAEHCKRIIRLKDGVIEKDEIVVNRRGG
>SEQF2502_01433 Macrolide export ATP-binding/permease protein MacB
MDFLESLKLSLSNLLSYKVRSFLTMLGIIIGIGAVIMMSSLGAGMKQNITGDLNKLGVGN
FNVSIDTSPGQTYKTEDLMTEKDIENIKKIEEVEAVSPTSSAFARIEVDGNTKMFMGTGV
TQDYFKISNFTIVKGRKFLPSEYKKDGRFIIIDSSTAEQLYPDENPIGKKVTLNFKKNRY
ELVIVGVYKDPYSSLNFGGGGGAPSSGLIPNQFLVFINGGEQNKFEELQVKATSANSLNI
AMAEVKDLMSRRGSSSDKYNVRSESSGLDQFNNILNMVTLFISGVAGISLFVGGIGVMNI
MLVSVTERIREVGLRKALGARTKDILVQFLIEAVILTFFGGIIGVAIGYSLALLIGMFIK
TSPVLSPGVVSVCIFVSTMIGLVFGVYPAKKAATLEPMEALRTD
>SEQF2502_01434 Carboxynorspermidine/carboxyspermidine decarboxylase
MSKNKYINMDITNLPTPVFIVDERLLKRNLEILKSVIDRTGCKILLAQKGFSMFYFYPLI
GKYLNGTTASSLFEARLGYEEMELKSKDRKLETHIFNPSYREDEFDEIMKITNHIVFNSF
NQWKKFKDKVREFEEKNGKKISCGLRLNPEFSEVETEIYNPAGRFSRFGVTLENFREDEL
EGLDGFHFHALCEQNSDALENVLKIFEKKFGKYLYNMKWLNFGGGHHITRADYDVEKLVK
CINYIKGKYGVEVYLEPGEAVALNTGFLVSEVLDITKNEMDILLMDTSASCHMPDVIEMP
YRPFIFGSGMSGKKKYTYRLGGPTCLAGDIIGDYSFDEPVKVGDKLIFTDMAHYSMVKTN
TFNGINLPAIAVYTEKGGVEVIRRFTYEDFRNRLS
>SEQF2502_01435 hypothetical protein
MKKMIIDRRKSIMLVMTCIIFMMTYSSLIGTPSFSHKLSVFVNENNLSHEDIRDLIVKIN
QFKSRDNRRFTEELEKIGKRKEKEKKNNNLFFLFKGSQDVIYYGNRNCQSYDKIFENSQD
IYAFFSKKNENNLRIRE
>SEQF2502_01436 Protein translocase subunit SecA
MLKKLGEKIFGTSDDREIKKMQKLVNKINEIEPIFEKLTDEQLQHKTVEFKERLAKESLD
DILVEAFATVRETAKRLLGMRHYDVQLIGGMILHKGSIAEMKTGEGKTLMSTLSIYLNAL
TGKGVHVVTVNDYLAKRDRDIMAGLFEFLGLTSGVVVGNITPEQRKNAYNCDITYGTNNE
FGFDYLRDNMVGELDEKVQRGHNYVIVDEIDSILIDEARTPLIISGAAEETTEWYNTFAE
VAKKLKRSYKTEEIKDKKNTVIPDEDWEDYEVDEKSHTVTITDKGIKNVERILKIENLYS
PEYVELTHFLTQALKAKELFKLDRDYIINDDNEVIIVDEFTGRLMEGRRYSDGLHQAIEA
KEKLEVAGENQTLATITLQNYFRMYEKLSGMTGTAKTEEDEFKQIYKLKVIVVPTNRPVA
RVDLPDVIYMNKNAKYKAIARKIEELYEKGQPVLVGTASIQHSEEVSALLKKAKIPHEIL
NAKHHEREAEIIAQAGRFKTVTIATNMAGRGTDIKLGGDAESFATKVAVKGTPEYEDVYK
TYAKECEEDKKRVIEAGGLFILGTERHESRRIDNQLRGRAGRQGDPGTSEFYLSLDDDLM
RLFGGDKLKAMMKMLKIDEDEEIRHKQISKSVENAQKRIESRNFSSRKSLIEYDDVNNTQ
REVVYEQRDAILKNENLKELITGMISDTVDDIVNSAYVGEGNGEKDFNLLADKFQETFEY
EISEDLQNASAEEISDKVYDDLIKVYDEKEEAIGSEVFRRIERYIMLEVLDSKWRQHLKD
LTELREGIRLRSYGQRNPIHDYKIVAFDVYNEMIDAIKRETSSFILKLRVRSEEDTNNLT
HEEVSNVKYEHNENEMIGDDVPNDAANKPRRPLSRRERRERERRNV
>SEQF2502_01437 Pyrimidine-nucleoside phosphorylase
MRAVDIIQKKRDNNELSEMEIEFLLNGYLSGNIPDYQMTAFLMAVYFNDMTKNELLKFTM
LMRDSGDTIKFDEINRFLVDKHSTGGVGDKVTVILSPILSALGMGNVKLSGKGLGHTGGT
IDKFESIQGFKFSTTREELAKIANKTGIGLMGYSDKIVPLDKKLYSLRDVTATVPSIPLI
ASSIMSKKLAIHSDVIILDVKVGDGAFMKNLDQAKKLAERMMEIGKGAGRKVKVVLSNMD
EPLGYAVGNANEIIEAIEFLKGNCADDVKEVVYTIVGLALKEKGEISELCEAYEKIDKVI
KNENALQILAEFIGESGGNKELVNNYDLLPKAKYKIEIFSENAGYIKRIKTEKIGKAAMI
IGAGRAKKEDKIDHSVGINIFKKVGEKIEKNEKIAEIYYNDNKNINESQNMVLEAFELTK
EKVEKPKAILEIIE
>SEQF2502_01438 Membrane lipoprotein TmpC
MKRILTIFSVIFALMLIAACGNKPATGEQVKDGKTFTDSTNSKKSVAVVYSTGGKGDKSF
NDATFRGLQKAQKELGISFKEYEPKDPATEAKNALTQFAETGEFDLIIAVGYTMKDSLVA
VAKAFPDQKFAIIDETVTGLPNVASILFKEHEGSFLVGALAGMMDKTGTIGFVGANESEL
INRFYAGYAQGARYVKPSIKVLPVYIGGSNSFNDQASAKAKTETLIQQGADVIYHAAGAS
GLGVFQAVKEKNVYGIGVDSNQDSLYPGTILTSMMKYVDNAVFDVIKTTAEGKFQAKVQT
FGIKENGVGTTDFEFTKDKIGEENIKRLEQIKQDIKDGKIIVKPSI
>SEQF2502_01439 putative protease YdcP
MKHEIDFDKKRKMNILAPAGNYEKLVAAVKAGANEVFFGLKGFGARRNNENLAMQEVFDG
IDYAHSRGVKTLMTLNTILKDSEINSMYNNVKRVYEHGIDAVIVQDLGFVKFLKENFPNL
KIHGSTQMTVANHVEANKLKELGLTRVCLARELSFEEIKSIREKTDIELEIFVSGSLCIS
YSGNCYISSFIGGRSGNRGLCAYSCRKKFTDENGKSAYFLSPNDQLLQEKEINLLKSIGI
DAIKVEGRKKSSEYVYETVSYYDNILKGTPRPTESYKLFNRGYSKGYFYLDDKLMNFKYS
SNFGYFLGVRIGESNNFKIDDKLILGDGVQFVDENFEQIGGEYVNKIRIIEAYENGNNEN
REFGKKDSEKKNKKQNPKSKGKENEDKKAEEKTSKADKYDIISIGKLPKGTKYIYKNYSK
EINDRIIHNIKVSKRYAAVNAKLLAKKGQEIELTLEIENLKNEIISATKKGNIIEQDARK
LITKEQIAEKIGELGDTTFELGKIQIDYDGTSFIPFSELKNLKRECVSELLEKLLESYKR
TAAERKKYDFELNKNSEIKENENTENKKRPVISALVANDEQEKACRETGITKIYRKQFDV
AKEKNLSKTDKIKIGTNLVSNLYQAIMGEKTGAKGQSLDWNLNVFNNHTIEMFSNFKNLE
TVFLSPELSCRQLKNIKSDKLKKGLVIYGYLKGMYIEHKIFDENYKELEGEFYDKYKIVK
NELDNIELYLDKPMNLIPRLNEIYELDLDELRLDFTFENADEVRKIIKSVDTKSGKYTPY
AFEQGVL
>SEQF2502_01440 hypothetical protein
MEIEKRQKYLEKLYLLLGASIFVHYALVILFNILILINIFTTGEYKKIFKDKSLITVGIV
LGFSLITSAFYKNILGLMAIPIFLCIIVGRYYTLIVNVEFKKNNLEWMAKFSGISLFIGI
GEFLFTHNRVGYFAYFNPNYLGSIMMMSAIINLYFTFEKRSKINFVIFIMNILTILITGS
RSSLIAVILGMFVLFFYFLKRRYFAGLILMLVSYIFGVISGVFPFLRESTLIEYFWLRIE
IIDMAIRIFKKTNLLYGHGNFFYYKFTNYVYPHSHNALVELLLSYGLIGTIALLTVFLRY
LYDILKNDRNNVMKIALIAGIVVHNFTDFAIFWIQTVLLFIMALAYKEKNEKIRGYRQIQ
NK
>SEQF2502_01441 hypothetical protein
MRDNIYVGLVHYPVYNKNNAVVATSVTNFDIHDISRTCRTYDIKKYFIITPVDAQKELTG
RIIGYWTEGNGIEFNKNRNEAFENTELEDSVQSAIKTIEKIEGKKPKIITTSAKIFPNTV
GYADLGKEIIEDDTPYLILFGTGWGLTSEIMDLSYKILEPIRGKTQYNHLCVRSAVSIVL
DRLLGEN
>SEQF2502_01442 Protein-lysine deacetylase
MKAKNKGLVGIVVVSHSNTLAEEVINFVKVFKQEDFALENGGNAKREVYGTNVENVKQAI
LRADKGAGVLVFVDMGSSVFNAVKAIKELEGQVEAKIADAPFLEGVISAVAGNFNGIDLN
DLKIIAEDSRKFTKLRKEI
>SEQF2502_01443 Ribosome maturation factor RimM
MENLVNIGTIVGTHHLRGSVKINSIFENIELIQNERVLLEKNDKKRLLVVKNVKRLNDKK
VILDFEGIDNVDSAKELNGYKVKIRRDLLPEKSEDNFYIKDIFGLEVFSENKKIGEIVDV
METAAHNILIIEDIDSKKEIMIPLIDEFVTKIDFPNGKMEVTLIDGMRE
>SEQF2502_01444 tRNA (guanine-N(1)-)-methyltransferase
MKFNVLTLFPELFEQYLSQTILKRASDKDIINFNIVNIRDYARNKHNQMDDIPFGGGAGM
VLKPEAYWNFFYENYDFYNNENKNSKKPYVIFLSPQGKQLTHKKVTEFSKKEEIVLISGR
YEGLDQRVIDKFVDEEISIGDYVLSSGDLPSLVIMDSVIRIKEGVIKKESFETDSFYNGL
LGFPQYTRPVEIDGFTVPEVLRSGNHAKIDEYRRFHSIEKTMKNRMDLFEKKLENINEDL
EFKKIYKKYLKNKN
>SEQF2502_01445 Trehalose-6-phosphate hydrolase
MIKDFEQKWWHKSVVYQIYPKSFNDTTGSGQGDIKGITQKLDYLKKLGVEVLWLTPMYKS
PQNDNGYDISDYYNIDESYGIMEDFEEMLNEAHKRGLKIVMDIVINHSSTENEWFKKSEA
RDPEFEDFYIWKDPVDGKEPTNWESKFGGNAWQWSEKRGQYYLHLFDVTQADLNWENENV
RKKLYEMIRYWLNKGVDGFRFDVINLISKDQRFLNDDGTDTRFVPDGRRYYTDGPRIHEF
LKELHKEVFGESDLLTVGEMSSTAIENCIKYSNPDEKELAMTFSFHHLKVDYPNGEKWVK
APFDFVQLKKILSKWQIGMYEGNGWNATFWNNHDQPRALSRFGNDKKYHDESAKMLATVL
HGLQGTPYVYQGEEFGMTNPYFDKIEKYRDVESTNIYKILLDRGCSEEEAIEILMQKSRD
NSRTPVQWDDSKNAGFTEGTPWISVPENYKEINVKKALEDPNSVFYHYQNLIKLRRNEEL
LITGRYEDFDIENEKVYAYKRVGENAELIVISNFYGETCEFDVKGLDLENASILLSNYIE
GPKISNDKIILKPYESIIFKK
>SEQF2502_01446 Putative competence-damage inducible protein
MKAEIICVGTELLVGDIVNTNAQYISAKFTNIGIDLYYQTTVGDNYGRLKECLENAFKRV
DLVITTGGLGPTVDDITKEVVADYFEEELEVIERYYDLIVKRYNERGFGEVASGGRKEAS
ILKNSKLLENEVGLAPGFFYEKDNKKIIVLPGPPREMTWMVDNQVLPLLKQYSNDVLLMR
TLEIRGIPEGRIDDRLKNYFEMSNPTVAPYAKEGCVHVRIAMKGDRGSSDYLIAEIDKIA
DEIKEIYPQAVEIKEN
>SEQF2502_01447 hypothetical protein
MKREIAIIGGGASGFLTAITAKKNGKDVVILERKDRVLKKVLTTGNGRCNLTNVNASNQN
YFGIEKMRQPIEKILGSFTSQDAMRFFEDEVGIICNEENRGKVYPLSGQAASIVDGLRFY
AQSLGIEIITDFYAMKIEKEMFDFKIISEDKRQITAKKVVLATGGKSYPELGSNGSGYEL
AKKFGHTVTKLTPVIVQLKAEKEKIRGLKGIKSDVEVTAFGENEDGEKIKICTYDGELLF
TDFGISGNVVFNISYVFPIYKNVEFEIDFMPKFTYNEIFEILKKRRKILKDFTMEQFFNG
VVNKKLGQFLTKSAGIEKLSKSINDLTDNEIRKICTILKKYKIKIIDTNGFKVAQVTAGG
IPLSEVNLENLESKKVKNLYFAGEILDVYGECGGFNLQWAWASGYFLGKNI
>SEQF2502_01448 hypothetical protein
MIRINNIKMPVIHNKNDLKKTVYKLYRINEEEVKSFEIAGQAIDARKKDNVVFVYAVDIS
FKFDEEMEKKRFENVKNVRKIEKKSYFTEKIENFTESENIKRPVVIGSGPAGIFAGLVLA
EAGLKPIIIEQGKNVNEREKDVYNFFKTGKLEKYSNVQFGEGGAGTFSDGKLNTNTNNFR
IQKVYDELILAGADPKINYMSKPHIGTDKLIEIMRKIRHKIESLGGEYRFSTKLIKINYE
KTDSENNRIKSILVENVKNIEDTDENKTYEIPANIVVLAIGHSARDTFFMLNEENVTMER
KTFSVGVRIEHLQSMINHSQYGKFANKLPAAEYKLNVKTSNGRGVYTFCMCPGGVVVPSS
SEEERLVVNGMSYSKRDLENANSAILVNVFPEDFPGKSVLAGVEFQRRLEEKAFELGGRN
YKAPIQLFGDFVNNKISTKLGKVKPSYLAGYKFANLNEIFPQYINDSIKEGIFLMDRKIK
GFASYDAILSGVESRSSSPVKIPRNEKFFSNIEGLMPCGEGAGYAGGIMSAAVDGIKCAE
YVIGYYQMICKTKE
>SEQF2502_01449 Cys-tRNA(Pro)/Cys-tRNA(Cys) deacylase YbaK
MKHKKDKIAKTNALRQLDKQKIPYIIHTYEWSEDKSGGLGVAEKFPELAERVFKTIVLKG
KSKNLYVCVIHGAAHLDLKKVAKACGEKNIDLLPLSELEKETGYIRGGCSPVGMKKLYRT
FFDKEVEKFEKIMVSAGRRGLQMEVETEKLVGIVNGTVVDLLMEEIK
>SEQF2502_01450 Transcriptional repressor CopY
MKESSRIDQKWYITDAEWEVMRVVWANNEVTSRFVAEVLCEKMNWKQATIKTLLNRLLEK
GVLKKREIGNKYIYSTDFTEKEVANSYILGTFNKICKTKVGEMIGKVIENSELSFDDLEL
ILKAVEEKRKTAVEEVLCDCVKGQCNCEHNGHRHV
>SEQF2502_01451 Copper-exporting P-type ATPase A
MAEKIYTVTGMSCAACANAVEKALNKNEDINASVNIATEKLNVEYDERKYDFDKIRKIVE
SAGYGLVENMTEDRKVELYQEKIASLKKRLILAIVFVVPLLYISMGHMLGAALPEFLNPK
VNALNFALAQFVLTLPIIYAGRDFFSHGFKNLVRKSPTMDSLIAIGATAAILYGIYATYR
IVTVDPEAHMDLYYESAGVIITLILFGKLLEAKTKGQTSSAIKKLIGLQPKKAKIIENGV
EKEILIENLKVGDIVIVKPGEKIAVDGKIVEGATSVDESMLTGESLPVSKKVGDKVVGGS
INKNGSIRFEATEIGKNTVLSQIIKLVEEAQGSKAPISRMADVVAAYFVPIVIGIAIITG
VAWFVSGSGLVTALSFFIAVLVIACPCALGLATPTSIMVGTGKGAENGILIKSGEALETT
YKIKTIVFDKTGTITKGKPVLTDLIAYGNYKEDELLKIAASVENDSEHPLAEAIVNEAKG
KNVEIKPYEKFRAMPGYGIRATFEGKEIQIGNKKLMENKKIDVKISQKDYNILSNEGKTP
MYISIDNELAGIVAVADVIKETSKEAIEKLKKMGIKTIMLTGDNEKTAEFIAKQVGIDDV
ISEVLPYQKSQKIKELQEKDEFVAMVGDGINDSPALAQANVGIAIGNGTDVAIESADIVL
IRNDLRDVAGAIALSKATITNIKENLFWAFFYNVLGIPFAAGIFYAFFNGPKLDPMIAAF
AMSFSSVSVLGNALRLKFFKVK
>SEQF2502_01452 hypothetical protein
MKAELDNLVSMKEANQNFSKVARMVDTNGSVVILKNNTPKYILVDYNLAKEVEKEPVKFA
EDNELEMVSSKILKKYKKTFEELAK
>SEQF2502_01453 Toxin Doc
MILLSEKQILKLHSELVEKFGGIDGVRDKGLIESSINNVYQSYFGVEKYPTIEEKAARLC
YSFIKNHAFLDGNKRIGIYVMMVLLELNGISLNCSNDELTELGLKIADSSIGYSEILEFI
YKFK
>SEQF2502_01454 PTS system fructose-specific EIIABC component
MKISDLLIKDRISLDVKSTTKVDIIKELARLHEKTGVLNDYDGYVEALMAREAQSSTGIG
EGIAIPHAKTKYVKKPALAMGRKPEGIDYDSLDGEPATLFFMIAAPDGANNTHIETLARL
SQLLLDDDFKEALENAKTADEVLEIINKAEAEKFAEEEKKDAVTAQAPTDENAPYIIAAT
ACPTGIAHTYMAAEALKKAADEMGINIKVETNGADGRKNVLTDEDIKKATGVILAINRNI
EVDRFDGKPLIQVEAKEGINNAKALIQQVLDGKAPIFHASGSKTADSSESSSSEKKGLYK
HLLSGVSYMLPLVISGGILIALAFLVDTLSGNGGAGAEYGSKAPLAKMLKDIGGQAFGLF
VPVLAGYIAYSISERAALAAGLVAGAIATAGGSGFIGALLGGFLAGYVVQGLVKALSGMP
RSLSGLKMILLYPVLSVLITGVAMVLVINPFAAIINNGLNAWLNGMSGSSAVLLGAVLGG
MMAIDMGGPVNKAAYVFGSGTLAATMTSGGSLPMAAVMAGGMVPPIAIALASTLFKNKFT
AQEREAGLTNYIMGFSFITEGAIPYAAADPTRVIPASVVGSAIAGALTGLFNIKIPAPHG
GILVMALSNNFFLYLVAVIIGSIVSAIVLGALKPAIKEG
>SEQF2502_01455 Tagatose-6-phosphate kinase
MIYTLTLNPALDYDMYLKDDLRAEHLNLAHKVNYRAGGKGINVSKVLKNLDVESIAIGFV
AGFVGDFIVRDLKKDNIKSEFVELEGNTRINVKVNGNDKETELTGVSPEITEEKLQELTN
KISDLKDGDILVLSGSIPSSISSKIYKQLSENVKANVEIVLDTRGNLLQDNIHNNLFVKP
NIHELREMFNEKLETKAEIVEKCKFFLDRGVKNVILSRGGEGALLVNKDFVLEASVPKGQ
LINSIGAGDSMVAGFTAGFVKGLSPEDSFRLAVASGSATAYSYGLAEKDLVDKLYDEIEI
SKETF
>SEQF2502_01456 Extracellular serine protease
MKSKIKKIFIYALLLSLISCGSSGGNGSTGKTPTPAPKPKPADPKPKPADPKPKGPSASD
VYYNGEIVIRNGGYSSKYPNGTILTTTTSDIVKIPSTAGIPIRKQDYQTSSGIPMNGKIF
LHSTGTTQQVTDFSSDLTASNSYRAAIGGDLMDEYIARVNSVSGGDNLYIWPAGNIRGNK
NPSLEGGLPYFEKTLEKSWINVVALVNKSGTAGLEWKDLEPLSNAGVASKWTITAVSEDG
TSAKAAENVAKAVDQVREKFPGMKMDMIRDIILSTATDIGAAGVDDVFGYGLLDATTALN
GPKRLDYGTSKFYVPNTKTWVFKNNIYGSYTDLEKSGKGTLVLEGKNSFYKIKVDGGTLI
LKGYNTSRYETIIKNGTLDVKRKFTPRNIEIETDGTLITNPNTVIGEITKDYYTNEITVN
VAVNIVNKGTLKNIGKGAIITGNYTAKYGSVTEAEIGSKLIVKGTIKIDGRERNQTLGSS
VKLLSNGYVTATPTTSTVIEAEKGIEGQFAKVETDELINGKVENKGNSIEATISRKNVED
YVNSLKNSDEMQKNTAKNVEVFFKELDKKIAEGNTNVSNFALGAAKLQKNSLSLSSSILD
SLSGQIYASAQALTFQQSQTINKDLSNRLVMLGTLDNASDKFGLWISSIGANGKLKQNGY
AEGKTKVYGGQVGIDKQFGENLILGTALAYSKGNVKFDRHGGKSDADNFGISLYGRVGNK
DNPMYLQGRVGLGFVNSEVKRDIILSENDISRGKIEHNDKVISGYLETGYDVKKGDFVLT
PFAGISHDTVQRGAFHEENSQFGLKADKKTYKQTSGLAGVRVSQKFNFENGSKTTLQGYI
THQRAFNNENLNFKASYSGLPDAKFKVKGIGLSKSQTWVGAGVLNEVSSKFAWYLNYDGK
IDKKAKNNVFTAGMRVNF
>SEQF2502_01457 hypothetical protein
MKKKKVLILILLAFMMVTPVMKADFWSKLRDAFIGGDNYSSSSSSSSDKNIVDGKIYNPK
DNREYRLVEKMKDERENSQSDYRKFENSSSKTFYYECTINSKDFLSIIGFRTFYGYADFP
VYEISSGVEKCYEKKENEYKKEVSKRKIYIDGKLAKHILKNEINVQKIAVYDAKLNDRGY
PLFSSKNPRVLINDKLVSY
>SEQF2502_01458 Alcohol dehydrogenase 1
MKAVVVNKEGTGIEVVEKELRGLKAGEALVDVEYCGVCHTDLHVAHGNFGKVPGRVLGHE
GIGIVREVAEGVTSLKPGDRVSIAWFFEGCGRCEYCINGQETLCRDVINAGYSADGGMAE
QCIVTADYAVKVPEGLDPAQASSITCAGVTTYKAIKVGKPQPGQWVVIYGAGGLGNLGVQ
YAKKVFNTHVIAVDINDDKLALAKEVGADYVINGKKEDPVAKIKELSGIGAHIAVVTAVS
KVAFNQAVDSVRAAGKVVAVGLPSETMDLPIVKTVLDGIEVIGSLVGTREDLREAFQFGA
EGLVVPVVQTRTIEEAPEIFKEMEEGTIQGRMVIDMHSHSCGCGHKH
>SEQF2502_01459 Magnesium transporter MgtE
MENNIIQKLIDEKKYFEIRKYLNDLNIVEVSELLNQFESSELIMIFRLLSKNRAADVFSY
LDSEHQEMIIKTMTDVETKNIFDELYFDDIVDIIEEMPSNVVKKILKNTDAKDRHTINLL
LKYPENSAGSIMTTEYMDLKKNMTASSAISKIRNVVEDMANVYTCYVIDESRKLEGVVSL
KELITSEDDEPIQNLMNKNVISVHTNDDQEKVAEIIKKYNLIVLPVTDNENRLLGIITID
DVMDVVEQEATEDFHRMAGISPVEESYLKTSAFTMARQRISWLIVLMISATFTGRIISKY
EDVLQSVVILSSFIPMLMDTGGNAGAQSSTIVIRALALGEVDIKDTFKILKKEFLISFIV
AIVLAAINFLRIITLTKTPLNVAITVSVTLIFVVIISKIIGAFLPVIAKAFKMDPAIMAG
PLITTILDALTLTIYFRFATMFLSNVIK
>SEQF2502_01460 Magnesium transporter MgtE
MKKIKRIVEDLLKEKKYFEIKKELDKLNAVEISDVINLFKLPELVIMIFRLLKKDKAADV
FSYLDSEHQEMIIHASTDVETREIFDELYFDDIVDIIEEMPSDIVKKILKNTDRKDRHLI
NQLLKYPDNSAGSIMTTEYVDFQKNMTVQEAIGQLKKTGKDKENIYTCYVTDKNGKLEGV
LSLKELISKKDGAVIEDIMNTNFVSVNTNDDQEKVADLFKKYDFIVMPVVDQENRILGII
TVDDVLDVVDQEVTEDFHKMAGITSPTDDSYLKTSIFTMARQRIGWLAVLMISDTISGNI
IQGYEKVLAKSIILTAFIPMLMSSGGNVGSQSSTVVIRSLALGEISPKDAFKVIKKEFSI
GIMVSIVLAILNFIRLVTLEKTNFVIAFVVSLTLVFTVIVSKLVGALLPLGAKIVKADPA
VMATPLITTISDAVTLIIYFNFATMFLKL
>SEQF2502_01461 hypothetical protein
MKVKILILLGMLLFVVSCGTHPAQKEFERQMKVIQSGNLSKFGKASGDVVVILNQFSKMY
GEGMKKITYKINKVEAKGDTATINVTVKSPDITPYIPELQSRISQKLSKAMPKNNEELQN
QISELGKEFFNEKFNSKDLKYTEKTLDVKYVKNGKEWEMSDENEEFFKILTFGLMN
>SEQF2502_01462 hypothetical protein
MIIKNYKYIKLAYTARFLIFLACISTPVLLKLGIFVIGICFVISSSIVFGTNACENIVSK
ELNRRMSKLPVPKNQIFKWNKNSSVGYAFTDLSKGTVWICSTQTKFELHIYFISEFDITE
SLGKIQFRKHPDTLKENELREFMIFKNSL
>SEQF2502_01463 Chaperone protein DnaJ
MKTLIRLVQFILSEIAELCSLISLAIMAIGFYTILPILVFFALLAFIFAGNWSWLLGVLI
YVLIACAVFLIFKAIPEFLNFILGILLNEREENKKIYKKYEQWFESARNQEYERRRKDQE
EYQKQQDREKQYWKEKSQEYSYYRHQQEYSREQYERKNNDYSNFDYQSTNDGEIIQKFEE
YLAVLKIDKNGEINEDVIKKAYRREIKKVHPDRNSDQTANAKTQELNMVKEFLDNQLEYY
LMQRRKG
>SEQF2502_01464 NADH dehydrogenase
MDFSLNLGALDEGKLAKIDENKLYDVTVVGSGPAAVSAAIYAARKGLNVAMIGVKIGGQV
LDTNEIENIIGTISTTGAKFAQTLEKHLKEYEVAFKEGHLVKEIKEDGKDKILVTDDGKS
YKSKTVIIATGAKPRSLNIPGEAEYVGKGVHYCSTCDGPFYKGLDVAVIGGGNSGVEAAL
DLSGIAKSVTLIEFMPELKADKVLQEKLAEQSNIKVILNSATTKVNGNEFVENIIYKNRE
TEEEKTLNVEGMFVEVGLSPRSEVVKDLVETNKIGEIVINPENNSTSAAGIFAAGDVTNI
KQKQIIIAMGEGAKAALGAFDYLITKY
>SEQF2502_01465 Nucleotide-binding protein YvcJ
MDKVKKELVIITGMSGAGKSEAMKFFEDREYFCIDNFPINLFQYLNEIFLSSEKRNQVAI
AIDVRNQEFIEQLTKQLEILDKEEISHTMIYLDARTDVLLSRYELSRRKHPLNMYDTLLA
NIKAERKIIKDFMVKADLVIDTSTLTVKKLQEVLEKEFSGQRKKISVNLTSFGFKYGIPL
DLHLMFDLRFLPNPYYIDNLKRKTGNHKEVQDYVMGLPESQEFYKMLLNMLLYLIPKYEK
EGKSHLRIGIGCSGGQHRSATFVNKLYDDLSQKMDYHIGKFHREVGDKKEI
>SEQF2502_01466 hypothetical protein
MEELNTFEKTLLDKLDFLIKLKQFVSLEKNSLEKVSLAVIFLELMQKNGKSAEIKKINGL
EYVYENLTGYYFLVSSKKSGNCYDYIIKIFHEKLFPNGVIDKIIGDYFSFDSIKERAEYL
LSRWIEIGKLDFYVSLLDFENINLKMEKLKVENKWKLIIYENIKTSYIKDYYLATEEALY
CDIFLEKLKIEPLYDKIQYNEFLKNISPLLKKELLDTAENYEIEILVDKYPITNNKMQFL
DDEMDIYITKNDSNMHPLESYPEIYFRDTVNSWKKCEIVKSRKQKIFILNIELSDEKWEK
LPEFKIMPKIEHKNVFPPVFKKIENNIFDIVYIPREWDDDDLGFSISEELLKKMIGLGYD
VEIISNKDRFFNTHSPYKLKTEKDILWIYDYENNWYILPLLDFDTLERKVVDGEVITYTT
TSVQVYHEKYCPDGKLYFQKSEIKDYGISDAIHLGFGEWVVNEYQKLIESYKSKI
>SEQF2502_01467 S-ribosylhomocysteine lyase
MERIASFTVDHKKLNRGIYVSRIDEINGNYITTFDVRMKLPNREPVINIAELHTMEHLGA
TFLRNHPTWKDEVIYFGPMGCRTGFYVILKGKLESKDIIDLMKELYKFMAEFKGEIPGAT
AIECGNYLDQNLAMANFESKRFLEETLENLTEANLVYPE
>SEQF2502_01468 D-alanine--D-alanine ligase
MSKLRVGVIRGGVSTEREVSLKTGSEIVANLNRDKYEVFDIVIDTEKEVYEKIKDLNLDF
AYIALHGVFGEDGRIQAILQSFGIAYSGPGVMSSAVCMDKEFSKRIVSEYGVRIAKWKSV
RVGETVDFETVKKELGDHLIVKPNNGGSSIGVSFVETEEELKKGLELVFGMDKEALIEEV
LHGVEISVPVIGGKVFPTIRIEALAGDYFDYESKYAKGGAKEYVFEFPEKVQAEINKFAQ
DSYYGLKCEGFARIDFMVVNEETPYFMEVNTSPGMTAASLLPKSTASKGYSYSETLDLLI
ESSLKVER
>SEQF2502_01469 33 kDa chaperonin
MEKSKIIRGTSKCARFFVCDTTEIVREAKKIHDLDPIATTIFGKLLTATAMMGKDLKNEK
DLVSVRINGDGPYGNMLATGNINGEVKGYIANPEEKFHQIVDENGNFIKDETGQIRFIGN
GTMQVIKDLGLRDPFSGVTKINGEDIADIVVHYFLLSEQIKSVVTLGVKLDENGEVKRAG
GYLIQLLPGVEDGFIDKLENKLQQIRTITELLEGGMSLEQIVELLYEDISVFEEETDVDG
AHKKVYVEDFEILEKSDLEYKCNCTRDKFYRGLITLGKDEINKILEEEGKIETECHFCRK
KYEFTKDDFNWD
>SEQF2502_01470 putative lipoprotein YiaD
MEKKSKITAMLSVLLVSAPTTAKKITTSNLRDNTMRSTAIEVDGTNIDDLEISKSENDPN
VVILDTSKLKFGFNSATIKEEYNPILEKLKDYIESKDCKISITGYTDSKGTKEYNRELSL
RRAESVEEKLIELGLPPEKVIETKGKGDSNPIASNDTEEGRTANRRIEIQFIN
>SEQF2502_01471 LPS-assembly protein LptD
MKRMKKYKVLFILLFYIILCGKLNAAGEVIDLETEKSRINLETEEIETEGNVTVKYGDYT
INADKLKKIANKNILSGSGNVEFSQGSQIIKADNLIFDMDTKLAKIFNSESYNADLKLRY
GGEETLSLGNKAIFIKNGWFTTSPYENPSYKINAEELEIYPNRKAVARNIGFFAGGKTWF
KLPYYVTSLKPSTQRATLFPYVGMDSDRGLFGIMGFDYDLGPLAQGFVDFELSTKQKLAL
KISNDYSFWGNNSGNIFVNRVVVPIGNHKKEWDFKWNHKVINVPKKAKEDRKFYDVGYGI
WNLNYQNITTNLMYAVDGAKLKDDYTAFVDKYRHIGFWDMNINQELGQNGEFNAKYYWTQ
DKHALKALTDINDKIMKDDDLDPRRTDVDLFKSIKYTNGNKDVEITVDNEDFRDINPGYV
GDLNSYRKKRNYGINFRGPKIKFDYLNTDKDEYGELLGMRDRGDDKTIHWVQNIAYDKRK
EWGLTFGNYYPFRESDFFGYQPRTGYQNLTNTLYFGVQAKQVEIIKKEYEYDYTRDNENY
NSLFLNPATTDESRIYKVYEDNGKIRRPKKIVYEKYRAQKFNMGNDRIDIPLRNSFIGYN
LAFENRDYSSLPVPEFRNGRKIEDLNSKTGYKVVRDASGDTIKQSPSMKIFTLDTRLFTT
IFDNTSKNNNKYDVKITNDATISFQRTTADSATYGGYDIVEIPTNAIGLRNDFNYHIGNI
TFNYNLSMRDDRHFMDHWLKNRYVRNYFKADIANKRFVSLNFENNDEYEFKDFKSERDFN
REIQYGYVSDDGDNFLYKFSDKNKQLFPYNTSLGWNQKIYKESLKERSFGVNFNEWGFEY
TNTLNKVNDIYGNIATFGYPALKLKTNYHKLGFVYDTSKMKNKKFESDHYFRINLGFGKK
IYRDLKNTPIITSDDRYIRGNDYTTIGFLYKYENNAKPRYAADLDKKEKDRGAEIVKSEN
QIKDINMVKNSNIQEFSINNANKSNIDNIVVNSDDRLFLSSEEEEAYKSYVEEENYRQNK
FSLNDFNAKLQNLRSHKKYFQIGMDMQIDGSDAANPSGMKGFDKINDLTFKVEAGYLEKM
FVRYAFIMERPDRIYRRDSTRNSTFDFRKHEFEGKYMFSRDPDKPWWVGGKIQYVQNGAP
KSSDPEIYESSWYAKKVNKLTLGMATLTHRFENVEWEIGAGMKWDKPNNKKLGYYPVVSL
KFGVTPFPEKNAQFNYSGKGFEFGAGL
>SEQF2502_01472 putative ATP-dependent Clp protease ATP-binding subunit
MINGREVTPEEFAQYRVTGKLPMSNEVQVQSPKGQGVKKDVILALGRNLTQEARDGKLDP
VIGRNKEIQETGEILSRRTKFPSRIFKPF
>SEQF2502_01473 hypothetical protein
MNELRKMLKSEKLSLSQYFEEAYKLFNEMIRNDNKDMIIIIVLSLISILFSKIQSLDFIG
TLVSFATLIRTWIFYRKVIFKIEEKEYEAGNVTVKSFILLGIVILAGFLSALLLLPFMGG
IIGMALYGRAGIGFLVAIIIPILILIAVFIIISLFILYFIPAYMSRRGSIGETFKYNLFL
CRGNRIRMFLPLVILSAIGLLIGVILGFLGTIGTIIGTLISSIVSILQVIIVSIVYLNVE
YNTEIPSEFYFARENYENEANKVEDESKRIETQLLNEKKDEENN
>SEQF2502_01474 putative peptidyl-prolyl cis-trans isomerase
MKKITILVSMLMLLMVSVVNAKGHRNQQKKEDKKFEKAMKDFQMEAVMKTTKGDITFFLY
PEAAPKNVANFVFLAKNDFYNGLKFFRVVPNGLVQGGDPAENGTGTTGYLIPDEIKKWLN
FDVEGILAMSNSGPNTNSSQFFITMQAMKELNGKYTIIGGIKSREDLSILRTLRENDKIL
NIDIKGKKIDKFLDYFPDEVSEWESKLEKTSNQ
>SEQF2502_01475 hypothetical protein
MAIIKFKKREELKILFAIKLPMIISELYKEARNKREANEIIRNSLNMKKNRVINTLELVD
GFGNQFSVLVIYDNIMEEKELLKYNLDVEEINFRILEFDFNNKIEVEETIKYIKRTR
>SEQF2502_01476 Manganese-dependent inorganic pyrophosphatase
MSILVFGHKNPDTDTICSAIAYAELKNKLGKDVKAVRLGEINEETKYALNYFKVEKPELV
KNVAGKEIILVDHNERTQTADGFEEAKVLELIDHHRISNFNVDEPLYARVEPVGCTATII
LKLFKENGLTPSKETAGLMLSAIISDTLLFKSPTCTQCDAKTGKELAEIAGVDLKEYGLE
MLKAGTALGDKSEAELLNMDMKIFEIDGAKIGVAQVNTVNEAEVLERKEKLLAEIDNIIA
KEGLKFFMLAITNILTNDSAALISGDGNDIVEKAFGEKVDSNLVTLKGVVSRKKQIIPPL
TKAIQG
>SEQF2502_01477 Putative ATP-dependent DNA helicase YjcD
MRKNNIILKASAGTGKTYRLSLEFIANLIRGVNYKNIVVMTFTKKATAEIKERIYDFLHQ
IAFNEGNRVELEKNLKEIYKFDNLNKKELQNIYFEMIKNKEDIRISTIDGFTNQIFKNAI
APYFNTYNYEILDKETDEFYSKILIKIIENKEIFKDFEFIIDEKKEKKNIKKYMEIIEEI
LGMQSNFVLAKDFEMMENEEKVSYNFLNNLDDIVDTLKKAHDKKKSKSIYRKKYENFFCE
YIKILENQKLNENEKLKEKIKLVEQNDALLVMVEDKEPYWINAVVGDTKKIDMSDERESA
EKSKDQLKERLSKYIYLTKILPLDKKLKNIAQIIFNIAKKIKISSKRLTYNDILVYTYEF
IFNKDLKFVKDDKVTEDFLELIGGKIDTIMIDEFQDTSVLQWKILKLLMNTSENIICVGD
EKQSIYNWRGGEKELFEKLETMIEGNVQNLDKSYRSYKAIIENVNKIFNGYDAKWNYADS
NYRDDKEYQKGYFGYFIQNTKEEAPRIYMKIIEMIENGQIKNLGKSAIICRTNTHLKEIA
DVLNEAKIPYTLESKTTILEYKPIVPMYQLIKFYAFDNFKYLLEFMRSDLIGGLNSHVKY
LLENKNEIIKYINGNSFEKVNKNSKIISFKEFIDMQEDENTKEELLKYERINILERNGLI
FEKILEKVKELRALSIDLNNKYEKENFSRKLVENFEITKFYSTNSDLKNIFIFFNILKKY
SNLYEFITFIEERKDNFRQVSSKDINAINLMTIHASKGLEFDTVFYYKRKSNKGNNDKEN
LKSYLDFDEKFSDVKKFILLFSGYDKKMIKNDLSKIIDKNAQKEEMEEINNDYVALTRAK
KNLILLFDAEITDKNGYTDTLAKRMIDVYGDENRYKIGEIVESEIPEETTDTSDVKISNS
LFKTYFDDDKFIVKTSLNTLENEFKRKKGLAMHYYFEHILNDLENEKKIAKSALLSRYGN
MLGKKIVEELIVRMDKFIEKNSGIYDEKYKVYTEFEIYDSDGKKRIIDRINIDENNRKIY
IYDYKTGFEPETKKEYQEQIEEYKNILRGKVSEDYEIDVKLLEV
>SEQF2502_01478 hypothetical protein
MEINYKNIGSDLKEILFEEFRKNEDVLFVFENSASFFEIKREFLRDEEIQQELGIFQNFK
MMNSYDFYENLFVTDKIVVKEEKQVVLFYNSLDEKLKKRLEVSSYYDIIDIAYNYYNLFA
ELQEHKINLEKVELEKWQEELFETLKMVDKKVMETCQLKGLILPYMLRNVKNISDNFLKR
YKKIYFVNKVRFSPFEKELVEKFEEKGIIVENILQLLENDFDEKELKISEGFSLPAKEVF
NEKNINIEIHEFGSKFGELLGLVRKLEKVEKENKKSSSKNELLKQNYRIFEAQENAEEMK
SDYQLLRQKKISSNLEITMKDTKIYRILNLIYNLLDNVKEIDRKNKEKLLLFRMKDFYDA
YKSNDLLEIFDLKESYYIFQDLVSKDYKYISKEELERINQEVLEKLEKENQKQKFKETYK
QRMMAVGKIIKFVEELEEICGYTTLKEYSDYLEKIYLDNEEKVKQDKNVKDKYFEALSEM
VVLEDFSFDNLWDKFFDENVSSNLLKLFLKYLDKKSIGLNLEDSIEDESEDAFSINSFAN
ISENTKENIIILNLQDSFPKVKIHNFLFSKVQRAKMGLPTSDDKKLIEIFKIYQNILAAK
NVYLAYVKDLESNVDSASVIEELKLKYGIGVIKGEISEAEELFFAKKYFLKDRTEKWVQK
EIGEFIPSKLEKNFEKIRNEKLSLGYYSFEKMRDFEYGYYLEKAIGEQEVEEIEDEINVK
IFGTIIHAFYENVVMENKVALENKIFKIDRNQLSEILKRVLNSFDYKVPKEYLEFYRKVS
FEEILNSAEKYFREFTEKLKEEEDIEIHFEERIKLSSEKELFENVFVNGVTDLHIKTSDK
DYLFDYKSGKLKDSKKGYKNYKVDKALEQLDYYSLMLENDGEKKIEKIVVDTWEGKLVSD
ERNEDKILTKKTVEEIITRYQTEKYYDLGNFKDQKNYFYKEYKSICRGEDEVGDEEE
>SEQF2502_01479 Glucosamine-6-phosphate deaminase
MFLKILEPCDFSRGRFRNENFFKHINIKKENINILNGCAEDLEEECHNYEEKIKKSGGIQ
LFLGGVGEDGHIAFNEPGSSLSSHTRDKDLTYDTILANSRFFDNDIEKVPKSALTIGVGT
LMDSKEVMILANGYKKARAVYHGVEGGVNHLWTISALQLHRRAVLVIDEMAASDIKVKTY
RYFKEIEAKNLDLEKYKKYLIELAK
>SEQF2502_01480 N-acetylglucosamine-6-phosphate deacetylase
MIIKNAKIFDGEKFIGENAVVLEGKFIRKIVDFSLIDEKELENQEVIDVEGMVLSPGFID
LQINGCGGVLFNDDISRKALEIMNETNKRYGCTSFLPTLITSPDEKIEKAIELVKGMEDN
EEIGVLGLHIEGPYISVEKKGIHRSEYIRVLSDEMIEKIAKAGPEVTRIITIAPEKAKVE
HLKKLRNAGINVAIGHTNATYKECVEKKEYYNCGTHLYNAMRGLDSREPGVVGFLFNNDT
TNCGIIVDGLHIDFASVEIAKKIMKDRLYLVTDAVSPAGTDNMTEFMFEGNRVLYRDGKC
ISPEGTLGGSSLVMIKGVQNLVEEVYISLEEALRMATSYPAEAVAIDEKYGFIKEGYFAD
LTYFDENFNVKGIISKGKLTRY
>SEQF2502_01481 Glucose-6-phosphate isomerase
MKLNFSYQFAKNFFNENELKQIKPYVELANEVLTSKTGAGNDFLGWVDLPETYDKDEFAR
IKKAAEKIKNDSEVLVVIGIGGSYLGAKAAIEFLSHSFYNNLPKDKRKTPEIYFAGTNMS
GVYLQHLIEVVGDRDFSVNVISKSGTTTEPAIAFRVFKKILEEKYGKEEAAKRIYATTDK
AKGALKTLATAEGYETFVVPDNVGGRFSVLTAVGLLPIAAAGIDIDDLMAGAKDAMNDFT
NKNMDENQALQYAAVRNILHRKGKDLELMVNYEPRVHYLAEWWKQLFGESEGKEGKGLYP
TSADFSADLHSLGQYIQQGQRLFFETVVSIGKPEVEFVIESDKENLDGLNFIAGKTLDYV
NKKATDGVILAHVDGNVPNLGINIPEVTPYHLGYTFYFFEKACGVSGYLLGVNPFDQPGV
EAYKKNMFALLGKPGYEEAGKELEKKLKEVK
>SEQF2502_01482 putative M18 family aminopeptidase 1
MTKENLWKSYTDEQKKVIFEFAEDYKKYLDLAKTEREFVDLTEKELIKNGFIDINKKSEL
KKGDKIYFKNRNKNIIAVIIGNDIKNGINMIVSHVDSPRLDLKPNPVMEDEEFALLNTHY
YGGIKKYQWAATPLALHGVVFLKSGEKVSLSIGEHDDEPVFSVPDILPHLSYNVQDERKA
RDVIKGEELKLLFGNMPVNDKNVNKKIKQFVLDKLKKDYGIEEDDFFTAELEVVPAGKLR
DVGLDQSMIGGYGQDDRICAFTSLRALLEIKETKKTVMIYLTDKEEIGSEGSTSLKSTLP
EYIVGKMLLLTEKNYNDQILRETLWNSKALSSDVTAAMNPVFKSAHDVENVARLSYGLAF
AKYTGSRGKSMANDADAEFIQEIRQIFDKNEIKYQSGGFGKVDEGGGGTVAKFLAYYGIR
TIDAGPALLSMHSLFEISSKADLYETYRAYRVFFELN
>SEQF2502_01483 Neopullulanase 2
MGYKLIIYKDNKFYREENLKQKWENFIYKWGNVESGSYFFEIKDEENGTISGVTYSHTAP
FAKKFEAVVGENLPPKSITGFQKGIDIYVEYSPSKKSFSLTKMKFYRMNLNIADFGLEKA
DKVEIAGNFNNWKPDTEPIHHFEGTNYEVTLASPEGVYEYKYLIDGKWYPGNENKKLIIG
ENGALFAQGDLGTGKFVYEAIDKNTNLKAIVHNYDSLQYFNKLSDSEYEFKIRTQMNDVE
RAYISIVLHEEDNYEMIYELERYQDKTNGFDYFERIINFGKEATKLLYYFILEDNGSRAY
FNGKTLSYSKPKRLVVNTTSKDIQLFNVPNWAKEAIWYNIFPDRFYNGNHYNDPIFNEFG
PEAFKPNRLHEQNFVEEYKWEKSNNVISHFDRNRWTADFKEQVIWEKLGEREIDYSLKYA
RMYGGDLQGIKEKISYMKELGINAVWLNPVFFSYQNHKYGANDFRHISPDFGTIKTSGST
HGVEINRNNKYGNKSYVDVLGNKATTSSELKLLEVNLKGESRGKNGYGETEDPATWVWTE
SDLIMVDLIKEFHKNGIRVIFDGVFNHSSSEHWTFNMVLADGENSKYKDWYKFTDFGQHV
PITDDMSDEQAFETLIANRKRTIYNAWGGFDSLPEFNTFNQEYKEYIFNITRKWMCGPDG
KESENWMEDDGIDGWRLDVPNCLENQNFWNEWREVVKGSKKDSYITAELWGNASGDINGG
NKFDTVMNYEWLKTVIGFFINQSREGGVRYKLKAQDFFNELREKRTWYPYQALQASQNLN
GSHDTDRLYSRIVNDVIGRNLEEGKQLEKGYNGIRPDLASNYHPNTTIDWRNSPIKPKDI
LKLISIFQMTYIGAPMLFYGDEVGMWGATDPYCRKPMLWKEFLYDNEKNPSHINQNEVYE
QKVDSDLFEWYKKLIRIRLENKTLVYGKFREIFADNDREIIVYERVIEDHTIIVVINNSF
NNWENVEFETNYQDERFIDLVTEGRTFRTGSNGKLKLDLKAKEGMILRKVGIDGDYE
>SEQF2502_01484 hypothetical protein
MGKREYSAGIVSKGFWFLEFKKFLEFLKDGKNENEIRRMQEEENIFSAPSKDYGKRIFSE
INKRIKVLSGDIKILFFKVDVGTMKIINLLSVMQTDKLFFEYVYNSYRNEMLLGTKEYSP
NSVKKFLDEKSLQNEEVAKFTENTKKRMRGSYGNYLKEAGLLEENKGKILYRKIYLDYEL
ENLLRENKMEMYIKALKGEV
>SEQF2502_01485 hypothetical protein
MTKTEIDLGKIENEIKKDSFLNSKGLGNEVSYYIFDYSPKDELIVREYLENIKKRDKEIG
DGYKIVIYDVYDIMIDLLEESEFLENCIEMEKNDGMDYLIESVNSLLKMNEDDNYFAKYI
EENTPEKSIVFLVGIGKIFPFVRSHKILNNLHQVFDRAPVVMFYPGKYDGQSLQLFEEFK
DDNYYRAFKLLK
>SEQF2502_01486 hypothetical protein
MKLKDMFRKPIDRDIKGVIKVGQKEEENMKQELEEYVVTNELQKHFRDFFSAYSKGINGN
TDDMGVWISGFFGSGKSHLLKILSYLLSNKEINGKKAIDYFLEDNKIKDEMVIADMKIAC
QTSTDSILFNIDSKSDSTGNKGKDDILKVFLKVFNEMQGFSSIPHLADLERELRENNKYE
EFKGKFQEITGKVWTEERHKFNFIRTKVAQTIEEIGFMSESGIKDWLEISKKDYSISIED
FAKMVNKYIKSKGNNHHVVFCVDEVGQYIGENTDLMLNLQTVTEDLGVQCKGKAWVVVTS
QQAIDSITKVKGNDFSKIQGRFKTRINLTSTDVSEVIKKRILDKNEHANRELSLKYNEKE
SVVRNLIIFDDGIEKKIYENKKDFQEVYPFIPYQFQILSHVLTSVREHSSSGKHLSEGER
SMLAMFKESAEKYKDSKVGILIPFDKFYDGLQSFLDHSHSIVITRAMENSYINPDKEENC
FNVNVLKVLFMIKYVKEIKGTLENITTLMVENIDEDRISLKEKVKEALDILIKQTLVQKS
GDVYIFLTNEEQEVEKIIDKIDVDTSEIAKRISEKVFEVFYKEKKYQYPKLGNYIFPFNK
IVDDFQKENITHDISVNIVTSNSDYSGNQSLLLMKSSQENSVFIDLGENNSYINEIEMDI
KIEKFLKSGELEGLPKGNSIKENKTIERREYIERSNRLLKEVLKNAEYYVGGNKLNLNAK
EYESKINEALEKLVNNVYHKLEYITKPMSEDDIREIFVEKGNTLTAVESIKYNENAISEI
VNHVRMIKEKNLKITLKEIKDKFSKAPYGWNEKDIEWIIARAFKNGKIELIKNRISLTLL
NETTENIINSIIKKDNSERIYLGIKEKIDDRSVKIMNYVAKELFDVTLDISDTDKMIQEF
KELSAEKINKIESFEKECQNKDYPGKEILSNGKKLFRKVLGLKDAREIFNEISGHEDDYY
DFSEDFEPIEKFFEGDQKDIWDEATKLYKKYTNSKNYFSDDELEKISKNIKNILNDNNPY
NRIKDLNELNRRFNEKYNKILDEKRKPITDSINETKEIALKRVEYAENIELKEQYIKKIN
NQFSEILEKVEKSENIKDIESYKNEAISLKNKLLNNFEKEEKILEEKEKANEISENIEEI
KAKKPKRIGISEINKDRVWEIRNSEDIKEYLDKLKKRLEEELEDSEIVQVEF
>SEQF2502_01487 hypothetical protein
MDKVALRNFAVNAKEKLEKEVRRKLELIGITENKIEEGIVSENDYLKIGNVELNKREIKQ
REILVKTLKEKVKEGNFQDALNELIEEIAYTWFNRIIAIRFMEVNDYLNDRIRILSSERE
NDREPQIIREVFNTDLEFSDDEKNYVYNLKEESKTEELFRFLFIKKCNKLNEILPELFEE
AEDYSELLLPISINDEEGILRKLVDGVPKESFDIKKEGQIEVIGWLYQYYNEEKKKEVDK
KTKKGKKVEQDDIPAKTQLFTPKWIVKYMVENSLGNLWMEGHPNENLEEKWKFLVKGEKQ
EEEIESKLEKLNENYKEMKVEEIKIIDPCMGSGHILVYAFDVLMDIYSNLGYSNRDAVQS
ILENNIYGLDIDKRAYQLAYFALMMKAREYYKRIFSKKLELNICYTRESNDINKEVIDFI
SNGNNKIKDELDLIYNSFLDAKEYGSLIEVPKIDYNKIKNRLLEIENTDFYNLFDELKKE
EIKNKFYYVIKTSEILSKKYEVVATNPPYMGSSMMDSKLSKYTKKNYPDSKSDMFAVFIE
KCNSLTAENGFCSMITMHAWMFLSSYEKLREKMTLIEILNMVHLGTRAFDEIGGEVVQTT
VWIQRKNKISNFKGSYIRLVDFPGEKNKRNKFLETVENKDKKYYFRKVKENFEKIPGMPI
GYWASENLLEDFEKGIKTSELIEPKQGLASSDNNLFLRQWYEVEEEKISYNTKSIEETEG
NGYKWYTYNKGGGRRQWYGNYDYVVNWENNGKEIKEYASKLYKNYSRTIKNISYYFKEAI
TWPLITSGGYSIRYRELGSIHDVSGMSAFSENKLRLKYILGIMGTKISNFIFNMLNPTVN
LQVGDFNNFPVIENEQIKPKVISIVDDCIKISKYDWNTFETAWDFKVSPLVNIERYVEEF
ENVKIGENGNVENKKIDKTQITLIEEAYSQYKEFTNNQFLKLKENEEELNRIFIDIYGLQ
DELTSDVSDKDITIAKIFDTDDEINDEIKGNNYVLTKADVVKQFISYAVGCMFGRYSLDE
EGLAFAGGEFEKNKYSKFIPDEDNCIPITDSKYFSDDIVTRFVEFVKTVYGEEILEENLK
FIAQALSDKNNAPKEIIREYFLKDFYKDHVKRYKKRPIYWLYDAGKKNGFKALIYMHRYN
EQTTAKVRIGYLHELQKHYERRASFLKDEIESNNNRKKAEQELKKIKLQLEECKQFDEKM
NHLSSEYISIDLDDGVKVNYEKVQTGRDGKKYEILGKVK
>SEQF2502_01488 hypothetical protein
MIINLIMALILMASAFLTGGLGLGIIFIMEYFRKKTKENTGKENELLFIILGLIIYMVYQ
FWFYIMLESEGIISFYWSTLGSWIYFEFSKIGMLENMKKTGVDTKFFDKNRFLLYSVLAI
VCIINIVVYKCIK
>SEQF2502_01489 Oligopeptide transport ATP-binding protein OppF
MNSENNILLKVSNITKSYTEKKFLKKSVKNVLNDVSFSLKKGKCLGIIGESGSGKSTLGR
ILTGIENADGGIVEFKGKNIHAKENKYLKREISIVFQNYVSSVNPKFSVAEIIAEPLTIE
SQLKKDEIQEELKKLIESVGLSEEFLQRFPNELSGGQLQRVCIARAIATKPKFIMLDEAV
SSLDVSTQVEILDLLQKLKKEYNLSYIFVTHDLLTITYICDSIIFFRNGKIEEEISDIKN
LKNIKKDYSRKLLNAVIEF
>SEQF2502_01490 HTH-type transcriptional regulator CysL
MDVHHLKIFFEACKEKSFTKAAKNLFISQSAVSIQIKKLETKLGIQLIERNSKNFRLTFA
GKELYRMSKDVFDKILRVEKEMEKISHYGKGKICIGATHNIGEPVLPRIMVEFKKNNPEI
EFDLYIKNRESLVRHLKEGTVDIALMEEYFIEDKEIKVIETEEYPFVVVAGREISDYREL
KRMQLLKRDTLLTSKYLDLFEKIIGFNLENRIVINGSIETMKNFIKSGLGFAVLPYYSVY
EEIEKGALKVIHNFEKSEDKFQIAYIRENGEKPGISKFVKFVKSYKITPALFSVKNK
>SEQF2502_01491 Phosphoheptose isomerase
MLKEDIRNSYLTAFETVKAFVENEENIEKTEKVAQELALVYKNGKKSLIAGNGGSNCDAM
HFAEEFTGRFRKDRRALPSISISDSSHITCVGNDFGFDFVFAKGVEAFGQEGDFFFGIST
SGNSKNVIEAVKMAKEKKLKTVALLGKDGGKLKGVCDYEFIIPGETSDRIQEVHMMILHI
IIEGVERTLFPENY
>SEQF2502_01492 hypothetical protein
MKLLKKSMLVLSAMTLIGGMSFAAATKTEKKAVAKKTVTKVVKKPAAKTTKKPATKAAKK
SAVKVAKKPAAKAAKKSAAK
>SEQF2502_01493 hypothetical protein
MKLLKKSMLVLSVMTLIGGMSFAAATKTRKKAVAKKTVAKKVASESYTCGSEKIRVVYPT
TKTARVTTKAGKVYNLNVAVSASGARYVSKNGNIEFFKGGKDAIYRGPNGIEKSCTKR
>SEQF2502_01494 Major cardiolipin synthase ClsA
MHELAIIISTWVIPFERIHYLIIIILAVAVLLSDKSPNAMLAWIFTIFTFPLGGAILYLL
FGINWRRNKIISKKMKGEERKLFSRLFNFMQRDVSDIFRSQDFFYYNRLKNINENVDKMS
ESEIKEKIQGQIDTMITNIGLPAQQKEIVKMLYNSEGTFLTNNDSYKLFYDGKGAFDSIL
KDIENAKKTIYMEYFIWRADELGERIKNALIKKAKEGVKIKLLFDGVGTWKLPRKYKKEL
RSAGIEIRWFLDVKFFISKMNYRNHRKIALIDNKIVHTGGMNVGQEYIDGGKRFESWRDT
NIRITGEIIGQYLAIFVTDWLNSGGKYSFGEDVKGEAVHELEEQKPIDKQKKLEYLMQVS
SSGPDTEWTTLKYLYSKMIATAKTEVLIQSPYFVPDTDLISQLKMAALSGVKIKIMITGV
PDKKMPYWIAETYFAELIEAGIEIFRYKAGFLHSKNVIVDEKTSTMGTCNFDMRSFEINY
EVNSVFYSEEISKDLKAQFGKDLEVCEKFDEARLKKVTFRKQLRNSIFKLISPIM
>SEQF2502_01495 tRNA pseudouridine synthase B
MEKNFTKDGLILLNKSKGVSSFAAINELKRKIRAKKVGHAGTLDPMAEGLMIVMINDATK
FSDDLMKKEKEYYVEMELGYKTDTYDLEGTVVERYESEISVSNAQIIKVINSFRGKIKQI
PPMYSAIKIDGKKLYDLARKGVEVERTERNVEISEIRKIKIIRPDKNSKDARNIKISFYV
KVSSGTYIRSLVYDIGEKLGVFATMTRLVRTKIGRFEIEDAIDLEKAEAEIDKLKELVEA
KRESESFWATKSDAAIRAEKIREIVCFVEIEYVLDYFGINVSNEKYGKLKNGMTVIDTFK
KFENISKEVNMRKNIKENQKFKIYVRNKNTNEREFRGIVKIVNIKGDRIYLKRDKYFL
>SEQF2502_01496 hypothetical protein
MKKSNKYVFDIEVFPNYFCIVLKKLNDEKILIIDSDNFNRQKKLLYRVISKNVLISYGGH
SFDDIVINDLLKYRNSNVNRNKLNSEIKIIRNMPKNEYKNENHEFNSYDLAYEYSLNLGV
KGFEFNCGDNIEEQDFANFNYVIKKNIYDKIVDKVIDYCIQDVLATEKMYNFIISEESNW
DEKENLLNILTNGNYSNNMKLKRKIKYLNYNNDKLVTMLLDQNSDNSSQSKINYSKRMKM
DDYDNYLQKKVYELTIKKDHLYEWLLENKIFYEKDKNIIKKIPKDLLLKSSFVKDVLNRY
RISIVKRIKRVFAREGIEMVGASENDIFITNVTDELLSKIKNKINHQYQDIFLIRDIDKF
LKNKSSILYKVNDKVKGINEYHYSKLIMPKNHKWISEILKLYFWEKQEIETAVRKVFSEN
PDIFFMYASVYEDIYACDENGKMEFESNKVLDKFRKYRLYFSKTGLYKVVIRKDEKYYEK
YGFGDINDNLYKVRNVETSVNEFENYEDIDLKSYIDYTQNYIEKYFE
>SEQF2502_01497 Crossover junction endodeoxyribonuclease RuvC
MRILGIDPGTAIVGYAVVDYENGDYTPLDYGCIFTDKDEDMPIRLEKIYDGLENIIKLWK
PTDMAIEDLFFFKNQKTVIKVGQARGVITLAGQKNKLNLYSYTPLQVKMGIASYGRADKK
QIQEMVKLILKLDEIPKPDDAADALAIAITHINSKIGFGGFNRGDNITKKLDKITSNRIK
LEDYKRLMK
>SEQF2502_01498 tRNA (cytidine(34)-2'-O)-methyltransferase
MNIVLLNPEIHVNTGNIGRTCVLTNTKLHLIKPLGFELDDKKIRRAGLDYWKDVQLFVWE
NLEHFWKENIETSNAKIYFATTKTKQRYTDVKFDDNDYIMFGPESRGIPEEILNKYKKNN
ITIPMLPLGRSLNLSNAVAIVLFEALRQNDFQY
>SEQF2502_01499 Thymidylate synthase
MKQYLDMVKYVLDNGVKKENRTGVDTISTFAYSYKVDLSKGYPLLTTKKMYFNSMLHELF
WYLSGEEHIKNLRKKTKIWDAWADEEGRLETAYGRFWRRYPVPEIALGGEVFADENNPWT
TREENGQLVFDQIQYVIDTLKEMKTNPNHKNGRRMIVIAWNPGNATISKLPPCHYTFAFN
VLGNKLNCHLTQRSGDIALGIPFNLACYSLLTMMIAKECGYEVGEFAHTIIDAHIYENHI
EGLKEQLTRKPLKLAKIKIADKPFNELTFEDITLEDYESYPVIKFEVAV
>SEQF2502_01500 Dihydrofolate reductase
MFSLIVAIGKNNEIGKNNQLLWHIPEDLKNFKKITTGKTVIMGRNTYKSIGRALPNRTNI
VLSRNFLETDEKVKEDKKKYENETTKLEFFNDFQKVIEKYKDLPEEIFIIGGGEIYKKSL
ELGIVKRIYMSRVDFSDDEADAYFPEIDWGKWVTLTEENYDGWKFCIYEKIK
>SEQF2502_01501 hypothetical protein
MPRLKFTKEIVVEAGYELMKKEGFQNVSVRKIANYLKCSTAPIYFNFRTVDELKEEIINM
CKEKLKKYLYGDYSERKILSGAIGFVIFAREEKELFRTIFLDTTERFEKLYEMTLNELLT
KENLHESFPALEKEEAKKVINKLWYFLFGYATMLCTRLDEDYRKNETDEVIENKISEIAK
YFQMKI
>SEQF2502_01502 hypothetical protein
MKRYKFLGAFLHFIYRMLSFMTRREYFFADGVEMNNPNIVVFWHRKIFTVCSATRIIKKK
ASIVSASKDGEILAELLRREGNELIRGSSNKDNIKSLKEAMKYAKKKYTLGIAIDGPAGP
IFEPKSGAIFIAKKTGMPIVPVSSYCSKKWIFKNMWDKLEIPMPFSRCVHYVAEPFYLTR
ESSMEESIELVKERIHEAGYKAFEIYNKKYNKNKKIEFNEESFGKE
>SEQF2502_01503 Methionine--tRNA ligase
MSKSFYITTPIYYPNAAPHVGTAYTTIICDMVARYKRLAGYDVKFLTGVDEHGQKIQEAA
EKNGYTPQQWVDKMSLNFTTLWEKLNISNTDFMRTTQERHINSVREIVKRVNDNGDIYKG
EYWGKYCVSEETFVPENQLVDGKYMGKEVIDVKEISYFFRLSKYEDALLKYIEENPEFIK
PEGKKNEVVAFIKQGLQDLSISRTTFDWGIPLELEEGHVIYVWFDALTNYLTGAGFAKDP
EEFANIWTNGTVNHVVGKDILRFHAIIWPAMLMSAGIKLPDTVAAHGWWTVEGEKMSKSL
GNVVNPEEEVEKYGLDAFRYYLMREATFGQDADYSKKAMVQRINADLANDLGNLLNRTIG
MQKKYFNSKVMLNEVEENFDVEIKELWENVLIDLDKHINNYQFSEALKDIWKFISRMNKY
IDECEPWKLSKDENQKDRLSTVMYNLVDSLYKIAVIISPFMPETAQKMISQLGLDKDVTK
LHLDDVREWKSYPVGNKLGEAIPLFPRIEFEEDPKKEYNEDLKIENPITIDDFNRIEIKV
VQIEKVEKIENADKLLKFIVNTGKEKRQIISGIAKWYPNMQELIGKKVQAVLNLKPVELK
GELSQGMLLTTTEKKKTKLVIINDEIKVGTTVK
>SEQF2502_01504 hypothetical protein
MKRCIYILFVLLFLASCSKTDAGYDALEKGLIGILEKKDYEYIMKNINEAAKEGNEDVYG
LAYTYLAENGSMFFNKYMKKSKGIAEYYQALLLQQTNGDELQILDLLESSAKQGNIKAYY
MIGNIYENKLQFTKAQEYLKKGRDAGEIYSLYSYEYNKKLMKFYKRIEELNQKLNDGTIT
IEEKKELGTLVLEKVSNPEKAYDILKDFLSENYSPALYAKAKLLENDDKEEEAVQIYNQI
FTQNKYYLAAFELASRLVKDQKNYNLALKILDDTNSDEVLILGYKGFIYENLKDFSKAEE
FYQKAADKDDIDAMNYLGRLYETQKEMKKAKNIYNKAYMLGSISAGYKLAYILEDEEKEK
NPVDNNDNEPAKRNKEAKKILERLANSGDDYSMVDLSLYYPENDRMVRILNLEAAAKLNT
TAFYNLGVYYYNKKNKDKAKFYFKVAKENGYDIGDVFSAYIAE
>SEQF2502_01505 Sporulation thiol-disulfide oxidoreductase A
MKKIILMISMLLLFVVSCGTKEFSVDVDGKGKVPDFELKDLNGKSANLGKIMKNGKKTLF
IIAAEWCPHCKEELPEVQKFYDANKDKVNVIVVFTNNNTNLGKTQTYVKDNEYTFPAYYD
EDGTVTRGFAVDGFPFNLKINNGKVDEKLELPVDFDSLTASFGK
>SEQF2502_01506 Adenine phosphoribosyltransferase
MTIEEKEELKKLVRSVEDFPEKGVIFRDITTALKNKKGLKIIIKDFTDRYKDKGIDYVVG
ADARGFIFGAAIAYNIGAGFVPARKPGKLPAEVESVEYSLEYGKNSIEIHKDAFEKNSKI
LIVDDLLATGGTAKAMVELVEKLGAKVYELAFMIELADLKARDLLKDYKVYTQLKY
>SEQF2502_01507 Phosphatase NudJ
MEETRPRIRVAGILIEDDKILLIQHHKNNKKYWLIPGGGNDWGETAKEALIREYKEETNM
NIEVDEFLFFSETIYPNKERHILNLFFRIHRNEKNNSIIKLGDEAVLTDLKFVTKEELKT
MIVYPNIKENLLKLMNGEKIENYLGSLWNE
>SEQF2502_01508 Magnesium and cobalt efflux protein CorC
MEEKRILLNVILLLVLLFFTSFLSAAESALSSLKQIHLKSDSKEKEVTRESELLKLWLEN
PNELLTTLLFIKTISYSSMVFTGVYLIKKIYEKGFYVGISFFVLIIFILLFSELVPRLVA
RNNIYGVSKTLIIPLNTVRIILRPLIQLFIHISRFVVGIFKIKVKDQMFEITEDEILTFL
KAGTESGVFEEGEEEMISSIFEFSETTVKEILTPRIDVFALEAESRIEDVWNEILDQGFT
RIPIYTETIDNIVGTVHMKDLLHYDRQTGENPPIKDFMKEAYFVPITKPLVELLEEFKLK
QLHMAIVIDEYGGTQGIVTIEDLLEEIVGEIRDEFDQEEENIQQIREKIFDIRGDTPIEE
INDKLEIEIPLSEEYDTISGYIQDKLGKVAEVFDQVKENNFILKVTDVDNKRVERVRAII
IEQKKNDEEARRENGRD
>SEQF2502_01509 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MKDKIKFIEKLAESMNENKIESVKYEDNDFEISLTKKKKERNVIFGSPIAQPAISSNISQ
EVQVQEEEVTAPVQQETPEEISGTKITSPMVGTFYASPSPTAGPFVKEGDSVTEGQTLCI
VEAMKLMNEVKSTVSGKVKKIFVKDNESIKKGQTLMIIE
>SEQF2502_01510 Bifunctional protein FolD protein
MTIIDGKALSEKTLEKIQEVHGELQEKVGRKAGLAVIIVGENPASKIYVRNKIRACEKVG
FHSETIRLDENILVENLLLEIKKLNNDDSIDGILVQLPLPKHIDELEVINAISAEKDVDG
FHTTNIGKMMIGDETGFLPCTPFGVIQMFEEYGIELTGKDVVVIGQSNIVGKPMSLLLMQ
KHATVQTCNSKTKNLSKKLQKADIIIAAAGSPKLVKGSDVKDGVVVIDIGINRVDGKLCG
DVDFNEVSKKASFITPVPGGVGPMTIAMLIKNTFESYKQRIKKSK
>SEQF2502_01511 Redox-sensing transcriptional repressor Rex
MKLKKLEISERVVQRLTEYLSILKEARKQDNEINSIELAKIMNTTSAQVRKDLSTFGEFG
VRGKGYDVDKLIEIITEILGIDKINNIIIVGHGKMGEMLSSNLDVLGEGFKIVGIFDKDS
NKIGKIAANDLIVQDIRNVGEFIKNMKNDSNTKIDMAILAVVKEQAQIAAEGLVKNGISA
ILNMTTYKLELGENVKVVDMDISAKLQELNFWRINNISEKI
>SEQF2502_01512 Methionyl-tRNA formyltransferase
MKTIFMGTPEFAIPSLEVVFKNTDLQLIFTKEDKRNARGNKIIFSPVKQFGIDNNVEIIQ
PRKMKDEEVINKIKEINPDLIVVVAYGKILPKEIIDIPKYGIINVHSSLLPKYRGASPIH
SAILNGDAETGVSIMYIEEGLDSGDVILREYCEITEDDTLGTLHDKLKELGADGLTKALK
LIENGEVQAEKQDDSKATLVKPITKEQAKIDWNNTKEVIYNQIRGLNPFPAAYTFNEKGE
NIKIYKSEKIDKKYEDENGNEIENGTVVEIINKKGPVVKVANGGLLILQAKFEGKKLQRG
ADIINGRKMTAGEKLL
>SEQF2502_01513 Peptide deformylase
MKIVLYGHPTLREKAEKVDEVDDNVRETLDEMVALMRKANGVGLAANQVDIAKRFFVLEH
DGILKKVVNPEILEFSEEIADMEEGCLSIPGVYKRVNRPAKIKVKYLNENGEEVVEELEE
MWARAFQHEFDHIEGILFTDRLSILNKRLVAKKLDVLKKDFAKGRVYRDLD
>SEQF2502_01514 hypothetical protein
MKQYLADFGLLFVGIFWGLGFVFVKIGLNTGIDPFYLSAIRFLVGGLILYGIFFRKIGNF
TKHDIFAGLIVGIFQFFGYAFQTYGAMLTTASKNAFFTSINVIIVPYIFWLLHKKRPDVF
AFLASVICVMGVAVISFDRKMNLANLNFGDILTIISAVFFAGQIATNGYFSKKVEPLKLV
IMQMLVAGILFVANFFIFSDVSKVEKPAGMMLVSIIYLTIFSTAIPTVLQTFCQKYTTST
RASILMSTESLFAPLFAFFILSERLSLRVAVGAGLVLFAVLVSETKLGFKKIEE
>SEQF2502_01515 ATP-dependent DNA helicase RecG
MKTYNLLYENLENVKIKGVTKTNIPKFKKLGVSTLYDLLYFFPRAYENRNNYKKIGEILA
DEFVILQGTVVNVANQYIKSGRTMFRAVLSDDSGMIELVWFNNRFVKNGIHIGDEITVYG
KVRKTMKFQLVNPEYKKIKQASFDIQEQKQILPIYPSTESLRQQAIRKVMENALMDYGYL
LQENLPKEFLQKEKLLGRKEAVLNIHFPENEEKQSKARKRFMLEEILLLEMGILQNRFSV
DKANKNIYKLEDNKSLVSKFIKSLDYKLTRAQKRVIKEIYSELKAGKIVNRLIQGDVGSG
KTIVSFIMLLYMVENNYQGVIMAPTEILAMQHYLGIIDEFMNLDVRVELLTGSVKGKKKE
KLLNEIKEGLVDIVIGTHSLIEDNVIFKNLGLIVIDEQHRFGVTQRKLLRDKGNLANLIV
MSATPIPRSLALTIYGDLDVSIIDELPAGRSPIKTKWIQNEIDRQKMYNFMEKKMKDGRQ
VYIVSPLIEESETLNVKSAQETYEEYISIFPNRKIGLMHGRQSYKEKQKVMEQFKNHELD
ILVSTTVIEVGVNVPNASIMVIRDAQRFGLSSLHQLRGRVGRGKYQSYCFLESETTNEIS
VKRLKAMEETTDGFKIAEEDLKLRNSGEILGTRQSGVSDMLFTDIVKNVKEIKLVHDFVV
EYLEKNDGKIENEFLKMDIYKKFFNNSED
>SEQF2502_01516 hypothetical protein
MSLIKERKVENIELFYDLIFVYAISKISGIIHHPHHGVIEPWTFFNFVLASLVVLQEWLY
MTNYLNRFGTFNFREIMTMCVNMTAAIYLSNSFLADWSQAYYPFTISMLIMALSVAFLYH
CQAMKKGFGEKEAVNARNILLVVSSLLIISLFVNFYIGSILLIITTFSGAFLPVIYKIEF
DNNVAKFGHLKERFELLTILFFGEMIVGITKYFDIKHFTIYPFIALIAIFSLFGTYTILI
NKMINHHLVTRGLVLMYSHFFLLISLGIITSAWNLIGQEPNKTFLAFFYILGYTGFYLML
FANSIYLDKEKRLNKKDFSKILGILTISFAAIFIFRQNLIIMEFSILFLTCSILLIIARK
YRKTQS
>SEQF2502_01517 ABC transporter glutamine-binding protein GlnH
MKKNFERFVKIIAILVLGVFAISCGKGGKGSAEPGSIEAIKKAGKIRIGVFGDKPPFGFV
DENGKNQGYDIYLAKRLAKDLLGDENKIEFITLEAANRVEYLLSNKVDIILANFTVTDER
KQKVDFAKPYMKVSLGIVSPEGAPIKDVKELKGKKLIVNKGTTAEIYFTKNYPDIELLKY
DQNTETFNALLDKRGAALAHDNTLVFAWATENPGFVVDIKQLGEQDYIAPAVRKGNKELL
DWLNTEIDALTKEGFFEKAYKATLEPVYGNKVDPKTVIIENK
>SEQF2502_01518 Glutamine transport ATP-binding protein GlnQ
MVFQSYELFDHMTVMQNLLLGPLKVQKRDKKEVAEQAEKLLERVGLLDKKNSYPRELSGG
QKQRIAIIRSLCMNPEIMLFDEVTAALDPEMVREVLDVMLELAKEGMTMIIVTHEMEFAK
AVADRIVFMDSGEIVETNYPLEFFRNPKTERAKKFLNIFNFEKKDKMESALLI
>SEQF2502_01519 hypothetical protein
MIKIKKLTGFMILLLFGMIFISCGKPSKKDIIDKGYILEVGVSNEIDREFAEKMEHSPTY
TVFEATEYKDNDIMVQNLKNGTVKAILSPMLSLGNSDYGYYPVYVDNKNYETVYLIYRKD
IPDFLKNSFEKEDKFMLNNMEKYSKEKYKDRFSFFSNIEDFEKKIMANEWTLVNIAGFEL
KNSKISIKLDKGNIVITGKNGKKYSGKYSLKNHRISFEIDNLNNLLKKESELSDSDKDFL
YDLSNADVITFMDNEQTLYIGVPESNLIFKKINKK
>SEQF2502_01520 hypothetical protein
MRNFEKIKNRNFADILLGAIKIVGIMIFTWSALIFQRGIFGSYYFNSVVKTGDLKAGEIV
TLVQTLFRLVVLIILSVIFIKMMKTRFGKENLNKIKFWTFVIIMITIVLFALGVTFSMIN
SIVKSIGSISLSDKITIFFKMGVLEGIKGMQLIGFLLTMCLFSIKVYENDKKKSLFAIIF
AGVSSIILMIIFYFVGLFLDVYLFQTSQGWKMKTLSGFIREIMQNANLQEVVFNYYFYLT
SSVIVIFTIILILNVFSDNKKKLYGEE
>SEQF2502_01521 hypothetical protein
MLYEDKGQKYSLFANPRTGKIIKIDIKDEKYFPAEDLKIGDYLTKEKMEKYEIYYNEADE
DMWLSGVIKELAIATELIGKYPNQKEKILWYVWFDYKEYSF
>SEQF2502_01522 hypothetical protein
MKLNLKELFAIAIIGAGIFVSQQSHAFMGYDYYMDPTNLPSDTLRENLLQQTFDNHNKVF
NNSNKTNGNMSLLPSIIFLAAWFYIYGKKKVK
>SEQF2502_01523 hypothetical protein
MEMNNRNGYFKKEITLSKEEEIKIVKIGFSWVTFFFGFLVPFYRKDWNTGWVLLTIMVIS
HMMLPLLMFLILVVFSFLYNRIYINTLLKSGWKFATKDDEILWENKKEMAEKVDNMVLTL
KEMEAKIDKKIEEYGFVKKFVWGGIYALSIGILIKNTPLLAVGIGFFVISFIKREKM
>SEQF2502_01524 hypothetical protein
MKKIIIILTFIFFNLSFSAEQIEKIMCYIPKELKINSKARLIYEDTEKYKDEEVPADVAN
PEIVKTLKEKRLVVFQMRCKYDGDMYRYITASDYAVEYLTKQTINREEGDYYLLELPTNK
ALAFQDMLFIGDFIDNSISTNDELFQILYMINVQFLEIRQQELEEEGLKVVY
>SEQF2502_01525 hypothetical protein
MEKNIEKSKIKELGLLILNTACYSAIVITSVIILLAILSSLLSKKIVLSDYSKQSFAINE
LLKFLVFYPVGEEFLLRGLMLHFLKKKTKYANLIQAIIFGILHLNPIKFIYTTISGIFFG
NVRLKPNPIWWIILLHSAFNLVSIFLYKPFIIIIEKIFYLQNMPIITLIIVFIPPLFIFD
YTLKQLKNKFNYEKLYKA
>SEQF2502_01526 hypothetical protein
MKKKFLKKLLILFFITMTGVFANENSVKKTKTIRVLNVDVKISIEQAKQLALNHSKVAKN
SAKMTKIRLDKENRKFIYEIEFYTERKKYKYNIDANTGKVLSYSEKERSSASTVIRDDGK
IINTNGSDTEIRKTPKYIGMEKAKEIAVSRITGAKRINITNIQLDNEKGRMIYEGRMVYK
NTEYKFDIDATTGEVIKWEVNEN
>SEQF2502_01527 Alkaline phosphatase synthesis sensor protein PhoR
MKINKFSIKSKIAFWYIGLMISLAIIFLTTIIYISENLIRANAYKNLKNSVASAFDEIEV
YDGELTIDNDFIIFNNNVHLSVYNDETGFIYGDIPLDFEYDETFSDKNNVRIIRHKNKKW
YIFDSKKNFQDYGIVHIRGITPATEVENIIETIVLISLIVLPFFLLFSAISGYFITKKAF
KPIEKIREAAEKINEGNDLTQRINIGEGNDEIYTLANTFDTMFDRLQSSFEREAQFTSDV
SHELRTPVSIIISECEYGLENLTSIENAKHTIFSVLEETKKMSKLISQLLTLSRMDRGNQ
KLNLDKINMSEMAHLIADSQLYNADSKNIKIHPEIEEDIFIIGDEMMIMRIFVNLISNAI
NYGRENGNIWIKLTQDKNFAICKIIDDGIGIEKENIPKIWGRFYQVESSRTTENLGLGLS
MVKWIIEAHKGDIYVESEIGKGSSFIFKLKKEVK
>SEQF2502_01528 Transcriptional activator protein CzcR
MRLLVVEDEKKLNDLITKKLEKEYYGVDSCFDGEEAVRYVEGTEYDAIILDIMLPKLDGF
EVIKRIRAKKNKVPILLLTARDNIDDKVKGLDYGADDYLVKPFIFEELMARIRVLLRRNS
GNADNIITIANLKVDLDAKTVFRDDVLIKLSGREYSILEYLIRNKGKILPRERIEDHIWN
YEYEGGTNVIDVYIRYLRKKIDDGYTPKLIHTVRGLGYVLRVDNENK
>SEQF2502_01529 hypothetical protein
MEIRKFLIKSGNYRNLIKRIFLLSLFLTVFMRYNKNELFTESDEKYEKIVKTEQLKLFCE
ENQCVLTETEESE
>SEQF2502_01530 hypothetical protein
MKQINRKRAILENGVLRKEVKFGFSRAAFLLGFIYPLIKEDYITAGITFVVISTAGIIFF
PLIFVLSIIFGFIYNKMYAKSLIKQGWYPFTKEDAQVLRMNGILFNDKNNFYENNKEREI
KEVKTYETQQSEKNEITEFEENDSNNTNNNSIINNVNADNSYNSNPNVPKTNYKNRTIQK
FIARLIGGGLVSLVSGVFTANIILILLGVVLTGGGAFLAVKNKDKIKWK
>SEQF2502_01534 hypothetical protein
MKKLVLFFMALLVFNVSFAKEKLDTTFTFQGYSPTSKSGISASPRTKIMKNSKISYPLFI
GGSNPDVIKNMNAIMTSFISNYKSTKHVSYDTSYEITANNSLFLSVLFTIKLTDNDTGQK
TILHNAISYNLKNGKQLQLKDLFVNGFNDSLADAVNSKFKQFGLPQIDKFDAIDRQQNFY
LENDALVLIYNKGEASNFADGEVYIPFLFTDLIGIIQ
>SEQF2502_01535 hypothetical protein
MKMELIKKLSDDVFADKKQHLMASRIALIMSVVPILSQIMSIFKVNYVIAHMFGAVNALC
ILGSFVLSVLCIKNQKNRNFMNVCSIIISGFFMLVVAVLMVIGLIYTIAYVVKH
>SEQF2502_01536 Transcriptional regulatory protein WalR
MIEKYLTNKCILIVDDEQEILDMTISILADYGYKNIQTAKSVKETMKCVEEKQPDLAILD
VMLPDGNGFELLEKLRKVGDYPILFLTARGEDEDKFKGFGLGADDYIVKPFLPKELLFRI
TAILRRTYKKESPIVNLNGCQIDFSRGEIIKDNKNIPLTAKEYELLQTLYRNAGRIVTID
TLCEAVWGENAYVYTNSLMTHIRRIREKIEINPSHPVSLITMKGLGYKLIVEGK
>SEQF2502_01537 Sensor protein SrrB
MKSILKLIRRFIITLILSFVLLLFLNIFLYGLWILKYVSKNPPMNYTFKVADMLKFENGK
YTLPDEVTADLKKQNIWAILIDNDSKKVIWQTDNLPDNIPKEYSISDIAIFSHAYIKNYP
VFTSKVENNLLVLGYPKNSYWKYPVANWKYGIVKNIPKFLLMLFCLNIIFIFLIYIISNS
KLLSSVNPIIKGIQNLHKDTPVHVKEKGVLSELAKSINKTSEILQNQREQLWNKDTARAN
WIAGVSHDIRTPLSMIMGYTSQLKTSLNLSDEMDKKLSVILKQSERIKNLINDLNLASKL
EYNMQPFEQKKENLVAVVRQVVVDFLNMDIDEKFPIEWKTKNELVSCFANIDSNLIKRAL
ANLIQNSINHNENGCIIYISVKEDEKNCIICVEDNGTGVSDKELEKLNNAPHYMVCDTNT
TEQRHGLGLLIVKQIIDVHNGKVMMKHSKYGGFKVTLQIPKI
>SEQF2502_01538 hypothetical protein
MEFSFSLKIKAKKEDAWEYYANIEKWYDWEKDLKNITLKGEFKTGSYGTMELEGMPPMEY
KLTLVKPFEEFWDKTETPLGDILFSHQIIDNNDGSINIKHTVILDSEDEQHLEFLSQVFS
DVPQSIFILKNYLER
>SEQF2502_01539 Transcriptional regulator HosA
MRVYNKWHSMIKKELKKMNLTHPQFVVLVSLAYLSQNGNEVTQVMISKLSGIDVMTISQI
LSLLEKHNFVKRKEHSRDTRAKAVILNKKGEEILQKAVPLVEQIDENFFEKLDTDEGQFK
HFLVRLNEE
>SEQF2502_01540 hypothetical protein
MSELTTEEFNVLYKKNFKEYFDKLKKGLQHFCVNSPFE
>SEQF2502_01541 Thiamine pyrophosphokinase
MEKKYVIFLNGEYKYSQEFMDKLVSENAVCFCADGGANFAFKYGKMPEVIIGDLDSVEKN
VLEYYKSKNILIKKFPKDKDFTDFELILEEIRKIKKDNNYLQQVFVVGGLGKRIDMTLSN
LFIMEKYKNLVFLQENEEIFYAEKSFVLKNKKECEFSIIPISEKVEKLTLKGFKFETNKI
DVKRESSRLVSNVILENEASVEFENGKLIIILKNNNKNILY
>SEQF2502_01542 Ribosomal large subunit pseudouridine synthase C
MKKFRIEKEHQRMKISQYLREVQNYSGRSLRNVEVFLNGKQVRLTKKLPSHGNLKVVEKK
KGTDIKPIKLPLDIVFEDENILVVNKEPFLLTHPTQKKVDFTLANGIVNHFLEKYGEVRV
PRFYNRLDMNTSGLIIIAKNSFTQAFLQNFSIFEKKYLAIVNGIIDDEEICRIKDELTKD
GENHKIQDFEKENLKTEVEKVNFGKMKKYDEIEKIENNSNFNSKNTKDNLNLKNKNDFNN
EILEKNGINKIVIERRIFRDGDNLERIIDERGQYAKTAVKVLKTYPEKNATLVECELFTG
RTHQIRVHLKSIGHTIVGDELYGNGLNKELGVNRQFLHAYKVKFTHPATKKEVELEIPMF
TDMKEFLEK
>SEQF2502_01543 DNA damage-inducible protein F
MKKFNFSVDLINDNILKSLLIFSIPILVSNIFQQLYNMADIAIVGHTLGDNSLAAIGASA
AIFELIFGFALGIGNGLSMVTARNYGANNKNLLKKSVAGSIVIGIWITVGVMILSRFILM
PLLKVLHTPENIIKEAFEYINIITMFIGVTFSYNLSSGLLRAIGNSFMSLVFLVIASILN
IFLDIYFITSLKMGIGGAAIATVIAQAISVILSIIYIYVKEPILIPRKKHFRFDKKLYKE
LLGQGLSMGFMIAIVLMGTLILQYAINGFGYLIIAGHTSARKLMGFCNIPLTTIALALAT
FVSQNKGANKVDRIRKGVFYANMMDIVFAIGITIFVYLFSKNMIHMMSGSESEIVLHNGS
TYLKIASPFFTILGILFNLRYALQALGEKLIPLVSSIIEFFGKIIFVIFIVPKLGYFGVM
ICEPLIWIVMVGQLGIAFYGNGYIRKMK
>SEQF2502_01544 Nitronate monooxygenase
MKKNRITEILGIKYPIIQGPMAWLTDAKLVAAVNNAGGLGILGPSAGQTTMTPSPQETME
RMREEIRKTRELTDKPFGVVILVDTDMRFTEPLLDMIIEEKVNVALVNGLDGTDYNGTFK
RLKDAGIKIVFRPLDPTIENARMAEKLGADVYVATGFDEGGTLPGAQIGTFSIVPLIVDS
VKNIPVMAAGGISDIRGVRAAFALGAEGVFLGTRFLATEEARTAQNVKELMLKTTAEDLH
IFRTLPYFYRSIPTKLSAELVEMDKNGATREELFLKQGGGKNMKLGMLNGDENGYISVGL
GVSFIKEIKSVKEVVNELMADFID
>SEQF2502_01545 HTH-type transcriptional activator HxlR
MEIFEKFEIENIKKNNRICGINYTQKIFAGKWKITIIWFLKNEVRRYSEIKKFLSNISQG
SLTKQLRELEEDGIVGRKVYPEVPPRVEYFLTEKGKKLIPVLDTMEEFGNFYVEEYIKNK
SI
>SEQF2502_01546 hypothetical protein
MHEYIKNCRRDFLHKLSKKLSEDYNAVAVEDLNMKGMSRALNFGKSVGDNGWGMFLRMLE
YKLMFLGKQFLKIDKWFPSSKTCSKCGNVKEKLKLSERIYKCECCGIEIDRDYNAALNIK
DIGKLMLEY
>SEQF2502_01547 hypothetical protein
MNNKKKVILFLGAISLVVFGNYRQFVENHKGKTTIEGKVSERATSSVGKNSKEGKTNEKA
TSSKDGVAKGGKTSEKATSSTGNNEPMAEVKSVPQSNKPVNNVPQKPSNEKEKRNSDNNQ
NKTDNSKNQDSKKIQQKESERLKIDKNKDVESQFKLNTPNKGKESKNDDSSSGK
>SEQF2502_01548 FAD:protein FMN transferase
MMYKVQVRFLFHSDIKIKIPEIYDDSVFDDLFGILEDVNKRYNSYSENSYIDKVNKNSGH
FVKVDIETVEILRKIIHLSKIIGGEYDITIMPLIRLWGFYKQNPVLPCFEKIKKVKRLVD
YKKIVIDRKRNRVRIGKNQEIITGSFIKAYAIEKMVEEMKKIGIKDAIVNAGGSSIIAID
EWGIIAENPEDEKEVLRNVNGMPVRITKYEYSGNGDNDLFEIKIKNMSYSTSNQKNTYLI
IDNEKYGHIISPKTGFPSQNKQVGVITENAFFGDIISTGLYNQTPEGFYEIMEKLSCEME
ISGFLIDKSGKIYYFNMEKYFLNFKK
>SEQF2502_01549 Arginase
MSKTLRLLIPQWQGGNREQYFLGAKLLNWLAPESEDETVEVPVDKETANNETRDGIVAKD
TLLKQYKKTFEILDEKNPDKIVVFGGDCSVELAPFGYLLEKYKNEKTAILWIDAHPDVTT
TADNWKNFHAMVLASLLGEADKDIDNLVTTKVKPENVIFAGIDDSREFDRVVYKKYNFKN
FTTEEFQKNGDKIVKELKSREIKNVIVHFDLDVLDLYEFNSQYFAEPEIFDKYKNEFPVG
AKISTVSKLINDVNDNFNLIGLGITEHLPWAAIKLAKLLRELPLIK
>SEQF2502_01550 H(+)/Cl(-) exchange transporter ClcA
MAKDILHELRDINSLKSRRNNVVLIFLCFVVGIFSGIIVGSYTLILKKMTIFREFFTTNL
GFPKIIIGITVFILLGLAIQFMLSKYPLISGSGIPQVSGLLTKKVKFKWLGELITKFVGG
ILAIGAGMSMGREGPSVHLGALVGSGIKKLTRRSEVEEKYLVTCGASAGISSTFNAPLAG
VIFSLEEIHKFFSPLLLICVMVASGTSNFVSRMILGSHTSFQYNFILPKDIPYYVIALVT
VIFCIVITITGRAFSYFLLLIQKYYRKINLNNYVKISIFMVIAYIVAVFFSDITGGGHEL
IEEMFGKNVMLKTIIIILILKFFYTMLCYATSAPGGIFLPMLVIGALTGKVYGEVLNHYF
SIPNEIIVHFMLLGMAAYFTAVVRAPITGITLILEMTGNFSYLYMLIVVCTITYIFTELL
KMEPIYERLYLNMFQKQILEENEENEKIQKHVKRLEILEKWWKNKKFGIGVRPDVKDKIV
TLLIPVGANSEFDNKSVKDLKLPENLLIVSVRKSGKDIIARGDTPIQSGNQLVIITDYET
ARKYAGELRERGMKIIE
>SEQF2502_01551 Valine--tRNA ligase
MSNELGKAYSPTEIEDKWYKIWEEKGYFNAQHNSEKPGYSIAIPPPNVTGILHMGHMLNN
AIQDAIIRYKRMSGFETLWIPGMDHAGIATQNKVERMLKEEGTSKEEIGYDEFLRRTWEW
KEKHGGLITKQLRKLGVSLDWDRERFTMDEGLSKAVKEVFIKLYNDGLIYRGEYIVNWCP
HDKTALADDEVNHIDKKGKIWEIKYRIKDTDDYVIIATTRPETMLGDTGVAVNPNDERYK
HLIGKKVILPLMNREIPVVADEYVDMEFGTGVVKMTPSHDPNDFEVAKRTGLEFINIFTE
DAHVNSNGGKYEGLERFAARKAILADLEAEGLLVGTKEHNHAVGHCYRCDSIIEPRVSTQ
WFVKMEPLAKRALEVVKNGQIQITPKRWEKVYYNWLENIRDWTISRQIWWGHRIPAYYAE
DGTVFVARNMEEAKAQAKEKFGKEVSLREETDVLDTWFSSALWPFSTLGWPDKTPDLEKF
FPTNALVTGADILFFWVARMVMMSLYINDEIPFSYVYLHGIIRDELGRKMSKSLGNSPDP
LDLIAKYGADAIRFSFLYNTSQGQDIHFSEKLLEMGSTFANKVWNASRFVLSNLEDFDAN
AVIDEKEFKLEDRWILSKLQTTSRQINEYMNKYELDSAAKVAYEFFRGNFCDWYVEIAKT
RVYGQEGSDKTVAQYVLKTVLDKGLRMLHPFMPFITEEIWQKLGLDEETIMLSEFPTENK
KYVDLAAEKEFDYLKEIVNAIRNIRGEANVSPAKKIEVIFKIVNDGEKEILEHNAKILDK
LANVEKYEFNTEIPALVGFKLVETTEIYVPLADLIDKEKEIAKLEKDIQKTQKELDRVLG
KLSNEKFLSKAPKEVINKENGIKEELENKIAKFRESIKLYQG
>SEQF2502_01552 hypothetical protein
MKKVILVTLMLFSLTSCVTGGIGIGSDGKVRGNIGVSTDGLIKGGIGIDTDGRLSGGIGF
>SEQF2502_01553 hypothetical protein
MKKIIITILMLLALTSCLSAGIGVGTGGVHGGIGIGF
>SEQF2502_01554 hypothetical protein
MGALFWAILSGIMAILEIIIPGLVTIWFALSALIVMFLSNFIGDSLIQFLIFAVLSIIFL
IFTRPVLRKYIEIQRKTNFDSSMKGTNIKVVKVVDTKKIEKEYEVKFKGSIWSGVSEEIF
SSGEIAKIKGFRGNKIILEKNK
>SEQF2502_01555 Modulator of FtsH protease HflK
MWALPIVVILIVIALIYILKSIKIVPESRVLIVEKLGKYDRSLNSGLSFLNPFFDRVARS
VSLKEQVVDFPPQPVITKDNATMQIDTVVYFQITDPKLYTYGVERPLSAIENLTATTLRN
IIGDMTVDQTLTSRDIINTKMRQELDDATDPWGIKVNRVELKSILPPADIRVAMEKEMKA
EREKRANILEAQAKREAAILVAEGEKQAAILRAEAKKEQQIKEAEGEAEAILSVQRAKAE
ALRLLNEAAPTKEVLSLRGMETFEKVADGKATKIIIPSELQNLAGMVTAFSELAKNDKTI
EK
>SEQF2502_01556 hypothetical protein
MGEKTGLVLEGGGLRGIFTAGVLDFFLEKNIEFDSCIGVSAGACHACSYLAKQYKRAFNV
SVDYLDDKRYCSFYSLIKTGDLFGVDFVYDEIPNKLNPIDNEAFKKNKTKFQVVITNCET
GEAEYPEVKDFDKDTIYVRASSSLPLLARMVEINGNVYLDGGVSDSIPIRKSIENGNKKN
VVILTRDKSYRKKQSALGRITGVKYKKFPKFVELMNTRYIRYNKELDYIDELEAKSEIFV
IRPEVGLTLGRIEKNRKKLFEVYNIGYETAKKNYEKLKKYLEI
>SEQF2502_01560 Trk system potassium uptake protein TrkH
MNKKMISFIIGKILILEAGLMVLPLIISFLYNESAKYKVAYGSVIGLLLAIGFALSAKLP
EDQRIQGREGYIIVSLSWILMSIFGALPFVFTKEIPSFIDAFFEIVSGFTTTGSSIITDL
TKISHSNLFWRSFTHFVGGMGVLVLALAIFPSSATSVHVMKAEVPGPTFGKLVSKLSTTA
RMLYKIYIVMTIVLIILLIFGGLDLFESSLLAFGTAGTGGFGVRNGSILPYKSPYIEVVL
GIGMIVFGVNFNIYYFILIGKIKDVFKNEELRYYLLIVFGAIVLIVLNICKGYDSILHCI
RDVFFSVSSVITTTGYSTADFGKWPLFSQVILLILMFFGACAGSTAGGLKISRVILMVKI
YFAEIIQMISPNRVVTIKYDDKPVNMKMQKSIAVYFLIYSLVFGGILLMISYSTDDFMTA
FSAVAATFNNIGPGLGKVGPAFSFVELNNFSKVILSFGMLAGRLEIFPMLILFSPTTWRL
K
>SEQF2502_01561 Trk system potassium uptake protein TrkA
MKIVIAGAGVVGESLCSELSAEGNDVILIEKVEKILNRLVETYDITGLVGNGASYETLLE
AGTDTADIFIAATESDELNIISSIIAKKLGTKFTIARVRNPEYSSNMQFVREGLGISLMI
NPEQETAKSIANKLMFPVALSVENFFGQRAGFISIRVQKDNFLNGMQLKELEFSSKDKVI
ICTVRRGEDVFIPSGDFTILEGDIVHIAGSKEAVHKFYDKIEKSNLKIDSALLVGGGTIS
HYLIGKLLENKIKVKVIENNKERAEKLSESYPKAIVIRGDEADQEFLMQEGINNYDSTVI
LTDSDEENTVITMFVNSITNSKLITKMNRTLMLSILEKNTRTSTVVPKKVISDMIISVVR
SKTNMRGSTMSFLYRLESQVEFITFEINKNSRAIDISLKDLKIKKGTLIASILRDGKMIF
PGGNDAIKINDSVMVVTTASSIEDFDDILE
>SEQF2502_01562 Delta-aminolevulinic acid dehydratase
MKKGEVKLFKRHRKLRKNEVIRNLVKDVYIAKEDLIYPIFVEEGENIKSEILSMPGIFRY
SIDRLSEELDELVKLGINSILLFGIPEKKDACATEAYNGNGIIQNAVRFIKKNYDNFLVI
CDICCCEYTDHGHCGILDENGYVKNDETLEVLGKTALSYAKAGVDIVAPSDMMDGRVEKI
SKVLAQNHLENIPIMAYSVKYSSAFYGPFRDAADSAPQFGDRKSYQMNFQYSKDAIDEVA
EDLRQGADIIIVKPAMAYLDVIKKVSDTFEVPIVAYSVSGEYSMVKAAAQNGWIDEMKIV
MEQMYAMKRAGADAIITYYAKEVARYI
>SEQF2502_01563 Precorrin-2 dehydrogenase
MWFPLFVNLKDKKVLVIGGGKVAFKKISKIMEYEADITVIAENIAEEKLLELENLRIENN
RKIENDNDEIEKLVKEYFLVIAATDNEELNENVAEICDSKGILINNVSSKTKMNVMFGGI
VKNDEFQIAVSTSGKNCRRSRAMKSEIQKILDRIEK
>SEQF2502_01564 Adenosylcobinamide-GDP ribazoletransferase
MKYIKNFFEQFIILIQFMTRIPIPLKISYSEKKFGKSIKFFPLVGLIIGLILYFANFLII
VYLKNIFYNKTIIAIFLIILEILIVGIIHIDGLADTFDGLFSYAKKEKMLEIMKDSRIGT
NGAVVLILYFITKTVLISEIITTNPKYLIIFPIIARLSTPVNAGLSNYARKSGMSNSIIS
ENGIFEAIFSLALSTILVFYIISIKGIITIFIAFIFIIIFMLNVRKKIDGITGDTMGACL
ELTSILVLFLGIVLR
>SEQF2502_01565 Adenosylcobalamin/alpha-ribazole phosphatase
MTEILFIRHGETDYNKKNLYYGHLNPGLNETGINQLKNTKKKLEEMNEKIDIVFSSDLKR
CRQSLELLELDENIEKYFSEELRELNFGDIEGKSYDKIRKEFPYYIDEMKNNWKYFRTKG
GESLDDLQKRIIKKIDEIKEKYQNKKILIVAHAGVIQTAISYYLFNNLDGYWKFKLDNGS
ITKMVVTDDGFIYFDYINHKPQY
>SEQF2502_01566 Pertactin autotransporter
MKEIERFLKKILKKKQKYTKALLITFLMTGGLAVATPITSNANGEYIVNSGTGDGDVLNY
NNYSHGVFRISEGKKFIFTGQGDIDSRTPSPLFTPRTLITVTDSNTEFKATGQIGVSSNI
DMNFGSSKEAILYTVINPITGANSSATNQKVTLKDVFITAPNSTVPTVKVEAKNGYGIKN
AELNLIGTNGFKSQIHSAVDGWLVEVDADEANGVYSELTVNGIDDSTEGDGGTQILGLMT
KHGKSVLNVNLVGGAYWGLSKNSSLSEQRAIINSLNIDKKSFLSFDESNVTESDGVTSIY
HIKLTSDGINNDGTLNNSGLIQLTNDSNKDKLIIEGNYHGDNGRIEMNTIWNAPGGENGE
NSESDLVYITGNATGTTKVVPIYIDDTPQENIFENYIPGNVQQLSQRINSVPVVKVAGNS
SPTTFTGTAKTAGAAEAQLTSRQVNGIWEYYWTISPLGSSGATAGIIGGTTGGSSGSSRP
IYIMAQPVSAYVLMPKVNMEMGYSTVGTLHERRGENRILDLENMSADKGQIWTRIYGSGL
NENGTDRFQYEGNLYGVQIGHDFKINKDKNGNDHLLGGYISYNRANTDFFDEYRAENGKI
SDSKYTGKGKSESISLGITKTKYTPKGSYYDLVGQVSYLQNKYNSRDDYSAKQNGFGLLL
SGEAGKSFNISKNGNWSVEPQAQLIYQYLNTKSFNDGLRNVNQDNRNGLRGRAGVRLAYN
GDNGNSRTNSYYAVANVWHDFTKYDSKYTNIGSDKITEKLGTTWGEIGLGAQAPLGQKSN
LYVDTRYEHSFNNSNRSGYKGTIGFKHTF
>SEQF2502_01567 hypothetical protein
MGNKGKMEIQKCIYFSISKMFRIVNKIAEESFEKIDIYPTHGFLMIILKEEENGLTVNQI
SETLAIAPSTVTRFVDKLISKGYVKREKSGKNSITKITEEGLKIIPDIYKSWDGISEKIE
EVVGNEEYLRKTGENFKEFADVLGKDKKYDKISEDFDFWII
>SEQF2502_01568 hypothetical protein
MKFYNEEKLLKLRNILIVTVLALLALLLFFRVYDNFAKQIKLVTSTIFPFILSFIIVYCL
MPFIDMISEKNKNDIFLKNDKLNELEKVEKMNISDSEKRKKIELFNEISQSKKKKRIKLN
RTFAILLVLTIFFVIFLYIVLTIVPIFTKQVSSLIDFLLKNQEKLQNNFFGFLKSNNIDL
KSSLMSSKDIIVSNVIKVLSSSFSLISSTFSLLFMTPIFTIMLIFSYDNMENGVKRALQN
MDREDLIVLIKNMDETIGKYILVTALDSMIVGVVSFIIFYFLKMDYSMLFSVIIGFGNVI
PFIGPFIGLIPAILYAFTKSFKLVIFIVVLITIVQTVEANIVKPWLTGKSVEMHPITTLL
VVLIGGALFGIGGAFIAIPAYIIIKLTFLFFWEKYTVDNKLNKNRK
>SEQF2502_01569 GTPase Der
MKHTVAIVGRPNVGKSTLFNKLVGDRLSIVKDEPGVTRDRLYREMEWSGKEFILVDTGGL
EPRTEDFMMGKIKQQAQVAIDEADVIIFLVDGKAGITGLDEDVATVLRKQDKKVVVAVNK
IDNYMRDQENIFEFYGLGFEEVIGISGEHKTNLGDLLDAVIDKFEDKKIKQTEDGLSIAI
LGRPNAGKSSLVNKLLNEERSIVSDIAGTTRDTIDSSLKYDGETYTLIDTAGIRRKSKVE
DDIEYYSVLRAMKSIKRADVCVLMLDATELLTDQDKRIAGMIYEERKPIIIAINKWDLIE
KDNNSVKEFTELVKADLAFLDYAPIVTISALTGKRTLNILEQARFINEEYHKKITTGLLN
QILSEIIAQNPVPTRKGRAVKINYATQVSQAPPKFVFFANNPELIHFSYQRYIENKLREY
FGFEGCPIDIVFNKKSEKSFG
>SEQF2502_01570 hypothetical protein
MSESNLPKNIENREPKCNKVIYCLLAWFFGTFEIHAFYAGRKQEGIYFLIAGIIGTLTTF
ILVGYVIILIEFIICVIQIVNAIQKPSDEFGRISD
>SEQF2502_01571 Nucleoid-associated protein
MVRKIKGAGNKSGGNQQDIIKQAQVMQQEMLKIQEGLKDKFVESSVAGGGITVKANGQKK
LVDLSISLDVLKDAIEENDSTIVSDLIINAVNEILDKAEEMAEKEMEVVTGGVSIPGLF
>SEQF2502_01577 IMPACT family member YigZ
MKSVQKETIIEFEEKKSKFIGYIKPVSAVIEAEKFIDSIKKIHPTATHNVPLYRVVEDGQ
EYFKYNDDGEPSNTAGKPMAEILKILDIYNVALVATRYFGGIKLGAGGLIRNYAKTAKLA
VNEAGIVEYVKKSIFILDYDYENISETEAFLSGNARKFGIEILEKNYLNRVTMKISANDE
IETELNRLQKIIVIKI
>SEQF2502_01578 Cobalt-precorrin-6A reductase
MISYLNERNIAGGKIKYVRFERKILDYGTENVFQFKNLQEINVFLNKFENKNILSTLGSN
TLAELRGIAEKNNLFIRILPTTTSIQNAEKLGYLPKNIIAMQGPFSKDMNAAILKNYKID
>SEQF2502_01579 hypothetical protein
MIWIIGGTKDSRIILDEVMKVREDDIMVSTATEYGGKLLEDVSKDKRIHVISEKLSILQI
ENIIFEKNID
>SEQF2502_01580 Adenosylcobalamin/alpha-ribazole phosphatase
MDNELKLYIVRHGQTEWNVLEKFQGQLNSPLTLEGIEKVKETAEKLKNIKFKAGYTSQMG
RTFATAKIILQNNNYEQEKTSDQKLKLKKLPELNEIHFGEWQGMTFKETFLKFPKEAHNY
FYDVKNYNAKNIKGEELKDGLERFLKGLKKIREEQKSGNILIVTHGTVLELFFNYIQNKE
ADDLDERKLIGNGQYKIFTFKNGKYITL
>SEQF2502_01583 hypothetical protein
MKKLIIVVVSLMVTTSSFAGYTSDMINRMEIKEKSVEKSFGGSNAEMKEATSVILEGWDS
ELNKVYKLLMKKLSKSGQIKLINEEKLWIKSRDNKAKEIANEFCDTVNGERLCGTGYGLA
YTQSLVESTKDRAVELSKRYEKLK
>SEQF2502_01584 D-aminoacyl-tRNA deacylase
MAKIIDTHTHIYDEQFAEDFDEVLERIEEQMESAVVIGCDLETSLTSVALANKYPFIYAV
IGVHPVDIKKYNDEVEKELEQLALNEEKVVAIGEIGLDYHWMEDPKDVQIAVFKKQMELA
ERVKKPVVIHTREALQDTINVLKEYPNVGGILHCYPGSLEAAKPLLDRYYIGVGGTLTFK
NNKKTKELVRELPLEKIVLETDCPYLTPVPFRGKRNEPIYTKYVAEEIARIKEISVEEVI
KVTTENAKRIYVMK
>SEQF2502_01585 Serotype-specific antigen 1
MKKTRFSIILASIILNINIFGAKLVYTDKKTKVSDYDVKENLVKYQKNEYRKGKIYYAIT
DNTTGYDNWKKEVGDEMPRTYLPENWEKIAKHSLKDQEGEDHTTLATKTFLETTGFDAGQ
VINYGAENEWNMLEGIFSYSTSTPYYSQYLLTDNAWYFGNVINETLLNNYMPRLVTTNTD
DRNLLVLAVPNAQKKENNSNAEVLLNDATAKLPLYSDEVAKLFRSQRIMVDAANCFVYGK
KDVTNSVLLNESYKGGKISDFSEKCTMSQTDDEVSADALYARSNTVVALGNIYSKTEEED
KFGTSFATPRTAGYAALILNKFKGLTYHQIKEILLTTAYRERDRLDNQMGWGIVDIRKAL
NGPTNLNAGLIEENKFYTGMYDKIFNKKSNDIYFWAEPETDWVWTNDINSGLSDKPSGTS
TYVMALDKDDNSKIGRVTIQNYLPSEENFYKETSKYVPGLRKAGKHKLTITGDLLYGGET
QVLEGTLKLTGNIPDSKIVVYEGATLELCGNANKVVLAGGKIEACPSAKYMLVNEDREDI
EVNKTKVIDIPKLFYFTQSNKIETKNFKNYDKYNKFLNKHYNHIKSNYNFGKMPKDEFFA
GKNQVYAHDYSYKLTGKWDFIDTYEFYKYMKGR
>SEQF2502_01586 Low molecular weight protein-tyrosine-phosphatase YfkJ
MKKVLFVCLGNICRSPMAEAVFKKMVADENLQDKIIIDSAATSSWEHGNPVHHGTRERLK
KEGISTAGMYSRTLEDSDLDSDYIIGMDENNIKDINSFINDKKTGEVKRLLEYAGEARDI
ADPWFTGDFEQTFVDVTKGCQALLKKLKEEI
>SEQF2502_01587 hypothetical protein
MKSKKIKTIILLGALSASLTSFGFSKKSPKTKKENIKKVDNLNQNKNINNNEDKNKNSQN
LSERPKLSISKEELNRVAKRIFQNEAAGKKNDLVVWNSGENFPSLGIGHFIWYKKGEKGK
FEESFPPLVEFYKSKNIELPKIIKDNKFAPWKSREEFLKLKQNNNPEITELINFLYNTQD
TQIEFIFNRLEDSLEKMLKVAKNKENVKKQFYRVANSPNGLYPLIDYVNFKGEGILPSET
YNGQGWGLLQVLENMKGSQTGKAALEEFSQSAKSVLERRVKNSGAKNEQKWLRGWLNRCE
TYNN
>SEQF2502_01588 hypothetical protein
MKKIIIIFLLFSSLSFSYTRKEQIQENLSKVGIKQEIIDETQKMDFEIRDLVTFENNENV
IGEKLNRLLALLKKDERNYIVSEDIITIYESKIGKDYEKYLNLFTKYTPYDYEKLFAKMV
YYRGIGEKDKSDSYYREIEKKYSNTPIMEVIKIYNTANEKDRLLQTKKVLDILKNEEIKR
QFGIPDEEVHSMNLTYTLTEVRKNYNNGEIEKAVSEYINNIVNSNVSNEVREYNRRKEIL
LLLNVLMINEEITNKKLREQNKKKMEGTYISKEIKKETMKNTDYLDKYLNEIQ
>SEQF2502_01589 Enolase
MTRIEDIYAREILDSRGNPTVEVEVYLEGGAMGRASVPSGASTGVHEAVELRDGDKSRYL
GQGVLKAVENVNKIIAEHLIGFDALDQVAIDKAMIELDGTPNKGKLGANAILGVSLAVAK
AAANQLGIPLYRYLGGVNAKELPVPMMNILNGGSHADSAVDVQEFMVQPVGAKTYKEALR
MGSEIFHHLGKILKANGDSTNVGNEGGYAPSNINGTEGALDVISQAVEAAGYKLGEDVTF
AMDAASSEFATQNADGSYTYTFKREGGVVRSSDEMIEWYKHLTSKYPIISIEDGLAEDDW
DGFKKLTEALGDKVQLVGDDLFVTNTKRLADGIAKGVANSILIKVNQIGTLTETLDAIEM
AKKAGYTAVVSHRSGETEDDTIADIAVATNAGQIKTGSASRTDRMAKYNQLLRIEDDLAE
EAIYEGKKAFYNIKLK
>SEQF2502_01590 hypothetical protein
MKKVGILFVLLSALSFSANSAKTTKTTKTRTTKTVTTQSVTGRFNQLEAEYERLVNMENQ
EYNKLKANADAAAARLAEKEAQKAQIEERIAKIEAAADSKAFKAQYADLAKQYKAVVKAL
DTEIKSLNTTVENFAAIESLKGNQ
>SEQF2502_01591 hypothetical protein
MKKKLAVLLGVLVLSSVSFAAPAKSTSGGSIENSLNNLENQLTKLQQMEDAKYRQQEAEA
NAATQRLENYTAMQAKIDERLAEIEANEDTSIFGKEFKAKATEYRNLRNQLDKEIAKEQQ
IISNFEVIKSLR
>SEQF2502_01592 putative inner membrane transporter YicL
MKEKMKLRGMLLASLASSLWAISGISGEILFKKYNFSSDWLVSIRTLISGILLFVIVIFI
EKKSVLKPLKNKKDFIGIILFGTAGMYLVQYTYFKTIELSNVSFSTILQFTAPFFIFIYE
SIKNKKIPAFSTLILLFMTILGVVFIATKGKISSLSVSPEALLLGLISAIMIAFYSIYPK
KLLKKYGSITVVGWGMIVGSVVSNIVHPIWKIQGNVNTESIIQVTVVVILGTSVAYLIYI
ASLNYISSSLAGILTAFEPVLAAILSVIIFRLKFSFVELIGFILVFVSIFILEKRL
>SEQF2502_01593 Aminopeptidase YpdF
MEKRTEKLSRILNELNIDGLFITDLYNLRYFTGFTGTTGVALATKNGNFFFSDFRYKTQA
TKQVTEMGFEFVEVSRGSLQTVGEYIKKFGLKNVGFEDINVSFSLYQTIKDIFKVELVPV
GNKLVMERMVKSDEEIALIKKAVEISDAAFSEALKIIKEGVSEKEVSSYMEYIQRKLGAD
DRSFTTIFASGYRSAMPHGVASDKKIQKEEFITMDFGAYYEGYVSDITRTVYYGNNITDR
HKEIYNTVLEAQLLGIETIKEGVMSDEVDKVVRNFFNEKGYGKYFGHGLGHGIGAEIHEL
PYLSSASQIELKENMVVTSEPGLYFDGWGGVRIEDDVVVKKDGREVLNKSNKELIILS
>SEQF2502_01594 hypothetical protein
MKLKIAILSALTAIFANAASIDYLSNNSASYFQNPSQTGKISVEGIFYNPAGTVFLDDGT
YINANLQNSMIDESMTLKGKKLKSHRYAGAPSFNLLYKKNNYSLFGNLSVIAGGATLRYN
DGVAGIELAGETFNNITGGRLRAKVTKNRFTGQNRYYQLMLGSVYKFNDTFSMSGGLKYV
YAHRKLDGEAQYSYNPLVGAAIGLNKNYLSMNSKRNSEGIGGIIGFDYRPTDTLNFAVKY
ETPVKLKFKSKAQENNKMLLAGRPLGISFFYPEYADGVHSRRDLPGVLALGVSKDVNKWT
FSGGYTYYFNKAAKIDRFKYNDGYEVNFGADYRINDKFTWHAGFNYADTGAKKESFSDVE
YAINSQIYATGLTYKPTESSEWKFGLAHVNFNSSNGKREKTSLPGITIDKSKVKYDKNVN
VFTLGYTHKF
>SEQF2502_01595 hypothetical protein
MKYIKRSLIVFIFLLMSLFALKFYISTKNFRGVLTLILKSSGLNVEFRNVKVIGFSKIQI
DNLKVKDLAGNVVIDAKKTTAGISLLMPTRLNRIDVYNGTVNLERRKNNDFNILHVIKKD
PKKPETFDPTSRIGKLHIHNAILNYTDTTYAKKIKKTLKKVNGRLEVAKSRGFSLFAKGF
GNKNEDGTTEVLKVELKQLIKSKQSIYSMFDKIKNSDVRRKDTRLNFGFENIKITEELGQ
YAQVEMIKVKDGILTGALKMEQNKIRKKTYILGSLKIKNGKLSYVDFDGDIEGVNAVVDM
KKDKITVNANTKLSESPVTLTLAYFIQNQKMNLKLVADKLPFNQVARYKMIKNTKIEADG
AVSGRLELNIDTKTKKGTLDGKFSSDNIRISNSNFQNIKTTMKITNEKLTLSDTSFVFNE
AFSGFKVNEDVKVGKFVYDLKNKTGTANYVLNNLGSDFNIKKITGSVKISSKNIITGTVR
SNVLKGRYTVNPKVQTVVINARSNGYFTVNYGGKSYKISPDVDNLIMKFKNKKPLRSGRI
RVRVKDLSVPFVKVIDVNIKIRNGNYKINGTAGINGGGVLNISGMTTSDMKHSYSLNLPK
HVDIAKLLRANGYNFNGLNKAKLPATVTANIKGVNNKFFGTYEIHSPYGEYMGKYKNLHV
KGKINDLTNLDMTINAKVNELQFENQRLRNVTGNLEIKDNVVNIASIRNENLNASGKYDI
KSGKIDINARLKNYMLSSNELPSKMDVKIGTLNANLSGTANKLSGNYELYSPYGKYIVEY
EKLHANGKINNLLNLDLTANAKMDELWFNYQRLKDVTANLKIKDNVVNILSAKNENLDAN
GNYNLKTGNMNINAGLKDYMIYDTSPYKLNLKVKNLNANLTGTVDKLSGSIIIPSAPTTI
KSTYVGDTNAHITIKDGIMSFDDVTLRDNRLSGTYNLKTGISDIGLTLNEPDIPKLLELK
DLTFGTKSNLNLKGDLNNFNLEGQIILGNMSFKTYKIPHIVADIKYSNGNIDKLFKYGTF
DLQKLRFVGDNQETLFETQTKFDLANVNIDYQLEKQKFSLDSIQDLKNKGYSGDIDFGFM
YRGSFEKFISGVKIKADSIKLSGFPVKNVDIDLQANEKSLNIGQFYLEYENNPLLVNGYV
QFTPIKYNVSMLAKDFNLDFLGINKGVEQAGGIANVDAIFSNESTTGHILLDNFNYKTRD
KLTLVDNVNANIDLKNSKLIVNRLDGGYNGGTFKVTGDLDVPTIPADFMKTKRLELGKFE
LNADLNNVGIHYGKGIDFALSGNAVFTENRLFGDLVVNNAQIREIPNFNSSKTKTGEPAQ
EAKKEQDKSIVEGIVEEVIDKIMKQYTVNIGVQAGNNVKINIPNVSLVKNIKGTVKGSSE
ITYEDGQIGIDGEYRITKGSFSINGNDFKIDGAEIRFVPSVNGVTASVSDPFVIFDASTR
VDGDRIEINVSGNVSNPKIRFSSSSGKTREEIISSLALNTLVGNSGNPGENGDNSVDGLV
VAGSLINTALNELFLSSVTGKIKDALGMSKVAVSTNVDRSNKTGEYSAATTLTLQDNLYK
DKLFWNAAFKFPYQTSKNDEKNPIGYNAWLSYSVSNGLDLRIGGESLKRSSSSANMGNGT
RINYYFGVDFSTRADTFGDILKKIFRKKKLDTLKK
>SEQF2502_01596 Outer membrane protein assembly factor BamA
MSKRKVKNKIYALIIVVTLFVSVNNLSQAEEKSTVAGMMLADNAGRISTKEELDNEGISD
IKSRYSAEEVEIGSEPGSKRVKRSRRNAARQAAKGKGKTNNIFETDRGTRDDLKVGSIEI
SNLKELSPEFLLSKIPVKSGDNYTNKDLSDIYLALKRTGYISDANVYPKIRGNTVNIMVE
VSEVENAAALVQRKQMQEEMKKETEYTVANVDIEGLQVRSQDKEKYLKSLPIKPGDIFIP
QKAVDGGQKIFDTGYFSTVEPKIDRKADNTVSIIYEVKENPAIRSISFEGNTLYKDAVLE
KALGIKKGEILNGNLLNPDENGITKLYNKDGYTVARIESINVSNEGDIKIGLTEGVVDSV
EFLKASSRKDNERLSEKHSTLRTKPYIFERVQKIKPGQIFQTKNIKDTVEELYRTGMFTS
IEPVLEGKEDDPNARVVKLLVEERPTTTINGSISYGTSVGLVGELKLSDSNFLGRGQDAS
ITLSASNKGDKTFDISWFDPWLRGTERVQLGGTAYWNVSVDDNADPDEVEKVKKIGTRWT
IGKGLNSDLYVRMAARYDHYEELFSNKKVNDRYNLFAIGPSLIYDTRNNQYSPTKGIYST
LSYERGELINDPRSYDQFEADLRAYHKTFFGDKNVMAYRVAWGSTGSGTPEALRFSIGGA
ESIRGYDYGAFDGYDKFHATIENRTKINDTLQLVAFFDIGNAWQNESRDPRTGKKIYKPN
RKDAHDFKDLKKGYGVGVRLNTPIGPLRFDYGWPMDPEKKGEKKDKGKFYFSFGQSF
>SEQF2502_01597 UDP-3-O-acylglucosamine N-acyltransferase
MYDIKEITKLIDGKINGNENLTFKRLSPFFYATEEELTFAADEKMLKSIDKCTAGAIIVP
PLENLPKNRTYIVVEKNPRELMPVLLNYFKPKIKPFEKAIEDSAVIDETASVSKINTYIG
HNVKIGKNVVIYPNVSIFEGTEIGDETIVYSNVTIREFSKIGKKCIFQPGAVIGSDGFGY
IKVKDNNVKIEQIGHVILEDEVEIGANTCVDRGAIGDTIIKRGTKIDNLVHIAHNDIIGS
NCFIIAQVGISGSVEVGDNTTLAGQVGVAGHLKIGNNVIIAAKSGVTNDVPDGKQMSGYP
LRDHMDDLRIKMSMGKVPELVKRVRKLEKIIK
>SEQF2502_01598 hypothetical protein
MKKLLLGIFMLLCLVSCGSGPSDTVSKFINNIKAGKPKEAAKYAIDDGFEGNLEVTYTNK
TQELLFKTLLKNLEYKIIGTEKQDSDTTIVTVEVTNLDVQKVFLQVFQKMSQEVFTNKDS
KPLSAEERFKQELEAKDKPKIKNTTKFVVKKTPQGEKVVVTAENVDVLLGKLNTTLLNLG
NLGKTDEETSVELPETGPSTGISQKPEELRNQNK
>SEQF2502_01599 hypothetical protein
MKKTLIGLFLVLGAASFADAGKIEARGGIDLGGQYHYGKDWKNQKTKNSSGEVGIEYRNE
VAPGLEIGGGTAFQFHKDLKDKVNGQNEKNFNSIPVYTTAKYTFDTQTVVKPYVKGDLGY
SFNNGNHDYGSLGKFTAKNGLYYGVGGGVNFNNVNVELMYKENQGEYKYEGPLRASKKYD
ANYRRVSLGVGYDFNLGD
>SEQF2502_01600 Leucine-, isoleucine-, valine-, threonine-, and alanine-binding protein
MRKVFLMMLLATVFIVGCGKKANDGNVIKIGVIAPLTGNYAQYGVAVKEGVELKVDAIND
AGGINGKKIELVTADSKGDVQEAVNAFKKMVSQDKVNVVIGEVVSATSQAISGLAQQAKV
PLISATATSLDVTKGKDFVFRTTFTDPYQGTATAKYAKSKGIKSIAILTNSSNDYSVGIA
NAFKAQAAKDGITITEEKYTNDDKDFKAILTKVKGQNPQAIFIPDYYNTIGLIISQAKDL
GINAQYLGGDGWDGIQTNFGKVAEGAIFASQFSPDDKAENVQKFMKAYKAKYNKEPIMFA
ALGYDTVQIVETALKSTKDMSGASIREAMNNVGGIDLITGKLKFDADRNPEKAVTFIQVK
GGKLTLKEKF
>SEQF2502_01601 Leu/Ile/Val-binding protein 
MKKTLFLISLLALFVFSCGAKTAKDKNVIKVGVIGALTGNVAQYGTSTINGFKLKVKEIN
AAGGINGKKIELVVADSKGDAQEAINAFKKMVSQDKIDIFMGEVTSGPSLAIAPLAQQAK
VPMITATGTAFDITKDKDFVFRTTFTDPYQGVVVAKYAKSKGYKNVTVLTNTGSDYSVGL
ANAFKEQAKKEGIQVKEEQYTADDKDFRALLTKVKGYNPEVIFVPDYYNTIGLILTQSKD
LGINAQFMGGDGWDGIQTNFGKVANGAIFASQFAPDDPDQNVQKFITSYKNEYKTDPIIF
AALGYDTGTILETALKNVKDLSSKDEIKDAIKNFNGTNLVTGSLKYDSERNPEKKVTFIE
VKNGKLTLKEKF
>SEQF2502_01602 High-affinity branched-chain amino acid transport system permease protein LivH
MLKSFIEQTINGLQTGSIYALIALGYTMVYGIVKLINFAHGDILMVGAYATLIAVSNGMP
LILAITLSIVLCAILGVVIDFFAYRPIRNAPKISALITAIGMSFLLESLALIIFGANPKV
IDPKYIPAFLSNDNKMKLGFLQISTLTIFVIAITVICMVALNLFIKKTKLGKATRAVSQD
TGAAQLMGINVNKTIAITFAIGSGLGALGGALYAIVYPQIEPYMGMLPGLKAFIAAVFGG
IGSIPGAMVGGYVLGLLEAYVKGSSLTTWANPIVFGVLILILIFRPNGLFGKNMKEKV
>SEQF2502_01603 hypothetical protein
MEKNNKDVKEKNINNLEKKQDKQPKKDKEIKNCKWNDLNYFNKLNVKNYIATFLLIIIFY
FVLSFTFDPNDAFSYTRGIYISILIYVLFSVSLNITVGLMGQLNLGQAGFIAIGGYSAAF
ISKILVHYNLPPFLQLILVSLFGGLVAAVFGLLVGGSTLRLRGDYLAIITLAFGEIVKYI
IQNLDFLGGATGLSGIPTLLSFSNTYFIVVISIVIIAMAMTSRKGKEVLSIREDEIAAEN
IGIGLNRVKLYGFAFSAFFAGVGGSLFAHNVGILTPDKFGFLFSIEILVMVVLGGLGSIT
GAIVAAVILTLLNEKLRDVSQFRYLVYAIILISLMIFRPKGIFGTKEFTFAGTKRRIKRI
RDHKNSKNESDEN
>SEQF2502_01604 Lipopolysaccharide export system ATP-binding protein LptB
MSLLKTTDLGISFGGLRAVDDVNIEIKEGELVGLIGPNGAGKTTIFNLLTGVYKPTDGDI
SINQISINKKTTPQIVALGVARTFQNIRLFKELSVLDNVKLAFNNSMSYNTFEAIFRLPR
FWKEEKEVTDKALDLLDIFDMAEMANITAGNLSYGQQRKLEIARALATNPKLLLLDEPAA
GMNPNETKELMNTISFIRNKFKIAILLIEHDMDLVMGICERLYVLNFGRIIASGLPDEIQ
NNKEVITAYLGE
>SEQF2502_01605 High-affinity branched-chain amino acid transport ATP-binding protein LivF
MNILNVNDLNVYYGVIHAIKNISFQIKKGEIVSLIGANGAGKTSTLHAISGLVPIKSGEI
SLSGENITNADAYKLVSRGMAHVPEGRRIFTELTVLENLEMGAYTRNDVDQIKKDMEHMF
SLFPRLAERKKQLAGTMSGGEQQMLAMARALMSNPSLLLLDEPSMGLAPLLVQEIFNIIE
KINKEENVTVLLVEQNANMALSIADRGYVLETGKIILEGTGKELLTNPEIKKAYLGG
>SEQF2502_01606 hypothetical protein
MLENFLFFSKKEGKDLEKKILMRLDKMIVEQEIINQRINMLQEIIDVSNEKLMNYQTKES
QNMYGILNQLLLKDVLENYDETLQELIRKHNSKS
>SEQF2502_01607 hypothetical protein
MKKNNLIKNLIEYVTENAEAIDKIIKIGERIVDWFKNIFNIGDTPSYDKDNATIDDTKKI
NKILQTYIKNSLNISKEYDDISKEQINKYFSQIKNGLTDINEISQNNTENFDKVIEDYIF
DSLELNRQSTLKSLDKIYSNRIKDAYSLSNDELLDILKMEKGREKKKKINEFSINTLKNA
NKFLFDELKSSISQQQNLVDKKLENYMNLREEETKRSIEKINEILNSIKTGEKEKQQLKN
SYVELLNEVKLFDEIFA
>SEQF2502_01608 Bacterial dynamin-like protein
MLNLEQYIRSNNEELVNIHWNETINEYVKRLNGSKILFKKLSEKEYFKSSNTLKENIFFK
EINSEISRYISDSKNPSYQIAIVGAVKAGKSTLINALIGYDLASTNVTPETATLTKIKTT
DKNSITVKFYSKKDWKKIWNDAQKSTNATIFKEEFDNLRAKEIECEMLEKSDVFKEFDNL
DSMKNEIKKWTSSHAREHYFVKEIEIGVEKLNLPPQVCLVDTPGLNDPVQYRSNITSEYI
HSANAVIICVNSKTLRNEEITTILEVLTKAQDKKDKVYILGTQIDIMNSQADWEQQQEEW
LKHLKEKQFYGSLEMAKKQLIGVSSYFYSNAIKLSSNTDIDSLEDVLDNLVKIEEMSKQE
RRELLKLYNKNNLTPKDIDQIKRRLINYSNIEILKDNIQNKLILGFNESLKIDFINRYNY
LKNKIETFKNEHIEKIQGNINSFTQSENELKQQILQNEEQKENLKNLNEKLKLKIKEITQ
AFNTDFEELNTNFNELMKNIRKVKFEEESEVK
>SEQF2502_01609 Sugar phosphatase YidA
MNYKLIATDMDGTLLDEEHGITSENIEAIVKVQKEKGVKFVLASGRPSYAMFDYAKELQM
DKYEGYVLAFNGGELIDMKTNEVIFHEGLDKPDIENVYKVSKEINVPMILYVGDTIYGTE
ATEGVMYEADQCKMKFQKFDSLEELEKKGIDKTTKCMIIGTPEEVLMAEKHMNKVHGNDY
FIAISKPIFLEIANKNVDKGKTLKKLGEIENIKPEEMIAVGDSANDKPLLELVGMPVAVE
NAIPEIKSISKFISTSNVEHGLKTVIEKFFEI
>SEQF2502_01610 Undecaprenyl-diphosphatase
MFIDIIKVFILSLVEGLTEFIPVSSTGHMIIVDQFLQLSKNEEFANAFKIIIQLGAILSV
VVYYWKRIFPFAKGLSQSQRMDIVQMWIKIVIAVLPAVVLGLLFDDVIDKVLFNSVVVAI
TLIIYGVILIWLESGEKKEGKITSITQMPIKTAIGVGLFQCLAMIPGTSRSAATIIGGVL
LGLNRILATEFSFFLAIPTMLGATLLKLVKLGTALSGYEWFLIALGFVLSFIFAYAVIKV
FMSYIKKHDFKVFGYYRIILGIIVLALYFVGVIK
>SEQF2502_01611 Oxygen-independent coproporphyrinogen-III oxidase-like protein HemZ
MIRANIEINQNKLEEFVRVLLPENYGIIFENSENNVEINVNFEKGKNVENFSKDCGKLEN
NKNKNAELITVNTALIDKNSGKILKKVTFSHKKINDEYFDQAEVMAKASLMELFDKKNKY
KWGILIGVRPTKIVGRFLKMGLSYDEIDEILEKIYFVSDEKRKLLLDIVKRQAPYLDKET
IGIYIGIAFCPTKCSYCSFPAYLLRGKYAERYDEYIGSIYHEIREIGQLTQELDLKINTI
YIGGGTPSILTAKEIDKLLKTVKENYNLDYLKEFTFEAGRIDTMDEEKLSVIKNYGVNKI
SINPQSFNEKTLKIVNRYHNREQFDNVYKIAKNLGLEINMDLILGLPRENTEDILYTMDE
ISKYNMENLTIHNLAIKNASRLNKENYAHKDVLDYGKIYEKIGNITKNKGLFPYYMYRQK
NSFQWGENLGYSLNGCESIYNIEMIEENKTIIGIGAGAITKLIWFDEEKNRYNIKRLVNP
KDPLVWMNELKDRLEQKKFEIKRVFKKDFL
>SEQF2502_01612 NADP-dependent glyceraldehyde-3-phosphate dehydrogenase
MNYQNLVNGEWKDSKNTITIYSPVNGEELGTVPAMSREDVDYAMESARKALPAWRALSAV
ERAAYLNKAADILERDKDKIGENLAKEVAKGIKAAISEVVRTADLIRYAAEEGLRITGEF
VNGGGFEAGSKRKYGAVKREPVGVVLAIAPFNYPVNLSASKIAPALIGGNVVIFKPPTQG
SISGLLLTKVFAEAGIPAGVFNSVTGKGSEIGDYLIEHKEVNFINFTGSTPIGKKIGKLA
GMRPIMLELGGKDAGIVLEDADLENAAKNIVAGAFSYSGQRCTAIKRVLVMDSVADKLAN
LIKEKVEKLTVGDPFDNADITTVIDTPSADFIEGLIKDAQEKGAKALTTVKREKNLIWPV
VFDNVTTDMRIAWEEPFGPVLPIIRVKSVDEAVEIANKSEYGLQSAVFTKNFPLAFEIAE
KLEVGTVHINNKTQRGPDSFPFLGIKGSGAGVQGIKYSIESMTRVKSIVFDI
>SEQF2502_01613 hypothetical protein
MKKTTMLLTLVLTVLSSTSCSYFKIPKGDGREKAGNLCTYTAKGKFIGCEPIR
>SEQF2502_01614 Class B acid phosphatase
MKKALLFLFAASVIFAAGPKVPYTHEGFYSTDKVQKAVHFVSVDDIKKSLEGKGPINVSF
DIDDTLLHSSGYFNYGQYHFQIPGDKRGAVSYLYNQKFWDYVAENGDEHSIPKQSAKDLI
KMHLERGDNVFFITGRTKHSKDKNYTSTKLSKTLQRYFDLPKEVYVEYTADTPTGGYKYD
KSFYIKKHNVSIHYGDSDDDILAAREVGIRGIRVQRAYNSTNPQKMNGGYGEEVLINSAW
>SEQF2502_01615 hypothetical protein
MKKMSILIGIFTVFLLNCFVLSAYSKKQNVYNLNGTSWELAQVSRKGKNVVIPKEAKITI
NFLENEINGFSGINNYSGDYTVKNNFTLSADVATTLMAGPENLMNIEQNFLDILQSFPKI
SYNTSTLTLSNKKEVWTFKVLTLNKKLKNTSWKLLNMDGKDISKLISKNDNNITLSFNEN
GINGNSGINNYFGKYEIVNNNIKVSPLGSTEMAGPENLMKIEREFLKLLENSKKIKLSNQ
KTLVLTTDKGKTLIFEKIYQ
>SEQF2502_01616 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MKKNKFLTAICMLSTFVGTNLHAKTSKGKKTVKAKTSHKPLNVKKTHSSGNSGIYGVSAK
NKSDLVETKMSELRQRHRKAMTSGTAQERKRATVEKKLLTSYSKWRGTRYALGGDSRRGI
DCSALTRRVYREVFNKELPRVSTQQVKQGTRVSAKNLRSGDIVYFKPENRTSHTAVYVGN
TLFINASSSKGVVMSSLKSPYWRKYFRYGVRVHNV
>SEQF2502_01617 hypothetical protein
MKISKKLIIMLFGILLIGYVLNGAVKRKNPVINDKRRELVFKKFNCNKKIYTVNYITDET
VQLLDMKTYKKWQLDRVVSSNGEKYSDENVKIHIKGNRMMLTQNGRNTSCLLVK
>SEQF2502_01618 hypothetical protein
MKKMLLIAILLIGAISYGAAGLDLKFNTDGKLHEEKLLNRSIVSEDTELEIRKTGNGEYE
IVRSSEEPDSEASVEKATVKKNSICDETICIGYDVELKKAVFIDPEDMRVIYPEW
>SEQF2502_01619 hypothetical protein
MKKLFFTLTVLLMGVVACSKSGKDEKKETKETEIKQEVNKTTAVSSSSIKSESSYETQIL
ERMEAVKKEIQPALDSGVTADMNNAIQKLGDSWEAEMKKVYELLLSKLSENEKAKLQKEQ
EEWIKKVKEDVEKSTEESEGGTISGTLGGNAWASGIEKRTLELAKRYDLLNNRYVR
>SEQF2502_01620 hypothetical protein
MKNKVFKIFVIMILSVNISYAGSNPKIDKATFQEIDAVYAKDKNGVYVWENRGWKKLEGI
DPITFQIINISGSARRYLKDKNGIYNIDGDSDNLVLEKLPYDPQTYEVINQLYSKDKNNI
YYSNRKIIGADLPTFQIGSDGFSKDKNNIYFGGKKILGVDRDTIKIIELPYIKDKNNVYY
GNKKIEGADKNTFELTYDFGSVVNGYYSKDKNNVYYENKKLKGIDVKTFKKISRLVDNFL
IEDKNGFYIVEKDGSIAPIDGKEVDIENLSQLAIKTNLYHDKDSMYFVKNHKLVKIKAAP
KVDPYNLSTYNDKYINKYDVVYYLDTDEGAFKKLEKAESHQFSAYGNTEYAKGRKNVYFK
GKILADADYESFGMKYNHEKDVYEIRDKNKVYETVKAD
>SEQF2502_01621 hypothetical protein
MKKIIMALLLLMGVIGFSEEEFSYKGYDLPFTSDGKLHEEILLKREISADDTSIEIKKLK
NGKYQFWDYASDTGDENEPPRITNAVKEKNVLCDEYICIGYDTKLKDPVILNRKTKRIIS
IVRENHDKIDDPEHLKEFPEDNPEMYKLYRDYYKLYK
>SEQF2502_01622 hypothetical protein
MRKLLLIAGLLVIGAVTFAGNYENELTERMKVSEEKAQAGWDSGVRADMVNASLNLDTEW
EKELNDVYNLILKKLPAKEKIKFKAEQNKWIKDRKVKVQKAYDKYTKEEGPRMAGELAAS
ERLSITKERALELAKRYDKMNVKK
>SEQF2502_01623 hypothetical protein
MKKILLLGMLLAGAIVFAGKYEDGMTERMKVAEEKFQPALNSGVTADMNDATQKLGKLWE
TEMRKIYDLLLSELPEKEKVELQEEQEKWAKKIKDEIAKDAEESKGGTIGTFNVLGTALG
NTEKRALELAKRYDKLNK
>SEQF2502_01624 Phosphocarrier protein HPr
MASKTVTMTNPTGLHTRPGGVFVAKAKEFESKVEVENEGKKVNGKSLLKLLSIGIKNGSE
VTIHAEGPDAEQAVEVLGELLATIRD
>SEQF2502_01625 hypothetical protein
MLYLDGIGISFLVKEIKEKILRYKLTKIFQYDRVSFSLFFGKNNLLFQVKDNSTIFYLKD
EKDPNTDFQSKFLLSLKKHLQNSILVNIRQEGFDRIVYFDFEKLNQFGDVEKYMLIIEIM
GKASNIFLTCKDKILSALYFTSIDVGNRVIMTGAKYTLPFEEKKISPIYLEKENFPFETE
TFLEKIEGAGRAFALQCSQDYNIFKRYLSSYRPVMYEILNRGKIQKVLTYNEFSEFSQKE
NANLENNPENKNNRKYFETLNEGLNAYFKTTITSNVISEKKKSLLKYVNSQIKKFKKIEK
NIKVDLKKNENFENYKNIGDILAANMHQIKYGMKKVTVFDFYNNQEITINLDPLLSPNDN
LNFYYNKYNKGKRTISALNLRFGDIQNEIKYFEEIKMFIEKENDFIGIEEIENELNLSDN
RNKIKNKIKLNKTKKRELLSFDYKGFQIFVGRNNKENEEISFSKGQPNDIWMHIKDIPGS
HVLILRNNQELPEDVLIYAANLACEYSKAKKGDKVTVDYCERKFVKKIKNSKPGNVTYTN
FHSLLINVPEKSL
>SEQF2502_01626 hypothetical protein
MYEKIETLLDKFYKTYYKIEEINLNQVIKCLTTSELHIIEAIGENEITMNELSDKIGITM
GTASVAVNKLTEKQFLERSRSNTDRRKVFVKLTQKGKVALNYHGNFHSTILERITDDIPK
EKLDTFVEVFETIMENLDKVKKDIQPESILSFEKGDLVQVSSIKGSTAIRKYLNEKGVMI
KSLIKIVNIDKYLITMVVDGDEKVLNVEDAENIMVRKNAL
>SEQF2502_01627 Ribulose-phosphate 3-epimerase
MDKKIIISPSLLAADFSKLREEIAEVEKFGAEYLHLDVMDGNFVPNISFGAPVISSLRKH
SNLVFDVHLMVNEPDYLIKDFAQFSDIITVHVEAIKHLNRTIQLIKSFGKKAGVALNPST
PLDVLRYELKNLDMVLIMTVNPGFGGQKFIPEMIQKIKDLREIDKDIDIEVDGGINDKTA
KLVKEAGANILVAGSYIFSGNYKKKIETLK
>SEQF2502_01628 Small ribosomal subunit biogenesis GTPase RsgA
MKNDKMNCIIGDFVEFDKKEKIIEKIEKRQNFLYRPLIANIDFIGILFSIKSPDFDFTNF
QKMLLNANSQNIPVVLILSKIDLVSQEELEKFLNKFKKIFKDVISIFPISTETRTGLSEL
KQYINKKSVVISGPSGAGKSTLINTLIGEEVLTTNDISGKTRKGRHTTIESRFFMTAPHS
YLIDTPGFSTLDFPKLKNKKELEKLFPEFLEFIPNCKFRDCIHVNEPNCAIKENVENGNI
SRERYDFYLYSLENIKFLKYT
>SEQF2502_01629 Serine/threonine-protein kinase PK-1
MATQYKFSYAKTFKTVIVVICLVTLAIFGKDVFERHFFNTRLTVIPDVTGLDKKEAIKYL
KEAGLKVKVINSKTEKVPLDTVYNQDPRSGKEVKVNRVVRIWVNNGEDVKVPNIIGLELL
EARSRLKGLNIQIETIDYYPSNQKYNTILGVYPKPGTKLEINQKISILVSSQQMIDPSVM
PNITGLDLNDARETLKQIGLEIGSVSQTNDPTLPVNTIISTNPAAGTKIQRGQKVSVVVN
SGASVKKRARSNEEIINRSRDNINEREIEKTIDDTINQIDNNTPKTPQQNDKQQNNGNTP
ASPPNNSNSGGTSSEPNTGGGDDDD
>SEQF2502_01630 hypothetical protein
MKKVAIALFSLLSVFSFGANENLVRKISVTGNAEREIMPDLAKINFKVEVKGKNLNQATD
EVNKKVEKFKNELRARRISLENLETTAFYNRKGTEYDNDDILDVKTVPNKNVKKSDKKPT
SYDVKMSILVKNTDFNKISALIDLEDGDNLQSIQKNFDENTFAFNINENGTTVDQALNKV
FNKLNTSRRKLISAGIPENDIILSDYEIKENYTENKGTKKDVYYVTDEFVLTTKNIKELN
TIISIADDNGININGSINFDLSDKDRIESEMYKDAYNQTKQKAESILRSSKMKLGEPIIV
SEDVEFQQKMIDRIDQDWSVTYNAAPAEFEYTNTMTKEMTAPAPMAMRAGKSRVDYTPKP
LKLTQNISVMYEMK
>SEQF2502_01631 hypothetical protein
MKRILALFMIIFSVLSFSDSEITGKRIQVRGVSKKEIMPNSAKIALIIQTENESLDKASA
ENSKILERYKRLLAQTGTKYNKINSTGYSTYETYNWDTVIENKGKKEYRTKLSVEVDRFS
LDTLKNFMNVLATEKIYSLNRSKNGTYIFTIESQNATNKQAYQNAMSKFNEIQQKLSKEG
IPASAVKIAGYDNKEISLEKRTNNKKNIQVVSHQIEVETRDLKNLGNIINVASALGIGTT
GQIEYDIDNKQQLENELYENAYKEALKKAQVILGKTDLNLKNPVTITDKSYGIIQPYYDY
SYNYYNEANYATNVVQLKKSDRELLDESSRRNIVISPKKLNISKTVYIEFEMN
>SEQF2502_01632 PTS system trehalose-specific EIIBC component
MSKYHNDAVKLLELIGGKENVVAVTHCATRMRFSLADEGKASPKEIGQLDSVKGTFTNAG
QFQVIVGNDVGDFYKEFINVSGIQAASKEDVKKAAMQKQPLLQRMVAHLAEIFVPLIPAL
VAGGLMLGIGNFLQANLPFLGGKSFKDVSELARVILFFTDWIGGAVFGMLPVLVCWSTVR
KFKGNEALGIVLGLMLVAGTMLNAYVYGDISSSKELAGAGVHLKDILINGSAKYAHLFGG
KDPFNIEAGKHVLNLGFTQLMLVGYQAQVLPAMFAGIALCYIEGFFNKRTPEVLKLVWVP
FITLIVTGFLTILFIGPFARTLGEWLVAIFAFLFKTPGLKYVGALLFGSTYAPLVITGLH
HTFIAVDLQLAAASGGTFIWPLIALSNMAQSGAVFATYFIYKQDKKQESVSLSSTVSACF
GITEPALFGANLKYMYPFYAAITASALAAVISTGFNVLANGIGVGGIALAFLSIKFEGAH
QLGFWLASIVAFGLAFVLTFVFSKNPKLNKGSLTK
>SEQF2502_01633 hypothetical protein
MKKNVVVLLFVALITGVIGNSANRKRISRKKIGNTKVSEKTVDLSNYDGIKKISIFVQGF
ESGPAVSKIILEMTDFRITNLNKNDWKIKTNRAERKVKDIYVSDKKGEKAFDTGVVTLEL
ENVFNQNTLKYEGTPFTYNRKKFFNEWTKEYIVEIEGKITVNGKDYLVNKKENVINNRVS
TDTELFNYRSSFTGNYKNPITKKIENLKLEMAAYEPENFKLGAKKLLIVWLHGQGEGGTD
PDIDILGTETSALAKEEIQKYFTTGGTDTKGAFVLAVQSPTYWMDEGDGTNGNGSGNSRY
TQILMDTIKEYVKHNPYVDTSRIYLAGDSNGGYMTVNMIITYPDYFAAAVPICEAYAYHE
YARNSDGTYKTNNLEVSAGGKNSAVSRFVETKKLWVTNEKIQKMKKTPVWFIAAADDGIV
TPQKFSLPTYRDLLKAGADNAWYSYYENVTGTDEPNSRFPGHFSWIYFLNNQVEGVQNRD
KIKNSKDETTFGFEPSNTGKGGNEKAQLKGKTFENVFEWMNSQKKVKRK
>SEQF2502_01634 CCA-adding enzyme
MKLENYIFDEKATKILRKLNLNGNKGYFVGGCLRDVLLGKTPKDIDIATNMEYDDIKKIF
SDYPTKEVGKAFGILIIHYEDENFEIAKFRTDIGSDGRRPDSVEFVNDIEDDLLRRDFTF
NAMAFNEKDGLIDIFNGQEDIKNKIIRFVGKPKKRLQEDGLRLMRAFRFMSQLGFDFEKN
TEIAIKENIHVLEKISQERITNELNKLIVGKYAVKSFEKMKELKVLDYVLPELKVIYDFD
QNNPYHKFTLWEHSMNVLDGVSPELTTRWSALLHDIGKPEAKTVDEKTGYFHFYKHEIIG
ASIAKRIMSRLGQSNNIRDDVYTIVKNHMKLHNSQSEKTIKTLISNYGELNTKRLIDLAI
SDDGGKDHENDRNDNLWKTFYHIVENMKVPTINSLNINGYDLMELGIYNKEIQKVKKYLL
NELLEGNIENFKEELIEKVKEYILKN
>SEQF2502_01635 Glutamate dehydrogenase
MAKETLNPFEIAQKQIKSACDKLNADPAVYEILKNPMRVLEVSFPVKLDNGTVKTFIGYR
SQHNNAVGPFKGGLRFHPGVTRDEVKALSTWMTFKCSVAGIPYGGGKGGMAIDPKEYSKD
ELERISKGFAKAISPIIGEKVDIPAPDVNTNGQIMSWMVDAYEEVAGKSTKGVFTGKPLE
FGGSLARTEATGYGVNLTAKKALAKLNIDVKGATYAVQGFGNVGFYTAYYAYKDGAKIVA
FSNSHVAIYNENGIDMEAVIKDFEENGRITENKGYGKDITNAELLELEVDVLAPCALENQ
ITSENADRVKAKVVAEGANGPTTPEADEILFKKGIVVVPDILANSGGVVVSYFEWVQNLQ
SYYWPFDEVQQKEDALLSGAFEDVWALADEYKVDLRNAAYMKSIERISKAMKLRGWY
>SEQF2502_01636 hypothetical protein
MKQIFIVATTYTKPLKEVGKFRQDHFAFIQKNIDAGKFIAGGRQNPSTGGLILAYNVTRE
ELEEILKEDPYYKNNLIETVVTEFTPALLDKEFEKYSK
>SEQF2502_01637 Long-chain-fatty-acid--CoA ligase FadD15
MFLERTERLALVDFENKHINYIDLINNIKYFSEYIVDLGSEKFGLIVMENRPEWIYSFFS
VWDKRSAGIAIDSNSNPNEILYVLEDSHPNVIFCSDETEKNVLEAVEKYSLKGSIKLVNV
DKITIEQEKMDVIKNMQFELDNPTGDETAAMLYTSGTTGNPKGVMLSFNNLNTEMEGIYE
KGIFDYRDQILAILPFHHVLPLTASVLLMMKYQTSIVFVKKIASKEIFEALEKNRVTAII
GVPRVFKLFYDGIKQQIDAKFITRFIYKMMSSVKSLKIKRKVFAKVHKKFGGHLDFIVVG
GAKMDPEISKFYETLGFYALEGYGLTETSPVIAVNSKKERKIGTVGKKLYNVDIKIVDEE
LWVKGPIVMKGYYNKPEKTAEVITEDGWFKTGDLVTIDEEGFVTIRGRKNTMIVLSNGKN
IDPETLENRVIAKSNGLIKEIGIFNYQNKLTAIIVPELLEFRKRGITNTKAYIRNIVEDY
NLKAHNYEKVLDYKLFEEELPKTRVGKIRRFMLPDLYEKNEITKKEKTPEPTDEAYKILK
EYVKKNKGIEPQPEENLELEIGMDSLDIVEFFAFIENSFGIQLDEEKFAEMPNLKLLSEY
IDQKATKFEDNDVDWKKIISETKPIQDNKKRWVTRLLKVFQPIVDLYFRVRKIDKKKLTN
EPQIFVSNHQSFVDPLILGSLFPRKIVFNTLFLAIDWYFKKGVMKLLVSNGNVVLIDINK
NIRKSVEEIVGYLKSGKSIVIFPEGARTKDGKVAHFKKVFAIIAKELNVDIQCIGIKGAF
KAYSRYMKFPKPKKIEVAVLEKFTPEGAYDEITQKAEKIIKEYVEK
>SEQF2502_01646 Tyrosine recombinase XerC
MRNPNGTGSIFKKKGKSRKPYIVRAAAYLTEEGKYKRPIIGSAETLKEAKKILFEFNSRN
LNVDYADLKLIDLFNRWTESNHVKNIKTEETFYRYSTDFKSIFEDILEYKFIFLDYKDYQ
TRLDKYAKNKGKAALTVLKSIYVDAIKNKIVSENIPLYLESSSQITKTVERVVFEDNFVR
LLWKRYENTKDRYSAMILMLFYSGMRSADLLRIENKNINLKERYFVTGSKTEAGMNRQIP
IHHLIFPIIKKFMNDDKYLFKEQYDSLKYQFDKILSEYNTSGNLHSIRHTFITKMRRLKN
ESASKIKKIVGHKEKDITDGVYTHWTIKELRDVINKLVY
>SEQF2502_01647 hypothetical protein
MERNFKKVTENTGRKEVFKVMHDKVEIINDFNTNEKREARIIFHNQKIYVILYQNLNFEE
LKWLNFYILIYGNQSYGKNTFFEFKLNKNNLIYHLQVWNIIENKKFKSESISLLLKTLSS
KAGV
>SEQF2502_01648 hypothetical protein
MKLHEKLKFEREKQGYTLNELSELTGLHRITLHDYETEKIKNIPSDKILLLSKIYKKDPN
YFLLDNDKNIKSHNENIHNIEDINAIMLVNKQLLESLSIDSEEIKKFLKKYYKFIIKNIE
>SEQF2502_01649 hypothetical protein
MGSAAVGGLGAAVGAVVGGVSTGGAGAIAGMKTGAKIGSKIGKYPGNLTASAAENAGKAI
KVMTMNFDPIASGGKVKNMASDGIKKFMGNKKNDTKDTEENKSGNADRTADTKEAEEKIR
SDNSKNASNKDFQKQTNEGNKDTQKHSENTKTKDTKNSNNETFAESEMRREKDSKK
>SEQF2502_01650 hypothetical protein
MATSSFTTELKFDTEEKVSLFLEAIENAKNNKPLDIDVEYEFIKGNDIKKFFEETSEKKG
E
>SEQF2502_01651 hypothetical protein
MKFTTFSLTGNKILKIAYELLLEIRQKIRVKFIWLECQNNEKILNFYQNFGFSKIDNFIS
ESGYNVMIMELK
>SEQF2502_01652 hypothetical protein
MKLYERIIPKTSSTSYISGWEALNIPDENRNTADWHPRTYLFSYDKDKAINLYNTTNVLG
NSGIKKRIIII
>SEQF2502_01653 hypothetical protein
MYIANFPRAIADLVLTMKDYQLSSLHNCCNDFLNEDETEHLYQYLRSIKDNPRVDEFLKY
EFTVRYFNDKKL
>SEQF2502_01654 hypothetical protein
MNKKAVPVGVENFERIIKDGYYYVDKSLLIEKILENRTPVTLFTRPRRFGKTLNMSMIKY
FFDVKNKDENKTLFENLKISDSKYMSEQGKYPVIFISLKDLKADTWEMCRLEIKKVISKL
YREFQYITEKMDEDDKEIYNSIKNRKNDIDLNTSLELLSDFLCEYYGKKVIVLIDEYDSP
IINAFDKGYYNETIEFFQVFYSSALKTNDSLKYGILTGITRIIKEGIFSGLNNLYVNTVL
SKNYAEYFGLLESEVIEMLDYFNMKYKIEEVRSWYNGYLFGNEQIYNPWSIVNYLREKEI
KSYWANVSGNTLLENMLENAGESVYADLKKFTDGESIEKYISDGTTIKSLLSNDDEIWQL
FLYSGYLTKAEKQAERTESKNTYNLKIPNREIRSYFGDLFLNRFFGTEVKTKTLIKALEN
GDIRKFEKTLSEIMINMLSHFDLDSEMEKIYQVFMIGLVGFLMGRYEIISNNESGYGRYD
LAMIPIKSNEKAYLMEFKISKTEKGMRAKAEEALKQIDKKKYDTRLKARGIMNILKIGIA
FYGKSVKVVSK
>SEQF2502_01655 hypothetical protein
MDVKFLSESPDDSNARAADLGIILEIKGKILAVANGDAEDDTRKVAQWSLVPAESSDAYR
TVALEVISAGQMVRKIDMTNAFVVDYEESYGDQAGTGTFSLKIKQKKEKVKEVAIEGGYA
AQEA
>SEQF2502_01656 hypothetical protein
MLLRKHNVTQGGRQSRLSPFIFIGGKTLIYIKIINLLIFFSIFVNIKPNIFIIIILTIFF
SIINSMKKSDLKLYIDKELLIFQIITSFFLYRKTNFFEIDMKSYMFYFYNYAKLLFLGIN
IAMIIYFFKRKTKDFYYYYFYIIFLFLLIFENRFDISFLSLLEFFIHIIDLLYSQYLLDL
IMLFIIIKFCVVKKSKNSLYLFLLLNIYIKLKIFIV
>SEQF2502_01657 hypothetical protein
MSNKKEETNNFVKRKGTKDENNDIKMSKLNISLKEKDANFLIKIIVNEVLKVASPVSVAA
KCLRYYLAYPLRISNQKYKAGQLLGLPKGKLYDICKKIYPEPRDYLSLGYSFWKRGDLNI
HIDIVKNYLINNVRWAHNNNNIPKEKILSFYSYREVKSFFRDKDRTNKAAATDLYYAIGD
GNHLFGKVHTIDMKRRRFQILLVLFDEYNWDNSATYFMKIKKIRMIHICYQ
>SEQF2502_01658 hypothetical protein
MFINKYPVFKKGNVLEKEDLDLLRDNPLEVLSLMYSDKSNGIIKGFDLIPNYSERIVTIT
KGMAKCNGELFWMKEDYIFDMPKQEERYILKLKLVSNIEERKYYVREGRFVLELGENVNE
DEIEITRFITREGAELRNDYQNFRDLRRDFNLMEIINTKYSSAHKWGTFHPHVLKLWGKE
VSKILIFLI
>SEQF2502_01659 hypothetical protein
MGKGSFENLDIFDINFYVTCLQQDVIERDVITSYINAKLNLTDENYTNEQMFRHLLTILD
NLGTERKKVEKKRIIPRKIIVE
>SEQF2502_01660 hypothetical protein
MKFRVSIAGGSNNTSNNPFGGLGNVSVPSVAMNFVSNGENKNPISNAMGGLTQQGGVILS
SDEILEVSYSTNPIYGETMSASQSQVTLRIVGRLLPTASENNSPEDEGEGIVSGIMGTLG
MGTLFNQYKSVKHLFDKDNEAGEELPEASLSSNLLSSSGITEPVAKKAKESSKSKLVSQV
LGVSSTLPMTNSFTNGIGNSLKGMFGGLGNFGESNLYDQNKQNVKELSLWAMTYGDEKST
RDVMVQTDLGGGKTFELYFPKMYVSGFDQRFNTRAGEGYFELELKQTAFNESDINLN
>SEQF2502_01661 hypothetical protein
MNRKGKITAIEINEIKNALKYGYIHYRELDSFFRNNLLGSDPLMIRTYVEEITFKVVKTI
EDNINPTKLPDNATRNYYYKLYQYIKRSGTIFRIIDDDDKLREVRNGREVYEHLSYLLAE
GKYNKEVRKSNKITKIIQSIIEKGLQEMQKKVSSFVFGLLEIKEVENQRDLLIIYVLSTL
SVDQKEIERIIKELDSELRKGKDANNNNKYLFQRRILIKILDIYKNFLN
>SEQF2502_01662 hypothetical protein
MKKCITIVLIFFSLIIVFIIREKQNNIKCKINSLEEEKEYYFNSYQELKKKNIKLYKLDD
NQNLVEVKSSWDIIVSLGMILSYGESKRNFFDSKKVVLSKMLGLEKNEKNILIYIPKEKE
KDILSKASKYQKMNACSLMEILKN
>SEQF2502_01663 hypothetical protein
MNKFFKLTLLFVSIIVVILLYKNHSKRVKVNVSDCPNNRYMANRKEYYQKNYKIFKERNI
KFYIDDENGKMREITNQDEFFTSLREAKDYAYEIVGKKWFYTKRKLFGIAFGIDKEAKIK
YILVPEEEKKNILKNIDKYPEKNIENRCVLVEVLKGNY
>SEQF2502_01664 hypothetical protein
MPMTNSFTNGIGNSLKGMFGGLGNFGESNLYDQNKQNVKELSLWAMTYGDEKSTRDVMVQ
TDLGGGKTFELYFPKMYVDSFNQSFSVRGGEGYFVLNLKQTGFNEDNNTLK
>SEQF2502_01665 Internalin-A
MKIRKILIKNIIIILSILIFFINCTKKINNKNLEKRNSTVDLKEKYLNYGIDLENVKDNL
VILKKINNNYFINFKDPILVTCKYNNNNIEKIFFENVNLNEIYNIDCISNYDKNREYLKW
FINLKSIENYESKDLKNLPPKLKKQIETISIDEFYRGDTFDINEIIEFKNLKNIAVADKK
LKNFNKMENFLEIEEINLDSVEIVDSDLSIFDNKLNNFTKLMKFKIFDVKEFKNINILNN
SPNLKILNIAGVENIKDIDILKNFKNLEEVDISNNKISDISPLKNSKNIRILSISNNLVK
DIEVIKNFKNLKEIYIPHNKIKDLTPLKSLEFLEYILLDDKISITEIKKNLPKRLYKNAK
IYTDDAAYLGLIEVSYEKGEN
>SEQF2502_01666 hypothetical protein
MYNIVKNYPRYETINSKDLVKKLFNSRRLLDLPAPNTCAIRVSEALNKAGFIIDGTILPK
NEYEKGKNDKWYVLTAMGMKRYLEKKYGGLARYSVNTPELYRRFRQYIDVLGSGIVIYYS
QILKALQDMLIYGLKKNLLERIIYIINGLKKFIFFQALN
>SEQF2502_01667 Chaperone protein DnaJ
MTDYYKRLGVSEDADAKEINAKYRKLAMKYHPDRNPDDKKAEEMFKTISEAYEILGDENK
RKEYDEKRKNKGNTGSQRFGEKKSSRAEQNSESAKRGAEAFFRNFSANPNDIKNMFESAK
DGLKEGVKNEEIYFDNLFLFVNRM
>SEQF2502_01668 hypothetical protein
MKKFILIIFFCLLIGCRNQGNDVVIKDIDDVYFYLENKKNPEKAQLMARIVFELERENYE
EAEKYFLKLAKYDKTAYVSLANMYYEHIDKKEGEKRYEIAFEKGNKRAGTILGMIAEDNN
DYKKAEEWYKKSLDKENMLGYKFFAKFLYKTNRKNEAEKYFIEAGNLKDADSMLYLIKIY
YMKKDTEKLKYWQDKILNTKEIFKFDDETNDLLKYSLSKDKIDKEFFELYIKGEESVLKK
DYEEAEKYLVQMEKLKKEGILYTADFYYRFKDEKEKGIEKYKRAYENGIKEAAAFMGIIE
HRNRNIDEAKKWYKIASEAGNTNSQIYLAQILKEEGDKTEALNLYLKAAELKDYRAINYL
LKYYYREKNLKEIKKWVDVVKKSNGLKNYSEVDSRRIKEYEKFLNKNN
>SEQF2502_01669 hypothetical protein
MENNLNNQKPVEFFSAERIKIEIDGQQILWRDMNLEIDSKIGEHTIGKIKYTASPNQLSL
YDALIDKKGDKTIVVTGRSNISDEAGNATDKIFLNGVISKLRIKETKAGALAVELLCSSK
SILLDRIPRYRSFQDPTLTYTDIAQEVNKNYNDGETLVNIGEDMQAVPRMTIQYNETDWE
YLKRIASYTGQPLMANSNKVLVGFFKNMPAQTPNLTYSYFGKETEEERTYYRVEGTEVYS
VSTPIKLKIRNRVSGEEVENDYYVIESRIYNEGNTLKCEYKLGKQTDYFVDPIPHEKIRG
AVIEARTVHIARTDESKSEHGRTDGSSNNLEGRTMGIKPVNIYVAEEQEKNNNRSQEVKE
SDIAVMTVDLTEGLRKLGGAVQSEADKYAGKSYFPYVTPYSQTNTGFTPAPEPNDRIALY
FPSENETHALVMGAVNNNGNGRFTNPDKRNFTLGPSQAARGGTPANEGKPMYNFTLDNEK
FIVNVGNLISLTSNGTAQMTAKSNIDLTSTDAIATLRGKSCVKAIAIENAELMAKNVNVG
LGEGGKANQTKIKEIKTALKTQMR
>SEQF2502_01670 Chaperone protein DnaJ
MAKRDYYEVLGVPKNASEQDIKKAYRSMAKKYHPDRNKDNPEAEAKFKEVQEANEVLSDP
QKRAAYDQYGHAAFENGGAGAGGFGGQGFGGQGFGGAGGFDFEDLGDIFGSFGSFFGGRG
QQSQGPRVHRGDDLRYNLTLTLEEVAFGVEKELKYKRNGQCHTCHGSGAEPGHGTKTCDK
CNGSGHIKIQQRTLFGMASGIQECDKCHGTGKIPEKECHTCHGTGLERETFTKKVRFPSG
LQTGQKLIVRGCGDAGANGGIFGDLRVYITVAKHDIFDRISEYDIRCEVPLKMTTAILGG
EVEVPTLNGKKKIVIPEGTQNGKIFRLKNEGIKYSRSENRGDEIVEIKVETPTNLTDKQK
EILREFDGSLDNKKNYKKAHSFKDKIKRFFSKFEN
>SEQF2502_01671 hypothetical protein
MLEILKNNFKKFAIFVGAFSFGRLFYNYGINFSNLNIFIYFLIVLGICFFVGKSLKAGFE
NAIIETFLLVLIHIFQLDVSFKSFLYGVFIFISISSVFNKIRESGKGKDPITGVLYLLIA
LTVLFIFYKNSGSILYFRGVENITNEMLILFGLISLIGSI
>SEQF2502_01672 hypothetical protein
MESTINILKYGNIEIIVADRGAELQSYKVNGEEFIWDRKPEFWAASSPVLFPFVGTIKNG
VYSYNGKEYKISTRHGFARTENFELVEKTENSLKFRFSSNKETLEKYPFDFELFITYTIA
GNALEIEYNVVNKNDSDMYFSLGTHPAFALDVNDNIKLSDYYLEFEKNETSKKYKLNEKG
LVLDEKADCLNNENKLQITENVFDDDAIIFEGLKSEKVVIKNSKNSKKLSVEYKGFPYVA
FWSKPKAPFVCIEPWYGISDFENTSGKLEEKIGILKLEAGEEFFAKLVIEGKK
>SEQF2502_01673 hypothetical protein
MSKNLKSKVKKLEEKELSSIAKLFLNYKGKYEKIDLDWDNEVVKEIWYKYESEKSK
>SEQF2502_01674 hypothetical protein
MNVASVKNLTDYLDIDKSFFGALSLGLFYLKISFVENIFIFKINIFIIIAIIITILSIIL
GYCSIKKFKEDYRQYVIFGIMIFVFPAVSSLIKNDILSKINDVLLGISLFYLLSTFFNDV
ILEKRRSQKLNKISNVKKEILIECSDRVTEIEEELLPKISKYLDIEKIKEKLKKIDKILM
KISEKLNDLTMLKESVCVEGNLEKLPDMKEVKRNLKELKLKLIEVKKEVKKESVKTENNI
KKTLKKMEVNLNESQEIIEKVQIKDPIELYPFKIAFLIIGIILSIVLIIYYYDHEIKFNR
FNEIHSGIYLLFSLLLLNSWINENEKIEE
>SEQF2502_01675 Chaperone protein DnaK
MSKIIGIDLGTTNSCVAVMEGGNFAIIPNSDGGRTTPSVVNIKDNGEIIVGEIAKRQAIT
NPDSTVISIKTQMGSDYKVNIHGKDYTPQEISAMILKKLKKDAESYLGETVTEAVITVPA
YFTDAQRQATKDAGEIAGLKVQRIINEPTAAALSYGLDKKKEEKVLVFDLGGGTFDVSVL
EIGDGVVEVISTSGNNHLGGDNFDQKIIDWLADEFKKETGIDLRNDKMAIQRLKDAAEDA
KKKLSTTLETQISLPFITMDASGPKHLEKKLTRAAFDELTKDLVEATKGPVKQALEDANL
DPSGIDEILLVGGSTRIPAVQEWVKSFFGKEPNKSINPDEVVAAGAAIQGGVLMGDVKDV
LLLDVTPLSLGIETMGGVFTKIIDRNTTVPVKKSQVFSTAADNQPAVSIVVLQGERARAA
DNHKLGEFNLNDIPPAPRGVPQIEVTFDIDANGIVHVSAKDLGTGKENTVTISGSSNLSK
EDIEKMKKDAEANEAEDAKFKELVEARNQADQLVIATEKTIKENESKLQGTEKEDIEKAI
EELKKVKDGDDIEAIRKGIEELSKVSQGFATRMYQEAAAAQQQAQGGEAAGENNNSGADD
VEDAEVVD
>SEQF2502_01676 hypothetical protein
MKYKRKNFLNEEEENEDEVTQADIDKLITPCGENG
>SEQF2502_01677 hypothetical protein
MKEQQKKDDEIHEYEKLKEILETIKLEYQMERNKKNSFETRAGFIIAFLSAIIISVIEKF
NLKNTINLFNINLTFGILIKILSGIILIISLIFICFSVFQMINIKFYNNLEIKEINDEFL
KQSRKKLLKLLIFMYRDIIEQHRKLHKKNAEILKRIITILLIFLISFFFYVSF
>SEQF2502_01678 Protein GrpE
MSEKDLEKEAKDNESKETLDKETKEAKADDSEKEVKEETPEEVIAKLEKDLEEWKSSYTR
KLAEFQNFTKRKENEVAEMKKYASEGIITKLLDNIDNLERAEQASAETKNFDALVEGVNM
ILRNLRNLLTEEGVEELEAAEGVKFNPYEHQAMMTENVEDLDNDVIVKVFQKGYKLKGKV
IRPAMVTVNKK
>SEQF2502_01679 Heat-inducible transcription repressor HrcA
MNDREQLILKAIIKHYLEFGESVGSRTLEKKYNIGVSSATIRNTMADLEDKGLIAKTHTS
SGRIPTSEGYKLYVDELLKIRDISQEEKAKVMQAYNKRMNQIDVIFEETSRLLSKISQYA
GVVLEPAFTQEGVRKVKLVHINDTTVLAVVIMNSSLTKNLNIFLENPVTENEVEKINDFL
NEKITNSQYFTLSDLKDFFTNTNLFSQSDFQGNGISDEGKLFFEGGTNLIENNTSDIMNI
INRVKLFNNPNDLRNVFSQFLQMEEFQDGEVNVIFGEDLKIAGLEDFSFVFSVYTLNNAK
GIIGVIGPKRMEYSKTVGLVEYVAEEVNQLLNQKNKQ
>SEQF2502_01680 hypothetical protein
MKKRKKKLPIGLSDFKEIIEYDYYYFDKTKFIENILEDRSKVKLFTRPRRFGKTLNISML
KYFFDVKNKDENRKLFEGLNISKSEYFEKQGEFPVISVSFKNYNKNDWESGFKSIKSTIS
DIYAKFEDLMEHLNKRELKKFEDIWLEKDEGDWEKSLLNLTKYLYNYYGKKVVVLIDEYD
QPIINSYIKGYYNKIIDFFKNFYGAVLKDNEYLEMSIITGILRVAKENIFSGLNNIKVHS
ILNKQFTEYFGILENEVEEALIKDFNLEYDLLDVQKWYNGYLFGDIKVYNPWSVINFLDE
KRLEAYWVNTSGNGLIKLYLQKLKDEIFDDFSKLLNKESVLKRVNDSMTFENLEANFEKN
IWNLFFHSGYLTLAEKYDGNREEIYLKIPNEEILKMFSEMFIEVYFKNYEIFSDMTFALK
NGNIEKFKFELNKILLENTGIFDVNGNYKEQFYHGLILGLILKLRNEYEITSNGFAGKGR
YDLLLKPKNILGGREGIIFELKIVNLVEKLEKDNLEKKLEKECEIALRQIDEKKYSSVLR
NAGVEKVLKIGIAFLGKEFEVKSEIDYC
>SEQF2502_01681 N-acetylmuramoyl-L-alanine amidase
MKLLLKLAILISSVSGFANAAEKVCIDPGHQAKGNMQTEEVAPGSSKRKTKVAYGTRGVA
TKKPEYQLALEIGLKLRDALKAKGYSVFMVREKNDVNISNKERALMTNKEGCDVYLRLHA
DAGGSSTRGATVLTSSSKNPYTKSVQQSSDKFSKAILSEYTKATGFKSRGVSYRDDLTGT
NWSTVTNTLLEMGFMTNPEEDRKMASPDFQNVMVKGIVNGIEKYFREK
>SEQF2502_01682 hypothetical protein
MKKLILGIFLLFGVLGFSRYVERCKVVEDDTCVSLDSGKRFNFSKYVFEDIQYGSVYRVY
FEGNGYRNLYFTGATYLYMKH
>SEQF2502_01683 Mycothiol acetyltransferase
MKKNYKIKILDAKKDSDLLFKIVEHENEVFGEATVGNWNIKPFTKYGKVFAMLSDDENTK
DELMSVIEVLSSFDREVAYVYGVSTVPKFQKHGYARILLQFVMETLKEMKIKKIELTVDM
DNFIAKRIYEKLGFEIVGNLDNEYGDNIERYLMRYFVK
>SEQF2502_01684 tRNA pseudouridine synthase A
MKKRNVKIIYQYDGSKFLGFQRQKHSNVKTVQGEIEKVILKTFSQKINMISSGRTDKGVH
AIEQVSNFLIDDNIPLKAIKRQINKSLKGEIKILKITEVSEDFNARFDAKNRTYLYIMRA
EEDITPFEANYVTGLYEKVDVEKFQKIMDSFIGKHNFSSFMKKDKAYRNRIREIFYIKCY
YDEKFGKNQVNIKICGNGFLKTMVRIMIGSALAIYFGKEKEDYIEKRLENPNADNKKILA
PSEGLYLYKVNY
>SEQF2502_01685 hypothetical protein
MLQSFYGIIQVKHYQNGRLRLQTEILKDNEELKEEFLHNIRRISGINSTKVNSITGSILI
YFDEKVIEGSFLYLVVLKLLHLDEEALKNKSGKIKELLKQVFESTDMAIYNKSKGYLDLK
TLTAGIFIFYGIKKLWKVPGLPKGATLLWWASRLLSDEKRK
>SEQF2502_01686 hypothetical protein
MLENFFKATYLMLNQIRVVHSIPGRLRLFVPNLSKVPEELKKYDGEVKKLILSKKGLKSV
EYSYITNKILLYYNSNLISEKEILEWINKVWKTVIEHSELYENKSLKEVEDNLEIFYDLI
KKI
>SEQF2502_01687 putative manganese/zinc-exporting P-type ATPase
MASRNYLLSCEILHEIRGRIRIRSRALKHIGIYKEEITKRLMKIHYIKNVEISTITGSAL
IYFNNFSLTGENFVSLLQNILNAYLVDIYKNEKKETSNKYVIERRLQEESPKEIMKNIGA
AVLLLLLPGPKTKLTGIRRLFNYKTISTISLAIPVLKNGIFSLIKNKRPNADTLSSTAII
SSIALGSERTALTIMILERIAELLTVYTMKKTRGVIKDMLSVGESYVWKIFEDKDQAAKK
VPIEEIKKGDLILVQIGEKISVDGTIEKGNAVIDQSAITGEYMPVKKETGQEVFAGTLLK
SGNITVRAEKVGDDRTASRIIKLVEDASFNKADIQSYADAFSAQLIPLNFLLAGIVYAST
RNLQKALSMLVIDYSCGIRLSTATAFSASINTAAKNGILIKGSNYLEELSKADTVIFDKT
GTITEGKPKVHTVKTFAKNMRDDRMIALAAAAEETSTHPLASAILNEVRNRGLKIPRHKE
DIIKVARGIETYVNKDIIRVGSRRYMEENNISVEMSFDVVKGMQNNGEIVIYVAKNENLI
GVIGVSDPPRENIKKAMNRLRNQGIDDIVLLTGDLRQQAETIANSMSMDRYESELLPEDK
AKDILKFRSIGSKVIMIGDGINDAPALSYANVGIALGSSRTDVAMEAADVTITSDDPLLI
PAVVGLAKNTVKIIKQNFAMAIGINSFALVLGATGLLPAIYSSVLHNSITILVVGNSLRL
LKYDVNK
>SEQF2502_01688 hypothetical protein
MKKLTLTVLHKLPNRVRFKISHEIIDIKKFFETIKVGAKSTALRYNRTINTLLITFEPEE
ITIDEMIYRTATALSVERDMTSVKLVEDFEEKSIDSLSVYSGAAILLSFLYGLGKSKIEK
LQLDINNFTAGLTTAAIMEHAYMETRRKGFFDIEILPALYLLRSYMSNRSVTAIALMWFT
TFGRHLVLNNVSNKEVRIYRLKADNGKFHYVVDVKNDNSIENLSDLIDHIFFNKQANMEL
DDKYIPLK
>SEQF2502_01689 hypothetical protein
MIKFGSVKKEHLVGAAIGVGTVAVGYYLYKKNQGKVDRFLRKQGINIKTSSQTAYDNMNL
EELVATKEHLEDLIAEKEMSTNNDISETVVEVEAK
>SEQF2502_01690 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
MKLVLIRHGESQWNLENKFTGWKDVDLSPKGVEEAKAGGKALKEQGLVFDVAYTSYLKRA
IKTLNYVLEELDELYIPVYKSWRLNERHYGALQGLNKAETAKKYGDDQVLIWRRSFDVAP
PAIDKSSEYYPKSDRRYADLTDEEAPLGESLKDTIARVLPYWHSDISKSLQEGKNVIVAA
HGNSLRALIKYLLNISDEDILKLNLTTGKPLIFEIDENLNVVSSPDSF
>SEQF2502_01691 hypothetical protein
MTLEITTPAVLFPTVSLLLLAYTNRFLALTAIVRQMDSSGEVEHEFYQVKNLRKRLNYIK
RMQYFGVSSLLMCAISMLFLFFQMDFIGKISFGISLVSLIISLLFSLLEIQISLEALRIH
LNHNSENEEKK
>SEQF2502_01692 Bifunctional protein GlmU
MISVILAAGKGTRMKSGHSKVLHKVNGVPMIRRVVDVLESIGNKKNVFVLGYKKEDILAE
MGDVDFVTQEEQLGTGHAILIAKDKIKSYGEDVIITYGDTPLLKEETLKKLKDMFNGKNL
DCIVLSCKVKNPFGYGRIVKENGKISNIVEEKEADENEKKIDEINTGVYIFKNESLLYAI
EKIDNNNSKGEYYLTDAIKILTSEGYNVDSFQIEDEDEILGVNSKVQLAQAEKILRNRKN
TELMDNGVILIDPDVTYIEDNVQIGQDTVIYPNVIIQGNTKIGKNCKILENTRIENSVIA
DNVRIEASVVEQSTLEEGVTVGPFAHLRPKAYLKQTVHVGNFVEIKNAILEKGVKTGHLT
YIGDAEIGQDTNVGAGTITCNYDGKNKHKTKIGKNAFIGSNSIIVAPVEIGDEVLTAAGS
VITKDIPDETLAFGRAKQVNKEKKINN
>SEQF2502_01693 Ribose-phosphate pyrophosphokinase
MSENKKLIKIKNINERKGNKMITLTKEDKDKIRVFAGTSSKKLAEKIAKYLDMDLSAAEI
VRFADGETFAKAKKSVRGCKVFIVQSTSKPVNESLMELLVFIDAIRRSSAKEIIAVIPYY
GYARQDRKASPREPITSKLVANLLTVAGATRVITMDLHARQIQGFFDIPVDHMEALPILA
KNFIKYGFSPEDTVVVSPDVGGVKRARGLANWLHTPLAIIDKRRAKANVSEVMNIIGDVK
GKKAILIDDMIDTAGTICNAAQALIDKGALEVYGCATHAVFSNPAVERLKNSAFTEVVVT
DTIELPEDKKFDKLKILTTSKMFAEIITRIATNNPISGLFEMPVDDGNDD
>SEQF2502_01694 Threonylcarbamoyl-AMP synthase
MTKIKKNKKKEIEKAVEILKNGGVAVFPTDTVYGIGSLPEKESVEKIYKIKKRDFSKKII
ALINDRKILKNLVNETEEDMKKFSKIFDECWPGELTVIFRVNCDFTKKFDEKMKTIGIRI
PKNKIALEIIEKSGGVVLTTSANISGESAVKRIEDLSKELIKNVDIVISNEKSELTGKPS
TIVKFENGGLTLLREGNILFEEIVKKLK
>SEQF2502_01695 hypothetical protein
MAKMVNPNTVSNMDLINAKSQAKMQQLVQKIGKGKRKVNVTFSKMSRSYLAKMIEEMRKM
MSQYEKQLPNVFSFFKYLENEVKITKVNKKEKTKNVKLSYEEVDFFKLQLKETLKGIDTQ
RAALKWYNLIKKGLFKTLKKQTELVLEEFNSGTVKKK
>SEQF2502_01696 putative type II secretion system protein HxcR
MNEKIIEKTNLKDISDNKKNNLLSKDTVSYLNEIIKAGFKERASDIHVKFDLLEGIEIKY
RVDGYLKESQKLYEIVSKKILEKNITEIIARMKILAGMNVAEKRKPQDGSFSFLLNTKNT
NKRYDIRAAYMPTVNGESMVLRILENYLKDTKLETLGFSTQSIRMLNEILDRKYGMILVS
GPTGSGKSTTLKSLINMLNDGRKKIITVEDPVENKIDGTVQIQVNQEIGVTFSEVLKATL
RNDPDIIVISEIRDEVTAEIAVRAALTGHLVISTIHTNDAVSTLIRLVDMGIPKYLILDS
LIGVISQRLVKKKCQKCMGESCDECSSGYSGRITINEVLVLNQDVRNILKEDNHLGSETK
NKLKMLNQKCFINFVEDANEKIENGLISEREKVTIIF
>SEQF2502_01702 30S ribosomal protein S1
MDILKNVASELNFNESQVENTIKLFDEGSTVPFIARYRKEVTGNLDEEQIRDVIEKVTYY
RNLEKRKEEVLRLIEEQGKLTDKLKSSITCATKLQEVEDLYLPYKKKKKTKADIAKEQGL
EPLTEFALLSTTTFEELQKEAEKYLSEEVVSVEDAINGVHLIIAQNISEDVKIREFLRNK
ISEFGILTSKVVEKNKENDEKGVYQDYYEYSELIKKAASNRILAINRGEKEKILKVDIEI
DEKTEKFIMDFILNTFENKNLVEFLSEVIKDSLDRLAYPSIKNEVRNIYTEKAEEEAINI
FSENLEKLLLQPPLSKKTLMGLDPGYRTGCKLVIINKDGFYETNDVLFLVEEMHNSKQLA
TAKKKILDYIKKYDVDIIAIGNGTASRETESFVADVIKEASKPVSYLIVSEAGASVYSAS
KIAIEEFPDLDVTARGAISIARRIQDPMAELVKIDPKSIGVGMYQHDVNQKKLNETLEQT
IEHVVNNVGVNINTASWALLSFVSGIKKNVAKNLVDYRHENGDFKDRKELKKVKGLGAKA
FEQMAGFVVVPDSENPLDNTIIHPESYHVAETILKEAGCKASDLKDNLKEVRQKLKNVDL
KKIISENEFGNETAKDVYEALLKDRRDPRDEFEKPLLRSDILKMDDLQEGMVLEGTVRNV
AKFGAFVDIGLKGDALLHISEIAEKFVSDATKELSVGQIIKVKILSLDKERGRVGLTRKG
L
>SEQF2502_01703 L-lactate permease
MEFLVGLVPIVVFLILLTFLKKSAMFSAYASLVVAIILNFVMPGWRMPIQGVFASIIEGF
ATAWMPIGFVVFAALFAYDLSVKTGKIETIKSMLGSISTDKRAQALILAWGFGGFIEGIA
GYGTAVAIPAAIMVSLGFTPLSAALICLIANSTPTAFGTVGLPVTTMISNFKLNAGETAF
YTSLLLLVLTCIIPFILVIMANKEIDGGKNAAFGRGILPVVIASIIGYLTQPFIAKAMGA
ELPTILSSLFAMILMIVATKIFIKEDESAKSNKGQAITGKDAFMAWVPYILMIILIIGTS
PVVEAVHKALEPTTTHFNFALGHEATWFKDKGDPSVIFKWILAPAAPLFVATVIAGFIQG
VKPKVMAETLKETILSKLPSVVVIMGIVALSVVMKHSGMIESIAKGFAATGKFFPVISPF
LGTIGTFVTGSDLASNLLFGGVQVNIAGSNEALKALYIAAGTGGATGGKMISPQNIAIAA
STVGLMGKEGDMLKFTVKYSIAYAAVLGILTFIGAGMLH
>SEQF2502_01704 Isoleucine--tRNA ligase
MSENNNPEKVDYAKTLNLPKTSFKMKANLAQKEPLTLRDWKKAEIYEKSLNEGAPFFVLH
DGPPYANGDIHIGHALNKILKDIILKYKRLRGYNAPYIPGWDTHGLPIEWKIMEELGEKA
KNMTPLQIRQECKKYALKWVEKQKEGFKRLGILGNWDNPYITLRPEYEAEQLKVFKEIYE
NGYIYKGLKPVYWSPTTETALAEAEIEYKDVTSHSIYVKFEGEKDLADKLGVDEASILIW
TTTPWTLPANLGVFLHPEFDYGLYKTEKGNLIVAKELAEDVFKTLDLSYELLKEFKGTEL
EYTHYKHPFLDRKGLVMNADYVTVDAGTGAVHTAPGHGADDYNYSLKYNIGILSPVDDKG
QMTKEAGKYEGMFYAKASKAIVEDLTESGHMLYHTTFVHSYPHDWRSKKPVIFRATEQWF
ISIDESDIRENAIKALENVEFVPSWGKNRIGSMLETRPDWTISRQRVWGVPIPLFYNRAT
DEVIYEPEIMDRIIELVKKEGTDIWWKYEAKEIIGDELLEKYNLKDVDIRKERSIMDVWF
DSGVSHRSVLVPRNLPRPADLYLEGSDQHRGWFQSSLLTSIASTKDAPYKRILTHGFTMD
GQGRKMSKSLGNTILPKDITEKYGADILRLWVSSVDYREDVRISENILQQMSDAYRRIRN
TARFLMGNLNDFDYANDKVDYKDMFEIDKWAMHKLEELKAKTTEFYDKYEFYSLFQEITY
FCSMEMSSFYLDIVKDRLYCEGTTSIERRSTQTVLTEVLKVLVRIIAPVLSFTADEIWER
IPETLKEEESVHLSKWIEARPEYLNKELAQKWDKIARLRREVNKKLEAERQNGLIGHSLD
ARVLLNIANDEYSFIKDYTENEVSDLFIVSQVKFVSDNLAESEIEGINIAVEKASGEKCE
RCWKYDEEVGHNHNHPDVCPRCASVLEKM
>SEQF2502_01705 Lipoprotein signal peptidase
MPYIIIILVLAALDQITKQSMFNVSGGVQGFSIPIIDKFFHLTYVENHGGVFGLLQGKIN
LFTIASAVLIIYVIAVEYKNFKNYSKWTKIGVAVIAAGATGNMIDRILRGYVIDMIDFRG
IWAFVFNVADMYVHIGIYIIIIDYLVKKYLKKNR
>SEQF2502_01706 hypothetical protein
MFGAVYLAMMLFWVLVVIIAVMAIIISVSKNKLRTIFGIDIAILIFTVLFFFVWFPVKEN
TVLNLKNGYSVSTEYNEAIPEVNYYLSNIGYLGKLGKIKGSWVGYVYNANEAIAEVFYVN
ADFDLMEDEKNKQEEMKEIDKKSGYFIINSKEQTLYLTEEQVKEKLKIKKVNLKNPKKIV
RKYGEKKELSTFYKIAEDYFLPKKIGATAFNVIKYVIISLLILVAVYLKKRLNKKK
>SEQF2502_01707 Glycine--tRNA ligase alpha subunit
MTFQEIILTLQKFWGDKGCIISNPYDIETGAGTFNPDTFLMSLGPEPWNVAYVEPSRRPK
DGRYGENPNRVYQHHQFQVIMKPSPENIQELYLESLVALGINPKEHDIRFVEDNWESPTL
GAWGLGWEVWLDGMEITQFTYFQQVGGLEVDIVPSEITYGLERIALYLQNKDDVKDLEWT
KGVKYGERRFQFEYELSKYSFEVADVPMHFQLFDMYEKESKNCLNNDLVFPAYEYVLKCS
HTFNNLDARGAISTTERMSYILRIRDLAKKCAEKFVEARERLGFPLLNKK
>SEQF2502_01708 Glycine--tRNA ligase beta subunit
MNFLFEIGLEELPARYVDQAEKDLKKIIENELKSERIKFSEIESFSTPRRVTAIIKDLAE
KQDDLDKKSVGPSVEIAYKDGQLTKAGEGFVKSQGATIDDIKIIENEKGKYISIEKFIAG
KNTKEILPEILKNAIKKIEFEKSMKWADRTFRFVRPIKWFVTLLDNGEILPFEFEGIKGG
NKTRGMRYFASQDIEINNPLDYEKILLENFVIVDGEKRREEILKSIKENGEKDGDTAIIN
KYLLDEVVNVVEYPYAIKGEFNKDYLQLPEDIITITLETHQRYFPVKDKDGKLSNKFIVI
RNAPEYSETVKKGNEKVVEPRLADAKFFFDEDLKNKFADNVEKLKEVTFQKDMGTIFEKV
KRSEKIAEYLISELNLNDKKENIIRTVDLAKADLVSNVIGEKEFTKLQGFMGSVYAQKQG
EDKNIALGIFEHYLPRYQGDKLPTTMEGAITGIADKMDTIIGCFAVGLKPTSSKDPYALR
RATQGIIQVVLNSKLSFDYKKLIEKSYEIFSADKKVLEKNVIKDVTEFFKQRMINVLSEK
YKKVLINYEINLESNIVKLDKKLAELLKLSQTENFEILINLLKRVKNIVKDEKSENLNVD
NTLFGSDEEKALYNFVNQLKSIESKDFLNYIEMLLNNANTINQFFDNVIINVDDEKLKNN
RVALLKKLEYSIDKMINI
>SEQF2502_01709 Outer membrane porin F
MKKLVILGTALLALNAVASEVQVKGGYDFYRKFKAGSSEFSEDYNLKHGPTLGLEYIVDN
QGEFEWGLGAEYKLSSHSGKLIRKDDKAKLMRSVPVYALGKFNLITTNNGNDALYVLGRA
GYNFAHEAKNVNGKVKGGLYTAAGIGTEFGPVSLEAIYERSGAKIKTTDALGNTERTRNN
IDSVGVRLGYRFGQLKNDRSPKIITQTVTVPVPTPVPAPAPEPAPIVKPNTAVLPFSCST
EEKKCVIRGFKVDGRVPNEGEAADLRTIAGVINQFADGGSIDFIGHTDSTGSAAYNQKLS
VARAQNVARLLRDYGLKNSISYGTITGQGESNPADTNDTVQGRYNNRRVELFFQNVDFSN
VKFINQ
>SEQF2502_01710 hypothetical protein
MDLSKIKLVVIIQCEIAKRRCSGYHCSQSFYERSGGFLKYPMEQDMRVLMFQCGGCNGKG
VNSLLSNVNKCLKKEGKITPEEVAIHFASCITLDNHHSSRCMFLNYMKQQVSKTPFRDSI
ILEDTWHSKTATRRRAEGIYKTNKN
>SEQF2502_01711 Phosphocarrier protein HPr
MKEIIVEIKNEQGIHARPSGQIVNIAKKYNATLEIEKVLENERAENNKGKNEKVDGKNVF
GVMMLGAEKGEKLKLRAISENGENPEEEAKLLEELRQLIEINKFFE
>SEQF2502_01712 30S ribosomal protein S1
MNEKEFETLLEDYLPEEKKSGDVVEGIITRKEMDYGFLDLNAKKEGRIYASEVKDFEIGD
KIEVKVLREDDDNIIVSKFMLDKAKELASFNVDDIVTGEIVKKIKGGYTVKIGKNDAFLP
FSLARFEKDKDYTGQKFKFIIKEKNKSNITISRIDLIKIEEEKYFESVNVGDVVTGKVKE
IFDFGIILDLGAASGFIHISEISWDQVDNLHERYKIGDEVTAKIIEKDVEKNRLKLSIKQ
LSEDPWVAFEKSHNVGDVVEAVVKGMLDFGIVVTVDGNSGFVHVSELAWHNGSKELKNYK
VGDKFPAKIIQIENEKKNVKLSVKQLSENPWNTVKEKYHIGDIIEKPITEVFDFGLLISL
EKDIDGLLHVSDLSYKRESNLTSKYKAGDLIKFKIVDFNDEKNRVTLSAKALLDDKWDVL
EETYDFDKSYKGKVMNVQDYGIFVELEKGIEVFIHKNEFSWDKREHKEYKVGDEVAFKVI
VIDKIEKKLSGSIKQLEKSPWKEVTEKYKKGNIINTEIVEIQENFVLVKLTDRFNGIIPK
RELTEEFLKDISEKFSVGDKVEAVITDINEKRKSIALSIKKVQEMEEKKEMDELMKVYGV
>SEQF2502_01713 Branched-chain-amino-acid aminotransferase
MAGKTEFMKYAYFNKEIVEFEKATVSIATHSLQYGTTCFGGVRGYYRNGKVAIFRLEDHY
KRLMTASKMLGFEFFMGWDEFKNIVTELVKKNDIKEDFYMRPFIFCKEPRLSPKKAGLDF
DLAIYMLPLADYVSTKGGLKLMSSTYRKYNDSSIPTKAKAGGSYINSFLATSDAQRNGYD
DALMFDDTGNVVEVSVANIVLIYRDQVIIPDTGNAALEGITVRSALELLEYNGYKVNRGK
IDRSMVFTADELLVTGTAMKITYAESLDQRPIGQLDFHAEPKPGKFYELLKGEYEKVING
DHELSKEWLFVVE
>SEQF2502_01714 Transcription antiterminator LicT
MKIKKILNNNAIISENDQKEEIIITGKGVAFGKKAGDLIDNDKIEKTFILKHNETSEKFK
LLLEDIPVNYVSISYDIIEYAKNILNVQFNDFIYVTLTDHLNFAIQRHKENISYVNALQW
EIKKFYPKEYGVGLKALEFIDDELGIKFSEDEAANIALHLVNAKINNKNEIRETMQLVKM
TQDILNIIKYTFGIELDESSLSYERFMTHLKFFFQRIMKNTQINDDNDFIYQEVRKKYIK
AYQCAEKIENYFFKIYKRKLSEEEKTYLAIHIQRITQK
>SEQF2502_01715 PTS system beta-glucoside-specific EIIBCA component
MKKYEKLSKDIVEAVGGKENVISLHHCVTRLRFKLKSNDKAAMERLKKMDGVATALISGE
QFQVVIGNHVADVFDEVLPLLGLSGNEKKEEPKREIKSIKDVLNILIDVLSKLFQPILGT
MAAAGMLKGIAAILISLGVSNTDGTYLTIQAAGDGLFQLLPVFLAWTSADWYKKVIASNG
ENLD
>SEQF2502_01716 NAD-dependent protein deacetylase
MDKINLLQKIIDESKRIVFFGGAGVSTESGIPDFRSANGVYNLKLDRNFSPEELVSHTMY
EKYPEEFYDFYKKHLVYPEAKPNFTHKYLAKLEENGKLTAIVTQNIDCLHEMAGSKNVLK
LHGTIDKNTCVICGNKYNLEEFLEICKTESIPHCPKCKGTIKPDVTLYEEVPDPDTFRNA
INEISRADTLIIGGTSLVVYPAASLVQYFQGKNLVLINKSKTEQDHFANLVIHENIGEVF
KKLKKII
>SEQF2502_01717 putative dihydroorotate dehydrogenase A (fumarate)
MATTKTKIGNSEFRNCFMNAAGVYCYDKNELEQVINSAAGTFVTKTATLQSRPGNPEPRY
HDTALGSINSMGLPNLGFDYYLDYLLELQKTHPDRTFFFSLVGMSTEDTHTLLKKVQESD
FNGITELNLSCPNVPGKPQIAYDMETTENLLTDIFSYFKKSLGVKLPPYFDIVHFDQAAT
VFNKFPLTFINCVNSIGNGLVIEDESVVIKPKNGFGGIGGEYIKPTALANVHAFYKRLNP
SIQIIGTGGVLTGQDAFEHILCGASMVQLGTTLHKEGPSAFERITNELKAIMDKKGYKTI
EDFKGKLKYL
>SEQF2502_01718 hypothetical protein
MENLEFDNFNDNNDSERLYQMGKNYYDNGSDTLAEKYLKEAAKSGNRNAVFILADIYLKY
DKLNLAEKYLKKIADGGDFQLQDKLGTVYKRKANFELAEYYYKQAINNGNQKSRYNLGNL
YYQYNKKDLALDYLKPAADERDQEAQVLLSKIYYDNGQIELAEEYLHKAKDNGEAYYLLG
KLYGEKQDIETAEKHLKTAADTYDSKKAQEVLYKLYADKQNQTLTKHYLTLLADENHLES
FVLLGNIFADEKNYNLAYTNYSHFFEGRKRTNTKIDMKKIDEEKLKFNFGKCCIKLGKFE
KAEQNLKENSYLKISDNIIEVAKLYEEAEQLKIAIQYYKSALHV
>SEQF2502_01719 Elongation factor G
MRIYDSSNIRNIGILGHSGSGKSNMVEGLEFTAGITNRIVGNENDTKITSSLSLHAVEYQ
GAKYNFVDIPGYGDFFGEVESGLAAVDGAIIIVDGTTDLTVGTETALELTDSRNIPRIIF
VNKIDNEKADYEKILSQLREKYGKRIAPFHVPWGSGENFRGHVNVVDMFAREFDKGKNEC
QTVEMPTDMDDEINSVREMLLEAVAETDEELMDKYFSGVEFTTAEIHRGLRQGVLDCSVI
PVICGSTLKNIGLHTTFDVVKDFLPSPDDNEKVQPEKDEFVCQIFKTTIDSFLGKVSYAK
IYSGEIKQDSEVFNLNRKTKEKIGKINTFVNNKMDEIQKGIAGDIVVFSKFNSTKTSDTL
STNEKKVPLRDITFPKPQLFVAIEPLNKNDDEKMSSGLNRLMEEDPSFIWHRNLETSQTV
LGVQGELHCATVIEKLKAKFGITIKTVELKVPYRETIKGTSDVQGKYKKQSGGHGQYGDV
LIKFSYADEDFVFEETITGGSVPKSYIPAVEKGLRESLKEGVLAGYPVTNVKAVLYDGSY
HDVDSSELAFKIAANLAFKKGMLEAKPILLEPIMELIIIVPEEYIGDIMGDINKKRGRVL
GMEAHKGTKQKIIAEAPMSETFKYANELKAITQGRGYFEMKLVRYEELMGDLAQKVIEKR
QKKK
>SEQF2502_01720 Choline trimethylamine-lyase
MREFVLKSERVKKLRESALSKFPGVSVERGRLLTKAYKEHEGESKYMVRAYAVKEILENM
TIYIKDGELIAGNQSVDERTAPLFPEYAVDWIIDEINTKGNFDHRDGDKFRIPEEEIPEL
LEICEWWRGKTLKDKAHAQMPQEIKEAGIVKIIHGEGNMTSGDGHIVPDFKKVLTKGLKG
VIEEAKASMEKVDITVYGGYNKIDFLKAVQIVAQATIDFAHRFANLAKELAEKETDSQRK
EELLQIHKNCLNVPENPAQTFWEGVQAIWFIHLVIQIESNGHSASLGRVDQYLYPLYKKD
VLEGDLDREFAKEMLQCLWVKLYSVIKVRSTSHSGYGAGYPTYQNVTIGGSTPSGKDSTN
ELSYLILESVAENKLTQPNLSARFHINSPEKFIRKCAEVAATGYGMPAMHTDEIIVPALL
NKGVKIEDAYNYSMVGCVEVAVPGKWGYRCTGMTFLNFVKATELVLNDGYDARTGLQLLK
AGKLTDYETYEDLWEAWKKYMKHYTKLSVALDVLADTHLEDFPDILLSSLVDDCIGRGLS
AKEGGAVYDIISGLQVGIANAANSLYALKTTVFDKKILTKEEVYNALQTNYEGENGERIR
KILLEVPKYGNDIDEVDEFATNIYWTYIDEIQKYHNTRYGRGPINGGYGVSTSGISSNVP
MGTVSGATPDGRYAYTPAAEGGSPTQGTDTNGPTAVLNSVNKLPTLMITGGQLLNQKYSP
ELVNTPEQFEKFVNIIKSFISSKGWHIQFNIISGKTLKQAQIEPEKHRDIIVRVAGYCAQ
FVTLDRTTQNDIISRTEQRI
>SEQF2502_01721 Choline trimethylamine-lyase activating enzyme
MRALVTDIERGATFDGPGIRTVVYFKGCLLRCLWCSNPETQKLENEFWDYDGSLYKGNRT
SCSDCLTTSTLKKVAKDMTLEEVFTIVMKDENFYRNSGGGVTLSGGEVLVNSAFAIKLFE
KLKEEYVNTAIETTGYGSYRELEKLAKLTDTILFDIKHMDSGKHKKYTAVSNEIILENLT
KLSKWHKKIIMRFPFIKGINDDEKNIHETAKFLKKLNLLEINILPYHTMGLEKYRKLRMP
YPMKTLEKHTQEELDNALQIMKSYGLKAKLNG
>SEQF2502_01722 Fructose-6-phosphate aldolase 1
MRVQYFIDTANLESIKKISDIFPIAGVTTNPTIIAKEKRDFKEIINDIFDIIGRDKIVHA
QAVGSTAEIMVKEVQLLRDTFGENFYTKIPVTPEGIKAMKILSKDGHKITATGILSPQQI
IMAAEAGAEYMAPYINRSDNIGENGIEIVKDAYKILEMNKKTDEEKLAQYKRIFEPKILG
ASFKNVRQVHETILAGAKSVTVAPDVFEKLIYHPYTDWSMDTFNSDWEKVYGDKTLLDLL
>SEQF2502_01723 hypothetical protein
MNFFQKRAKFPRFKSKKNNVKSYTTNCVNNSIRIEENKYLILPKLKRVKLKYHREIPKDY
KIKSVTLTNCNGNYYVSVLMEFKKEIQRMPNSDKVIGLDFSMSELFVSSENQRADYPKYF
RMLEKKLKKLQKSLSRKVKFSKNWYKQKAKISKLHEYIKDCRRDFLHKLSKKLSEVYNAV
VVEDLNMKGMSQALNFGKSVGDNGLGMFLRMLEYKLMFLGKQFLKIDKWFPSSKTCSRCG
NVKEELKLSERSYKCECCGIEIDRDYNAALNIKDIGKLMLEY
>SEQF2502_01724 hypothetical protein
MLEKMPKNIKSAYIISIFTMIFFPLLGIFFNCVELYFGYLVGAIISTININLLINGVEKI
LFFQDKPKLRGNLEYFKRMAIFCLGMFIVGKISQKYFPNHVLTNILATGIGVLNFKFSYF
LSHFGKKFLLKNKNKGS
>SEQF2502_01725 hypothetical protein
MKKENEENKKNDLTEEERIKEEEKRKQRLFEIEKKLGRHNNDKAVKNKRNNKIMKYFALA
TNMVYILALPILIMLGFYLFLKKYLFKTDQPIVLIIFLILGAISGYWSLIKQINNIK
>SEQF2502_01726 tRNA (cmo5U34)-methyltransferase
MHKQFAEIYDIFMKYVDYDGWYNFLKRFIKTKGTVLDLGCGTGEFVLRFLKDGFSVVGVD
LSEKMLEVAEKKLNDPKIIGEKFSKDRYRLIKENIINFENTVDFENNKNNNLCQVDYIVC
NFDTVNYLKNEKEFLKFIEKCNKNLKKDGYLIFDAVTEDIFTEIFENDIFLDEEPEYTSI
WRHEQLSKKKHLIEIDLFIRENENDNLFRKYNEIQNKFIFDPEWIIKTVQNKGFEIFDTA
SNPEFGESRIFFILKKL
>SEQF2502_01727 hypothetical protein
MELMNFIITGTELIKEKETNLKSILMKEFLKGIQMSLTDTYLQKVYFMDIYPN
>SEQF2502_01728 hypothetical protein
MVIGLNPGEKANTANPGRPNTNFDPFVTSILRQIGSALEVPYELLIKNFTSSYSASRAAL
LEAWKMFRKRREWFAANFTQIVYEEWLNEAFLLGRIDLKNYGTDILIDKAWSKSQWNGPS
QGQIDPLKEANAAVIRINNGLSTRTRETAELNGGDFELNVGMLAKENKLFEKKGVVINAE
TTKILESSEE
>SEQF2502_01729 hypothetical protein
MVNVIDFDETTKLKELAKVIGLSERHLQRLSQEGIIKKNDKGKYLLYESIRSYINYLKEI
ESTPQQLQEEKLKNEIEYLKTRDRKENIKIKILEADLHEASDVKRVMNNIISGFKGQLQT
IPYKLAPLVIGIDNLGEIQEIITNNINSVLLELSEYDRSKFLKNKEYVNSEDEEGQ
>SEQF2502_01730 hypothetical protein
MNEKDIEKIADRVAERLIQISKTDKYKETEALLRAYPNYKRIIEKNNERINEILKTGLGK
IKKIKPVESVQGGLKKYEGLPELELERIEHLKSENAKIEKRIIRVDNALEGIKNDGYYDI
IILRYFKEWTIDEIAEDFEVDRRTIGRNRTRLIKKLQYSLFPEVLLD
>SEQF2502_01731 hypothetical protein
MKQVIIYSENGKGVIVRKKSKKELEKWLKWEIDMRQRLNVHKRIEVYGFNFNYKNFSDET
LLMLFEKSRKEMFNRMFIKKY
>SEQF2502_01732 hypothetical protein
MEQWEMMAKMVKEFYLAFKQEEFLNKDMTEEREHLRDLLLMEEKTEYMKAEIENDTVGKL
DAVADMAYVYIGTLLERCKGNVDLVARILYFDSADSELAEICDKIEKNNFNGIFLTAFKE
VHRSNMTKLDKNGQPVYYTKGAKKGKIVKSELFEEPNLKEIIEGEDENETSDHLQ
>SEQF2502_01733 RNA polymerase-associated protein RapA
MEFKAHNYQKYCIEKVIETPNVGLLLDMGLGKTIITLTAIDELKFNRFEVDRVLIIAPKK
VAESTWLNEAKKWDHLKYLKFSKVLGSEKKRIAALNTPADIYVINRENVQWLVEYYKNDW
PFDMVVIDEFSSFKNHASKRFKALKLVLGKIERVVGLTGTPAPNGLKDIWAQIYLLDKGE
RLGKNITAFRERYFDYSKYGGNPFGEYELKEGSEKSIMNKISDICVSMKAEDYLELPDIT
YNTIPVELDSKSRKQYEELEKQMILELNESEEISVASAAALTGKLLQLSNGAIYDEERKV
HKIHDCKIERFMELIEELNGKPALVFYSFQHDLERIKKTLAKSKLRVRQLKTPEDEKDWN
SGKIDILLAHPASAAYGLNLQDGGNHVIWFGLNWSLELYQQANKRLHRQGQKEKVIIHHL
VTQDTRDEDIMKALQSKGDVQEELLQSLKARIEKYKKEEEK
>SEQF2502_01734 hypothetical protein
MSEKEIENYLVRKIKNKKGVAYKFTSPGNSGVPDRLCLLPNGKIFFVELKSPGKKPRALQ
VNQITKITKLGQKVYVVDSKEMIDNILEDELFNWKEE
>SEQF2502_01735 hypothetical protein
MKSRKNIWENLDNEVDQIWAEAYTNYIIGTDLFLTGEALKIAEQKQEEHRISNAKEGIII
DFLEKDIPEDWHKWDSERRKGFYSGFNTGGIRLVPRDRVCAVEILVECFGMKKGYIRNSD
SMEINGILENIKGWERIRHPLKYGDYGQQRGFKKVEK
>SEQF2502_01736 hypothetical protein
MENIMDLVKIERNKNYGLVVSSRVIAKGLGKRHSHVIRDLENILETPINSENPNLGFLIF
PNEYRVSNQKRKYKEYLLTKDGFILYMFNIQGHNKFKMSYINEFNRMEKALNERKENETK
VIQIEAPKKLTFRGEIVITLSQLSEILGKDRETIGSKLEHRNVISGNDLREFKSENQGKK
YMSCLTILNKDEAVQVAERIKNVSEESKQELMRYFIPDMESIKDSKHWRRIKDMQSELCV
SGKVFFAEVKKLEESIEKLKELKMHILAYIQFMNYDIHELEK
>SEQF2502_01737 hypothetical protein
MDLIKQGEINSIDVKNGKARVIFLDRDNKVSDWLNILVPFSDSHSDSYNLAVGQSVLVLS
LPDMPEVGYILGCPMRASEIKEGEVKRTFSDGGFYSYSNGTLTLNPISEVIINANATING
DLTVSGTTITGGSINLNTHKHDGVTAGGDKTGGPE
>SEQF2502_01738 hypothetical protein
MVGSFGDVVFEISDKKVFSINNEINRAYKSKISEHTAIFGPGMIRHQGRELTELSFGISL
VASLIPDTTPSEQLDKIKTMWEFGEYDYLTLGGQTFGAFPFLIIDMSEKSSHFNKETSNF
DFINLELTLKEYIDNPQKYNQIIEQLKIQKKEQEKLTEVEVANVEAEQKSKLQEFAEKVG
NKVNDIAGKVDKAIEIAENKKKEILDQLEKIKKDAKIDELMDLVRAGMITADKANEMIDY
AKNFSKTDKEILLNFLRNQTGGK
>SEQF2502_01739 hypothetical protein
MIYISSNQEINYNPQNTLEEVKTNVGMILRVCKEEQPLNRDFSFDSDLIDKNINIVENKL
TSHLLKAFRKYEPRASLEQTRIIMKDTYNNDFDIELGIEVVNIE
>SEQF2502_01740 hypothetical protein
MSEISNEEYEIIDADSWELKRDMIDKFQELSGRKLTESSPETLIFETVAYLFGLREEKYN
DEMKQNYLRFARDERLDLKGEFYGNRGKRLVEQPAVATFRFYITDIQATDIIIPKGSRIQ
YNELYFSTDEQYKIEKGDLYVDGIATCNTSGTVGNDIPVGQINTMVDIFPHYDKVENITA
SNNGAEIEQDDNYRARIREIPESFTTAGSKGAYEFWAKSTSANIVDVVAYSPSATNVDIY
VLTDSLTLTNELKKRIEEMLNTDNIRPLTDNVTIKQAIKTSYTIDFDYYIDKSNETLVNV
IKNNVEKAVKDFKTWQQNKMGRDINPDELIKLLKLAGVKRVVLRSPTFRILDFNEIAENT
SVTSNYLGVENI
>SEQF2502_01741 hypothetical protein
MITIDDLNLTDIVAKSTLNDKTTLWIYESINFAVKKKHDAIKRKFFLELSELNDVELDFL
MWEYHVDYIDSNITRETKIKLIKRSIFSHFNKGTVGGIKEICEILFNGNVEIIEWFKYGG
NPGYFKVNTNGNLSNYEGYKKIIEVVEQYKNIRSWLEGIRLLRNEENKNYYGFIEKNKKK
YYLGSTDINIPNEIIVANFGTVHRTRVLREIG
>SEQF2502_01742 hypothetical protein
MAKFNGFILTEKGRELLAKGLSGETITFTKMAIGDGTSLTSERERTELVNQITTLPILNI
NVKRNGTCEINALLTNKSVTTGFYIKELGIFAHGNDNVEILYAYNISTSPDFVPPFSANN
VVEIEYVDTIIVDQVANVTAVIDPSITYITKKYADENYLVSSRLAEILGLQFGGNIQDIG
NKTKGKFYYDSVTKFYYECIEDNSLTYNDSGKFRAISNKPISDKVEKLFKNANGGFNFAN
LIFKSGNGRYQKSDLERGTRMLFGTPFDNSCLFVVAQDNNVGAHSVAVLSFDREGFKVIG
RDNSSQLADTDVNWFAVGY
>SEQF2502_01743 hypothetical protein
MTVVYIYLIATMECIARPTITTIEEFKEKPNLFYPDWNDKTMKWSEVLLNNPTVDSKNNK
LREMTEIEKVKNGILILSDGSYLDEVNETIVTIVKPNDWSVWDKDSHAWKIDNNLLNKKL
KELRTKASKDLVEAKLNFLNQALEIEKAGKKYTFENNEENRNRLALKFSLMSLLEQDKIE
KVKVLNDKGLVEFIELNKTELKALATKIQDIIEVADMGEQMAVVGISRYTIDQMLELNVS
DFFQN
>SEQF2502_01744 hypothetical protein
MNRFEKIFDYLIKVEGGYSNDKNDKGGKTKYGIVEEEARGFGYKGNMQDLTMDFAKNIYL
KKYYLGNKLDKVTNDKVALSICDWAVNSGKNGIKNAQVAINQLTNANLDVDGIIGNKTLE
ALNAADPEKFLEVYHNLQRIYYRSKVEGDKTQKEFLTGWLNRVQRKEEYFKDWDKENTAT
ENKTYSFSQESLDKMKKVHPKLVEVIKAAIVNSPFDFRITDGARTTEEQFALYQKGRTLP
GPKVTNCDGKNFKSNHQIKSDGYGHAVDIFPCGVIENGVYRKFTSEEGYDDKKLKSIANH
ILAIAKSKNINVEWGGNWKMHDTPHFELK
>SEQF2502_01745 hypothetical protein
MDKQLQVILIGMLVDFTRKEVLEKEIIFGAKKGTEKLEAVKNNFFGKFKDFVKKSQEINN
PYIPDDIERFTEDLLLKGAEALEKTINVDEIVHRILGEEKTAVGI
>SEQF2502_01746 hypothetical protein
MIEDLKVIIDNHGLFLILFFSGVLFGVVAQKMIDNQPVKPYVKRIAVAGMTMAIALSLNK
VVGHFNAGFLYPWSPVLGFFGEAMMETINQKRYGISKGFLELMLEKLGFVKKRDGKDEDL
S
>SEQF2502_01747 hypothetical protein
MKTYHRSRKFAIVVLALIFLNSVITLELRGYQRRQNLNLLRSKLKNESNKEIFDSIEEKS
KTEDLILLISTNFVALMITVGFDRFGVFEESDETVKKNKKKLVKIFL
>SEQF2502_01748 L-cystine transport system permease protein YecS
MDFNFIVENIPKYLEAMKLTVFIGIFGIIFSILIGIACALVLYYRVPVVRQIVGIYIELS
RNTPLVIQLFFLYFGLPKIGITFNSYVCAVIGLSFLGGSYMCEAFRSGLESVSKGQRESG
LSIGLTESQLITNVILPQAFTVSFPAIAANIIFLLKETSVIGILALMELMYLTRDLIGLY
YKTNESLFMLVAAYLIIILPVSFVLTVIERRIRYATVGN
>SEQF2502_01749 hypothetical protein
MSGGILFGNRLLDVAVISCFSAQFYKVFFPLFKGQKPQWARLIQTGGMPSSHASTVVSLV
TGVFLLKGFRSVEFAIAMVFAGIVLYDATGVRQQAGKHARAINRLVDAIEHNDGIEIINE
KFKELLGHTPIEVFWGSILGIAVGLLFKGYILG
>SEQF2502_01750 RNA-binding protein
MIQLSSKERAFLRKLAHNLDPIVRIGKDGIDENVINSIAEVVKKRELIKVKILQNSSVKF
DREMGDEIARGTKSIFVDKIGNILIFFKPKHKKDAKITPEFDKFRKSKAKK
>SEQF2502_01751 Ribonuclease J1
MSEKEKGEFGNQILKRNFSKKEDINKIKSGMKRFRRKSTNRRHLDEKNEIRYIPRVNDRN
RHIDRKVDGKEEKMYVIPLGGLEEVGKNMTAFQYKDEIIVVDAGLTFPEDEHLGIDVIIP
DFSYLESNRHKIKGLLLTHGHEDHIGAIPYFYQKLGTENIPMYGGRLTLALARAKFEKKD
AKLPKEKVISGRTILKVSKYFTVEFVSVTHSIADCYAICIKTPAATILHSGDFKVDLTPV
DGEGFDFGRLAQLGEEGVDLLLSDSTNAQIPGFTPSERTVGESLKDEFAKAKGRIILAAF
ASHVHRLQQIVNIATKHGRKIAIDGRSMVKIFEICSNLGYLKIPRDTMIDIDKVETYPAN
KVLILCTGTQGEPLAALSRIANGTHKHISLREGDTVVISATPIPGNEKAATKNINQLMKR
DANVVFEKGIGIHVSGHGCQEEQKLMINLVKPKYFLPVHGEYAMIKKHKELAMAVGIPEK
NVILTENGAKLELSKNSFRSVGRVPSGATFIDGFGIGDVGNAVLKDRQNLADDGIVIITI
SQYRNGKFNRQIELVTRGFVYNKDAESLLSETKKLVRTELANMENEGIKEIGKIKQKIRA
KVGEFLNKETDREPIILPIIMEV
>SEQF2502_01752 Peptidoglycan D,D-transpeptidase MrdA
MRELDKEEKNVRFIAFLILVGAVFLILIARLFTLQILEASQYAEQALQNRIRTNIIKATR
GEIYDREGKLLAKNTTGYQLVHMHTYTLDPNDLKLLKEVKGMTPEQMDARLANERKAVAK
RIKETMGDINTISQLTGYQVDYLIDRFYKQQRMGTDKKILVIEDLDKQVALRAIEKINND
RIDIVEYNKRFYPEDALASHVIGYVKPISEKEFKDLEKDGYRNSDLIGKKGVERSYDKEM
KGQDGRENVEVDAKGNVIRQVEATESVAGKNVYLSIDMELQKYMTDAFSGKSGAFIAMEA
KTGKIITFVSNPEISLNLLSSRIPDNQWTELVNSKAKPLVNKGIAGLYPPGSTFKAVTGM
GILESGISPYATVNSTGQYRYGKLIFRDSHKSGNGITNFAKSIEQSVNTYYYVFSQKAGI
NNIVKYAKEFGIGSKTGIDIPGELTGTLPSPEWKKKRFKKKQDQRWLPGDLINMSIGQGY
VLATPIQIASVYQTIANNGVKLRPTVVDRFVTYSGKVENNKPVVIKKLKVSPKNLKLLQN
ALRLPVSGPGGTVKVLYIPNYPVSAKTGTAQNSGFGDNHSWIAGYFPSDNPQIVFVSIVE
GGGYGGVASGAMAQKFIYKYRDKYVLKKQDAEKKKQEEEKKKQEEKNKNLKNNNNVKN
>SEQF2502_01753 Ribosomal silencing factor RsfS
MSEVSHNYEKEVQEIIDIMEDKKAQDIKVYDMRGKSPFFDYSILCTGSSSRNIEAIATDI
KKSLENVKNVEGLEEANWVLIDAGDLVISVFSKDARDYYRLDDFYNGVNEGNEETE
>SEQF2502_01754 Ribosomal RNA small subunit methyltransferase E
MLTVIAEKENIDENNGKILIKDRLDCNHVQNVYRLNIGDELRVIDGECEYFTKIAEISKK
EIAVKILEKKEDSYSLSINIDIAMGILKNDKMNLAIQKLTEIGVNRIIPLKTERVVVKIN
EKKEKWDVVARETLKQCRGIKFTEITPVKKLSEIDYQKYDKIIFAYENSGESKSLSEIIK
KEDKSILYIIGPEGGITADEVDFLKNNKAIEISLGKRILRAETAAIVVCGIIANFYI
>SEQF2502_01755 Holliday junction ATP-dependent DNA helicase RuvB
MRNESLDHILLYGPPGLGKTTLAGVIATEMGVNLKVTTGPVLEKAGDLAAILTSLEENDI
LFIDEIHRLNTSVEEILYPAMEDGELDILIGKGPSARSIRVELPQFTLIGATTRAGQLST
PLRDRFGVTHRMEYYKLEELKEIIRRGANILDISYDEDGIAEIAKRSRGTPRIANRLLKR
ARDFALVEGSGVLEKESVDGILKLLGVDDNGLDELDRNILLSIINVYNGGPVGIETLSLL
LGEDRRTIEEVYEPYLVKIGFIKRTPRGRVVTELGYNHLGIEKIFSEKK
>SEQF2502_01756 hypothetical protein
MSKKIIFIFVFLLLGTFSCTPLSEGLSMKSQVYNADDVDFYYDLTYKKDGETHYERQIWE
QAYKILDEAQDFFLMDIFVFNDFVGKGVEEKLHPLPLAEEFTEKILEKRKKDPNVEIYLI
LDESNTFYGAYDNKMHKKLEQAGVKIGYVDLMKLRDPMLVYSAPWRLFIQPFGNPKNRGK
IKNPIYEGTDKVTIRSILRALNAKADHRKLIMNENTAMLTSANPHAEGSKHSNIAFKFSA
PILKEIYDAEKPVARITKKDGSLKRRLPNKDFSKIPFSSNDKLKIQYFTNDATAKDISEE
LKNTQFGEKVIIAQFFLADRGIINDIRKAAKRGVKFEIILNNSDAGLPNKAAAGELMKYA
RKHNYDIDVKFYNKGEEMYHVKMMSILKKNYLITYGGSTNFTRRNMRNYNLENELKIMSA
YDQKVSKDILDYYDRLWTNRDGDFTLPYDTQKNEKFMNDMLFRFMEVNGFGAF
>SEQF2502_01757 Serine/threonine-protein phosphatase 1
MENRVKVERIDENNYDRIFAISDLHGQYDLFLKLLEKINLKREDLLLILGDICDRGKKSY
EIYMKCMKMIKLGYNLKFILGNHEDMLLENFENDYPLNYETEYSIYKNSKYFEKKNIEKW
HKENFYAEVKWLIKWLKDCPLIVYGNENIFVHAGLDLSKDLENQERENVLWTREEFWMDK
KNILEEYKNKNIYFGHTPNMNGKISKKSNKIYDIDCGAFFTHSLGCMEVKNKKSKGIREI
YVHC
>SEQF2502_01758 hypothetical protein
MKKIPVGIEDFKEIINNNCYYIDKTKFIANILDDGSKVKLFIRPRRFGKTLNMSTLKYFF
DIHNAKENKKLFNGLDIKKSKHFSEQGQHPAVFISLKGIKADSWENFLNAIKSLISNLYN
EFEYVRNSLNEAELKNFDKIWFKKDDGDYENSLKYLTAYLYKYYNKEVVLLIDEYDSPLI
SAYEYHYYDKAVIFFKIFYGEALKTNQYLKMGIMTGIIRVIKAGIFSDLNNLSIYSILNE
HYSDFFGFTEAEVEKVLKDFEIEFKLSDVKSWYNGYKFGNSDVYNPWSILKFLQFKKLAP
YWVETSGNFLINDILKNADTETTETLEQLFSGESVEENINGNSDLSVLLGQEKIWELLLF
SGYLTIDEKIGEDYENVYSLRLPNREVREFFRQKFIEVNFGESLFRKAMESLKRLKFNYF
EKYLQNILLKSTSYNDTKNEDFYHGLVLGMMFYLDNHYYVKSNEESGLGRYDLMIEPKNK
NTRGFILEFKVTKDENSLEKVSKEAVNQIIKKKYDVALKNRGIEDVTLVGVAFCGKLVKI
SYF
>SEQF2502_01759 hypothetical protein
MFATGAGSKAVNYGNIRLEGESAIGMYLDRGAIGENYGEIEGNAQSLKGVVAINGGYIKN
YGHINVTGSGSYGIVTDGSRFIVDANGNPTEVLKSTDSRYTSSSAVTAGQTNGNGGTDLY
GGKESSIEEGTSGNPKTTGVGTTITAPDIVPITKVSVDGIDTPIFDVESDAANPGDWAKN
ITVSSSIQTGGTRIIDLSVKNEWGNPVWEHAYKDPLSEVTSIGMYVDTSGVRYTNPIDGI
QNLPKLGKVDLYFGPEATLYTNSKAIRIGDKVDVNGNVTKSNILKPFNDALSRLPGGAKV
NVLSASLTWQVLAKLDSNNQLSEIYMSKVPYHSFAYDNDKSLVNFTNNLDNIYEIARQES
AEKVIFNKLNSLGNGEGHILAQAFDQMRGHIYGGVQQRIKSTSDILGGEISSLRSERNVS
KDSNKFKAFGQRNEFKTDTAGMPDWYSNAGGFAFVHEDETVRLGQSSGWSAGVVNNYFTF
KDLSKSYENQAMAKVGVFKSIPLDANGTFILSLGGDGFFGRNDMKRRFWVVDQQFRAKAS
YYSYGAGLNAGLEKSFVVNDGFSIVPNLGIRAEYGRFSSIHEKGDMALNVKSDDYVSVKP
SVGIDFRYNQEVFKNSNLTASLGFAYENEIGKLYDVENEARIVGAWTDYFGIRGDKEDKR
GNFKSDLKLGLDNGRFGFNVNTGYDSKGHNFRAGLGLKVLY
>SEQF2502_01760 Mycothiol acetyltransferase
MKEIRPAQEKDIPKIENLLEQILLVHHKNRPDIFNATGKKYNAQELTEMLNDPNKPIFVA
TDENDNVIGYVFCIFKQQTNHNVLTDIKTLFIDDLCVDENTRGQNIGKKLYDFALDFAKK
EGCYNLTLDAWADNAGAVKFYERLGMKVQKYVFEEILY
>SEQF2502_01761 Argininosuccinate lyase
MKKMWEGRFHKETNKLLEKFNASITFDKRMYEEDITGSIAHSRMLAKQGIIAESEQKKIE
NGLLQIKEEIQSGKFEFKIEDEDIHMSIEKRLTQIIGSIAGKLHTARSRNDQVALDVRMY
VRKEAHEISKLLVKMENVLLELSEKYKNVIIPGYTHLQRAQPILFSHHLMAYFQMFKRDI
SRIKDFLERSDEMPLGAGALAGTTFDLDRHFVAKELGFSKPTENSLDSVSDRDFIIELAM
IISVISMHLSRFSEEIIIWCSSEFSFINLDDAFATGSSIMPQKKNPDIAELVRGKTGRIY
GNLMGILTTMKALPLAYNKDMQEDKEGIFDSIDNIKLSIEIFYSMLNTLTVNNEKIYASM
KSGFLNATDVADYLAKHDVPFRQAHKIVGEIVSYCEDKKIAIDDMQLEEFHKFSDVFKDD
ILSEITIENCVNKRNSFGGTSIKNVEMQIENGKKFLQAL
>SEQF2502_01762 hypothetical protein
MRSNKKVKLPVGISDFKDVIENNYYYFDKTKFIENILEDGSKVKLFTRPRRFGKTLNISM
LKYFFNVKNKYENKKLFENLEISKSEYFEKQGNYPVISISFRNYDEENWDDGLKTIKGIL
KRVYSEYKFLTEKMDDIEIEEFNSVRRGLDSVEWEASLINLSKYLYEYYGKKVVVLIDEY
DQPIIDSYVKGYYDKAISFFKSFYGLVLKDNEYLEMGVMTGILRVAKENIFSGLNNLEVH
TILDSEFTEYFGVMENEVENSLKDFELEYELDDVQKWYNGYLFGNRKVYNPWSIINFLKR
GKLKPYWVNTSGNGLIKLYLQKLKNEIFEDFSKLLNKESIFKRINDNMTFGNLEANFEKN
IWNLFFHSGYLTLAEEYEENKEETYLKIPNEEILKMFSEMFIEIYFENYENFWSLTNALK
KGDIDKFKLELNKVLLENAGVFDVNGNYKEQFYHGLMLGLVLMLKNEYEIVSNGFAGKGR
YDLLLKPKNILKGKEGIIIELKALNMAKKLDKDKIKAKLENECEIALNQIDEKEYGSILK
NAGIERMLKIGIAFLGKEFEIKFTRE
>SEQF2502_01763 Oligoendopeptidase F, plasmid
MGKNKIEKKELKRDNVGQEYKWNLSDIYENYSAWEKDFEKVSELKKELAGFKGQFGNEGK
LLEFFQKQEEMDKISYKLYRYPQLARDLNSSDKEAVEHLQKVQFLFAEISTELSWVNSEL
VDNRENIEKWIEKKEFDDYRFGLKNLFRLQKHILEEKESKLLSYYSSFFSAPRSIYSEVT
VTDVEWPQVTLSSGEKVDVTPANYSKILSTNRNQEDRKLMFQTFYTIYEKKKNTIAAIYN
SILQKGIASKKAYNYDSFLLSHLESDNIPEEIYLNLVNTAKNNTKPLQRYLKLRKKILGL
EKYYNFDGSINLIEFDKEYEYDDAKEIVLNSVAPLGKDYVEKMKKAISEGWLDVFEAKGK
RTGAYSAGVYGVHPYMLLNYNKTLDSVFTLAHELGHTLHTLYSDENQPFLMADYTIFVAE
VASTFNERLLLDYMLENTNDPKERIALLEQEIGNIVGTFYFQALLADYEYQAHKLAEAGE
PITAEVLSKIMEDLFDKYYGDIIEKDDLIYIFWARVPHFFNSPFYVYQYATCFASSAILY
EKMINSSDENEKKQTLDKYIQLLSSGGNDFPMEQLKKAGVDLSKIETIKAVAKQFNLLLD
KLEVEIGKL
>SEQF2502_01765 Glucosamine-6-phosphate deaminase
MRVIILKNADEVARWSAYQITKKILKFKPTREKPFVLGLPTGSTPLATYRELINLYNKGI
LSFENVMTFNMDEYVGLKPEDPQSYHYFIK
>SEQF2502_01766 dTDP-glucose 4,6-dehydratase 2
MKTYLVTGAAGFIGSNYLKYILNKYKDDDIRVIVVDVLTYAGNLGTIANEIKNERVKFEK
VDIRDQREIARVFSENEVDFVVNFAAESHVDRSIENPQIFLETNILGTQNLLENAKKAWT
IAKDENGYPIYKDGVKYLQVSTDEVYGSLSKDYDIAIDLVIDDEEVKKVVKNRTNLKTYG
KNFFTEKTTLDPRSPYSASKASADHIVIAYGETYKMPINITRCSNNYGPYHFPEKLIPLM
IKNVLEGKKLPVYGKGDNVRDWLYVEDHCKGIDLVLRNADIYEIYNIGGFNEEQNINIVK
LVIDVLREEIENNDEYKKVLKTDLQNINYDLITYVQDRLGHDMRYAIDPSKIARDLGWYP
ETDFETGIRKTVKWYLEHQDWVNEVVSGDYQKYYEEMYGNK
>SEQF2502_01767 dTDP-4-dehydrorhamnose 3,5-epimerase
MNNFTIKETPIKGLVIIEPKIFGDKRGFFMETYNKKSFEELGLTMDFVQDNHSKSKKGVL
RGLHFQTKHSQGKLVRVIKGSVYDVAVDLRKDSETFGKWHAVKLSAENKLMFYIPEGFAH
GFLTLEDETEFTYKCTDLYAPEYDSGILWNDETINIDWKFEEFGINSDELTISEKDKIQQ
KFDKTKNYFE
>SEQF2502_01768 Beta-glucanase
MKKKIFYRIVLFTLIGNTIFAAGKNEKRITPQQFENGVIEAKEKLENNLNKAEESVKTKR
GKLNKFISKVKGKSWKLVWDDEFNGDYLDSTKWAYWENGNPWNAGNYIDENGKLVNQYGF
DAKHYYLRDNVKVENGNMVITLKKENDKKVNVDGIERKILYSSGAIHTRNLYNVKYGKIE
MRAAMPKGIGTWPAFWLWPEGYSQADGKPAIGEIDIVETDGGEMNRVTGTAHVLRSDNTY
ESFEGSDYKISKWSKEKLTNFNTYAVEWDDKEIKWLFNNKVYKRFSYKELEKKGLQNPFN
QPYFIMINVALSKKTGEDGDVDFPTEMKVDYVRVYQKK
>SEQF2502_01769 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MYDFTVCIVTYNTPKSDLEKIIKCFQSINLNFKLWISDNSETDELKNFFENIGDARIEYI
FNDSNKGFGAGHNVIINKLINNSEISEFHLIINADIYFEKNVIEKIIEYMRDHNEIGQIG
PKIRDFKRKFSYTCRLFPTPVNLIFRRFLPFKNIVEKMNYDYEMKWANFDDIMEVPILSG
CFIFLRVSVLKEIGGFDEQYFMYMEDYDLCRRIGEKYKVIYYPKVEIFHEHEKASYKSKK
LMILHMKSAIKYFNKWGWFFDKKRKIKNRECMDKYKCN
>SEQF2502_01772 hypothetical protein
MAKFLVSQSVSQSVSQSVSQSVSQSVSQSVSQHNVTFSENDNLIIKGNNLIALASLLKRY
EGKVKCIYIDPPYNTGNDSFKYNDRFNHSTWLTFMKNRLELAKKLLSDNGVITVQCDDRE
HIDG
>SEQF2502_01773 Modification methylase MboII
MDEIFGRENFLNCVAIKMSESSGVKMNHAKNKFPKLKEYILIYVKPKFKGFIEIDKYKET
KWDLENNIFIENLTMEQRNLLINLEMKEINSEEDEIVANDILKFSKKISLSEKIKTLNFK
NKEEKEEWLFKNSYRIIKTAGSSSLTTLVKKIKEIPNQDLAAAVSKKGVLFFYITDFNRK
SKQPRLQVIFADSNIFKNPCDFWQDVKTTGAISDEGGVKFVNSKKPEKILYRLIKMITKP
NDIILDFFLGSGTTAAVAHKMGRRYIGIEQMDYIEDITVKRLKKVIDGEQTGISKTVNWQ
GGGSFVYCELKENGQKLIDSILSSDEKSIDEIKEKIFSDDRIVPYITRQELEKADKDFFD
LKFEEKKKVLIDLVDKNKLYINYSDIDNEEYDISKEEKQFNDSFYKDVR
>SEQF2502_01774 hypothetical protein
MERFLYEKLDVSRETGAIKEIPNFLKQGLSKRIELREYQKEAFENFITYFENEKLNKNKQ
VHTLFHMATGSGKTVIMAGLILYLYEKGYRNFLFFVNQTNILEKTKDNFINVLSNKYLFN
EDLNYLGEKVKINVVDNFQRDVFKNNNINICFTTIQKLHLDLFENKENAMTGDDFENNKV
VFISDESHHVNTFTKNRTKEEKEIQKSWETSIMNAFYSNKNSILLEFTATADLKDKNVEE
KYRDKIIYNYPLKNFRESGYTKDFVNFSINTDTWKRTLIALILNEYRRFLFSDCG
>SEQF2502_01775 hypothetical protein
MLKSKVIKESRSFYDEFFEKINKLDSSDFENLPKEDKYLKKALDYFRDKDKNKTFEFLKE
SIRDSFVEEKAIIINGNEDNNVEKQLLLNSLEDKKNNKRIIFAVDMLNEGWDVLNLFDIV
RLYDTRSSASYTIKEAQLIGRGARYCPFLVNEEQEKFKRKYDFDLDNKYRILETMFFHSI
DDSKYISELKKALIEIGLQEKNMIERKYILKAEFKNTDFYNHGYVFSNSRIEKTRENIYE
IEEDLKYKTFYPKSKNKNAKIENLIDNKNEKISDNIEIKKIKLSEIDYNILSGTAIYFNE
LKFNFLKEKYPNLKTLKEFLTGENYLGNIGIEFKYVKGSEITGKDVYRELKQEVFPVICK
HINEIKTEYEGREEFEPYKIKNVIKDKTIYLSRISSDGKGESQIKTSSSEFKLDLSVEDW
YVYDDNYGTTEEKSFIKYFKTEIKPKLDKKNLEYYVIRNERFSELAIYSFDKGKRFEPDY
LLFIKNKTLDEGKNKEYQIYAEPKGEHLLEKDNWKEEFLLKIEKKQKISKNNQKIIGLPF
FYGKGTKLKEFSEVINKFLDQI
>SEQF2502_01776 putative ABC transporter ATP-binding protein YlmA
MEKTGEILHYENITFRREGREILKGVDWHINKGENWALLGLNGSGKSTLLGMIPAYNFPT
SGEVRVFSHKFGNYAWTKIRDRVGFVSSALNNFLSTLNSQKLEDIVISGKFSSIGIYQEV
TDEDRKKAEKIIEDFGITYIKDKYFATLSQGEQRRTLLARAFMNEPDLLILDEPCSGLDV
KAREYLLSVLEKNSKNENAVPFIYVTHQIEEVIPAITHVALLKDGKVFAKGRKKDILIDK
ILSEMFEMPVKIVWENDRPWLIVK
>SEQF2502_01778 hypothetical protein
MKKELKDFIYFMNEENIEKLNKEICKNFYLKNEEIKDKNIEKIQFDNLTFGIYFSKTNDN
KERILVLKNEKKIKCGYFSINGVKKEFYSDLYFLILHNNEKDKNVIFEDLIEKILGIIKI
KEISL
>SEQF2502_01779 Glucose-1-phosphate adenylyltransferase
MKVLAMILAGGRGSRLDILSEKRVKPSVPFAGKFRIIDFALSNCSNSGIYDVALLTQYLP
LSLNEHIGSGKPWDFDRRDSSITMLQPHEKLGGNSWYQGTADAIRQNIDFIKSKNPKYVL
ILSGDHIYKMDYRWMLKEHEENEAELTIAVQPVPIEEASRFGIFEVDKDKKILNFEEKPA
EPKSNLASMGIYIFNTDSLLEYLEKLENSDLDFGKHVIPSMIQEDRKVYVHTYDSYWKDV
GTYDSYLEANLDLIKKSEEVGINLYDQGWKIYTRSEDLAPVRIGVTGSVQNSLICNGCKI
EGSVENSVLGPGVTVRKGATVRNSIIFSGTYVDENSHLDTIIADKKTYIGKNSFIGNGNA
NIPNKERPDLLSSGITVIGKGVVIPDGSIVGKNVRIFAEVKVHDDNRLIEPGETIKW
>SEQF2502_01780 Glycogen synthase
MKIVYLASEVAPFYKSGGLADVLGALPKKMQELGHEVSIIMPKYDIIPLKYLEKLEWVAR
LESHGDVFNLVRYPDDKINYYFIENKALYERGHVYGDFDQDVQYAMFSELALRFLKEINL
QADILHCNDWQTGPVPYFLNVRYNYDPFYWDMRTVYSIHNLMYQGRFSKYSFERMGYYMD
DRNDLNFMEIGIGYGDVVNTVSPTYAEEIKYAYFGEGLEWITNRKYIHGILNGIDTDVFN
PETTKGIIHFNKESLDKKRENKYLLQEKLGLPKSDVALISIISRLVEGKGLDLVSAALEN
LLQYDAVQIVILGSGDKFYEDYYNHLAWKYPDKFKVYLGYNGQLANEIYAGSDMFLMPSR
YEPCGLSQMIAMRFGTIPIVRETGGLKDSVKPYNIFTDEGNGFSFTNFNADDMLFTIKVA
EGIYYDRPDIWEKLVKRNMDLDFSWDRSAKEYEKLYELAKSY
>SEQF2502_01781 hypothetical protein
MNFKRFKYREKSKAKVEVILFAVEYNLRKYVHKKYRNVKACNFMNWPLIKF
>SEQF2502_01782 hypothetical protein
MRGMKVVENMSFNEETDTYTCANNRELEFRHVSKQKNKSGYISEKKVYGCTNCAGCPLAE
KCKMTPHNKKLYVADNFLRFRKQSQENIATEKGIILRMNRSIQVEGQFSRI
>SEQF2502_01785 hypothetical protein
MNKKDIFSKGLDSFTLHILAMTFMVADHLWNIFFLNQIWLNVLGRLAFPIFAFMLVEGFY
RTKNIKKYLTRIFIFAAISEIPFNLFASLALRGEIMVFYPYNNVLWTFGIALCGMNLLEK
VDKSENLNKIIKFFAKAVISIIIAIIAHFARSDYLEYGIITILIFYFFREKNYRNIIFQT
LLMVLLNIFIMPGLEFPFNFFGNEIFIKTQIFAIFSLPIIWLYNGKQGIHNKFTKYMFYF
FYPLHLLMIVAIYVSFMIYLISLIGKNYGN
>SEQF2502_01786 hypothetical protein
MKKILIIAMIVFIVFSCNKKQEQNKTKKDNNIDTSQSDKNKTEENKKNSEKDSPEIEKQK
EVSSEEAIKKAEEEFLKDSKNLEKYRNYVTVAFYQNREFKRTKEITEIFLKNAPDYSYGY
RVMADILFYEKKYNKSTEYYEKAIGLLKHGKQSYAEYKDIKVLNNVLSEIIEKELIQAYR
LSGDNEKAVETFIINQKFLKENYNPLLYNIALNNAKKDNETLKSSNSKKYEENKKKLSNL
N
>SEQF2502_01787 hypothetical protein
MKTKFMKKIFLLSVLTLGFGISGQAYADYSDAFKNGIMQELLNITSSSQNNSYGKSSLTF
TQDGSTDGLETLVASYPKSQHKEVRASLKQLYEAFPQVARSVGIPTNDLSSAVAAVIAGA
YMAYNNISLNDDYVKPMANQFKAHLENSRFFDGMSNREKKSMYDQMVMVGMTLAVGQSLN
QSNPNSQTTAQLREAGKQILETILKVDASRVRITSQGISY
>SEQF2502_01788 hypothetical protein
MNLIIVLVYFSVAVILIVFGVKQIKNRKNLRKINQKQEDEVKEKIKLGILSADTVYRERT
ETGRVFYEVPKDLKKAVILNLICFAIMLILIFLGIKIGILLLIVCAVISMIYGYKYYYSK
EKTKNTLEIINEDFYLNGKLLDIKGYNWGTELFPLFGSRIIRLKSHIYLLDGKKEICFVP
ERQLKRSQIDIIIEDDRISKIIDDIIDVIQKRQIPKVKFRLFKMKKMQSILLFLLFISIV
TLVSLYKSKAYMYLF
>SEQF2502_01789 hypothetical protein
MKNKKINLAMMAGMILMSMGCEAKKKASQNSISGKYNVETLTTKGQTVKVAGQECFEDSY
FEIKGNIAYISLNNVVNGNCITKAGTYDMQSKGNGRYILVGNGKESDEIIVKNGKVQYNQ
DTGISMTFSKDVASTLENIKK
>SEQF2502_01790 hypothetical protein
MKRFISFILLAMMFITSCGISESSENDDKKAVASAFSDYINAAKNEDTKKVNEYHLIWRN
VWRTSQESYKYLTYKINKIELTKQKNGNGRDIKLAYVNVSLKYPDLNYIMSKFYKNKDFN
SLVKGKSSLTQMEIIEQEISSFLKSELKKNDIKYIEKEMTVKFEYNIPIGRWVIPKDCNK
EFINILSLDNYKIKGMDKTIGEIARSPITTKEEKELLISEKEEKIKNKTAKIDDYKMLLI
LYSPVKNPDNINFKRISQKLIENLPDYPEGYRIMTDFIYHNYPDNYSEILNYAQKGIEAY
KNVDTKKYPEFVYESSRNHPMNELFRIMIDVYLKKGEKEKALDVFNKNKKIIKYWMPPAN
YVQLAKRLGVKW
>SEQF2502_01791 hypothetical protein
MKKIIFAFLILGSIYSFAAQKTLRTVEKCRVTSRGITKDGKKFANCISLQSGKTFNFTGL
VDQTYYKFSKGTIFKVYFYGSGNRNLTLETFDYIQ
>SEQF2502_01792 Maltodextrin phosphorylase
MSYKFTDFLNKKSEKQLSKMTNQEIYYKLLEYVKERADEKTKNESKKKIYYISAEFLIGK
LLSNNLINLGIYKEVRDELKAAGKNLSHVEEVETEPSLGNGGLGRLASCFIDSMSTLGIN
GEGVGLNYHCGLFKQIFKNNEQKAEANYWIENESWLRDTNIGYDVKFKNFTLHSKLKRID
ILGYERDTKNYLNLFDIESVDYNLIKDGISFDEENIKKNLTLFLYPDDSTKKGELLRIYQ
QYFMVSNAARLIIAEATEKGSNIHDLADYAFVQINDTHPSMVIPELIRIMTEEHNISFDE
AVEIVTKMTGYTNHTILAEALEKWPLDYLEEVVPNIVEIIKKLDKIIKAKYSNKKVQIID
EQNRVHMAHMDIHFSSSVNGVAYLHTEILKNSELKDFYEIYPEKFNNKTNGITFRRWLES
CNEDLADYFKELIGTGYLKDAEKLKDLLKFVDDKNVYERLEQIKHGNKIKLKKYLKHTQG
IIIDENSIIDTQIKRFHEYKRQQMNALYVIKKYLDIKNGKLPETKITVLFGGKAAPAYII
AQDIIHLILCLSEIINNDPEVNKYLNVYLVENYNVGLAEKIIPATDISEQISLASKEASG
TGNMKFMLNGALTLGTMDGANVEIHDLVGDENIYIFGKQSDEIIKLYETSGYVSKDYYKQ
EEIKEVVDFITSDKLIKVGNKERLERLKNELINKDWFMTLIDFVDYYNTKEKMFKDYENK
DLWYKKVINNIAKAGFFSSDRTIAQYENEIWKTK
>SEQF2502_01793 O-acetyltransferase OatA
MKKILFMLVVVLFSSGIIVASEVPENIVFVGDSIMDSSKQYIAPNFKNPYFDTKISRQFS
TLPGIVTKLVENGKLKTTLVVHLGTNGKFTDKDFDYVMKMADGKDVFFMNTAHKDPWEQE
VNRKLKEKVAQYPNAYLIDWYSYAKGKNQYFYKDRTHPNDKGQRYYADFLTNEIKKHYLE
ENKEDENREIKKNDILKNNSLNSQNNNRNSEKTIDLRNMIKNVK
>SEQF2502_01794 O-acetyltransferase OatA
MKKQRIQSLDVLRAVALVLICVYHWFSYKGTYIGVVIFFALSGYLMTGSLLSRNFSIFSV
INRRLKKIYPSLLIVILVSTIALYFVNNGLEDKYKYSALFSILGLNNIYQIFSKMSYFDN
FGIILPLTHVWALSFLTQMYVFFPILIQGLKKLKLKNNIIGIVLLVIGIASDLMMAYVFY
VTSNSPEGADFSRIYYGTDTRAFAFFIPAGIACFYVNREIKNKIEKKIVFILGMLGLASL
VFFSFGIDYRNAYNYYGLMFLASILIGFTILLFSKPELQKFSLSKYPKFFDPIIRLGQHQ
YQYYLWQYPIMIFSREYFKWAKLSNAQQFFFQVIILVTISELCYILLEKNSKKYEKAINY
ASYPVLAAILAILVYSPVYENKDLEEMKEVQKALETPAVEENKKETPANTASAAAQNSQN
EELTIDKLLAALNAPSKSIEAESKIQDEILKKYPNDEREILFIGDSVLHMTKIDLKKKYP
NAIIETKVGRQFYELPNMLKNYAQNGKLKKIVVIALGTNGTIFEKDMKSVLQTLQGHNVY
FINTVMPDPWQDSVNAEIKKVSSENPNIKVIDWYSYSKGKQEYFYKDGTHPKPHAAKRYV
NLLYSVLSKDILNSSNSSNSN
>SEQF2502_01795 Peptide methionine sulfoxide reductase MsrA/MsrB 1
MANINEIYLAGGCFWGVEKFFKMAPGVIKTSVGYANGQTLDTNYDILKMTDHAETVHITY
DADIVSLNQLLNYYFSIIDPTSINRQGLDEGRQYRTGIYYVDKEELNTIRMRVEDEQNRY
SREIQVEVRPLKHYILAEEYHQNYLNKNPNGYCHLDLENAVKIFSKK
>SEQF2502_01796 Cystathionine beta-lyase PatB
MKYNFDEIIDRKSNHSVKYNELTRKFGVDDVIPLWIADMDFRTAQPVIDALEKKVQHGIF
GYVYRPDEYFESFINWQKRRFGWEPRKEFLSFSIGIVPTLGSLIQLFSEKGDKILIQTPV
YSEFYDISEDNARVVIENKFIEKNGEYLLDLKDLENKLKEKPKLFIFCNPHNPLGHVWTH
EELEAIGNLCIKYKVPVISDEIHADLTLWDNKHIPMASVSEEIRQNTITCTSTGKAFNLA
GLQSATIVFNNLEMKAKFDKFWKNLEVHRNNPFNLVATIAAYSDGGEEYVKQLKKYLENN
ILFLNNFFKEYIPEITPNIPQATYLVWLDCRKLCEKFGFNQENLEKFMLTKAKLGLNEGR
VYQKGLVGFMRLNTACPRAILEKALNQLKDAISNENEKLK
>SEQF2502_01797 putative HTH-type transcriptional regulator YxaF
MTKKYSKNFIIQQSAKLFYYKGYKNTELTDIFKACEMPNDTFYKFFSSKEELLIDVIKYH
TENLINFFNNNVDDLSIQKFHYFFEKYFENIVNNKFHGGSPLGNLALELSDINRNIREEL
VKSYKKIELRFSFFITTLKYAFPEKYNKIVPETTARILIALLEGTILMLKTEKESFAIND
FFVIFDSIFVINENNETKEIKEEIENKSQNQISDIQNNKKNTDSISQNILDNTSKKSNNT
DQEIGEIGNFNTEENNYYNDDIYYDVDSESLINVFDNLDSASKTENNNENNKK
>SEQF2502_01798 hypothetical protein
MGKKIKKVVIILCFGILISCSSVGKRVVPNSAVVSRDTVVNNSIVEVNRKFNEEIESQNV
GLYKKGFRNWKVILYGKQAYYQVFVTEDGKIVSSERFDYK
>SEQF2502_01799 hypothetical protein
MVDFNMFNYLKIKGFSNNQLAANFQEIEQANQNINEILENNPDAVLKKVEYKYLDKEKKQ
LQFEIKIEVVNN
>SEQF2502_01800 Bifunctional oligoribonuclease and PAP phosphatase NrnA
MNKNYKGNITPKEIIKEIKVAKNIVLTVHINPDGDALGSVLAFYFMIGEYCKKNNIEKDM
KIVVDDKLPKYMRHFEDTKLISNYEKFCDEFNKNSQDNKKFDLFISLDCANEERYGRAVE
IKKLSKKSINIDHHISNTEHANFNYVEDICSTGELLYQFLEILDIKLTKKIAEYMYLGII
NDTGNFRHDNVTEQTFLVCSKLIGAGVNNHKIANIIFEVSEKKVELIGEVYKNKQINETY
KFASYYLTQAKIKELGIEKDDTDGTAEMLLRIEGVEISLFVRENTDGSLKGSFRANDKYD
VNKIASIFGGGGHIKAAGFRTDLSFEEILEKTYKELGK
>SEQF2502_01801 hypothetical protein
MSFRLNPFKVMRAVGIVAIVAYGAVLVIGYKKSKVNTTESITKDMKVRNKDFYNSKDYKN
NLTLPKQVVENNNETVAKELKQTKPAETVDLQKDSVNSNKQQADKKVADETKKKEEQAKL
EAQKLEMQKKAQQKADEQKRQEEAKIAAKQAEIKKQQQIEATRKEQAAAQARADAARQRA
KEEAVKKAKEEAAKRARENAKKHQGPKKYIQVASVSTEASARGIAKKLGGNFYYKKTTVN
GRTAYVVMSNMTDNPNTLKAMENQAKKVGGGYMIRSVGK
>SEQF2502_01802 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase
MIGIIGAVIEEAEAIKKEIKEIKENVINGISFFTGKFNYKDVVFVQSGIGKVNAAITATL
LIEKFKVSEVIFSGVAGALDERLKVGDVVIGCDIVQHDVDATAFGYKMGQIPQMKEWAFE
SDKKLVEKAQNISDFDHHIFLGRILTGDQFVSKKDVKIQLGKNFEALCVDMESGAVAQVC
TRLGIKFLIIRSISDSITDESDMEYETFVKLAAKNSTKILKNLTL
>SEQF2502_01803 hypothetical protein
MKKRILLFGIMLGTSSCGIIGGVGSVVGGTIKAAGGVTGAVIGTTGKLIGGIIGGSDGEI
KAKNTKYKFSNAEVEISGGKTIVTGILTHNGVTKKNLTIEIPCFDKNGAKIGDAVDNISS
LVKNEKWEFQAILNTNETKTCKLKDTYIYEGNMNMVIEGNDEDNDNIHNVEEK
>SEQF2502_01804 putative mannose-6-phosphate isomerase GmuF
MLYPMKFKKFFVEKVWGGREFETKLGMKLPEGKKIGESWEVSAHPHGMGIVENGTLAGKR
LDDIYKEYKGELVGKKVYEKYPNKFPLLIKYLDVNDRLSIQVHPSDEVALKKHNEFGKSE
SWYIMEASDDATLILGMKPGITKEKFLEKVKKNDFDGLFEEKTVKKGDFIDITPGTVHAS
LKGSVIFAEIQQNSDVTYRIYDFDRIDKNGKKRELHLQDSADVIDFGKEVEIKHTDFNHS
ENGKDILRKNIIEKEYYSIDKIRFYSSFKDINNESMTIYSFLEGEGKIVWGENEELLVKK
GETILIPVGIKTKTIGNFEILRTII
>SEQF2502_01805 hypothetical protein
MYIYDEQKLKKENRKRRLFILMDSLLYVILPITIGFLKISKNIISIWLIIIFGILKFYLK
TKKDFVNDYKKENKEAGDFEKILRKEKLKKKIFYLKIGCVSTCLIVITLTSINIFQLPSY
VRDLKEIRKIISNSKEFYVNGKKLKNTEDVKKWILDSTNYFEILWDYKRTYNLKNSKIKV
ILSNEKGQHFIIEKEDYEWGVIKIKENLYYKLGVIHRNDTNRTIEMEKSLGLIPQN
>SEQF2502_01806 Energy-coupling factor transporter ATP-binding protein EcfA3
MSFITVKNLSFKYPNGTENVLNNVSLEVKKSEKVAIIGQNGAGKTTLVKMLNGLLKPVSG
DVIADDWNTKDYTVAKMSRKVGYVFQNPMDQIFHNNVYDEIAFGAKKLKYSPDEIKKMVE
NAIKLTELEKYQRENPYNLPYSLRKFVTIAAVIAMGSDVIVMDEPTAGQDFKGMKVLHNL
IDKLQKQGKTIITITHDMEFVVKNFDRVIVMTNGEVIADGDKRDIFWQFDTLEKSMVKQP
YISDLAREMELDGKVLSVEEFVENYKDMC
>SEQF2502_01807 Energy-coupling factor transporter ATP-binding protein EcfA2
MDYLKLENVNYKYPLEEKNTLQNINIEIKKGEFWAVIGKNGSGKTTLCNILRRFVPDFYK
GELTGKITLEGKELKDYSQKEIVQKIGFVFQNPFTQISGVKNTVFEEIAYGLENLGIERE
IIISEVEKILKLLEIERLRDKNPYNLSGGQKQRVALASIIAMNPDILVIDEPTSQLDPKG
TEDIFKIINLMANEGKTIILVEHKLELIAEYAENILVLDEGEIILSGKASEVLNNKILLE
KEIGMTQYSMLAYELEKARKTKFEEIPITKEKIIELLKK
>SEQF2502_01808 Energy-coupling factor transporter transmembrane protein EcfT
MKRDFFKKLYPLTKLYLALALIISAFIIPSHIYDYSMIIICGIIVSFENKLKIYSKRIFL
SLFWLFTAIFIIQSLFIPAGEVWLKFGFISVYKEGVMKAIGLTSKLTAIVSALTMLTLIT
PVKDFTLALEKKGLNPKAAFILMLTLQTIPEMKKQADVIMDSQKARGIETEGNVFVRAKA
LIPIFIPLVLSSIANTEERAITLEARGFSVGEKRTILYDIEETKNDKVMKIILAIFIVLN
IVWRVLWTILN
>SEQF2502_01809 hypothetical protein
MKSLKNDFSLMSSLLIPVAVAINFTGFGLVKLLQVPIFLDSIGTVFISLIAGPWVGVVTA
VITSLITGSFSPEYFAFIPVAVIMALAMGFLARFRMKNIVIKTLVCAFCLVFIAIVVSAP
IIVMVYGGNTGNSTFGVTAFFLATGQNIWTAVFSTNFITETTDKIITAIVAMAIIKAMSP
RYLIKFKYGENYINNQKG
>SEQF2502_01810 hypothetical protein
MSIQIKKTNETKLKMKRENFWKYILISHEKAKNNNEFIDYLIDILSKKTDEEIFDFEIIT
FELMRESYNEKLWCASYLVNGDTASWSFDFFRLWLISQGEQIFYSIMRNQDNLSEYINVS
FETKLMTNYFENENFAFISAYAFTRKNDSYNILKKENCKINDKTIFRDDFIDSYNRKLNE
YKRRIGYINKEYPKITFHWCTQFPDSMKEVCPTLFKKMYF
>SEQF2502_01811 hypothetical protein
MEKYVMFRGKVVDKWYDFDKRAHYHIVAVDKNGKKYDLAVNIGSIYEKKNEIISSNLKVY
YRKNYFCEGSVISKMLLQKSGITECDRDLCLDYVRMKLFPHNKMIQMKGFDEEHIYLTGI
IEKYVEKAKNNENYEVFAFGRLYANGKGLHDIHLNQGSINKFRKNDARYSDGGLFFRNRQ
SNRIIAIFIAFVTQSLDESL
>SEQF2502_01812 hypothetical protein
MKNKIFKVLIIAILSANVVYAESSRKIRISDVPMSKIEEDYKKLGDREDLFIKDKNGVYK
YSYGDTVQKLNGIDPKTVEVFNKFYLKDKNGVYYLDKNKIKILNLEGMDLKTLEVVDNSY
LKDKNSVYLVQENKLKRLEKIDPNTFKNVGGNYVKDKNGVYKYYFTYITINDKELKKEPN
FDAKTFEIVDPDGRYVKDKNNVYCDGEIINGADPATFEMLKKGNINYTKDKNNIYYWKTK
IEGVDRDTFKIMENPNFSKDKNNIYFLGEKTESESYPPEYEKKGNDVYYKNKKLKDIDAN
TFETMISFFGFKDKNGYYVLDRDGSVVKINDKEVKIKNLAKSSFNSNFFYDGKNLYFIKN
HKFEKIKKAPKTDGISEISDRYVEIGKVYYLDYDKGELIKLEKNDGRGVFFALGEDYGKD
FNLNAEGVETTRRYIYFKGRILKNADYDSFGIKYNDQKNVFEIRDKNRVYETLKNE
>SEQF2502_01813 Folylpolyglutamate synthase
MKKDKIKINEILEKIFNMRTINKRITKKSLNQNNEKLKKIYELLGKPCENKKIIHIAGTN
GKGSTATFLENIFFAAGYSVAKFTSPHILRFNERILVNKEMILDEDVVKYCEAVMNVLKE
NGLQINFFEIATFVALLYFKEKNPDFIFLETGLGGRYDATNIVKSTIAAITNVSFDHVAL
LGNSLYEIADRKAGIIKNRQLCIYAQNLTELEEAVKRETDNSVNVLEKYKGFQAELDNQN
YKTIVKIVENKNSKESGNIKKSENIEKINNNKNNLKKTFILPLFGKFQANNFLIAYEIAK
IYGINDKIIQKGLDEISLAGRFEIFSKNPATILDVAHNDDSVKVLTENLNELFKDDEVIF
VLSVLGTKDIANIFKRILEKNYKIFITSLKEVIYGLSAEEIKKNLEDSNISTKNIIFEDD
ILQAYNQAKKMILKNDNSYKVIVVCGSFYEIAKFKKLFL
>SEQF2502_01814 hypothetical protein
MINNLRVLKKELKSFAKRVKNFKYTESALITFLLTGLIELTGVSFNLFSAENEIQAQTKA
INTSITSIKSDFRFARHENNKLLKKTNLELVKLMEQGDHVVKSPWSSWQYGINGFYNSWQ
GSYKGRGDKTADYKYERDKTMSKTKYEAYPHTLYGNTTELGLKQEPNASIPVSATLNPLI
PKVKHANVSMAVDISELPSFNPRTVTPPTAPTISPMKGINTPSFSMKSSSLSNWGESHFD
NANTASNGVIESVAILGGDFNVERLDPGSASRWKYNYTGYRVKNAFNTGNMTSDYIISGI
TNILTPNSEITVPSRTVAASNSKSGFLRMTNDSPVSQGSTLLNQATFTYTNSSGGNYVRE
LAHLDMHGSNSFSTERGKLLAITGLKASVVPNFDDVSTIAQNTTGSTKSQTFINAGKIII
KGDQASFTNSYDHDWDDQNRVASVINTEDGEVSVSPLDPNNKGSAVFIVSPEIDKAGNPQ
IFYNAGKINLYSKKSAIFFLNPNGDVRWNHDGSFHERNYENNRLGLPDNDQDDPREITIV
NRARGNNKIISYGDGNVGIYLKTSKYIKVTNLDFRTQNLTDYVTKNGTWAPMIMYGDNNI
GLYAPKDTESQLFVGDPGPIIGNFAVSIGDSNGNYFLNNNDDAYIDSSYGIFSSVNIDLS
NDVKDIKSGHQITINKNSKNGIGVLTSNNAEIKLGAGKIELNGGFDNTGIVIGGSKASSG
DVKDTDGSVIGDVISINGISNADRGNRAIYAWDGNNRGNSVEVNAIKSENTINSIAIVAE
KNAKITVNGTASSNPSIIGTTDGTGFEYGVKINDSKYVYDPNRVVSATDATSTDNVGAAY
ANNEAVITINRTSVPSVANGPNISIEGGIDTYAKKIIGFGLFADNKAKINAQNNWIKVTN
GATNVASLSNAEIDLKGATVEYKGEGYALYTNTTSKNSGAINMSDAKLVLDGKAVGYVHY
QDQPNMITVNPNTSIDILDDDVIVADLRKTSGQVTVNVENKATPDRLRDQLIGGVGSVGS
TNGKTRYKYAVVDNAQINIKSAVDKADNSGTDTDSEVFAKRFLYQNSKIDVTTAGSVKAE
LDDTQMKAIDVNLKTPVGLAVTASAQTKDNDTTGISNSGTVSTDKTVGSDRGGIGLYVDY
GYINNNAAGTVNVEKGTVNNPNDKAIGIFGTNSTKIVNDGKVNAGGKKSIGILGLSYRID
SKTGLAINPADETYYSNVITNNGTKFGTVNVENGATGKITMDNDGAVGIFVKNNSIDKNS
FGNYVVTNPSDIRTKNDTRGVNKGEITINGSNSSVGIGANNGIITNASSGKINVNGTKSA
GMYGTNDSDLINNGEINVAATSAGNESIGMYIDDQVSTIANTGKINVGKSSYGIYGKDVN
MTAGEINVADDGVGVYSTGPSVNLSGGKIDVANNNSVGVYIADDSKNPQATTVTSSVDMK
VGDTDSFGYLITASKAKTDLTINSTANSIHVGEKSVYVYSGAPQSLGGKVINKSDIVMDK
NNGYGIYSSQDAENYGSIDLRAGIGNIGIYSTQGNGKNFGVIAVGSSNVTSKQYGIGMAT
GYYNEITKVSTNEGTIENYGTINVSDDNSVGIYAVGSGSKAINKGTINLSGNNTTGMYID
RYATGENYGTIQTTPTTNGTGIKGVVVANGGVIKNYGTINIVGSKNIGVYAFRGDVTDSS
YVPYEAHGTGNVSTRPYLEGTATDQKVTGKAIVKVPPASLPSSVSISIDGVDVAPVKVDT
NIASPEAPEVLITDLSGVTKLNLETEKMDHNHTHSNGEISTIGMYVDTSGINYTNPIQGL
NNLSGLTDVDLIMGTEVTKYLNAKAIQIGDNILKPYNNALASVVSTGVTLNVNSASLTWI
AQPVESGNIAAPIKTVYMVKIPYTDFASKNDVDTEHFLDGLEQRYGVEGIHSREKQIFNK
LNDLGKGEPHIFAQAVNEMKGYEYSNTQQRINATGNALDKEFKYLWKDWRNPSKQNNKIK
VFGMKDEYKTNTAGVIDYDSNAWGVAYVHEDEKVQIGKSIGWYAGAVTNRFKFKDLGKSR
EDETMVKLGIFKTMSPRKDYNGALQWTIAGDIFGGINNMYRKYWVVDDTFEAKSTYNSYG
AALKNELGYDIRMSERTHLRPYGALKMEYGRFNEIKENSGQMRLEVKGNDYFSVKPEAGL
EFKYIQPLAVRTQLSIGLTAAYENEISKLNKLNQARVRYTTADWYNLRNEKENRRENGKF
DLNIGVDNTRFGMTVNAGYDTKGNNVRGGIGFRAIY
>SEQF2502_01815 30S ribosomal protein S16
MLKLRLTRLGRKKVPFYRIVAMEALSRRDGKAVAYLGTFNPLVEDDKQVVLKEDEILKYL
SNGAQPTETVKSILTKAGVWAKFQETKKK
>SEQF2502_01816 hypothetical protein
MSSFVRNLILDKIYDEITKEDEKRILKRQEKSKLEKNKFS
>SEQF2502_01817 Lipoate-protein ligase LplJ
MIYYISKTHDTAFNIALEEYCFKNLRDEDEIFLLWINEPSIIVGKYQNTIEEINTEYTRE
KGIHVIRRISGGGAVYHDLNNLNYTIISNRDKGQEGFNFKEFSKPIIETLAELGVEAEFT
GRNDLEIDGQKFCGNAQAYIKDRVMHHGCLLFNVDFSALGNALKVSKDKIESKGVKSVRS
RVTNILPHLKTPITVEEFGDKIMEYMKKQYPDMKEYVFSKEELDYIAKRAEVKRSWEWNY
GESPEFNITRGKRFKNGKIQIFATVENSRIKNIKFYGDFFGKNEDLSEIENLLKNVKYTV
EDVKKKLESIDIGEYFSKFTVDEIVEVIVE
>SEQF2502_01818 Dihydrolipoyl dehydrogenase
MAVEVIMPKAGIDMTEGQIVKWNKKEGEKVEEGEILLEIMTDKTSMELEAEASGYLIKVL
KQDGETVPVTEVIGYIGAEGEEAPTGAAPQAAPEPKAAEPVAAAQPAASISNEPKAPKGD
DEFDVVVIGGGPAGYVAAIKAAQLGGKVAIVEKVHFGGTCLNKGCIPTKTFLKNAEIIEG
IEMAGKRGIILENDKFTIDMPKVVKLKNDIVKTLTNGVQGLLKSNDVKIYNGIGKINVDK
DVVVTNDKGETVLRTDKIILAGGSKVGRINIPGIDSPKVLTSDDILDIQQIPKSLAVIGG
GVVGIELGQVFNSFGSEVTVVEMMDRIIPGVDRESSETLRKELEKKGMKILTSTAIKEIV
DNGDTLTIKVDGKDDIVAEKALLSIGRVPDLEGIGEIDLELENGKVKVDKYMETSVKGIY
APGDINGTRMLAHAAFRMGEIAAENAIQGNHRATRLETNSSASIYTIPSAIYTVPEVAMV
GLTEEQAKEKYDVSVGKFAFSGNGRALASGESAGFVKVIADKKYGEILGVHIVGPSAAEI
INEASTLMKMEITVDEVIKTIHGHPTYSEALFEACADVLGEAVHLPKKRK
>SEQF2502_01819 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MENSKLRATPAARDLAKMMGIDLLNVRGSGAKGRIHKEDVEEFNFEKKVRITPLASKIAQ
EYNIDLSTVEGSGHNGKIMKEDILNIIAKPKETEELARHEKAILAEKEQVEEADIEVVPM
SPMRKVIAKRMSDSYFTAPTFTLNYEVDMTELISLRKKVMDTIMENTGKKITVTDLISFA
VVKTLMKHKYVNSELSADGTQITLHNYVNLSIAVGMDDGLLVPVIKGADKMSLSELVVAS
KDIIKKALAMKLSPSEQSGSTFTISNLGMFGTQSFNPIINQPNSAILGVAATVEKPVVVD
GEIVIRPIMTMCLTIDHRVVDGLAGAKFMQDLKKLLENPLAMLI
>SEQF2502_01820 2-oxoisovalerate dehydrogenase subunit beta
METKLMSVKEAIITAMSEEMRRDENVFLMGEDVGIFGGDFGTSVGMLEEFGEERIKDMPI
SESAISGAAIGAAMTGLRPIVDVTFMDFIVYMMDNIVNQAAKTRYMFGGKGRVPVTFRCA
AGSGVGSAAQHSQSLEAWFTHIPGVKVVAPGTPADVKGLLKAAIRDNNPVIFLEYKAQYN
MKGEVPTDPEFVIPLGKGEIKREGTDITIVSYGRMLERVLKAAEIVAEEGISVEVVDPRT
LIPLDKEIILDSVKKTGRVILVNDAHKTSGFIGEISAIISESDAFDYLDHPIVRLAGEDV
PMPYNHTLETAMVPSVEKIVEAIRKVKNKQ
>SEQF2502_01821 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit alpha
MENISKDKLLSMYESMLDIRNFDLKVNQLVKRGMVPGMTHLSVGEEAANVGAIAALNPDD
FITSNHRGHGQVIAKGIDLNGMMAEIMGKATGTCKGKGGSMHIADLESGNLGANGIVGGG
HGMAVGAAYTQKVKNTGKIVMCCFGDGATNEGSFHEAMNLASVWNVPIIFYSINNGYGIS
TDIKKVTNVEHIYQRAAAYGIPGYFIEDGNDVLAVYEKFRKAVDDVRAGKGPVLIESVTY
RWFGHSSSDPGKYRTKEEVDSWKAKDPNIKFRNRLIEEGIATEEELTKLEENSKQKIEEA
VDFAKNSPEPALESAFEDIFAD
>SEQF2502_01822 Aspartate--ammonia ligase
MSKTIIPKNYDPKYGIMETEIAIKAAKDCFERELAKALDLTRISAPMFVRKSVGINDNLN
GVERPVAFEMKEMPDVTLEIVHSLAKWKRIALKQYGVENGKGIYTDMNAIRRDEDLDNMH
SIYVDQWDWEKVISKEDRNIDFLKATVKKIYQVFLNTEKELTEKFEKFEKFLPKEVTFIT
SQELENLYPELTPNEREDKFAKEHKAIFIMQIGKVLNSGKRHDGRAPDYDDWELNGDLIM
WNPVLDRSLELSSMGIRVDKDALERQLKELNLEERKNLDFHKMLLNDELPLTIGGGIGQS
RICMFLLQKAHIGEVQASVWTPEIVKTCKENGINLLWY
>SEQF2502_01823 Serine/threonine transporter SstT
MKKIGLVPRLIISIVLGILLGLVLPSPIIRIFVTFSSLFSKYLSFIIPFMIIGFVVTGIS
DLRHGAGKLLGITTLLAYLSTIVAGTLSYLMAISIFPKILNFASFTTVEHPEKNLLTAYF
DIPVAPMFDVTSAIIFAFIMGLSISWLRNNGEGQTTYNLFREFSKIITKLLSTSIIPLLP
VYIFGTFMNMTYSGQIFATLSIFLKVFICVIILHILYTAGLFIFAGGLSGKNPFVCMKNQ
IPGYFTALGTQSSAATIPINIECAKRNGTSPEIREFVVPLCATIHLAGSIITITSCVVTV
LMMHSMSYGISTIFPFIMVLGVAMVAAPGAPGGAIMSALPFLGMVGIASSSPMASLLIAL
YITQDSFGTAANVSGDNAIAIIVDWIYHKFIKK
>SEQF2502_01824 hypothetical protein
MKIAEALILRADIQKRIAQLKVRLNNNAKVQENEEPTEDPEFLLAELENLISQLNDLIVK
INRTNTLSKVDGISLVELIAKKDTLSQKAGILREFIEIASQKVNLYSTTEIKVFSTVNVS
ELQKKLDKLSKEIRETDTKLQQANWTIDLVEE
>SEQF2502_01825 Capsule biosynthesis protein CapA
MKKNILLILFAILAFSLALIITSPNFKDFRNKFMNLEKILRNKKIDISKNRNDEKNKKDE
KSEFTIIGVGDIMLGSNYPFEYLLPKNDVNILQNTQNILKNADITAGNLEGTLFDTSGTP
KNCNNPNVCYVFRMPSRYGTYLKQAGFDYLSIANNHSNDFGEIGVKKTIKNLDNLGIKYS
GIKDIAESAIFEKNGKKFGFISFSPNSATVKLNDYNYAKKLISELKSKVDIVIVMFHGGA
EGANAEHITKKHEIFHGEDRGNVYEFAHFAIDNGADIIFGQGPHVTRAVELYKNKFISYS
AGNFATFGKINISGSMGIAPIFKIKINNKGDFISGEIIPVRQTYKSLGPFIDSEKLAIKK
IIYLNKSDFPNGNGLSISEEGKITKTNNLN
>SEQF2502_01826 Multidrug resistance protein MdtA
MPAIFIFIILFMIKFCTPKINQKYVIEKITLENLEFFVDMKGTVVANNVTKIGLDVNLSV
DDVYYKAGDFVKKGDVIVKFSDYQKNGLNEKRTLLVIKNRELRNLEKQRELGSDVSQKIQ
ELRGEISGLEIEIKDEMRNTRLVQRSVRSPFDAYIVKINAVKGGITNKNEPILILSKRED
LKIVSENVKSEKVKNLNIGNVAKISIFRRENKKIGEEKILEELIEMKNDKNKEILQDKDK
IKENSDLFSEKKVIEAELFKINKIGDMNVFEFLPTLFKDLFLNEQVDIRVIYKKKENILA
VPKKAVIFKNQKSYIYLIDKNNLVKEKKVFIGMDNGEKIEIFGIDIGEGMEIIGNPDDKI
GNNVIVERRNIKDEEIENRKKLERLEWENEKLGNRMDENEREIIRLKRK
>SEQF2502_01827 hypothetical protein
MRLFYEEELRRKSYYEMYQIAIEEHLVNVHVETPTREELISLLMKYRGVKENYCIDKYNK
NGLVNVQELFDNKLGERIHHENKIRVPHKIILYKELDLMREDNYKIEIPENVSSANVFLI
NANNYLCGIFQLEKDLNSRNKYFLISKKEFFRVETLRNNKFSFLFFKENDLKFIHKFYNL
KEDETTPLYPYQMDYYKVEIENFVVKNLETTNTPLCIDFGTVNTALGAYLDKNYVKDLPT
NDILNGNVVIDAINYVKFDDGERRYREIFPTLVYVDDCSDANNIKYSFGYDVIRKLERND
YIVNGSIFYSLKRWVHEHNKLEKINDEFGNILYVKRKDIIKAYLKYVVNRAEYMFKCKFK
KIHASSPVKLKEQFLTMFQEIFMVENKFNKNQNSEISEKNIISSEKNYEYEIIRENAMDE
AIAVLYNTIEIQIRKERYKENEEYSALIIDCGGGTTDLAACKYVISKDKISYYLDIRTSF
ENGDENFGGNDLTYRIMQFLKIVLGAKYSENRVVSINDLIKYDNDIIYKVIDDSGVEKIF
ENMNLEYEKYENVIPTKYSQFENKMSEEYQKIRNNFYMLWEAAENLKKEFFTSDGRLRTR
FDVPRNYEKRNDIHITQLKSWKIHTYENGIFTTITDYPRHIFTIKEIEKIVKADIYGMLR
KFLNTYYKEGLLFEYSLIKLSGQSTKISTFQEVLKEFVPGKMIEYKELSHRDDYELKLNC
LDGAIKYLDYKRFGHIDVEIVNEVPLVPYSVWVEKYDGEKVEMIQTSRKADILIGQIDKK
ISAEELKIYVYTAEGELKKEMIYKNEDNYEEMDAQEILPEFTNIISQNDTDTIQNNTVRF
FIYTDLNNWGFFVVPIQRKSDQLYLGRKEYSPYEDNLSENSYFDGNH
>SEQF2502_01828 Serine/threonine-protein kinase PrkC
MDFLLKGTILNRKYKILNYVAKSDFSNIYMCEDRQGEKVIIKECYPSEIVMRNSKEVFTE
KYKKDFENLKECFWKEKCILEKFLKKSKRRKRKFVDDVIKFVDFFSENGTNYIVTEYFCG
VTLKKYILENRIKNGKLRINHILEIFFKIAEVVCKIHKKGIIHCDLKPSNILIDIRGNIR
IIDFGASLKKKEKVEFVKVSDGYSPIEICSEKVEIDERTDVYSLGALLYFMLCGVKVDGA
IKRFYKAELEFGREVILGFEKIEIFKEVEEVIKKGLEFDRQKRFGSVREMIEKLRKIFA
>SEQF2502_01829 hypothetical protein
MIKNIKLNTFFFKEYAQIAEKNTYSAYIPNGNRGIWCIADFEEKIYVQEDIEINQKIENN
DIRSKKIKKNIKRKNLAKIGVYKIIEKYLENSSFSIENMKKMIQSSKDKVIFEKSKLLKI
EKDNEKNFDLKNFYSQIVVIIEKNNMIVGNMGKTEFVLYRENRIVEKISGEQFKKIRLKK
HDYLLAGSPEFWKVVNESEIEEVYVDKKSKENIEQSLSEQIKLAEKKLGKVIPFLSIFVE
DIEVEKNYELLESEVSKKNQKREMTVKYIFLSAMFAFMLVSVGKNIQKGNFENRKNENVK
NVMAKKISEKSNLLENNLYVKAEIENNKIEQGNLANVKVEVKKTAENENAVENQNVETGN
KEIEKNHAKNLEITQNITKSKEKGDKKLNNSRIKKKVSKNKKYNRKNLNADNRNFKKNYK
VKSNGISQLEKEIEQNWEVLGRDRNGNNFVKNREFKRENKNGFFVKGNNIE
>SEQF2502_01830 hypothetical protein
MRKDEAKFITEFLSEAGTKTENSDYFGYVLLDNYAIWAVADGFDEEEGAKVAARIAVESV
IEYFMLCPRFNYDVIKEMMDYANLKVKEKQEEAQKYSLMHTSLLIVISNYNSILYGNVGN
TRFYHIRGGYIVSQSKDDTIAQLLVDEEALNVSDIRFHRQRNDLLQAIGDFGKINPNIIR
SPVELMEKDIFCLTTVGFWENIDEHDMENDLSRFEDKKQWLNSLEKRILASLRDNIENYT
IAQVEVQAVASPEPMEKDRSKIIKKILLIIMIVVVIILFIVIWNVKRRNGILQAATQYEK
LADEEILKKNFNNSIDDLKLEIGEYEKLKPKSRGIIGFFTNAEKKRNDADKKIDEINKKI
GEIEKIKEAFTDIDEGNELFNNGNYDEANVKYQQAKYNLNDNTYKRDELNTEEILTTLDS
RINSAVKLKEAKALEMAGDNAVNEGSFNLAKVSYKNAMDIYLANGKADYVSQIEKKIEEI
SDKEKTAYNGAMLAENKGDSLAQSNINSSREAYYQARQMYQVLGDTVKVGEVDNKIQELN
SQQNADLQTANNLVQEGLSQITANNPAQAISILTQAKNIYQKMKDTNNVNIVGKYINQAQ
EFIKFESQNVEKLKAQKLEYSEKLKSQETEYSEKLKQQEIQLQQQLQAKEMEIKVQQEQM
EQERQKREEISRKIENALNLEMQADQLAIDEKFEESIAKYEETKKILEEVNTDGNFGNQV
AKIEGLNKKIEKIEGYLLKKNGEEDLKNKRWKDAVEKLTQAKEKLEKSGTKQNEIAEIEK
KLKKAEKKANKKWWQFWKIF
>SEQF2502_01831 hypothetical protein
MKLDRCKNGHIYDVSRYSSCPYCKSEGLETEVQDDKINLVEQMEDEDRTTAYWSKDSTVD
PVVGWLTCIEGHDKGKDYRIVSERNFIGRGENMDIQILGDTMISRKNHCSISYNPKQRKF
MLTPGDSNGLIYLNGEAVYNTVELRAYSVVEMGESKFVFVNLCGDYFDWEKEKARDENVK
RKYEKNLDNKKIDENINFVNRNSRNGDLEVKIEDYEENL
>SEQF2502_01832 hypothetical protein
MLWGIRRLLSNFRSIFRQPFGRGSIYRLERLKSVVRMKENGENRSEKNGLGVDKGIRKYE
KRKLNARSQKAYKFFNVKNILIILILIFTFIFVHFSGYSTKSLYFSIFIYIGVTLYLLIL
ERFFEKVEVQEEIKNIKNDREREHNVFLERVKEIEDLEKNQIEHIFLKDSEDYDMKIWKV
GRATSLLIGKQSPRNRVDIDVSEGIYSNLVSRAHGILNRVNGIWYYEDLGSQNGSGIEKS
LDKRKMKLKKNIPVKVESGDIIYLATTKILLK
>SEQF2502_01833 Chaperone protein DnaJ
MNYYELLGVSENADISEIKKKYRKLAMKYHPDRNSGDENATKKFREVTEAYEVLGDEKKR
EEYDCKRKNVQSQRRNKNKKENVKDEFSQNDFTFGRDFFKSAKEMKGMFENSFRMDKMGE
KRARSEKENIKSRFDQFFDVKKKNNDNFR
>SEQF2502_01834 hypothetical protein
MNMKNTFKKMVAILGITGISIVSLAMPPKPKNPKPKPMIVQPERKKTNKILEKKRTVNFQ
EKRNNKKTMVKKHGK
>SEQF2502_01835 Holliday junction ATP-dependent DNA helicase RuvA
MFEYILGKLAVKKIDYVALEINGLAYKIHISLKTFEKIGNIGNDEKLYIFTNVKEDDISL
YGFKTQNERELFKALISISGVGPKLAIAILSTFNMREIIEIVTEDESKIFTRVPGLGIKK
AQKIILDLKDKVKKIDISEMLEETSNLSNGKLITSESFDPKISLMKEDLKLALESLGYTN
TDISKWIKDSELAQLKDISEAIKIVLQKIQNKK
>SEQF2502_01836 Glutamate racemase
MSIGVFDSGIGGLTVLKEIRKVLPDEKIYYLGDTARVPYGEKTKELIIRYSKEIVEFLLE
KNVSAIVVACNTATALALKELKETFKIPIIGVIEAGARTAIEATKSGKIGVIGTKATIQS
GKYEEEIKLFNKKVEVLQKACPLFVPAVEEGILSGKLVNQIIKTYLDDFKGKVDTLILGC
THYPLLKDAISKIYPDIKIVDPAKETALDLKEILEQNEFLKNDAKKDEEVKYYVTDGQEK
FKEIGIMFLEEDIPKVELVKL
>SEQF2502_01837 D-alanyl-D-alanine carboxypeptidase DacF
MRKKVKIGIKSKKMVLSMAFLAISAFSFADGENYHDYKALLIGDVNGNIIKEDNSLAVRP
LASVTKIMTSILTLDKIKTGQISYDDKVTISSKAASVPYGVKLTAGKQYTVRDLLKATII
KSSNNAAYALAEYVGGDVPSFVHSMNEKAKSYGLDSLRYCSPNGLPPSYTGSCMDQGNAR
DLYKLAQITLKDYSEYLNFSKNKVEYIDNGNTKVTSTNTLLGNVQGVDGLKTGYHDAAGS
NIVLTASRGDDRMIAVILGSNHAKDRNAIGAREINDYYINGYAKKNGGNSYAYAGDNSNK
NRRNYNNNQNSNRNSNNNGNEFNNNNAENNNAQKGNKIEQFFNSIFGKNNNNNSAKKMKI
ISKNDIVAVAEIGEKKYNLYPTKDVEITATQRPNLTYTVNLNSGVNKNSRGKIVGTYIAT
DGTLTYSGELIMK
>SEQF2502_01838 LPS-assembly protein LptD
MWKRIGYGGLVLILIYFIYAVFFKKIPAPLDQMQKDMKAKKVVYRLKDEAIVYADEQIGS
EGDEVIKFKNVIIDLVKKQMVISGKEGIVNTKTLDVSLMKKVVGTTKDRKWEIYTERVDY
KKQGDQLISPVKTKLVNTFDDTFSEADKVETTTKFETIVATGHAKYNNKKDKKTMTADKI
TYNDPTKVSFAEGHVVYKEEKTKRMLTADKMRYDDINKIGNAEGHVHYTSPESKLDAQKA
DYYMNGDDERVEGFGNVVYIGKESVITADSAVYFIKKKQINGNGHVVYKSKESVITGDSA
VYLVDKKQVDGRGHVRYTGKTMIITGDHVFYDKIANIITGDGNGTYNYLPRRTTGTYRSG
VYDLKTHTMTTSDYYTANYDDYKMDGTGLVYVFPTGNATMNGPFNVKKQNFNVHGANGKM
NTISKDIFANKMEMTSIQGDKISSDIGQGSFEKKEFRFDGHVKGKIRGNVKDLVNDPRPL
VESEAVHFIGNTAKVYFVSHKNGSNMSITRSEIKENVHMTYKDITLDSQYNEMDSRRNLI
LARDKVMVDFKNNTKMTANYLYMDMNKQEGYARNNIKIVSTLPQFRAINTSADKAIIYLK
DKKIKLNGNVVTYQGKNQISSKSAIYDMDKKILENEGNIQMRYEVQNNGDNNGSNEIQGK
SDPRNSAAVQEVIGKLSVSEGGHLPKSMTASNGVPVTIRWHSSNSSLYSVSGRVNKQFYG
GGSKGATLTATAKAGVDTAERTFSVSVPTESAHEMLVRAASNIYVPEDGENLPSSVRVNV
NKGTIDIPISWSKNGDRNVATLRYGGASYRQQF
>SEQF2502_01839 DNA mismatch repair protein MutS
MADTPLMKQYKEIKSNFEDSILFFRLGDFYEMFFEDAVKASRELGLTLTSRNKEKNVDVP
LAGVPFHSADSYITKLVSKGYKVAICEQTEDPKMAKGIVKREVVKIITPGTVVDVEALDA
KSNNYLMSILKIENKLGIAYIDITTGEFKVTEVEKDDDFVKLFNEINKIEPKEVLVTEDF
YGEIKEKLDDFLQKNDSVVTFVNKVRDSAKYLMDYFEIVSLESYGIKDKKAIIGAAAMAL
DYAATMQVEHELTVEKIEFVNISNYAEINAITSRNLELLKNQREKTVYGSLLWVLDECKT
SMGTRLLKRFINNPLLNIEKIQKRQEDVQYFIDNILIREDLREKLENIYDLERLLGKIIF
GSENGKDLTALKKTIKSAVEIMKILENTDFFKDIDANILFECYKIIDDSINEDAPFSVRE
GGIIKSGYNAELDEIRNIMNSGKDFLLDIEQREREATGIRNMKIKFNKVFGYFIEITKAN
LDMVPEHYIRKQTLSNSERYITPELKKYEDTIINSKAKIEDLEYHLFKEISGKLKEHRKI
LSELAERLAYIDVMVSFAVSAIENDYAKPEMNEEYSFEIEGGRHPVVEKLIGRTDYVSND
TVFTEKESFVVLTGPNMSGKSTYMKQIALISIMAQIGSFVPAKKANLSIIDKYLTRIGAS
DDILTGQSTFMVEMSEVSNILNNATEKSLIILDEVGRGTSTTDGVSIATAISMYIHDKIG
AKTVFATHYHELTDLENKFAHIVNYRIEVDEKQGKVMFLRNIVKGGADKSYGIEVAKLAG
LPKEILVESKKVLKRLEQKKELIEKTVDVHQLSLFGGNLEFEDNFDEAEKDFKNVENNQL
YEEKLAQIEEEKEKLRKIMNKIEDYDINNITPMDAMKFLFELKENMKKDNK
>SEQF2502_01840 Teichoic acid poly(glycerol phosphate) polymerase
MDKIKCLINMIIAYLIYPFNKGNFKNRNIWLVGGNAGELFVDNGRAMYEYLRSKQQEEVY
WVINRNAKIAKKIPGEKLIKGSVKSYLYFMNAKVALFSHSISADIVPYLFVVPLINKFHK
KVFKVFLNHGTVGFKVRQAMNPKTAKVAEALVKSYDLNICDSEFERKVKTETWWEVPKET
AVITGYPRYDKLYNLKITEKQIFFMPTWRNWLKSENSENQKFEDTKYFQNISNLITDKKL
NDYLEKNNIKLNVYIHQLMQDHLKNFGNIKLGKNIRILPKEVNITEELQKSKLLITDYSS
VAYDFYYLNKPIIFFQFDKREYEEKVGSYVDLDKDLFGKQAKTVEKCVEEIIEISENNFH
YDKDMKQKSDKLREKFLKYVDKGNCERVYDEILKRIN
>SEQF2502_01841 GalNAc(5)-diNAcBac-PP-undecaprenol beta-1,3-glucosyltransferase
MKVSLVMPTINVTTELELFLKSLRTQTYKDFELIVVDQNEGNEAFEIVKDYEEEFKIKYA
KSDEKGLSLNRNRGLVLMEGEIVGFPDDDCEYQPDTLEKVVAFFERKKNYRIYSCRTLER
GKTYGTGVMEKKDMEITKDNVDKTVKSITFFVNYKKDDIILFDENLGVGATFGSGEETDY
VLTLLHKGYKGRYFANDIIFHPAKKGNYSDLDRAYKYALGFGALVKKEVKGRKNRFYILK
YWKRQFRSFVGMIVTRNRAYHRVVMKGRKIGYTKYKI
>SEQF2502_01842 hypothetical protein
MSKLKKVLLSLMICGATVSWAKEFKMMTYNIYGARLTNGQKLGESIKPYAPDFVSLQEVD
KFTKRSNFRDVTSDIAKVLGYDYYFFKKSRDYDGGEYGISFISKYPLEKIYTYELPSEGE
ERRQLVVAELSKKTFGKKVLVMNTHLDFKPSIKPEEMESLDLLTKFFDKDDIKFISGDFN
FLPSTKYYGQMTKDWRDTYMEANFSGARSLSDPRIDYIFGSQSKKWKVKSSYFINDATQD
WTKLSDHLPYITTVDIK
>SEQF2502_01843 hypothetical protein
MIEKKIYYVWVGNAKKPDIFYKCLESWKKNLPDFEIIEINEKNFDMETHLAKNRFFRECY
ERRLWAYVSDYMRVHFMYENSGIYVDTDMEIIKNLTPILEEKDSFFKNPKNEKLKKMDFF
IGYEDEKHISVGIFGTSKHNEVLKDIKEFYEKEIWEKPVWTIPKIFTYVFEKKYNLSGKR
ENLLKDGEIVIFPKEYFYPYGFHEKYTDDCIKPETYGIHWWNDSWSSLKARLFLEAKHLS
GIKKLVKKTRIIARYYLKEKHK
>SEQF2502_01844 Acetyltransferase
MEVENIKIINGINDNNKNDIVKWTNEKGKDFLEQWAGKSLDFPLTESQIDDLKDIYSIFC
ENEFVGIIQKIRKEMNNIHIGRFLINPELTGKGLGKRALIEFINLIFQDEGVNSITLNVF
DYNVGAKKLYEKVGFIVVNVVENPMKKYMMIMKKGEK
>SEQF2502_01845 hypothetical protein
MGEKEQVFKVHWVEKLKMVFNLIYIPVLFFYGWRFSLDFSINEIFFKCFLTVLLSIIIFL
ILSIFVFNKKIEVLENILTYYERGKEVLCVRIEKDNIRILYEKHWSSELKHLSVDYYDVP
IYLFGKKNCLKLEKIICKFQLEKKEIENIVFEISKKELFIEKYKDIFKNAIIIIIFIFIV
VKYSDNIFLNYFLIIIILGVIILEIISLIRMKICTPKIIKIFNNFISIDDEKYSKYDIKK
LMFTSPNTKSGTIDFGYRILKIFGNDEKKFFTLITSKNSEFKNEDYETFYGEIVKFCIVN
GIEYELV
>SEQF2502_01846 hypothetical protein
MKRNNFIKEDKIGFLIFHMFVIAFVLFLKSMVTFPNDALKMKFLECLLMGVYIYTFFTAK
IYLEWLNSYMIFLYTLFLFNFTRIFLDIVNYKEFGWATKFANFYFYYDVRNEIITVFLLV
LLFTHLGFFIGISNEKISEIRSSITLESRRMFTDIGMALFIISLPALAYKMFIQLRVILH
AGYEAYYTGILKGVDYPAFTKGSGTVMTIGFLIFLISIPSKRKFLTISSLYLMVKLLDSF
KGARAIFLTQLLFIMWYYAKVYGIRIKAKTMVKLVGFTVIFSQILVSIRSKKIFSLDLIN
TIYNFLFSQGVSYLVLGYTINFKHNIVGHGSYPYILQGLLGFQPQSLETLETTNSLADRL
TYYLNSGAYLKGEGIGSNYIAEMYDLGYIWLIIISILLGIAIIKYEKYVVKNRFLLLTSY
YFIPNLFYIPRGSFFGEGLIKNMAMLIAVYVLVFSFDYMYRKIEEKKELI
>SEQF2502_01847 Thioredoxin reductase
MYDSVIIGSGPAGLTAAIYLSRAGLKNIVINGMEPGGQLTTTTEVENFPGFPQGISGPQL
MEDIKSQSQNFGTEFLQAVVKDIKDVENNGKKTFELHLDNGNIVETKTIILSTGASAKYL
GIENERENIGKGVSACATCDGFFYRGKEVVVIGGGDTAMEEALFLTKFVNKVTIINRREF
LRASAIMQKRAKDNDKIEWKLDYTPKKVLADEKVTGIELINNKTGKTETLATDGIFVAIG
RTPNTKFLEGKVEIDDRGYIVTKGKSSKTSTSGIFAAGDVQDSKYQQAIVAAGSGAIAAL
DVEEYLRENNL
>SEQF2502_01848 Thioredoxin
MALNLNKDNFEQSIANGVALVDFWASWCGPCKMQLPIIEEFSGEMEGKATVGKVNVDEEL
ELAQSFGIQSIPTLILFKDGKPVKKLVGLHSKEALYEEVNQVL
>SEQF2502_01849 putative HTH-type transcriptional regulator
MDKICENYKNSLYSGLSKIGKCLSSEKRIEILDLLVQGSKTVESISNETGMSIANTSRHL
QILKDGNLVINEKKGNYVVYEIANTQIIDLVYLLIGVGEKQLADIQRIHNEFNDSCMKIR
PITLEQAYEMAKKSETLIIDLRPQDEFNSSHIENAINIPMKELEKNITNLPKNKKIIVYC
RGRNCAYANLASKLLNDNGFQAYSLNQSYYDWQKNKNF
>SEQF2502_01850 Bifunctional adenosylcobalamin biosynthesis protein CobU
MGLIFVTGGAKSGKSKFAEEMLLKLNNGKQKNIYLATSLIFDEEMKEKIRLHKKRRKNDW
FTVETYKNFENELNNFFENNDKIKNNLLVDCLTNMITNIIFENQNIDWNNFERKLYIQTL
KKLNKNVENSVDELLNITNQFENTVIVSNELGMGLVPSYPLGRYFREIAGKMNQIVAEKA
DEVYFVVSGISMKIK
>SEQF2502_01851 5-formyltetrahydrofolate cyclo-ligase
MRKQKTDLQIKKDEIRRQILEKRNNLSSKEVDKKSELIIKNLAPYLKNAQNIMIFMDMKN
EVRITKLIELYPKKNFFISKIVNSKNREMKINKYNENELILHKFGYYESSSNDFYDEKIL
DIVIVPALAFDYKKNRIGFGGGYYDTFLNNVRKQNKKALFIGVCYDFQMVEEVPTEKHDI
TLDFIINENEVI
>SEQF2502_01852 hypothetical protein
MKKKLKNNNYLIPSFLVGVTGLGFGEKIGSNNAPSVNISNGNLSRNKRNTEFSKNEEIYD
IIKNNLKNEDEFKVDFEYTNGFHKSRINDSFSESEKKNNLKNSSETGITIPYVIINPENG
PSDKVEYEYIVQIRKNKEMGIKNLGYITTNEYTKSIKMITSEIDKYIQFYGSDNISGIFI
DEISSGVNPLEVDYMAQIYNYIKDKYPDSIVVANPGGTITDEMSKYSDLWLTSEQSADNY
INHWTPRTYNFESNPENANRIVHVIHSATPEQYETLLKLSKERNAGFLMIATNVPNIPGN
LPQNFKNLIMSINAPRLETLSDVKNSLSEQSIMKNTDVISNFDNLENPISEKIAENITKD
NFELQPFISPKKYNINGNLKISSLDLWSLLSSHCETDIFLSYLNVGYNILEEITINPSKE
INKFGDFKFDLGKKLDV
>SEQF2502_01853 Iron-sulfur cluster assembly scaffold protein IscU
MNLEKIYQQTILEYSRRRELNREIENPTFAERGHNPNCGDDLTLEIKTDENDIIADAAFI
GSGCAISTASMAMLIDLIKGKSMEEAKEKVDLFFKMMKQEEKLTREESKKLGDAVLMEYV
AQMPARVKCATLSWHSLKVIVEKDRKY
>SEQF2502_01854 putative cysteine desulfurase
MDYRKEFPIFKNRDSHYLDTAATSQKPKRVLDKIMEYYEKYNGNPGRGSHTLSMEASNLM
ANARKTVQKFINAKYPEEVIFTKNTTESINLIAYSYGMEFINENDEIILGVSNHHANIVP
WQFVAKKKNAKIKFVYLTENGQFDIEDFKSKLSDKTKLVAISAVVNVTGVIQPIKEIIEI
TRNKNKNALVLVDAAQSMLHFRHDVQDLDADFLVFSGHKLFTPMGIGVMYGKKELLEKMP
PFLYGGDMIEFVTEQKSTFAQLPNKFEGGTQNVEGAVTLEEAINFIEEISYEKINEIENS
LTKNALEKLKKLDFVETYFTKDVEHTGIIAFNVKNVHSHDVAFILDSYDVAVRSGHHCAQ
PLMNYLGIPSCCRASFSIYNNEEDIDKLIEGLLKVKEVFEL
>SEQF2502_01855 FeS cluster assembly protein SufD
MLEKSSIQNLDNSDYRLKIFEEYKTLEKVNWKRVGYQYEEPEAFKEFNNLEIKNENQDGV
VIKNINESLEELKKLKNDNDYGLGDFFKKQNFAFYNEGKYLKIGERKKIDKPIYLNYHTN
KENNFLVDYNVIEVADFAKVTVIINYDSLDETPVYHNGIIKVVTGRNSEVKIIKIQTLNT
KSSNFESSKIETLGQGKTEYYSVELGGKINAISHKSYLEEDSSEVYVWPAYLADEDRKLD
LEYSVVFRGRRTIGELQARGAVKDTAKKVFRGNLYFKQGSSKSEGREGEFAILLNDEIKA
DSIPTLFCSEDDVIGEHAASVGKVDEAKLFYLMSRGLSESRAKKLIVESSFRPIMDNIDD
EKLRDKLFDELERRI
>SEQF2502_01856 FeS cluster assembly protein SufB
MESVGIMENRKKTYIADIERGVYDIKDEEHYRYKVEKGLTPEIIKKISERKNEPEWMREF
RLKALEVYNSKPMTDWGPDLSDLDMNDIVHYLEPDSAPMNENWDDVPSYIRDTFDRLGIP
EAEKQSLAGVGAQYDSEVVYHSVHKELEEQGVIYTDIETAIVKYGDMLKEYFMTLITVND
HKFAALHGAVWSGGSFIYVPKGVKVKMPLQSYFRLNAPEAGQFEHTLIIVDEGADLHFIE
GCSAPKYQKNALHAGAVELFVRKGARLRYSTIENWSRNMYNLNTKRALVEEDGVIEWVSG
SFGSRVSMLYPMSILKGDRSRCEFTGVTFAAAGQYLDTGCKIIHQGKNTSSTVHSKSISK
NGGTAFYRGLLKVLPEATGTRSTVECESLMLDNESASDTIPIIDINNDSVDIGHEAKIGR
ISDEAIFYLMSRGISEDEAKAMIVRGFVEPISKELPLEYAVELNKLIELELEGTIG
>SEQF2502_01857 Vegetative protein 296
MSLLELKNVKSEVEGKEILKGLNLTINKGEVHVIMGPNGAGKSTLASILVGHPKHELVSG
DVILDGENINDATVDERAKKGIFLSFQYPEEIPGLTVEDFLRTAKEAVTGEKQYLMQFHN
ELVEKMEKLHINPEYADRHLNVGFSGGEKKKNEILQMAILEPKLAILDETDSGLDIDATK
IVFEGVQKLKTKDTALLIITHYDKVLDYLKPDFVHILMNGKIVKTGGQELVERIEKEGYA
KIKEELGL
>SEQF2502_01858 GTP pyrophosphokinase
MDEKSKLKNDWKMTDEEMGNTNVPVIINKTYNELLQQLTDTIKKNGLDVDMIKISEAFTL
AYESHMGQKRKSGEDYILHPVEVAEILADMRMDTDTIVAGLLHDVVEDTLISLADIEYNF
GVNVRKLVDGVTKLRNLPRTNSKKLENIRKMVVAMSEDIRVVVIKLADRLHNMRTLKYMT
PEKQLEKSKETLEIYAPIAHRIGMARIKWELEDISFRFLYPDDYYEIKELVNSKRKEREE
YTAKFIEKIKEELEKNHIKGEVTGRPKHLYSIYRKMHEKEKRFVDLHDLIAIRIIVEKKN
ECYNVLGIIHDLFIPVFKRFKDYVSQPKPNGYQSIHTTVKGPNDQNVEIQIRTRKMHEIA
EEGVAAHWKYKEKKSKSKNEKFYADAKKLTDSVQRKMDEKEQKGFAQEITGDVLKQTIFV
FTPKDDVVEMPRNSTALDFAFQVHTQIGYRTIGVKVNGRITQLNQVLKNGDKVEIMTSKS
INKGPGKDWIEMVNNHSSRVKIRKWFKDKEFEEKSKEGEQILEKEFERLGLKLKDMLEDE
RVFLYMKKFNIPDNKTLFYRFAIGDLSLDGFLNKFEKKEEKALEKVLEEETEKANKQKEK
NNGGIKISGTENTMYRFAKCCSPLPGDEIRGYVTRGRGIAIHRSDCENFISLMEREPERE
VDVYWDKSAISANTTYEFNFTIKASDRNGLLLDIIRILNEYKMSLLNVNTNSFKENGNRR
ILIHLRITIRSREDFERLANNLKSMSEVIEIIKK
>SEQF2502_01859 hypothetical protein
MDLKFLIALIIFILLFKILINITKKIIFLIFIIVIFMVIINYLRY
>SEQF2502_01860 Glycerol-3-phosphate regulon repressor
MFLDERLEKILEILENEKKVKVTDLAEKFNVSEVIIRKNLKRLEQEGKLKRTHGGAILLK
ELVHSSTLEERIINRTKQKEIVARKIIENIENGETIFFDITSINYIASEYLANSEKEITL
ITNMPSITTHFNKNSKVDIIMIGGEYNKKVGGNVGSEAINYIKRYNVDKAFIGSAGIDLE
AEKVMNFELNDGNTKKEIMKISKKIFLVTEYKKLGILGSYKFSNLSDFDIFICEKNKKDY
LENYKKIFDECEVEII
>SEQF2502_01861 hypothetical protein
MLKEIQTINYKMWDLAWQIAYLDGMMCMVMIQHGEKLKILNQDL
>SEQF2502_01862 hypothetical protein
MSPKKDYNGALQWTIGGDLFVGINDMKRRYLVVDDVFQAKSDYHSYGAALKTDLGYDVRL
SERTHFRPYGALKMEYGRFNSIKEDRGEMRLEVKGNDYFSVKPEVGMEFRYVQPLAVRTN
LTIGLTAAYENELGKVGDVNNKARVRYTTADWFGIRGEKEDRKGNGKFDLNVGVDNTRFG
VTVNGGYDTKGKNVRAGIGFRAVY
>SEQF2502_01863 D-alanyl-D-alanine carboxypeptidase DacF
MVKRVKRVLVLGVVALLASLVYAEGEQEGGSAAPKENSVIIREEKKNSSVVKENNERRSE
FEYQTVKRKGTRREKKKKFEKSNEQLKIVNQKNLKDNTTREVSNKNKSTKNNDSTPAPKR
KVVKAIEHEQEGVSQYSGEVIKYIATTDGKVLKDKMSRQKHPIASLTKVMNILVALDQVD
RGNAKLDDKVCFTPETVNMGGSWLNAKAGDCYTLRDLLRAEIIYSANNAAYLVAYHIGHG
NYDNFVKLMNEKAKELGMKDTHYYTPAGLPSSMTKKNMDISTAYDMYLLGKRAIRDERLR
AWMKESELVLHNSEGEDVVYNNRNHLLDQFGIYGLKTGFHAQAGYNMIVSSKIGNLEIIS
VTLGNKTDNDRTEDQKREFAQLEKRMIPVYKAGQEIGSKFKVKNAEQKEISGILSSNVYQ
IDNTNYKFEIKDLQVTAEKQGISEGDVIGKLEVLSNDNKVVGTVDILAQNNYKQLSMFGR
ILRFVTFGMA
>SEQF2502_01864 Endonuclease III
MTKKERLKKVFPILKEKFGNPKAALEFETPYQLMVAVILSAQCTDARVNIVTKELFKVIK
EPKDIRKMDLETLEKYIKSTGFYRNKAKNIKLNAEMMLEKYGDKIPKELEKLVELPGVGR
KTANVVLGELWNIREGIVVDTHVKRVSNRIGFVKSENPEIIERELMKFVPKKDWFVYSHY
MILHGRDKCIARSPKCDICEIRDYCKYNLENFKK
>SEQF2502_01865 hypothetical protein
MSLFILKIIGIVTMFLDHYHYIVGGSEILNVIGRIAFPIFAFTLNEGYVHTRSLKKYLLR
LFIFAVSIQMPSILFGYDYPMNIFFTLFLGLLSIYIFNLKKMNVILKIILIGFVLFLSQK
FKLDYGIYGILVIINFNIFRNNKFKILMNFLVLNIYNVIFPKVFDLPDTQLFSLISLVFI
FMYNGKKGRSMKYFFYLFYPIHFFILEVIKFILEKM
>SEQF2502_01866 hypothetical protein
MFLGKQFLKIDKWFPSSKTCSKCGNVKEELELSERSYKCNCCGIEIDRDYNAALNIRDVG
KEMLEY
>SEQF2502_01867 hypothetical protein
MVEEMIKNLVESAKTEHIRNEIRYFLNGSVEKIVNIHKRDLRYINNLEMNKFMEKDEFLE
SEAGKILIKYFKYMYDNFSEELSYQFTNFPLKYKIYKILGFSNEFVKKDFENNSEIKTKE
ILWNNCKYFINYFEDLANEYIQNYKLYSNNFLIKLGVLIIVKNIEAVNKGKVRNEVEIKK
LDNIFTGYIASKINKIGMDEMFEKYLDSGNFRKYFQSMETLEFGEVRKYLEKRFYEVIIE
NSQISDIIAEGIKLFIIFSGIEFSPTNNDYNYRNRMFKKIMENFEKYDFSHGQKTYLLVN
YGSNIIFENLKNSKIIYKLFKDTIKENLKNTKEILCYNLNENRLEYSFLLHFLIRENLIN
ENEKNKLLKKSESILIEQLKRLFEMSAWEWHPANFRNLNFLQENDINWENIFVSCQGSKA
AIILWEKSKIIFSLLKYSNMYQKIFQLLIRCVERVNIFEDIFIKYSIIYGITDLRQMLDE
LWNYNLPISFINKKYFEYIEKIDNNNENNKIWMEFLHEHEKELYESFENDIISSKVIEKY
VNILYSKDNGFDYVKLPELLIRADITVKNKIEKILKNQMNNAQVRLKIEEISKNQNDSVE
SIASNLIKYWKNIEAQEKIEGLTDLNDIIDYADNLCLEKHEENAVFSTEVDYNSIRLKGE
NKRIPSKLIKYYISEYILSEDIRSIDVCNKIEEIAQKEDLRKFVKKIFERWKASKFNPKY
KNLFIPLIRTASLKQIYEMINIVDMLVSEYNKIAVAAYGIRVLTLRKEVKEIGILLNGFS
LNYKDKRIRIAADEALGMITEREGISRDELNDILVPDFGFGMDRIKIFNYGEKKVTAVLE
IEEEPQKVILFDESGRSMRSFPRINKKRRSDDVLEKCKKELKYIKKQLKVISLVQNDNLL
KAFFTQRKWTVKKWKEVFIKNPVMQKYAMLLIWKEIDNENKTINTFRYTRNGIFKTINEK
EYELGEDTYINLLYLPEISSNDQEYWKKYFKDNKLKQPISQLNMPIYKLIGKNQESIEVL
DYNEKEFLIKELRKQSSKLGFEISCGNDGMAYGIHYYDENAKTKIVIMTDSFFPREYSKI
SKIRKILFFKDNVSFHYEDISQSMKKQDVKPLKLKDVSDRVLSLACYVSEIL
>SEQF2502_01868 PTS system mannose-specific EIID component
MAEDKIKSSNDKIKLSKADRRSVMLRSQFLQGSWNYERMQNGGWAYSLIPALKKLYPNKD
DAAAALKRHLEFFNTHPYIAAPILGVTLALEEEKANGAAIDDAAIQGVKVGMMGPLAGIG
DPVFWFTIRPILGAIAASLATSGSVIAPLFFFIIWNVIRIAFLWYTQEFGYQKGSEITKD
LSGGLLQTITKGASILGMFIMGILVQRWITIKFPRVISRVPLADGAYIKFPNGSVTGPQL
QKILEDFGNKLSLSNTQITTLQDNLDKLVPGLAALLLTFLCMWLLKKKVSPILIIFGLFL
VGIVGHVVGIF
>SEQF2502_01869 PTS system sorbose-specific EIIC component
MDFNILAVILILIVAFLAGMEGILDQFQFHQPIIACSLVGLATGHMKECIMLGGALQLMA
LGWANVGAAVAPDAALASVASAIIFVKAGKFDAAGQNVAIGTAIALATAGLVLTMVVRTL
SVVIVHQADREAEKGNFKGVELWHMVALACQGLRIAIPALLLLFIPSHVIQHALNSLPKW
FTDGMTIGGGFVVAVGYAMVINLMATKEVWPFFFLGFAIAPLNELTLIATGIIGVCAAII
YLNVTSNGGGGNSGGGDGGSSASGDPLGDILNDY
>SEQF2502_01870 PTS system mannose-specific EIIAB component
MVGIIVASHGEFAAGIKQSASMILGEAELLESVVFMPSEGPDDLYKKIQDAITKLGTEEV
LFLVDLWGGSPFNQSNRFFEEDPKKRAIVAGLNLPMLLAALSEREDVETAHEVAKAIVPE
GKDQVRVRPEDLQPKEEAPKAAAQDDTPKGAIPAGTVIGDGKIKFVLARIDTRLLHGQVA
TSWTKATNPNRIIVVSDTVSKDELRKKLIEQAAPPGVRAHVIPLDKLVEVSKDPRFGNTK
ALLLFENPQDALYVIERGVDIKELNVGSMAHSVGKVMVNNVLSMDQKDVDTYKKLRDLGV
KFDVRKVAADKRADLFKLISEKANEGLKL
>SEQF2502_01871 hypothetical protein
MKKIMRGVLLFGMLGGMLLSCGNKKGNDSQEQKKDSKVSEKVYKIGLSQIVDHPALNAAK
QGFKDALAKAGVKADYDDKIANNDMSNQTLIMQQFAADKKDLVFAITTPTAQAAKNQVGH
ETPVVFGSVTDPKSAGLEGIPNVTGTSGAAPVTENLKLMRELLPGAKKIGIIYNSSEQNS
VSEVNNLKKLAGKYGFTVIEKAVTNGTEMVAAANLIAKDIDIYYAIQDNTVASYFAAILD
VFNKSKIPVLATNNVFSNAGGLISQGTTDYNIGYRSGEIAAEILLKGKKPSEIPIETVKN
LQIEINKQNMESLGIKIPDSILKQAKMVETKK
>SEQF2502_01872 GTP-binding protein TypA/BipA 
MNKIKNIAIIAHVDHGKTTLVDALLKQAGTFGEHEKVDERIMDSDDLEKERGITIFSKNA
SFHYDGYKINIVDTPGHADFGGEVQRILKMVDSVLLLVDAFEGVMPQTKYVLKQALEHGL
RPIVVVNKIDRPNSDPDAVVDSVFDLFVDLGANDAQLDFPVVYASAKNGYAKLELEDEDK
DMKPLYDEIMKHVDDPEGDVNEPLQMLVTNTEYDEYVGKLGTGRIYNGKIEKNQEVTLIK
RNGDLVNGKITRIYGYDGLKKVEMEEAFAGDIVTIAGIEKIDIGETVASKENPKPLPLID
IDEPTLAMTFVVNDSPFAGQDGKFVTSRNILERLQKEVNHNVSMRLEMTDSPDAFIVKGR
GELQLSILLENMRREGYEVAVSKPEVIFKEKNGQKMEPIELAIIDVADEFVGVVIEKLGL
RKGEMVNMNQGSDGYTRLEFKVPSRGLIGFRNEFLTETRGTGILNHSFYEYEPFKGEVTG
RRRGVLIAMEPGTSLGYSLNNLQPRGILFIGPGVEVYEGMIVGEHSRENDLVVNVCKGKK
LTNMRAAGSDDAVKLAPPKEFTLELALEYIENDELVEITPNFIRLRKKYLNANERKKHEN
KN
>SEQF2502_01873 hypothetical protein
MSKDDFVRISSYQLGSVEDWIRLYGYKNKFLKDRGFKEVDPFTFYRDLFPEGSLQKKGEH
LDENHSIKGNIIGIQISKAKKRSKSFIITDDLEGIKYVTDVSFGLIAPVNYFGKNRISKN
ARFLFAFVIDLDYVRENNIRDLLFQIKNKLLPNPTYIVNSGRGLHLYYFLDEPLPLYRHY
QKTLTQFKELLIDRIWNDYTSSKKEKDMTGVLQGFRTVGSWSKLGKEYPVRAFKVGKRTN
LEELKASIPFCKFDVSLKFPQKDKKKSKKLEYYKKNFPDWYERRIINKEPARERKWIVKR
ALYDWWKMKIIEKIGAGHRYFGIMTLAIYAKKCGISYEELEKDAFGFLEILDNRTEEEDN
HFEIDDIVAALNCYHDNYFTFPRDTIAKLTNVDIPKNKRNGRKQKVHLMGARAVQEVNDR
MNGTNWREGNGRPKGSGTKENQVKEWRKNNPDGKKAQCIRDTGLSKMTVYKWWNQ
>SEQF2502_01874 hypothetical protein
MGRTVKYKIIPTPHFAKDFSKLDEFVKKRIKIYLENITKDPRSKGKMLKANRKGQWRYRI
GDFRVIVNIQDENLVVLALEVGHRKNIYNS
>SEQF2502_01875 hypothetical protein
MASISLKVSDMEKKFLQSMAQFEGVTLSELIKSKVFDSLEDEYDAKIADLRLSEYESYLK
NGGEVLKWEEL
>SEQF2502_01877 hypothetical protein
MKKVLGVLALVLSVSSLAIADQEQDTLKEIHFSSELRQTYTDKKSNTGNGLGIAGFKGEN
KEKTRWRNILGGDLHLVDEGNMGLRFEFQNDQDRVKNDFDYQNKKLVKNGTYDKSQTWEN
DIALYRDVTLGSWTSKWDLGWKYKTTNGNGKYAGHRGTLNEIYLGPTFGINFFGQHFDGK
AQFVYFDQSGEKDGDNAWSGNDFRNGKTSGVGANFDLATNGKIFDNGAGNLNYYVTLNNH
LRDAKGKLTETGKDAKSTVYLDYVTGATYKTPELAGFYGLINTENEWEKQTARHGFKNNF
SVWTGLGYKTGIDLSVGTLTVNPEVKYRVVNKETVKGYANDGRYNTDKYTREYNELRAGL
NLGLEVK
>SEQF2502_01878 Elongation factor Tu 2
MERGQVLAKPGTITPHTGFKSEVYVLTKDEGGRHTPFFTGYKPQFYFRTTDITGEVNLPE
GVEMVMPGDNIEMTVELIHPIAMEEGLRFAIREGGRTVASGVVATITK
>SEQF2502_01879 Carbon starvation protein A
MISFILAIVALILGYAFYSKFVEKVFGIEPDRTPPSIEYYDGVDYVQISTPKAFLIQFLN
IAGTGPIFGAIAGALWGPAAFLWIVFGCIFGGAVHDFLIGMLSLRDKGSSIGELVGQNLG
VVMQQIMRVFSIVLLILVGVVFIKSPADILHNLIPGVSAMTFTIIIIAYYILATILPLDK
IIAKIYPIFGFALLFMAIGIGTMLIYGQFKGAFAIPEITEIFKGNPHPKGTSMFPYLFIS
IACGAVSGFHATQSPMVARCLKNETEGRKVFYGAMISEGVVALVWAAAAMTVFGGIKELA
AAGTPAVVVNKASVQLLGVFGAFLAVLGVVACPITSGDTAFRGSRLIIADIFKIKQAPIK
NRFLIAIPLFVVGIYLTTIDFNVIWRYFAWANQTLAAVSLWTATVWLVKKGKPFLFALIP
SMFMTMVVTTYIIIAPEGFVRFFKNVPVHTIEFYGTLIASVVTIICTALLFNYKHHLHGK
SHHAERLNVAK
>SEQF2502_01883 hypothetical protein
MKLKRKLRKQKEKKEITSKMTDYVKFTQDENERAKVFSMMGLSNLCKHYRNYFNIPNITD
ENLVNGDTKIPVLTEKNTLWCTFKLEDIIQRTFRAVSRLIQEYEYEDLQNPNQRKIKDFK
NEFVIVEFSKMYQKELMELKFRFGKYLKSNYKETEKALKEMIVLFAYYEIFKKQIRDKLK
DFNKNNRMYMKTFITKTDRKFEEIKDVIMEGGEPDFKKDMLELLKFEEAGIKIKWIGYSR
KTALKMKFQGIN
>SEQF2502_01884 hypothetical protein
MVGIQTDEGELLIDGTIKCESEEDYYMILDELYRDRREEIENESFE
>SEQF2502_01885 hypothetical protein
MNKKKECEELWAKNKYYVLSKSHKVYLEIRNYLKEKEIDIVFISERIQKVRDMKESKKDF
SNAILHLWGYFKKKATKIEKQGLFNILEEYMGGRNNQKSVIEYINTLLKKYPNKYLQEST
LLTGEKDETMA
>SEQF2502_01886 hypothetical protein
MRLWHEQIIHLLPKNQLLGQHRECCALRGNGWKKKHKTVDYVFLYSPYYLFVYHSLVMDE
MEKRGYKVSKEWRDKNYRGKKAENYNNLEEKIIDSPIYKEHDNEYLVECIENLRKKGIKL
EL
>SEQF2502_01887 Antitoxin DinJ
MANANLSIRVDKETKEKANELFNKFGLTMTTAVNMFLKTAIRENRIPFELKLEEEPNEVT
LEAMREADRIARDDNVKGYDSIEELREALGV
>SEQF2502_01888 hypothetical protein
MKKIFFVLIIIIILIIIFVKLYKRKIKSDSEHTAEEFVNKLDELGYFKYAKKGDAPSLKK
EMLEMIRKYGSEGTLTTLWDENANVAKDYRFYFCDGETVFEGDGIPDLINDLQPSFEKFG
VKIKIDSFSEEWDDEKGLSTKIKINGTEYEIFKNFKKSGWGEAPMRIAYAVNKELEKKGI
NEKIYLISGGNDGKLVFLTEEQHKYIYAFFKDSKEKPLELNEWGKVMKTEPLNF
>SEQF2502_01889 hypothetical protein
MKKIILLFTIILEFNLFSNTPYDEFSQKVEKLEEKIKNRDKKAINNLGNLYAKDENSRNI
PKAKEYYRLAIKNGSEIASKNLEIANKLPKLCSDGAICENWTTIRFVDKDGKIVKMIIKG
FPVNKEEVTEIEKREIKGEIEYLLNVFLENEEFVIVGYADKTENNKNKLSLLRAEKMAEF
LKRNELRKDIKITKMIGKGAEDPIDTNDTVEGRYNNRRVEILLKNGKVKKIDISNLLNQL
KDE
>SEQF2502_01890 hypothetical protein
MKKIFNKKIGILVFSLVCAGFLNAKPVRSENEALRLVQNSIIKHRFGGSQGTKCMRFYVD
ETAEEFEIDVRSNNAKCGGDPSVEPRLFSYTVNKITGELATDNFSYAEDQGIDWEGDFLP
ID
>SEQF2502_01891 Cardiolipin synthase
MKKTTTKRTNNSTKKTVKTKTERKKSIPKFEQSFLEGISCDIYIGKKAGISVRNAIQKAK
KSITVISPFLSGDMITEDIFEALNKDVQVNIISKDNERIYPFLKKNLYSQNLILGSEKWL
FLLGKSLLIFFYIILSIAALEIFTSFIFDISFTKNILPISKNNFLALTIIFGILTLFLRK
LTINHEFYYSKRDNFNIHILEKSYNLHSKIYIIDSKIAFLGSLNFTTTGFLFNHETCIRI
TDKSVIRHLNNVYKDLIKTSKSIPLGELKKRINQK
>SEQF2502_01892 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MKEIMKDILIGSTFKAAEIVIAKNIIAKLLYHEYKIKIYYEKNDKSRKNQDFLVLLHGIY
GKSSDMESIAQNFKDNYRIINIQYPTTKETAEEISDLYIEPNIETIKEQILSENFHKKIN
KNFNQNIKINFVAHSMGTGILRYYLKENPLENLGKVVFISPPSHGSHLADVPFVDKLPSM
LGKVVPQFSTKKDSFVNQLGEPDYDYMILIGNKTNNPLYSMIIRGEDDGMVPLKTAKMKS
DNFKIIENTTHTSILKDKRTMKEISEFFKSSDLNKEKEK
>SEQF2502_01893 Type III pantothenate kinase
MILGFDIGNTHIVPIFYNEDGNILATFRIPTHLEFTEDTLFIMLNEFSKSKNLEISNIKN
IIVSSVVPNINENFTRLGKKYFEIDPTFVTLDNVENKIKEIKILPNMERGLGADRIVDIL
ATKKLYPEKELLIIDFGTATTFDMIKDSTYMGGCIIPGIALSINALFSNTAALPKIEFTE
PETVLGINTVSQINAGIFYGNVGSIKELILQYKKFFPNAYVIATGGQGEKISEYIEQIDE
YVPKLGEMGIFEFYRLNFLKENSDGI
>SEQF2502_01894 hypothetical protein
MGKTKKVATKTERNGINITFPAVFTGIIGAILVSSSSFYIALKFGALPWPTIMVTLLSMI
TLSLFKKTNNKEITVAHTIMSAGSMVAGGVAFTMPAYIILGGKLTDINQYQLLLAILSGS
IAGAFLSYIFRAKLIEEEKLEFPIGEAAYNLVDSGKSAENIRYVAFGTLFSSIVAFFRDF
SSTKGKASLIPTVVTLKNGLFSIYISPLLVGIGYVLGFINTFVWFLGGAIVLFIGEPLAK
MFKIADFPIMKNSFGMGFMIGIGIAIVLKIIFVNKMKKDTENKSIVVKLLVLSVISIIII
TFIYKLPIFLSLILVLISILCTIIAGYSTGKTGVNPMEIYAIITILLISFLNKMLNGLNI
GGIKFYTNLNTLILFMLACIITVACGLAGDILNDFKSGYKMKVKPSEQLFGELIGAIVSS
FVITFLFFVFFKVYKVIGPVENTELIALQASIVATVINGIPFLGIFFMGLVAGLILSLLN
LPVLTFGIGIYVPFYLTSTVFLGGLVSFIGNKVSKNSHSKLLLISNGLMSGEAIVGVILS
IMAYIGLFMK
>SEQF2502_01895 Asparagine--tRNA ligase
MLLELRELQKNTKEYLGKEIEINGWVKKIRSQKNFGFIELNDGTFFTGIQVVFDEALENF
EEISKLTISTSVKVTGIVVESLGKGQDYEIKATKISVYQKADSDYPLQNKRHTFEFLRTI
AHLRPRTNAFFATFRVRSILSYAIHKFFQEKNFVYVQTPIITGSDAEGAGEMFRLTTLDI
NNVPRTENGSIDFKQDFFGKEANLTVSGQLNVETFATAFKNTYTFGPTFRAEKSNTPKHA
AEFWMMEPEIAFADLDVNMDIIEEMIKYIVNYVRENAKEEMEFFNKFVDKDLFARLDTLV
NNKFDRITYTEAIEILKNAKKDFEYEVEWGIDLQTEHERYLAEEHFKKPVFVTDYPKDIK
AFYMKLNEDGKTVRAVDLLAPGIGEIVGGSQREDDYDTLLGKIREMGLKEEDYWWYLDLR
KYGSVPHSGFGLGFDRMLMYITGMTNIRDVIPFPRTTKNLEF
>SEQF2502_01896 hypothetical protein
MGKTKRVMMMVAILFTFATVVKGNYYIAENTETEGGDATTVNEEESIVPPTTKADETTKK
AFKPPKEEAVKPKERDTGTMPATQTEDVSTEAKYNSYTNYENATLAKKSSSATFRMAQLY
FRDGLYEKAVNLALKDENPDIPVMYVIAIGSRLMGNNDRSIDYYTRILSQDENQAEAKLG
IGIAYKSKGDFSKALGYLRDYNSTHSDDEVKKEITILNEILAGSR
>SEQF2502_01897 DNA processing protein DprA
MEWLRLKEYGMKNNHIKKLMLIFQDFEELFYEENFKLFNDELKHQLEESMKIDMKERIEL
YERNKVRIISVNDKEYPKKLKKIKDYPVFLYLKGKKLKDYEKIKIDKDKISVENKRNIAV
VGTRRATKFGKTACEKIINELVNYDVTLISGLAEGIDTVALKTALDKGIEVASVVGTGLD
IVYPYDNRGLWERIAETGTIISEYPLGTQPTRWTFPRRNRIIAGMSDGILVAESFKKGGA
LITAELGFSMNREIFAIPGFINYPSFEGCNDLIKNNKAKLITCGNDIAIEFLWDIKKEKS
KLQKLTEEEQTVFETITEEVSFEQILQNVKEKIEKNKLFSIIMSLKIKGLITETNGAKYI
RIV
>SEQF2502_01898 hypothetical protein
MAIKYSKNEILEMIENAKFDIRSFYKQDFVNYAGKTKDSREYYTEIIAEWLLSHVDLFNK
IKLINREGSYRIESHDGKIINQESNRAEEKIAMKLFDYSQNKGEIFDKIGKIIDYQTPLK
NIQTDDAGKIDLLAYNEDTDTLRILELKKSDSKETMLKCLLEVYTYLKIVNKDKLLKDFG
LPKNTIVKASPLVFFEGMQYMEMQEDRKNLKKLMEKMEIEPVYLIEENGKYKVKL
>SEQF2502_01899 DNA topoisomerase 1
MARKLVIVESPSKAKTIEKILGRNYEVVASYGHVIDLPKTKIGIDVENNFEPQYKVIKGK
GEILKKLKEKAKKASNIYLASDQDREGEAIAWHISNYIKQPDKTRRIEFNEITKTAVNNA
IKSPRDINDNLVNAQQARRLLDRIVGYKISPLLWKIINRNASAGRVQSVALKLICDLEDE
INAFVPQKYWEVSTLIEKDINLNLVKIADEKVNKIFDEKVIKKLKKDLKNESLTLEKIEI
KKKSQKPPLVFKTSTLQQLASSYLGYGASKTMRIAQQLYEGLEIDGGNKGLITYMRTDST
RISIDAINMAKDYIIQNYGEKYVGKYVVKNSKSNVQDAHEGIRPSDINLVPDNIKGYLTN
EQYKLYKLIWDRFLVSQFAAMQYEQMQINATNKDYHFRGTINKVIFDGYYKIFKDEDEIK
TGDFPELKEGSVHPIEKLNVEEGITKPPTRFSEATLVKKLESEGIGRPSTYASIVETLKT
REYVEIIEKRFFPTYLGYEVKDELVKNFKDIMNVKFTANMEKELDKVEEGTVEWVQLLRD
FYSSLEKDIVKFEKEIDEIKKRRVVADVMDSEGNPMILKTGLYGKYLISEANEKEKISLK
GIPVSPEEIKKGEIFVKEAVEKLQNNKKGIPTDYTDENGVKYVLKVGRYGEYLESENYET
DEKRMSLPLELKQKYRKGSVIELDGVLQINEEMKRLYEIDKKLIEEAGVCEFCGRPYEIK
VGRYGKFLACTGYPECKTIKNIKTGKVTKVTEKEEKAKTKKTAKKSTSKVKSSTAKKKKT
ATAKKKKTTKKS
>SEQF2502_01900 hypothetical protein
MKKNGMDKLFDKYMKKIQSGDTKAMNEIALIFQNNYEDENAEKWFLKAIEAGDYSYANNL
GYLYASRHDFENAEKYYQIAIKNNDYDALNNLAILCEQYGKIEEAEKYYLESVEKNCEGA
EKNLLMFYDSTNQTEKAKDLYLHLAWKNDIDAMNRLGMIFGNEGNFKESEKWFLKAAALG
DEHAKNNLKILKENVKK
>SEQF2502_01901 Ktr system potassium uptake protein A
MAGYLVIGAGKFGRSIAKTLYNHNETVLVIDKNEELTQQIIDDGIVGEAVSFDVTEENSL
KKVVSSDDFEVAFICIEGSLQTSALVTVMLKELGIKTIICKAITKIEGKILEKIGARKVV
FPDESVGRELAFEFLKPDVTEHLKFSEKYRIFEFKAPKKIIGKSLVELGLRKKYEMNVIG
IKRKGEELRISLSPDEKILENDMLLVVVNVEKMIQFNKEYLDN
>SEQF2502_01902 Ktr system potassium uptake protein B
MFLKNKSFSPYMTILLSFMVVTILGGILLSLPISMRYGKSVKLIDGFFIATSAICVTGLS
SIDIGSVYNIFGQMVILVLIQLGGLGVITFTSVIIIMISKKIGYYTKKIVQEDINIDTTF
KIEEYVKKVILSVIVIEFIGTVILFFEFIKKFGFLKAVYYSFFHSVSAFCNAGFSLFSDN
LYGFKNSFIINMTIPLLIFLGGIGFSTILNCYNVLRKKEKRLTSTTKLSIKISIFLVIIG
MIAMFILEYSNKSTIGNLSFGQKLEASFFQSVTTRTAGFNTISILGLKRSTSLLFVILMF
IGASPGSTGGGIKTTTIGLIILGTLATLKNKDTIEYDKRSVSWRIYSKAITVLFISLIYM
TICVFLLILFERNKNLLDLVFEVFSAFGTVGLSRNLTPSLADISKFILIVTMFVGRVGPL
TIALALSKSNLKKGRYTYPQENILIG
>SEQF2502_01903 HTH-type transcriptional regulator TreR
MTKYEKVYYDIKHKIKNGIIKPGDFLKKEDDLAKDYNFSKLTVRKALSMLEAEGFIQKVK
GKKSIVLEKKNLENISLTSIQTVQELNKLQNINLETDLISLYIVQGNKKLMKEFQVSESA
DFYKVVRTNSLNGEVLNYSTSFFDRRIVPFLNEEIAKKSIYEYLEKDLKLKIGYSRRDIN
FRKITPEEQKYLKLKDINMVVVIETHAYLSNGTLFQYETIIHHPEKFTFTAIAKR
>SEQF2502_01904 6-phospho-alpha-glucosidase
MKKFSIVVAGGGSTFTPGIVLMLLENLDKFPIRQIKFYDNDAQRQEVIAKACDIIIKEKA
PDINFVYTTDPETAFSDIDFVMAHIRVGKYAMREKDEKIPLRHGVLGQETCGPGGIAYGM
RSIGGVIELVDFMEKYSPNAWMLNYSNPAAIVAEATRRLRPNSKILNICDMPIGIELRMA
EMLGLKSRKEMVVRYFGLNHFGWWTDIRDKQGNDLMPALREKVAKVGYNVEIEGENTEAS
WNDTFTKAKDVFAVDPTTMPNTYLKYYLFPDYVVKHSNPNHTRANEVMEGREKFVFGECR
AIAEKGTAKDSKLHVDDHASYIVDLARAIAYNTKERMLLIVENDGAISNFDPTAMVEVPC
IVGSNGPEKIVQGKIPQFQKGLMEQQVSVEKLTVEAWIEGSYQKLWQAITLSRTVPSASV
AKAILDDLIEANKDFWPVLK
>SEQF2502_01905 Oligo-1,6-glucosidase
MDIKKLDKKWWKKEVGYQIYPRSFYDSNNDGIGDLNGITEKLDYLKDLGITLIWVCPIFK
SPMDDNGYDISDYYDVNPEFGTKEDLERLISEAKKRGIKIILDLVINHTSDEHEWFLEAL
RNPESKYRNYYIFKRGENGLPPTNWRSHFGGSAWEKVEGEADENGNEMYYLHLFSKKQPD
LNWENPEVREELYKMVNYWLEKGIAGFRVDAINSIKKNARYLDLPVDGADGFAYSIKYTL
NQPGIEEFLGELAKKTFKKHNCMTVAETPLLEYERYNDFIGEDGFFSMIFDFSYSDLDMT
KGGFYYSLRDIPTVELRNKIFESQLTQQKYGWGAPFLENHDLPRSLNKFFGKKANETNAK
LLANVFFFLRGTPFIYQGQEIGMDNFVRNDISEFDDIASKDQYQRALGEGFSSEEALHFV
NKRSRDNSRTPMQWDSSKNAGFSKDKDSKSWIKLTGSQAATNVADQINDKNSIFSHYKKM
IDLRQNGKYSDCLTFGDFISVPLENEKIIAYVRKYKNQKVLCINNFSELKQEVKLSEIAK
VLGEKEIKIGEILINNFKGLENNEVKVVLEEFQSLLVEIL
>SEQF2502_01906 Proton/glutamate-aspartate symporter
MGKEAVFYTAKKFMKKFGLTTRIMIGLALGVVFGMILSPFAANPFVKDVVIDSVLAFFGG
MFINLMKVMIVPLVSISLAMGAASIGDVKKLRRIGTKVLGFYFATTAIAVAIGLFVAKIT
NVGKGMIHGNLPKGEYEIAQQSKLIDVLLDMIPKNIVNAMSEEKMLAIIIFFLLLGVAIT
ALGDKVKNLKTLLEEANELVLKMVELIMQVAPLGVFALISKVVASTGIDVLVKLIGFVVV
TLIAFVIHTGVYQIMLVGMAKMNPIKFFKNFLNVVSVAFSTSSSNATIPVNIETLSEKFG
VSEEISSFTIPLGATVNMDGTAIMQGVAAVFIANLYNIHLGPTQYIGIILTAVLASVGTA
GVPGAGMLMLSLVLKQAGLPLEGIGVVIGVDRIIDMFRTVVNITGDAVCTIVVAKSENEI
REVNNNEFYD
>SEQF2502_01907 hypothetical protein
MKKFLLLMTFFTSMVAYARVGEVGTKTFENVIGYCENEKVTSIKEDPNTESYLAYVRVTY
PLCKINGLRYRNIKFSYRTRDDGKFVAKQVKNINLDGYDIEINYDTRTIIYVRH
>SEQF2502_01908 hypothetical protein
MKYKVIIREKAEKQLNKLDNSIKLKIMRYIKQNLNETDNPKKFGKALRYNLKGFWRYQVE
NYRIIAKIEESELFILVVQINKRDKIYI
>SEQF2502_01909 hypothetical protein
MITVSINANPDIENKINNYVKENNINLNQVMLDLILEKIEDEEDYKLAVEAYEEYKTNKE
KAISFDDLVKKMGLEDEI
>SEQF2502_01910 Methylated-DNA--protein-cysteine methyltransferase, constitutive
MKKNIYFYETNTPIGKIGIATTENDSHITDLIWESDFEDFKKHNDFKICETELIKQAKKQ
LFEYFERKRKNFDLPFLEEGTPFQISVWSALEKIPYGETRSYKDIAIAINNLKAVRAVGM
ANNRNKISIFIPCHRVIGADGKLVGYGGGLHIKRFLLELEGVQIK
>SEQF2502_01911 hypothetical protein
MKMRNRKKKKLPIGISDFKEIIENNYYYFDKTKFIENILEDGSKVKLFTRPRRFGKTLNI
SMLKYFFDIKNKDENKKLFENLEISKSEYFEKQGNFFVISISFKNYDAENWESGFNMIKN
EIKLLYNEFYLIRDDLNQSDLADFDAIWLKKDNADWINSLFNLTRYLYELSGKKVVVLID
EYDQPIIDSYIKGNYEKCIAFFKAFYGKVLKDNNYLEMGILTGILRVAKENVFSGLNNLE
VHTILDDEFTEYFGIMENEVEKSLEDFDLEYELNDVQKWYNGYLFGEKKVYNPWSIINFL
KNGKLKPYWVNTSENGFIKLYLQKMKKEIFDDFSKLLNKEEIFEIINDSMTFGNLEANFE
KNIWNLFFHSGYLTLSRKYNENSEETYLKIPNEEILKMFSNMFVEVYFGNSNNFSKLTNA
LKNGNIENFKIELNKILLENTSIFDVSGIYKEQFYHGLILGLILKLKSEYEISSNNFSGK
GRYDLLLKPKNIFERKEGIIIELKAINIDNLKLDSEKIHEKLLSECEVALNQIEEKEYTS
ILKNAGIDNILKIGIAFFGKEFEIKFKRE
>SEQF2502_01912 Replication-associated recombination protein A
MNLFDKVYENKKPLAFRYRPKSLDDFYGQEKLVGENGILRKIIERGNFMNAIFWGAPGTG
KTTLAEIVAEKMNYHYDYLNAIKASVTDIKEISDKAHNRFRTNGQQTLLFLDEIHRFNKL
QQDSLLQDLENGNIILIGATTENPYYNLNNALLSRCMAFEFKKLSEKDLLKILENINEKE
KIGISDEILKYISEIIEGDARQAINILELIANVGVDFTFDEVKEVLNTKKSYHKTEDKYN
TVSAMIKSIRGSDPDAAVYWMAKMLSGGEDILYIARRLVILASEDIGLANPRALPIAVAG
LNAIKEIGMPEARIILSEVAIYLAISPKSNSAYNAINSALKHIENEKIQEVPVHLTKVGA
KDYKYPHNYKNHYVDQIYMNEKIKFYEHGENKFEKAADEWLRKIKKNGK
>SEQF2502_01913 hypothetical protein
MRNLKLFLTIILLFCIFSCNKKNEKNENEKKINDNMISNEITADKNNKNSNENTENVNIK
SQKNNFDYYIKTVKQMKTNNTLPINFYNCNSISDIVFALLKAAYPNDKIGTTPKWKIEGD
LGDGGKMIRVSYKNAIVRIEAYKKGDYINVIPRNITLESNNRKFSLLKFLTYGRNNRNIS
TNNSQQISNSHLKTSSNENLSKSHSTSYDELDLDDLNNLKYEVMEEGNESAFSRYSKEQL
KILRNMIFAEKGFAFEEGGELRKYFENKSWYSPTILDQSVIQLNDYDKEFVLKLKKYEGI
D
>SEQF2502_01914 hypothetical protein
MRKLLLILSLFVINIVGLAYEKCNSGMIYDINVDTLNGSYLGQDETGTVIIKLSKNAKVS
GTQYIDEKDVDTYGFGDLGDCTPNPKITEIHIEDAVFNSIYNNFFEIFSSKSESNPHSFK
VDFTSCIDKNKVFCKIYNDKGFDGKPSGITFINQEVVDFEIHGNIIDVVRRGDFVSGYNN
YEDLEEKRAKREKYIVNSPNGYVKFMRKPDNNSTIRGKVKNGKTVSLINEKGNWYYVQVL
DGEEFGYVNKEYLKKKDGVK
>SEQF2502_01915 hypothetical protein
MGFINPFQIYSKGENTITNNILLLLSNLYRINPKIYELFINSVLPENINYEVIPIFTQQK
SQKEGGIIDGHIQTKATKIIIETKIAGLDNTKKLINYCKNENLAETNILIHISDSTFDET
TIKSINQKIRIYNFNFVSITFSELLSSLQEITEKYPFNEELYRLSKDFYYYCSSMDLIKN
VFRIVPCNKSFELNEKYHLYFQPESRGYSNHQFTGIYTAKEVKYIGKVNKVFLAELTKEG
KLITEKISGEGEITTEEENRIISTIKEFPEIYGYGDISKGHIFFLFDDNDFCPTKFKKIS
KYGLLGSRLFDLKADLEIENVEKLSTLEIAEKLNDITW
>SEQF2502_01916 Bifunctional purine biosynthesis protein PurH
MKKRALISVFDKTGILEFAQFLDKKGVEIISTGGTYKYLKENGLSVIDVSEVTNFKEMLD
GRVKTLHPNIHGGILAIRDNKEHMDTIAKEGIETIDYVIVNLYPFFREVQTDKTFDEKIE
FIDIGGPTMLRSAAKSFKDVTVICETEDYSAVMEEMEKDGEVSYKIKKRLAGKVFNLTSA
YDAAISNFLLEEEYPKYLNVSYEKKFNLRYGENPHQSSAYYVSTTENGSMKDIKQLNGKE
LSFNNIRDMDIAWKVVGEFDGPAACAIKHSTPCGVAVADDILTAYKKAHDCDPVSIFGGI
VALNREVNKETAEELKKIFLEIVIAPSFTDEALEILKTKKNLRVIECKTPKSQDKFDYVK
VDGGILVQGTNNKMIDEMNVVTEKQPTEKEKADMELGMKVVKYVKSNAIVVVKDGMAIGV
GTGQTNRIWSTEHALQHAQEKVGKNLTGAVLASDAFFPFRDCVDTATKTGIKAIVQPGGS
IRDKESIDACNEHGITMVFTGIRHFKH
>SEQF2502_01918 hypothetical protein
MILKNDKTEVELNIWKEGLVDEIFFDENSTVENLPRLEKLLNVQECDFLSLFQGKVEVVI
EGHIIAMMNGKETVKYNFKKKYEFLDNYGNILNKLNSEQLKLVEKSQNMFEKAIIYISEE
TRWIADAFKFLSISLKILKEKNEYNKQELINYLKKIDNKKN
>SEQF2502_01919 hypothetical protein
MENRSHFDGGLLSYVGWIILGSLITSCTFGICYPWALCMIYGWKINHTVIEGRRLQFNGT
AVGLFGNWIKWLLLIVVTFGIYGFWVHIKLEQWKVKNTTFLD
>SEQF2502_01920 hypothetical protein
MKKFFRMLGLIILIGNIGFAEYTIKDGKVYWDDELVVKYVNGVVSQYNKFLPDVESFKIL
KNGYARDKGTIYYNGETVQKQNGDNEVDIKTFEILEGNVARDKNTVYINGIDFPNVDVNT
VKIVKSKYDFINYVKDKNGIYWIGSPDVEANRHYDKETFEDLGDFFARDKNYIYYFEKPL
KFIDKASFKRLSDSYISDKNGIYYLDKIIKGADKNSFEIMGRGYAKDKNNIYYEDKKLSG
ADINTFEVKEDIVKDKNSIYFNGKKLEGADIQSFRKLNEYYAIDKNNIYYNLDSDSDIKR
IKNTDGNFKIIEEKLIKNKDGVYYLGKKIKEIDPNSFKIIRKNNLKKDNSYYAKDSKNVY
YIQLDPSFIWDSYNTLKNVVKVLRGANPNTFEVINDYYSKDDKNIFYISWIVEKEPLIKG
VDIKTFEVLNNEFSKDKNNVYFGTDREEDLDSKSFKILNLNSQNRNGYYLEDKNGIYFLK
INDFGNYFNKITDKGKFLNDFYIKDNNYVYCNEDVLNNADPNTFKVVDEYSSRAEDKNHK
YEYCKVLK
>SEQF2502_01921 hypothetical protein
MKKIRILLLFALIMIFSANLLANDWEFGSEGGHIVPMNVSNVSIKSERLRFKLEKFKSEY
GTLDNEMVVTVRFVFDSPEAGEKYIGFITPEGGNEEWDERDHFKDFKTSVNGQNVSTKAY
RLTDFAPKDVKQLEEVKKYYKEYDEDKARKEYEYYKKSYVYYFKANFKKGENIVEHSYRY
DGSSGVGIVDFNYVWSTISKWKNQKVDNFEVIVEPGDALIAMPVVKTKDGKEIKWQLAGE
GNVDYAYKENYETNEPYKVLYAKLKKGYLYFKTNNFKPEEEFELREIKGLRVNYVFPDKT
EKGFKFKDDLTDDAYAIKYLDKDEIKDISDEELKIMRNYPYAMAGYDFSDKKLKDYFSKF
LWYVPIGKDAKLGKDDYEYVKDVDKVINDRKNGK
>SEQF2502_01922 hypothetical protein
MKEYVEKIREKALSENRTEYENALEKYRKYLLKEILQNIEEIKNDEEYAKNMMEEEILEI
IKAEKKRLENINLVSEKILNTDFKPKMEIFMFFKNECWLLDCPQHLIIDED
>SEQF2502_01923 hypothetical protein
MKQTKEEWARYIQDEIKKNDSYDNYKHTFIEYKDYLEKCLLKNPRDVEKVCQLAIAYFTV
YQDGKTSLNVLEEFLKKYSKDLNDDEKAIIYQDLADLYEKDAYDDKMCKYYLTKLIKMGK
QSVVVWEVLGEYYLKRKKYKKALECFQEMEKFSDEKEIEDDYNYGITLFYCGYFEKAKEM
LLRCYEKEPESAGILYALALCLHYTNDKKLAEPILDKLLEKVSLEKYYYDEQILFEELID
LYYLFEEYDRCVLVFEKEIDELDWEERFYYNMVFSFYFYSLKKLGNFKKAENKLSELIQK
HNKYIEKIEVGEIYDKKYWNEEEIDEFIEEEKNEIKKILEIYKKIMNSNYKPQNTKINLE
KMYKTCYLVDCPMHQKLD
>SEQF2502_01924 hypothetical protein
MEKQKNLERKTIKEWIKYIQEKIRNNSDYDSVYEEYKTFLENKLKDNPQDVEKVCQLAAV
YNELTYQWKDIYKLLNEFIKKYENELTDEEKSRIYTNLGYYYDDQRDGSKRAIRTLRKAV
AFNPNNSKAYYGLGANYYGAGKYEKSEEMYKRACELENNPIYKFEYANLLMVNGKNEEAK
IILEKLIKKDFEFGKEDFAKIKYSYIVNRIRLKEFENIESEINELMLETVNKDDFFEEEF
AELYYLAGSYEKSRKIYSKFKIQDYQFPAWWLRFYFYSLKQLNEIEKLQENFKIVLKIKD
EEIESIKNGEFLTECTKSYKKEEIREIKRQIKNLKAEYGKILKTDYKPEVKIYPKFLYDC
FLIDCPRHQKLDKLS
>SEQF2502_01925 Sugar fermentation stimulation protein A
MKKNKILYTINYDKIVNFKERVTRFTVRFEFKDSENEEYSGEDFAHLHDTGRLTELLIDG
AELLIKKANNENRKTKWDIIAVKVHEEIILINTAFHRYITEAIFHDNEISPFGEPSYIKP
EIKHNNSKLDFYLETEKEKIYIEVKGCTLVNGKIAQFPGSPSIRALKHLRELMELKKEGF
RTAVFILIFRKSEIFAPEHIIDREFSETFYEAIENGVEIYPMLLEYREDGNVYFVKKIRI
MEKRF
>SEQF2502_01926 hypothetical protein
MTIIEKIFLLAAICSILQFALEVYREYQKHKKNKDQ
>SEQF2502_01927 hypothetical protein
MFEKIMLVLSVIIIILAIITWTLKYINWKNEKKDKKNKPQ
>SEQF2502_01928 Phosphoribosylamine--glycine ligase
MKVLIVGAGGREHAIAWKISQNEKVEKIFIAPGNAGAELLPKAENVNLSNNIDEYVKFAK
ENNIDLTFVGSEELLVAGIVDEFHKNGLKIFGPNKQAAILEGSKAYSKDFMKKYGIKTAV
YEIFDNAEKAKEFLNNWKDFPVVVKASGLAAGKGVIIAQNLDEAIKAVDDIMIDEKFGDA
GSQVVIEEFLDGVEASILSFTDSKIIVPLLSAKDHKKIGENETGLNTGGMGVISPNPYVT
DEVFESFKNDIMNPTLKGMQAEGMDFEGVIFFGLMITAKGVYLLEYNMRLGDPETQAVLP
LLENDLLELVEYSFDKKLSELNVTWKPLHACCVVGAAEGYPESYKKGDVITGIENATDDE
LVFIAGAKFEDGKFKTNGGRVLNAVAFGKTLNKAKENAYKLLDKIKFDGMYFRKDIGRIK
>SEQF2502_01929 hypothetical protein
MNKQEFNQYRKVKFYIAVCFWIFSLSMFAVGSKKSVENKSNEKKVSRNRVEDEAVKIDII
INKNDNNNFEEDKDLEKTDEEDGDLIYLDQIQDEEEEKKQKKLKKTNRIERFIKKIDEKV
NPIIKFQISKSYGTWYLIKTDDNLEKNLKNVRYDFLQEENGYHIIKSYFDPQTDKWNEEM
QRGWIEENKGKIYLDIEKKYFKNNRNEIIFFDKNYRYMIIRYYNGVTRVLSRYPNNNKIS
LEDEEMNEFEKIVDNESNLKNLNYDVNMKNIREIENERKKAELKSKTDDLERRLSENPAS
VFQIDTIGAKREFERRLRKEGMAKFETKDGTKNVEVIELNDKDLKGKDLKDKNLKEKNLK
NSNNEK
>SEQF2502_01930 Endolytic murein transglycosylase
MKNTLKIIYAIIFLILFMCLSLFFNFFFAKREYKNVNINVKKGTNFVQIYKDLKLNYGIM
DRIYLKLNGENIKLKVGTYKFNGKFSKYEIIKKIKNSETNGIRLTIPEGFTSKQVFARME
ALELGNTEEINKVLSEVNFPYPHENNNFEGYFYPETYIFSENVTTKQVIRTILDEFLKKF
PPEKYPDKKKFYDDLKLASIVEAEVPDEADKPKVAGIFLKRLEIGMKLESDATLKYELGR
QATRNDLKSQNTAYNSYKVKGLPPTPIGNPPIETVKAVLNAQKTDDLFFFTHKGKTYYSK
THEEHLKKRRESGQLK
>SEQF2502_01931 tRNA(Ile)-lysidine synthase
MEKLKKIEKKILKRTMEIIEKKLISNGDKILIAFSGGPDSIFLYNFLKFLKSRILIEISL
VYVNHNLRIDVENDLKFVKKFAAENNVDCYIQSVDVKEYSKENKKSVELAARELRYEAIE
KVRKKIGYNKIATGHNMDDNVETFVFRILRGTSITGLKGIPEVRENIVRPILGFEKSEIL
CFLKSQNWEYLVDYTNNENDYTRNFIRNKIFPFFERINPNFKRKVESLIVEINERNFAGL
EKFENEKNLEKENFKILKKNGVNQKDELSFLLKKNNVQISREKIDQIFKSFFTKSGELRD
AGTKEFYLGENKILQNVYGELRIIEITNKNKIKNLRSNKIGILSDKNIILKENQSIKWYN
YKITLYENIENFKKDENAEYAIFKIDDRIENGEFFVRNRKDGDRISLKNLGHKKVKKILI
DKKIPKGERDFVPIVGVKIFGSENNLQFSNDAVKLENRDNNEMTEILAVSDIKFSKFLEK
IQENKIKKLGNESKSKLLIIGRKNGRKR
>SEQF2502_01932 ATP-dependent zinc metalloprotease FtsH
MAEKDKNDIRKRLEELRKDNNRKNNRQDDGNKSPFSGFLFFIFVVLLFTFTAIFHQDIQT
YFQAKKEISYTEFVNRTQAGEFSEISEKDDKLIAQARENGKDILYFTKKITDRVGNEPII
INAIERKKVKLNSLQPSGGSFFLLLLGQFLPMIIMIAIMVYLAKKMVGGSQGGGPGNIFG
FGKSRVNKIDKKPDVKFDDVAGVDGAKEELREVVDFLKNPEKYTKAGARVPKGVLLLGRP
GTGKTLLAKAVAGESGASFFSISGSEFVEMFVGVGASRVRDLFEKAKESSPSIIFIDEID
AIGRRRSVGKNSGSNDEREQTLNQLLVEMDGFETDTKVIVLAATNREDVLDPALLRAGRF
DRRVTVDAPDLQGRIAILKVHSRNKKLDKDVRLEDIAKITPGFVGADLANLLNEAAILAA
RRASDTIKMSDLDEAVDKIGMGLGQKGKIIKPEEKKLLAYHEAGHAIMTELTPEADPVHK
VTIIPRGEAGGFMMPLPEEKLVTTSKQMLAEIKVLFGGRAAEEIGLEDISTGAYSDIKRA
TKVARVYVESVGMSKKLGPINFENADDEYSFAPNKSDETVREIDLEIRKILTEEYLNTLN
TLQDNWSKLEEVVALLLKKETITGDEVRRIIKGETAEQILKEYENFDKKDEKSQSFETKE
IKNKDSEVKDKEIQKSESERAVENVKQELELENKIENQVEEDTKKLEEKNKTEKLAEAVR
EITGKSDWALEEDFDSEEIENNKDNENKDNDKKDNDSNNSDDSSDNNGSSENGKNEDNKN
NDSSNETGNKKKKKNNFKLPSFME
>SEQF2502_01933 hypothetical protein
MKKIILIIVILTLGIVSCSKSRKENKKSKKSNMTIISKKPDILKISYENYMKQRMDDTRR
DVLPVDVVGQMQEAWKSEIAKLYNLLLGELSDKEREKLRLDQKEWEKKVNTEPKEKKLEK
TEKRAIEMARRYDKIHKK
>SEQF2502_01934 hypothetical protein
MKKMLLMVGLLLIGVSTFAGKYEDELTERMKVEEEKAQSAWDSGVRADMINASVNLDDEW
EKELDKVYNLILKKLSVREKAKFKTEQQKWKKDTEIKLKKAYNKYVEEEGERMAGELAAS
DSLEATKARALKLAKMYDKLSK
>SEQF2502_01935 hypothetical protein
MKKFFLFKGNKIFFIMISLLFTQAIFPITFKYDTGENLVTKKKEEDAKEKRIKSVLNAIR
RHNNKYVQFYLAIEKNIKNRKKLLEEYINRPAGVYGVDLDESSLIAGGGNELVDVNSRSE
DGYTPIIVAIEAKNQEILQLLIENGANLYERHPVFNRTTVGTAAYYENEEAVEILLKKDS
KLANIGSTVDGWTPLEDATLKANVAIVKMLLQYGANPTITDKHGGTPMDMATKFGKGEIV
KILRDHIKANRSKYYK
>SEQF2502_01936 Phosphoenolpyruvate-protein phosphotransferase
MKRMTGIGASEGVSIGKVLLFITEEIVVPETKDENSTIEAELAKLENGLKKSKTQLIAIR
EKVKEKMGEDKAAIFDGHIMLLEDDDLITEVEDKIKGDGLPAAKALHDGIIEYCDMISQL
DDPYLRERAADLKDIGKRWLKNLLGMKIHDLSNLEPGTIVVTEDLTPSDTAQLDLENCIG
FITEVGGKTAHSAIMARSLELPAIVGVKGILTEVKDGEIVVMDGETGELYLEPSDELIKE
YVKKQEVLKKEKEELRKLIHEDAVTIDGRKVDIWGNIGSPNDVDAVIESGATGIGLYRTE
FLFMNSDHFPTEEEQYQAYRVVAEKMQGKPVTIRTMDIGGDKELPYLDLPKELNPFLGYR
AIRISLENKDMFKTQLRAILRASQYGQIKIMYPMISSINEIRKANAILEECKKELDEIGK
IYDRNIKVGIMVETPSTAIVAYKFAKEVDFFSIGTNDLTQYFLAVDRGNEMVSTLYNSFN
PAVLEAIQKVIDAAHGAHISVSMCGEFAGDKRATKLLLGMGLDSFSMSASSGLTVKKIIR
NSSYADAQKFRDLILQQDTPEDVIAKLV
>SEQF2502_01937 Putative cysteine protease YraA
MKEKKVAVFLTNGFEEIEAITPIDLLQRAGINVDTVSITSDNLVESARKVKIMTDKVIGK
IDFLEYDMLVMPGGPGTENYFKSQLLLDNVLKFSKNIENKKVAAICAAPTVLASLGILKG
KNAVCFPACEDDLLKGKAILKKDRAVVDGNIITSRSAGTAMDFSLAIISELLGKEVAGKI
AKEIVL
>SEQF2502_01938 Ribosomal RNA small subunit methyltransferase H
MEYHKPVLFNEVMENIITVRDAVYVDCTLGGGGHTQGILEKSSKNSSVIAIDQDMQAIEF
AKKRLKKFGNKLQIFQDNFRNIDMAVYLAGFEKVDRILMDIGVSSNQLDNAKRGFSYRFE
ARLDMRMDSNLKTSAYEVINEFSEKEIADIIYKYGEEPKSRRIAKKIVEYRKNKPIETTT
ELADVVIRSIGKSMKKHPAKRTFQAIRIFVNKELEVLSETLDKAVKLLNKNGRLLVITFH
SLEDRIVKEKFREFEDPCTCPKDIPICVCNKKSLGKIITRKPIIAKTLELEENNRAHSAK
LRIFERSE
>SEQF2502_01939 hypothetical protein
MNGVSKNKKMQIEILNVPKITNTARSHEEAKRKKVIAPTEVKRKLSRTAGLDKKIIKTVM
FYIIIVTAVALLRSFVGYDVTSLGKKIQQEEAKLKELKKEVARLDNEFINSDDLKTQEQK
AREKGFSVPSDPTYIDLGK
>SEQF2502_01940 hypothetical protein
MRKYEKKYNIIDNSLFAMFANVGYRKEIEKFEKLYFKALKRYLELSNGVPS
>SEQF2502_01941 hypothetical protein
MAKEVLEKIKSAEVESDQIIADANEKAKNILKDVDQKIKNDGDKIISEAKIEAQNLEKHS
IEEAEKKVNSLLSSEEENINSILNIDEQKIDEVVNLLAERIVK
>SEQF2502_01942 hypothetical protein
MAIVKMSKFELVVFAEQRAKVLKALQKFKEVNFVDIKLRDENGEIDKDTVEGVTKYVNNE
ELTHIDERLYQLSSAISLIKKYDERKTRLRDIIHGNENYTFDTLSKKALTYDWKKISSEL
NSIGVQYSQIKSEISKKYTRYDEIDLWERLDVNPMELKKLKKVNTFLGTIPLKLKGDFIE
GISKLDKTYYEELKIVKDEVYYLVISSIDESEKEKLSEVFRNSSFSVENLDIDAVPQDYK
NELQKEIGELKKQKRKLKAQIKTYSEDLTDLQAVYEYMQNKKLRIVESEKLAQTENTVLI
KGWIPTEKIQEFEKVVKNEAGSSYYLMFEKAEKDDATVPIKLKNGKVASVFENLTGMYAY
PRYNEIDPTPLFTPFYILFFGMMGADVGYGLVLLLATMFVLKVVNLSSQMRKSVKFFFYL
SFSVIFWGILYGSYFGAEIPGMWRLINPSKQYNTLLIGSIVFGVVHIFIGLAIKAYMLIR
DGKALDAVYDVLFWYMALMGGMAYLVFKMKNLSPAVTSVSMWIMIVGMVGIVLTGGRDAK
GVGAKLGGGLYSLYGISSYVGDFVSYSRLMALGLSGGFIASAINMIAGMIIGSWVGMIFI
PVILLGGHLFNMFLSFLGAYVHTSRLMYVEYFGKFYEGGGKPFKDFRTENKYINLDD
>SEQF2502_01943 V-type sodium ATPase subunit K
MNFSQFLVQNGGIVMATLGAALATLLAGIGSAKGVGIVGEVASGLMSEEPEKFGKSLVLQ
LLPGTQGLYGFVIGLMVLGKLKPEMPIQTGLGILMACLPIAFAGYGSAIAQGRVAASGIS
LLAKNEEQNTKGIIYAVMVETYALLAFVVSIMLLAKF
>SEQF2502_01944 V-type proton ATPase subunit E
MSNLDNLTSKILADAKAQADKIVKDAQEKAQHKYDLEIKKINAKKETVLENARRDRELLS
ERIKSSANLKARNKKLEAKQAVIDKVIDKLKTKLVNMDEKKYINYLNQNIDKKTITGKEL
IVKKEFVEKVKKEFPGAKVKENEFVTSGFIVEENGIQENYTFEVKLDFMRDELEVEISKL
LFS
>SEQF2502_01945 V-type sodium ATPase subunit C
MDRMDYGQSVVTIRVLEKRLLTRNRLERMIEAETPEEVLKLLGETEYSQDMADIHGSQDY
ETILKRETERVFSIVRKMVKNTAIVDILSLKYDYHNLKVLLKSKITGKDFSHLLMQAGTI
DAGKFKTKFELQSNDLPKEIIEAIIEVQKDFEENHNPQRIDILVDKHYFRNLSRLAKEID
VKVITDYVEGLIDFQNMITLLRVQKQNRDARFLETVIFDGGTISKNKIVSSMNDNIDTIL
NKFKKEKLGMYLAKGLETFSETKRLSELEKISDNYLMELNKESKYVVFGPEPLFTYLVAK
EREINAVRMIMVSKINNISSDKIRERLRETYA
>SEQF2502_01946 V-type sodium ATPase subunit G
MHKIGVVGDKDSILSFKALGIDVYPVVTKEEARSTIDAMASNNYGIIFVTEQIATMVEST
IERYNREVLPAVILIPNNQGSLGIGLKKIDEYVEKAIGSNIF
>SEQF2502_01947 V-type sodium ATPase catalytic subunit A
MKTGKIIKVSGPLVVAEGMENANVYDVVRVSEKKLIGEIIEMRGDQASIQVYEETSGIGP
GEEVFTTGEPLSVELGPGLIEAMFDGIQRPLKEYQEIAGDFLDKGVEVKPLDRKKKWEFE
PVLSAGATVETGDVLGTVQETSVVNHKIMVPAGIKGTLKTIKSGSYTVVDTIAVIKTEKG
DVEVQMMQKWPVRRGRKYKQKLNPEAPLITGQRVIDTFFPVTKGGTACVPGPFGSGKTVV
QHQMAKWADAEIIVYVGCGERGNEMTDVLMEFPEIIDPKTGQSLMKRTVLIANTSNMPVA
AREASIYTGITIAEYFRDMGYSVAIMADSTSRWAEALREMSGRLEEMPGDEGYPAYLGSR
AAEFYERAGKVICLGQDGREGALTVIGAVSPPGGDISEPVSQATLRIVKVFWGLDANLAY
RRHFPAINWLNSYSLYQAKVDNWMNQNVGPEFSRNRARAMSLLQEENSLQEIVRLVGKDT
LSEKDQLKLEVAKSIREDYLQQNAFMESDTYTSLEKQDKMLDLVLKFYDEGLRGLENGAY
LNEIIAMPVRERIARAKYLPEAELNKIDEVAKELGKGIDELVNKGGVANA
>SEQF2502_01948 V-type sodium ATPase subunit B
MLKEYKTIKEVVGPLMMVEGVEGIKYEELVEIETQKGELRRGRVLEVNGDKAVIQLFENS
AGINLKDSKVRFLGRPLSLGVSEDMIGRVFDGLGRPKDNGPKIIPEKTLDINGTAINPVA
RDYPSEFIQTGVSAIDGLNTLVRGQKLPIFSGSGLPHAELALQIARQAKVLGTDSKFAVV
FGAIGITFEEAQTFTEDFIKTGAIDRAVLFMNLANDPAIERLSTPKMALTCAEYLAFEKG
MHVLVILTDLTNYCEALREVSAARKEVPGRRGYPGYLYTDLSTIYERAGRIKGREGSITQ
IPILTMPEDDKTHPIPDLTGYITEGQIILSRDLYKQNLMPPIDVLPSLSRLKDKGIGKGK
TREDHADTMNQLFAAYATGKEAKELAVILGESALSETDKAFVKFTTAFEEQYVAQGFDNN
RTIEDTLNLGWDLLKILPRTELKRIRDEYLEKYLPAGDE
>SEQF2502_01949 V-type sodium ATPase subunit D
MARLNVNPTRMELSRLKARLKTAKSGHKLLKDKQDELMRQFIILVKQNRKLRVEVEGKLQ
DSFKDFLLARGVMSDEMLENAIAYSEDKLSVNIETKNVMSVIVPKMTFNKNMESTEVTYP
YGYAQTSADLDDAVDGLNRVMKDLLELAEIEKACQLMADEVEKTRRRVNALEYMTIPQLE
ETIRYIQMKLDENERSSITRLMKVKDMMAEKA
>SEQF2502_01950 Threonine synthase
MNYKSTREINPSNVKSSTFAALHGLCEDGGLYIPEKLPEVKLTYDELKDLSYQEISEKII
KLFFTEFSDEEIKTAINNAYNSTTFNDKNIVPVHKLNDKVSFGELFHGRTLAFKDLALSL
FPYLLLLSKEKQKEDKKILILAATSGDTGKAALEGFKDVDGINIVVFYPKNGVSPMQEEQ
MRKQLGNNVEIVAINGNFDDAQSAIKVIFSSDEFKKYANEHDVMFSSANSINIGRLFPQI
IYYVTTYVNLVNAGTIKAGEEFNVVVPTGNFGNILAGFIAKKLGIPIKKFISASNKNKVL
ADFFQTGTYNKNRDFYATNSPSMDILLSSNFERYLYYALNEDSKRVSELIKNLLSGGELS
VSDKELKNIQTEFYGEFANDEETVSAIKEIYENYHYLMDPHTAVAYSVYEKLDEKHLDKD
IHTVIMSTAHPFKFPAPIAKALGIDDTKEPYAILDEVSEITGVKFPEKLTEVRNSEIRFS
DVIDKADIQKFVKKYIKDLK
>SEQF2502_01951 hypothetical protein
MKKILLILLLLFTVVSCELEDARDAYNKKEYLKSIELVFNYFETNPKKINKIKPEIKNEI
MEKFLNITNHYKEMTGSRDLSERQKGYEELVKIYALFDTYKNSSTFSDFQQKYPLDESLN
NIEKTITQRLKNNNYNYEYYGYDHFKDVTNDINNYYEDILKFIDSIEKNPKISNEMALKY
KEISKQINKNKANKFIEFANASENKKNYREAQRFYEEADKLFVITRQDAKKVSIKTKELK
EKADLQAAENAYNFALSRLKNAKTRNDYRNAVWNLERVNELVSNYKDSVSLISKYKDKIY
VKYNIFGCSNSWVEKYLDKKLENVIGKKTSSSSAEVQINCRVTDNYNISTFPSNIENLRE
IRELVNNAGEKVTKEFIFQKIKSLAIEKITFNYEIEVSGLVKQRYSNNLSEKNEVHSLQY
TGDIPKEYKDKDKIEKPLGETKMKNKILEKSNLERELNQIIDAIDRL
>SEQF2502_01952 hypothetical protein
MKKIFLILLLLFTIVSCELKKAQEAYDNKEYIRSIYLTLSYFEKHPNKVEKIKPDIKNEI
MEKFSNIVNYYKTEAGSSNLKERQDGYEGLYKIYALFDVYSQSSNFTDFLSKYDGDELLG
EIYKIIDERIKTGELEVKYSRDIISILDEYYRNMIGYTKELSGIKKIDENKILKYESISR
KMSQAEADKLIEYANIKEKAEEYREAQKLNEAAQETYGQYQKNYKNMYIKIRELKKKADY
QEADKLYQSAIRTSGAVTKHGYRESIEKLKKAQEIIPNFKDSKEKIAEYSKKAYVKYNIS
GCDNSHVPAYINGHLSKVGVYTKYSSEAEVQINCKVTDNYQVSTYPSQIKNLSQVKEVKN
NDGQMVKKEFIFQESKTKSVEKLDFSYEIELSGYVRKKYSGNAYKQHEINSLQYLGNVPS
EYSGKDKIEKLWGESEMRRKVYDSASFFKDLKDIVKELEKL
>SEQF2502_01953 hypothetical protein
MKSRIEEQNGKVINRNVTSNRIKKNMELNENNLENESKVKKEEILKNMLKNVDNEIKREE
IIHMLLEQKVSKVIKEEESEKKQFSNKVLNFVGSGKFIAFMVVFILVWTLVDVFFLLTDK
FNPYSFVIMNVVLSLVVLIFCSLIVFNQNKKKKMDRRKSENDYKVNLKNEIIIEDLHYKL
DDLIEKQDKIAKRVLELEKKKKAAATKGNKEYKFIDISEGEKKK
>SEQF2502_01954 hypothetical protein
MNIFDLKDLSENEEIVKILVKNENVKIEEIISTGQVTGWQESDKNEFVILVQGNAEIEYY
ENKNLKTNENIIKNQKNTNDMKLQLGKGDTVLIRKGERHRVSYTSKNPCCIWICIFFE
>SEQF2502_01955 hypothetical protein
MMLFIIFALVVVIATGIPYVKKGIENRKLMKEYMEEQGLGKNEAIGKVRDAKTTNDKVIE
GLFYLSLIALLGGGFYNIYLYNNENSDNMSAQQQSEGTMANITTDQNQNQNQDQNQQDQN
RQNQGTPVVQNNIISNPNDAQVQENVKREQARIDKMFADSERNTSSLMDMLKKSFEKKDT
GEGIKNGEKALENVKKSSNLFKNTKCNPTGDATFDKECPKLLQKGKELYSSKQIDVEKML
SALKGIEKSINDVKNSELGQQAVQEGNKLWDSLMKKVDEFQKK
>SEQF2502_01956 hypothetical protein
MKMKSLGNAVLGALIILVGLVILTESKDNHIDIKIADKGNLSVNNVKNVTTVTEKKGSGK
KVKAVVIEFDKSIKNEKLSKNAVTVTQKNISKKNIENKNDEPIVNTTETKVNREVSKIYT
SDKIDDENVEAKDGKYLYLELAEDKDTDDKAAQNDMEDLKISVSQSKKNYFTNNSKSFNV
NNKS
>SEQF2502_01957 hypothetical protein
MKNKKMLLILAAIVFVLSCSNENSVEKSNIKKQSVVENAKNSKTEKEYLKSINYSNIADK
MAQDEIKESLENAGVDSNNIDIFFKSVNYYNEATENKGLIKSGFINSKNINPIYDEVAIQ
KIWDKKNKNFPGFNCRITAFTLMKDYIKMEKPAIKAGEMLFMDIESFKNMPFKLFSQNEE
NKFINLFSEIPTKMTKDVRVHIENVKNAWKDRGIKFDKNSKISMISVFFHFNDDPEENIL
FIGHVGILVPEKNGKLLFIEKLAFQQPYQVLKFNNRTELNDYLMNKYDTAWGQPVAKPFI
MENDELLKEYRTNPNNK
>SEQF2502_01958 DEAD-box ATP-dependent RNA helicase CshA
MQKFEDFGLSIEMLNALSKKGFEEPSEIQKLVIPELLKERTHLIGQAQTGTGKTAAFGIP
ILETIEADKTVRALILAPTRELANQVADEIYSLKGEKNLKVLAVYGGASIENQIKKLKSG
VDIVVGTPGRVMDLMRKKILKVDQLDYFVLDEADEMLNMGFLEDIEAILEKTNDEKKMLF
FSATIPKAIMAIAKKFMPEHKLLKVAKKELTTNLTEQIYYEVKQEDKFEALCRVLDYEQD
FYGIVFCRTKSEVDDVTNKLKARNYDAECIHGDITQALRQKALDLFKKKILTILVATDVA
ARGIDVSNLTHVINYSIPQEAESYVHRIGRTGRAGQKGVAITFVTPREASKLAQIKRITK
TEIKREHIPNVEEILEAKKEALLAYVDEIIMENDFDAYSELAQRLMDGRDAKQVLASVLR
HVYEDEFLPENYNEITDVKVKIDDKTRLFIALGSKDGYNVGRLLDLLNKKAKTPGRKVKD
VKIMDKYSFITVPLQEAEYIMRALNSKKDAKPLVEEATGSRNGGGEKSGKKSDRRRDRKG
RKKSSGKTSGKKSDKSSKGKKDKKTRKVKK
>SEQF2502_01959 10 kDa chaperonin
MIIKPLGERVLIKQTEQEEVTKSGIVLPGTASKEKPIIGEVLAIGSKIEEVKVGDKVIFE
KYSGTEVKDGEESYLILEKDNVLAIVE
>SEQF2502_01960 60 kDa chaperonin
MGKIIKFNEDARKALEVGVDTLADAVKITLGPKGRNVVLDRGFGAPMITNDGVTIAKEIE
LKDPIENLGAQIVKEVATKSNDVAGDGTTTATVLAQALIKEGLKMVASGANPVFIRRGME
LASKKVIEELTKRAKKVESNDEIAQVGAISAGDTEIGQLIAQAMEKVGESGVITVEEARS
LDTTLDVVEGMQFDNGYLSPYMVSDSERMVVEMDNPFILITDKKISNMKELLPVLEKTVE
TGRPMLIIAEDVEGEALATLVVNKLRGTLNVAAVKAPAFGDRRKAMLQDIAILTGGEVIS
EEKGIKLENADISLLGQAKKVRITKDNTVIVDGLGEKDEIQARIGQIKNAIAETTSDYDK
EKLQERLAKLSGGVAVIKVGAATETEMKERKLRIEDALNATKAAVEEGIVPGGGTILIQI
AKAIEDFKLEGEEGLGVEIVKRALSAPLRQIVINAGIDAGVVIEKVKNSENGIGFDAAKE
EYVDMVKAGIIDPAKVTRSAIQNAVSVSSVLLTTEVAVGNEKEESPADGMPGGMGMPGMM
>SEQF2502_01961 3-hydroxy-3-methylglutaryl-coenzyme A reductase
MKKENQKKLNWLGFQKKERTERIQMLKDNGFLTEEFEQLLKKNENLPLETANQMAENGIG
TFALPFSVAPNFVIDEKDYAVPMVTEEPSVVAGCSYAAKIIGKSGGFTTKILDRKMIGQV
ALYDILDFDNAISMILENKNEILKIANDAHPSIVARGGGAINIEVKNIDEFLIVYLIADV
KEAMGANILNTMLEAIKMPLENITNGKSLMAILSNYATESLVNAECEVNVKLLSSSMETS
IETAKKIELASKFAKLDIYRATTHNKGIFNGIDAVVIATGNDWRAIEAGGNAFAVKNGKY
EGLTTWTFDESTNKLKGELTLPMPIASVGGSIGLNPSVKAAFNILGNPDARTLASIITSV
GLAQNFAAVKALVTTGIQHGHMKLQARSLALFAGAKGKEIDIIVEKLLESGKSINLENVK
TILEEIKIKK
>SEQF2502_01962 Maltose O-acetyltransferase
MNLEEQRQFILSGKVYNDLTPELIKARENTVFLTNKYNESFGKPSSEREAILKNLLKSIG
KNVHFEPTFRCEFGFNISIGNNFYANFDCVMLDGGGIEIGNNVLFGPRVGIYTSNHSIDA
EERINGGCYAKPVKIGNNVWIGAGVHINQGVTIGNNTIIGSGSVVTKDIPDNVIAAGVPC
KVIRKITEKDKTGYKP
>SEQF2502_01963 Hydroxymethylglutaryl-CoA synthase
MRIKEIKEKIKIGIDKIGFAMPKYFLDIRDLAIGRNENENKFVKGLMQSEMSVAPVTEDI
VSLGASAAEQILDEEDKKNIEMIIVGTESSVDQSKASAVFIHHLLDIQPFARSVEIKEAC
YGATAALSFAKNYIEKNENASVLVIASDTAKYGINTPGESTQGAGSIAMLIKKEPKIAVI
NDENVCQTRDIMDFWRPNYSDFPIVDGHFSTKQYLDCLTTTFDEYKKRYNQDLSDFDAFC
FHLPFPKLGLKAINSLLEKNVEKETKNKFLEKFHTSIIYGKRVGNIYTGSLYLSLLSLLE
NCDSLKAGDKIGMYSYGSGAVCEFFNLTLAEGFKNHLRHDRLNDFDNRKQLSINEYENLF
FEKIILDNEGNCDFSNSKLIQESDNAFVLEKVENHKRIYKKIN
>SEQF2502_01964 hypothetical protein
MLENLLIVALVILSIIMISVILLQPDRSQGLAKSSANILDEEKEGIEKFTEIVATLFLVV
AILFQIVR
>SEQF2502_01965 Triosephosphate isomerase
MRKVIVAGNWKMNKTAKEAAKFFNELKPLVADVKNAGIIIGAPFTALETATRETAGSNIK
IAAENMNAKESGAYTGEVSPLMLKDLGVEYVILGHSERREYYHENDEIINEKVKSALAHD
LKPILCIGEKLEQREAGTTNDVVKTQIVGGLKDVTAEQMANVILAYEPVWAIGTGKTATP
DQAQEVHAFIRGLLTDLYGKEVAENVTVQYGGSMNDGNAADLIAQTDIDGGLVGGASLIP
EKFAVIIKAGDAAAK
>SEQF2502_01966 hypothetical protein
MPKLDIERFERDDDSPVYMEIDEDHMKCRRSKNTYMRMVSIHRGIEELCRDRNKLIDKHT
IMFPASVSLEEVSEYVLNYLEKRYNMDKKKLIVNSDGGIWIDSFAGELRIYNPIHIYDKF
HLAKAIVEISKKDKGISKNLYRWLEKDNFAGLENFYENFKEKENVSQRRKEQMKMLLNQY
EKIRRIYTEEDYIGSRTEALVSHECSRFLSSRPKAFSRRKIKARALYHTFFANYGKNREK
AYELYFSGKRTSSLEKVIEMERLPEIVNETGKSTNIPYLRGGECPIREVLKEISQSKIF
>SEQF2502_01967 hypothetical protein
MKKLYDKYKIYIINFFKYLTKDEVKPYEDKIKNYFKNITEKSAKKNFSKKETNTGLKIFI
ALASFLIALISFPLIFIFGPFWVAIYLSLSTSIMYAFFSKDLED
>SEQF2502_01968 hypothetical protein
MQDCITTLVEVLNYSDENKTSINVSYETLINCRLYELEYWNLRAEKLLEDSEKRSSESE
>SEQF2502_01969 Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase
MGKLLFNTIKKIKPLDKNRMEEKEKELNSLLKTPKGLGKLEELAIRLEGIDKNYKPDKKM
VLVMAADNGVEREKVSKSKRVITQYVVEAMLNGKTSINALGMVYDADIRVVDLGIDESSD
IKNEINLSGIIEKKIIKSGTNNIAKEAAMTYEQAVKAIETGIEMVDEFVKDGYNLFATGE
MGIGNTTTSSAVLKVLTDLPIDEIVGYGSGIDDKTLEHKKNVVKKAIQVNGLLDFFEKSK
NVEEKKNVKKDKKNTDFESKINFENFKTEEYQKSIINVLAKVGGLDIAGMAGTYLGCAKN
RVPVVIDGFISAVSALIAYKICPISREFMIASHLSEEPGMKYIMKELDLEPMLFMNMKLG
EGTGAVMMFPVIEGACNITKVVREYPDV
>SEQF2502_01970 Glutamate-1-semialdehyde 2,1-aminomutase
MNTNNSKKIYEKAKESIPGGVNSPVRAFQSVNNEYPIFIKSGNGSKLYDEDGNEYVDMIG
SWGPMILGHNYPQVLKVVKKELEKGTSFGLPTKKEVELAELVKSCFPSIEKLRLTTSGTE
AAMASVRLARAFTGKNKIIKFEGCYHGHSDSLLVKAGSGLLTFEHQDSNGITEGVVKDTI
TLPFGDFEKLKETLENDKDIACVIIEPIPANMGIIETEKEYLEKVREITQKENIVLIFDE
VISGFRVSLGGVQKVFGITPDLTILGKIIGGGYPVGGFGGKREIMDLISPVGNVYHAGTL
SGNPISVAAGIETISILKENPEIYESINKKTENLVNKINELIKKYDVPATVNYFGSLFTI
FFAKEKVKTLEDAMSTNSEFYSIYFNTMLENGVIVPPSKYEAHFVSYVHNDEDMEKILAG
VEKTFEKIAKKSGTIPKYI
>SEQF2502_01972 tRNA-specific 2-thiouridylase MnmA
MDKKLDDKKVVVGMSGGIDSSVAALLLKQQGYEVIGVTLKHLPDELSENPGKTCCSLDDI
NDARYTCYTLEIPHYVLNVVEEFKRDVMEYFVKMYNAGKTPSPCVICDEKVKIRKLVEFA
DKMGIKYISTGHYSKVSPNNVLLWDKNNRKDQSYMLYRLDKEVVERFLFPLSEYKKSEVR
EIARQNGIHTHNKPDSQGICFAPNGYIPFLKKVLGNDVKKGNFVDKSGKIIGEHIGYQFY
TVGQRRGLGLNLGKPFFVLELRPETNEVVVGDFEELLVKEIEVINYKFHCGLENIIGVKL
TARPRFSSRGLTGKLKILEDEKNKLIFEFDEKTHENSEGQHIVFYLENEIVGGGEIKNI
>SEQF2502_01973 GalNAc(5)-diNAcBac-PP-undecaprenol beta-1,3-glucosyltransferase
MKFTVFTPTFNRKELLEKLYKSLQKQTFKDFEWLIVDDGSTDGTKEKVKKFLCEKKLDIK
YYFKENGGKQRAYNFATEKANGELFICLDSDDEYVENGLEIILKYWKKYEKNADIAGMGY
LSTYPNGGIIGSSFPEKEMISTQFEIYNKYGVKGDKGIMFRTEIIKKYKFPVFEDEKFIT
EAVVYNRICEKYKMVYVNEKIEIKEYQEDGLTAKYNNLLLRNPKGQALYHNEINSQKLTF
KRKILNNAVYYKFCKVAGYKFRKIFKESKNKLFLIFAIPVGEFMWKKVKL
>SEQF2502_01974 hypothetical protein
MDNKNLLKGTMVYSLMNLVTKMGSFVFLPIITRLLTQEEFGIVGTLAPITSLFTVILGLG
LYNAQMKKYVDLKENEDEFGSYMFSSTLIIVVFNILTYIFLFTPMAQKLFSYIVNLSKVS
YYPLIIVSILIATANAFNNLSTTLFRMKRMYMKVAIGSVISLFTTYILAIYFIKYLKWGV
FGNQFANLIALLIVFLFYFKDYFGKFRFKLNFDYVKYSLRNGLPLIFIELTDQVVNLSDR
LVLAKFVSLAVVGGYTLAFTGGRVLSVVTGSFVNSWTPEFYEAMKEDKTNPTITRSVENF
IAIISFACVIAQLFAPEGIKLIFPKSYYQAINYMPLILAGIVIQALFCLDYFFHFHEDSI
YIFYFTMFAMIFNLAGNIIFIPKFPEIGPIIAAWTTLFAFLFRAIMEMMIIRKKYKISFN
YKKLFLYFIIIVNPVIFYLSNDQISIVKFGLKIVYLVIVTKLLVNKEVLTKIMNLVNGIK
RKIMKQ
>SEQF2502_01975 1,4-alpha-glucan branching enzyme
MNGYFSLVLHAHLPYVRHPEYEEFLEEDWLYEAITETYIPLLEMFENLTRDNIPWNITIT
MSGTLVNMLNDGLLRERYLRHINKLIEFCENEVERLSPYPDMLNVAKHNLWFNTRARQVF
EEKYNKDLVGAFRKFQDQGNLEIIPVTATHGFLPVMKDYPEAVNAQVLMAKKDYIKNFGR
DPKGIWLAECAYYPGQDKFLEKHGIRYFLVDAHGIMHSDPRPVYGIYSPVYTKNYVAAFA
RDLESSEQVWSSESGYPGDGLYREFHKDAGYELDYELVKPYLHSDGVRRNIGIKYHAITD
KKGTYKAVYNPQAAADRAKEHAYNFVFNRSKQIEFLASKMKYRKPIVVSPYDAELYGHWW
YEGPIFLEWVFRAIAESDFSTITPYKYLQKYPTNQIVDVSMSSWGANGYYDVWIDGSNDY
AYRHLHKAAQKMIELANGREPHNELEYRALNQAARELLMAQTSCWEFIMYTGTMVGYAHK
KISDHIHRLFKIYEDYKNGNLDESWLREIESRDNIFPEMDYRIYRSDWL
>SEQF2502_01976 Diacylglycerol kinase
MEKLKKAILVYNPKSGNANMILSNFDLITTKLLEKGITLTLYSINKDYDLFTEILKNEKY
DILILSGGDGTLSRCLSELYSKNIKFPEVAIFPTGTSNDFAKALKIEENIENWIEKITDK
TAKNIDFGLINGKTVFLSSYAGGLFTKISYNTDKTLKKTFGKVAYYINGLGELTNIKTFD
LDIVLDGNKTIKEKAILYAILNGKSVGGFENVIDEASMNDGFMDILIVKNIDNPMDIPKI
LIDLMNSNLTNNDYIRTLQAKKCEIKKVVEEIDVSIDGEEGENMDVKIEFINGKLKIFC
>SEQF2502_01977 Single-stranded-DNA-specific exonuclease RecJ
MRKTKWAAKIIPNPRQEREYIERDNKQNVDDRTKKIKQSGNKKQIVEGSNLNSFIDSDIL
KILYSRGITSEKEVIKFLNPKMENIQNPYGLQDMEKTVLEIERAIEEKKNIWIFGDYDVD
GITSTSILYMALKELGAENVNYYIPIRDEGYGLNNEALKKIKESGADLVITVDCGITAFP
EVEFANSINLPIIITDHHNLHGGKLPSAIAVVNPKRPENKFSFEFLAGVGTIFMVILCLY
ERIGKKVKAYKYLDLVAIGTVADIVPLVQENRILTKFGLEQLNRSKNKGLRFLLYKLFNT
QNSDFNEKTEYNSYDVGFVIAPVFNAAGRLKDAKMVVKLLISDNDREIEIIVKELINKNF
ERKELQNEIVEKVEKHIEESDLKEDYVIVDYSPEYHHGVIGIAASKIVDKYYKPAIIIEV
KEDEGIAVGSCRSIGNFNILEALQSMPELFLKFGGHSGAAGFTIGIKNLELFKEKINKFA
KTKLKEEDFVKIIEIDKQIPIQKVSYEFFQVIELLKPFGFGNPMPTFRTNNVLFENIKFI
GENKNHIMFDIKQKGFFSRNAVWFNSGEYFKELNENLFYDIVYKLKTEMFQDRYYTKVYI
EDVKVSQLKDDTLSYYHSLFNTSFPMKSIFYTNIELDLEKKITMKMEFDQVSLFQGRKFI
GRLDYSISNLLILLNQYYNWNFTVKIEDVKQTASHSIVNILVKKDYSFKCYDHTQVGIFK
KIKEFLIGEMEYNSQTKSLLSQFFRQNKNLIIKNIFNEEEKYKYKMSDFENFLLTIGIYY
KKMTNKKSQIIINSEKKSVFNNFIKSYFDINEEYLENDYPFTLFYNYKNTQELENIIKSY
FSMQNEIGYETIENIQNFEINENFETEEDLKLLEYKKIEEIELKNNQAENPNENYVKIGE
DNQKKNQNVENTKNLSESKTEDENKSKEVEKRFCVIVNSEDFMIKTEKLDKSNIKELNIQ
IEVPENIVFLQDSTKKERKNAKNIFLEYLPIEKKIMLKKLLEDGEKIFSDYSVNEIL
>SEQF2502_01978 Pyruvate synthase
MTKNMKTMDGNQAAAHIAYAFTEVAGIYPITPSSTMSELVDQWASYGKENLFGMPVKVVE
MQSEAGAAGIVHGSLQTGALTTTFTASQGLLLKIPNMYKIAGELLPGVMHVAARAISAQA
LSIFGDHQDIYSARMTGWTMLATSSVQEVMDLAGIAHLTAIKSRVPVMHFFDGFRTSHEI
NKIEVMDYEFLESLLDKKAVQEFRERALNPENPVTRGTAQNDDIYFQAREAQNKFYEAVP
DIVNDYMKKISEKTGRNYAPFVYYGSETAEKVIIAMGSVNETIKEVVDYLNKNGENVGVL
NVHLYRPFSSRYFFDAMPKSVKKIAVLDRTKEPGALGEPLYMDVKALYYGRENAPEIVGG
RYGLSSKDTTPEQIIAVFKNIAQKEPKNNFTIGIIDDVTFTSLALEDEVFTGNEDVKECL
FYGLGSDGTVGANKNSIKIIGDKTDLYAQGYFAYDSKKAGGVTRSHLRFSKNPIHSTYLV
TRPGFVACSAPAYLGKYDMISGLKEGGTFLLNTIWDKEKLVKNIPNEIKRELARKKIRFF
IINATKLAKEIGLGNRTNTIMQSAFFYLSKVIPHEEAKEYMKEYAQRSYGRKGKDVVQKN
WDAIDRGVDGLEEVEVLPEWADLEVNEQIIEAAKPEFIKKIVDPINHMKGNELPVSSIIE
NGMVDGSFQPGTANYEKRGVASEVPEWQPDLCIQCNQCAYVCPHAVIRPFLLDEEEMAKA
PEGMPTIKALGRGMNDLNYKIQVSPLDCTGCSACVDVCPAPRGKAIVMKSTQSQIEKNEV
EYTDYLFNNVSYKDKILGKNTVKGSQFAKPLFEFSGACAGCGETPYIKLVTQLFGERMIV
ANATGCSSIYGASTPSSPYTTGESGCGPAWASSLFEDNAEYGYGMFQAVNTIRHRILKRM
KEVKEDVSPVLAELFNKFAENFDNGDKTTEIRDELVTALEKENAENANEKVKNNIDEILE
LKQYLIKKSIWMFGGDGWAYDIGFGGLDHVLASGDDVNILVLDTEVYSNTGGQSSKSSRT
GAVAKFAASGKPVKKKDLAAILMTYGNIYVAKVSMGANQNQTLKAIREAESYPGPSIIIA
YSPCIEHGIKAGMGKFQTEEKLATEVGYWPIFRFDPRLAERGKNPFQLDTRNPAWEKYEE
FLLGERRYATLAAEFPEKAKELLEINLKNAKDSWNYYKRLAAMDYSIEE
>SEQF2502_01979 Sulfate transport system permease protein CysW
MFRKGERVMDKKNNIIKYVLIAVSILFVGIMLVLPLIAIIVNSLQKGWAFYIRSLTDKYV
LSALKITVIATISALIINTFFGVAAAWLLTKFSFRGKHILATLIDIPFSISPVIAGLAFI
MTFGRMGWAAPYIEHLNKFFVLDIKIVFAIPGVILATVFVTFPFISREIVPILNAQGKDE
EEAAALMGADGFTIFRKITLPQIKWGLFYGIILCTARALGEFGAVNALSKARGKTFTLPL
EIDALYLSGSSESIVSAFAVSSLLVIISIFILIIKNIIEHKSKNKFIK
>SEQF2502_01980 Sulfate transport system permease protein CysT
MKILALRRKEQSVIPGFGLTFGISLTMLSILILIPLASILVYSFRLSPSEFWKLITEKPV
LNAFFTSVICSFIAAAVNCVFGVILAWVLVKYDFFGKRFLDGMLELPFALPTAVAGITLS
KMYSDTGMVGKYFAKIGIKISYTHIGIIIALIFVGIPFVVRAVQPILEKLDNQYEEAAYI
LGADGKTTFWKVISPEIRPALLTGFGLAFSRGLGEYGSVIYISGNSLKEHTQVVSYVIMQ
KLNYVDYPSATVIALVMLIFSFILLFLINLVQMNQFKRTNNV
>SEQF2502_01981 Sulfate-binding protein
MLKKLKIPVIFAIIVIFLYFIGIMRQNSKSGKSRKKLEIVNVSYDPTRELYEKYNKLFIE
YYRQKYGQDVKISQSHGGSGSQARSVIEGLDADVVTLALENDVALLEKVDLLEKDWVNKF
PGSSSPYTSTIVFLVRKGNPKNIKDWNSLTEKGIKVITPDPKSSGGACWNFLAAWSYGRE
KFGNDEYKIQNFVKNIYDNVAVMDSGARAATTTFVENNQGDVLIAWENEAIATIREYPEK
YEIVYPSVSILAQPTVAVVDKVAKSNRTYQISTEYLKYLYSEKAQEIIAESGYRPYNQKI
LKKYENKFDLKMKLTKIDDFGGWKKAYEKFFNEGALFDKIYEN
>SEQF2502_01982 Sulfate adenylyltransferase subunit 1
MVRLLKFITCGSVDDGKSTLIGNILYNSKLLYADQEEALILDSKVGSRGGKIDYSLLLDG
LMAEREQGITIDVAYRYFTTNKRSFIVADTPGHEEYTRNMAVGASFAEVAILLLDVTKGV
LVQTRRHARICSMVGIRHFIFAVNKMDLAKYSEEKFNKIADEVKELAKELELENIKIIPV
SATEGDNVTKKSENMDWYKGESIIEYLETVDVTENNENSDFYIPIQRVCRPNHEFRGFQG
QIESGIIRTGEEITVLPSNETATVKTILNGDKNVEEAFSGQAVTIQLDKEVDVSRGSVIT
KNKNLPVAKSVEAVLLWMDDDKLTVGKEYLAKLGTKKLSAILKEIVYKIDVNTGEKIETQ
SITKNEIAFCKIEFSDKVIVDLFKKNKALGELILIDRLSHQTAAAGVVENIDTIGEKPYF
EKDDIKIDGYIFEELYFDFENARMSKEGTKERTYHVGDEVPQKGDSFEYPQYFDVISLES
EAAVLVRDCKIFDIVKLEDYHFTGLPILDTAGFGLQIKTREDMKNYLLDYNQNVNKVEIH
KKWAKFETYRRVVSGDNFYMI
>SEQF2502_01983 Sulfate adenylyltransferase subunit 2
MNELSHLDELEAEAIYIIREVAAECENPVMLYSIGKDSSVMLHLAMKAFYPEKPPFPFLH
VNTGWKFKEMINFRDRRAKELGIEMIEYINPEGVEKNINPFDHGASFTDIMKTQALKQAL
NKYGFTAAFGGGRRDEEKSRAKERIFSFRNAAQAWDPKNQRPEMWKLYNTEISKGESIRV
FPISNWTEKDIWEYIQRENIPIVSLYSAAERPVVERDGNLIMVDDERMRLEEGEEPEIRM
VRFRTLGDYPLSGAVESNAVTLEEIIDETLSSVESERTSRVIDKDSGAASMEKRKREGYF
>SEQF2502_01984 Adenylylsulfate reductase subunit beta
MSIVIDPYVCIGCTKCTLVCPGTLIEMQKVDDMKIEKAVMQYPKDCWGCVSCVKECPVQA
ISFFLGADIGGNGSTMTTKEEGDVLKWIIEKRDGTVEEIDINRKDANKY
>SEQF2502_01985 Adenylylsulfate reductase subunit alpha
MVENKADKNKNNKERKKIEIKELETDVLIIGGGTAGCYAAITLGKNSDLSVIVAEKANIK
RSGCLAAGINAINAYNVKGRVPQDYVDYAAKDANGIVRHDLLITAANRFNEITAEVEKLG
LVILKDENGEYVARGNRNIKINGENFKPILADAVKKTKNVRVLNTLNITDLLVKDGKVYG
AVGFSIKKEEAIVIRAKKVIISTGGAAGLYKPNNPGFSRHKMWYPPFNTGAGYAMGILAG
AEMTTFEMRFIALRCKDTIAPVGTIAQGVGAKQVNSRGVVYEDKYGLTTSERVYGTVREN
QLGNGPCYLKTSGISEEESESLLKAYLNMAPSQTLKWIESGKNPNEQDVEIEGTEPYIVG
GHTASGFWVNTNRETTINGLYAAGDVAGGCPQKYVTGALAEGEIAALDIISKLADEKNIN
CGKIDENVENFLNEQKNQIINQYEKIRNTEAKRFSTEDMEEGMQKIMDEYAGGISTNYQF
NEKQLNLAKQKIDQLIELSDELSAENMHDLMFAYELKERLIVCKSLIEHLFFRKETRWHS
FNENLDYPETDENYFKYVNSRLVNGELEVFTREIVKEEKYEHSN
>SEQF2502_01986 Sulfate/thiosulfate import ATP-binding protein CysA
MYVELKNINKMYNSYKASDNINLGIRKGKLVALLGPSGSGKSTILRMIAGLETPDSGEII
IDGKVVNDVSPSKRGIGFVFQNYALFRYMTVFDNIAFGLKIVKEKKSVIKERVEKLMELV
NIKGLGKRYPNQLSGGQRQRVAFARALAPHPELLLLDEPFAAIDAKVRQELRNWLRETID
KVGITSIFVTHDQEEAIEVADEIIVTNKGRIEQIGSPKEIYSNPKTAFVAKFMGNPIELE
NINRFKGFENLKNGQKAIIRPENVSIIKANEKFRYSASTESGIVKYTLFRGKEVEIGVQI
NGILIKGNRKIEEDAVSVGEEVNIYIYRAYAFGKNEEVEIVENENTRNQNDVVI
>SEQF2502_01987 Sulfite reductase [NADPH] hemoprotein beta-component
MKLDNFEKIENYEAEREKKELDFIINLTREALTDPEKEKEWNAVRTSFALYTEGRKKGTY
MIRPRFFESKIDIEDFEYLLDTVQKYSDKRLHLTTRQDFQLHGIKKKNLPDILETISKRD
FFTKATCGDSTRAVITPETTGFEEEVFDVSPYAKITTDYILDGRTFMHLPRKYKIAFSNK
EENSLYVKINDIGFQAVIQNGKKGFRVYVGGGIGPISTNAIVLREFIEEDEFLYYVHAIR
SVFNDHGNRKIRARARLRYVLLNLGEEKFLELCNEYISNFYAEKGDSLKIYTRKLLDERE
ILDKEKKLKKIELFSSEENTDESIKNDEFVKSDRNIVAGKYKGEYGYYLRPARGNIYKED
GEKLIKFVKSLNYKVELKLTSFQSILVKGLKKEDVLKLKEIMEEYYGGNEFFNSYSCIGS
TTCNVGILDTPPILDYIFKYFENEEKRELTNYLPQIKIAGCPNSCATPQIAKLGFSGRRK
KDGEYFAIFARGEFTGKTVKLNEIVGEIKASKIPYFLEDIANIIKEENIEFEEFVHEERF
IELIEKYKEFELEVVDFNDFRKADMERAW
>SEQF2502_01988 Arginine--tRNA ligase
MRYPKINVNFERKEKNFKIMELLTIKLKKLFSENINNIFGADYAEKIDIQNSTKKEFGDF
QTNFAMVSSKLIEKNPREIASTLVENFSENDIIQKLEIAGPGFINIYLKNGFLNEEIKKV
ENEKYDFSFLNTDKTVIIDYSSPNIAKRMHIGHLRSTIIGDSIKRILQFLGFHTLADNHI
GDWGTQFGKLIVAYKNWLDKKAYEKDPIGELEKIYVKFSDEAKINPALEDEAREELKKLQ
LGDENNQKLWKEFIDISLKEYNKVYDRLNVNFDYYFGESFYNDMMPSVLEELKQKGIAKE
DQGALVVFFENNRLPPAIVQKKDGSFLYTTSDLATMKFRKDELKVDEAVYLTDDRQQNHF
KQVFEIGRMLGEPYNYKKTHIVFGIMRLGNGIIFSSRSGNTIRLVDLLDEAKAQVKKVID
EKNPDIPEDEKDKIAEIVGSGAIKYFDLSQNRTSDITFTWDKVLSFEGNTGPYLQYTYVR
IMSIFRKLKEENIEVKNNDIISDDMNGIERELAVELLRFPQAVVKSYENYRPNIIADYLF
DTAKLFNNFYNSSSILKEEDKKVMDARILLARKTAFVLKEGLSLLGINTVNRM
>SEQF2502_01989 hypothetical protein
MSKQHEFIYDYRDDHNEENNKKLARNAIILLVISILLFLFSHFVLIKQGEKFKQEIPALK
ENKQKLEKEVEVLNGNIKHGEDSYKKVEALINKYK
>SEQF2502_01990 Bifunctional xylanase/deacetylase
MKKTFSVIGIIVAIIGFIYSGVHIFGTTAKFIEHHSLESSIKKLTHEKNTKTADLAAVTK
KNDDVKAQYQKLKADKKIKTVYLTFDDGPSGHTDQILEILKRNNIKATFFVIGIGKNFKD
YKKITDQGHSIGLHSFTHEYKKVYANEDSFFKEFYQIHDAIKSTTGQDVKIIRFPGGSSN
TIASKALKTAIINRLTREGFVYFDWNCDSTDASGNNVPVAKLVKYGVCTTHPDINVLMHD
TNAKKTTVQALQQIIDGYKKAGYTFETLNVNSPRIQHVKQPEIK
>SEQF2502_01991 Endolytic peptidoglycan transglycosylase RlpA
MRKIITMFAGLMVSLSLVSETKTDGTNIIYIKKEMMKAADDVDNVTDLTVSKKDETSEAA
KSKTSKHSQKGIASYYGKKLHGSRTASGERHNSNEMVAAHRSLPFGTKVKVTNLSNGKEV
IVKINDRGPFAKGRVIDLSYGAFSKIESPGKGLTNVKLEVLNNLY
>SEQF2502_01992 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MLNGKIALITGGSRGIGKEIALKFAENGATVISGDLIDPDYSHENVSHIKLNVTDRENIK
EAAKEIKEKYGRLDILVNNAGITRDALLQRMKEADWDLVIDINLKGVYNVMQGFVSLLLK
SKASSVINMASVVGIDGNAGQTNYAATKGGVIAMAKTWAKEFGRKNLRANAIAPGFIETN
MTHALPEKIVENVLANTPLRKMGDAEDVANAALYLASDMSKFVTGQVLRVDGGLNL
>SEQF2502_01993 hypothetical protein
MSKNQKFYAYFIIDTNETGILENWTDCQKKVSGKKARYKSFKSLLEAQNWLNSGANYEKK
EKKNLTELYSELERDAIYFDAGTGRGNGVEVRLTDFEGNSLLHKIMDKKIINEFGNYYVA
DTRTNNFGELVGIYTALVYAKKYDTKIICGDSSIVIEYWTKGRYNSSNLENDTVELIKKT
TLMRNEFEKKGGIVKKISGDINPADLGFHK
>SEQF2502_01994 hypothetical protein
MKKLLLLMMMLVMSVIGTAAKKTLNRSFEGQYVRSTNTFTYVKDNLIFPNKTINYTVKDD
SGLLDQIYNFIGSKYGVTDTDIIVLDVNGVVSNKNKTITIKKVTNYQIPEDRLHPSAFGL
PSSSTTNTNTETNENTTGVSNDETKAPNTPNLNNTGSFFNQEN
>SEQF2502_01995 Alkyl hydroperoxide reductase subunit F
MALLDSNIVEQLKGYFDKINANIELVAFLDDSEKSKELDSFLKEVDAISEKVNYVKKSFE
NDKADLDKANITRPTSFTILKDGENTGINFSGIPGGHEFNSFILAVLGLAGLGKKLEGDQ
LSKVESVDKPLNVETFVSLSCTHCPDVIQALNLISTYNKNITVTMVDSAVFFEEAKEKDI
QAVPVVFINGEQKSVGAKTIEELINLIANA
>SEQF2502_01996 Alkyl hydroperoxide reductase subunit C
MSLIGKKIENFTAQAYQNEEFREVSFEKDFLGKWNVVVFYPADFTFVCPTELEDLEDHRE
ELEKLGFNVYSVSTDTHFTHKAWHDHSEAIGKVKFTMIGDPTKAISREFEVLNEESGLAY
RGTFIINPEGKIVAYEVNDEGIGRDASELVRRAKAAKFVADNPGLVCPAKWKEGEATLKP
GLDLVGKI
>SEQF2502_01997 hypothetical protein
MNKKTIFKLIKEYFLIGIGTLFLAMGLQFFFFPNKIASGGVTGLALVINSLFGFPTGLFV
AISNLILFALAFIVISGHFGFKSIYATVLLSFFLSVFEKYYPNYTITKDIFLATVFGSAI
CALGITIIYLYEASTGGTSIIARIINKYCHIGYGMSSFIVDAIVTLLAIFAFGVELGLVG
LLSVYVTGFITDKFIEGFNSRKQIMVITSNKDLVLNYILKDFDRGCTILKGIGGYSGTEK
DVLLTIIERRQFIQLRKFLKAHDPTAFVTVTDTTKVFGEGFDQLH
>SEQF2502_01998 Protease 4
MKFWDFFKKFLIFTAKEIYSFFLKLSLSIFIIFIIGMSIIAVVNSKNKNENVKKSYEYIL
FNVSDVVEDKVIGSDFLSDRENLSYMDVLNSLDDIKKNNQVKGVIIALDTVNLSSAKVEE
LSKKFEELKANNKKIYAFGAYITNANYKLASIANEVVMIPSASASLDLTGYHYSDMYYKG
LFDKLGVNMEVVRIGNYKSYGENYTGNEMTPELRSELTRILENRYGKFIEDISKNRKIDK
NTLNNDIVNGTDTNLTPFAARDKNLVDKLEQFSDFTKRLNIREDNVADITDYYEKRVKDE
KVGNPRNGTIAVIYAEGSIMYDPNGVTEGVITPDNILEKVEKAMQTKNLRGIVLRVNSGG
GSALASEVIYQELTKLNIPIYVSMSDTTASGGYYISMAGNKVFANNATITGSIGVVSMIP
KFYNAQEKFGVHSNSISKGKYSDINDSFAPLSQESRDKITQSMQETYSEFKSRVSKSRKI
DENILENYAQGKIWLGDEAKNIKLVDGIASLDEVIKIMARDLGLRNNYAVENIYLEEDFT
KKIKALTKMIAERFSLSAQLQKNIPQAKNVFNEYDFAMQNQNKPLYYLTYKLNLY
>SEQF2502_01999 hypothetical protein
MNDRIVITVIGADKTGIVANVSTKLSELNLNIIDITQKVFEDDIFAMIMLVEAPKNTDIK
GLQEEFKVFEDQIGVRVYLQHENIFKTMHRI
>SEQF2502_02000 hypothetical protein
MNLLPDEILETINMVEMQHLDVRTVTMGISLLDCIEADAQKTAENIYNKITENGKDLVRI
ADEVASKYNMPIINKRVSVTPISIIGNATDAQDYTIFAKVLDKAAKEIGIDFIGGFSALV
DKGFTKGDINLINSIPKALSETDRVCSSVNVGSTKSGINLDAVKMMGKTVKELAELSKDN
DGLAAAKFVVFTNAVSDNPFMAGAFHGVENPDVVLNVGISGPGVVRHTLANISKTATIDE
ITEAIKKVSFKITRMGELIGKEVAQRLGVEFGIIDLSLAPTPAVGDSVGNVLEEFGLESV
GAYGTTLALAILNDAVKKGGAMAATRVGGLTGAFIPVSEDQGMIEATSKGYLTLEKLEAM
TCVCSVGLDMIAIPGDTSEAVISGIIADEMAIGMVNSKTTAVRVIPVPGKKAGDRVVFGG
LLGEANIININNLDCSILINRGGKVAPPIQALKN
>SEQF2502_02001 Cobalt-factor III methyltransferase
MNKNGKIYVVGIGPGKKADMTFKAYKAMKNSDIIVGYKTYTDLVKEYFPNIEIKSSSMMK
EVDRCIEVLKLAKDGKNVALISSGDAGVYGMAGIMYEVINENDDIEVEIIAGVTATNAAA
AIVGAPIMHDYVTISLSNLLTDWKLIKKRLELAAQGDFIVSLYNPKSKGRTTQIAEAQQI
MLKYKSKNTPVAIVRNAGRENEEYEITTLENMLNFEINMLTIVLIGNSNTYIKKGKMITP
RGYEKKYDY
>SEQF2502_02002 Aldehyde-alcohol dehydrogenase
MAIVKDLESLKDLIQRVRKAQEEFATFDQERVDKIFRKVAQKMNDERITLANLAVAETGM
GIVEDKVIKNHFASEYIYNKYKDEKTCGVLEDDRSYGVKKIATPIGIIAGIVPTTNPTST
AMFKTLISLKTRNAIIFSPHPRAKQATIETARIALETAVKYGAPKDIIGWIDEPSVELSR
ELMANADLILATGGPGMVKAAYSSGTPAIGVGAGNTPVVIDKSADIKMTANYILMSKTFD
NGVICATEQSVIIDKEIYDKVRNEFLNRGAYILNEEELDKVREVLFKNGSLNADIVGKSA
YIIASMAGFEIPKNSKVLIGEVTSTGIEEPFAHEKLSPVLAMYKAEDFEDGLKKADELVR
LGGLGHTSSLYINLAEKEKIDKFGRLMKTGRTLINMPASLGAIGDVFNFKLEPSLTLGCG
SWGGNSVSENVGVKHLLNVKTIAERRENMLWFRVPEKVYFKYGSLPTALEELKGKHKKAF
IVTDKVLAELGYTEHITKVLDNLNIDYRIFSEVKEDPTLSSAQAGAKAMLEYNPDVIIAL
GGGSAMDAAKIMWVLYEHPKLRFRDLAMRFMDIRKRIVEFPEMGKKAKFIAVATSAGTGS
EVTPFSVITDDETGIKYPLADYALTPNVAINDPELMLTMPKGLTVASGIDVFTHALESYV
SVMATEYTKPYSKEAARLVFKYLPESVELGAKAIKAKEKMANASCLAGMAFANAFLGINH
SLAHKLGGKFHIPHGIANAIILEEVIRYNSAEAPTKMGLFPQYRYPDAMQRYAEMGEHLG
FGGNTKEEKVENLIKGINELNKKIGIPATIKEWGIPERDFLEAVDEMSLEAFDDQCTSAN
PRYPLMEELREIYLKSYYGKEWENEKERVGKILGF
>SEQF2502_02003 Phosphoenolpyruvate carboxylase
MDLKNLPITPLPSVKLDKHQEDLLLHNELFSNLLGETIFRYAGLHIYEVTEKLKEASSKY
YKTQKQEARKNLSSFCSDLTDVEILRVIRSFSIFSALANIAEDVYQTHEQRYAKISNKLQ
IGSLEKSLKNLKNKGISQEKILKAMEKVSIVPVLTAHPTQVQRKSILDLTKKLTDILDKY
ENVKLHQIDENEWLNDLSRGIQIWWQTAMLRATKLRVTDEISNALSYYNITFFNEIPRLM
NKFQEISKTLGNSELKSQALLPLTMGMWIGGDRDGNPYVTVNTLEKSAQEQAIKLFQHYL
DVVREIYRDLSMSIAMTNVTEELQKLADASGEVSPHRTHEPYRRALTAIRDRLLATAYNL
CEYNRDLLPPKRKNGVDIPYKSASEFTKDLVIVAESLKKNNSEFLTQGKLNNLISATKIF
GFHLATIDLRQDSSVHEVCVAELLKSANILGDYLSLSEDARCEILLRELEYDPRILSDPT
IPQSETLASELAIYRKAKSLRDRFGDKIIEKNLISHATSVSDMLEIAILLKEANLAKGNE
GNEFCDLQIVPLFETVEDLVAAPDILRKWFNLPLVKKWMDKKGRKQEVMLGYSDSNKDGG
YLSSSWSLYKAQKELTAIGREFDVEISFFHGRGGTVGRGGGPSYEAILAQPEGSTDGTIR
LTEQGEVIGAKYGNPDLGLKNLEALVSAALESSALTVEDANWEEYEKIIEDVSELSYHAY
RDLVYNTDGFSDFFFEVTPINFIAGLNIGSRPSSRKKTQSLESLRAIPWVFSWSQARIML
PGWYGVGTAFTKWINNNDKNLEILQKMYKEWPFFRSTISNVDMVLSKSDLSIFSEYVKLA
SDQETAQKIFKEIAKEWILTIDVLKKITGNDVLLADNPELVSSLRNRLPYFDSMNYLQIE
LIKRSRAGDNSEELKKAIHISINGLATGLRNSG
>SEQF2502_02004 Endonuclease MutS2
MEKNYDVLEFYKIVNELIDLSRLEKTKEKFLDIDIIKEKSVLDKELMLMMEMIDFYKYDD
GLELAGLADITKMMNSIDIIGSYLSAEDLAVLKKNLTIFRISKSRAKNVRDKYRAIWNLF
SDVEEVKDIENFISEAINDEGVLKDDASIGLRDVRRQKQNINANIKEKFDELISNKNTQN
AIQERIVTQRNDRYVIAVKTDFKGLVKGIEHDRSATGSTVYIEPLNVVSLNNKLREYEAR
EREEIRKILLRITEIVKTKKEEILEIKEILERLDFIDAKTTYSVNKKCIVPKIINKEYLK
LVEARHPLIDENIVVPINFELGNPENIMLITGPNTGGKTVTLKVAGLLTIMALSGIPIPA
NEKTEIGYFHNVLADIGDEQSLEQNLSSFSGHVSKIKDIIENANSKSLVLMDELGSGTDP
MEGAAFAMAIIDYLNKKHVTSIITTHYSEVKAYAFNTTGIKSASMEFNVETLSPTYRLLE
GIPGESNALIIARKYGISEEIIENAKSYISEDNQRVEEMLKSIKEKNDELETMQAQLEAT
RTELDKQKSIYEQNMIKLENEKNEIIKRAYEEADNYLKNMQAKAKNLIDKINSEESKKED
AKNAQRSLNMLRESFITDKKKNVKEKKIVTQNVDFAVGEEVLVKTMNQNGKILKIMPNNR
IQVQTGILKLVVSTDDIVKIQKKKTNKFKNFASLKRTSQVRGEIDLRGMNADEAIAELET
YMDRAMLTGYHEICIIHGKGTMVLRKKIHEYLRTSKYVTEFKDANQNEGGIGCTVVTLK
>SEQF2502_02005 DNA replication and repair protein RecF
MKIKNLHIKEFKGLRDISINFEKNDEPLDLVVLAGSNGSGKTRILESILDYFNIILVVPE
EAQNKIELFFESMEEKCIDKLGHELSFMYCLKFGSKEKKISVGSVGARYLDIKKELNILP
KIIYAPAEMNFKKMDMASTTLIQEYNFINIVNTNLVKDIPSYIATKIISAIFKNKNEKVG
DVQKKVFDEINEIFEILDIDVKIEDISQDGRNIPIFTNSAGDKFDINELSSGEKQLFLRT
LAIKMLNPENSIILIDEPELSLHPKWQQRIVDVYRKIGKNNQIIIATHSPHILGSVRKEN
IMLLDKNDEGKIVIKTGDEFYDSYGQPTERILEDIMGLKTTRNQEIFDKLEKIREMVNED
KYETDDFKKEYGDLKEILGTMDEDIMLINAEIQIRRKGLKNVKNK
>SEQF2502_02006 hypothetical protein
MLKINKTSEPNFLKEFKKKEKPKNWKDFDFEIKKELKNYMLENEQKIGNNSYCPYCERKI
IASKNSQIEHIKPKDRFPELFLDYKNFITGCLNIESCGSKKSNKWSDLFINPVIDNPEKY
FSYNRMTGEIIPRKDISEKELEKVEYTIKILNLNGDKRLLKGRKSVIKIIENYQKTYDDE
ILREISEDFDFPTLRNFLVESFK
>SEQF2502_02007 hypothetical protein
MGKITIIFLLFGILLFSENYPKEKIIRIIEKNEKYECVPDKKVRKIGWELNGQSFIGHLD
ENGERYGEFREIDDDTLRECYLEDGYINYYKNRYFYKENKKISLIVSYGEKKDNIQLILK
NVKGIRRAYFFERKGKKYKRKNLIMTFDPAIIFYPSDLIKEKSE
>SEQF2502_02008 Cysteine--tRNA ligase
MKLYNTMTNKIEEFKTIEENKVKMYVCGPTVYNYIHLGNARPIVVFDMLARYFKYKGMEV
DYVQNFTDVDDKIINKSIEEGISASEVSEKYIKCFFEDINRLNILDSVKRPKVTENMEKI
IEIIQKLIDNGFAYEKDGDVYFEVKKYKDYGKLSNQKIEELELGARIDVSEIKKNPMDFA
LWKKKKDGEPFWVSPWGEGRPGWHIECSAMAKKYLGDTFDIHGGGQDLVFPHHENEIAQS
KCAYHGNFANYWLHNGFIQINGDKMSKSLGNFFLLREILEKFSGNVVRLFILSTHYRKPI
NFSFENMEDTKKALQNIVKSMNKFEGIVEKYKNEKTADIKNLDFSQKIDEFDKKFEDAMD
EDMNTPQALATIFDQIRETNKFISVNKDELSTIYAEIEKSYESLKRKIGNVFGIEIEMEN
SAKEEDGENMELTKKLIELLIKLRSEARSEKNFKLSDEIRDELKVLGIEIKDNRDGTTDY
DFM
>SEQF2502_02009 Coenzyme A biosynthesis bifunctional protein CoaBC
MKNILIGVTGGIAAYKSAGIVSLLKKKGYNAKVVMTENATKIIGPLTLETLSRNRIYVDM
WDSNPHYEVEHISLADWADIVLIAPATYNIIGKVANGIADDMLTTILAAVSVRKPVFFAL
AMNVNMYENPILKENINKLSSFGYRFIDAEEGLLACNYSAKGRMSEPEDIVDEIERYSIF
SKIENFDTVLKGKKILITSGRTKENIDPIRYLSNNSSGKMGYSLAQAAVDLGAEVTLISG
PTDLKIPNGLENFISVESTLEMYEKVDEYFKNTDIFIACAAVADYRPKEYKKEKIKKSDS
DLVMELVRNPDILLEMSKKKEKQLLVGFAAETNEIRENALKKLEKKNLDIIVANNASVMG
SDENVIEIIKKDRTSVEISQKSKIELAYDILNEVIFELKKR
>SEQF2502_02010 hypothetical protein
MKSEKQKIKKVYMLYHRDEKDDDKLIGFFSTKEKALEIVGKWKEMKGFRDFPEGFKIRTM
IIGKDYYTKGFKSKSLK
>SEQF2502_02011 hypothetical protein
MEIWILSHGYDYGDVYDKYKWNDEARFLGAYYTKEEGLKALEKYKKIKGFCSHLDGFWLE
KCRLDKYAGWEGGYVTYYKEDEVKIDNSKNQKLYVLSHFYYTGKDKIKEKHRILSVCLSK
LEARKKIKEYQKIEGFSSHISNFYIEEYILDEEKNK
>SEQF2502_02012 Glycyl-glycine endopeptidase ALE-1
MDNEKKNINKVLNEKKENLEKRNSKSRKKTGIILGITALLILGIIILGMIFGRKNINFRN
IATEDEDDKIFRINPVKNPQVTYYNFRGEVYPDWAKFGLTRSNGARGHQGIDIFALPGTD
VYAVLDGKIVDMYVDKTGYGLNFYLEVDPKELEKIKRKNYKPKESAREWAYSPNYDPNTM
QIKYIRYCHLSEVNVKIGDTVKAGQVIAKTGTTGNASGTHAPHLHFEIAFEMRGKGLTNR
VDPEMYFKIKNGNQMSKHEIKIQTEAARTEWFEPKGYDIGFRNKSIFLEKKDDLHKKEKI
INNTKNTKNFKKANLKKVGKK
>SEQF2502_02013 Chorismate synthase
MAANFGKNYKISIFGESHGNALGVNIDGIPAGTELDLEFISQEMRRRAPGRSKLTTPRVE
KDEFEILSGFFDGKTTGTPLAMIIRNSNQRSKDYSELKRKPRPGHADWSGFNRYNGFNDI
RGSGHFSGRITASLVFAGAIAKQILKEQGILIAAHIKSVKDIEDRDFVESDITEENINKL
RNMTLPVLNEEVVEKIEKAVEKTREEKNSLGGIVELMVTGLPAGIGDPYFESMESELSRM
IFSVPATKGIEFGAGFGITEMTGYEANDEMYFDENGEIKSFTNNNGGIIGGITTGMPISF
KVAIKPTASIEKAQKTVNLEIKKNDILEVHGRHDPIIVPRAVPVLEAATAIVILDRVLEA
KKRSL
>SEQF2502_02014 hypothetical protein
MKLNCKKKLYFEMMVLFLAGMAFSTISVAKTMNKSKISKSILADNAIVNVKSYGFVDLEG
AKTSAIIVEYNQNIKADSVDKSDYEIIDYAIYSEKKDGFEKTVEIDRDGTKGNEGQITRV
YVNNKPEISKNGGTKEGKYVVIEVNTAYMLMGQNLSYTSTMMAGVKQIGEITGKNEKIDA
GTKEISNYTLSEEKQTRQSEETVTKTVITTDKNKIILPEFDKSSGWKIHYIENGGFKVTK
AYSEYTGKYENFELPYAIYVPNKEILEKNKGNISVVLHMEHAGANDTDPMASLTSSKAAA
KMASKELQEKHPAIIIVPQVEENRRSTNDVVSSSEENPAIWELLDSVLKEYKGYINESRI
YGTGQSMGGMLLLDMAAQRDNFFAGVAILGSQWSNNYNKEFQNNGTPARSPENDPISFNG
FGLDKKNYQNWYYMISDDNVLVHTAADDLMATSLWKTIQEYFKAAGVEIAHDEWDPYLSV
EEQNKIDRKMTTRDNTKPGTGINWGEFSKGSHMSTWKYGYQIDYPFEWLFEQRRETAQAR
GKVEQLKNKWLGRDKDGKIKKGSGTAGLNTAQYTPNGKSDIYTEDWKPYIIVSKLISDIP
NAEKIVLNKRTGEKYTKKSYLEMIRKLYNLLSKEEKTKVKNYKDLVKAEK
>SEQF2502_02015 3-phosphoshikimate 1-carboxyvinyltransferase
MKIAIKPSILNGTIEIPPSKSYSHRAVIAAALAEGGKKSKIDNLKFSVDITTTTDIMENW
GAKINREESSLEIIGNGGKVVPKDKYVQCNESGSTIRFLIPIGITDENELIFDGKGKLVD
RPLDSYYKIFDKQGIFYKNENGKLPLTVNGKLKAGNYEIDGNISSQFITGLLYALPLLDG
DSKLTINKNLESKGYIDLTLEILELAGIEIVNNDYKSFDIRGNQIYRPFDYTVEGDYSQV
AFWIVAGIISANRDNEMKCLHVNKNSLQGDREIIEIVTRMGANLEIFEDYVIVKPSKTKG
TVIDISQCPDIAPILTVLAALSEGETRIINGERLRIKESDRITSIKTELNKLGANVAEEG
DSLIIQGVEGFAGGVTVSAWNDHRIAMSLAVASSRCEKEIILEEAESVRKSYPHFWDDFV
KMGGEIEIIEK
>SEQF2502_02016 Putative ATP-dependent DNA helicase YjcD
MVERRLEIEDEVKEMLQYIENKQNFILTGGAGSGKTYSLISLIQEIGRMYPNKSIVCITY
TNNAVAEIKSRISNDKLFVSTIHEFLWKIIKKYQKELKETIIELIYSEEEKYKKFTLPKD
NLEKNKMKINLEYFLNSEIVYDEYYSLKSEEDSKIGHDEVLLIAEKMFEKYSKLCDILKD
NANFIFIDEYQDTSEEVANIFLNHINNSKKENIIGFFGDSMQSIYDSGIGNIKDDSLKRI
NKIQNRRSSLKVIELTNKLRDDGIKQIPSKNTKETNIDEKTGKIKEGNVKFIYSNNNILE
ELKKTYIFNDWDFKNTLNTKELRLTHKLNAENSGFKELYNLYTNDFIYSKLISKLKEKKI
SEDEDINNFGYIIEKFPIFSGKGKIKKNILEQVDMKSKKEIEKIKDIEWGKIKNSFINKD
SLLGYKFNGLTEKYESTSNRDKILQKLDLIYESINLYNENKYVELFKKLKIKISSYEDKI
KIRKEMNELIELMKSQNDKIYQIIDKANNILNIKNDERYIEFIENKGWYLWNRIKDISFS
EYVKSIEYQKEYFPYSTQHSVKGSEFDNVLVILDNGKWSKYNFNLLLENIFDENNILDKT
KKDIFNRTKKLFYVCCTRAKENLIVFIQINNQKINKEKIISNAKELFGEENVINGDELIN
NI
>SEQF2502_02017 DNA replication and repair protein RecF
MKLKKIEVKNYRILKDFKLDLKDNTTLIIGKNNTGKTSVLTIMDKLLNQGKKNFKWDDFN
IEFQNKIYEKITTRDFQVLEENRKINEYGIRLTLFIEYTKEDFYGNIQDFMMDLDEDNNY
IIIEFNYNCKEDNLRELLIEFNKKNKRDKNNFTKFMRKNSEKYFNLEMYALKYNKSTNSY
LENEILEISNLNQIKRVISFNGIKANREVSNKENENSLSKLSEKYFDISKTKNDKEFDDL
RQAIEDTDKKLNILYNGRSQSQVGVFSGITRKIREFSGNRNEINININSQIQEKELFKSS
SRLYFNYNKMKLPENHNGLGYLNLIGMIFEIENIVNDFTNNVSDINILYIEEPEAHTHPQ
LQYIFIRNIKKLIDSYRESSIKLQTLITTHSSHIVSECNFNDIRYFVKNNEGVESKNIEI
LKENYKNDEKAYKFLKQYLTLNSAELFFSEKVIFIEGTTERILLPYMMKKIDLEDKTKKF
LPLLSQNISVIEVGNYTQKFKNFIEFLNIKVLIITDIDAAKENKKCNPVEATESTNSSIK
VYLEEKLKFKKGQNEFKKILTLTKKEKIVKCGDSEIMIVYQVKEKNYQARSFEDAFISIN
YDFIKENKGEFSEGLKNKKKLNEEKIDFYNLAQECIDKKSSFAIEILLCSDENYSNWKIP
KYIKEGLEWLKED
>SEQF2502_02018 3-dehydroquinate synthase
MEILNVGLGKNSYDILIGENFFEKFPEYIGNVYGGKKLFVITDSNVDKIYKNEYEKMFKG
FDYTIYVLEAGEKNKHIGIMPAIYSGMVKAGLTRKDMVVAFGGGVVGDIAGFAAASYMRG
IGFIQIPTTIVSQVDSSVGGKVGVDLPEGKNLVGAFHQPKLVLIDNYFLNTLTDRYFYDG
FAEIVKYGCIYDKKFFDRLVEIVGTVDGSYDDENYKQKLREHLMKYVNELVYRSCEIKKE
VVEKDEKESNLRMILNFGHTIGHAIEQFTNYEKYSHGEAISAGMVDITKIGEKKGFTKKD
EFLKIEKLLKALNLPTEIEYPKDKISEIMKRDKKSTSDGINFVILKEIGEVKIMKIGEKE
IFE
>SEQF2502_02019 hypothetical protein
MAEVIKDELLGEIECVDGFETEVNWVNNKKIDVYFDISDYQLLNEKDEEKTDKEKMEDRI
KTLKEILSDVNGWNEKIIKNSAEVMLELANDWFDVEDYYEDDEIDEFVEDMKQVLSEESA
EKLRDSEITQETMEKIMSVERLTIYGDGNFSIYLSDNDMIFSGHIINVLANINGEFSEGD
IMG
>SEQF2502_02020 Acetyltransferase
MENNSEKKKYLKTLVGDNIYFSPISLDDIEEYTEMVNDIKVSVGLGSVSYTNITDFESEK
EFLTSIKKEKMFAVRLLENDELLGNIGFNSLDMVNRNGVLGVLIGNPKHQRKGYGTEALK
LILDYGFSFLNLRNISLNVFEYNEPAYNLYKNIGFKEVGRLRKAVEIMGKTYDVIIMDML
KEEFQSVYIKRELEKRYNL
>SEQF2502_02021 Prephenate dehydrogenase
MMKNNLKRIEDLTVTIVGLGVIGAAFAQSFKEIGIKTVYGIDIDEETIKKAEEKNMINKG
FLETREPLETSDFVVITLYPNLMKSFFVNNINYFKENAIITDVVGIKEKIIGDIDPIIEE
SNKKNGKNIDFIFGHPMAGREKRGIDFADNRVFKDANYIIIKDEKNKKENLELLSEIVKL
MGFKKVSFLTAQEHDEIIAFTSQLTHAIAVSLVNSDSEKYDTNRFIGDSYRDLTRIAKIN
EDLWAELFMGNKKNLLKMIQQFEKELDVIKDALNNNDLGTLKEKFIISTKRREKID
>SEQF2502_02022 Phospho-2-dehydro-3-deoxyheptonate aldolase
MMIIKVDGGIDEKILEKMINRLETENNVSVKLIAGKDYSILGLVGDISTIDIKHIQSLDY
VLDVQRVQEPYKRASRKFKPEDTIVKVGDVEIGGSNLVMMAGPCSVENEKQIIDTAKAVK
AAGATILRGGVVKPRTSPYAFQGLGMEGIKLMEKAKEETGLPIICEIMSISQLHEFGPHV
DMIQLGARNMQNFDLLKEVGKTNIPVLLKRGLSATIEEWLMSAEYILAGGNENVVLCERG
IRTYETAYRNVLDLNAVPMIKKLTHLPIIVDSAHATGKYWMVKPLAMAGVAAGADGLMVE
VHPEPDKALSDGPQSLKFNVFEDLMQDVEKIANVLGKTFKVK
>SEQF2502_02023 hypothetical protein
MVITTTNEVQDKKVVEYKGIVFGEVISGVNMFKDLGANLRNIFGGRSKGYENELLAARTN
ALEEMESRAAAMGANAVIGVKMDYEVLGADNGMLMVTCSGTAVIVD
>SEQF2502_02024 hypothetical protein
MVKKLIFLLLAVIGIIGCSASKKYYHNHDNGRYYNCEGGYCENRSYHHRYHYYSNDNMPC
GRHHYMGN
>SEQF2502_02025 50S ribosomal protein L31 type B
MKKDLHPSYGFVVFEDTSNGEKFLGKSTKTSKETTTFEGKEYPVIKVATSSTSHPFYTGK
SKFVDETGRVDKFKKKYNL
>SEQF2502_02026 hypothetical protein
MEKQKYILNNTYGINGIEKISLKEVMKIFSVPEEVEMKLSDDKITISIDLIYKGLKIYYS
LYFFVENLKKPDNQSLTFCMEKLYLNNWESIKVGDEIKTVLPKIRKYLKRNNKNIKFDYE
EDRFFGEYLFDDGNIHIFFEKFGNKKVMDDIMISLPYEDILPENKEILVEISKIMEIKNK
IDELFWDE
>SEQF2502_02027 Putative TrmH family tRNA/rRNA methyltransferase
MEKIIGINPVIEVLKSDKNIEKLEVYKKIKKETIKEILNLASKRNIKIFYTDRRTENSQG
VVALVSEFDYYVDFAEFLEKLLRKEKSIVVVLDQIQDPRNFGAIIRSAECFGVDGIIIQD
RNSVKVTETVVKSSTGAIEHVDIVKVTNISDTIDKLKKYGYTVYGAEADGQNYYYEENYP
EKTCLVLGSEGNGMRKKVKEHCDKIVKIHLKGQINSLNVSVAGGIILSEMSK
>SEQF2502_02028 Arabinose 5-phosphate isomerase KdsD
MEIDIIKEARNVFDIEIAELEKLKSKLGDTFQKLVQMILELKNNNKVIITGIGKSGIIGK
KIAATLASTGTTAVFINAAEALHGDLGMVSNGDVVIAISNSGNSDEVLSILAPIRKIGGK
IVAFTGNPNSTLGKYAELTVNVGVEKEACPLGQAPMSSTTATLVTGDALAACLMKLKDFT
ENDFAKYHPGGSLGKRLLLHVSDLMHIGDELPVVKKDEKIENVLMVLTKKKLGAVCISDT
GLENGKLLGIITEGDIRRALKHKDKFFDYVASDIMISAPVTIEKNAMALDALHLMENRKS
QINVLPVVENGNIVGLIRIHDLIGLR
>SEQF2502_02029 Mannose-1-phosphate guanylyltransferase RfbM
MDKVALIMAGGSGTRFWPLSTNDKPKQFLDLVSEKTMIKETIDRIKEIIPVEKIFISTNI
KYFDIIKKELPEIADRNIIFEPMARDTAACIGYAACIIRKIYKNSIMAVLPSDHLIKKEK
EFLESLKFAFCEAQKNKIVTLGVKPTYAETGYGYIEYIDRKNKKNDCEKNGIKEKFESYK
VKKFREKPNKELAEKYIEQGNYLWNSGMFVWKTEFILSEIKKHMETHKVILENIEKILEN
VDLDQVFGETLSNFVKDEFEKFEKISIDFGVMEHTKSVSVIPVDIDWNDVGNFKSLEDIF
PRDKYRNVVQASHFEQIESEGNIVINKENDKIIATIGLENIVIVNTKDALLVCHKDKSQE
VKKILNKIELNKKN
>SEQF2502_02030 hypothetical protein
MYLTLKQQVKHLSKKEFKNLKYLCHIAKNLKNQAIYNVRQHYFKNKKYLSYNENYKILKN
SENYKKLNSNMAQQILKEVDESFKSFFALLKLAKNGQYNSKIKLPNYLDKDGFTTLVIGF
VRLKDDMLIVPYSNSFKKTHQEVKIKLPPVLKNKKIKEIRIIPKQHSRYFEIQYIYKVEE
VQRELNKENVLGIDLGIDNLCTCVTNAGASFIIDGRKLKSINQYYNKTNAKLQSIKDKQK
IEHTTLRQKRIARKRNNRINDYLSKAARIIINYCLNNDIGKLVLGYNENFQRNSNIGSIN
NQNFVNIPYGKLRDKLIYLCKLYGIEFKLQEESYTSKASFFDGDEIPIYDKENPQEYIFS
GKXIKRGLYQTSKGYQLNADCNGALNILKKSKVVDLSVLYNRGDLNTPKRIRVV
>SEQF2502_02031 Holliday junction ATP-dependent DNA helicase RuvB
MNEERILEPKELGEDNIQKSLRPRTFKEYIGQQDLKEKMNIFIK
>SEQF2502_02032 hypothetical protein
MENLLIQLAIMVFVGILIGWFTNYLAIKLLFRPYKEVNFLFFKIQGLIPKNRDKISENIA
DTIEKELISVKYITEKLKDSGVINDEVLDKLLDKIIGEKLKKSILEKNPLLKMFLNDSVI
EKIKAYFKKAILENKEEIVEEILKIAEDKIDFKEIMLEKMKNFSLEEMEKIILSVSKNEL
KHIEIIGGVLGGIIALFQFFIMLLLKQI
>SEQF2502_02033 Flavodoxin
MSTLNIIYYTGTGNTEEMAKYIGEGAENAGAAVKLINVEEANESAIDADFIAFGSPAVGA
EEIAPEMVEFFEGIKDKIIGKTVGLFGSYDWGQGGWMETWREEIINEGLSVVNDGLIIHL
AVDDDEKIEKCKEYGRAIVG
>SEQF2502_02034 Acetate kinase
MKVLVINCGSSSAKFELIDMTNEQSLAKGNCERIGIANPIFSYKNLITGEKISELETPME
NHTVAVELILKTLQDEKIGVIASTDEIDAIGHRIVHGGEYYEKSVLVDDEVIKNLEEIAP
LAPLHNPAHIMGIKVIQKLLPGKKNVVVFDTAFHQTMPAKAYMYPYPYEDYTELKVRKYG
FHGTSHRYVSGVAQEMLGKKDSKIIVCHLGNGASISAVQNGKVVDTSMGMTPLAGVMMGT
RTGDVDPASVIYVMRKRELSLDEMNDRMNKKSGILGMIGTSSDFRDLDTAKRAGDEKAIL
AYDMFCYRIQLYIGAYVAAMNGVDAIAFTGGIGENSVGAKKQICEGLSFFGVELDEEKNA
KRLPGNVELSTKNSKVKVYKIETAEELVIARDTYELTK
>SEQF2502_02035 Ethanolamine utilization protein EutD
MNTLTNELKERAKKLNKTIILPETEDERVLRATEKIINEGIAKIALVGNEKEIKERADKI
GVSLEGAIFYNPDSCATIDAMSELLKKRREKKGMTFETAKAILMSDPRYFAAMLVHQGRV
DGMVAGSSSPTAHVLRAAIHVIGPREGLKTVSSSFVMITNTPEFGDNGTFVYSDGGVIPD
PTAMQLADIAISAAEKARFTAGIKEPKVAFLSFSTKGSADGVSVSKVREAIEILKVRNVD
FDFDGELQLDAAIVPEVAAAKAPNSKVAGQANVLIFPDLDSGNIGYKLTQRLAKAKALGP
LIQGLARPVHDLSRGCSVEDIVEVVAITAVESEM
>SEQF2502_02036 Signal recognition particle receptor FtsY
MLKNFFKFGKKKKSEEEQKSKLENQLDKEIQESENEIEKIKKETENEIKKAADEILKKDN
KINKDSEFETKKNIGKNIEENSDSESKLSENNLEKSEKTKKKPKLKPLKDRLATPKKGFF
GKLKEMLLGKTIDDDLYEDLEELLIQSDIGMNMTMQLVGELEKSVSRKKLKTSEQIYDEL
KELLKAKLVYNDENNTKLKLHEGKLNILLIVGVNGVGKTTSIGKIAKKLKDSGKKVIIGA
GDTFRAAAIEQVEEWGRRTGVEVIKQAHGSDPAAVIFDTVKTAKNRGFDVAILDTAGRLH
NKRDLMKELEKINKIIREQSGETDFETLLVIDSTTGQNGLEQARIFNEIVDLTGIILTKF
DGTAKGGIIFPITEELKKPIKFIGVGEGIEDLREFDTKEFVEAMFD
>SEQF2502_02037 tRNA threonylcarbamoyladenosine biosynthesis protein TsaB
MLTFAMTTTTKLAGLSLYEKDKLLGEIHVEMAKTHSTTILEQIDSLLKWTGKKLGEIENV
IVSIGPGSFTGVRIAISVIKGIFFGKNVNFYEVNELDALGFQGYYNLKINLENEENVKIY
SLIDSRKEKVYCAAYEIFNGKAGNRLKLVKNYEVMKLDNVIEEIIENKQNGENNKKIYLI
GDAVFNYKVKILDKLGDFVRIFEDKNLAINTMTYVEMFLDENFKNDDVIGLKKTVIFNLK
PDYLEKSQAERDKK
>SEQF2502_02038 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MGKKIMTFEEIDKLAIALAEKLRSGGCLGLIGDLGAGKTTFTKKICECYNITENVKSPTF
TYVIEYTSGDLPVYHFDVYRISNPEEIYEIGFEDYIGEDGSVVIIEWADKILDEMPEYAV
FVEINHYSDDAREVSVYTFLNGEKVDFEIK
>SEQF2502_02039 Bifunctional protein HldE
MKKNFKDNLLTTEEMRKKIVKLQKAGKKIVFTNGVFDILHIGHLTYLEEAGNLGDILVVG
VNSDTSVKVNKGDKRPINSEKNRAYVLLGTKFVDYAVIFDEKTPEKLLDVLRPDVHVKGG
DYKKEDLPETKIVEENGGEVKILSFVDNISTTQIINKIIEAYKN
>SEQF2502_02040 Cell division protein FtsZ
MDGVGIKVIGIGTVGNDVLNKMMKKEIAEVGFVGIDTNQENLDKLNVESKILASENLSEK
VQSTLKNTGLVFILTEMSEKKNNEIACIVSEVAKTMGILTVVVVATSINSNGENDEIKKL
EEVSDTVIVLPLKKLVEADSSATFDKLFEKRDEIFIKNVEFITNLIKKQGVVNLDFDDVK
IMLGNSGEGITAFGKGEGQDKVKLATEQIINSPFIKNLPKARKMLLSITAGPDIGLTDLQ
EVSMIINEKFGADQTNILWGYIMDVELEDKIEMEMLITDFAE
>SEQF2502_02041 Endoribonuclease ToxN
MRLYEVDESYINYLKLFDNRVLNYSGENYTKTRKYIGVLLKVNNCDYLAPLSSPNKKSDY
TNGKIRKSNNFIIRITDKQRNILLGTIKISNMIPIFDKTVIKYYDIHKETDEGYKKLILK
ELRFIYANKEKIKKTAIKLYNQKIHNMSMDYIKHTIDFLLLEEKAKLYKK
>SEQF2502_02042 Cell division protein FtsZ
MKNTLNGVKVKIVALGKTGSNVINKMILNNIVRADFIVIDTEKLNLDSSKAPKKIFVSSI
TSFEAMEDLRKQTEKEFQNADMVFIIAEMGEKTGTLLSSAVAEIVKSMNILTVAIVSKPF
DFEDRNKIKLAKKGKERLKHFADTVIVIPYQRLNDLYVNLPIENIYEKGEKAFVTIVKGI
LDLIKKQGIVNLDFADIKSILQNSGKTVLGFGKAHGEDRAKKAVEQALNTPLLERSIKGA
GKILMNITSGNDIRLEEISQIATAVATSTENPDLFLAWGTVFEETKFENPEDFEQKGSCV
KVYLIATDFRN
>SEQF2502_02043 Peptide methionine sulfoxide reductase MsrA/MsrB
MKSRSLLLFLILSLALFSVVLSNKNKNRKNRNENKLKKENMIQAGNENIREIYLAGGCFW
GLEAYMERIDGVKDATVGYANGKTEKTSYNIVASTDHAETVHVKYDANKISLSKLLKYYF
QVVDPTSINQQGNDRGRQYRTGIYYTNPKDKEIILQEIEEEQKKYTDKIQVEVQPLKNYI
LAEEYHQDYLRKNPNGYCHIDITKADEVIIDPKDYPKPSDEELKKRLTPLQYSVTQKKNT
EHSFSNEYWDNHEAGIYVDITTGEPLFSSKDKYDSGCGWPSFTKPISKDVVTYANDTSFN
MVRTEVLSRSGKAHLGHVFDDGPKDKGGLRYCINSASIKFIPLKDMEKEHYGYLIKLVQ
>SEQF2502_02044 Thiol:disulfide interchange protein DsbD
MFNQPLLVGSVFLGGVASFLSPCILPIVPVYLGILSKGKKTVLNTFLFILGLSLTFVSIG
FSFSFLTGIFFNDTIKVLAGILVIILGLHQTSILKFNFLEKNKSVNLNLIGKNSSLQAFL
LGLTFSLGWTPCVGPILASVLTLAGEKGSAVYGGLMMFIYVLGLATPFVLFSFFSQELLK
KVRSLNQYTNYFKIFGGFLIIFMGILLIMNKF
>SEQF2502_02045 Peptide methionine sulfoxide reductase MsrA/MsrB
MKKLIVTIVTLLSFGSISFGNTLQGVQLKDINNKPVSLNKYKGKKIYIKMWASWCPICLS
GLSEINSLSADKSKNFTVITIASPGQKGEKPTAKFIQWYKGLNYKNTTVLLDEKGEVLKR
AKVLGYPSNIILDGNLNIVKTLPGHLTAAQIKGAVK
>SEQF2502_02046 putative response regulatory protein
MYSILIIDDEPIIRRGIKTFIDFEKYKISDVYEAEDGNSAFKTFSEVLPDLVLLDINIPF
KNGLTLAEEMKYLKSDVKIAIISGYDYFEYAQKALKIGVEDYILKPVSKTDINEIISKLI
YKLEEDKRYNEARKIINKISQSKKSNKNISHSKYKDILTKKIEEKYSDISFNLNSLADEM
NLSSGYLSSLFKNLFGIPFQDYLNNIRMEKAKLLLLTTDLKNYQIGELVGMENFNYFNSK
FKKTFGMTPKEFKKSVLEKI
>SEQF2502_02047 Sensor histidine kinase YehU
MKLKKTMRNSMLLQLFFYYLVGNLLFILFLSSIFYYTSKYIIMNKEIEYTNKNVMSTSRY
ITLYVEKLQNIINLLSVNADVRNFLTLGNNNSKKSIEKMVYSILDNNKGIKNITVIGKNG
SIISSDKNNDMKISANMMKEKWYVDAINNSDMPVFNPVRKDEDSSMNSNSWFLSISRDIK
NSKGENLGVIVFDIKYEMFERYLRSNAFGRQSDSIIIDNHGNVIYYRDVKCFADKKCLEK
FSEKNKNKDTYLYETQIENTNWNLRSLANTNDLVTLKKNFSHIVIIIFLVSLAFSSIITF
IVITKILRPLIKLENHMQNFENNLREFHLSEKTGYEIQNLVEHFNVMVEKIKYLREYEIK
ALHSQINPHFLYNTLDTIIWMAEFEDNEKVISITKSLANYFRLSLSNGHEKIPLKDEIMH
TKEYLFIQKQRYEDKLSYFFNIEDESLLSIEVPKIIIQPIVENSIYHGIKNLSGNGIITI
DVYRQNSTINISVKDNGIGFEKAKQFKKSKTGGVGIKNVDKRIKFYYGKNYGVFINKDNK
TEGAEVIIKIPFKSNL
>SEQF2502_02048 Uracil phosphoribosyltransferase
MAVFELKHPLIEHKLSNLRNKHTDTKLFRESLNEIAGLMVYEATKHLPLKEIETETPIQK
TTTKVLDKPITLVPILRAGLGMIDGILQLLPNAKVGHLGVYRNEETLEPVYYYAKMPTNV
VESQVFVVDPMLATGGSMIYTLDYLKEKGVKNITVLCIIGAPEGIKKFTEKHPDVDLYIA
AIDDGLNEHAYIYPGLGDAGDRIFGTK
>SEQF2502_02049 hypothetical protein
MKRLEIYFDSFYTEKMKEELREYGIDQYFIVPAIHSSWSKTFKHFNTHVWPGTDSILVTY
LEDRHAQEIIRIIKIMKIDLGRGISMGAVILPVEDIIL
>SEQF2502_02050 Swarming motility protein SwrC
MTVAEFATKRVVSTTMILIFMVFAGWVAMTGMKQERIPDFDIPIVVINATWTGATAEDVK
TQVSKKLEDAALNVDGIKNITTSSSYGSSVVTIEFNYGVDTDIKQVQVQTQIDKIKGQLP
DDDNFKDPTVSKMDATGSSNMALMIGITGENKQLITSFVEETLQPRLKRNRGIGNISIMG
NATRQIKVWLDPARLKEYNLSAAEIYSKIKAANTVTPAGTITDGTKEFILKVDGELKELD
QIQDIIISNQNNQTVRLADVAKVEYGTEDPTSYVTYNGKEMVAVMIQKSKDGNLVEVAKK
AKETLKEAKPLFPEGSNYNIIVDNSEKVSESIKNVASSGIQAVIITIIVLFVFLKNLRAS
LVVGTLIPISAMFTFFLLTTQGITLNMISLMGLSLAVGSLVDNGVVTLDNIFDHIQINKE
PADVAAVRGTNEVILPMMASTATSVCVFLPIILFEGITKEVFKSIAFSMMFALSASIIVA
MLWVPMASSLFLDVKKISDNAEKAARFNAFRDKYKELVAKVLENRWKMVIGVVIAFVVVV
FGIGKTVKTTFFPTIDDNQYSVVATLATGLDLDVSKDIANKMEAVVKADPATKDINVLAS
KDAAVINVDVKKDTMKAMNRVREKLKDLPNVTLAVSPQKAGGRSSQKDYSFQIEGDDPQE
LNRIANAIMADMKSQSWFKDVKSSTEGGYPQAKLEVDRVKAESYGITVTDITQMLFMTAS
GSANPIDVTQSTETLDVVLELEKNQKNSLNKIMDLEIKTNKGTYVRLGDIATMQYEESAS
TISTENGTRIVTIGANLDSSKGFNDAAAFIQQSFKKTNPAEGYKIGVAGQAKNQSEMGGQ
IMKDLLLAIVLIYTVLAVQLESFILPLMIMTTLPLSMIGVILGLAITRVQLSMFVMIGIL
MLFGMAVNNAIVMLDFVAGLRKKGWTIHDALVEACGSRLRPILMTTLTTVLGWLPMVFSS
KGSSGYYQGMAIAVMFGLSFCTVLTLFFTPVLYSLVEERKERKQKEREERRRQEKEEERR
GYAK
>SEQF2502_02051 Multidrug resistance protein MdtE
MKINKKAIIVMIVLALLTVSCGKKKPKGNLSTARPVKVQVIGQNQMSLGYTASGSIKGIE
EIPYTATSSGEVVVINGKNGDYVNAGQVIVAIDNQAARSGVREAVSNVRTAESNISSAHG
DISAAKGNIASAEAAVEEARINYQKYKMLYDKRLITETDFLTAQTKLSSAQANLNSARSN
YNTAVNALSSRRNSLSSAQANLATANDTNSKTVIKTKVSGYIANMDLERHQQVSAGAKLF
TLVNESEMKLEIGVPAEIVKKIQMGSQATIKVDELNGKEIVGTVYEIAASADSASRQFIV
KVKFPNPDRELKSGMYGKANIATGAEDGLIIPKKAIVVRGVQQVIYVIRDGKAVMIPINI
SNQNETYAAVTGDGLTAGDQLVVDGQNVVQANEKVNIVQ
>SEQF2502_02052 Toluene efflux pump outer membrane protein TtgC
MKKNKLRMIVVSLLLLIAIPGFAEKITIQEAAEMAIKNNKDIKIEMLKAEQGKIDVDRAW
ASKFFTVGYSGSAQGHLDKDFNRTGEAYQHYLTLSQPIYTGGKLKLNHEISKEKLTLSQL
SLDKVKKDTVLSTVQAYIDVYNAMSTLGVLQKSKETLDENLKTQKELYDLRMTTQPELTE
AERSVASIEAQIVEQEGNIEVSKEALGILIGVKNSSQIEIVPFGVEDNFTKTIKLDEDLA
KLPIENTEYKMAVKQNDLSKKNIKVQEADFKPTVSGMINYGVLQSQDKFGNIFKTKNFTT
SAGVKWSWDIFDWGTRKNNVNYAKKTQEISAVQVEQTLETVQANMKKTYYQLRSLEKSIA
ALQLAVQKAEESYNLEKERYSYRLITMENLLQSETNLRQARVNYAQAKLNYYFLVSKYGA
FLD
>SEQF2502_02053 HTH-type transcriptional repressor KstR2
MFEKEKNIKKQKKRKILEKAFELFRKNGYKDTKVEDITRKLGISKGSFYTYFKTKEELLY
ELLENVKKSEMERYSKVEIDENPKKTLENFIKERFKSFLELLNNADIGIMNSFTQNTIVG
KFREEMTKFFKSFIKENILLRYESNKEYDMEIISDFIILAINNCLIEKIVCKKEYTFSSK
EEFDGIVEDNQKLINEIVKFVDNALK
>SEQF2502_02057 hypothetical protein
MKIINIKFRKTKKVYPFMISDLEDYKKGDYVLVDTIRGEQIGIVLGIALNKGNSEQDDLK
IREVKRKLTEEEVKKLADLDKKADEAYFKCKKIVKRLLPEMNLVIGEYTFDEGKLIFYFT
ANNRLDFRELVKEVNKTFKKRVEFYQIKTNDEGRILSAFGKYGREIYW
>SEQF2502_02058 hypothetical protein
MKRDNGNKNNEKIGFEQILDEEKEKGHRERLRQRFLLTGSKGFTDYEILELLLTYIVTRK
NCRGIANELLRKYRDLYTILKQPGEELQKNKYMTERTVVFFKLLFEIIENELYKKVCNER
IVLSSNLKLLKYLEFSLLNRDIEVFKVLFLNTQNELLKEEELFFGTIDRSTVYIRELVKK
ILEYNAKGVILVHNHPSGSLKPSESDILLTRKLKEVFENIEIRLLDHLIISEKGHFSFLE
GGIL
>SEQF2502_02059 hypothetical protein
MKKILLFLAFFGMLISTCIISAETTTAFKTEKIKYPRGIRSVTSVTEVFGTGQQITHIIL
EFNEKVVNSQLTKNTFTVSDRTVEKIYSNTRPEKTDIVKDGRFVIIELNPKDSGASLRLE
GNDEVGFQMKKATSKVTQKEDILFTNGKKLEKSIAILENNKIKNLIVENFKQFVYKDPKT
GTTVKYNLYIPKNYDKNKKYPLVLFMHDAGVLSEDTKTTLLQGNGAISFATPEEQERHEA
FVLAPQYSRKVVDDNGDITSDLDATVNLIKDYLISKYSIDEKKLYATGQSMGGMMAIVMN
YKYPELFAASYLVACQWDPKEVSTMARNNLWITVSTGDAKAYPGMNAITSELIKRGATVA
KDSWRADYTDAQFLEGARKVIAQKSNIKYTTLEKDTNPYLPKDANPGLEHSGTWKVAYSI
PGIKDWMFLQSKQ
>SEQF2502_02060 hypothetical protein
MTFSYFSPIHIETFVVSTLICIFLFYVPKIFKDINIEKYSTILGYFLLIFKIVDSIYRLM
YQNEPVTNVMPVHLCNFAAIFAGLYLIFRTKFLYNAVYYLTFGPVLALILPGIIYYHDNY
YVYIFMIMHALIVFTAFFGYAYLNEKPTKKGLIQSIITLLFIFLYAFTYNFIFKGINAMF
LKSYIISQVSFIKPIWLYDIVLILTMIFLQFLFYLPIMKKNKKTI
>SEQF2502_02061 Putative septation protein SpoVG
MKVTDIRIRIGKQTENIERLKAYADITFDESFVIHGLKIIDGQNGLFVAMPSRRMPNGEF
KDIVHPIKPELRAEITKVVLEKFEHEKAAHTEAE
>SEQF2502_02062 hypothetical protein
MRLDKFLKVTRIIKRRTVAKELADNGNIVVNGDPKKSSYDVKKGDIFEIKYFNKNIKVKV
LDLPPESLKKEFVEDYVKIIG
>SEQF2502_02063 Phosphate-import protein PhnD
MKKNILRSLLLVMVFLFTISCGKKNDTIKIVFLPNETNDSLKKSREEFARIVQEATGKKV
EIVTTTDYNITVENIVSGQSQIAYIGAEAYLNARKRTKNIEAVLTNAGESGTLKDALYYS
FIAVRGEDANKYRSGDGFDLKKIKGKSMGFVTNSSTSGFKVPGSVIVKEFGLKNTDELLG
NRVFSKVMFGNSHPGTQVLLFKGDVDVATFAIPKSFTIYELVAGKDFNSGATYKVKKGAV
APFGEFAGKTFTVIKSIPVYNGPIVFNTRTLSKEDQEKIKKALMAKSTTDNPHIFSNKKS
KVRGLFLKENDNVGFVETNTAWYEGMKNIK
>SEQF2502_02064 Bifunctional ligase/repressor BirA
MKKNINLYKFKELDSTNDYLERNHKNYEEFDVICTKNQTHGRARRQNDWVSMEGMAIFSF
FLEKRENWEIEDYLKLPLIAGLATIKGLRGIENLEYKFKWTNDVYLENKKLCGILIEKID
DVYIVGIGININNILPGKLKNKAISLTQVTNKKYEIEKIIKNIISEFQMLCEKLENGLWE
DILKEINEINYLKNKKIELKFGNEKVLGIAQDINENGEIEVLVKKDEVGKGEIKSFSIGE
VFEKIVF
>SEQF2502_02065 Glutaconyl-CoA decarboxylase subunit beta
MELLKILYGTTGISMITGRQLIMIIISLILLYLAIKKQYEPYLLLPISFGMLLANLPAVA
NEGLMEKGGLLYYLYQGVKLGIYPPLIFLAIGASTDFGPLIANPKSLLLGAAAQLGIFVA
FLGAILLGLTGKEAASIGIIGGADGPTAIYLTTKLAPHLLGSIAIAAYSYMALVPVIQPP
IIKLLTTKKERMVEMKQLRFVSQREKIIFPIAVTIIVILLVPSSAPLIGMLMLGNLIKEA
GVVSNLVEHARGAMLYCITIVLGMTVGATADGEHFLSFVTIKIIILGLIAFSFGTVGGVL
FGKIMYKFTRGKVNPMIGAAGVSAVPMAARVVQKIGQSENPKNFLLMHAMGPNIAGVIGS
AVAAGALLIIFR
>SEQF2502_02066 Glutaconyl-CoA decarboxylase subunit gamma
MIKLYKIKIGEKVYEVEVEEVTEKDGTIETSTYSNSKQKIDKSENPPLQGGTGKSEVIKA
PMQGLIVDVKVKAGEKVKAGDEIVILEAMKMENPIVAPCDGVIDEIKVIKGDKVNVDDVL
AVLS
>SEQF2502_02067 hypothetical protein
MKSILFGNLAVTFTDAVYISIVSMLIVFFILFLISFMLSFFKYFSNFEGRSKDSKKTNDN
KVLKKTEKLSNEGKLDKKETFNMEKIKDETMMAAMMAALIEAAGDNKNSRIKIRNIREIK
>SEQF2502_02068 hypothetical protein
MNLDIDYFKRKLKEITDWYENTAWNKKALLEKILELDTEINKTRDKENLIDWEKLTHTEE
KVVSDMVHLRNKMKLSHKEKFDSYYKIK
>SEQF2502_02069 Methylmalonyl-CoA carboxyltransferase 5S subunit
MGRVKITETSLRDGHQSLMATRMTTAEILPIIETMDKIGYYAMEVWGGATYDAAIRFLHE
DPWERLREIRKRAKNTKLQMLLRGQNLLGYRHYADDIVDKFVELSIKNGIDIIRTFDALN
DTRNIRQASESTKKYGGHSQLAICYTISPVHTIEYYKKLALEMESMGADSIAIKDMSGIL
LPNMAYELVGELKSILKVPLELHTHATAGLAGMSTLKAIEAGVDIVDTAISPFGGGTSQP
PTESLVRTLQGSKYDTGLDLELLKEVAEYFKPIRKKYIDNGTLNPKALAVEPSIVEYQLP
GGMLSNLVSQLKAQGAEDKYEDVLREIPKVRKDLGYPPLVTPMSQMVGTQSVFNVLTGQR
YKMIPKEIKDYVKGMYGKSPVEISGEIKSIIIGNNKVFTGRPADLLENEYDAMKSEIGSL
AKSDEDVLTYACFPQIAKNYLKEKYETKYLKETEKQKKSKDEISIQNIEVFF
>SEQF2502_02070 Phosphoenolpyruvate carboxykinase (ATP)
MKKVTKDLEKLGIVNVAQVYRNLTPAELVEHALKREEGILSASGALVVTTGKYTGRSPKD
KYIVDTPGIHEKIAWGNVNKPIEKEKFDSIYNKLIAYLQNREIFIFDGMAGADPACRKKF
RIINERASQNLFIHQLLIRPTEEELKDYGHADFTIIAVPGFKCNAKIDGINSSAAIIINY
EAKVGIICGTEYSGEIKKSVFSIMNFVMPEMDVLPMHCSANMDPKTGQTAIFFGLSGTGK
TTLSTDPNRKLIGDDEHGWSDHSIFNFEGGCYAKCINLDPEHEPDIYNAIKFGSLVENVV
MNPVTRELDFYDKSLTENTRVGYPINHIKNAQIPGIGGIPNVVVFLTADAFGVLPPVSRL
SRDAAIYHFVTGFTSKLAGTERGITEPQPTFSTCFGEPFMPLDPLVYAEMLGKKIDLHNT
KVFLINTGWSGGPYGVGSRMNLIYTRAMVTAALNGELDEVEYKHDDIFNLEIPQYCPNVP
SELLNPIDTWANKEAYEAAAKKLAKMFRENFEKKYPNMPEHIVNAGPAYFE
>SEQF2502_02071 3-deoxy-D-manno-octulosonate 8-phosphate phosphatase KdsC
MIKLILLDVDGTLTDGGIYLGNSGEELKKFNVKDGYAIANVQKLGIEFGIITGGKSELLK
RRAEKLKIKYLFQGISEKTLILDEIINQTGLKEEEIAYMGDDLNDMAIIERIGFSGTPLD
GISEVKAIADFISTKNGGEGAVREFIEVILKKENLFQKFLSIIK
>SEQF2502_02072 DegV domain-containing protein
MAIKYLDAKRLRLVFIGGGKWVTKHEELLNELNVYPVPDGDTGSNMSMTLNSMINDLEEK
TDEKIKMPQLIDVVEEAVLMGARGNSGTILSQVITGFLRGIGEKVKLLPKDVAEALVSAK
ETAYNAVSEPIEGTMLTVIRKISEKATECADKFEDLVVFLKEIVEAGKKAVDETPELLPK
LKEAGVVDAGGKGLFFFFEGFYKVTTELNLLAELQKAQVKENEFDKTIANINHDPESIHF
QYCTEFIILNGNFDTNEYKKRVLELGDSAVFAQTSKKFKTHIHTNHPGKAIEIALEYGPL
EKMKVENMRLQHDNLQIFSEKDEAKIFTNKKIDKTKSAFVILADSENLKDEFLKLGADVV
ILGGQSKNPSVQEILNAIGKTEKENVYILPNNKNVITTAKIASEKSKKTVIVLNTKTMLD
GYYFLKNKYSDIDELKEAASRNYSVEITKAVRDTKIEDLSIEKDDFIGLINGKIKYAKKS
LKEVTDAIIDDLVTKNTLTAVVVSGNEKDETVQKSIEEKLAGLKTTIINGNQENYYYYLY
IENKDPNMPEIAILTDSVSDLTNEDIEGLPIKIVPLKIDINGELYKDGVEISKSEFWHEM
LDNDARIKTSQPSPQDFLNAYNKLFEKGYKKIISIHPSSKLSGTIQAAKVGRSLTNREND
IELIDSLGASLLQGFLVLGAAGKSVRGESFTEIINWVNNFRTKGKLLMIIPDLKYLEKGG
RIGKASSTIAGALNMKPILTVNQGEVTVEKKVLGERNAQKYIEKYIERESKKQSIVLMSG
WGGTPTELENVVRIYSEIENNPKINSLILNREIGAVIGAHAGPVYGVFIFPRLS
>SEQF2502_02073 Bifunctional ligase/repressor BirA
MKFKFFDKINSTNTYLRRQLKIEEFEVIVAKNQTDGKGKRDSTWISSEGAALFSFAVNDN
YELDEKITIFTGYIVYKILKNYIESKDKLTFKWPNDIYYENKKICGILCEKVRDHIIIGI
GININNTDFGIFREKAIALVEITGKKYSVQGIIEEIVSTFENEFHSLNREWESILHIVNE
NSYLKGKKIVIQQNGKLSKKEYRFLRVDRRGRISIIAKGDSDELKFTSLQFKVI
>SEQF2502_02074 dTDP-4-dehydrorhamnose reductase
MKILLTGSNGQLGHDFKKIFDRKNIEYIATDSKELDITNDEKLKKFFQGNREITHIINCA
AYNDVDKAENDEKVWLLNAKAPKKLAEISKEIGAIFVTYSTDFVFDGNKSSPYLEEDETN
GLSEYGKSKAKGEKEVFKIYDKSFVIRTSWVFGIANNNFNKQVINWSKSRNELNIVDNQV
SAPTYSVDLAKFSWKLIQTEKFGLYHITNDGIASKYDQAKYVLEKIGWNGTLVRAKTADF
NLPAKRPAYSKLDSSKVEKLLGEKIPAWQSGIDRFLEEMKENGEL
>SEQF2502_02075 UTP--glucose-1-phosphate uridylyltransferase
MKKIRKAVIPAAGLGTRVLPATKAQPKEMLVVVDKPALQYLVEELVDSGIEEILIVTGRN
KSSIENHFDYSFELEKTLEEKGKKDLLKVINDISKLSNIYYVRQKKPLGLGHAIGCAEAF
VGDEPFVVVLGDDIVYTDKAKGELPAIKQLIDKYSELKGGNILGVQKVPEKDVNKYGIIK
PLKKIDERTVEVENFVEKPNLDEAPSRLAALGRYVLEPEIFGYLKNTKPGKGGEIQVTDA
ILSMKNDGGKLYAYNYEGLRYDTGNKFGMFVANVEFGLRHPELKDKVKEYLKKLIEYEI
>SEQF2502_02076 UDP-glucose 4-epimerase
MKNILVIGGAGYIGSHTVNLLKKSGYNPIIYDNLSKGYKDVAEILNVKFIKGDLGDRKKL
KEVFETENITAVMHFAAFIEVGESVQEPAKYYENNVVKVTKLLDQMVESGVKNFIFSSTA
ATFGEPVKEKIDETHQQLPINPYGKSKLMVEKILEDYDAAYGLKSVVLRYFNASGSDKDG
IIGESHIPETHLIPLILQAASGKRESIKIFGDDYPTKDGTCIRDFVHVYDLAKAHILGME
KMLKENKSLNYNLGSGEGFSVKEVIEKVKEVTGKDFKVETVEKRAGDPAILVANSEKAKK
ELGWEPEYSLEEIIDSAWKWENSRKY
>SEQF2502_02077 hypothetical protein
MRKILFVCEGVTEVFLLYKILKEIENLEINKKILENGNLKMKSLDKLINLFFEKQNLKIF
INNLKGKNKLNNFLEEFSNSREIEEISKILFIIDSDFSSKNNEETGFERTKKSIENKSKD
LKQINRNLEIDYFITPNNKDDGMTETLIINSLKCTQIVEYMKTVIKDVKEMDEADIKNET
KSAFLMIAATQNPLTGTTPAFLSGCYEKINKEYIDFKKIVEFIMKEIN
>SEQF2502_02078 ATP/GTP phosphatase
MIEKIEIKNYRGIEEISIDNFKKYNIFVGDNSSCKTSVMEAIYSSLPNVRDGIITTANSR
GMQVRLDNIHNFFYNADIKKEIQFILDDKIITKINRKENNNVENEKIIENIENNTISKNL
MNMNVLNANMKYLYDILQKDKNNDKEHMDISVMIDNFIQILFQERINIKSGNYYGKSSWI
TPLSKYQNDTAKVVKKIIEKKKKNELLKIINILEPEIDDIISDGFEIQLSKNNAEKMLSL
SSFGNGLSSIVTTTSSLVNNETKILFIDEIEDGIHYLNYSKFCENLIKITEILDIQLFIT
THSKEFLEAFYDKLSNNEVTLYRFQKSKNKIKKIYYPKEKVLYAIKEGWDIR
>SEQF2502_02079 hypothetical protein
MSLIKKLVNKETILYLVFGVLVTLLNIILFYIFVTRMKMSTFYGNMLDTILCILFQYFTN
RIWVFESKNKGKEAVKEFIQFILARGVTAVIDQIFVVVGVDFFVAKYVSHSQQGVFSIGI
KILSNIIVIILNYIFSKLFVFNKK
>SEQF2502_02080 hypothetical protein
MIKTLEQNYISVVLVINDDNMQVEKKIKEIKKVLNNNFKNSEIVIVDNTTKTDSLESLKS
LNFKHTEIKLPIKHRTQQALNAGTAIAIGDYIVEIEDISFDIDYNKIMEMYRKSQEGYDF
VFLTPKKSRKSSKVFYNILNKYFKNSFNEDINSSVMTLSSRRGQNKVAEVGKRIINRNVA
YVVSGLKSSYIVINMDYKNNRGFSENLMLMFDTLIYYTDAIMIFTQRLAFGFFILFGLGV
VYSIITKIARETVEGWASLFIILSLGFFGLFFILSIVIRYLHHILQNSLNTKDYIYRSVD
KK
>SEQF2502_02081 hypothetical protein
MKKYNKIIIGAGIYGMYAAKRSLEKNPDEKVLIIEVEKEPFNRGSYINQARLHNGYHYPR
SFSTASKSAKYFNRFYNDFKKGINDKFEKIYAVASDYSWANGEQFQKFCDNLNVRCDEIP
RGKFFNENTIDKAFLTQEYSFDAKIIGKMLYEELVKLGCNFKFETKITEIKKEEKEYVFK
TSNGKIYSAPFVLNATYAGINIIHNLLGFEYLPIKYEFCEVILCEVSNNIKNVGLTVMDG
PFFSLMPFGLTGYHSITTVSRTPHFTNYENLPPYDCCGDIEKQKHPEHSKGCIHCGIFPE
TAFEEMVQIAKKYLNEDIEIKYVKSLFTIKPILVASEIDDSRPTIIKQYSQSPDFYTVFS
GKINTMYDLDEIL
>SEQF2502_02082 putative oxidoreductase YhhX
MEVAVVGYGYWGKILKKYLDENNLFKVAGICDPLYVNSIKLEEILNNPNIESVFVCNPID
IHYSTVKILLEKKKNVFCEKPLSKSYKESIELFEIAKKNNVTLYVDYIYTNSPSINKIKE
MKEKLGKILYIEANINQFGKFYENDDVFDVLGVHLISSINYILDKNIKVEKIIIKKENSK
KIIENGSIVFLVEDIAGIMNCNLLSYEKERKIIFTCEKGIMIFNMLGEKTVKIIEHVEKD
ESFEENLIFEEKIDEVNNLKYVLEEFYNYVISKKSNEKIAIGVAKAIEQINILKNGCNL
>SEQF2502_02083 Polyprenol monophosphomannose synthase
MILEITIPVLNEEQTIKEKISEMINYVKTNIMNISINFIIADNGSTDKTQEYSQELIKEY
SNLSYIKLPEKGVGLALRTSWSRSKADYVGYMDLDIATDLDALKIVVSEMKKNTKIINGS
RLLKDSTVINRTLLREISSRSFNLILKLILGIKFSDGMCGFKFFDRNTAQELINTGIDTK
GWFFSTEMLVKGYWKNFEIKEIPVKWTDDRNSKVKIVSLSLNYLKSIFKLKKEEKEFKKR
WK
>SEQF2502_02084 hypothetical protein
MLKIKKVKLLAFIIPIFIFWMVLISAKVYPFGEKSILVSDLSNEYIDYLSWYKNMLMGKH
SFMYSWNFGMGMNMFSTIFYFLSSPLNILILIPFLEIQDTVLIITLLKIGLCGLTCNFYL
SKKFGLNNNQSLVFSTCYALMSFNICYIQHLMWLDGIILLPILIFYLDEFIEKDKKLGLI
LTLIISFYSNFYISYMIGLFMIIYFWYRFFSSDLKITLKSAIIKFVKFGLYSISSLMICG
IFLLPTYISLEKEKNTELFKLGIRYRIGDIISKLFIGNFDTLHPGGSPNIYCGLIVLVFF
LLYFINKNISIKKKISAGVVLIIMFISIEISFFYMMWHGFDNPEWFEGRFSFLVSFFLIY
IASESYEKKNGVLIKRSLEKISLILILLLISSSILIENLRDKLFINLVFIILYCVAFKIN
LLKKFLLIIVCCELLMNGILVNKKIRTEENYEDRSYYIQYKKNLRETVNELKRKDNSIYR
TEKDFRRRENEGALADYKGIAIFDSNFNKGVHNLLSKLGMPFFDKVGNFEGTTLFSESLL
GVKYVLSHNIGKTIFYSKPVLKVNDTYVFKNNQALPFFSLVNEGILSVNINKENENPFEL
QNKIAEKITNNKVRIFENLNVNKKIENLKVEDEKNDNIKYVKINPNKEAFLEFKVSNLTN
DINYMYIKKFNQNTLVEINGINNPYEFGGYNKIFRLNNDDIVKISLKENELEINKNLFYS
FNKNNYNIIMSKIDRTPIIKKFNDTYIEVKIENIKENELLMTSIPYDEGWKLYVNGKKQV
KEKILGAFIGIRLKNKESNIILKYEAPGVKLGVIISLIGLVGLIILSFVDKKFLVVEEGI
LKSNNKRLS
>SEQF2502_02085 Galactofuranosyltransferase GlfT2
MNIIQRSVFPKINLCTEQDLYFRVNEFASLDLKNSIIHFEKNGRVFTDTYFNSFTVGKWK
NNTVIEDLNLKIKFKGKIKIIFKLSCLYSSNRVLSELYFENKDIKEILIPLYFFNELKNG
MLFFEIRGLDTSEVYSFEYFTNTQIKNNINLGIVITHFNRQQYVLPAMERLKKELIEVPE
FKGKVSLNIVDNSQNLPEVKGVNIIKNANLGGAGGFTRGLIYLQDQKKYTHCLFMDDDAS
CEVEGIKRTINLLEFAKKDNLSIAGAMLNEAKSYIQYENGAKFPGYWQPINNNFDLRDYR
CLLKNEEEVAIPAYGGWWFFAFPISEVRHYAFPYFVRGDDIGFGLSHKFNIITLNGISSW
QGDFEIKNGVVPAYLDTRNHIMQRFHNLVPCSLKSIIKISLLFLARNLLTYNYETALATV
YAIEDVCKGPNFWRENVNMMKRRPEIAALAKEEKVIDIPLTEVDRSITFEENENGEEVEV
HEKKLKTFFRWITLNGHLIPTIFFKSGMVQQKKGFGGTLRKVFRYKEVLYLHKLSNKGFI
LKHSKAKFFKVLFKYFGAILKLSLKYRKLHKEYLSTYDEFTSREFWEKQFYQ
>SEQF2502_02086 UDP-galactopyranose mutase
MRYDYLVVGAGPFGATFAYEANKRGKKVLVIDKRDHVGGNMYCENIEGINVHKYGAHIFH
TSNKKVWDYVNQFCTFNNYINSPIANYKGEIYNLPFNMNTFNKLWGVVTPAEAKTKIDEQ
IKESGITEPKNLEEQAISLVGKDIYEKLIKGYTEKQWGRSTTELPAFIIKRLPVRYTYDN
NYFNDKYQGIPEGGYNVIFDKLLEGIDVELNVDFFGKKEELLAKADKVVFTGMIDQYFDY
KFGVLEYRSLRFEHETLDEENHQGNAVVNYNEREVPYTRIIEHKHFEFGKQSKTVITKEY
PAEWKQGDEPYYPVNNNKNAEIFKKYQELAKQEKNVIFGGRLANYKYYDMHHVFEVALEV
VEEEFGGM
>SEQF2502_02087 Teichoic acids export ATP-binding protein TagH
MEEIVKVKNISMRFNMSSEIIHSFKEYIIKLLKRQLFFKEFWALRDVSFSLRKGEILGIV
GFNGSGKSTILKVVAGVLEPTSGSIEVIGKVAPLIELGAGFDPDLTARENIFLNGAVLGY
DKKFMEEKFDEIVEFSELGEFLDTPLKNFSSGMYARLGFAIATVVRPDILIADEILAVGD
FHFQEKCEQKIKEMMAQGTSILFVSHSIEQVEKLCDRVVWLEKGKLKMVGDTKKVCEAYK
NS
>SEQF2502_02088 Polysialic acid transport protein KpsM
MKEIFEYRALLIELIKRDIKKKYRRSILGILWSMLNPFLTMLIMAMVFSSFFKFAIKNFP
VYLLTGQLIFNFYSEATNTAMGSILENASLIKKVYVPKHIFPIAKVLSSCVNFILSLPGL
VLVILITKAPVKFSIIFSIIPVLYVLFFCLGIGLLLASVTVYFRDMFHLYGVLLTAISYL
TPLFYPKEIVPEQYMFLLNLNPMVYFVDLFRDMVYYGKMPTLDEHLNCIFIIIISLFIGV
VTFNMNKKKFILHI
>SEQF2502_02089 hypothetical protein
MLKTKGFIGVAFHKKFFSYKDDIIVPIHVGSKKSKENLEYLKDSLGDNISEKNKNFCELT
GIYWMWKNVDANFYGMMHYRRYISLENKLGYILKRGLYVFSRLFYLKPVINMLDMRELFQ
IKISDKQVMEQEIKKLSEKITREIQKYDVILPKKEIFNKSVYLQYKKSHIVEHLDKLLEI
IKEDYEYIYPYYEKKIKKNNTIYPLNVFIMKKEYFFEYSQFIFDVLFKLEKKIKIPSDAY
QMRVFGFLSERMMLPFIEYLKDKKNINVKEGVVLYLDRKEKNEGNI
>SEQF2502_02090 Putative glycosyltransferase EpsH
MENPKLCILLASYNGEKYIKEQLDSIINQTYKNWKLVIRDDGSKDKTVVILNEYEKKDER
IKVLRDSKGNLGFLKNFEELLFNADEEFVLFSDQDDFWLKNKLEKFVEKISKLDGKTLSK
PLLIHCNSSICNDRLEVIKKEFIDSKLAKERNSNIYFFEYMVQGSTSMVNKKMIRKSIPF
LKNVTLHDRYFHLLSQFFGTRVFINKSLVKYRQHERNEIGANKSMLKKIMNKKYFYIEDR
KLIQEIKEKYKKQLRKKDLNDIERYLEVTDRSKNRLERFWLSKYFKMKLLKRLVLLIKG
>SEQF2502_02091 Glucose-1-phosphate thymidylyltransferase
MRGIILAGGSGTRLYPLTKAISKQILPIYDKPMIYYPLSVLMLANIREILIISTPRDLLV
FEELLGDGSQLGIKLEFKIQKYPNGLAEAFIIGEEFIGDDNVCLILGDNVFYGAGFSGLI
EEAAILKDGAIVFGYPVKDPRAYGVVEFDKSGKAISLEEKPENPKSNYAIPGLYFYDNTV
VKKSKSIKPSARGELEITTINEKYLKEGKLNVKQLGRGITWLDTGTHEALLQAANYVETI
QNRQGYYIACIEEIAYRKKWIKEAQLKQLASSMLKTEYGKYLMDLLK
>SEQF2502_02092 UDP-N-acetylgalactosamine-undecaprenyl-phosphate N-acetylgalactosaminephosphotransferase
MKLNKDIRIRILYIFILYIVYSLLLDKYNYVARYLTNFIFILFIFVKFIFGQLDFYAERF
RFKDVFITLGIDVIFSVMLYAFWKQFNIFYIYLLIFVFQVIFRKIVCSIYMKKQNVLIFG
SNHIKNNIQEDIINTLDYNYVGYISNNKSGATKYLIGNYDQMEEIISKKEIDVLVIVKNI
KSPDFKKYLKRIFDLKINGLKIINYEEFNEDIQKKIDINQINEEWLLQSNGFDILSNEMQ
KNIKRGIDLILALTLMVILSPLALITAIIIKMESKGPVIFKQTRIGENMKPFKVYKFRSM
KIHDPEKYSKYTLDNDTRVTNFGKFMRKTRIDELPQLWNIIKGTMSFIGPRPEWDILAKD
YAKQINHYNLRHLIKPGITGWAQVMFPYGESLEDAKRKLEYDLYYLKHQDLVLDVLIVMK
TAKAVLFGKGK
>SEQF2502_02093 Transposase from transposon Tn916
MEIMNKNMSISKCMDIWLKNEHNYIKESTYFLYLAIIENHLKTYFKRRRVNTISNKDFQS
FILDKLNYGRLDGRGGLSKKTVKDMTVVLKSILTFAMNHKIIDRMEFEFKIPRKKKARKV
EVFNVEERRRIYKYVKNNLCNQTLGILICICTGLRIGEICALKWEDVDLRTEVINVNHTI
QRIYINTAKKSKIIISSPKTESSRRKIPIATELMFLLQRFKSNSDFYVISGNEKYIEPRT
YRKFFTKMLNILKISKLKFHSLRHTFATQAIENGIDYKTVSEILGHASVGITLNLYVHPD
LEYKKECLNKIFNNFVKKS
>SEQF2502_02094 hypothetical protein
MKFNEYEYEHLDLEKIKAEFSRLIESFKKAKNMKGQVVAFDEIIKLRNHIETMQTLVSVR
HSIDTNDEFYDKENEYMDEISPILFGFTNDFYKALVNSKFKDELIQKYGKFLFDLAENTL
KTFSPEIIPDAQEENRLSSKYSKLIASAKIDFDGKELNLSQMVPYTQSKDRNIRIEAAKK
VAQFFAENQDEFDNIYDSLVKVRTRMAQKMGYKNFVEFGYKQLSRLEYDAKMVEDYRKQV
LENIVPLHTELRERQGKRLGVEKLRFYDEAIKFNSGNADPHGSPEWILNNGKTMYKELSK
ETDEFFTFMTENNLLDLLSKKGKMSGGYCTYIPEHKAPFIFANFNGTSHDIDVLTHEAGH
AFQVYQSRGFEVPEYLWPSYEACEIHSMSMEFLTWPWMDLFFENDTDKYKFIHLSEALLF
IPYGVTVDEFQHWVYENPEATPKERREKWIEIEKKYLPTRDYGEVEELKNGIFWFRQGHI
FSSPFYYIDYTLAQVCAFQFWIKSRENREKAWQDYLNLCKLGGSKPFFELMKSANLKNPF
EEGTLAFVIPKIKEYLDNVDDMNL
>SEQF2502_02095 Cysteine synthase
MIYENILDLIGNTPVVKLKFLNDENIADIYVKLEKYNIGGSVKDRAALGMIEAAEKEGKL
KPGGTIVEPTSGNTGIALALIGKAKGYRVVIVMPDSMSVERRSILAAYGAELILTEGAKG
MKGAIAEAEKLAAENGYFLPQQFENPANPAKHYETTAKEILDDFPQIDAFISGVGTAGTL
SGVGKRLKEERPGVKVFAVEPATSAVLSGEQPGKHFQQGLGAGFIPGNYDASLVDGIIKV
TNEQAVEFATRASKENGLFIGISSGSAIAAAYEVAKKLGKGKKVVAILPDGGEKYLSIEA
FRNSL
>SEQF2502_02096 Serine acetyltransferase
MIIIFKWLVSEINNIAEKDPAVRYKIEVFLYPSLHAIINHKIAHFFQKHKLYFLARLISQ
ISRFFTGIEIHPGAKLGSKVFFDHGMGIVIGETAEIGDNCVIYHGVTLGGVSTSKTKRHP
TLKNNVIVGTGAKLLGNIVVGNNVKIGANSVVLKDIPDNAVAVGIPARIIPKTEEDYYMW
HI
>SEQF2502_02097 Flavodoxin
MAKVGIFFGSTTGVTEDIAHKIAEKIDGAEVFNIDGNEDKLEDYDVLLLGTSTWGFGDLQ
DDWAAVLDDLASKDLSSKKVGYFGSGDQGTFSDTFMDGIAIIDEEIQKTGATIIGKTSTE
GYEFNESRAAKDGEFLGLALDEVNQSELTDERIDAWVEQIQKEF
>SEQF2502_02098 hypothetical protein
MKNKFLKVVLLGCLVLGSLSFAGSKDYKKSNFSHKKSSYKRSKITPARAKQIALAKVPGA
TLRNIKDFEFDEDSYEGEIHYRGYTYEFEIDAYTGRITDWDVDRD
>SEQF2502_02099 Lysine--tRNA ligase
MSNQNQNDNGIIKEKLKKVEELKEIGVEPYGRKYEKLNNISEINQYDETCDKVFKTAGRI
VAFRRMGKNGFGKIQDPTGQIQYYVKKEEVGENQYEIYKKMGLGDFIGLEGHLFRTKTGE
LTLRVDSFEVLSKNIRPLPEKFHGLTNVETRYRQRYVDLVMNREVMETMKKRFQVIRFFR
SYLEKKGFTEVETPMMHPIAGGATARPFVTHHNALDMELFLRIAPELYLKRLLVGGFEKV
FEINRSFRNEGISVKHNPEFTMMELYQAYADFNDMMDLTEDLISSLTMELHGKYEIQYED
KKINMAKPWRRVTMKEIVKETTGFDFDSISSDEEAVSIAKEFGIPLEKDKTYTKFGILNL
FFEEKVEETLISPTFVTEYPKEISPLSKNQKGETEWVDRFELFISGREFANAYSELNDPR
DQKERFEEQVKLKEAGDDEAQGMDLDYIRALEYGMPPAGGLGIGIDRLVMLQTNSASIRD
VILFPTLRKEDIEL
>SEQF2502_02100 hypothetical protein
MKVKIKSLDNFNQNYEKLFELEKVLEQKEKKEYYYGDEYGNCKIIDKGDSIEIYRYGEIN
SRQIFQSNKNTPFTYITKQFHGKYKIFTKKIQKENRKIVLEYDIIHSNEVINSINLELQF
IDVPSK
>SEQF2502_02101 hypothetical protein
MYSAGEEFEKTNSEGEVEEYTCLSNVTVGDKEYLVCDSETGEKKVFYYDSIEEELYDLDE
DEEDQVLEIWNDEYYGSDKDYMYWNEDFGEYDKDENEDGEFNENNFDSLNENDENEFFED
EEETDDEDLSEFLDDFFDDENE
>SEQF2502_02102 Ribosomal RNA large subunit methyltransferase H
MIRINVVCIGKVKKKYIREGIAEFSKRLSKYTKFEIIELAEEDDNKGIENAINSETERII
NVISKKNYSYNILLDLKGKMLTSEEMADKIEKISMTNSEINFIIGGSNGVDDNLREIVDY
RLCFSKMTFPHQLMRLILSEQIYRWISINNNIKYHK
>SEQF2502_02103 DNA mismatch repair protein MutL
MYEELKDKFYNKKIESQHLLLPLKMEVTQIEKNIIFENINIFNDFGFDIDEFSENEIVIR
AVPAFDFRDSIENVFLQLLLDLKNEVEIKDLRENIIISMSCKGAVKAGQKLDMFEMQNMV
RRIHEVGKYTCPHGRPIIVKLSKNDLDKMFGRKK
>SEQF2502_02104 Nickel-binding periplasmic protein
MKKKKNFKFLLLLTGILLFVLSCGGNVRKNASKDEIVAANFRDIRDLNPHNYAGELYAQN
ILYEGLVIINKDGSIAPQLAEKWEISKDGREYTFHLRKNVVFSDGEKFDAKAVKANFDAI
MENKDRHGWLESVRLFDGFETPDDYTFKIKLKEPYYPMLIELGSIRPFRFISPKAMKNGK
STKNGVDKYVGTGPYVLKSNKTDEEAVFEVNDKYWGTKPKIKRIRVKVIPEEQTRALALE
KGNIDIVFGRDMIDSETFKKFKDKKGFSAMMSEPVATRMMLVNTTKGALTDKNVRKALQH
VLNKKEISEGIFEGTETPADTILAKTVPYANINVPVYNYSLDEAKKLLDAAGWTAGADGK
RQKNGKP
>SEQF2502_02105 hypothetical protein
MVEQLFKELSLLEEVEAIALGGSRAGVNYDEKSDYDVYLYVTSPINEEKRKNILKNFCSH
MEIGNSFWEYEDNCILNNGIEIDILYRDMEDFMKGIQRVVVECQPSNSYTTCMWHNLITC
KILYDKNGKLEKYKNKYSIPYPKQLKENIIKRQLELIDSSMPAYPKQIKKAILRKDFVSI
NHRITEFLASYFDLLFAINEITHPGEKRLVQLCKKQCKILPKNFEENLNLLFSYMYLEEK
NIFFMETLEQIVDNIKKII
>SEQF2502_02106 Gamma-glutamyl-gamma-aminobutyrate hydrolase PuuD
MKKPIIGISSNILGLEKGLFAGYKRSYVDVSYINAVINAGGVPHILPLNEHEDIIEEFVK
SVDGIILTGGNDVFPLLYGEEPKEKLGEIFPERDKFDSLLIRYAITYEKPIFGICRGMQI
INVECGGSLYQDLSYDENVKIKHFQKARAHTPTHSISVATNCFLSDIYPEGIGFINSYHH
QTINQLAPGFSTIAKSTDGVIEAIENISNKTFIIGVQWHPEMMAINDELAQKLFKKFVNE
VSLRKKD
>SEQF2502_02107 Glutamate synthase [NADPH] small chain
MGKLGGFLEIHREEKKIREISDRIKDFNEIDVPLNDEYIKTQAARCMDCGVPFCHWACPV
DNHCPEWQDLVYNGEWKKALDLLLSTNPFPEFTGRICPALCEGSCTLGKNDKPVTTKNIE
LALIEKGWENGWVKPKTPKKRFDKKIAVIGSGPSGLAAAQTLNRFGYNVTVYEKSERAGG
LLALGIPDFKLDKKIIDRRVKLMEEEGVKFIYNTEAGKDISNEELEKEFDIILMSCGSKQ
ARDLNIKGREAKGVYLAMDFLTQQNRKVNNIPLYNEEIDVKDKNVLVIGGGDTGSDCVGT
SVRQGAASVKQIEILNKPSETRTSKNPWPQFPMYLKTSTSHKEATEVYGNDPREWNVTTK
EFVKDENGNLCGVKIAKVESFVNEDGRLGFREVEGSEEIIKVDFVFLAIGFLHPYFEGLL
ENSKVKLDGRGNVSANVIDFKTSAPKYFAAGDVRRGQSLVVWAISEGRNAAKAIHEYLRK
NRN
>SEQF2502_02108 Ferredoxin-dependent glutamate synthase 1
MDNNIQNVKSQKYELSKNSLYEPYFEKDNCGMGFIANIDNKKTNQIVKDGIRILAGLEHR
GAEGYDSDTGDGAGLLFEVPHEFFAEIIPNLPEFGDYGVGNIFFPTVKEEFEKIKAIIEE
TVKNSKDEILTWREVPIKKDAVGVQAQSTMPSVWQLFIKRVNSSKEDFEKNLYILRRKIE
NAVKKANCDTEDKFYITKLSSKSIIYKGLVKPDQIENFYIDLQSDKLVSSYCLVHQRFST
NTFPAWKLAHPFRFLAHNGEINTVKGNVNWMKAREIALSSPNYEDIKELFPVNDEEWSDS
ANLDAVIELLVFSGKTLMEAISILVPAAWEKDHTKSEDLKAFYDYYSGLMEPWDGPAAMI
MTDSRYLVAKLDRNGLRPLRYILTDDNQMLVGSEVGTLPIKPENIVQSGRVKPGKVFVID
LEEKKLYNDDEVNEKVLNGTDFKKLIKDKKNVNDLMKEANFDYNRNSDLDDIYNKLRLFS
YSREDLHILISRMAITGQEPLGSMGNDAALSIFSKKPKLLYSYFKQLFAQVTNPPIDPIR
ENFVMSLRTQLYRKANILEEVPEAGKTVVLDSPIMDNKTMEFLKNYERDGKKPAILDITF
KPTENLEERLDKIFKLAEDAIDSGIKSIILSDRNADTENVAIPALLAVAGLHHYLIRNKK
RNEIDILVETGEAREIMHFALLIGYGATAINPYLALDSIEYMVKNKLYLNADESEIKDLQ
YNYLKAQKKSILKTMSKMGISTVDSYRGAQIFEAVGLSTELVKKYFTGTVSRIEGLTIKT
LEDEVLNNFDDAIDSINLGAETLYVDGEYSWMKEGTNRILTPDAISKVQDAANRDDYNTY
KEFAKIVNDQSQHLLTIRGMLKFHSDRKPVSIDKVEPVEAIMKRFVTGAMSFGSISKEAH
EAIARALNTIGGRSNCGEGGEDPKRFLDNRRSATKQIASGRFGVTTDYLVNADELQIKMA
QGAKPGEGGQLPGFKVNKEIGATRHTTPGISLISPPPHHDIYSIEDLAQLIFDLKNVNEK
ARISVKLVSEAGVGVVASGVAKAKSEMILISGHDGGTGASPLSSIKHAGLPWELGLSEAH
QILKEHKLRSRVTLQVDGKLKTGRDLVIGAILGAEEFGFATMPLVILGCIMMRKCHTNMC
PVGVATQSEELRKKFTGQYENIIRYFRFISQEAREIMAELGVTKLDELIGKADEFLEVSK
TSKLEKVKNVDLGKILYTNKNSDSPNVKTQNQDFKMENIIDRKLIKLASATFESDKNNVA
KTVINEKIENFDRSFGAMLSGEIARTFGGYKLEDDTITLNLEGIGGQSFGVFGAKGITYN
LTGQSNDYIGKGLFGAKIIIKKPEVSKYEADENIIGGNAILYGAIRGEAYLNGVAGERFC
VRNSGAVAVVEGVGDHGCEYMTGGRAIVLGETGKNFAAGMSGGIAYVYDKNNTFEKNLNK
EMVDFDELNEVYENEIKTYVEKHFNYTGSAVAKEILNNWEAEKQNFKVVIAPEFKEIFER
GEA
>SEQF2502_02109 Glutamine synthetase
MENAMKSFGENVFRDSNLKKRVSKEVFKEFKASQLGKTELSKETAEVIANAIKDWATKRG
ATHYCHWFQPLTDLTAEKHDSFLEPTESEELIYKFSGSNLIKGEPDASSFPNGGLRSTFE
ARGYTIWDTSSYPFIRENKNGVTLYIPTAFISFTGEALDKKVPLLRTMKYISEQSLRVLR
ALGNTTSKHVFNTLGVEQEYFLVKKEMFEARDDLLLTGRTLFGAPAPKGQELSDHYFGKI
KDKVINFMSDVDVELWKLGIPSKTRHNEVAPNQFEVAPLFSVANLASDQNQIIMETIEKT
ALKHDLVALLHEKPFDGVNGSGKHNNWSLGTDDGENLFSPGKEPKTNKKFLIFVSAVIEA
VDRYYPMLRYSTATATNDHRLGGHEAPPAIISIFLGEELTTILDNIANKKDAPVSEASEV
NLSVDVLPTFSMDAGDRNRTSPFAFTGNKFEFRMPGSSSTPATTAAVINAAVGKVLSEYA
DKLEKATEKTLPKVINEIIANAYKKHHRIIFNGNGYSEEWVKEAKRRGLTNEVSANTALR
KMLDPEILELVNEIGMLSEQESAARYNAYAERYVKQLSIESRTLIDIVNKNILPSALKFA
NLLADHIEKNSKYGKAFIKEQEELLKDVLSNVTALRKETKSLEKEIARVSNEEDLSKQTD
LAKEKLISGLEALRVPCDNLEKVIEKDLWKFPTYTDLLFKL
>SEQF2502_02110 hypothetical protein
MTNNLRKISKDLRAFAKRTKDFKYTDSALIIFLMTGMVSITTNLFPATTTTSKSIEAQKQ
EISSSIKGLHQKVKETRRENEKLLKDTNLELVKLMEQGDHVVKAPWSSWQFGMNYFYNDW
HGTYKGRGDKKEKYPYEGVFQRSSDVYERTVSPDSDKYGLLSRNRKPNSASGSAAGYGVA
SFKPVKEPIVPFEVNAGIRPRSINKSAIRIADKTAVTPTLPEAISFTPPKPVISIPKDPF
TPNPPTFAVILGADCNSNCNSYDWRNGGGITPRQRTKNGFLPNALSNQNTTAWLHYTWRD
GSHTPAEQSYAFKMYAEETTSDINSPQGTLVAGNTTPGGNTYYFNSYNFGNEFDDPISDP
QDITPTLNKNKQYFFIGGSRFWEIDNLSSGNRVFPNGKTLNLGGILTLGLVSQQNGVTLK
NEGTITDIKEREEKYIQDMPYDTTGAGAGKYKTIYGPASSVYHVKRSDDGYVGYKVGIAQ
VYENAEGYDQKNQILENAGKIDFRGERSIGMYTYIPNDQSYVIMKNDSNGTISMSGKESY
GMKFAAKKSSNDRPSMINAGTIELRKNPDGNDKADNSAAMALMEDTSVLNHVSMARGKAI
NESTGIIKLENVQNSLGMFVNIDSDMTNKNKIQIDSDIDEVDTDQPMNVAMRADYGTGHG
GSTAVGSNAEVINDTTGEISLKGKFAIGQLARLSTATNRTGGKIITASDVKNSIGMSTLG
GVLNNDGTITVTGSGVTKNIGVFLNKYELSGTIYNPKGTLGSNSNITVSGDRSTGILING
SSTGTPASLKYGGNVSVTGNGVSGIIVGDNDTGKAEVTVENDGTVTVNNGTSTSAGVYEY
MEGANKKKQGSYGIIVSKDSKLVSDGTHKINADINVKGQESVGLYTGENAKLDVNNHTVK
AYEGAVNYDAEKGSTLTLTGTGTATTGQKSLLFYTGSDNANQGKVLINGTMTATIEGGTT
PNERGNAFLYVGNGGDFGKSQIENWAKSNFGNGTSTTLGNLTLNMNSGSRLFIAQNVKMN
LSDTTGNTVSTATGAHINGTDYKTFMLYLSKLTINQDVNLDDANDAYNQLEISNSSITNA
NTKTITGTKADQVAMAQENDKVLYHRNDVVLSNEGTISLSGTGSTGMYAKFGELYNKATG
VMTIGDKSTAIYGIDDSLIENAGKITIGSNSTGLYSEGTKTQTIKNTGTIETTGNDSVAI
SYKPDAGLGSGIVLENAGKITMTGDRNTAIYATGTPGYTAKNSGTITLGDSASITSPNVG
LYTDHNSVTLQNTGKIESGKNTIGVYGHNVENSGDLKIGNAAVGIYSQSGNVNLTGGTIT
TGTDEAVGVYTVGSGQTVTNSGTAFNIGNNSFGFVNVGKGNTITSSISNVGLGNNNVYLY
SNDTAGTVTNSTKITSTGEQNYGIYSAGTVTNNGNIDLSSGKGSVAIYSIKGGTATNNAT
ITVGASDVANSLYSIGMGAGYSTTDTGNIVNKGTINVNGKHSIGMYASGAGSTATNDGNI
VLNASNTTGIYADNGATAINNKSITTGSGTYTNTVGVYLGKDSKLINSKGATININAKNG
VGVYLKGGTVANYGTITVNGVSKTNNNDVDGNMIYKFTVPETGKGVGGVAINAPAGAQTA
TITANGVPQTPVVVNTTGRNPISVSASSIGLYVNTSGVDYTKSIDGLQNLTSEADLIIGN
EAAESTNSKYILVNDPNIINPYKTAMLSNPNIKWNVYSGSIGWIATPTLDPNDGSITSLY
MAKVPYTEWAGRESTPINSLDTYNFADGLEQRYGVEALGTRERQIFSKLNGIGNNEEVLL
YQAFDEMMGHQYGNTQMRINATGNILDKEFRYLKDNWRNPSKQNNKIKIFGARDEYNTDT
AGIIDYTSNAYGVAYVHEDEKIKMGNSQGWYAGAVTNRFKFKDIGHSREEQTQIKAGIFK
TMSPKKDYNGSLQWTIGGDIFAGVNNMKRKYLVVDDIFQAKSNYHSYGAALKTDLGYDIR
MSERTHLRPYGALKMEYGRFNKIKEDSGEMRLEVKGNDYFSVKPEVGLEFKYVQPLAVRT
NLSVGLTAAYTDELGKVGNVNNEGRVRYTNADWFGIRGEKEDRRGSGKFDLNIGVDNTRF
GVTVNGGYDTKGNNVRGGIGFRAIY
>SEQF2502_02111 Phosphoglucosamine mutase
MARKYFGTDGMRGEANKDLTIDLVTSLGLALGYYLKKHRKKAGKPKVILGTDTRISGYMI
RSALTAGLNSMGVNIDFVGVLPTPGVCYLTRKLKADAGIMISASHNPVKDNGIKIFSQNG
YKLPDAVEEKLEELMGKKDELLQKHQVAGDDLGTFKYVEDDMKIYLDYLTSTVKNTNFSK
LRIVIDTANGAAYRVASKVFQNLGADVIVINNIPNGKNINVNCGSTHPELLQEVVKVYKA
DLGLAYDGDADRLIAVDNTGAIINGDLIIAIIAEYMQSRGLLNDNKVVTTVLSNMGFEKY
LDEKGIGLIRANVGDRYVLEKMKEYGLNIGGEQSGHILMLDYNTTGDGVLSSIQLVAAIL
ESGRTLHELVKDIKLWPQNSKNITVAKEKKATWESNKDLIDFIKAKEKEIAGKGRILVRA
SGTESLIRVMVEAESQEIVDKYVEELSKKVEETLC
>SEQF2502_02112 Signal transduction histidine-protein kinase ArlS
MKNLKLEDRISANYALLFLVLILVSNIILVYSLQRQSNKVLENSAEEKLEEINSFLDKVG
VFSDKTNVLTLDFNPEIQEGKKVIHVKPFNPGEDNYLYVLEIKQNKDSVIPINTIGDTDT
EEASMTNEKMVELLESFNLKSNVSDGKLINIEKNKYFVFKVSREIKNYKFNIYTLKNVTN
ENKIYKRLEYLVILFTIIGVVITIIVSKIMSRRILKPINNVIKTAKSISTDDLSKRIEIP
KEEDELQDLTLIINEMLDRLETSFENQKKFVSDASHELRTPLAIIKGYAEIIRKRGTTDI
DIFVESIDSIISETDNMRNLIQKLLFLAKGEITKINTKFTEIDANEMVRQIHSDTVVSTK
THKFHLEMGEDYKIKGDETLLQQAIRALIENATKYSEPNTNIYIKSFIKNGFGRISIRDE
GVGISDEDAKRIFDRFYRVDLSRTKATGGTGLGLAIVKRIVEIHNGKIEIDSKMNEGTEI
SIVLPIGDSVISSQEEINKNTNKEKTEKKKNIFGFLKKKNKKK
>SEQF2502_02113 Response regulator MprA
MREKILVIEDDPKISRLLEIELKFEGFDVFFAYDGKEGLNMAKYGSYDIILLDVMLPKMS
GMEVCKRIRETSQVPIIMLTAKDEISDKVVGFDYGADDYMTKPFSNEELLARIKALLRRT
KKSVVHKGIFEFEDLTINYSTYEVFRNYGKDLIQLSKREFELLDFLVLNKGIVLSRDKIL
EEVWGFDYIGNDNILDLYIKYLRDKIDKPYERRFIQTVRGIGFIFK
>SEQF2502_02114 putative protease YdcP
METKKRVELLAPAGNMEKLKTAFHFGADACFVGGSAFNLRGMSSNFKNKELKEAVDYVHS
LGKKIYVTLNIFAHNAEIEYMPRFIKKLDEFGVDAVIVADLGVFQMVREHAPNMKIHVST
QANNTNWMSVKTWKDLGAKRVILAREMSLKEIKTIREKVPDVEIEVFIHGAMCMAYSGRC
LLSNYFTNRDANRGICAQDCRWNYKVIAEGHEETGAHDIVENEEGTYMFNAKDLCSIEFI
DKIIETGVDSLKIEGRMKSIYYNSTVVKQYKRALDNYYSGNYKYDPDWLAELKTISHRQY
SNGFYLGPTSEKDQNYETGLSYSQTYRLVANVLEKVDTNKYKIQIRNKVFATETLELVRP
IGDAVKFKVENFLNTKNDEYQEYVNPNTIAIIETDVEMGPMDLIRIKLPEGQSDSDMDTS
EF
>SEQF2502_02115 Replicative DNA helicase
MGLYDEDVKNSEPYSIEAEEALLGSIFINPNVMGDVVDIVTAEDFYKNNYKIIFSEMTNA
YNSGKIIDVLLIIEALKKKELMDEVGNEDVIYDLTEVVPTAANATNYAQIIKDKSVQRQL
IAIGEKIVRMATRGYEETDAMLDKSESMIFKIAESKQKKEIVKLSELVQSKVKHLDDGSK
IIGKITGISSGFDRYDSITSGFHGSDLIILAARPAMGKTAFALNLAINVAKQGKGVLIYS
LEMGNEQLFDRLVASESKIRLKGIKDGTLTAEELVALGNGLGRLSEMPIYISDSASVTML
EIKANARRLKAEGKLDFMLIDYLQLISPSANSRKSREQEISEISRSLKILAKELNIPIVT
LSQLSRGVEQRVDKRPILSDLRESGAIEQDADMVMFLYREKYYNKDTATEVNNVDIPEKY
VKKPQNLPENEEKQGMEKVELIIGKHRSGPTGTIELGFFPNYQQFVNVVDDKFAPPAE
>SEQF2502_02116 50S ribosomal protein L9
MKIKVILKENIKGVGKKDEIVEVKDGYANNFLLNKNKAILATPENINKLKARNEKIQKNH
DRDVKNAKELKETLASKEIVLKVKAGENNKVFGSIGAKEIVQAIKEQLNIDIDKKKISAD
SKVKEIGVHNVELKLHSEVRANLKVRVEAE
>SEQF2502_02117 DNA polymerase III subunit tau
MLDNITLYRKYRPQNFDEIAGQEFVLRAIKNSLRENKLSHAYLFTGPRGVGKTTIARLIA
KGVNCLNSENVTDNPCGKCENCREISSGISMDMIEIDAASNRGIDEIRELKEKINYQPVK
GRKKIYIIDEVHMLTKEAFNALLKTLEEPPAHVIFILATTEIDKIPDTVISRCQRYDFLP
IDKKDIKKLLQNVAEKENIKIDDASLDLIYRKSEGSARDSFSIFEQVVSNFNNEEINLEK
TQKALGVVPDVILEEFLNLIKKSDKGKLVDFIDKIWEDGLVIETFLKDFSYYLKEQFKKQ
TDLSVDFLLDTISAIFFTLNEFKYEEDKRLLGYVLVYELYKNQKKNLNRIKTLETDNFAS
NKTAIDKNYIKDVSDHIYEKVMSQISENPKIVNSANETKIAELREIKKVEKIEKSVKNYD
ISVFSEKWRRILSGIKEESVMLGALSVESKPDRVEDGVLFIRFPSNQKFHSEQLMIPEKK
VKVEKVINQICNSDIEIKTFFENNDAQNGEDKFLKDAVKFFDGEILEKK
>SEQF2502_02118 hypothetical protein
MDNNRVSEQKSIAGLRANAAAFLVNLSFFTIIGGLIVPIFALILEDKNSFVRSYAKQTLT
ISVLLIVSGVLNFVIIVGNILYLVIFVILVILQIVATVSSILEKEFRIPYVEKIMSLLFL
N
>SEQF2502_02119 Ornithine carbamoyltransferase
MLKGKSFLKLLDFTTEELQYLLDLAKKLKIDKKNGTEKKTMIGKNIALIFEKTSTRTRCA
FEVGAYDQGANVTYIGPSASQIGDKESMEDTAKVLGRFYDGIEYRGYGQELVETLVEHSG
VPVWNGLTTEFHPTQILADFLTITEKKGKLKGIKFAFLGDGKNNMANSLMIGAAKFGMDF
RIVCPKEYFPEEKLVEEAKKISKKTGGKILLTEDRIEGVKDADVVYTDVWVSMGEPKEIW
KERIDKLLPYQVNADLVKYCANDYLFMHCLPAFHDLNTKVAKNIEKEYGLKEMEVTDEVF
RSKNSVVFDEAENRMHTIKAVMVATLGDREYPM
>SEQF2502_02120 hypothetical protein
MKTFRKISILFLLVSLMNFGASNIEGKIAQIRKDFASTNAVKNYVIKEVEDLEQSTDGGV
VKYYFQNGIVKKIVAEHFGESWNSLTEYYVKNGKVYFIFEKTEKYNVPYYVDSKWYKENE
LKNGEIFDKRKSKFSEKRYYFDENEKLIRYVGENKKIVENGQKLKEIEKDILNEYYRIKN
>SEQF2502_02121 Acetylornithine aminotransferase
MLLNVYSRYNKIFEKGKGTYIYDNEGNEYLDFVSGISVNCLGHASPVITKALTEQSQKLV
HISNLYYSQPQLDLANKLTENSEMESVFFTNSGTEAIELALKIARKYGNNLSYDENGNKI
ADKTEIIYMKNSFHGRSTGALAVTGQPKYQKPFEPLMKNVTECNFNDVKDLKAKVSEKTA
AIILEPIQGESGLESATPEFMEAIKELSKKYDTLVIFDEIQCGMGRTGKLFAYENFNLVP
DIVTIAKSLGGGVPIGACLTKGKANDVLVPGDHGSTYGGNPLVCAVANAVLHELIDNKLI
EKNVVEKGQYSVEKLEKLKEKFDFIEEIRGKGLLLGIKFDEKKVLAKDVVLKTLENGLLL
VGAGNNVVRFFPPFNVTDGEIDKAISILEKVLKTF
>SEQF2502_02122 Acetylglutamate kinase
MISNLDKAKILVKALPFIKKYHNKTIVIKYGGSAMVNPVAREQFIQDVVLMKYVGINPVI
VHGGGPEINEMLNKIGKESKFVAGNRVTDEETMEIVEMVLSGKVNKGIVSDINKYGGKAV
GLSGKDGNMVFVEKKFVEVDGEKVDIGFVGEIKEINTEVIKLLESNDTIPVISSIGVDKN
GQTYNINADYVAGAIAGKLQADRLIFLTDVDGILLDYNNKQTLIDEIDVEKVNDLIERGI
ISGGMLPKVTTCLNAIENGVENVVILNGKLEHSVILELFTVEGAGTLIKKDANLED
>SEQF2502_02123 Arginine biosynthesis bifunctional protein ArgJ
MKIIENGTITDVKGIKATGISAKLKKSEKKDMALIYSEEKAVSAAVFTKNLAKAAPIILD
IKHIKNENTQAIVVNSGNANSCTGDTGLANAKKMTELVANKLGLKAEEVLVQSTGIIGVQ
LDMEKIENGIEKVVENLSENGGIDAATAIMTTDTFVKQICLEIEIAGKKAKVAGMCKGSG
MIHPNMATMLSFTVTDVNIEKSLLQKMFSEIADNTFNMISIDGDTSTNDMACVLANGLAG
NEKIVDENSVGYDEFKKALYKVNEELAKLIAKDGEGATKLIQVTTNGAKTLEDAKKVSKS
VITSSLFKAAVFGGDPNWGRILCAVGYSEADLMIDKVNIFLKTGNDIVQVAKNGMAQDFD
VPKAEKILKAETVEIIIELNDGQFEATAWGCDLSYDYVKINAEYHT
>SEQF2502_02124 N-acetyl-gamma-glutamyl-phosphate reductase
MIKAGIIGATGYAGQQLVWILNNHKEVELEFISSHSNTGEDMGNVYTNYKKYFEKKLISL
EEAKENFKNIDVLFLALPHGLSEKLTKKALENNVKVIDLGADFRLDDSEIYEKWYKVKHN
YPEINKNAVYGLPEFYKEKIKNTKVVASPGCYPTSAILGVAPLLKNGLVDTKKIIVDSKS
GVSGAGRSAKLDLIYAEVNENFKAYNVLKHRHTPEIKQEMDKLANGNINLVFTPHLLPIN
RGILSTIYLDVKDEFKESLTEEKIYEIYNEFYKNEYFVRVTKDLPEIKNVKNSNICEIGV
RYDEEFGNIVVVSAIDNLIKGAGGQAVQSMNILFGFEENEGLEFLSMYL
>SEQF2502_02125 hypothetical protein
MKFLLYNIRYGTGKYLNQPFKHIRGYLGRSVKHIYRIGKFINRYKPDIVGLVEVDLGSFR
MYSRNQATLLGRITRNNNVYQYKYEEDSNYMKFPMVRKQGNALLSKSSIIREEFHYLDIG
MKKLIIEVETKDVIVFLVHLALGGKTRQKQIVQLYNLVKNCKKPVIVAGDFNVFWGEEEI
EMFLKASNLKNINTRKDPTFPSWNPKRELDFILCSEEIKINNYKVIQTQLSDHLPILIDF
DIVHVHS
>SEQF2502_02126 Putative O-methyltransferase/MSMEI_4947
MIENFIESSKYTQNLFKIQNEIVQNIKNESLAGNVPIITDEVLNYMIFTARNMKAGNILE
IGTATGYSGLFLARVANENGGFLTTMEIDEKRYGKAVENFKKLGLFEKNRMILGDALEEI
PRLDKDIKYDFIFIDASKGQYLKFFEMSYELLNGNGIIFIDNLMFRGFVAVKKEEIPKRY
KTIVKRLKEFIEKLNKEYNFVLLPFGDGVGIVKK
>SEQF2502_02127 Putative type II secretion system protein F
MVGIIKSKESELSEKDLLSFTKSVYYLLNGKISLIDTLGIVSQNYDGDLRSKIIRTKQQI
ERGVSLHRAFSKITANREFMEMVKIGEETGNLEIVFKNLYEKYEFNQKIKKDIKNLSIYP
VTVIITALVIVFILLKFVVPKFVLIYSDIGQELPKVTKIVINFSKIVDKYGIIFLIIIVF
LSFCFKKWKRQNEKTFEKKILGIKIIGKMYKNICILNFTRNMYSLTDANVPLIQSLKMCT
NSKSYVLNEELKKIILKIEKGESIQKSFKNTTFFDNEYRSFLTIGEKTGEMKISFFNLNE
IYYEKVSEKIKWFLKMFEPLSIIFIGVIIGLIVFSVMLPIFKMGEML
>SEQF2502_02128 Putative fructokinase
MAVIAAVEAGGTKFICGLGTEDGEIIDRVSIPTTTPEETMAQVIEYFKDKKFDVMGVGSF
GPIDPVKGSKTYGYITKTPKPYWSDYNLIGELKKYYDVPMEFDTDVNGAALAESWWGAGE
NLKNVMYITVGTGIGAGAVVDGKMLQGLTHPEMGHIFLKRHKDDKFEGRCPFHKDCMEGM
AAGPAIEDRWGKKGFDLADRDEVWDMEAYYLAQAVVNYILILSPQKIIMGGGVMKQQQLF
PLIRKYVLEFLNGYVQKEEILEKIDEYVVYPGLGDEAGFIGAIALGKIALENSRK
>SEQF2502_02129 Bifunctional protein HldE
MVSIQRIEEIIKKFNSVRIAVIGDMMLDEYLIGKVNRISPEAPVPIVNIERERFVLGGAS
NVANNLTSLKGKVFVYGVIGDDANGEKFVRELEDKNINSDGIVKDETRPTIIKSRVLSQG
QQLLRLDWEKDTDILEDIQNQLLENFEKNIENIDAVLLSDYNKGLLTKHLAKNVIEIAKK
YSKRVMVDPKPQNFKNYVGATSMTPNRKEILDYFGMKKFTSEEQIAEKMAQLKDELKLDS
VVLTRSEEGVSLFKTKHKRIPTVAREVYDVTGAGDTFISTFLLSICAGADLYEAGVIANM
ASGIVVAKIGTATATQDEILEFYKDNDNILKKI
>SEQF2502_02130 Type II secretion system protein D
MKGKRRFRFMTVLVLFSYFSGNNIFGAKVADYVNKSDVESAKKIFIYEVPKKVQTDNKKK
TNDGNKAKNNSKQGSKNSQDGHKNNNSANKKEEDKNKGNSQNQSQNQVRQTVKEIKKKTG
EIDLEYRNGKDITEALNGFFGFEVIGIDNKIIFSGDENKIEEMKKIIKSLDKEKEQVIIK
GTIIDTSSNLFERLGIDWSINSDNAGANKDNLVAKFLNGEVSIASIFSKGGKFLGIDFNL
LKENGDIRIEAMPTLMIMENEEGELKVTEEVLVGEKKTTKNDTEYAEPIFSEAGIVFKIN
PEIRRINGVKKILLKIDTEISNFKLTSSYNASSGAKQKNQTKTTITLNNGGSTFIGGLKQ
DVSRETIRRVPILSKIPIIGPLFKYRRNNREVRDIYIEIEAIIQDKT
>SEQF2502_02131 hypothetical protein
MIKLNFKMIIFVVGIVFMLVSINKKYGKYKEILNNRKILIENKRNLENKIVNVVESKNAE
RSKIMGEYNEIMAITDKLSFLSIKNESEFKKMIYVFSHDSGLKMKEISKSENVWERNGYR
LKYIHFTVYGSLNNFGKFVYFVNKSRKYIDTSKMFMELTSDGFKISLGFIEKVENKGKIS
I
>SEQF2502_02132 hypothetical protein
MEEKIKIYIRSKNKIYIFFNDEIYFFENQELEMALESFFEENNIEKNVKLAVILHYSYFL
FDNFDRNMEETGKRENNIEDSEKKSLKFEDISEVFKKKINFVKRKMVINHLENQFLDIYL
DKREIVRIKNCLKKYSAVISELKIDFEAVYNYYKDGNFETNQNKNFENKENFQNVIGDVE
EIQEVEVFENRDVEEVQEIEILENRKINRNFGEIKEIDINEEFLENSNNLENENGKIEIL
QLGEENSLRILIEDEKIVEVEKIELKIEDVDDVENFDFGDMVVVGDEENDVKVIFAGEEL
SNSLDFIKRMAIFDKESVKNIKVLDVVIAGILIFAYFLIYNSIPLQKKTVENEVIQREIK
SLEKDYLKRKAEEIPDYSKELATLRDIDGGIKRREYYSVIKFLIENSKNGIDYTKINYEK
AKWIVQGEMENFNNFERLENNILRRYPNSELGYLKDNDTATVFEYVIEPFQN
>SEQF2502_02133 hypothetical protein
MISINNGFFYQEVKFTLSNNGIQYKLRFWVMKNKYFDEIRNKRLDREKSNLNNKGVKNKK
RNKGASLVYVLVILSIISAFSINFVYYVQQKKDMIFLKSHKETKIEKKFLIQKENQNIER
ILKNGINFDGNLVLLEKKERYFDSVLKKDGQNAELKNLIFLGKDIESIGNYRIKSISDES
DNEYSLPLEENKVYGELKVIFARKILDEEILFCEKIVFKRVSPLEVEMRVVESEFL
>SEQF2502_02134 hypothetical protein
MIGKIKSRKDGYLLVEILISMSIFSVLVFVISVFLKRIVIVEKAKKNNQKMYEKMYFSMD
KIVLDIKNRDIRKFSYEKENNDIFIRENLIVFKLNEIFYKIEYEKGKLFVSDAENLGKFG
SKVEIGKFDEAKFEKVGELLIIRLKENKNEDVRVVKI
>SEQF2502_02135 hypothetical protein
MVKNRGETLIESLISMFFVTVAIIPIANLFLKTFQTDVKVDDLNKKNVNIENMIEIIKAK
KYEEILNFNGKYEISEVDDFYNRFAVEKKYQILKNLEGRKDKKGKTQEEKINVEIKRTDE
YFINESGKKEYIFEIKVDKIKDYYFPDFDKNS
>SEQF2502_02136 hypothetical protein
MKFEIINSIIEVVKYCIFFRIIWVDIKKRIIPEESVVILIILGLIAAIQNDNLEKYYLGI
CAYSMPMIVLYILEDYFRKTLIGFGDVKLMMGIGGLLEYFGIEKILNFYMILYIFSGVIA
SLFLFLKKWKKYEYIPFAPFIVASYIIFEILINKSW
>SEQF2502_02137 Fimbrial protein
MNKDMKNVKNKIEKTKRKEEDKELRDREKGFTLVEVILVVAIITIISAIAVPQVGKYLNK
ANRSKVIGAVAELNNTTTSWSIDHGGNSPKNLQDILTEHGNLNKLGIGLDSSGKFKIGNI
EGNIVYQDGEVFAKVAAGSKAFAGEEIRK
>SEQF2502_02138 Malonyl CoA-acyl carrier protein transacylase
MSKIAFVFPGQGTQYAGMGKKLYDEVNDENKKLIDKIFENNEDVKKVIFEGTDEELKNTK
YAQPAIALFSVILTKLLKKKGMNADFVAGHSLGEYSSLYAAGVLNEIDTLKLISKRGEIM
SNANISGGMAAILGLSAADIENICNEIDGTVEAVNYNEPKQTVIAGEKEVIEKNLELFKA
KGARRALPLAVSGPFHSSLMKPVAETLKKEFENYTWSDPTTPIIANTTANILASAEEIKR
ELYNQTFGPVKWVDTINRLSENGVTKIYEIGPGKVLAGLIKKINKEIEVINIENVESL
>SEQF2502_02139 hypothetical protein
MNSKIFWGLVIVVLSLFKFIPEDIMKYIVNYQVVMILVGAYFLVKKKKHGWIFLGIGVYL
YITSYVWEGLPLFIVPLIFGLAVIGLGIKETVDKEKLTKFSNKNTKESKEEVVDAEEIKK
>SEQF2502_02140 3-oxoacyl-[acyl-carrier-protein] synthase 3
MKVGILGTGSYVPEKIMTNDDLAGIVDTNDEWITVRTGIKERRIADENEATSDLAFRAAE
KAIEDAGIDKNEIDLIIVATMTPDYGTPSTAALVQDKLGINAAAFDLGAACTGFVYAYSS
GHSFIAAGLYKKVLVIGAETMSRVVDWTDRGTCILFGDGAGAVVLGEVENGGYLASHLVA
DGSGASELLVPAGGTKEPISKEKIENKDIYLKMNGREIFKFAVRVFPETVENVLEQAGIT
ADDIDLFIPHQANIRIIESIAKRFKQPLDKFFVNLNKYGNTSAGSIPIALDEAIKEGKLK
KGDKFVATGFGGGLTYGSIMVEISK
>SEQF2502_02141 50S ribosomal protein L32
MAVPKKRTSKAKRNMRRSHDSIKAPNIVVEADGSIRRPHRLNLETGVYRGRQVIANEATE
AE
>SEQF2502_02142 hypothetical protein
MIEKIKHEKYKILKRNIIEDSDFTKETMFILICAMIIASIGLNTNSVAVIIGAMLISPLM
SPIQSIGLGLSNGNLKRVYVSLFRLGIFILISVISSTFYFLVSPINEATPQILARTSPTL
WDVLIAIFGGIAGVIGKAEEDGGNVVPGVAIATALMPPLCVVGFGIAHGNPKIFLGAGYL
FIINVFFIMMATLVGLIIYSGNIFEAGHKISIKKQIIFYIGSLIVIVPSIYTAATLVQDT
ATENSLKKFISKELNNHYVFDNSVNKKDKTVTLKIVGEAFKKQDIEKLEKKLEKYKLKNY
KLKIQQLSNEKYLTAQDLSKYLNEEKTKENTESIALPSKNEDQAILESDLKTVENVLYKN
FSNSISGVKIGKLIDANNNENFVVLVIGNETMTDEIAEKIKNLEFNTEKNYKIIIEKN
>SEQF2502_02143 Ferrous-iron efflux pump FieF
MKVVEWDRKENINKILIDILEIDPKFSFDKEKEDIYFLYNEEDLYGYAVLSLNDIAELKK
IFILPKLRNNGYGTFFLKHIINWLTNKNFGSLIITNHKKMNNFLEKHRFIRTQDGYILNN
LRERKKQEENMLFISKFAICVNIILAFLKIVAGKIFFSMSLLSDGLNSLSDLITNVLVIV
GLKVGSNPEDKEHPFGHGKIESVFSVIIGTFIMITAFELIKDNFSKLISLSSENNLNITV
IPIVVTILAILIKIFQLSFMKKRAKKYNNSLINSLLADYNTDIVISTSVLVGLFLSRIHP
VFDTIVGFIVSIYIIKSGYELIKENSLILLDSQDNELIEKIRSEILQFKEIENAHDFRMT
TSGKDIYVFADVRMDKNKTIEEAHEVTNRISKKIKHKYKNIKRVLIHIEPVYEDD
>SEQF2502_02147 ATP-dependent RNA helicase RhlB
MEGIFDRLRKLTALSIVNRGVEYFNKQKVKLMLFMKKDDKIVVESQVDGNYRNAYNVNIT
YFYEDGKPDNRIIYGCDCPNFKDTKKPCKHIIATGMAADVEVKAGNIYFKENREFKREKE
DKNSSNRIKISENEVYDEILREAEKILGKKEENTYEKIEEKEIKEFREKLEKLKKRIDKT
KIPDSEKNEYKLALEIEQLSSTLSTLRVKAGEKSLNYIKELEYFIYSVENEQFYEITQKN
IYNPNLHYFNEIDKKVIKNLGNYFKKKNEFGMNFNNNSYYYYGKPQGEIMNPMLAEQIFS
AIENKKTIRSGSKTIYVTGEYEPIFAFQEDKNGNKKIIIRNFTVLSSTSRYFTLKNGVSN
IEKFHKMSDAEWEIMNTLTDGTRKGTEYLNEISGKLFDEIKEVLSKYEIPIAKVTEKYGA
VNIFVEEGNGKNKLQVTISCIEESIRTDDEYFIPKKNKKLQREISEDFQKYASAQIIDLE
YKIYIGFREKQLKSDDIVLVIDRNEFSAMADIIDEKYSEKVNINVSDKIKKVRKIGVDIN
IRSVGNELFSVNFNIEGIDEKDVETVLESVRNEEKFVTLSSGELVKIANRSTEEMVGIVD
AMNDLKIGENKISKIKALQLAQVSSSINKELNEIEEFKQLFQKIKKRENKEPSNIKVKLF
PYQQIGFNWLKNMYDIGFGGILADDMGLGKTLQAISLISEIQLENEDLLGIIIVPTSLLH
NWKEEFYKFSDIKPILVEGNAETRKELIEKTERGILITTYQTFRNDVKNYNNKKFDVAIL
DEAQNIKNVSSLVKKATSKLKSTVNFALTGTPIENSIMELWSIFDFILPGYLDNITKFRK
KYKNSLNNPDSKKIFNLKNIVSPFILRRTKDEVLTELPEKVENNMIVELSKEQKKLYMAY
VKRAKKELRGFDKEENNNLKVLAILTKLRQICNSPQLFDENYTGEVAKIELLREMIPDIL
ENGHRMIIFSQFLGTLEEIKEELEKEKVEYFYIDGSVKSKERMEISKKFNSGEGQVVLIS
LKAGGTGLNLVGADVVIHYDPWWNFAVENQASDRAHRIGQKRSVQVIKLITEGTIEEKII
KIQENKRALSENILGKNNGNNNKDSKEIFEMDEKELMELLSFEK
>SEQF2502_02148 hypothetical protein
MKNKNLFLKIVLFMLVIAFGIVSCDLLANKTLRVPDSMITKELNKKFPIEKNFLLGKVGL
KSPVISFAGDRLYFSAEYDVSLLAGKAKGSIFLNSQVKFDPKTNKLYLVDLDVTKITDEK
GNKIDDSVMAKSLKALVSNYLETNEVYTYDDDKKVKVKNMFIKDGKLFVQT
>SEQF2502_02149 UvrABC system protein A
MKDNKIKITGAREHNLQNIDIEIPKNELVVITGVSGSGKSSLAFDTIYSEGQRRYVESLS
AYARMFIGQMKKPELDSIEGLSPAISIEQKSVSKNPRSTVGTTTEIYDYMRLLWAHIGEA
HCPICHRKVEKQSIQEIVDNLMSSRKEKDKMIILSPVVIDKKGTHKNLFLNLQKRGFQRV
RVNGDILDLSDEIVLDKNKRHHIEVVVDRVVFKADNKEFLSRLTEAIETASELSDGKIIV
NINGEDNKFSENFSCPEHPDVMFPDVVPRLFSFNAPYGACEVCNGLGSRLEVDENKLIVD
ENLSINEGGIIFPGATTKKGWNWDLFIAMAKAHKIDLDKKVSELTRKEKDIIFYGSNKKF
KFSWSGDSFSYNGNRDFEGIVNGIERRYRETASESAKEEMEAKYMTERTCKTCHGKRLKD
VVLAITVNDKSIIDLTEVSVVDALDFYEKIQLTEKQMQIAAEILKEIKERLKFMINVGLD
YLSLARMTKTLSGGESQRIRLATQIGSRLTGVIYVLDEPSIGLHQRDNDKLLATLKDLRD
IGNSLIVVEHDEDTMREADYLIDIGPGAGINGGKVVAQGTPKQVMRNKKSLTAQYLNGKI
KIEVPEKRRKATKEIVLKNAKGNNLKNVTAHIPLEVLTVVTGVSGSGKSTLINQTLFPEL
HNRLNKGKLYPLENGGIDGLENLEKVIDIDQSPIGRTPRSNTATYTKIFDDIRDLFSQTN
DAKVRGYSKGRFSFNVKGGRCEACSGAGINKIEMNFLPDVYVECEVCKGKRYNRETLEVQ
YKGKSIADVLEMTVEEAYEFFKNIPSLERKLQTLMDVGMNYIQLGQPATTLSGGEAQRIK
LATELSKMSRGKTIYILDEPTTGLHFEDIRKLLEVLNRLVDKGNTVLVIEHNLDVIKVAD
HIIDIGPEGGYKGGQIIAEGTPEEIAKNKKSWTGKFLKKYLKKDY
>SEQF2502_02150 hypothetical protein
MRKIIFIFVVFSLVSFSKDLEIKTVKFFSACGENDNEHLKILENEQGKMNEIYNKLIQKF
NKNGRHHSKLKQKLINSQEIWIKYSDEEMRNYGMYRNWYNLCVREKSETREQINLIQQRI
LELTNEYKKYLD
>SEQF2502_02151 Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE
MIKSYQEINAETIDRWVEEGWEWGQPISHETYLNAKNGNWNVLLTPTNPVPHEWFGNIKD
KKILGLASGGGQQMPIFSALGANCTVLDYSDKQLEAEKMVAEREKYEIEIIKADMTKKLP
FADNSFDIIFHPVSNCYIEKVEPVFKECYRILKKGGILLCGLDIGTNYTVDEKEEKIINS
LPFNPLVNEEQRTQLEEQDCGIQFSHTISEQIGGQLKAGFRLTDIYDDTNGFGRLHELNI
ASFVATRAIKE
>SEQF2502_02152 hypothetical protein
MIIKQIFDLIQQTIVIAPPILITAVGACISEKSGVINIGLEGIMLSSAFATAVVNIATGN
PYLGIIFGVIVGILISLIHAVISINLKGNQIISGVAINLFAAATTSYLIKAIYKTAGNTP
LAKSLANRPLMIIVIYGIAIAMYFFLYKTVLGLRIRSVGEHPLAADTVGISVYKTRYISV
LISGALGGLGGAYLTAVLLPAFSNNMSAGRGYIAMAAMIFGKWNPLGAILASLLFAFGQA
FADVSKTIGLPISQQFLTMIPYILTLLALVGFVGKSKAPKASGLPYEK
>SEQF2502_02153 hypothetical protein
MIKNKIKDFLPSIIAVLIALIIGGIIMITKGVNPFTAYIDMMRAAFYQPYPRSPLFSGLA
NTLFIATPLIFSALATMVAFKAGLFNIGMQGQMIAGGLAATFWAITFKNYVFGNVLVVII
VAVIAGFLWAGIAGFLRAKFGVSEVISTIMLNYIMLELQNFLLNGPLKDPASQNTQSPRV
FEGARLPLLFANVTRQNLNFGFIIAILLTIGIFFFFKYFKKGYEIKAVGQSDTVAENAGI
NPKYIMFLAMGIAGACAGLGGAERVLGGASEYSYTELIMGDYGFTGLAVALLGKNNPFGI
LVAAIFYAALEVGGQMLQQRYQIDKEIVFIIQALIIIFVASENLFKFMLNKKKAA
>SEQF2502_02154 Ribose import ATP-binding protein RbsA
MSEYILEMKNIRKEFLGGKIVANDDITLKVKKGEIHAIVGENGAGKSTLMKILNGLYSPT
SGEIFYKGEKIDIDSPTTAANLGIGMVYQHFMLIDTLTVAENMVLGFEPKKGGVFFDLNT
ARKQVREVSEKYGLNIDPDAKVSDLSVGIHQRIEILKILFKGAELLVFDEPSAVLTPQEV
KELYEIMRNLIKEGKTIIFISHKLQEVLDLSDNITVIRRGSDVGELKTKEATKEKIANLM
VGRVVLFEVKRPDVKLGNVVVKVDNLTVKSGGIEKVKGVSFEIREGEVLGIAGVQGNGQT
ELIEALAGLAKVDSGTYFIDNDELENKTPKLIKEKGLSHIPEDRHKRATIDDFTMEENMA
LGLQDQYSKGALLDYSEIEKKTNEYIEKYDIRPTDGKIKFGGLSGGNQQKVVVARELERE
NKFIIAAQPTRGVDIGAIEMIHNTILNEKTQKKAIMLVSAELSEIMALSDRIAVMYSGKI
VGILDRKDATTEKLGILMAGGEIND
>SEQF2502_02155 hypothetical protein
MKKLIMLILLGCSMTSFALFDKIKKEIKWREEEKPRFNQVKVTIDGKEKMRKVIPGRYEI
KLFEITYPTDLFGKNRFYNEFNAFLKNIKKGKKYSLLLEDRFYQEMQDIKVDQLSEEEKI
LELPASSLDEYYRQQIIAMSKEVNLTEYVGTDQEYLNRQIYVLYELLNKTDFNPKNVYSE
LDKEFLIEELKNNRKEVVENFEKSNVEFFIKETYENSGLNKFKDDSVYKFDKDILISDKL
EDQAVLPELQRNVYLTGFPNEIIEELAKNQLKLKRTPLLLENSEYHGYTYNENNTVVFIG
GEKPKYYYNDYKINVVKKPIEVLNLLKTSSNYYVSDFF
>SEQF2502_02156 UvrABC system protein C
MEEERKLEKKIKLEKEIKSPIKYKDIPTNPGVYLMKNERGKIIYVGKAKNLQNRVKSYFT
NVNSHNQKTLELVKNIRDIEFFICKSEVEALILENNLIKKNKPKYNILLKDEKTYPYIKF
TKEKFPKVEIVRSTKKLNDNAEYFGPYPMGIFFAMKTLLKIFPMRDCNRNMEKITRPCLK
YYMKTCPAPCQYKNIEEEYSANVKNFKDFLKGRSDKVIEMLESRMKKFSDNMEFERAISE
REKLTVLKKMLEIQIIEYSKEIDEDVFVFEEKRENVFLCVLNIREGKVINKNHIIISMER
SQEESLFERLITSYYEKRNIPKHIICDERFLQSEHLIKEWAKIEKHKEIKIYFPKINSRR
LKLLEMGYLNLREEVDKYYRKRRLVQEGLRNLKKELRLKSLPYRIECFDISNIQGKDAVA
AMTVALDGETVPREYRHFKITVKDTPDDFLMMREALTRRYSKIENDKMPNLILIDGGKGQ
LGVAVNVLEKLGKIEYTDVIGIAKREEEIFKSYESEPYLFEKTDETLKILQRLRDEAHRF
GITHHRKLRSKRNVKSALDDIYGIGPKRKKELIKKFGLIKNIRNATLAELMEIVPENIAI
SIKENL
>SEQF2502_02157 hypothetical protein
MKKLQKSLSRKVKFSKNWYKQKAKISKLHEYIKNCRRDFLHKLSKKLSEVYNAVVVEDLN
MRGISQALNFGKSVGDNGWGIFLRMLEYKLMFLGKQFLKIDKWFPSSKTCSRCGNIKEKL
KLSERSYKCECCGIGIDRDYNAALNIKNIGKAMLEY
